Citrus Sinensis ID: 013816
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 436 | 2.2.26 [Sep-21-2011] | |||||||
| Q6NLQ6 | 538 | Calcium-dependent protein | yes | no | 0.928 | 0.752 | 0.822 | 0.0 | |
| Q38873 | 535 | Calcium-dependent protein | no | no | 0.931 | 0.758 | 0.786 | 0.0 | |
| Q42438 | 533 | Calcium-dependent protein | no | no | 0.931 | 0.761 | 0.788 | 0.0 | |
| P93759 | 530 | Calcium-dependent protein | no | no | 0.949 | 0.781 | 0.749 | 0.0 | |
| Q8W4I7 | 528 | Calcium-dependent protein | no | no | 0.967 | 0.799 | 0.656 | 1e-169 | |
| Q9SSF8 | 541 | Calcium-dependent protein | no | no | 0.917 | 0.739 | 0.680 | 1e-161 | |
| Q9M9V8 | 545 | Calcium-dependent protein | no | no | 0.915 | 0.732 | 0.674 | 1e-158 | |
| Q9SIQ7 | 582 | Calcium-dependent protein | no | no | 0.832 | 0.623 | 0.652 | 1e-147 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.830 | 0.685 | 0.608 | 1e-130 | |
| Q38870 | 646 | Calcium-dependent protein | no | no | 0.970 | 0.654 | 0.523 | 1e-130 |
| >sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 694 bits (1791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/411 (82%), Positives = 367/411 (89%), Gaps = 6/411 (1%)
Query: 1 MGNCCVTPAAAKQG--KKKTNKKKQNPFSIDYGTHHQGNGGH----KLCVLKEPTGREIE 54
MGNCC T + Q K K +KKQNPFSIDYG HH G G KL VL +PTGREIE
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+Y LGRELGRGEFG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQH 354
MLDPD KRRLTAQQVL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+VIA+H
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAEH 360
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
LS EE +GI+EGF +MD RGKINIDEL++GL KLGH IP D+QILMDA
Sbjct: 361 LSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDA 411
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/408 (78%), Positives = 363/408 (88%), Gaps = 2/408 (0%)
Query: 1 MGNCCVTPAAA-KQGKKKTNKKKQNPF-SIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC P++A Q K+ K K NPF S +Y T + G KL VLK+PTG +I +Y+
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRE+GRGEFGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVE 358
DPK+RLTA QVLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
E AGIKE F MMD+ RGKIN++EL+ GL K G QI DTD+QILM+A
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEAT 408
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/407 (78%), Positives = 358/407 (87%), Gaps = 1/407 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC +P + KK K K NPF + T + G KL VLK+PTG +I Y+LG
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFKLSVLKDPTGHDISLMYDLG 60
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+GRGEFGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 61 REVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIVS 120
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMHR
Sbjct: 121 LKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMHR 180
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD+
Sbjct: 181 DLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVDI 240
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PDP
Sbjct: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPDP 300
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
K+RL+A QVLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVEEV
Sbjct: 301 KKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEEV 360
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQILMDAV 406
AGIKE F MMD GKIN++EL+ GLHKLG QIPDTD+QILM+A
Sbjct: 361 AGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAA 407
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 314/419 (74%), Positives = 361/419 (86%), Gaps = 5/419 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC T + Q K+K K NPFS +YG HH G KL VLKEPTG EI+++Y+LG
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDG---LKLIVLKEPTGHEIKQKYKLG 57
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
+RRLTAQQVL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HLSVEE
Sbjct: 298 RRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVEET 357
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
+ IKE F +MD NRGKI I EL +GL KLG +P D+QILMDA V +LD+ F
Sbjct: 358 SCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDAGDVDKDGYLDVNEF 416
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 594 bits (1531), Expect = e-169, Method: Compositional matrix adjust.
Identities = 292/445 (65%), Positives = 346/445 (77%), Gaps = 23/445 (5%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHK---LCVLKEPTGREIEERY 57
MGNCC +PAA + K+N +S GG K + VL + IE+RY
Sbjct: 1 MGNCCRSPAAVAREDVKSN------YSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
L RELGRGEFG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSV 357
PDPKRRLTA+QVLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+VIA+ LS
Sbjct: 295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLST 354
Query: 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH--------- 408
EEV IK F+ MD N G ++I+EL+ GL Q+ +++VQ+L++AV
Sbjct: 355 EEVEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAVDTKGKGTLDYG 414
Query: 409 -----TLHLDLAFFREKVRLKISFF 428
+LHL E +R S+F
Sbjct: 415 EFVAVSLHLQKVANDEHLRKAFSYF 439
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1462), Expect = e-161, Method: Compositional matrix adjust.
Identities = 279/410 (68%), Positives = 332/410 (80%), Gaps = 10/410 (2%)
Query: 1 MGNC--CV--TPAAAK--QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE 54
MGNC CV P +K Q KK +++NP+ G L V+ +I
Sbjct: 1 MGNCIACVKFDPDNSKPNQKKKPPRGRQRNPYDDPDGLRTHA----PLRVIPMSHQSQIS 56
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+
Sbjct: 57 DKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPE 116
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK TYED+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH
Sbjct: 117 HPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHV 176
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
+GVMHRDLKPENFLFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 177 NGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNY 236
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVDVWSAGVILYILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++
Sbjct: 237 GPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQ 296
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQH 354
ML+PD +RLTAQQVL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+VIA+H
Sbjct: 297 MLEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEH 356
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
LS++EV I+ F +MD N GKI+ ELR GL K+G Q+ + ++++LM+
Sbjct: 357 LSIQEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLME 406
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1439), Expect = e-158, Method: Compositional matrix adjust.
Identities = 280/415 (67%), Positives = 332/415 (80%), Gaps = 16/415 (3%)
Query: 1 MGNC--CVTP-----AAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKE----PT 49
MGNC CV P + + KK +K NPF+ D+ + VLK+
Sbjct: 1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFT-----RSPAPIRVLKDVIPMSN 55
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+I ++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM
Sbjct: 56 QTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIM 115
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
LP+H N+V LK +YED+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV
Sbjct: 116 STLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVV 175
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
MCH +GVMHRDLKPENFLFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEV
Sbjct: 176 MMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEV 235
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
LKR+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK
Sbjct: 236 LKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAK 295
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALK 349
LV++MLDPDP +RLTAQQVL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+
Sbjct: 296 SLVKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLR 355
Query: 350 VIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
VIA+HLS++EV IK F +MD GKI EL+ GL K+G Q+ + ++++LM+
Sbjct: 356 VIAEHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLME 410
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1340), Expect = e-147, Method: Compositional matrix adjust.
Identities = 237/363 (65%), Positives = 299/363 (82%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
VL EP G I +Y+LG+ELGRGEFG+T+ C + + FACK ISK+KLRT +D+EDVR
Sbjct: 53 VLPEPIGDGIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVR 112
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV+IMR LPKH NIV K+ +ED AV+LVME+CEGGELFDRIV+RGHYTERAAA+V K
Sbjct: 113 REVEIMRCLPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAK 172
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
TI+EVV++CH+HGV+HRDLKPENFLF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPY
Sbjct: 173 TILEVVKVCHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPY 232
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
YMAPEVL+RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R +DF RDPWPK
Sbjct: 233 YMAPEVLRRNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPK 292
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
VS AK+LV+ MLD +P RLT Q+VLEHPW++NA++APNV+LG+ V+ +++QF +MN+
Sbjct: 293 VSHEAKELVKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRF 352
Query: 344 KKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
KK+ L+++A +L EE+A I + F MD G + +ELR GL K+G +PD DV++LM
Sbjct: 353 KKKVLRIVADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLM 412
Query: 404 DAV 406
DA
Sbjct: 413 DAA 415
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1196), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/363 (60%), Positives = 272/363 (74%), Gaps = 1/363 (0%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
VL P +++ Y LG+ELGRG+FG+T+LCT + G FACK+I+K+KL DIEDVR
Sbjct: 61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV IM HL NIV LK YED +VHLVMELC GGELFDRI+A+GHY+ERAAA++ +
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
TIV++V CH GV+HRDLKPENFL NK E +PLKA DFGLSVF+KPGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+R +DF DPWP
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
+S AKDLV+KML+ DPK+RLTA QVL HPW++ +AP+V L V +RLKQF MN
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359
Query: 344 KKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
KK AL+VIA LS EE+ G+KE F MD + G I ++ELR GL K G ++ + +VQ LM
Sbjct: 360 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLM 419
Query: 404 DAV 406
+A
Sbjct: 420 EAA 422
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-130, Method: Compositional matrix adjust.
Identities = 231/441 (52%), Positives = 300/441 (68%), Gaps = 18/441 (4%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
P + K +T + Q P + G VL+ T +E Y LGR+LG+G+
Sbjct: 141 PETTSETKPETKAEPQKP---KHMRRVSSAGLRTESVLQRKT-ENFKEFYSLGRKLGQGQ 196
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 197 FGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 256
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH GVMHRDLKPENF
Sbjct: 257 VVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENF 316
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 317 LFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIV 376
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPKRRLTA
Sbjct: 377 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAH 436
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
QVL HPW+Q AP+ L V +R+KQFS MNK KK AL+VIA+ LS EE+AG+K+ F
Sbjct: 437 QVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAESLSEEEIAGLKQMF 496
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--------------VSHTLHLD 413
M+D N G+I +EL+ GL ++G + ++++ LM A ++ TLHL+
Sbjct: 497 KMIDADNSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTIDYKEFIAATLHLN 556
Query: 414 LAFFREKVRLKISFFRWYEIG 434
+ + S+F E G
Sbjct: 557 KIEREDHLFAAFSYFDKDESG 577
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 436 | ||||||
| 337729587 | 530 | calcium-dependent protein kinase [Hevea | 0.951 | 0.783 | 0.868 | 0.0 | |
| 260408334 | 550 | calcium dependent protein kinase 32 [Gos | 0.956 | 0.758 | 0.857 | 0.0 | |
| 359481709 | 526 | PREDICTED: calcium-dependent protein kin | 0.947 | 0.785 | 0.854 | 0.0 | |
| 317106768 | 531 | JMS10C05.3 [Jatropha curcas] | 0.949 | 0.779 | 0.845 | 0.0 | |
| 343126682 | 534 | calcium-dependent protein kinase [Dimoca | 0.956 | 0.780 | 0.852 | 0.0 | |
| 356504799 | 534 | PREDICTED: calcium-dependent protein kin | 0.956 | 0.780 | 0.833 | 0.0 | |
| 224138018 | 532 | calcium dependent protein kinase 7 [Popu | 0.993 | 0.813 | 0.787 | 0.0 | |
| 255577483 | 529 | calcium-dependent protein kinase, putati | 0.947 | 0.780 | 0.842 | 0.0 | |
| 449466099 | 535 | PREDICTED: calcium-dependent protein kin | 0.928 | 0.757 | 0.850 | 0.0 | |
| 356572042 | 535 | PREDICTED: calcium-dependent protein kin | 0.956 | 0.779 | 0.824 | 0.0 |
| >gi|337729587|gb|AEI70328.1| calcium-dependent protein kinase [Hevea brasiliensis] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/419 (86%), Positives = 384/419 (91%), Gaps = 4/419 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP+ A + + K NKKKQNPF+IDYG H HKL VLK+PTGREIE+RYELG
Sbjct: 1 MGNCCVTPSTASKHEHKKNKKKQNPFAIDYG--HSNGVQHKLTVLKDPTGREIEQRYELG 58
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E D FACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 59 RELGRGEFGITYLCTDKETRDTFACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIVS 118
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 119 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 178
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 179 DLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVDV 238
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPDP
Sbjct: 239 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPDP 298
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
KRRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVEEV
Sbjct: 299 KRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEEV 358
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
AGIKEGF +MD N+GKINIDELR+GL KLGHQI DTD+QILM+A V HLD F
Sbjct: 359 AGIKEGFQLMDTSNKGKINIDELRIGLQKLGHQITDTDLQILMEAGDVDRDGHLDYGEF 417
|
Source: Hevea brasiliensis Species: Hevea brasiliensis Genus: Hevea Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|260408334|gb|ACX37460.1| calcium dependent protein kinase 32 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/421 (85%), Positives = 385/421 (91%), Gaps = 4/421 (0%)
Query: 1 MGNCCVTPA--AAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC TP+ A+ + K+K KKKQNPFS+DYG H GNGGHKL VL +PTG EIE+RYE
Sbjct: 1 MGNCCATPSTTASHEKKEKKGKKKQNPFSLDYGQRHHGNGGHKLTVLNDPTGGEIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRELGRGEFGIT+LCTD+E GD FACKSISKKKLRTAVDIEDVRREV+IM+HLP H NI
Sbjct: 61 LGRELGRGEFGITFLCTDKETGDTFACKSISKKKLRTAVDIEDVRREVEIMKHLPHHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQVCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKETA LK+IDFGLSVFFKPGE F+EIVGSPYYMAPEVLKRNYG EV
Sbjct: 181 HRDLKPENFLFANKKETAALKSIDFGLSVFFKPGEIFTEIVGSPYYMAPEVLKRNYGREV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLNP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVE 358
DPKRRLTAQ+VL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA+HLSVE
Sbjct: 301 DPKRRLTAQEVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAEHLSVE 360
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAF 416
EVAGIKEGF +MD NRGKINIDELRVGLHKLGH IPD D+QILM+A V +LD
Sbjct: 361 EVAGIKEGFQLMDTANRGKINIDELRVGLHKLGHTIPDADLQILMEAGDVDKDGYLDYGE 420
Query: 417 F 417
F
Sbjct: 421 F 421
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481709|ref|XP_002283549.2| PREDICTED: calcium-dependent protein kinase 32-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/419 (85%), Positives = 387/419 (92%), Gaps = 6/419 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +++ K KKKQNPFS+DY + QGNGG KL VLK+PTGREIE RYELG
Sbjct: 1 MGNCCVTPVPSEK---KKGKKKQNPFSLDYAAN-QGNGGSKLSVLKDPTGREIELRYELG 56
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGIT+LCTD+ GD +ACKSISKKKLRTAVDI+DVRREV+IM+HLPKH NIV
Sbjct: 57 RELGRGEFGITHLCTDKSTGDVYACKSISKKKLRTAVDIDDVRREVEIMKHLPKHPNIVT 116
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 117 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 176
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 177 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 236
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF+RDPWPKVSENAKDLV+KMLDPDP
Sbjct: 237 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFKRDPWPKVSENAKDLVKKMLDPDP 296
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
KRRL+AQ+VL+HPWLQNAKKAPNVSLGETV+ARLKQFS+MNKLKKRAL+VIA+HLSVEEV
Sbjct: 297 KRRLSAQEVLDHPWLQNAKKAPNVSLGETVRARLKQFSMMNKLKKRALRVIAEHLSVEEV 356
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
AGIKEGF +MD GN+GKIN+DELRVGL KLGHQIP+ D+QILM+A V HLD F
Sbjct: 357 AGIKEGFQLMDTGNKGKINMDELRVGLQKLGHQIPEQDLQILMEAGDVDGDGHLDYGEF 415
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106768|dbj|BAJ53260.1| JMS10C05.3 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/420 (84%), Positives = 380/420 (90%), Gaps = 6/420 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCCVTP+A K +KKKQNPF+IDYG Q NG HKL VLKEPTGREIE+RYEL
Sbjct: 1 MGNCCVTPSAVPSPDNKKHKKKQNPFAIDYG---QNNGVHHKLTVLKEPTGREIEQRYEL 57
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFGITYLCTD+E + +ACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 58 GGELGRGEFGITYLCTDKETAEKYACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIV 117
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 118 SLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 177
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 178 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 237
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 238 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPD 297
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEE 359
P RRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFS+MNKLKKRAL+VIA+HLSVEE
Sbjct: 298 PNRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSLMNKLKKRALRVIAEHLSVEE 357
Query: 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
VAGIKEGF +MD N+GKINID+LR+GL KLGHQI +TD+Q LM+A + HLD F
Sbjct: 358 VAGIKEGFQVMDTSNKGKINIDDLRIGLQKLGHQITETDLQFLMEAGDLDRDGHLDYGEF 417
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|343126682|gb|AEL88279.1| calcium-dependent protein kinase [Dimocarpus longan] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/421 (85%), Positives = 382/421 (90%), Gaps = 4/421 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQ-NPFSIDYG-THHQGNGGHKLCVLKEPTGREIEERYE 58
MG CC +PAA KK+ +KK+ N FSIDYG HH GN GHKLCVLKEPTGREIE+RYE
Sbjct: 1 MGICCGSPAADNHHKKQKKQKKKPNQFSIDYGVNHHHGNDGHKLCVLKEPTGREIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGREL RGEFG+TYLCTD+ N + FACKSISKKKLRTAVDIEDVRREV IMRHLP+H NI
Sbjct: 61 LGRELRRGEFGVTYLCTDKSNAETFACKSISKKKLRTAVDIEDVRREVAIMRHLPQHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENF FANK+ETA LKAIDFG S+FFKPGE+FSE VGSPYYMA EVLKRNYGPEV
Sbjct: 181 HRDLKPENFFFANKQETAALKAIDFGCSIFFKPGERFSERVGSPYYMALEVLKRNYGPEV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILL GVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKMLDP
Sbjct: 241 DVWSAGVILYILLSGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKMLDP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVE 358
DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HLSVE
Sbjct: 301 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAF 416
EVAGIKEGF +MD GNRGKINIDEL+VGLHKLGHQIPD+D+QILMDA V +LD
Sbjct: 361 EVAGIKEGFRLMDTGNRGKINIDELKVGLHKLGHQIPDSDLQILMDAGDVDRDGYLDYGE 420
Query: 417 F 417
F
Sbjct: 421 F 421
|
Source: Dimocarpus longan Species: Dimocarpus longan Genus: Dimocarpus Family: Sapindaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504799|ref|XP_003521182.1| PREDICTED: calcium-dependent protein kinase 32-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/420 (83%), Positives = 376/420 (89%), Gaps = 3/420 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKK-QNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYEL 59
MGNCC TP+ + KK K K +NPF+IDYG + G KL VLK PTGREIE RYEL
Sbjct: 1 MGNCCATPSTDETANKKGKKGKKENPFAIDYGFNATAANGSKLTVLKSPTGREIEARYEL 60
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
GRELGRGEFGITYLCTD+ G+ ACKSISKKKLRTA+DIEDVRREV+IMRHLP+H NIV
Sbjct: 61 GRELGRGEFGITYLCTDKGTGEELACKSISKKKLRTAIDIEDVRREVEIMRHLPQHANIV 120
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 121 TLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 180
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 181 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVD 240
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 241 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 300
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEE 359
PKRRLTAQ VL+HPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HL+VEE
Sbjct: 301 PKRRLTAQDVLDHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLTVEE 360
Query: 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
AG+KEGF +MD NRGKINIDELRVGLHKLGHQ+P++DVQ LMDA V HLD F
Sbjct: 361 AAGLKEGFQVMDTNNRGKINIDELRVGLHKLGHQVPESDVQALMDAGDVDGDGHLDYGEF 420
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138018|ref|XP_002322709.1| calcium dependent protein kinase 7 [Populus trichocarpa] gi|222867339|gb|EEF04470.1| calcium dependent protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1864), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/448 (78%), Positives = 392/448 (87%), Gaps = 15/448 (3%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +KK +KKKQNPF++D+G H++G HKL VL++PTG+EIE+RYELG
Sbjct: 1 MGNCCVTPPGVPDHEKKKHKKKQNPFALDFGHHNRGTN-HKLIVLRDPTGKEIEQRYELG 59
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E G+ FACKSISKKKLRTAVDIEDVRREV+IM+ +P+H N+V
Sbjct: 60 RELGRGEFGITYLCTDKETGENFACKSISKKKLRTAVDIEDVRREVEIMKQMPQHPNLVT 119
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD+AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CH+HGVMHR
Sbjct: 120 LKDTYEDDSAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQICHEHGVMHR 179
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 180 DLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 239
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKMLDPDP
Sbjct: 240 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLDPDP 299
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
KRRLTAQQVL+HPWLQNAKKAPNVSLGETV+ RLKQFSVMNKLKKRAL+VIA+HLSVEEV
Sbjct: 300 KRRLTAQQVLDHPWLQNAKKAPNVSLGETVRTRLKQFSVMNKLKKRALRVIAEHLSVEEV 359
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--------------V 406
AGIKEGF +MD GN+GKINIDELRVGL KLG Q+P+ D+QILM+ V
Sbjct: 360 AGIKEGFQLMDTGNKGKINIDELRVGLQKLGQQVPEIDLQILMEVGDADRDGYLDYGEFV 419
Query: 407 SHTLHLDLAFFREKVRLKISFFRWYEIG 434
+ T+HL E +R FF + G
Sbjct: 420 AITVHLRKMGNDEHLRKAFEFFDQNQSG 447
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577483|ref|XP_002529620.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530905|gb|EEF32765.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1860), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/420 (84%), Positives = 382/420 (90%), Gaps = 7/420 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCC TP + + K KKK NPFSIDYG + NG H+L VLK+PTGREIE+RYEL
Sbjct: 1 MGNCCATPPSDPH-ENKKYKKKPNPFSIDYGLN---NGVSHRLTVLKDPTGREIEQRYEL 56
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFG+TYLCTD+E+G+ FACKSISKKKLRTAVDIEDVRREV IM+HLPKH NIV
Sbjct: 57 GGELGRGEFGVTYLCTDKESGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 116
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIV+RGHYTERAAAAVTKTIVEVVQMCHKHGVMH
Sbjct: 117 SLKDTYEDDNAVHLVMELCEGGELFDRIVSRGHYTERAAAAVTKTIVEVVQMCHKHGVMH 176
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKE+A LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFANKKESAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 296
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEE 359
PKRRLTAQQVL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVEE
Sbjct: 297 PKRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 356
Query: 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
VAGIKEGF +MD N+GKIN+DELR+GL KLGHQI DTDVQ+LM+A V HLD F
Sbjct: 357 VAGIKEGFRLMDTSNKGKINLDELRIGLQKLGHQITDTDVQMLMEAGDVDRDGHLDYGEF 416
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449466099|ref|XP_004150764.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] gi|449508351|ref|XP_004163290.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/409 (85%), Positives = 370/409 (90%), Gaps = 4/409 (0%)
Query: 1 MGNCCVTPAAAKQGKKK-TNKKKQNPFSIDYGTHH--QGNGG-HKLCVLKEPTGREIEER 56
MGNCCV P + + K KKK NPFS+DYG +H GNGG HKL VL PTG EI +
Sbjct: 1 MGNCCVAPPRNPEDQNKGKRKKKPNPFSVDYGVNHFAGGNGGSHKLTVLTNPTGCEIGLQ 60
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YELGRELGRGEFGIT+LCTD+ G+ FACKSISKKKLRTA+DIEDVRREV IMRHLPKHQ
Sbjct: 61 YELGRELGRGEFGITHLCTDKVTGEKFACKSISKKKLRTAIDIEDVRREVQIMRHLPKHQ 120
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV LKDT+EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQMCHK G
Sbjct: 121 NIVSLKDTFEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAVVTKTIVEVVQMCHKQG 180
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGP 236
VMHRDLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGP
Sbjct: 181 VMHRDLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGP 240
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKML
Sbjct: 241 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKML 300
Query: 297 DPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLS 356
DPDPKRRLTAQ VL+HPWLQN KKAPNVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HLS
Sbjct: 301 DPDPKRRLTAQGVLDHPWLQNVKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLS 360
Query: 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
VEEVAGIKEGF MD GN+GKINIDELRVGLHKLGHQI D D+QILM+A
Sbjct: 361 VEEVAGIKEGFEKMDTGNKGKINIDELRVGLHKLGHQIADADLQILMEA 409
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572042|ref|XP_003554179.1| PREDICTED: calcium-dependent protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/421 (82%), Positives = 377/421 (89%), Gaps = 4/421 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKK-QNPFSIDYG-THHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC TP+ + KK K K +NPF+IDYG G KL VLK PTGREIE RYE
Sbjct: 1 MGNCCATPSTDETANKKGKKGKKENPFAIDYGFNAAAAANGSKLTVLKSPTGREIEARYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRELGRGEFGITYLCTD+E G+ ACKSISKKKLRTA+DI+DVRREV+IMRHLP+H NI
Sbjct: 61 LGRELGRGEFGITYLCTDKETGEELACKSISKKKLRTAIDIDDVRREVEIMRHLPQHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEV
Sbjct: 181 HRDLKPENFLFANKKETAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDP
Sbjct: 241 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVE 358
DP+RRLTAQ+VL+HPWLQNAKKAPNVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HL+VE
Sbjct: 301 DPRRRLTAQEVLDHPWLQNAKKAPNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLTVE 360
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAF 416
E AG+KEGF +MD NRGKINIDELRVGLHKLGHQ+P++DVQ LM+A V HLD
Sbjct: 361 EAAGLKEGFQLMDTNNRGKINIDELRVGLHKLGHQVPESDVQALMEAGDVDGDGHLDYGE 420
Query: 417 F 417
F
Sbjct: 421 F 421
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 436 | ||||||
| TAIR|locus:2103498 | 538 | CPK32 "calcium-dependent prote | 0.928 | 0.752 | 0.773 | 1.7e-169 | |
| TAIR|locus:505006616 | 535 | CPK7 "calmodulin-domain protei | 0.928 | 0.757 | 0.749 | 9.1e-167 | |
| TAIR|locus:2150230 | 533 | CDPK19 "calcium-dependent prot | 0.926 | 0.757 | 0.756 | 1.2e-163 | |
| TAIR|locus:2054386 | 530 | CPK14 "calcium-dependent prote | 0.949 | 0.781 | 0.706 | 4.8e-158 | |
| TAIR|locus:2074338 | 528 | CPK13 "calcium-dependent prote | 0.917 | 0.757 | 0.662 | 4.2e-143 | |
| TAIR|locus:2011201 | 545 | CDPK1 "calcium-dependent prote | 0.772 | 0.618 | 0.747 | 5.1e-138 | |
| TAIR|locus:2027227 | 541 | CPK30 "calcium-dependent prote | 0.772 | 0.622 | 0.747 | 2.2e-137 | |
| TAIR|locus:2061290 | 582 | CPK24 "AT2G31500" [Arabidopsis | 0.775 | 0.580 | 0.656 | 2.9e-126 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.775 | 0.523 | 0.609 | 8.4e-113 | |
| TAIR|locus:2175503 | 610 | CPK1 "calcium dependent protei | 0.775 | 0.554 | 0.609 | 1.4e-112 |
| TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1648 (585.2 bits), Expect = 1.7e-169, P = 1.7e-169
Identities = 318/411 (77%), Positives = 344/411 (83%)
Query: 1 MGNCCVTPA--AAXXXXXXXXXXXXXPFSIDYGTHHQGN--GGH--KLCVLKEPTXXXXX 54
MGNCC T A PFSIDYG HH G GG KL VL +PT
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 XXXXXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
FG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQH 354
MLDPD KRRLTAQQVL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+VIA+H
Sbjct: 301 MLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAEH 360
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
LS EE +GI+EGF +MD RGKINIDEL++GL KLGH IP D+QILMDA
Sbjct: 361 LSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDA 411
|
|
| TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 9.1e-167, Sum P(2) = 9.1e-167
Identities = 305/407 (74%), Positives = 342/407 (84%)
Query: 1 MGNCCVTPAAAXXXXXXXX-XXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXX 58
MGNCC P++A PF S +Y T + G KL VLK+PT
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 XXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
FGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVE 358
DPK+RLTA QVLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
E AGIKE F MMD+ RGKIN++EL+ GL K G QI DTD+QILM+A
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEA 407
|
|
| TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1593 (565.8 bits), Expect = 1.2e-163, P = 1.2e-163
Identities = 308/407 (75%), Positives = 341/407 (83%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXX 59
MGNCC +P + PF S Y T+ G G KL VLK+PT
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTG-FKLSVLKDPTGHDISLMYDL 59
Query: 60 XXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
FGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 60 GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEE 359
PK+RL+A QVLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VIA+HLSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359
Query: 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ-IPDTDVQILMDA 405
VAGIKE F MMD GKIN++EL+ GLHKLG Q IPDTD+QILM+A
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEA 406
|
|
| TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1540 (547.2 bits), Expect = 4.8e-158, P = 4.8e-158
Identities = 296/419 (70%), Positives = 338/419 (80%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXXX 60
MGNCC T + PFS +YG HH G KL VLKEPT
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGL---KLIVLKEPTGHEIKQKYKLG 57
Query: 61 XXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
FG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEV 360
+RRLTAQQVL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+VIA+HLSVEE
Sbjct: 298 RRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVEET 357
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLHLDLAFF 417
+ IKE F +MD NRGKI I EL +GL KLG +P D+QILMDA V +LD+ F
Sbjct: 358 SCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDAGDVDKDGYLDVNEF 416
|
|
| TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1399 (497.5 bits), Expect = 4.2e-143, P = 4.2e-143
Identities = 271/409 (66%), Positives = 319/409 (77%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHK---LCVLKEPTXXXXXXXX 57
MGNCC +PAA D+ GG K + VL +
Sbjct: 1 MGNCCRSPAAVAREDVKSNYSGH-----DHA-RKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 XXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
FG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSV 357
PDPKRRLTA+QVLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+VIA+ LS
Sbjct: 295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLST 354
Query: 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
EEV IK F+ MD N G ++I+EL+ GL Q+ +++VQ+L++AV
Sbjct: 355 EEVEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAV 403
|
|
| TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1351 (480.6 bits), Expect = 5.1e-138, P = 5.1e-138
Identities = 252/337 (74%), Positives = 294/337 (87%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM LP+H N+V LK +YED
Sbjct: 74 FGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTLPEHPNVVKLKASYED 133
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV MCH +GVMHRDLKPENF
Sbjct: 134 NENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHSNGVMHRDLKPENF 193
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEVLKR+YGP VDVWSAGVI+
Sbjct: 194 LFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDYGPGVDVWSAGVII 253
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK LV++MLDPDP +RLTAQ
Sbjct: 254 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQMLDPDPTKRLTAQ 313
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
QVL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+VIA+HLS++EV IK F
Sbjct: 314 QVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVIAEHLSIQEVEVIKNMF 373
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
+MD GKI EL+ GL K+G Q+ + ++++LM+
Sbjct: 374 SLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLME 410
|
|
| TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1345 (478.5 bits), Expect = 2.2e-137, P = 2.2e-137
Identities = 252/337 (74%), Positives = 296/337 (87%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+H N+V LK TYED
Sbjct: 70 FGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPNVVKLKATYED 129
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH +GVMHRDLKPENF
Sbjct: 130 NENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGVMHRDLKPENF 189
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL
Sbjct: 190 LFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 249
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++ML+PD +RLTAQ
Sbjct: 250 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQ 309
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
QVL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+VIA+HLS++EV I+ F
Sbjct: 310 QVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEHLSIQEVEVIRNMF 369
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
+MD N GKI+ ELR GL K+G Q+ + ++++LM+
Sbjct: 370 TLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLME 406
|
|
| TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 222/338 (65%), Positives = 281/338 (83%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+T+ C + + FACK ISK+KLRT +D+EDVRREV+IMR LPKH NIV K+ +ED
Sbjct: 77 FGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRCLPKHPNIVSFKEAFED 136
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AV+LVME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV++CH+HGV+HRDLKPENF
Sbjct: 137 KDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKVCHEHGVIHRDLKPENF 196
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPYYMAPEVL+RNYGPE+DVWSAGVIL
Sbjct: 197 LFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLRRNYGPEIDVWSAGVIL 256
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETE+G+A AI+R +DF RDPWPKVS AK+LV+ MLD +P RLT Q
Sbjct: 257 YILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKELVKNMLDANPYSRLTVQ 316
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
+VLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L+++A +L EE+A I + F
Sbjct: 317 EVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIVADNLPNEEIAAIVQMF 376
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
MD G + +ELR GL K+G +PD DV++LMDA
Sbjct: 377 QTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDA 414
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
Identities = 206/338 (60%), Positives = 260/338 (76%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 197 FGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 256
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH GVMHRDLKPENF
Sbjct: 257 VVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENF 316
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 317 LFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIV 376
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPKRRLTA
Sbjct: 377 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAH 436
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
QVL HPW+Q AP+ L V +R+KQFS MNK KK AL+VIA+ LS EE+AG+K+ F
Sbjct: 437 QVLCHPWVQIDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAESLSEEEIAGLKQMF 496
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
M+D N G+I +EL+ GL ++G + ++++ LM A
Sbjct: 497 KMIDADNSGQITFEELKAGLKRVGANLKESEILDLMQA 534
|
|
| TAIR|locus:2175503 CPK1 "calcium dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
Identities = 206/338 (60%), Positives = 258/338 (76%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G FACKSI+K+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 161 FGTTFLCVEKTTGKEFACKSIAKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 220
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVME C GGELFDRI+ RGHYTER AA +T+TIV VV+ CH GVMHRDLKPENF
Sbjct: 221 VVAVHLVMECCAGGELFDRIIQRGHYTERKAAELTRTIVGVVEACHSLGVMHRDLKPENF 280
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +K E + LK IDFGLS+FFKP + F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 281 LFVSKHEDSLLKTIDFGLSMFFKPDDVFTDVVGSPYYVAPEVLRKRYGPEADVWSAGVIV 340
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPK+RLTA
Sbjct: 341 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKKRLTAH 400
Query: 308 QVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
QVL HPW+Q AP+ L V +R+KQFS MNK KK AL+VIA+ LS EE+AG+KE F
Sbjct: 401 QVLCHPWVQVDGVAPDKPLDSAVLSRMKQFSAMNKFKKMALRVIAESLSEEEIAGLKEMF 460
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA 405
+M+D G+I +EL+ GL ++G + ++++ LM A
Sbjct: 461 NMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQA 498
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6NLQ6 | CDPKW_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8223 | 0.9288 | 0.7527 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025568001 | SubName- Full=Chromosome chr8 scaffold_34, whole genome shotgun sequence; (526 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00027665001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (769 aa) | • | 0.800 | |||||||
 | GSVIVG00022728001 | SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (873 aa) | • | 0.800 | |||||||
 | GSVIVG00006233001 | SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (805 aa) | • | 0.800 | |||||||
 | GSVIVG00002525001 | SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (943 aa) | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 436 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-103 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-94 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-61 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-59 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-58 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-52 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-49 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-48 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-47 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-45 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-44 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-43 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-43 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-42 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-39 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-38 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-36 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-32 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-32 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-32 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-32 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-32 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-31 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-31 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-31 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-30 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-30 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-29 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-29 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-28 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-28 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-28 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-28 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-27 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-26 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-25 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-25 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-23 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-19 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 306 bits (787), Expect = e-103
Identities = 114/260 (43%), Positives = 153/260 (58%), Gaps = 7/260 (2%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +LG G FG YL D++ G A K I KKK++ D E + RE+ I++ L KH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED+ ++LVME CEGG+LFD + RG +E A + I+ ++ H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
++HRDLKPEN L +K DFGL+ PGEK + VG+P YMAPEVL YG
Sbjct: 118 IVHRDLKPENILLDEDGH---VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD+WS GVILY LL G PPF + + I P +S AKDL+RK+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 296 LDPDPKRRLTAQQVLEHPWL 315
L DP++RLTA++ L+HP+
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 283 bits (726), Expect = 6e-94
Identities = 113/266 (42%), Positives = 151/266 (56%), Gaps = 13/266 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YEL R+LG G FG Y + G A K + K+ ++ D RRE+ I+R L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED ++LVME CEGG+LFD + G +E A + I+ ++ H +G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--RN 233
++HRDLKPEN L +K DFGL+ K + VG+P+YMAPEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDPWPKVSENAK 289
YGP+VDVWS GVILY LL G PPF E +IR +L +F W SE AK
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315
DL++K L+ DP +R TA+++L+HPW
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 1e-67
Identities = 89/257 (34%), Positives = 137/257 (53%), Gaps = 13/257 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + KKK+ ++E E +I+ + H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + ++LV+E GGELF + G ++E A IV ++ H G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L +K DFGL+ G + + G+P Y+APEVL YG VD
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PPF+AE + + + I++ L F P +S A+DL+ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232
Query: 301 KRRLT---AQQVLEHPW 314
+RL A+++ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 4e-61
Identities = 91/255 (35%), Positives = 127/255 (49%), Gaps = 44/255 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG YL D++ G A K I K+ + + E++ RE++I++ L H NIV L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKL-NHPNIVKLY 57
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+ED+ ++LVME CEGG L D + G +E + I+E ++ H +G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN--YGPEV 238
LKPEN L + +K DFGLS IVG+P YMAPEVL Y +
Sbjct: 118 LKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D+WS GVILY L KDL+RKML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 299 DPKRRLTAQQVLEHP 313
DP++R +A+++LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 8e-59
Identities = 80/272 (29%), Positives = 138/272 (50%), Gaps = 30/272 (11%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE+ +++G+G FG YL + +G + K I + + ED EV I++ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV-VQ 170
NI+ +++E+ + +VME +GG+L +I + + E + I++ VQ
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-------EQILDWFVQ 111
Query: 171 MC------HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSP 222
+C H ++HRD+KP+N FL +N +K DFG+S V + +VG+P
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YY++PE+ + Y + D+WS G +LY L PF E +A I++ + P
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP- 224
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ S ++LV +L DP+ R + Q+L+ P
Sbjct: 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 9e-58
Identities = 87/268 (32%), Positives = 137/268 (51%), Gaps = 19/268 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ +G +G +L + GD +A K I K + ++ V E DI+ + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++LVME GG+L + G E A IV ++ H +G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVF---------FKPGEKFSEIVGSPYYMAPEV-LKR 232
KP+N L + LK DFGLS ++ IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ VD WS G ILY L G+PPF ET + + Q I+ +++ D +VS+ A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 293 RKMLDPDPKRRLTA---QQVLEHPWLQN 317
K+L PDP++RL A +++ HP+ +
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 4e-56
Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ +G G F L ++E +A K + K++L ++ V+ E +++ L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
I+ L T++D+ ++ V+E GEL I G E+ I+ ++ H G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI------------------ 218
++HRDLKPEN L +K DFG + P
Sbjct: 123 IIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 219 ---VGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
VG+ Y++PE+L G D+W+ G I+Y +L G PPF E Q I++
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA----QQVLEHPW 314
F P +AKDL+ K+L DP+ RL ++ HP+
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-56
Identities = 86/267 (32%), Positives = 132/267 (49%), Gaps = 14/267 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+ G LGRG FG YL D++ G+ A KS+ + + ++E + RE+ I+ L +H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
NIV + D+ L +E GG L + G E T+ I+E + H
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEVL 230
+G++HRD+K N L + +K DFG + E + G+PY+MAPEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ YG D+WS G + + G PP W+E A+ + P+ +SE A
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315
KD +RK L DPK+R TA ++L+HP+L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 5e-54
Identities = 85/262 (32%), Positives = 137/262 (52%), Gaps = 14/262 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG Y + G A K I KL + E + E+ I++ KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKH 175
NIV +Y + +VME C GG L D + + TE A V K +++ ++ H +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NY 234
G++HRD+K N L + E +K IDFGLS + + +VG+PY+MAPEV+ Y
Sbjct: 118 GIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVLDFRRDPWP-KVSENAKDLV 292
+ D+WS G+ L G PP+ +E +A+ + + P K S+ KD +
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 293 RKMLDPDPKRRLTAQQVLEHPW 314
+K L +P++R TA+Q+L+HP+
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 7e-52
Identities = 94/293 (32%), Positives = 140/293 (47%), Gaps = 28/293 (9%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
Y + R+LG G FG YL DR+ A K ++KK + ++E RE+ I+ L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCH 173
NIV L D ++D+ +++LVME +GG L D + G +E A + I+ ++ H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-------EKFSEIVGSPYYMA 226
G++HRD+KPEN L ++ +K IDFGL+ S VG+P YMA
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 227 PEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------- 274
PEVL D+WS G+ LY LL G+PPF E ++ +L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
+S+ A DL++K+L DPK RL++ L H L + K +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
|
Length = 384 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 86/293 (29%), Positives = 133/293 (45%), Gaps = 41/293 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G G GI + DRE G+ A K ++ ++L + RE+ ++ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHK 174
+V L D + + LVME +L + + E + + +++ V H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVL-- 230
+G+MHRDLKP N L + LK DFGL+ F E +S V + +Y APE+L
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL--------------- 274
R Y P VD+W+ G I LL G P F E + + Q AI+ L
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 275 DF--------RRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
D+ + P P S A DL++ +L DP +RL+A + L HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 2e-48
Identities = 83/265 (31%), Positives = 131/265 (49%), Gaps = 18/265 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG L + FA K + K+ + E + E +I+ H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++D ++++ME C GGEL+ + RG + E A +V + H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVW 241
KPEN L + +K +DFG + K G+K G+P Y+APE+ L + Y VD W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 242 SAGVILYILLCGVPPFWAETE--QGVAQAIIRSV--LDFRRDPWPKVSENAKDLVRKMLD 297
S G++LY LL G PPF + E + I++ L+F + + AKDL++++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 298 PDPKRRLTAQQ-----VLEHPWLQN 317
+P+ RL + + +H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-47
Identities = 86/264 (32%), Positives = 139/264 (52%), Gaps = 14/264 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y+LG +GRG FG+ Y + E GD A K IS +K++ ++ + +E+D++++L KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV + E ++++++E E G L I G + E A +++ + H+
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRNY 234
GV+HRD+K N L K L DFG++ + + +VG+PY+MAPEV+
Sbjct: 119 GVIHRDIKAANILT-TKDGVVKLA--DFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174
Query: 235 GPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDL 291
G D+WS G + LL G PP++ + A+ R V D P P+ +S KD
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
+ + DP R TA+Q+L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-46
Identities = 92/295 (31%), Positives = 142/295 (48%), Gaps = 37/295 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG +L D++ G +A K + K + I VR E DI+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
IV L +++D+ ++LVME GG+L + ++ + + E A +V + HK
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLS--------------------------VF 208
G +HRD+KP+N L +K DFGL V
Sbjct: 120 LGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 209 FKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ ++ + VG+P Y+APEVL+ YG E D WS GVILY +L G PPF+++T Q
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQN 317
II R P P VS A DL+ ++L DP+ RL +++ HP+ +
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 24/274 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRH 111
E Y+ ++G G G Y TDR G A K + K+ + E+ IM+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII------NEILIMKD 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVTKTIVEV 168
KH NIV D+Y + +VME +GG L D + ++ E A V + +++
Sbjct: 72 C-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQG 128
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAP 227
++ H V+HRD+K +N L + +K DFG + K K + +VG+PY+MAP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI--IRSVLDFRRDPWPKV 284
EV+KR YGP+VD+WS G++ + G PP+ E +A+ I + K
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLKNPEKW 242
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
S KD + K L DP++R +A+++L+HP+L+ A
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 84/264 (31%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + LG G FG L + +G +A K +SK K+ +E V E I++ + +H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++DD+ ++LVME GGELF + G + E A +V ++ H
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYG 235
+++RDLKPEN L + +K DFG + K + G+P Y+APE+ L + YG
Sbjct: 122 IVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYG 176
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ G+++Y +L G PPF+ + + + I+ + F P S +AKDL+R +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF---P-SFFSPDAKDLIRNL 232
Query: 296 LDPDPKRRL-----TAQQVLEHPW 314
L D +RL + HPW
Sbjct: 233 LQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 3e-44
Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 8/262 (3%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+EL R +G+G FG + R+ FA K ++K+K + +V E I++ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++D+ ++LV++L GG+L + + ++E IV ++ H G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYG 235
++HRD+KP+N L E + DF ++ P + G+P YMAPEVL R Y
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD WS GV Y L G P+ + Q I S A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236
Query: 296 LDPDPKRRL--TAQQVLEHPWL 315
L+ DP++RL + + HP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 82/263 (31%), Positives = 129/263 (49%), Gaps = 10/263 (3%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ + +G FG YL R GD FA K + K + + +V+ E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++ ++LVME GG+ I G E A +V V+ H+ G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-VD 239
D+KPEN L +T LK DFGLS + G + + VG+P Y+APE + + D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
WS G +++ L G PPF AET V I+ +++ + S A DL+ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 300 PKRRLTA---QQVLEHPWLQNAK 319
P +RL A Q++ HP+ ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE +LG G +G+ Y D++ G+ A K K+R + E + RE+ +++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV L D + ++LV E C+ + D+ G + ++ ++ +
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRDLKP+N + N+ LK DFGL+ F P ++ V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------SVL 274
L ++Y VD+WS G I ++ G P F ++E I + + L
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 275 DFRRDPWPK------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ +PK + DL+ KML +P +R++A++ L+HP+
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 86/262 (32%), Positives = 131/262 (50%), Gaps = 13/262 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G+G +G +L ++ G+ A K + K L ++ V E DI+ K + +V L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++DD ++L ME GG+ + G +E A + E V H+ G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
LKPENFL + +K DFGLS + +VGSP YMAPEVL+ + Y VD
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKML 296
WS G +LY LCG PPF T + + +R DP +S+ A DL+ K++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241
Query: 297 DPDPKRRLTA-QQVLEHPWLQN 317
+ DP RR + + + HP+ +
Sbjct: 242 N-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 84/292 (28%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y+ ++G G +G+ Y D+ G+ A K I KLR + RE+ +++ L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-N 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NI+ L D + ++LV E + +L + E + +++ + C
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFC 114
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H HG++HRDLKPEN L LK DFGL+ F P ++ V + +Y APE+L
Sbjct: 115 HSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQAII 270
+ Y VD+WS G I LL P F ++E
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 271 RSVLDFR---RDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
F P PK+ S A DL+ +ML DP +R+TA+Q L HP+
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 4e-42
Identities = 95/297 (31%), Positives = 143/297 (48%), Gaps = 52/297 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++LG G FG YL ++E G+ A K + KKK + E+ REV +R L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRKLNE 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMC 172
H NIV LK+ + ++ ++ V E EG L+ + R ++E ++ I++ +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
HKHG HRDLKPEN L + E +K DFGL+ + +++ V + +Y APE+L R
Sbjct: 116 HKHGFFHRDLKPENLLVSG-PEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 233 --NYGPEVDVWSAGVI---LYIL---------------LCGV-----PPFWAETEQGVAQ 267
+Y VD+W+ G I LY L +C V W E + +A
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LAS 231
Query: 268 AIIRSVLDFR---------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
L FR P S A DL++ ML DPK+R TA Q L+HP+
Sbjct: 232 K-----LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 6e-41
Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 41/296 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHL 112
RYE G++LG G + + Y D+E G A K I +K+ + ++ RE+ +++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALREIKLLQEL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
KH NI+ L D + + ++LV E E + D+ + T + + +
Sbjct: 60 -KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPE 228
+ H + ++HRDLKP N L A+ LK DFGL+ F P K + V + +Y APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
+L R+YG VD+WS G I LL VP +++ I ++ + WP V
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 285 ----------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
S++A DL++++L +P +R+TA+Q LEHP+ N
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 20/272 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
R++ G ++G G FG Y + + G+ A K I + I+++ E+ ++ L KH
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
N+V V++ ME C GG L + + E T ++E + H H
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYYMAPEVL 230
G++HRD+KP N + +K DFG +V K GE+ + G+P YMAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 231 KRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---K 283
+G D+WS G ++ + G P W+E + I+ V + P P +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN--EFQIMFHVGAGHKPPIPDSLQ 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+S KD + + L+ DPK+R TA ++L+HP++
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E + LG+G G+ Y + G +A K I E+ R RE+ +R
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRSCE 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+V + + + +V+E +GG L D + G E A + + I++ + H
Sbjct: 58 -SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK 231
K ++HRD+KP N L +K E +K DFG+S + ++ + VG+ YM+PE ++
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK--VSENA 288
+Y D+WS G+ L G PF Q +++++ D P S
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+D + L DPK+R +A ++L+HP+++ A
Sbjct: 233 RDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 91/276 (32%), Positives = 139/276 (50%), Gaps = 23/276 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA---FACKSISK----KKLRTAVDIEDVRREVDIM 109
+EL R LG G +G +L DA +A K + K +K +TA E R E ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA---EHTRTERQVL 58
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +V L ++ DT +HL+++ GGELF + R H+TE IV +
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EIVGSPYYMAP 227
H+ G+++RD+K EN L + DFGLS F E+ G+ YMAP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 228 EVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
EV++ + VD WS GV+ + LL G PF + EQ I R +L + P+PK
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKT 234
Query: 284 VSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQ 316
+S A+D ++K+L+ DPK+RL A ++ HP+ Q
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E + +G G FG +L DR + +A K ++ ++ + V E +++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ L T D ++++ME GGELF + G ++ IV ++ H
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + +K DFG + K ++ + G+P Y+APEV++
Sbjct: 120 KEIVYRDLKPENILLDKEGH---IKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKG 174
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--DPWPKVSENAKDL 291
+ VD W+ G+++Y +L G PPF+ + G+ + I+ L+F R D + AKDL
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDL 228
Query: 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQ 316
++K+L D RRL A V H W +
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 85/271 (31%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +G+G FG + +G K I + T + + + EV+I+R L KH
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHP 59
Query: 117 NIV--CLKDTYEDDTAVHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQ 170
NIV + + +++VME CEGG+L I R + E + ++ +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 171 MCH-----KHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKF-SEIVGSPY 223
CH + V+HRDLKP N FL AN +K DFGL+ F VG+PY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE L Y + D+WS G ++Y L PPF A + +A I FRR P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFRRIP-Y 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ S ++++ ML+ DP +R + +++L+ P
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 93/273 (34%), Positives = 134/273 (49%), Gaps = 25/273 (9%)
Query: 56 RYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
R L ++G G GI + TD+ G A K K LR E + EV IMR
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV + +Y + +VME EGG L D IV E A V +++ + H
Sbjct: 75 -HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG + K + +VG+PY+MAPEV+ R
Sbjct: 133 AQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YG EVD+WS G+++ ++ G PP++ E QA+ R R + P KVS
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKR----IRDNLPPKLKNLHKVS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
+ + +ML DP +R TA ++L HP+L A
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 94/307 (30%), Positives = 143/307 (46%), Gaps = 65/307 (21%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE+ +G G +G+ C ++ G+ A K K + + D EDV+ REV ++R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-----AAAAVTKTI 165
L +H+NIV LK+ + ++LV E E L E AV I
Sbjct: 56 QL-RHENIVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYI 106
Query: 166 VEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVG 220
+++Q CH H ++HRD+KPEN L E+ LK DFG + +P ++ V
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVA 163
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA-IIRSVL--- 274
+ +Y APE+L NYG VDVW+ G I+ LL G P F +++ + Q +I+ L
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPL 221
Query: 275 ------DFRRDP------WP--------------KVSENAKDLVRKMLDPDPKRRLTAQQ 308
F +P +P KVS A D ++ L DPK RLT +
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 309 VLEHPWL 315
+L+HP+
Sbjct: 282 LLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 94/310 (30%), Positives = 136/310 (43%), Gaps = 66/310 (21%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHL 112
RYEL + +G G +G+ D+ G A K IS D+ D + RE+ ++RHL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL 56
Query: 113 PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ L D + ED V++V EL E +L I + T+
Sbjct: 57 -RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL----- 109
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSE 217
Q+ H V+HRDLKP N + N LK DFGL+ P E +E
Sbjct: 110 -YQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTE 165
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVIL--------------YI----LLC---GV 254
V + +Y APE+L Y +D+WS G I YI L+ G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 255 PPFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTA 306
P E + + A+ ++S+ + P P S A DL+ KML DPK+R+TA
Sbjct: 226 PS--EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 307 QQVLEHPWLQ 316
+ L HP+L
Sbjct: 284 DEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 82/268 (30%), Positives = 131/268 (48%), Gaps = 18/268 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRHLP 113
R+ G LG G FG Y + ++GD FA K S++ ++ + +E+ ++ L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H NIV T ++ +++ +EL GG L + G + E T+ I+ ++ H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL 230
+HRD+K N L +K DFG++ K +FS GSPY+MAPEV+
Sbjct: 120 DRNTVHRDIKGANILVDTNGV---VKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 231 KR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG D+WS G + + G PP W++ E A+ + P P +S+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDE 230
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
AKD + K L DP R TA ++LEHP++
Sbjct: 231 AKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 26/288 (9%)
Query: 57 YELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L + ++G +A K + K + + A E R E ++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ DT +HL+++ GGELF + R + E+ + IV ++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMAPEVL 230
HK G+++RD+K EN L + DFGLS F E+ G+ YMAP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVV---LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 231 K---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSE 286
+ + VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSA 237
Query: 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN-------AKKAP 322
AKD+++++L DPK+RL A ++ +HP+ Q AKK P
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 81/283 (28%), Positives = 139/283 (49%), Gaps = 29/283 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLP 113
E + L +G+G FG Y D+ A K I L A D IED+++E+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ I ++ + + ++ME C GG D ++ G E A + + ++ ++ H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE------KFSEIVGSPYYMAP 227
+ G +HRD+K N L + E +K DFG+S G+ K + VG+P++MAP
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWPK 283
EV+K++ Y + D+WS G+ L G PP V I ++ L+ + +
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKF-- 223
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
S+ KD V L+ DPK R +A+++L+H +++ AKK ++L
Sbjct: 224 -SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 89/259 (34%), Positives = 139/259 (53%), Gaps = 11/259 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T + +G A K K LR E + EV IMR +H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E AAV +++ + + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K + +VG+PY+MAPE++ R YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A +IR L + KVS + K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 300 PKRRLTAQQVLEHPWLQNA 318
P +R TA ++L+HP+L A
Sbjct: 258 PAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 16/266 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y R LG+G FG L E+ K ++ +L D E+ I+ L +H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCH 173
NI+ + + DD + + ME GG L+D+IV + + E IV V H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVL 230
K G++HRD+K N +F K +K DFG+S G ++S +VG+PYYM+PE+
Sbjct: 119 KAGILHRDIKTLN-IFLTK--AGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + D+W+ G +LY LL F A + I++ + S
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315
LV +L DP++R TA +VL+ P L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-35
Identities = 83/275 (30%), Positives = 141/275 (51%), Gaps = 18/275 (6%)
Query: 57 YELGRELGRGEFGITYL---CTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L T + G +A K + K L + A +E R E +++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ + +HL+++ GGE+F + R +++E + I+ ++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEV 229
HK G+++RD+K EN L ++ DFGLS F EK +S G+ YMAPE+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVV---LTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEI 177
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ K +G VD WS G++++ LL G PF E E+ + R +L +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237
Query: 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
A+DL+ K+L DPK+RL A ++ EHP+ +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 83/282 (29%), Positives = 132/282 (46%), Gaps = 28/282 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ +E+ ELG G FG Y +E G A K I ++ + ++ED E+DI+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
KH NIV L + Y + + +++E C+GG L ++ TE V + ++E +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVL- 230
H H V+HRDLK N L + +K DFG+S K +K +G+PY+MAPEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284
Y + D+WS G+ L L PP E +R +L + P +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPH-HELN------PMRVLLKILKSEPPTLD 229
Query: 285 -----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321
S + D ++ L DP R TA ++L+HP++ +
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 20/280 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLPK 114
R EL +GRG +G Y G A K I+ L T D + D++REV ++ L +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQ 58
Query: 115 HQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
Q NI +Y + ++ME EGG + R + + G E+ + + + ++ ++
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL 230
HK GV+HRD+K N L N T +K DFG++ K S VG+PY+MAPEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 231 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ Y + D+WS G+ +Y + G PP+ I +S R S+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP--RLEDNGYSKLL 231
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE 328
++ V LD +PK RL+A+++L+ W++ K P L E
Sbjct: 232 REFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 85/298 (28%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE ++G G +G Y +++ G+ A K I + + I +R E+ +++ L +H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58
Query: 117 NIVCLKD--TYEDDTAVHLVMELCEGGELFD--RIVARG--HYTERAAAAVTKTIVEVVQ 170
NIV LK+ T + ++++V E + D ++ +TE K ++E +Q
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
H +G++HRD+K N L N LK DFGL+ + ++ V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVLDFRRDPWPK 283
+L YGPEVD+WS G IL L G P F TE + I S D + WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD---ENWPG 228
Query: 284 V---------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
V +A DL+ K+L DPK+R++A Q L+H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 81/268 (30%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G LG G FG + + G+ +A K + K+++ ++ V +E I+ L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHP 78
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV + +++D+ V+ ++E GGELF + G + A +V + H
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYG 235
+++RDLKPEN L NK +K DFG + K ++ + G+P Y+APEV++ + +G
Sbjct: 139 IIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHG 193
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ GV+LY + G PPF+ +T + + I+ L F W A+DLV+ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249
Query: 296 LDPDPKRRLTA-----QQVLEHPWLQNA 318
L D +RL V HP+ A
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGA 277
|
Length = 329 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 13/265 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + ++ D++++ +E+ I++
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC- 55
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
IV +Y +T + +VME C G + D + TE AA+ ++ ++
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
H + +HRD+K N L + + K DFG+S K + ++G+P++MAPEV++
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 232 R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y + D+WS G+ + G PP+ I DP K S D
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP-EKWSPEFND 231
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315
V+K L DP+ R +A Q+L+HP++
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 2e-33
Identities = 86/262 (32%), Positives = 141/262 (53%), Gaps = 23/262 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + ++ +G A K + LR E + EV IMR +HQN+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY-QHQNVVEM 83
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+Y + ++ME +GG L D IV++ E A V +++++ + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
+K ++ L +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 143 IKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVSENAKDLVR 293
+WS G+++ ++ G PP+++++ QA+ R R P P K+S +D +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 294 KMLDPDPKRRLTAQQVLEHPWL 315
+ML +P+ R TAQ++L+HP+L
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-33
Identities = 81/266 (30%), Positives = 131/266 (49%), Gaps = 17/266 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPK 114
+ G+ LG+G FG YLC D + G A K + T ++ + E+ ++++L +
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-Q 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+ IV DD + + ME GG + D++ A G TE T+ I+E V+ H
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEVL 230
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV+
Sbjct: 123 NMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PKVSEN 287
YG + DVWS G + +L PP WAE E A A I + +P VS +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVSPD 235
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHP 313
A++ +R+ + K+R +A+++L H
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 52/297 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG L ++ G +A K + K ++ + VR E DI+ + +V L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D+ ++L+ME GG++ ++ + +TE + + HK G +HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFK---------------PGEKFSEI--------- 218
KP+N L K +K DFGL K P I
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 219 ---------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262
VG+P Y+APEV L+ Y E D WS GVI+Y +L G PPF ++
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 263 QGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE---HPW 314
Q + II + L F + +S AKDL++++ + +RRL V E HP+
Sbjct: 245 QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 83/294 (28%), Positives = 134/294 (45%), Gaps = 49/294 (16%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++G G F R+ G +A K + KK + +E V RE+ +R L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFK---SLEQVNNLREIQALRRLSP 56
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171
H NI+ L + D + LV EL + L++ I R E+ + +++ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEV 229
H++G+ HRD+KPEN L K + LK DFG ++ KP ++E + + +Y APE
Sbjct: 116 MHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-------DFRRD 279
L + YGP++D+W+ G + + +L P F E + Q A I VL +
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFR 227
Query: 280 PW-------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P S DL++K+L DP R+TA+Q L HP+
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 79/267 (29%), Positives = 138/267 (51%), Gaps = 21/267 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVC 120
+G+G FG Y ++ +A K +SKK++ ++ E +I+ L + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ D+ ++LV + GGELF + G ++E A +V ++ HK+ +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVL--KRNY 234
DLKPEN L T + DFGLS K + + G+ Y+APEVL ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
VD WS GV+++ + CG PF+AE Q + + I + F ++ +S+ + V+
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKG 231
Query: 295 MLDPDPKRRL----TAQQVLEHPWLQN 317
+L+ +P+ RL A ++ EHP+ +
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 85/273 (31%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG + ++ GD +A K + K L + E DI+ + I L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 123 DTYEDDTAVHLVMELCEGGEL----------FDRIVARGHYTERAAAAVTKTIVEVVQMC 172
++D ++LVME GG+L FD +A+ + E +V +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE---------LVLAIHSV 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEI-VGSPYYMAPEVL 230
H+ G +HRD+KPEN L T +K DFG + + S++ VG+P Y+APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 231 -------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPW 281
K YG E D WS GVI Y ++ G PF T I+ + L F D
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED-- 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
PKVS + DL++ +L K RL + + HP+
Sbjct: 234 PKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 90/259 (34%), Positives = 134/259 (51%), Gaps = 11/259 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T++ G A K K LR E + EV IMR H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHENVVDM 84
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E A V +++ + H GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 144 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A IR L R KVS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 300 PKRRLTAQQVLEHPWLQNA 318
P +R TAQ++L+HP+L+ A
Sbjct: 260 PSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 24/272 (8%)
Query: 57 YELGRELGRGEFGITY--LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YEL +G G + Y +C N + A K I +K +T ++++R+EV M
Sbjct: 3 YELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQT--SVDELRKEVQAM-SQCN 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTKTIVEVVQM 171
H N+V ++ + LVM GG L D RG E A V K +++ ++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPGEKFSE----IVGSPYYMA 226
H +G +HRD+K N L E +K DFG+S G++ + VG+P +MA
Sbjct: 118 LHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 227 PEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPW 281
PEV++ Y + D+WS G+ L G P+ V +++ L+ D +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD-Y 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
K S++ + ++ L DP +R TA+++L+H
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 82/296 (27%), Positives = 136/296 (45%), Gaps = 43/296 (14%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G+ G +L + G FA K + KK++ ++ V E +I+ L H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFD-RIVARGHY-TERAAAAVTKTIVEVVQMCHKHGVM 178
L +++ +T + LVM+ C GGELF G +E A ++ ++ H G++
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS------------------------------VF 208
+RDLKPEN L E+ + DF LS
Sbjct: 126 YRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+P + + VG+ Y+APEV+ + +G VD W+ G++LY +L G PF
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL----TAQQVLEHPWLQNAK 319
I++ + F P VS +A+DL+RK+L DP +RL A ++ +HP+ +
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
KH NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D ++R +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 48/289 (16%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIMRHLPKHQ 116
+LG G + Y +R G+ A K I +D E+ RE+ +M+ L KH+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIH-------LDAEEGTPSTAIREISLMKEL-KHE 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV---TKTIVEVVQMCH 173
NIV L D + + LV E + +L + G V T +++ + CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL-- 230
++ V+HRDLKP+N L + E LK DFGL+ F P FS V + +Y AP+VL
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE---- 286
R Y +D+WS G I+ ++ G P F + I R + WP +S+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 287 ---------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
DL+ ++L +P+ R++A L+HPW
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G + D G A K I+ +K E + E+ +M+ L
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D++ + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 ANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D ++R +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 46/296 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE E+G G +G Y D G + ++ KK+R + E + RE+ +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 113 PK--HQNIV-----CLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTK 163
H NIV C + + + LV E + + G + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ V H H ++HRDLKP+N L + + +K DFGL+ + + +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------ 270
Y APEVL ++ Y VD+WS G I L P F +E I
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231
Query: 271 ------RSVLDFR-----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
RS + P++ E DL++KML +P +R++A + L+HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 23/269 (8%)
Query: 61 RELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G +G + T + G FA K + K + R D + E +I+ + KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L ++ ++L++E GGELF + G + E A I ++ H+ G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFGL S+ G G+ YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+G VD WS G ++Y +L G PPF AE + I++ L+ P ++ A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPWLQ 316
+K+L +P RL A +V HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVDIMRHLP 113
+++ ++LG+G +G Y + +A K + L + E D E+ I+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIRILASV- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H NI+ K+ + D + +VME G+L I R E+ + ++ +
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 170 QMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
Q H+ ++HRDLK N L AN +K D G+S K ++I G+P+YMAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNMAKTQI-GTPHYMAPE 171
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SE 286
V K R Y + D+WS G +LY + PPF A + Q + + R + P P + S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ ++ +R ML PK R ++L P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 51/302 (16%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ ++G G +G Y D++ G+ A K + + I +R E+ I+R L H+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-NHR 66
Query: 117 NIVCLKDTYEDDT----------AVHLVMELCEG---GELFDRIVARGHYTERAAAAVTK 163
NIV LK+ D A +LV E + G L +V H++E + K
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSFMK 123
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS 221
++E + CHK +HRD+K N L NK + +K DFGL+ + E ++ V +
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVIT 180
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y PE+L + YGP +DVWS G IL L P F A E + I R
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 280 PWPKVSE--------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHP 313
WP V + A DL+ ML DP +R TA++ L P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 314 WL 315
WL
Sbjct: 301 WL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 83/261 (31%), Positives = 124/261 (47%), Gaps = 16/261 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
LG+G FG C + G +ACK + KK+L R + +++ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR---FIVS 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L +E + LVM L GG+L I G + E A I+ ++ H+ ++
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
+RDLKPEN L + ++ D GL+V K G+K G+P YMAPEVL+ Y
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD ++ G LY ++ G PF E+ + + R L+ + K S AKDL +L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
Query: 298 PDPKRRL-----TAQQVLEHP 313
DP++RL +A +V EHP
Sbjct: 235 KDPEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-31
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A I + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-N 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + LD D ++R +A+++L+H +L+ AK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 94/299 (31%), Positives = 139/299 (46%), Gaps = 49/299 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
EI RY + +G G FG+ D+ G A K I K T V + RE+ +++H
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65
Query: 112 LPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
L +H+NI+ L D + ED ++ V EL G R++ ++ I+
Sbjct: 66 L-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H GV+HRDLKP N L E LK DFGL+ P + + V + YY AP
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAP 174
Query: 228 EVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-----DF--- 276
E++ + Y EVD+WSAG I +L G P F + V Q +II +L D
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVINT 232
Query: 277 --------------RRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R+P P +A DL+ KML DP++R++A + L HP+L
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 80/298 (26%), Positives = 134/298 (44%), Gaps = 51/298 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-------VRREVD 107
E+YE ++G G +G+ + C +RE G A K V+ ED RE+
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIR 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIV 166
+++ L KH N+V L + + +HLV E C+ + + + E + +
Sbjct: 53 MLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEIVGSPYYM 225
+ V CHKH +HRD+KPEN L + + +K DFG + +++ V + +Y
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYR 167
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276
APE+L YGP VDVW+ G + LL G P + +++ I +++ D
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 277 ----------------RRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
R+P +P +S A ++ L DP RL+ +++LEHP+
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-31
Identities = 84/268 (31%), Positives = 138/268 (51%), Gaps = 11/268 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-N 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ + H
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P ++S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ + L+ D RR +A+++L+HP+L+ AK
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G FG L + + +A K + K + D+E E ++ KH +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I G + E A IV +Q H+ G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVLK-RNYG 235
DLK +N L ++ +K DFG+ K G S G+P Y+APE+L + YG
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
P VD W+ GV+LY +L G PF + E + Q+I+ + + R W +S+ AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSF 230
Query: 296 LDPDPKRRLTA-----QQVLEHPWLQN 317
L +P++RL Q + HP+ +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 9e-31
Identities = 82/269 (30%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPKHQN 117
G+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L +H+
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHER 65
Query: 118 IV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV CL+D E + + ME GG + D++ A G TE T+ I+E + H
Sbjct: 66 IVQYYGCLRDRAE--KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV
Sbjct: 124 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG + DVWS G + +L PP WAE E AI + P +SE+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHISEH 237
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
A+D + + + + R +A+++L HP+ Q
Sbjct: 238 ARDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 86/272 (31%), Positives = 129/272 (47%), Gaps = 24/272 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+E YEL + +G G +G Y D G+ A K I KL D E +++E+ +++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC- 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMC 172
+H NIV +Y + +VME C GG L D V RG +E A V + ++ +
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H+ G +HRD+K N L E +K DFG+S K +G+PY+MAPEV
Sbjct: 118 HETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
K Y + D+W+ G+ L PP + I +S P PK+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----PP-PKLKDK 229
Query: 288 AK------DLVRKMLDPDPKRRLTAQQVLEHP 313
K D ++K L DPK+R TA ++L+HP
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 10/261 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE R +GRG FGI +LC + + K I +++ T + + E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCH 173
NI+ + + +D A+ +VME GG L + I R + E I+ + H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R 232
++HRDLK +N L +K + +K DFG+S K +VG+P Y++PE+ + +
Sbjct: 119 TKLILHRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y + D+W+ G +LY L F A + I+ D + S + + L+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLI 233
Query: 293 RKMLDPDPKRRLTAQQVLEHP 313
ML+ DP +R Q++ P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 82/269 (30%), Positives = 136/269 (50%), Gaps = 24/269 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHLPK 114
+ LG+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-L 62
Query: 115 HQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ IV CL+D E + + ME GG + D++ + G TE T+ I+E V
Sbjct: 63 HERIVQYYGCLRDPME--RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMA 226
H + ++HRD+K N L + +K DFG S + G + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PK 283
PEV+ YG + D+WS G + +L PP WAE E A A I + +P P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPPH 233
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
VS++ +D ++++ + K R +A ++L H
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 87/274 (31%), Positives = 137/274 (50%), Gaps = 18/274 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++ + +GRG FG L + + +A K +SK ++ D E DIM H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-AN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEI-VGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D ++S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEIS 275
Query: 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
+ AKDL+ L R R ++ HP+ +N
Sbjct: 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 87/296 (29%), Positives = 140/296 (47%), Gaps = 53/296 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + + G +G YL +E FA K I+K+ L I+ V E DI+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAE 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGE---LFDRI------VARGHYTERAAAAVTKTI 165
+ +V + ++E + +VME EGG+ L I +AR ++ E A
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA------ 113
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------------KP 211
++ H +G++HRDLKP+N L + +K DFGLS K
Sbjct: 114 ---LEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 212 GEKFS--EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQ 267
+F ++ G+P Y+APEV L++ YG VD W+ G+ILY L G PF+ +T E+ Q
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 268 AIIRSVLDFRRDPWPK----VSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQ 316
I + WP+ + +A+DL+ ++L +P RL A +V +H +
Sbjct: 228 VISDDIE------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 42/294 (14%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L +PTG +EL +G G +G Y ++ G A K + + E+++
Sbjct: 1 LPDPTGI-----FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKE 51
Query: 105 EVDIMRHLPKHQNIV------CLKDTYEDDTAVHLVMELCEGG---ELFDRIVARGH-YT 154
E +I+R H NI K+ +D + LVMELC GG +L + +G
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213
E A + + + + H++ V+HRD+K +N L + A +K +DFG+S
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 214 KFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+ + +G+PY+MAPEV+ + P+ DVWS G+ L G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDM 221
Query: 268 AIIRSVLDFRRDPWPKVSENAK------DLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P P + D + + L + ++R +++LEHP++
Sbjct: 222 HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 34/295 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQ 116
EL R LG G G C + G FA K+I+ D++ + RE++I + K
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSC-KSP 59
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGEL---FDRIVARGHYT-ERAAAAVTKTIVEVVQ 170
IV + E +++ + ME CEGG L + ++ RG E+ + +++++ +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMA 226
H ++HRD+KP N L K + +K DFG+S GE + + G+ +YMA
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMA 171
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIR-SVLDFRRD 279
PE ++ + Y DVWS G+ L + PF E E + I+ + + +
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 280 PWPKV--SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
P + SE KD +++ L+ DP RR T +LEHPW++ K V++ + V
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK-VNMAKFVAQ 285
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 84/265 (31%), Positives = 126/265 (47%), Gaps = 12/265 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + Q +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E A I+ ++ H+ +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEVL + Y
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R VL+ K SE AK + + +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 298 PDPKRRLTAQ-----QVLEHPWLQN 317
DPK+RL Q +V HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 24/268 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++G+G+F + Y +G A K + ++ A +D +E+D+++ L H
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ ++ +++V+EL + G+L I H+ ++ +TI + VQ+C
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMA 226
H +MHRD+KP N F+ A +K D GL FF K S +VG+PYYM+
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPK 283
PE + N Y + D+WS G +LY + PF+ + + + I + D+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311
SE +DLV + ++PDP++R VL+
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 83/261 (31%), Positives = 129/261 (49%), Gaps = 19/261 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVC 120
LG+G FG L ++ G +A K I KK++ A D +V + R L +H +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKD--EVAHTLTESRVLQNTRHPFLTA 59
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ + VME GGELF + ++E A IV + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK EN + + +K DFGL G G+P Y+APEVL+ N YG V
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 299 DPKRRL-----TAQQVLEHPW 314
DPK+RL A++++EH +
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 41/299 (13%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + E +L R +G G +GI Y D +G+ A K + R + I +R E+ ++
Sbjct: 4 RSVTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61
Query: 111 HLPKHQNIVCLKDTYEDD--TAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIV 166
+L +H NIV LK+ ++ LVME CE L D + ++E + ++
Sbjct: 62 NL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYM 225
+Q H++ ++HRDLK N L +K LK DFGL+ + P + + V + +Y
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------ 271
APE+L Y +D+W+ G IL LL P ++E II+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 272 -------SVLDFRRDPW-------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ P+ P +SE L+ +L DPK+R TA++ LE + +
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 47 EPTGREIEERYE---LGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDV 102
+ R+ + +YE R LG G FG L T + E+ A K K K+ ++ V
Sbjct: 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E I+ ++ H V L +++D++ ++LV+E GGE F + +
Sbjct: 79 FSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
IV + + +++RDLKPEN L + +K DFG + + + G+P
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTP 192
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y+APE+L +G D W+ G+ +Y +L G PPF+A + Q I+ ++ F
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF----- 247
Query: 282 PK-VSENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
PK + N K L++K+L D +R AQ V EHPW N
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 92/303 (30%), Positives = 138/303 (45%), Gaps = 51/303 (16%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDA--FACKSISK---KKLRTAVDIEDVRREVDIMR 110
RYEL +ELG+G +GI + E + A K I+ KK+ + RE+ ++R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 111 HLPKHQNIVCLKD----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
H H+NI CL D + ++L EL E +L I + T+ + I+
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-----EKFSEIVGS 221
++ H V+HRDLKP N L E LK DFGL+ F +E V +
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA-------------------E 260
+Y APE++ ++Y +DVWS G IL LL P F E
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 261 TEQGV----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
T + AQ IRS+ + + P +P + A DL+ K+L DP +R++ ++ LEH
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292
Query: 313 PWL 315
P+L
Sbjct: 293 PYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 80/271 (29%), Positives = 121/271 (44%), Gaps = 25/271 (9%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
G LG+G +G Y C G A K + + L + E ++ EVD+++ L KH
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHV 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV T DD + + ME GG + + G E TK I++ V H +
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFG-------LSVFFKPGEKFSEIVGSPYYMAPEV 229
V+HRD+K N + +K IDFG + + + G+PY+MAPEV
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV---- 284
+ + YG + D+WS G ++ + G PP A ++ A I + R P++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFYIGA----HRGLMPRLPDSF 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
S A D V L D R +A Q+L H +L
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 71/272 (26%), Positives = 114/272 (41%), Gaps = 36/272 (13%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y + G A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H N+V L ++ +++VME EGG+L + ++ +++
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL---------SLSDLLSFAL 109
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + + G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + + V + + +R
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN---GYRLP 223
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
P DL+ + DP+ R T +++E
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234
Query: 301 KRRL-----TAQQVLEHPWLQN 317
K+RL A++V+EH + +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 94/343 (27%), Positives = 146/343 (42%), Gaps = 73/343 (21%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ I +YE+ ++LG+G +GI + DR + A K I R A D + RE+ ++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQ 61
Query: 111 HLPKHQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L + E+D ++LV E E +L H A + I+E
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DL--------H------AVIRANILED 106
Query: 169 VQMC-------------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214
V H V+HRDLKP N L + +K DFGL+ E+
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEEN 163
Query: 215 -----FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------- 257
++ V + +Y APE+L Y VD+WS G IL +L G P F
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 258 ------WAETEQGVAQ-------AIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDP 300
+ + + ++ S+ R P PK S++A DL++K+L +P
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283
Query: 301 KRRLTAQQVLEHPWLQNAKK-APNVSLGETVKARL---KQFSV 339
+RLTA++ LEHP++ + L + L + SV
Sbjct: 284 NKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSV 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 77/273 (28%), Positives = 142/273 (52%), Gaps = 30/273 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y +++G G FG L +E+G + K I+ K+ + E+ R+EV ++ ++ KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV ++++E++ +++VM+ CEGG+L+ +I A+ R I++ VQ+C
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLA 113
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
H ++HRD+K +N +F K T L DFG++ V E +G+PYY++P
Sbjct: 114 LKHVHDRKILHRDIKSQN-IFLTKDGTIKLG--DFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
E+ + R Y + D+W+ G +LY + F A + + IIR +P V
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSS 223
Query: 285 --SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
S + ++LV ++ +P+ R + +LE ++
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 83/271 (30%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHL 112
+ LG+ LGRG FG YLC D + G A K + T+ ++ + E+ ++++L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 113 PKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+H IV CL+D E ++ +E GG + D++ A G TE T+ I++
Sbjct: 62 -RHDRIVQYYGCLRDPEEKKLSI--FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSPYY 224
V H + ++HRD+K N L + +K DFG S G + G+PY+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
M+PEV+ YG + DVWS + +L PP WAE E AI + + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPD 232
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
VS+ +D ++++ + KRR TA+ +L HP
Sbjct: 233 GVSDACRDFLKQIF-VEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 81/299 (27%), Positives = 139/299 (46%), Gaps = 44/299 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ +RY+ +G G +G D + G A K +S+ ++A+ + RE+ +++H
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+N++ L D + ED V+LV L G +L + IV ++ + I
Sbjct: 71 M-DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQI 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + N E LK +DFGL+ ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSN-IAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYR 182
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILL---------------------CGVPP--FWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242
Query: 261 TEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+ I+S+ + + + + A DL+ KML DP +R+TA + L HP+L
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 21/270 (7%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI------SKKKLRTAVDIEDVRREVDIMRHLP 113
G +G G FG YL + +G+ A K + + K R ++ + RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL- 63
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H+NIV + D +++ +E GG + + G + E + I++ + H
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------VFFKPGEKFSEIVGSPYYMA 226
G++HRD+K N L NK +K DFG+S + K + GS ++MA
Sbjct: 124 NRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PEV+K+ Y + D+WS G ++ +L G P + + Q QAI + + + +S
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNIS 237
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A D + K + D +R TA ++L+HP+L
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 83/260 (31%), Positives = 127/260 (48%), Gaps = 17/260 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
+G+G FG R+ +A K+I K + R+ V R V + P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP---FIVP 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ ++LV+ GGELF + G + A T ++ ++ HK V++R
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLKPEN L + DFGL + K +K + G+P Y+APE+L Y V
Sbjct: 118 DLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +L G+PPF+ E + + I++ L F +AKDL+ +L
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSR 230
Query: 299 DPKRRL---TAQQVLEHPWL 315
DP RRL AQ++ HP+
Sbjct: 231 DPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 56/308 (18%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK-----LRTAVDIEDVRREV 106
++ RY+ +G G +G+ T + G A K IS + RT RE+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------REI 54
Query: 107 DIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
I+R KH+NI+ + D ++E V++V EL E +L+ +++ H +
Sbjct: 55 KILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYF 111
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----E 217
I+ ++ H V+HRDLKP N L LK DFGL+ P + E
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------------ 257
V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 258 -WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQ 308
E + A+ I+S+ + PW P A DL+ KML +P +R+T ++
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288
Query: 309 VLEHPWLQ 316
L HP+L+
Sbjct: 289 ALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 85/266 (31%), Positives = 132/266 (49%), Gaps = 27/266 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y + R +G G FG L + +A K I K ++ +ED R+E ++ + KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KH 57
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV K+++E D +++VME C+GG+L +I +R TI++ VQMC
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-----KLQRGKLFPEDTILQWFVQMCLG 112
Query: 173 ----HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
H+ V+HRD+K +N FL N K +K DFG + + PG VG+PYY+
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 227 PEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ + Y + D+WS G ILY L PF A + +I V P P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA----NSWKNLILKVCQGSYKPLPSHY 224
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S + L+++M +P+ R +A +L
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-28
Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 15/264 (5%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG L +E+G +A K + K + D+E E I+ H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I + E A I + H G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK +N L ++ K DFG+ G+ S G+P Y+APE+L+ YGP V
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +LCG PF AE E + +AI+ + + W +S++A D+++ +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFMTK 233
Query: 299 DPKRRLTA------QQVLEHPWLQ 316
+P RL + + +L HP+ +
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 80/288 (27%), Positives = 133/288 (46%), Gaps = 43/288 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y +++ G + ++ KK+R + E V RE+ +++ L +H N
Sbjct: 7 KIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPN 60
Query: 118 IVCLKDTYEDDTAVHLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVCL+D ++ ++L+ E + + D + + + I++ + CH
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KR 232
V+HRDLKP+N L NK +K DFGL+ F P ++ V + +Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS------- 285
Y VD+WS G I + P F ++E I R + D WP V+
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237
Query: 286 ------------------ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
E+ DL+ KML DP +R++A++ L HP+
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 33/272 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG G G+ R G A K+I + ++ + RE+DI+
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVE-VVQMCHK 174
IV + ++ + + ME +GG L D+I +G ER + +++ + + K
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVL 230
H ++HRD+KP N L ++ + +K DFG+S G+ + + VG+ YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIRSVLDFRRDPWPKV 284
+ N Y + D+WS G+ L L G P+ E + Q I+ R P K
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKF 229
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S + +D V L DP+ R + +++LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 87/304 (28%), Positives = 137/304 (45%), Gaps = 49/304 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E++ +Y + +GRG +GI + E + A K I+ +D + RE+ ++RH
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRH 60
Query: 112 LPKHQNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
L H+N++ +KD + D V++V EL + +L I + ++
Sbjct: 61 L-DHENVIAIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLF-ANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
++ ++ H V+HRDLKP N L AN LK DFGL+ + G+ +E V +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNAN----CDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ET 261
+Y APE+L Y +DVWS G I LL P F E
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231
Query: 262 EQGV-----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ G A+ IRS+ R +P + A DL+ KML DP +R+T ++ L H
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291
Query: 313 PWLQ 316
P+L
Sbjct: 292 PYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-27
Identities = 78/262 (29%), Positives = 122/262 (46%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG C R G +ACK ++KK+L+ E E I+ + + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
++ T + LVM + GG+L I + E A T I+ ++ H+ ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK-RNYGP 236
+RDLKPEN L N ++ D GL+V K G K G+P +MAPE+L+ Y
Sbjct: 120 YRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + +L+ K S +K +L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236
Query: 297 DPDPKRRL-----TAQQVLEHP 313
DP++RL + HP
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHP 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 18/274 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FAN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGE-KFSEIVGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + K G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDIS 275
Query: 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
+ AK+L+ L R R +++ H + +N
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 12/265 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E+ A + ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L ++ ++ D GL+V GE VG+ YMAPEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R V + + + K SE+AK + R +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 298 PDPKRRL-----TAQQVLEHPWLQN 317
+PK RL A V +HP +N
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 46/286 (16%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-- 123
G +G+ Y D++ G+ A K + +K + I +R E++I+ L +H NIV +K+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVV 73
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQMCHKHGVMH 179
+ +++VME E +L + + + K ++ V H + ++H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--KRNYGP 236
RDLK N L N+ LK DFGL+ + P + ++++V + +Y APE+L + Y
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-------------- 282
+D+WS G I LL P F ++E I + + WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+S+N DL+ ++L DP +R++A+ L+HP+
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 86/308 (27%), Positives = 138/308 (44%), Gaps = 55/308 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE ++G G +G+ Y DR + +I+ KK+R + E V RE+ +++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLK 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV-- 168
+ +H NIV L+D + ++LV E + + + H A +++
Sbjct: 57 EM-QHGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 169 ------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+ CH H V+HRDLKP+N L + T LK DFGL+ F P F+ V +
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y APE+L R+Y VD+WS G I ++ P F ++E I R + +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 280 PWPKVSE-------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP V+ DL+ KML DP +R+TA+ LEH +
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 315 LQNAKKAP 322
++ AP
Sbjct: 287 FKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRD 181
+++ + VME GGELF + ++E A IV + H + V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 182 LKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
LK EN + + +K DFGL K G G+P Y+APEVL+ N YG VD
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
W GV++Y ++CG PF+ + + + + I+ + F R P+ AK L+ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLLKKD 234
Query: 300 PKRRL-----TAQQVLEH 312
PK+RL A+++++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/309 (25%), Positives = 138/309 (44%), Gaps = 29/309 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D + A K +S ++ +D+ +EV ++ L
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL- 72
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+H N + K Y + LVME C G ++ + V + E AA+ ++ +
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H +HRD+K N L E +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ Y +VDVWS G+ L PP + I ++ D P +S N
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------DS-PTLSSN 237
Query: 288 A-----KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNK 342
++ V L P+ R +++++L+H ++ ++ P + + ++ ++
Sbjct: 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL--RERPPTVIIDLIQRTKDAVRELDN 295
Query: 343 LKKRALKVI 351
L+ R +K I
Sbjct: 296 LQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 71/272 (26%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 58 ELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y T A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H NIV L ++ + +VME GG+L D + ++ +++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--------SLSDLLSFAL 110
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + G P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + V + + + +R
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK---GYRLP 224
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
P L+ + DP+ R T +++E
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 81/261 (31%), Positives = 125/261 (47%), Gaps = 12/261 (4%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ L GG+L I G + E A I ++ H+ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W+ G +LY ++ G PF ++ + + R V + + + K S +A+ L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 298 PDPKRRL-----TAQQVLEHP 313
DPK RL A++V EHP
Sbjct: 242 KDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM-----RHLPKH 115
R LG+G FG C R G +ACK + KK+++ +R+ + M + L K
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--------KRKGEAMALNEKQILEKV 57
Query: 116 QN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQM 171
+ +V L YE A+ LV+ L GG+L I G+ + E A I ++
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
H+ +++RDLKPEN L + ++ D GL+V GE VG+ YMAPEV+K
Sbjct: 118 LHRERIVYRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK 174
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D W G ++Y ++ G PF E+ + + R V + + + K SE A+
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS 234
Query: 291 LVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318
+ R++L DP RL A++V HP+ + A
Sbjct: 235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 23/263 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAF-ACKSIS-------KKKLRTAVDIEDVRREVDI 108
Y + LG G FG Y + NG A K I+ K K I D+ EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARG-HYTERAAAAVTKT 164
++ +H NIV T+ ++ +++VM+L EG GE F+ + + +TE +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 165 IVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V ++ HK ++HRDL P N + + DFGL+ +P K + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT---ITDFGLAKQKQPESKLTSVVGTIL 178
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y PE++K YG + DVW+ G ILY + PPF++ +A I+ +V +P P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY----EPLP 234
Query: 283 K--VSENAKDLVRKMLDPDPKRR 303
+ SE+ D++ L PD + R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 21/263 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ +G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ + VME GGELF + ++E IV + H +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN + + +K DFGL K G G+P Y+APEVL+ N YG
Sbjct: 122 KLENLML---DKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W GV++Y ++CG PF+ + + + + I+ + F R +S +AK L+ +L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231
Query: 298 PDPKRRL-----TAQQVLEHPWL 315
DP +RL A++++ H +
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 14/264 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG+ + + + +A K I K+ + E+ E ++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DSS 59
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGH-YTERAAAAVTKTIVEVVQMCHK 174
I+ +++ D +++VME E G+L + RG E I+ + H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVLK-R 232
++HRD+K N LF + + +K D G++ F+ IVG+PYY++PE+ + +
Sbjct: 120 KKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENAKDL 291
Y + DVW+ GV+LY G PF A QG A+I ++ P S+ L
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANN-QG---ALILKIIRGVFPPVSQMYSQQLAQL 232
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
+ + L D ++R Q+L +P L
Sbjct: 233 IDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 84/308 (27%), Positives = 129/308 (41%), Gaps = 61/308 (19%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--I 118
+ +G G FG L + +A K++ K + V+ E DI L + N +
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI---LAEADNEWV 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L +++D ++ VM+ GG++ ++ G + E A + ++ HK G +
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI 218
HRD+KP+N L +K DFGL F+ P E++SEI
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 219 ------------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
VG+P Y+APEVL R Y D WS GVILY +L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 254 VPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQ 308
PPF A+T +I + L K+S A DL+ + L + RL A +
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHI--PSQAKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 309 VLEHPWLQ 316
+ HP+ +
Sbjct: 298 IKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 83/286 (29%), Positives = 145/286 (50%), Gaps = 19/286 (6%)
Query: 44 VLKEPTGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
++++ +++ E Y++ + +GRG FG L + + +A K +SK ++ D
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E DIM +V L ++DD +++VME GG+L + +++ E+ A T
Sbjct: 91 WEERDIMA-FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYT 148
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVG 220
+V + H G++HRD+KP+N L + LK DFG + + VG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 221 SPYYMAPEVLKRN-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSV 273
+P Y++PEVLK YG E D WS GV L+ +L G PF+A++ G I+ ++
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317
L+F D ++S++AK+L+ L R R +++ +HP+ +N
Sbjct: 266 LNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 84/294 (28%), Positives = 132/294 (44%), Gaps = 46/294 (15%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRH 111
+YE ++G G +G + +RE + A K ++R D E V RE+ +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKE 55
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVV 169
L KH+NIV L D D + LV E C+ + FD G + +++ +
Sbjct: 56 L-KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGL 112
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPE 228
CH H V+HRDLKP+N L E LK DFGL+ F P +S V + +Y P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 229 VL--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
VL + Y +D+WSAG I L G P F + I R + + WP VS
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 286 E-------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ +DL++ +L +P +R++A++ L+HP+
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-26
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 18/288 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +E+ ELG G FG Y ++E G A K I K + ++ED E+DI+
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQM 171
H NIV L D + + + +++E C GG + D ++ TE V K +E +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H++ ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
R Y + DVWS G+ L + PP V I +S P +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRW 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
S KD ++K L+ + R T Q+L+HP++ P L KA
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 23/267 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVC 120
LGRG FG L ++ G+ +A K++ K + ++E + E I H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + V VME GG+L I ++E A +V +Q H++ +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVL-KRNYG 235
DLK +N L + +K DFGL K G++ S G+P ++APEVL + +Y
Sbjct: 126 DLKLDNLLLDTE---GFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W GV++Y +L G PF + E+ V +I+ + + R +S A ++R++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRL 235
Query: 296 LDPDPKRRL-----TAQQVLEHPWLQN 317
L +P+RRL A+ V + P+ ++
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 74/264 (28%), Positives = 127/264 (48%), Gaps = 19/264 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----GSPYYMAPEVLKRN-YGPE 237
KPEN L ++ DFGL K G S+ G+P Y+APEV+++ Y
Sbjct: 123 KPENILLDSQGHVV---LTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W G +LY +L G+PPF+ + I+ L R P S A ++ ++L+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 298 PDPKRRLTAQ----QVLEHPWLQN 317
D +RRL A+ ++ EHP+ ++
Sbjct: 233 KDRQRRLGAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 71/256 (27%), Positives = 126/256 (49%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++GRG+F Y T + A K + ++ A +D +E+D+++ L H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ D++ +D +++V+EL + G+L I ++ ++ +T+ + VQ+C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 288 AKDLVRKMLDPDPKRR 303
++LV + PDP +R
Sbjct: 237 LRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 87/286 (30%), Positives = 134/286 (46%), Gaps = 22/286 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ ELG G FG Y ++E G A K I K + ++ED E++I+
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQM 171
H IV L + D + +++E C GG + D I+ RG TE + + ++E +Q
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQY 125
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H ++HRDLK N L + +K DFG+S K ++ +G+PY+MAPEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
Y + D+WS G+ L + PP V I +S P K
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKW 241
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV 330
S +D ++ LD P+ R +A Q+LEHP++ + N L E V
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 83/257 (32%), Positives = 128/257 (49%), Gaps = 10/257 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + G + E A I+ +Q HK G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N L + +K DFG+ GE K S G+P Y+APE+LK + Y VD
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF E E + +I+ F R W +S+ AKD + K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235
Query: 301 KRRL-TAQQVLEHPWLQ 316
+RL + +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ + +++GRG+F Y T +G A K + L A D +E+D+++ L H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ +D +++V+EL + G+L I H+ ++ KT+ + VQ+C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 288 AKDLVRKMLDPDPKRR 303
+ LV ++PDP++R
Sbjct: 237 LRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 23/277 (8%)
Query: 53 IEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+E YE LG+G +GI Y D A K I ++ R ++ + E+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIA 57
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKT 164
+ +L KH+NIV + ++ + ME GG L + ++ E+ TK
Sbjct: 58 LHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPY 223
I+E ++ H + ++HRD+K +N L + +K DFG S +E G+
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 224 YMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
YMAPEV+ R YG D+WS G + + G PPF E G QA + V F+ P
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFKIHP 231
Query: 281 W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+S AK+ + + +PDP +R +A +L+ P+L
Sbjct: 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P +S +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235
Query: 301 KRRLTA 306
+RL A
Sbjct: 236 TKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 17/296 (5%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L +H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ Y + LVME C G V + E AAVT ++ + H H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGP 236
D+K N L + E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKM 295
+VDVWS G+ L PP + I ++ + W SE ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVI 351
L P+ R T++ +L+H ++ ++ P + + ++ ++ L+ R +K I
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 47/300 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+ YE ++G G +G Y D+ G K ++ KK R +D E + RE+ +++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQ 55
Query: 111 HLPKHQNIV---CLKDTYEDD--TAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKT 164
L + IV ++ E + +++LV E L + F RG A +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 165 IVEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVG 220
+ ++++ CHKHGVMHRDLKP+N L +K LK D GL F P + ++ +
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHEIV 173
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+ +Y APEVL +Y VD+WS G I + P F ++E I + +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 279 DPWPKV------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP V S DL++KML DP +R++A+ L HP+
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 9/247 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P ++ +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 301 KRRLTAQ 307
+RL A+
Sbjct: 236 TKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 44/293 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
Y+ ++G G +G+ Y D+ G+ A K K+R + E V RE+ +++ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H NIV L D + ++LV E + + D G + +++ +
Sbjct: 56 -NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIA 113
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEV 229
CH H V+HRDLKP+N L +++ LK DFGL+ F P ++ V + +Y APE+
Sbjct: 114 YCHSHRVLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 170
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SV 273
L R Y VD+WS G I ++ P F ++E I R S+
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230
Query: 274 LDF-------RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
D+ R KV E+ DL+ KML DP +R++A+ L+HP+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 54/305 (17%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE ++G+G FG + ++ A K + + + I +R E+ I++ L KH
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL-KH 70
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTKT 164
+N+V L + + +LV E CE G L ++ V +T V K
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKM 127
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIV 219
++ + H++ ++HRD+K N L + LK DFGL+ F + +++ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277
+ +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 278 RDPWPKV----------------------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ WP V +A DL+ K+L DP +R+ A
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 310 LEHPW 314
L H +
Sbjct: 305 LNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 16/263 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D++ E I+ KH + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L +I + E + + + H+HGV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV++Y ++ G PPF A+ E + ++I+ D W +S+ A +++ + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 301 KRRL-------TAQQVLEHPWLQ 316
+RL + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y ++ G + ++ KK+R + E V RE+ +++ L H N
Sbjct: 7 KIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 118 IVCLKDTYEDDTAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L D + ++LV E L + + F + +++ + CH H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
V+HRDLKP+N L +K DFGL+ F P ++ V + +Y APE+L +
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS-------- 285
Y VD+WS G I ++ F ++E I R++ WP V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237
Query: 286 -----------------ENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
E+ +DL+ +ML DP +R++A+ L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RYE+ +++G G FG YL + + + K I K+ + E ++EV ++ + KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH 173
NIV +++++ + +VME C+GG+L RI RG ++E + I ++ H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-VGSPYYMAPEVLK- 231
++HRD+K +N + A L DFG++ + + VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLG--DFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSENAKD 290
R Y + D+WS G +LY L PF + I + P P S + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YFAPISPNFSRDLRS 232
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315
L+ ++ P+ R + +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 58/320 (18%)
Query: 51 REIEERYE-LGRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDV 102
I ERY G LG G +G D G A K S K R V + +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 103 R----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE+ IM + KH+NI+ L D Y + ++LVM++ +L + + TE
Sbjct: 64 HFTTLRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------- 209
+ I+ + + HK MHRDL P N +F N K K DFGL+ +
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPAN-IFINSKGIC--KIADFGLARRYGYPPYSDTL 178
Query: 210 ------KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ E+ + V + +Y APE+L Y VD+WS G I LL G P F E
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 262 EQGVAQAIIRSVLDFRRDPWPKV------------------------SENAKDLVRKMLD 297
E I + D WP+ S++A DL++ +L
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 298 PDPKRRLTAQQVLEHPWLQN 317
+P R++A++ L+H + ++
Sbjct: 299 LNPLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 81/275 (29%), Positives = 127/275 (46%), Gaps = 23/275 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R +E +EL + +G G +G Y + G+ A K I KL D V++E+ +M+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V++ ++ +
Sbjct: 62 DC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + +K DFG+S K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 230 L----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
K Y D+W+ G+ L PP + + +S +F+ PK+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVLEHPW 314
+ K V+ L +PK+R TA+++L+HP+
Sbjct: 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 9/247 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A + + H +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L ++ DFGL +P E S G+P Y+APEVL++ Y VD
Sbjct: 123 KPENILLDSQGHVV---LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + A DL+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 301 KRRLTAQ 307
+RRL A+
Sbjct: 236 RRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 47/278 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V + +++D ++L+ME GG++ ++ + TE V + H+
Sbjct: 61 LW-VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-------------------- 214
G +HRD+KP+N L +K +K DFGL K +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 215 -----------------FSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPP 256
FS VG+P Y+APEV + Y D WS GVI+Y +L G PP
Sbjct: 177 NSKRKAETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 257 FWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLV 292
F +ET Q + ++ + L F P +SE AKDL+
Sbjct: 236 FCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 87/311 (27%), Positives = 130/311 (41%), Gaps = 54/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY R LG G G+ + D + A K I L ++ RE+ I+R
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRR 58
Query: 112 LPKHQNIV----CLKDTYEDDT----------AVHLVMELCEGGELFDRIVARGHYTERA 157
L H NIV L + D T +V++V E E ++ +G +E
Sbjct: 59 L-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEH 115
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--- 214
A ++ ++ H V+HRDLKP N +F N E LK DFGL+ P
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKG 173
Query: 215 -FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
SE + + +Y +P +L NY +D+W+AG I +L G P F E Q I+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 272 SVLDFR--------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLT 305
SV R RD P V+ A D + ++L +P RLT
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 306 AQQVLEHPWLQ 316
A++ L HP++
Sbjct: 294 AEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 16/260 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
K +N L +K DFG+ G+ K G+P Y+APE+L + Y VD
Sbjct: 123 KLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--WPK-VSENAKDLVRKMLD 297
WS GV+LY +L G PF E+ + Q+I R D +P+ ++ AKD++ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDNPCYPRWLTREAKDILVKLFV 232
Query: 298 PDPKRRLTAQ-QVLEHPWLQ 316
+P+RRL + + +HP+ +
Sbjct: 233 REPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 53/304 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V + +++D ++L+ME GG++ ++ + +E A V + H+ G
Sbjct: 63 -VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------PGEKFS------ 216
+HRD+KP+N L K +K DFGL K P FS
Sbjct: 122 FIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 217 ----------------EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF +
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 260 ETEQGVAQAIIRSVLDFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE---H 312
ET Q R V++++ P +SE AKDL+ + D + R+ + V E H
Sbjct: 239 ET----PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293
Query: 313 PWLQ 316
P+ +
Sbjct: 294 PFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 83/283 (29%), Positives = 138/283 (48%), Gaps = 38/283 (13%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + G +A K ++K ++ + R E D++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELF-------DRI---VARGHYTERAAAAVTKT 164
+ I L ++D+ ++LVM+ GG+L DR+ +AR + E
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE--------- 110
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI-VGSP 222
+V + H+ G +HRD+KP+N L + ++ DFG + G S + VG+P
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 223 YYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVL 274
Y++PE+L K YGPE D WS GV +Y +L G PF+AE+ I+ +
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPW 314
F D VSE AKDL+R+++ P+ RL Q +HP+
Sbjct: 228 QFPPDV-TDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 85/307 (27%), Positives = 132/307 (42%), Gaps = 52/307 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVD 107
++ RY+ +G G +G+ D +G A K I A D+ + RE+
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-----AFDVPTLAKRTLRELK 56
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
I+RH KH NI+ ++D D V++VM+L E +L I + TE
Sbjct: 57 ILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLY 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL--SVFFKPGEK---FSEI 218
++ ++ H V+HRDLKP N L E L+ DFG+ + P E +E
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVP 255
V + +Y APE+L Y +D+WS G I L + + G P
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 256 P--FWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I+++ + PW PK S A DL+ +ML DP+ R+T +Q
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 310 LEHPWLQ 316
L+HP+L
Sbjct: 292 LQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 7e-24
Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 39/280 (13%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDVRREVDIMRHL 112
G +G+G +G YL + G+ A K + R ++ +R E++ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NIV + + + +E GG + + G + E+ T+ ++E +
Sbjct: 66 -DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----------GSP 222
H G++HRDLK +N L K DFG+S K S+ + GS
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGIS-------KKSDDIYDNDQNMSMQGSV 174
Query: 223 YYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
++MAPEV+ + Y +VD+WS G ++ + G P W++ E A+ +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAP 231
Query: 280 PWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P P +S A D + +P R TA+++L+HP+
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 91/298 (30%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSI----SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG+G +G Y R G A K I + K + E+DI+ H
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDIL-HKAVSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--- 174
IV + + AV++ ME + G L D++ A G TE V + I V K
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 175 --HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
H ++HRD+KP N L + +K DFG+S G + + +G YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171
Query: 229 VLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVLDFRR 278
+K Y + DVWS G+ + + G P+ ET + AI+ D
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
P S++A+D V K L+ P RR T Q+LEHPWL K +V + E V LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 20/264 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPE-VLKRNYGPEV 238
K +N + +K DFG+ ++F G+ G+P Y+APE + + YG V
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLD 297
D W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + +L
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLLT 237
Query: 298 PDPKRRLTA-----QQVLEHPWLQ 316
P +RL + + EH + +
Sbjct: 238 KHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 84/316 (26%), Positives = 142/316 (44%), Gaps = 23/316 (7%)
Query: 45 LKEPTGREI------EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD 98
LK+P E+ E+ + RE+G G FG Y D + A K +S ++
Sbjct: 9 LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+D+ +EV ++ + KH N + K Y + LVME C G V + E
Sbjct: 69 WQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 127
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
AA+T ++ + H H ++HRD+K N L E +K DFG + P F
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF--- 181
Query: 219 VGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-V 273
VG+PY+MAPEV+ + Y +VDVWS G+ L PP + I ++
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333
+ + W S+ ++ V L P+ R T++++L+H ++ ++ P L + ++
Sbjct: 242 PTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFV--LRERPETVLIDLIQRT 296
Query: 334 LKQFSVMNKLKKRALK 349
++ L+ R +K
Sbjct: 297 KDAVRELDNLQYRKMK 312
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-23
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 19/267 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED--VRREVDIMRHLPK 114
Y R +G+G +G L R +G + I K LR A E +E ++ L K
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQL-K 57
Query: 115 HQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIV-ARGHY-TERAAAAVTKTIVEVVQM 171
H NIV ++++E +D +++VM CEGG+L+ ++ +G E I +Q
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL 230
H+ ++HRDLK +N T +K D G++ V + S ++G+PYYM+PE+
Sbjct: 118 LHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ Y + DVW+ G +Y + F A+ + II L P PK S
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPEL 230
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+L+ ML P++R + + +L P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 75/257 (29%), Positives = 125/257 (48%), Gaps = 10/257 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + G+ FA K++ K + D+E E ++ ++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I +G + A IV +Q H G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + +K DFG+ G+ + S G+P Y+APE+L+ Y VD
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E + ++I + R W +++ +KD++ K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235
Query: 301 KRRL-TAQQVLEHPWLQ 316
RRL + HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 79/287 (27%), Positives = 123/287 (42%), Gaps = 34/287 (11%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG G G G A K + +K +R + + RE+ IM +
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-----KQILRELQIMHEC-RSPY 64
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKH 175
IV + ++ + + ME + G L DRI + G + +VE + + + H
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLK 231
+MHRD+KP N L ++ + +K DFG+S GE + I VG+ YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQ 175
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKV-- 284
Y + DVWS G+ + L G PF Q +LD + +P P++
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE 328
E+ +D V L DP R T QQ+ P A +A NV L
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQA 282
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 84/309 (27%), Positives = 129/309 (41%), Gaps = 57/309 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ G + E A + V+ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFF------------------------------- 209
D+KP+N L +K DFGL F
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 210 -------KPGEKFS----------EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL 251
KP E+ + +VG+P Y+APEVL R Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQ 308
G PPF A+T +I P K+S A DL+ K+ P+ RL A +
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADE 301
Query: 309 VLEHPWLQN 317
+ HP+ +
Sbjct: 302 IKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE +G G +G+ C +E G A K K + D + V+ RE+ +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L +H+N+V L + + ++LV E + L D E I+ ++
Sbjct: 56 QL-RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRD+KPEN L + K DFG + PGE +++ V + +Y APE+
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVV---KLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------FRRD 279
L + YG VD+W+ G ++ +L G P F +++ II+ + + F+++
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 280 P-------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P +PK+S DL ++ L DP R ++ Q+L H +
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-23
Identities = 79/295 (26%), Positives = 131/295 (44%), Gaps = 17/295 (5%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G FG Y T+ + A K +S +T +D+ +EV ++ L KH N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEY 86
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
K Y + LVME C G V + E AA+T ++ + H H ++HRD
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGPE 237
+K N L E +K DFG + P F VG+PY+MAPEV+ + Y +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VLDFRRDPWPKVSENAKDLVRKML 296
VDVWS G+ L PP + I ++ + + W +++ + V L
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCL 257
Query: 297 DPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVI 351
P+ R + ++L H +++ + P L + ++ ++ L+ R +K I
Sbjct: 258 QKIPQERPASAELLRHDFVR--RDRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ + +GRG FG + + FA K ++K ++ + R E D++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
+Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEVL- 230
+ +HRD+KP+N L ++ DFG L + + S VG+P Y++PE+L
Sbjct: 120 QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQV 233
Query: 283 -KVSENAKDLVRKML 296
VSE+AKDL+R+++
Sbjct: 234 TDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 7e-23
Identities = 70/274 (25%), Positives = 127/274 (46%), Gaps = 24/274 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K + K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L ++ +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233
Query: 290 DLVRKMLDPDPKRRLTA------QQVLEHPWLQN 317
+++ L+ DPK RL + HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-22
Identities = 85/294 (28%), Positives = 140/294 (47%), Gaps = 41/294 (13%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +++G G FG +L + + F K+IS + L+ + V EV++MR L KH+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMREL-KHK 72
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQ 170
NIV D + + + ++++ME C+ G+L I G E A +T+ ++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 171 MCH--KHG-----VMHRDLKPENFLF-------------ANKKETAPLKAI-DFGLSVFF 209
CH K G V+HRDLKP+N AN P+ I DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 210 KPGEKFSEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
VG+PYY +PE+L ++Y + D+W+ G I+Y L G PF A
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------A 246
Query: 267 QAIIRSVLDFRRDPWPKVSENAKD---LVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ + + +R P + +K+ L++ +L+ K R +A Q L + ++N
Sbjct: 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 16/256 (6%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++N +A K + K+ + DI+ V+ E + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + + LV+E GG+L + + E A I + H+ G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L +K D+G+ PG+ S G+P Y+APE+L+ YG V
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF-------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
D W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 292 VRKMLDPDPKRRLTAQ 307
++ L+ DPK RL Q
Sbjct: 234 LKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 6e-22
Identities = 85/317 (26%), Positives = 125/317 (39%), Gaps = 86/317 (27%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
E Y+ +LG G + Y + G A K I + TA+ RE +++
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLV-----------MELCEGG------ELFDRIVARGHY 153
L KH NIV L D + LV M+ C GG LF + RG
Sbjct: 59 DL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRG-- 115
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFF 209
+ CH+ V+HRDLKP+N L + + E LK DFGL SV
Sbjct: 116 ---------------LAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV-- 155
Query: 210 KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVA 266
P + +S V + +Y P+VL Y +D+W G I Y + G P F T+ +
Sbjct: 156 -PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214
Query: 267 QAIIRSVLDFRRDPWPKVSENAK----------------------------DLVRKMLDP 298
I R + + WP VS N + +L K L
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274
Query: 299 DPKRRLTAQQVLEHPWL 315
+PK+R++A + ++HP+
Sbjct: 275 EPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 38/293 (12%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK- 114
+YE E+G G +G Y D +G A KS+ + + + VR EV +++ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAF 59
Query: 115 -HQNIVCLKDT-----YEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIV 166
H NIV L D + +T V LV E + D++ G E + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ H + ++HRDLKPEN L + + +K DFGL+ + + +V + +Y A
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 227 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---- 281
PEV L+ Y VD+WS G I + P F +E I + D W
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235
Query: 282 -------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
P++ E+ L+ +ML +P +R++A + L+HP+
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 39/266 (14%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQNIVCLKDT 124
G+FG + + F K I K IE V +M+ + N + L +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVH---QLMKD---NPNFIKLYYS 77
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
L+M+ + G+LFD + G +E + + +VE + HKH ++H D+K
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-------YMAPE-VLKRNYGP 236
EN L+ K+ L D+GL +I+G+P Y +PE + NY
Sbjct: 138 ENVLYDRAKDRIYL--CDYGL----------CKIIGTPSCYDGTLDYFSPEKIKGHNYDV 185
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPK---VSENAKDLV 292
D W+ GV+ Y LL G PF ++ + + L R + P VS+NA D V
Sbjct: 186 SFDWWAVGVLTYELLTGKHPF----KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 293 RKMLDPDPKRRLTA-QQVLEHPWLQN 317
+ ML + RLT ++++HP+L+
Sbjct: 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 71/266 (26%), Positives = 127/266 (47%), Gaps = 17/266 (6%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMRHLPKH 115
G++LG G F Y D + G A K ++ + T+ + E+V R+E+ +M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NH 62
Query: 116 QNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+I+ L T ED + +L +E GG + + G + E T+ ++ + H+
Sbjct: 63 PHIIRMLGATCED-SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-----FFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + + L+ DFG + GE +++G+ +MAPEV
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
L+ YG DVWS G ++ + PP+ AE I + P+ +S
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHP 313
+D+ + L+ P+ R ++++L+HP
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 66/320 (20%)
Query: 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSI-SKKKLRTAVDIEDVRREVDIMRHL 112
+YE+ +GRG +G Y + G +A K K+ T + R E+ ++R L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 113 PKHQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------ 164
KH+N+V L + + + V+L+ + E +L+ I + H + +
Sbjct: 60 -KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLW 115
Query: 165 -IVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSE---I 218
I+ V H + V+HRDLKP N + E +K D GL+ +F P + ++ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------Q 267
V + +Y APE+L R+Y +D+W+ G I LL P F + +
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 268 AII---------------------RSVLDFRRDPWP------------KVSENAKDLVRK 294
I + DF+ +P K DL+RK
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 295 MLDPDPKRRLTAQQVLEHPW 314
+L+ DP +R+TA++ LEHP+
Sbjct: 296 LLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 81/309 (26%), Positives = 139/309 (44%), Gaps = 41/309 (13%)
Query: 30 YGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
YG + L L +PT +E+ +G+G +G Y T++++G A K +
Sbjct: 2 YGLFPYNSSMLGLESLGDPTDT-----WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD 56
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDTAVH----LVMELCEGG--- 141
VD E++ E +I++ LP H N+V Y+ D V LV+ELC GG
Sbjct: 57 PIS---DVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT 112
Query: 142 ELFDRIVARGHYTERAAAA-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200
EL ++ G + A + + + +Q H + ++HRD+K N L + +K
Sbjct: 113 ELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKL 169
Query: 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG 253
+DFG+S + + VG+P++MAPEV+ +Y DVWS G+ L G
Sbjct: 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQ 307
PP + ++++ R+P P K + + + L D + R +
Sbjct: 230 DPPLFDMHP-------VKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVT 282
Query: 308 QVLEHPWLQ 316
+LEHP+++
Sbjct: 283 HLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-21
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H IV D ++ D + L+ME GG+L +I R + E + IV +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMA 226
H +MHRDLK N T +K DFG S + S G+PYY+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ +R Y + D+WS GVILY LL PF ++ + I++ VL + DP+P V
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYDPFPCPV 295
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S K L+ +L +P R T QQ+L +L+
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 5e-21
Identities = 75/291 (25%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L++P G +EL +G G +G Y + G A K + T + E++++
Sbjct: 1 LRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQ 51
Query: 105 EVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYT--ER 156
E+++++ H+NI K+ D + LVME C G + D I T E
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215
A + + I+ + H+H V+HRD+K +N L E A +K +DFG+S + +
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 216 SEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHP 221
Query: 270 IRSVLDFRRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P P++ S+ + + L + +R T +Q+++HP++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 75/250 (30%), Positives = 121/250 (48%), Gaps = 16/250 (6%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L T + G +A K + K L+ D + E DI+ + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPFIV 61
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSPYYMAPEVL-KRNYGPE 237
RDLKPEN L E +K DFGLS EK + G+ YMAPEV+ +R +
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKML 296
D WS GV+++ +L G PF + + I+++ L P+ +S A+ L+R +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----PQFLSPEAQSLLRALF 233
Query: 297 DPDPKRRLTA 306
+P RL A
Sbjct: 234 KRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 47/306 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY +++G G +G D+ G+ A K +S+ ++ + + RE+ +++H
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKH 70
Query: 112 LPKHQNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH-YTERAAAAVTKT 164
+ +H+N++ L D + + LVM + D GH +E +
Sbjct: 71 M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQ 125
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N L N E LK +DFGL+ + + V + +Y
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 225 MAPEVLKR--NYGPEVDVWSAGVILYILLCGV-----------------------PPFWA 259
APEV+ +Y VD+WS G I+ +L G P F
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 260 ETEQGVAQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ E A++ I+S+ + R +PK S A DL+ KML+ D +RLTA + LEHP+
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
Query: 316 QNAKKA 321
+ + A
Sbjct: 301 DSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-21
Identities = 77/280 (27%), Positives = 131/280 (46%), Gaps = 40/280 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI--------EDVR--RE 105
RY L + LG+G FG YL D+ K++++++L+ +I E V+ +E
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDK--------KAVAEERLKVLKEIPVGELNPNETVQANQE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTKT 164
++ L H IV ++ + A ++ E CEG +L ++ H + + V +
Sbjct: 53 AQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 165 IVEV---VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVG 220
+++ V H+ ++HRDLK +N N LK DFG+S + + G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTG 167
Query: 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+PYYM+PE LK + Y + D+WS G ILY + C F Q + VL
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-------EGQNFLSVVLRIVEG 220
Query: 280 PWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
P P + S +++ ML+ DP R +A ++L +P++
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 83/293 (28%), Positives = 135/293 (46%), Gaps = 44/293 (15%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
++E+ +G G +G+ C +E + A K + V E RE+ ++R L K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQ 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+NIV LK+ + ++LV E E EL + + G E+ + + + +++ + CH
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPE-VL 230
K+ ++HRD+KPEN L ++ LK DFG + G ++E V + +Y +PE +L
Sbjct: 118 KNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVLD---------FRRDP 280
YG VD+WS G IL L G P F E+E + Q I+ VL F +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNP 232
Query: 281 ------WPKVSENAK--------------DLVRKMLDPDPKRRLTAQQVLEHP 313
+P V+ DL++ +L +P R +Q L HP
Sbjct: 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ + E A + ++ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI-- 218
D+KP+N L +K DFGL F+ P + + ++
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 219 --------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILL 251
VG+P Y+APEV L++ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR--RLTAQQV 309
G PPF A T +I P K+S A DL+ K+ +R R A +
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 310 LEHPWLQNAKKAPNV 324
HP+ + ++
Sbjct: 303 KAHPFFSEVDFSSDI 317
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-20
Identities = 76/280 (27%), Positives = 133/280 (47%), Gaps = 23/280 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG + D A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +Y T + ++ME GG D + A G + E A + K I++ +
Sbjct: 60 -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV++
Sbjct: 118 HSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWL-QNAKKAPNVS 325
K+ + L+ DP R TA+++L+H ++ +NAKK ++
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 23/273 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + YEL + +G G +G Y + G+ A K I KL D +++E+ +++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V + ++ +
Sbjct: 62 EC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + + +K DFG++ K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 230 --LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++N Y D+W+ G+ L PP + + + S +F+ PK+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMSKSNFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVLEH 312
+ K + V+ L +PK+R TA+++L H
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 77/262 (29%), Positives = 124/262 (47%), Gaps = 22/262 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + G +ACK + KK+L+ + E +I+ + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIV---ARGHYTERA---AAAVTKTIVEVVQMCHKHG 176
+E T + LVM L GG+L I RG ER +A +T I+ + H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSMD 115
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
+++RD+KPEN L ++ + D GL+V K G+ ++ G+ YMAPE+LK Y
Sbjct: 116 IVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----FRRDPWPKVSENAKDL 291
VD ++ G +Y ++ G PF E+ + + R L+ F +E +KD+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDI 229
Query: 292 VRKMLDPDPKRRLTAQQVLEHP 313
R L P+ RL +++ + P
Sbjct: 230 CRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-20
Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H+ G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-20
Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 21/274 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K+
Sbjct: 119 SEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN---- 287
+ Y + D+WS G+ L G PP +E + + L + +P P + N
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLF---LIPKNNP-PTLEGNYSKP 228
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW-LQNAKK 320
K+ V L+ +P R TA+++L+H + ++ AKK
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 80/285 (28%), Positives = 130/285 (45%), Gaps = 40/285 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-EDVRREVDIMRHLP 113
+ +E+ +G+G +G + +++NG A K L DI E++ E +I++ L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALS 72
Query: 114 KHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRI---VARG-HYTERAAAAVTK 163
H N+V KD D + LV+ELC GG + D + + RG E A +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSP 222
+ +Q H + +HRD+K N L + +K +DFG+S + + VG+P
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 223 YYMAPEV------LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++MAPEV L Y DVWS G+ L G PP A+ +R++
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKI 241
Query: 277 RRDPWPKV------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
R+P P + S D +RK L D ++R T +L+H ++
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 77/294 (26%), Positives = 135/294 (45%), Gaps = 39/294 (13%)
Query: 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
L L++P G +EL +G G +G Y + G A K + T + E+
Sbjct: 8 LSALRDPAGI-----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEE 58
Query: 102 VRREVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIV-ARGH-Y 153
++ E+++++ H+NI K D + LVME C G + D + +G+
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212
E A + + I+ + H H V+HRD+K +N L E A +K +DFG+S +
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 175
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CD 228
Query: 267 QAIIRSVLDFRRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+R++ R+P PK+ S+ D + L + R + +Q+L+HP++
Sbjct: 229 MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E T +E ++Y + R LG G G T LC R +G+ FA K + + + + D + E
Sbjct: 24 EATAKEQAKKYWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTA-------VHLVMELCEGGELFDRIVARGH----YT 154
V + + + C +D + D + LV++ G+L I +R +
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--- 211
E A + ++ V H ++HRD+K N L + +K DFG S +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVS 198
Query: 212 ---GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
G F G+PYY+APE+ +R Y + D++S GV+LY LL PF E + V
Sbjct: 199 DDVGRTF---CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
Query: 268 AIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
L R DP P +S +++V +L DPKRR ++ ++L P
Sbjct: 256 ----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + +A K ++K ++ + R E +++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEI-VGSPYYMAPEVLK 231
+ +HRD+KP+N L ++ DFG + + G S + VG+P Y++PE+L+
Sbjct: 120 QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 232 R------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-- 283
YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHI 233
Query: 284 --VSENAKDLVRKMLDPDPKR 302
VSE AKDL+++++ +R
Sbjct: 234 TDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 80/313 (25%), Positives = 125/313 (39%), Gaps = 63/313 (20%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE+ +LG G FG Y + G A K I + I +R E+ I++ L K
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-K 65
Query: 115 HQNIVCLKD-TYE--DDTA-----VHLVM-----ELCEGGELFDRIVARGHYTERAAAAV 161
H N+V L D E D + V++V +L G L + V TE
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-----KPG---- 212
++E + H++ ++HRD+K N L N+ LK DFGL+ + P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGGGG 177
Query: 213 ---EKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K++ +V + +Y PE+L +R Y VD+W G + + P +++
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 268 AIIRSVLDFRRDPWP--------------------------KVSENAKDLVRKMLDPDPK 301
I + + WP K+ DL+ K+L DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 302 RRLTAQQVLEHPW 314
+RLTA LEHP+
Sbjct: 298 KRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 24/274 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K I K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L + +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 290 DLVRKMLDPDPKRRLTAQ------QVLEHPWLQN 317
+++ L+ DPK RL + HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 50/281 (17%)
Query: 61 RELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
++LG G FG Y + A K++ K+ + + +D +E +M+ L H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKL-GHPN 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----- 172
+V L ++ ++LV+E EGG+L D + + ++ +++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAK 116
Query: 173 -----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
+HRDL N L +K DFGLS ++ YY
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSR---------DVYDDDYYRKK 164
Query: 225 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV-AQAIIRS 272
MAPE LK + + DVWS GV+L+ I G P+ G+ + ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-----GLSNEEVLEY 219
Query: 273 VLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ R P P+ + +L+ DP+ R T +++E
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 72/282 (25%), Positives = 114/282 (40%), Gaps = 53/282 (18%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPK 114
ELG++LG G FG Y T + +G+ ++ K L+ + + E+ E IM+ L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGE-GTETKVAVKTLKEGASEEEREEFLEEASIMKKL-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
H NIV L +++V E GG+L D + G T+ +++QM
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------KLTLKDLLQMALQ 110
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
+HRDL N L +K DFGLS +I YY
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYY 158
Query: 225 ------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
MAPE LK + + DVWS GV+L+ I G P+ + + V + +
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+R + +L+ + DP+ R T +++E
Sbjct: 219 D---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 76/306 (24%), Positives = 140/306 (45%), Gaps = 50/306 (16%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ +RY +++G G +G DR G A K + + ++ + + RE+ +
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 67
Query: 109 MRHLPKHQNIVCLKDTYEDDTAV------HLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ KH+N++ L D + D ++ +LVM G +++ +E +
Sbjct: 68 LKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV 124
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-- 220
+++ ++ H G++HRDLKP N E LK +DFGL+ + SE+ G
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA-----RQTDSEMTGYV 176
Query: 221 -SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVP---------------------- 255
+ +Y APEV+ +Y VD+WS G I+ +L G P
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 256 -PFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F + + A+ ++ + FR+ + P + A +++ KML D + R+TA + L
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
Query: 311 EHPWLQ 316
HP+ +
Sbjct: 297 AHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 85/310 (27%), Positives = 127/310 (40%), Gaps = 51/310 (16%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G+G +G+ D G+ A K I D + RE+ ++R L +H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL-RH 58
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+IV +K ++D +++V EL E +L I A T ++
Sbjct: 59 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFK--PGEKF-SEIVGSPY 223
++ H V HRDLKP+N L AN LK DFGL+ V F P F ++ V + +
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL-ANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 224 YMAPEV---LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 261
Y APE+ Y P +D+WS G I +L G P F ET
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 262 EQGVAQAIIRSVLDFRR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
V R L R +P A L+ ++L DPK R TA++ L P
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 314 WLQNAKKAPN 323
+ + K
Sbjct: 292 YFKGLAKVER 301
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 55/252 (21%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV ++++L KH NIV L D + + LV E + Y + ++
Sbjct: 52 REVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDSD--------LKQYLDNCGNLMSM 102
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFFKP 211
V++ + CHK ++HRDLKP+N L K E LK DFGL SV P
Sbjct: 103 HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---P 156
Query: 212 GEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +S V + +Y P+VL Y +D+W G ILY + G P F T + I
Sbjct: 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
Query: 270 IRSVLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRR 303
R + + WP ++ N + DL+ +L + K R
Sbjct: 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSR 276
Query: 304 LTAQQVLEHPWL 315
++A+ L H +
Sbjct: 277 ISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 27/270 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E +G G G Y R G +A K I + VR RE++I+R +
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDV- 129
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N+V D ++ + + +++E +GG L +A E+ A V + I+ + H
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLH 185
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKR 232
+ ++HRD+KP N L + K +K DFG+S + + + + VG+ YM+PE +
Sbjct: 186 RRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 233 NY------GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFRRDPWPKVS 285
+ G D+WS GV + G PF QG +++ ++ + + S
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEAPATAS 301
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ + L +P +R +A Q+L+HP++
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 46/300 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV T+ + I
Sbjct: 73 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYR 184
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------- 273
APE++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244
Query: 274 ------------------LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
++F + + + A DL+ KML D +R+TA Q L H +
Sbjct: 245 ISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG Y D + A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I +Y T + ++ME GG D ++ G E A + + I++ +
Sbjct: 60 -DSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K
Sbjct: 118 HSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPN-------SDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
K+ V L+ DP+ R TA+++L+H ++ K
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 77/266 (28%), Positives = 120/266 (45%), Gaps = 18/266 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E I+ ++ H V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F +K VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENAKDLVRKML 296
D +S G +L+ LL G PF + I R L + P S + L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVE-LPDSFSPELRSLLEGLL 234
Query: 297 DPDPKRRL-----TAQQVLEHPWLQN 317
D RRL AQ+V EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 84/296 (28%), Positives = 116/296 (39%), Gaps = 56/296 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLPKHQ 116
+LG G + Y R NG A K IS K TA+ RE +++ L KH
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL-KHA 63
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D + V E I G ++ + H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL--KRN 233
++HRDLKP+N L + E LK DFGL+ P + +S V + +Y P+VL +
Sbjct: 124 ILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-----IRSVLDF-RRDPWPKVSE- 286
Y +D+W AG I +L G P F GV+ I +VL D WP VS+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 287 ---------------------------NAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+DL +ML PK R++AQ L HP+
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 74/299 (24%), Positives = 130/299 (43%), Gaps = 44/299 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D A K +S+ ++ + RE+ +++H
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV ++ + +
Sbjct: 71 M-KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N E L+ +DFGL+ + ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAK----DLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+ I+S+ + K+ A DL+ KML D +R++A + L HP+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 28/279 (10%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIM 109
++ + LG E+G G G Y ++ G A K + RT E+ R ++D++
Sbjct: 13 DLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRILMDLDVV 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVE 167
IV + D+ V + MEL D+++ R G E +T IV+
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 168 VVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ + KHGV+HRD+KP N L + +K DFG+S + + G YMA
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 227 PEVL-----KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRS---VLDFR 277
PE + Y DVWS G+ L L G P+ +TE V I++ L
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242
Query: 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S + V L D ++R +++L+HP+++
Sbjct: 243 EG----FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE E+G G +G + D +NG F ++ K++R E + REV ++R
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLR 56
Query: 111 HLP--KHQNIV-----CLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAV 161
HL +H N+V C + +T + LV E + D++ G TE +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + + +V +
Sbjct: 117 FQ-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVT 172
Query: 222 PYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+Y APEV L+ +Y VD+WS G I + P F ++ I+ + +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 281 WPK-----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
WP+ + E KDL+ K L +P +R++A L HP+
Sbjct: 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L +I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-----PKSMSKEAVAICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 49/251 (19%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D D ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P+VL Y ++D+W G I + + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220
Query: 273 VLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRRLTA 306
+ + WP +S N + +L+ K L + K+R++A
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 307 QQVLEHPWLQN 317
++ ++H + ++
Sbjct: 281 EEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 16/264 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E+ I+ ++ H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D +S G +L+ LL G PF + I R L + S K L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 298 PDPKRRL-----TAQQVLEHPWLQ 316
D +RL AQ+V EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 63/250 (25%), Positives = 112/250 (44%), Gaps = 49/250 (19%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D + ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEY------LDKDLKQ--YLDDCGNSINM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
Query: 273 VLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRRLTA 306
+ + WP + N + +L+ K+L + ++R++A
Sbjct: 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA 280
Query: 307 QQVLEHPWLQ 316
++ ++HP+
Sbjct: 281 EEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 82/306 (26%), Positives = 129/306 (42%), Gaps = 63/306 (20%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLP 113
E R +G G FG+ + TD +G K ++ KK+ V + V RE+ ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFF- 56
Query: 114 KHQNIVCLKDT--------YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
KH N++ D +E+ +++V EL + +L IV+ + I
Sbjct: 57 KHDNVLSALDILQPPHIDPFEE---IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPY 223
+ ++ H G++HRD+KP N L + LK DFGL+ +P E ++ V + Y
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVVTQY 169
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPPFWAE 260
Y APE+L R+Y VD+WS G I L L G P A
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 261 TE--QGVAQAIIRSVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRRLTAQQVL 310
+G I+R + P V + A L+ +ML DP +R++A L
Sbjct: 230 RSACEGARAHILRGPH---KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 311 EHPWLQ 316
HP+L
Sbjct: 287 AHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 73/312 (23%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L ++ G +A K++ K ++ + V+ E D++ +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D ++L+ME GG+L ++ ++E V ++ HK G +HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM--------APEVLKRN- 233
KP+N L +K DFGLS F + S YY + RN
Sbjct: 128 KPDNILI---DRGGHIKLSDFGLST------GFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 234 ------------------------------------YGPEV----------DVWSAGVIL 247
PE+ D WS G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 248 YILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL- 304
+ L G PPF +E + II R L F D +S A+DL+R+++ + + RL
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLG 295
Query: 305 --TAQQVLEHPW 314
A ++ HP+
Sbjct: 296 RGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 54/314 (17%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
ELG G G+ R +G A K I +++ A+ + RE+ ++ H IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGVMH 179
+ D + + ME +GG L D+++ + G E ++ ++ + + KH +MH
Sbjct: 65 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLKRN-Y 234
RD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE L+ Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI------------------------- 269
+ D+WS G+ L + G P + +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 270 ---IRSVLDF-RRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
I +LD+ +P PK+ S+ +D V K L +PK R +++ +HP+++ A +
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA-E 294
Query: 321 APNVSLGETVKARL 334
V V + +
Sbjct: 295 LEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 41/101 (40%), Positives = 61/101 (60%), Gaps = 10/101 (9%)
Query: 218 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
I+G+P Y+APE+L + +GP VD W+ GV L+ L G+PPF ET Q V Q I+
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594
Query: 277 RRDPWP----KVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
R PWP K+S NA++ + +L DP +R +++ +HP
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 85/351 (24%), Positives = 148/351 (42%), Gaps = 63/351 (17%)
Query: 14 GKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY- 72
GK + N KK + + + + + + + R + Y+LG +G G FG+ Y
Sbjct: 26 GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDND-INRSPNKSYKLGNIIGNGSFGVVYE 84
Query: 73 -LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------ 125
+C D A KK L+ D + RE+ IM++L H NI+ LKD Y
Sbjct: 85 AICIDTSEKVAI------KKVLQ---DPQYKNRELLIMKNL-NHINIIFLKDYYYTECFK 134
Query: 126 --EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--QMC------HKH 175
E + +++VME + + + R A+ +V++ Q+C H
Sbjct: 135 KNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
+ HRDLKP+N L T LK DFG + G++ + S +Y APE++ N
Sbjct: 190 FICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN 247
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---------------SVLDFR- 277
Y +D+WS G I+ ++ G P F ++ II+ + D +
Sbjct: 248 YTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKF 307
Query: 278 --------RDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
+ +PK ++A + + + L +P +RL + L P+ + +
Sbjct: 308 PDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358
|
Length = 440 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
IEE + + + + RG FG YL + N +A K + K + + V+ E D + L
Sbjct: 3 IEE-FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-L 60
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--- 169
K IV L + + V+LVME GG++ + G++ E A K I EV
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---VKYISEVALAL 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
H+HG++HRDLKP+N L +N+ +K DFGLS
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 85/332 (25%), Positives = 129/332 (38%), Gaps = 100/332 (30%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ +RY+ + +G G GI D G A K +S+ + + RE+ +M+ L
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMK-L 71
Query: 113 PKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
H+NI+ L + + E+ V+LVMEL + +
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-----------------------MDANLC 108
Query: 167 EVVQM---------------C-----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+V+QM C H G++HRDLKP N + K LK +DFGL+
Sbjct: 109 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 165
Query: 207 VFFKPGEKF--SEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---------------- 247
G F + V + YY APEV L Y VD+WS G I+
Sbjct: 166 R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223
Query: 248 -----YILLCGVPP--FWAETEQGVA---------QAIIRSVLDFRRDPWPKVSEN---- 287
I G P F + + V L F +P SE+
Sbjct: 224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKL 282
Query: 288 ----AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
A+DL+ KML DP++R++ L+HP++
Sbjct: 283 KASQARDLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 82/312 (26%), Positives = 127/312 (40%), Gaps = 72/312 (23%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
+ YE +LG G + Y + NG A K I ++ TA+ RE +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTKTI 165
L KH NIV L D + LV E LC+ Y ++ +
Sbjct: 59 GL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ-------------YMDKHPGGLHPEN 104
Query: 166 VEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFS 216
V++ + H+ ++HRDLKP+N L + +T LK DFGL+ P +S
Sbjct: 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYS 161
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI---- 269
V + +Y P+VL Y +D+W G I ++ GV F + Q + I
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
Query: 270 ----------IRSVLDFR------------RDPWPKVS--ENAKDLVRKMLDPDPKRRLT 305
+ S+ F+ R W K+S +A+DL K+L PK RL+
Sbjct: 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281
Query: 306 AQQVLEHPWLQN 317
AQ L H + +
Sbjct: 282 AQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 77/306 (25%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D G A K +S+ + + RE+ +++ +
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-N 78
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGI 136
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 137 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA-------QAIIRS 272
V L Y VD+WS G I+ L+ G F W + + + + +
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 273 VLDF--RRDPWPKVS---------------------ENAKDLVRKMLDPDPKRRLTAQQV 309
V ++ R +P +S A+DL+ KML DP +R++ +
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 310 LEHPWL 315
L HP++
Sbjct: 313 LRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 20/223 (8%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE + L H NIV L D+ E + V E G L + + A G +
Sbjct: 26 RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--------- 212
+++ + H G++HRDLKP+N + + K +DFG+ PG
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143
Query: 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ +E++G+P Y APE L+ P D+++ G+I L G + VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200
Query: 272 --SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
S +D PW ++RK L+ DP++R +A + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 76/306 (24%), Positives = 131/306 (42%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 74
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 133 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 229 V-LKRNYGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGV 265
V L Y VD+WS G I+ I G P P + + Q
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 266 AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + + +PK+ + A+DL+ KML DP +R++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 310 LEHPWL 315
L+HP++
Sbjct: 309 LQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTA---VDIEDVRREVDI 108
E+R+ + ++LG G FG LC D + ++ K L + D RE++I
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAV--KSLNHSGEEQHRSDFEREIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+R L H+NIV K E ++ L+ME G L R + H R + + ++
Sbjct: 60 LRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLL 113
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SE 217
Q+C +HRDL N L ++ +K DFGL+ + + E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKE 170
Query: 218 IVGSP-YYMAPEVLK-RNYGPEVDVWSAGVILYILL 251
SP ++ APE L+ + DVWS GV LY L
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 72/277 (25%), Positives = 104/277 (37%), Gaps = 54/277 (19%)
Query: 63 LGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPKHQNI 118
LG G FG Y T G ++ K LR ++ + +E +M + H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVVQMC-- 172
V L + +++MEL EGG+L Y A T+ E++ +C
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDICLD 114
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGSP 222
+ +HRDL N L + K A +K DFGL+ +I S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 223 YY------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 268
YY MAPE L + + DVWS GV+++ IL G P+ A Q V Q
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ R + L+ DP R T
Sbjct: 226 VTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 77/293 (26%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY++ R +G+G G YL D A K I + + + RE I L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-I 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAAA---VTK 163
H IV + D V+ M EG L +++ + + A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK------------- 210
I ++ H GV+HRDLKP+N L E L D+G ++F K
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVDE 177
Query: 211 PGEKFSE------IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQ 263
+S IVG+P YMAPE L E D+++ GVILY +L P+ ++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKK 235
Query: 264 GVAQAIIRSVLD------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G + +L +R P P +S+ + K L DP R ++ Q L
Sbjct: 236 GRKISYRDVILSPIEVAPYREIP-PFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 53/306 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 81
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V++VMEL + +++ ER + + + + +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 140 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAI 269
V L Y VD+WS G I+ ++ G F W + + + Q
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 270 IRSVLDFR--------RDPWPKV------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+R+ ++ R +P V + A+DL+ KML D +R++ +
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 310 LEHPWL 315
L+HP++
Sbjct: 316 LQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 47/255 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVD 107
ELG G FG Y + + S++ K L+ + ++ R+E +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT--- 164
+M L +H NIVCL + ++ E G+L + +V +++ A + +T
Sbjct: 61 LMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 165 -------------IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
I ++ H +HRDL N L +K DFGLS
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS----- 171
Query: 212 GEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I + YY M PE +L + E D+WS GV+L+ I G+ P+
Sbjct: 172 ----RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
Query: 258 WAETEQGVAQAIIRS 272
+ + Q V + +IRS
Sbjct: 228 YGFSNQEVIE-MIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 80/324 (24%), Positives = 137/324 (42%), Gaps = 75/324 (23%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERA-----------AAAV 161
H N++ L+ + D V L+ + E +L+ + + H +A ++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFS 216
I++ + H + V+HRDLKP N L + E +K D G + F KP
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE------------ 262
+V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233
Query: 263 ----------------QGVAQAIIRSVL--DFRRDPWP-----------KVSENAK--DL 291
+ + + S L DFRR+ + KV ++K L
Sbjct: 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWL 315
++K+L DP +R+T++Q ++ P+
Sbjct: 294 LQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 82/321 (25%), Positives = 132/321 (41%), Gaps = 69/321 (21%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGEL----FDRIVARGHYTERAAAAVTKT---- 164
H N++ L+ + D V L+ + E F R + ++ K+
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFSEIV 219
I++ + H + V+HRDLKP N L + E +K D G + F KP +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
Query: 270 IRSVL----------------------DFRRDPWP-----------KVSENAKD--LVRK 294
I SV+ DFRR + KV ++K L++K
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296
Query: 295 MLDPDPKRRLTAQQVLEHPWL 315
+L DP +R+T++Q L+ P+
Sbjct: 297 LLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 61 RELGRGEFG-ITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R LG G FG ++ C D N G+ A K++ K+ + ++E++I++ L H+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL-YHE 66
Query: 117 NIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
NIV K + + L+ME G L D Y + + + ++ Q+C
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSP-YY 224
H +HRDL N L N + +K DFGL+ G ++ E SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILL 251
A E LK N + DVWS GV LY LL
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 80/330 (24%), Positives = 138/330 (41%), Gaps = 56/330 (16%)
Query: 35 QGNGGHKLCVLKEPTG--REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
Q + + C + + +Y + L G G ++CT GD K I K
Sbjct: 70 QTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVK-- 125
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ RE+DI++ + H+ I+ L Y + V +VM + +LF + G
Sbjct: 126 --AVTGGKTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP 181
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
A + + ++E + H G++HRD+K EN +F ++ E A L DFG + K
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLD 236
Query: 213 E-----KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G+ +PE+L + Y + D+WSAG++L+ + + V F + +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 266 AQ--AIIRSV----LDF------------------RRDPW--PKV------SENAKDLVR 293
+Q +IIR + L+F R P+ P V + + L+
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIA 356
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
KML D + R +AQ +L P K+ N
Sbjct: 357 KMLTFDQEFRPSAQDILSLPLF--TKEPIN 384
|
Length = 392 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 59/314 (18%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + G E+ V+ +++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG----VPPFWAETEQGVAQAI-------------- 269
L+ +Y + D+WS G+ L + G PP E E +
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232
Query: 270 ------------------IRSVLDF-RRDPWPKV-----SENAKDLVRKMLDPDPKRRLT 305
I +LD+ +P PK+ +D V K L +P R
Sbjct: 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292
Query: 306 AQQVLEHPWLQNAK 319
+Q++ H +++ ++
Sbjct: 293 LKQLMVHAFIKRSE 306
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G+FG+ +L A K+I + A+ ED E +M L H +V L
Sbjct: 11 EIGSGQFGLVWLGY-WLEKRKVAIKTIREG----AMSEEDFIEEAQVMMKL-SHPKLVQL 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + + LV E E G L D + A RG +++ + + E + V+HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLK-RNYGP 236
DL N L E +K DFG++ F ++++ G+ + + +PEV Y
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 237 EVDVWSAGVILY 248
+ DVWS GV+++
Sbjct: 181 KSDVWSFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 54/287 (18%)
Query: 61 RELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R+LG G FG LC GD A KS+ K I D+++E++I+R+L H+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 66
Query: 117 NIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT-KTIVE-VVQMC 172
NIV K +D + L+ME G L + Y R + K ++ VQ+C
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 173 H------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSP- 222
+HRDL N L ++ + +K DFGL+ + +++ + + SP
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETE----------------QGV 265
++ APE L + + DVWS GV LY LL + ++E Q
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQMT 231
Query: 266 AQAIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
++R + + +R P P E L+RK + P +R T Q ++E
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 56/197 (28%), Positives = 80/197 (40%), Gaps = 17/197 (8%)
Query: 62 ELGRGEFGITYLCT-DRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+LG G FG+ G A K + KL +D D +E IM L H+N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL-DHENL 58
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L + +V EL G L DR+ A GH+ I ++
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPY-YMAPEVLK- 231
+HRDL N L A+ + +K DFGL E E + P+ + APE L+
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 232 RNYGPEVDVWSAGVILY 248
R + DVW GV L+
Sbjct: 175 RTFSHASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 72/270 (26%), Positives = 108/270 (40%), Gaps = 32/270 (11%)
Query: 55 ERYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E LGR +G G+FG Y + A + K + E +E IMR
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF- 64
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEVVQM 171
H +IV L ++ V +VMEL GEL Y + + + I+ Q+
Sbjct: 65 DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQL 116
Query: 172 C------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY- 223
+HRD+ N L ++ +K DFGLS + + + G P
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVLDFRRDP 280
+MAPE + R + DVW GV ++ IL+ GV PF QGV +I + + R P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRIENGERLP 228
Query: 281 WPKVSENA-KDLVRKMLDPDPKRRLTAQQV 309
P L+ K DP +R ++
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPKHQN 117
ELGRG +G+ G A K ++R V+ ++ +R ++DI
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARG-HYTERAAAAVTKTIVEVVQMCH- 173
V + V + ME+ + + + ++ +G E + +IV+ ++ H
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
K V+HRD+KP N L N+ +K DFG+S + + G YMAPE +
Sbjct: 122 KLSVIHRDVKPSNVL-INRN--GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 231 --KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
++ Y + DVWS G+ + L G P+ W Q + Q + +P P++
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQLPA 230
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
S +D V K L + K R ++L+HP+ +
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 21/259 (8%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG +G+GEFG L R G A K + K TA E +M L +H N
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCL--KDDSTAAQ--AFLAEASVMTTL-RHPN 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKH 175
+V L +++V E G L D + +RG T + E ++ +
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLKRN- 233
+HRDL N L + E K DFGL+ K + + P + APE L+
Sbjct: 122 NFVHRDLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKK 175
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS G++L+ I G P+ + V + + +R + ++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYKVM 232
Query: 293 RKMLDPDPKRRLTAQQVLE 311
+ + DP +R T +Q+ E
Sbjct: 233 KDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 71/328 (21%), Positives = 129/328 (39%), Gaps = 67/328 (20%)
Query: 58 ELGRELGRGEFGIT--YLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHL 112
EL +G+ + +L + A K I+ L + ED++ E+ R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSK-EDLKLLQQEIITSRQL 56
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT----ERAAAAVTKTIVEV 168
+H NI+ ++ D+ +++V L G D + + H+ E A A + K ++
Sbjct: 57 -QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV---FFKPGEKFSEIVGSP--- 222
+ H G +HR +K + L + K + GL K G++ + P
Sbjct: 114 LDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 223 ----YYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETE---------QGVA 266
+++PEVL++N Y + D++S G+ L G PF + +G
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF-KDMPATQMLLEKVRGTV 227
Query: 267 QAII-RSVL--------------------DFRRDPWPKV-SENAKDLVRKMLDPDPKRRL 304
++ +S D P+ + SE+ V L DP+ R
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
Query: 305 TAQQVLEHPWLQNAKKAPNVSLGETVKA 332
+A Q+L H + + K+ N SL + +K
Sbjct: 288 SASQLLNHSFFKQCKRR-NTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 21/260 (8%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G+FG+ +L R A K I + A+ +D E +M L H N+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG----AMSEDDFIEEAKVMMKL-SHPNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGV 177
V L + +V E G L + + R + + E ++ +G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN- 233
+HRDL N L E +K DFGL+ + + S G+ + + PEV +
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSR 177
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDL 291
+ + DVWS GV+++ + G P+ + V +++ R PK+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----RLYRPKLAPTEVYTI 233
Query: 292 VRKMLDPDPKRRLTAQQVLE 311
+ P+ R +++L
Sbjct: 234 MYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 58/242 (23%), Positives = 99/242 (40%), Gaps = 48/242 (19%)
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCH 173
H +++ +KDT +V+ +L+ + R A + K I+E ++ H
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRD+K EN +F N + + D G + F F + G+ APEVL R+
Sbjct: 175 AQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----VLD-----------FR 277
Y + D+WSAG++L+ +L P E + ++S +L F
Sbjct: 232 KYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290
Query: 278 RDP---------------------WPKVS-----ENAKDLVRKMLDPDPKRRLTAQQVLE 311
RDP +P + + LV KML D R +A+++L
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350
Query: 312 HP 313
+P
Sbjct: 351 YP 352
|
Length = 357 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + E V+ ++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG---VPP 256
L+ +Y + D+WS G+ L L G +PP
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR-----EVDIMRHLPKHQNIVCLK 122
F I T G AFAC K V I+ +R E I+R + H +I+ LK
Sbjct: 94 FSILETFTPGAEGFAFAC---IDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLK 149
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T+ + L++ + +L+ + A+ + A+ ++++ +Q H++ ++HRD+
Sbjct: 150 GTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN +F N L DFG + F P K+ G+ APE+L R+ YGP
Sbjct: 209 KAEN-IFINHPGDVCLG--DFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPA 263
Query: 238 VDVWSAGVILY 248
VD+WSAG++L+
Sbjct: 264 VDIWSAGIVLF 274
|
Length = 391 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIV 119
+ELG G+FG+ +L G A ++ K + A+ ED E +M L H +V
Sbjct: 10 KELGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLV 62
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVM 178
L +++V E E G L + + R G ++ ++ + + E ++ ++ +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-Y 234
HRDL N L + T +K DFG++ + E S G+ + + PEV + Y
Sbjct: 123 HRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKY 178
Query: 235 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ DVWS GV+++ + G PF ++ V + I R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 65/269 (24%), Positives = 102/269 (37%), Gaps = 23/269 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVDIMRH 111
G+ LG G FG T + A ++ K L+ E + E+ IM H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTIVEVV 169
L H+NIV L + ++ E C G+L + R T + + + + +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL-------SVFFKPGEKFSEIVGSP 222
+HRDL N L + K K DFGL S + G +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIV---KICDFGLARDIMNDSNYVVKGNARLPV---- 207
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MAPE + Y E DVWS G++L+ I G P+ +I+ +R
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMAQ 265
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
D+++ D DP +R T +Q+
Sbjct: 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 63 LGRGEFGITYLC----TDRENGDAF-ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
LGRGEFG +L + E G+ K++ K K + RRE+D+ R L H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVV-QMCH- 173
+V L + ++++E + G+L F R + TK V + Q+
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 174 -----KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMA 226
+HRDL N L ++++E +K LS V+ K + ++A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 227 PE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE V + ++ + DVWS GV+++ + G PF+ +++ V + L+ P V
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----LP-V 240
Query: 285 SENAKDLVRKML----DPDPKRRLTAQQVL 310
E + K++ +PK R + +++
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 53/287 (18%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
L RELG G FG +L C E + A K++ + A +D RE +++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF- 65
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVV 169
+H+NIV + +V E E G+L + + G + + T+ +++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 170 Q-----------MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
Q + +H V HRDL N L +K DFG+S ++
Sbjct: 126 QIAVQIASGMVYLASQHFV-HRDLATRNCLVGYD---LVVKIGDFGMS---------RDV 172
Query: 219 VGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+ YY M PE ++ R + E DVWS GV+L+ I G P++ + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
V + I + L R P D++ DP++R+ + + E
Sbjct: 233 VIECITQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 50/243 (20%)
Query: 62 ELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
ELG FG Y E A A K++ K K + E+ + E +MR +H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMRSRLQHP 68
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI---VEVVQMCH 173
NIVCL + + ++ C +L + +V R +++ + KT+ +E H
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 174 -------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
H V+H+DL N L +K +K D GL F E+
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYA 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M+PE ++ + + D+WS GV+L+ + G+ P+ + Q V
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 267 QAI 269
+ I
Sbjct: 237 EMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMR 110
EER+ + ++LG+G FG LC D + ++ KKL+ TA + D RE++I++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTG-EVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 111 HLPKHQNIVCLKDT-YE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L +H NIV K Y + LVME G L D + + K ++
Sbjct: 61 SL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----RKLLLYA 114
Query: 169 VQMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
Q+C +HRDL N L ++ +K DFGL+ P +K V P
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVL-PQDKEYYKVREP 170
Query: 223 -----YYMAPEVLKRN-YGPEVDVWSAGVILYIL 250
++ APE L + + DVWS GV+LY L
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 30/199 (15%)
Query: 131 VHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188
+ + E +GG L + +I H R A AV K + + + ++HRD+KP N L
Sbjct: 74 ISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNML 127
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE-VLKRNYGPEVDVWSA 243
+ + +K DFG+S + + I VG+ YMAPE + YG DVWS
Sbjct: 128 VNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 244 GVILYILLCGVPPF-WAETEQG------VAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
G+ L G P+ + QG + Q I+ D P + SE + + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVLPVGQFSEKFVHFITQCM 237
Query: 297 DPDPKRRLTAQQVLEHPWL 315
PK R + +++HP++
Sbjct: 238 RKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 71/265 (26%), Positives = 107/265 (40%), Gaps = 26/265 (9%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQN 117
+ +G GEFG + G ++ K L+ + D E IM H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPN 66
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
I+ L+ V ++ E E G L F R G +T + + I ++ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG--SPY-YMAPEVLK- 231
+HRDL N L N K DFGLS + E G P + APE +
Sbjct: 126 NYVHRDLAARNIL-VNSNLVC--KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 232 RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
R + DVWS G++++ ++ G P+W + Q V I++V D R P P +A
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVEDGYRLPPPMDCPSA-- 236
Query: 291 LVRKMLD---PDPKRRLTAQQVLEH 312
L + MLD D R T Q++
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LG +G GEFG + + ++ K ++ V + E +M L H+N+
Sbjct: 10 LGEIIGEGEFGAVL-------QGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------IVEVVQMC 172
V L + +++VMEL G L + + RG RA +V + + E ++
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLK 231
++HRDL N L + E K DFGL+ + G + P + APE LK
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALK 170
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + DVWS GV+L+ + G P+ + + V + + + +R +P +
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVY 227
Query: 290 DLVRKMLDPDPKRRLTAQQVLE 311
L+ + +PK+R + ++ E
Sbjct: 228 VLMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 55/215 (25%), Positives = 78/215 (36%), Gaps = 53/215 (24%)
Query: 61 RELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ELG G FG A K++ ++ + ++ RE +M L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---- 173
IV L + + + LVMEL G L + R ++ ++ H
Sbjct: 58 IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPV----------SDLKELAHQVAM 106
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
KH V HRDL N L N+ + K DFG+S GS YY A
Sbjct: 107 GMAYLESKHFV-HRDLAARNVLLVNRHQA---KISDFGMSRALGA--------GSDYYRA 154
Query: 227 PEVLK---RNYGPEV----------DVWSAGVILY 248
+ + Y PE DVWS GV L+
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPK 114
+LG E+GRG FG + +G A K I R+ VD ++ +R ++D++
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGG-ELFDRIV---ARGHYTERAAAAVTKT 164
IV + E D + MEL + + F + V + E +
Sbjct: 62 CPYIV----KFYGALFREGDCWI--CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 165 IVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
V+ + + + ++HRD+KP N L +K DFG+S + G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRP 172
Query: 224 YMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDFR 277
YMAPE + + Y DVWS G+ LY + G P+ W + Q +
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232
Query: 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ S + + + L D +R +++LEHP+++
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
+R LG+ LG G FG D+ D +++ K L+ T D+ D+ E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTV--TVAVKMLKDNATDKDLADLISEME 69
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+M+ + KH+NI+ L + +++++E G L + + AR +TK E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 168 VVQMCHKHGV------------------MHRDLKPENFLFANKKETAPLKAIDFGLSV-- 207
Q+ K V +HRDL N L E +K DFGL+
Sbjct: 130 --QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGV 184
Query: 208 ----FFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
++K K S +MAPE L R Y + DVWS G++++ I G P+
Sbjct: 185 HDIDYYK---KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 70/279 (25%), Positives = 105/279 (37%), Gaps = 37/279 (13%)
Query: 58 ELGRELGRGEFGITYLCTDR-ENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
L R LG G FG Y R +GDA + + + D D E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQ 170
HQNIV L + +++EL GG+L + ER ++ K ++ +V +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 171 MCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
C ++ +HRD+ N L K K DFG++ +I + YY
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKG 178
Query: 225 ---------MAPEV-LKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 273
M PE L + + DVWS GV+L+ I G P+ T Q V + +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
R DP ++ P+ R +LE
Sbjct: 239 ---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 55 ERYELGRELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+R LG+ LG G FG + A K + K T D+ D+ E+++M
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMM 69
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---GHYTERAAAAVTK--- 163
+ + KH+NI+ L + +++V+E G L D + AR G Y +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 164 TIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
T ++V ++ +HRDL N L E +K DFGL+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA------- 179
Query: 214 KFSEIVGSPYY------------MAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 180 --RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 23/251 (9%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
+LG G++G Y ++ A K++ + + +E+ +E +M+ + KH N+V L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KHPNLVQL 67
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMCHKHGVMH 179
+ +++ E G L D + A + I ++ K +H
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-YG 235
RDL N L E +K DFGLS G+ ++ G+ + + APE L N +
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLD--FRRDPWPKVSENAKDLV 292
+ DVW+ GV+L+ I G+ P+ G+ + + +L+ +R + +L+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238
Query: 293 RKMLDPDPKRR 303
R +P R
Sbjct: 239 RACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 21/251 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPKHQNIVC 120
+GRG FG + R + A KS + D++ +E I++ H NIV
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQY-SHPNIVR 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L +++VMEL +GG+ + G + + + ++ +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPY-YMAPEVLKRNYG- 235
RDL N L K LK DFG+S + G S + P + APE L NYG
Sbjct: 118 RDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGR 172
Query: 236 --PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
E DVWS G++L+ G P+ + Q +AI + V R + L+
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLM 229
Query: 293 RKMLDPDPKRR 303
+ + DP +R
Sbjct: 230 ERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 34/251 (13%)
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
L D F K LR + + R + I +P N+VCL + +V
Sbjct: 11 LVMDTRTQQTFILKG-----LRKSSEYSRERLTI-IPHCVP---NMVCLHKYIVSEDSVF 61
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LV++ EGG+L+ I + E +V + H+ G++ RDL P N L ++
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 193 KETAPLKAIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLKRNYGPEV-DVWSAGVILY 248
++ F + GE + Y APEV + E D WS G IL+
Sbjct: 122 GH---IQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILF 173
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA-- 306
LL G G+ ++ ++ VSE A+ L++++L +P RL A
Sbjct: 174 ELLTGKTLVECHP-SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGAGV 225
Query: 307 ---QQVLEHPW 314
+ + HP+
Sbjct: 226 AGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
++ LG+ LG G FG + D++ +++ K L+ T D+ D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAV--TVAVKMLKDDATEKDLSDLVSEME 72
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----------------G 151
+M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
T + + T + ++ +HRDL N L E +K DFGL+
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 212 GEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+++ I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE- 217
AV + ++ + H G++HRD+K EN + N E L DFG + F + G +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFAR-GSWSTPF 318
Query: 218 ---IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
I G+ APEVL + Y P VD+WSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRRE 105
++ + +G GEFG +C+ R K K+++ A+ D E
Sbjct: 5 CIKIEKVIGAGEFG--EVCSGR-------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSE 55
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTK 163
IM H NI+ L+ V +V E E G L D + + G +T + +
Sbjct: 56 ASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLR 113
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS 221
I ++ G +HRDL N L K DFGLS + P ++ G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 222 -PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
P + APE + R + DVWS G++++ ++ G P+W + Q V +AI
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 74/279 (26%), Positives = 111/279 (39%), Gaps = 55/279 (19%)
Query: 52 EIEER-YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIM 109
EI+ +L R+LG G+FG + N ++ K L+ +D +D E IM
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVW--EGLWNNTT----PVAVKTLKPGTMDPKDFLAEAQIM 55
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H ++ L + +++V EL + G L + Y + A K + +++
Sbjct: 56 KKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALK-LPQLI 106
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PG 212
M +HRDL N L E K DFGL+ K G
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEAREG 163
Query: 213 EKFSEIVGSPY-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
KF P + APE N + + DVWS G++L I+ G P+ T V Q +
Sbjct: 164 AKF------PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLD---PDPKRRLT 305
+ R P P K+L MLD DP R T
Sbjct: 218 DQGY----RMPCPPGCP--KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLR---TAVD 98
++P +R LG+ LG G FG + D+E + ++ K L+ T D
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKD 66
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG------H 152
+ D+ E+++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 153 YTERAAAAVTKTIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAID 202
Y + ++V ++ +HRDL N L E +K D
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIAD 183
Query: 203 FGLSVFFKPGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
FGL+ + + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
++G+G FG Y + N + A K+ + +E +I++ H NIV
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTC--RSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-------- 172
L +++VMEL GG L + + +T +++QM
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVK--KLLQMSLDAAAGME 107
Query: 173 --HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-----VFFKPGEKFSEIVGSPY-Y 224
+HRDL N L E LK DFG+S + + +I P +
Sbjct: 108 YLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKW 161
Query: 225 MAPEVLKRNYG---PEVDVWSAGVILY-ILLCGVPPF 257
APE L NYG E DVWS G++L+ G P+
Sbjct: 162 TAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 59/303 (19%)
Query: 59 LGRELGRGEFGITYL------CTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMR 110
L RELG G FG +L C +++ ++ K L+ A D +D RE +++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDK------ILVAVKTLKDASDNARKDFHREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L +H++IV + + +V E + G+L + A G A + Q
Sbjct: 63 NL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 171 MCH-------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
M H +HRDL N L E +K DFG+S +
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RD 169
Query: 218 IVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ + YY M PE ++ R + E DVWS GV+L+ I G P++ +
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
V + I + + R P + DL+ +P RL +++ H LQN KA
Sbjct: 230 EVIECITQGRVLQRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASP 284
Query: 324 VSL 326
V L
Sbjct: 285 VYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 56 RYELGRELGRGEFGITYLC------TDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
R LG+ LG G FG + D+ N +++ K L+ T D+ D+ E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPV----TVAVKMLKDDATDKDLSDLVSEM 68
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---------------- 150
++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 69 EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L E +K DFGL+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVH 185
Query: 211 PGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 45/238 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---------EDVRRE 105
E + L R+LG G FG + + + K ++R A+ I +D ++E
Sbjct: 6 EEFTLERKLGSGYFGEVW-------------EGLWKNRVRVAIKILKSDDLLKQQDFQKE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVT 162
V ++ L +H++++ L V+++ EL E G L + E V
Sbjct: 53 VQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVA 104
Query: 163 KTIVEVVQ----MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I Q M + + +HRDL N L E K DFGL+ K S
Sbjct: 105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLS 161
Query: 217 EIVGSPY-YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
PY + APE + + DVWS G++LY + G P+ V I
Sbjct: 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 67/255 (26%), Positives = 101/255 (39%), Gaps = 40/255 (15%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------EDVRR----EVDIMRHL 112
+G GEFG +C R K K+++ A+ E RR E IM
Sbjct: 12 IGAGEFG--EVCRGR-------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQ 170
H NI+ L+ V ++ E E G L F R G +T + + I ++
Sbjct: 63 -DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMK 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY---Y 224
+ +HRDL N L K DFGLS F + ++ +G +
Sbjct: 121 YLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
APE + R + DVWS G++++ ++ G P+W + Q V AI + D+R P
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPM 234
Query: 283 KVSENAKDLVRKMLD 297
L MLD
Sbjct: 235 DCPTALHQL---MLD 246
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 50/243 (20%)
Query: 62 ELGRGEFGITY----LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG FG Y ++ A K++ K + + ++E +M L H N
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA----------------- 160
IVCL + V ++ E G+L + ++ R +++ ++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ I ++ H +H+DL N L E +K D GLS EI
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M PE ++ + + D+WS GV+L+ I G+ P++ + Q V
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236
Query: 267 QAI 269
+ +
Sbjct: 237 EMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 18/218 (8%)
Query: 63 LGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
+G GEFG + L A A K++ K T +D E IM H NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQF-SHHNII 69
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGV 177
L+ ++ E E G L D+ + G ++ + + I ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS-PY-YMAPEVLK-R 232
+HRDL N L + E K DFGLS + P ++ G P + APE + R
Sbjct: 129 VHRDLAARNILVNSNLEC---KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+ DVWS G++++ ++ G P+W + V +AI
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 92/395 (23%), Positives = 152/395 (38%), Gaps = 103/395 (26%)
Query: 6 VTPAAAKQGKKKTNKKKQNPFSIDYGTHHQG-NGGHKLCVLKEPTGREIE---ERYELGR 61
TP + KKK + Y +Q GH VL G +I+ +R+++
Sbjct: 85 TTPTTNVEVAPPPKKKK-----VTYALPNQSREEGHFYVVL----GEDIDVSTQRFKILS 135
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISK--KKLRTA-VDIEDVR--REVDIMRHLPKHQ 116
LG G FG DR+ + A K + K R A ++I+ + R+ D P
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFP--- 192
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGE-LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++ ++ ++++T H+ + + + G L D I+ G ++ R A + + H
Sbjct: 193 -LMKIQRYFQNETG-HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 176 -GVMHRDLKPENFLF---------ANKKETAP----LKAIDFGLSVFFKPGEKFSE--IV 219
+MH DLKPEN L + P ++ D G E+ S IV
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIV 306
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYIL----------------------LCGVPP 256
+ +Y +PEV L + D+WS G I+Y L L +P
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS 366
Query: 257 FWAE---TEQG---------------------VAQAIIRSVLDFRRDPWPKVSENAKDLV 292
WA TE+ +A+A R V + RD DL+
Sbjct: 367 EWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA--RPVREVIRDDL------LCDLI 418
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN----AKKAPN 323
+L D ++RL A+Q+ HP++ ++ PN
Sbjct: 419 YGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPN 453
|
Length = 467 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ N A K++ + +E E ++M+ L +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E G L D + + G + I E +
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + E+ K DFGL+ + E ++ G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ N+G + DVWS G++LY I+ G P+ + V A+ R
Sbjct: 176 I--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 73/293 (24%), Positives = 123/293 (41%), Gaps = 45/293 (15%)
Query: 55 ERYELGRELGRGEFGITY--LCTDRENGDA---FACKSISKK-KLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y D G+A A K++++ LR ++ + E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + + E T+ E+
Sbjct: 63 MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 169 VQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV------FFKPG 212
+QM + +HRDL N + A +K DFG++ +++ G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 213 EKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAII 270
K V +MAPE LK + D+WS GV+L+ + + QG++ + ++
Sbjct: 179 GKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLW----EITSLAEQPYQGLSNEQVL 231
Query: 271 RSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLE------HPWLQ 316
+ V+D P E DL+R +PK R T +++ HP
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 54 EERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y L G+ A K++++ + + + E +
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + +R E T+ +
Sbjct: 63 MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 169 VQMC-----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGL------SVFFKP 211
+QM K V HRDL N + A E +K DFG+ + +++
Sbjct: 122 IQMAAEIADGMAYLAAKKFV-HRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 212 GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
G K V +MAPE LK + + DVWS GV+L+
Sbjct: 178 GGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 61/269 (22%), Positives = 118/269 (43%), Gaps = 28/269 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ T ++ A K++ + + E ++M+ L +
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA----EANVMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMC 172
H +V L + ++++ E G L D + + + + + I E +
Sbjct: 60 HDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + + K DFGL+ + E ++ G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+ N+G + DVWS G++L I+ G P+ + V +A+ R R + P
Sbjct: 175 I--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP--- 229
Query: 286 ENAKDLVRKMLDPDPKRRLT---AQQVLE 311
E +++ + P+ R T Q VL+
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 31/254 (12%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + T ++ A K+ K+ L + I+ + E I++ H NIV L
Sbjct: 3 LGKGNFGEVFKGTLKDK-TPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV---VQMCHKHGVMH 179
+++VMEL GG+ + R E + K ++ + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
RDL N L E LK DFG+S ++ G K I + APE L N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167
Query: 234 YG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E DVWS G++L+ GV P+ T Q + + + +R K ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCPDDVY 224
Query: 290 DLVRKMLDPDPKRR 303
++++ D P+ R
Sbjct: 225 KVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 83/326 (25%), Positives = 118/326 (36%), Gaps = 95/326 (29%)
Query: 54 EERYELGRELGRGEFGITYLCT-----------DRENGDAFACKSISKKKLRTAVDI--- 99
+ +LG G+FG +LC EN +A A ++ K LR
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 100 EDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT 154
ED +EV I+ L NI VC D + +ME E G+L +
Sbjct: 64 EDFLKEVKILSRL-SDPNIARLLGVCTVD---PPLCM--IMEYMENGDL-------NQFL 110
Query: 155 ERAAAAVTKTIVE---------VVQMC----------HKHGVMHRDLKPENFLFANKKET 195
+ A T + ++ M +HRDL N L K T
Sbjct: 111 -QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL-VGKNYT 168
Query: 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWS 242
+K DFG+S + S YY MA E VL + + DVW+
Sbjct: 169 --IKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 243 AGVILY-IL-LCGVPPFWAETEQGVAQAIIRSVLDFRRD------PWPKVSENAKDLVRK 294
GV L+ IL LC P+ T+Q V + FR D P P KD+
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHF---FRDDGRQIYLPRPPNC--PKDIYEL 272
Query: 295 MLD---PDPKRRLTAQQVLEHPWLQN 317
ML+ D + R T +++ H +LQ
Sbjct: 273 MLECWRRDEEDRPTFREI--HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +L + +G+GEFG L R N A C ++ + E +M L +
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQL-R 57
Query: 115 HQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQM 171
H N+V L E+ +++V E G L D + +RG + + + E ++
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVL 230
+ +HRDL N L + E K DFGL+ K + P + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 171
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + + + DVWS G++L+
Sbjct: 172 REKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 15/193 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ELG G+FG+ R D A K I + + ++ E +M L H+ +V
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSE----DEFIEEAKVMMKL-SHEKLVQ 63
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGVMH 179
L +++V E G L + + G + + + K + E + +H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKR-NYG 235
RDL N L + +K DFGLS + E S VGS + + PEVL +
Sbjct: 124 RDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179
Query: 236 PEVDVWSAGVILY 248
+ DVW+ GV+++
Sbjct: 180 SKSDVWAFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 50/284 (17%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
L RELG G FG +L C + ++ K T +D +RE +++ +L +H+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHE 67
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT-----------------ERAAA 159
+IV D + +V E + G+L + A G +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ +V + +H V HRDL N L +K DFG+S ++
Sbjct: 128 IASQIASGMVYLASQHFV-HRDLATRNCLVGA---NLLVKIGDFGMS---------RDVY 174
Query: 220 GSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ YY M PE ++ R + E DVWS GVIL+ I G P++ + V
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I + + R PK D++ +P++RL +++
Sbjct: 235 IECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 34/270 (12%)
Query: 57 YELGRELGRGEFGI---TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ LGR LG+GEFG L ++ + A K + K + ++ DIE+ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58
Query: 114 KHQNI-----VCLKDTYEDDTAVHLV-MELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
H N+ V L+ + + +V + + G+L ++ E + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
++ + +HRDL N + E + DFGLS G+ + + S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 222 PY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL-- 274
++A E L N Y DVW+ GV ++ I+ G P+ GV + I + L
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLIK 230
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ + P P E+ +L+ + P+PK R
Sbjct: 231 GNRLKQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 67/279 (24%), Positives = 114/279 (40%), Gaps = 49/279 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---------- 104
E+ + RELG+G FG+ Y G A K + K + T V I+ V
Sbjct: 6 EKITMSRELGQGSFGMVY------EGIA---KGVVKDEPETRVAIKTVNEAASMRERIEF 56
Query: 105 --EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E +M+ H ++V L ++MEL G+L + + E
Sbjct: 57 LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 163 KTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV----- 207
++ +++QM + + +HRDL N + A E +K DFG++
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYET 172
Query: 208 -FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+++ G K V +M+PE LK + DVWS GV+L+ I P+ + +
Sbjct: 173 DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
V + ++ L + D P + +L+R +PK R
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 14/120 (11%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K + D REV I++ L + V + + E D +L+ME EG L
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80
Query: 150 RGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+E + + + E++ H+ + H DL P N L + K ID+ +
Sbjct: 81 -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG---IIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E E + LG G FG Y G+ ++ K LR +++ E +M
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMA 64
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H ++V CL V L+ +L G L D + R H + +
Sbjct: 65 SV-DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWC 115
Query: 166 VEVVQ-MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
V++ + M + + ++HRDL N L K +K DFGL+ EK G
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 223 Y---YMAPE-VLKRNYGPEVDVWSAGVILYILL 251
+MA E +L R Y + DVWS GV ++ L+
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 70/269 (26%), Positives = 102/269 (37%), Gaps = 40/269 (14%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ RG+ G +Y +NG F K I+ + +I D M L +H NIV L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKL-QHPNIVKLI 749
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMH 179
+ +L+ E EG L + V R ER + I + ++ H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-V 238
+L PE + K E ++ L K S Y+APE + E
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC-------FISSAYVAPETRETKDITEKS 859
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVLDFRRDPW------PKVSENA 288
D++ G+IL LL G P A+ E GV +I+ D D W VS N
Sbjct: 860 DIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 289 KDLVRKM------LDPDPKRRLTAQQVLE 311
++V M DP R A VL+
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 123 DTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAV--TKTIVEVVQMCH------ 173
E ++L +E G L D + +R T+ A A T + + Q+ H
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSP 222
+ +HRDL N L E K DFGLS V+ K +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 187
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L + Y DVWS GV+L+ I+ G P+ T A+ + +R +
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLEK 244
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ DL+R+ P R + Q+L
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 40/264 (15%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
L R+LG G+FG ++ T A K++ + E +E IM+ L +H +
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKV-AVKTLKP----GTMSPEAFLQEAQIMKKL-RHDKL 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC------ 172
V L ++ +++V E G L D + ++ + ++V M
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFL--------KSGEGKKLRLPQLVDMAAQIAEG 115
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YM 225
+HRDL N L E K DFGL+ + E ++ G+ + +
Sbjct: 116 MAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWT 171
Query: 226 APEVLKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
APE NYG + DVWS G++L I+ G P+ T + V + + R +R
Sbjct: 172 APEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---YRMPRP 226
Query: 282 PKVSENAKDLVRKMLDPDPKRRLT 305
P E DL+ + D DP+ R T
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 37/129 (28%), Positives = 53/129 (41%), Gaps = 17/129 (13%)
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG 253
T G SV FK E PY+MAPEV++ +Y + D++S G+ LY L
Sbjct: 45 TWDGLLKLDG-SVAFKTPE--QSRPD-PYFMAPEVIQGQSYTEKADIYSLGITLYEALDY 100
Query: 254 VPPFWAETEQGVAQAIIRSVLDF-------RRDPWPKVSE--NAKDLVRKMLDPDPKRRL 304
P E+ AI+ +L+ R VS + +D +R P+RR
Sbjct: 101 ELP---YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRRE 157
Query: 305 TAQQVLEHP 313
A L H
Sbjct: 158 AANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 34/290 (11%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGH-----YTERAAAAVTKTIV 166
E+ +++ +E G L D R++ A+ H T + +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+Q + +HRDL N L E K DFGLS GE+ + +G P
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS----RGEEVYVKKTMGRLPV 182
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L + Y + DVWS GV+L+ I+ G P+ T + + + + +R +
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRMEK 239
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQV-LEHPWLQNAKKA-PNVSLGE 328
+ +L+R+ P R Q+ ++ + A+KA N++L E
Sbjct: 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 71/297 (23%), Positives = 114/297 (38%), Gaps = 71/297 (23%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-----------EDVRREVDIMR 110
ELG G FG +L C ++ ++ + V + +D +RE +++
Sbjct: 12 ELGEGAFGKVFLAE---------CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDR-------------IVARGHYTE 155
L +HQ+IV + + +V E G+L F R VA G T
Sbjct: 63 VL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 156 RAAAAVTKTIVE-VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
A+ I +V + H V HRDL N L + +K DFG+S
Sbjct: 122 GQMLAIASQIASGMVYLASLHFV-HRDLATRNCLVG---QGLVVKIGDFGMS-------- 169
Query: 215 FSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE +L R + E D+WS GV+L+ I G P W +
Sbjct: 170 -RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WYQ 227
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSEN-AKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
A I + R P+ +++ +P++R+ + + H LQ
Sbjct: 228 LSNTEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 72/269 (26%), Positives = 116/269 (43%), Gaps = 28/269 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ A KS+ + + E E ++M+ L +
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E E G L D + G T + I E +
Sbjct: 60 HPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + ET K DFGL+ + E ++ G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+ NYG + DVWS G++L I+ G P+ T V Q + R R D P
Sbjct: 175 I--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP--- 229
Query: 286 ENAKDLVRKMLDPDPKRRLT---AQQVLE 311
E +L+R P+ R T + VLE
Sbjct: 230 EELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSE- 217
A+ K ++ V+ H ++HRD+K EN +F N L DFG ++ F K E F
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327
Query: 218 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVIL 247
VG+ +PE+L + Y D+WS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 23/199 (11%)
Query: 62 ELGRGEFGIT---YLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPK 114
ELG G FG + + K+++ K L+ + ++ RE ++M+ L
Sbjct: 2 ELGSGNFGTVKKGMYKMKK------SEKTVAVKILKNDNNDPALKDELLREANVMQQL-D 54
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV + E + + LVMEL E G L + H TE+ + + ++ +
Sbjct: 55 NPYIVRMIGICEAE-SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS---PY-YMAPEVL 230
+HRDL N L + K DFGLS E + + P + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + DVWS GV+++
Sbjct: 171 NYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKH 115
LG+ LG GEFG T +++ K L+ ++ ++ D+ E ++++ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVAR------GHYTERAAAAVTKTIVE 167
+++ L D + L++E + G L F R + G R ++ +
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 168 VV----------QMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFF 209
+ Q+ + ++HRDL N L A ++ +K DFGLS V+
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDVYE 179
Query: 210 KPGE-KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ K S+ +MA E L + Y + DVWS GV+L+ I+ G P+ G+A
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIA 234
Query: 267 QAIIRSVLD--FRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ ++L +R + SE +L+ +P +R
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 39/266 (14%)
Query: 61 RELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPK 114
R +G+G FG Y L A KS+++ D+E+V +E IM+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-----ITDLEEVEQFLKEGIIMKDF-S 54
Query: 115 HQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N++ L + + +V+ + G+L + I +E V I +Q+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109
Query: 174 ------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-- 223
+HRDL N + E+ +K DFGL+ ++ K G+
Sbjct: 110 GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 224 -YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L+ + + + DVWS GV+L+ L+ G PP+ + I +L RR
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVDSFDITVYLLQGRRLL 222
Query: 281 WPKVSENA-KDLVRKMLDPDPKRRLT 305
P+ + +++ P P+ R T
Sbjct: 223 QPEYCPDPLYEVMLSCWHPKPEMRPT 248
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
V + ++ ++ H+ G++HRD+KPEN L + +K IDFG +V G F+ +
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLY 369
Query: 220 G--SPYYMAPEVL 230
G P Y PE L
Sbjct: 370 GMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPE-V 229
+H ++HR+L N L K + ++ DFG++ P +K +SE +MA E +
Sbjct: 127 EHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 230 LKRNYGPEVDVWSAGVILYILLC-GVPPF 257
L Y + DVWS GV ++ ++ G P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 40/256 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKS--ISKKKLRTAVDI---EDV 102
++ L +LG G+FG +LC E F + ++ K LR V D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA-- 160
+E+ IM L K+ NI+ L D + ++ E E G+L + R + A
Sbjct: 65 LKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 161 ----------VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ I ++ +HRDL N L N +K DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLY 180
Query: 211 PGEKFSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQ 263
G+ + I G +MA E +L + DVW+ GV L+ LC P+ +++
Sbjct: 181 SGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 264 GVAQAIIRSVLDFRRD 279
V I + +F R+
Sbjct: 240 QV----IENTGEFFRN 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 30/216 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGHYT-----ERAAAAVTKTIV 166
E ++L +E G L D R++ A + T + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+ + +HRDL N L E K DFGLS G++ + +G P
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYVKKTMGRLPV 175
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 255
+MA E L + Y DVWS GV+L+ + L G P
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 14/114 (12%)
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPE-VLKR 232
++HRDL N L + +K DFGL+ EK G +MA E +L R
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 233 NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKV 284
Y + DVWS GV ++ L+ G P+ G+ + I S+L+ R P P +
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEISSILEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-YMAPE-VLKRN 233
+HRDL N L + E +K DFGL+ ++ P P +MAPE + R
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y + DVWS GV+L+ I G P+ + + R + + R P + ++
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTRMRAPDYT--TPEMY 312
Query: 293 RKMLD---PDPKRRLTAQQVLEH 312
+ MLD +P +R T +++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-YMAPE-VLKRN 233
+HRDL N L E +K DFGLS ++ K SE P +M PE +
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
Y E DVW+ GV+L+ I G+ P++ + V
Sbjct: 209 YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EI 218
+ + I+ + H G++HRD+KP+N +F+ + K ID G + + G + E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEF 317
Query: 219 VGSPYYMAPE 228
+ P Y APE
Sbjct: 318 LLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 14/107 (13%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDT-AVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE I+ + V + Y+ D +VME EG L D E A +
Sbjct: 47 RREARILAKARE--AGVPVPIVYDVDPDNGLIVMEYIEGELLKD-------ALEEARPDL 97
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ + +V HK G++H DL N + + + + IDFGL F
Sbjct: 98 LREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 55/296 (18%)
Query: 62 ELGRGEFGITYLC--------TDRENGDAFACKS---ISKKKLRTAVDI---EDVRREVD 107
+LG G+FG +LC D++ + ++ K LR + D +E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
IM L K NI+ L + ++ E E G+L ++ ++R H + AA +
Sbjct: 72 IMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADVVTIS 128
Query: 168 VVQMCH---------KH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+ K+ +HRDL N L K T +K DFG+S G+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL-VGKNYT--IKIADFGMSRNLYSGD- 184
Query: 215 FSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 267
+ I G +M+ E +L + DVW+ GV L+ + LC P+ +++ V
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-- 242
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
I + +F RD +V L + L PD + +++ W +NAK+ P+
Sbjct: 243 --IENTGEFFRDQGRQVY-----LPKPALCPD-----SLYKLMLSCWRRNAKERPS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 43/209 (20%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRREVDIMRH 111
ELG G FG C + + KK++ A+ + +++ RE +IM
Sbjct: 2 ELGSGNFG----CVKK------GVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV--- 168
L + IV + E + A+ LVME+ GG L + + +VE+
Sbjct: 52 L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGK------KDEITVSNVVELMHQ 103
Query: 169 VQMCHKH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGS- 221
V M K+ +HRDL N L N+ K DFGLS + + + G
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKW 160
Query: 222 PY-YMAPE-VLKRNYGPEVDVWSAGVILY 248
P + APE + R + DVWS G+ ++
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLPKH 115
LGR LG G FG T + + ++ K L++ + + + E+ IM HL H
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFD 145
NIV L ++++ E C G+L D
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 26/94 (27%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------M 225
+HRDL N L + +K DFGL+ +I P Y M
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 226 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 34/121 (28%), Positives = 49/121 (40%), Gaps = 22/121 (18%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
++ RT RRE IM K + V D +VME EG L D I
Sbjct: 42 RRERT-------RREARIMSRARKAGVNVPAVYFVDPENFI----IVMEYIEGEPLKDLI 90
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ G +++ I +V H G++H DL N + + K + IDFGL+
Sbjct: 91 NSNG----MEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLAE 142
Query: 208 F 208
F
Sbjct: 143 F 143
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 436 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.44 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.22 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 99.04 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 99.03 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.82 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.81 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.79 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.77 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.76 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.71 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 98.69 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.68 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.67 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.66 | |
| PTZ00183 | 158 | centrin; Provisional | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.59 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.54 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.53 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.35 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.34 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.32 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 98.31 | |
| PLN02964 | 644 | phosphatidylserine decarboxylase | 98.26 | |
| PTZ00183 | 158 | centrin; Provisional | 98.25 | |
| cd00051 | 63 | EFh EF-hand, calcium binding motif; A diverse supe | 98.16 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.15 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.07 | |
| cd05030 | 88 | calgranulins Calgranulins: S-100 domain found in p | 97.98 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-65 Score=464.55 Aligned_cols=267 Identities=37% Similarity=0.682 Sum_probs=246.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh----hhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++...... .....+.+|+++|++| .|||||+++++|+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeec
Confidence 456789999999999999999999999999999999988765432 2344578999999999 99999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+..||||||++||+|.+.+..++.+.+...+.+++||+.|+.|||+.||+||||||+|||+..+.+...+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred ccCCCCcccccccCCcccchhcccc-c---CCCCCchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHccccCCCCCCc
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~-~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 282 (436)
......-+.+.||||.|.|||++.. . +..+.||||+||+||-+++|.+||.+..... ..++|.++...+.+..|.
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 9887888899999999999999862 2 4458999999999999999999998776555 888999999999999999
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+|++..+||.+||..||++|||+.|+|+||||+...
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999999999999999999999999999999754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-63 Score=420.13 Aligned_cols=302 Identities=39% Similarity=0.744 Sum_probs=276.4
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.+.|++-+.||+|.|+.||++.+..+|+.+|+|++....+... +.+.+.+|+.|.+.| +|||||++.+.+.+...
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEESF 84 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccce
Confidence 3567899999999999999999999999999999999988777554 788999999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.|+|+|++.|++|..-+..+-.++|..+..+++||++||.|+|.+||||||+||+|+++.+......+||+|||+|..+.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999999888877778999999999999999999999999999999999999998888899999999999988
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.+......+|||+|||||+++ .+|+..+||||.|||||-|+.|.+|||+.+...+.+.|..+..+++.+.|+.++++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 777778899999999999998 5699999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhh
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQH 354 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~ 354 (436)
+|+.+||..||.+|+|+.|+|+|||+.+........-.+.....|++|....+++-+++..+...
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s~ 309 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIAT 309 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999875443222223455678999999999999998776543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=446.23 Aligned_cols=256 Identities=38% Similarity=0.633 Sum_probs=240.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+......+.+.+||++.+.| +|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999999999999999999998888888889999999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~ 213 (436)
.|+|+.++|..+++.++.++|.+++.+++||+.||.|||+++|+|||||..|++++ ++.+|||+|||+|..+... +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---ENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---CcCcEEecccceeeeecCccc
Confidence 99999999999999999999999999999999999999999999999999999995 4556999999999988744 7
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
...+.+|||.|.|||++. ..++..+||||+||++|.||+|++||...+-.+.+..|......++. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 778899999999999987 56999999999999999999999999999999999999988776654 6899999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccC
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+||++||.+|||+.++|.|+||+..
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-58 Score=437.26 Aligned_cols=321 Identities=58% Similarity=1.000 Sum_probs=290.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+...|++.+.||+|.||.||+|+++.+|+.+|+|.+.+.........+.+.+|+.+|+++..|||||.+++.|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 45678999999999999999999999999999999999988877666678999999999999559999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~-~~~ikl~DfG~a~~~ 209 (436)
+++|||+|.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+..... ...+|++|||+|...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999887 5999999999999999999999999999999999999987654 458999999999998
Q ss_pred CCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
..+......+||+.|+|||++. ..|+..+||||+|+++|.|++|..||++.+..+....+..+.+.+...+|+.+|..+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 8877788899999999999998 689999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhchhhhhhhhhhhcc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFH 368 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~ 368 (436)
++||..||..||.+|+|+.++|+|||++.....+..........+.+++...+++++..+.......+ ...++..|.
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 346 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMFK 346 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHHH
Confidence 99999999999999999999999999998766666566666666777888888887776666666655 666777788
Q ss_pred ccCCCCC
Q 013816 369 MMDIGNR 375 (436)
Q Consensus 369 ~~D~~~~ 375 (436)
.+|.+.+
T Consensus 347 ~~~~~~~ 353 (382)
T KOG0032|consen 347 LMDTDNN 353 (382)
T ss_pred hhccccc
Confidence 8888766
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=415.64 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=225.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-eEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~l 133 (436)
.+.+.++.||+|..|+||+|+|+.|++.+|+|+|... .+....+++.+|+++++.. +|||||.+|+.|..+. .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 3677889999999999999999999999999999443 3455678999999999999 9999999999999999 5999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||+||+|.+++...++++|.....|+.+++.||.|||+ ++||||||||+|||++..++ |||||||.+..+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence 99999999999999988999999999999999999999996 99999999999999976554 999999999887655
Q ss_pred CcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHccccCCCCCCc-ccC
Q 013816 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVAQAIIRSVLDFRRDPWP-KVS 285 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~-~~~ 285 (436)
...+.+||..|||||.+.+ .|+.++||||||++++|+++|+.||... ...+....|..+.. +.... .+|
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp---P~lP~~~fS 308 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP---PRLPEGEFS 308 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC---CCCCcccCC
Confidence 5578899999999999985 6999999999999999999999999764 44556666665432 22222 489
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+++++||..||++||.+|||+.|+|+|||++....
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999999999997644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=412.63 Aligned_cols=264 Identities=37% Similarity=0.640 Sum_probs=238.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|.+.+.||+|+||+||+|+++.++..||||.|.+..+ .....+.+..|+++|+.+ +|||||+++++.+.++.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEE
Confidence 34679999999999999999999999999999999988765 455678899999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC---CCeEEEeecccccc
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET---APLKAIDFGLSVFF 209 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~---~~ikl~DfG~a~~~ 209 (436)
+|||||.||+|.+++..++.+++..++.++.||+.||++||+++||||||||+|||++..... ..+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875233 67999999999999
Q ss_pred CCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.++....+.+|+|.|||||++. ++|+.|+|+||+|+|+|+|++|+.||...+..+....+.++.-..+. ....+++..
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-~~~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-LPAELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-hhhhccCch
Confidence 9888888999999999999985 78999999999999999999999999999999888866655433322 223567778
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8999999999999999999999999987643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-57 Score=405.46 Aligned_cols=258 Identities=34% Similarity=0.639 Sum_probs=236.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
-++|++++.||+|+||+||+++.+.+++.+|+|++++..+....+.+....|..+|.++ +||.||+++..|++...+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 36799999999999999999999999999999999998887777788999999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc-CCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~-~~~ 212 (436)
|+||+.||.|+-.|.+.+.++|..++-++..|+.||.|||++|||||||||+|||++ ..++|+|+|||+++.. ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcccCC
Confidence 999999999999999999999999999999999999999999999999999999995 5667999999999844 444
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
....+.+||+.|||||++. ..|+..+|.||||+++|+|++|.+||.+.+.....+.|.++.....+ ..++.+++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence 5667789999999999976 67999999999999999999999999999999999999887633322 2479999999
Q ss_pred HHHccCCCcCCCC----CHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRL----TAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rp----s~~e~l~h~~~~~~ 318 (436)
+.++|..||++|. ++.++-+||||...
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 9999999999995 79999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=412.03 Aligned_cols=256 Identities=34% Similarity=0.631 Sum_probs=235.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|.+++.||+|+|++|++|+++.+++.||||++.+..+-.....+.+.+|-.+|.+|.+||.|++|+-.|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 57999999999999999999999999999999999887766666778899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
+||+++|+|.++|++.+.+++..++.++.+|+.||+|||++|||||||||+|||++ .++++||+|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999995 556699999999987754211
Q ss_pred --------------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 215 --------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 215 --------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
..+++||-.|.+||+|. +..++.+|||+||||||+|+.|.+||.+.++-.+.+.|+.-...++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 14589999999999998 45789999999999999999999999999999999999988776654
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..++.+++||.++|..||.+|+|+.++.+||||..
T Consensus 309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred ---CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 57899999999999999999999999999999975
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-56 Score=383.94 Aligned_cols=263 Identities=37% Similarity=0.697 Sum_probs=241.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
+-..|.-.+.||+|..++|..+.++.+|+.+|+|++........ .-.+.-.+|+.+|+++..||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 44678888999999999999999999999999999865432211 1234567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+..+++|+|.|+.|.|+|++...-.+++...++|++|+++|+.|||.++||||||||+|||+++ +..|||+|||+|+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd---n~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD---NMNIKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc---ccceEEeccceee
Confidence 9999999999999999999999889999999999999999999999999999999999999964 4459999999999
Q ss_pred ccCCCCcccccccCCcccchhccc-------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
.+.+++.....+|||+|.|||.+. ..|+...|+||+|||+|.|+.|.+|||.....-++..|..+...+..+.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 999999999999999999999874 2478899999999999999999999999999999999999999999999
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
|..+|.+.++||++||+.||.+|.|++|+|.||||...
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 99999999999999999999999999999999999653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=411.50 Aligned_cols=260 Identities=41% Similarity=0.718 Sum_probs=232.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh--hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
...++|.+.+.||+|+||.|+.|.+..+|..||+|++.+...... ...+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999999999999999998876532211 234567799999999944999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+||||+.||+|++++...+++.|..++.+++|+++|++|||++||+||||||+|||++.+. ..+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEecccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999997642 56999999999988
Q ss_pred -CCCCcccccccCCcccchhcccc-c-C-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCccc-
Q 013816 210 -KPGEKFSEIVGSPYYMAPEVLKR-N-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284 (436)
Q Consensus 210 -~~~~~~~~~~gt~~y~aPE~l~~-~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 284 (436)
.......+.+||+.|+|||++.+ . | +.++||||+||+||.|++|..||...+...+...|.++.+.++.. +
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence 46667788999999999999874 3 5 478999999999999999999999988888888888877665543 4
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
|+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-55 Score=379.41 Aligned_cols=255 Identities=30% Similarity=0.603 Sum_probs=237.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
-++|++++.||.|+||.|.+++++.+|..+|+|++++...-...+.+...+|..+|+.+ .||.++++++.+.+.+.+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEE
Confidence 46799999999999999999999999999999999988877777788899999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++||.|+.++.+.+++++..++-++.||+.||+|||+++|++|||||+|||++ .++.+||+|||+|+....
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccceEEecC--
Confidence 999999999999999999999999999999999999999999999999999999995 556699999999998753
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
...+.||||.|+|||++. ..|+.++|.|||||++|||+.|.+||...+...+.+.|..+...++. .+++++++||
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 367789999999999987 67999999999999999999999999999999999999999888764 5799999999
Q ss_pred HHccCCCcCCC-----CCHHHHhcCcccccC
Q 013816 293 RKMLDPDPKRR-----LTAQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~R-----ps~~e~l~h~~~~~~ 318 (436)
+++|+.|-.+| ....++.+||||+..
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 99999999999 357799999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=414.14 Aligned_cols=258 Identities=38% Similarity=0.672 Sum_probs=238.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+-|++++.||.|+-|.|.+|++..||+.+|||+|.+..-........+.+||-+|+-+ .|||++++|++|++..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEE
Confidence 3489999999999999999999999999999999887544455567789999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
.||++||.|++++..++++++.+++.+++||+.|+.|||..+|+||||||+|+|++..++ |||+|||+|..-.++.-
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCcc
Confidence 999999999999999999999999999999999999999999999999999999975443 99999999998777777
Q ss_pred ccccccCCcccchhccccc-C-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
..+.||+|+|.|||++.+. | +.++||||+|||||.||||++||.+.+....+..+.++.+..+ ..+|.++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHH
Confidence 7889999999999998853 4 7899999999999999999999999999999999999988776 46899999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+||..||++|+|.+|+++|||+.....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999999987544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-55 Score=383.34 Aligned_cols=257 Identities=28% Similarity=0.597 Sum_probs=221.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|+.+.++|+|+||+||+|+++.||+.||||++..+. .++.-.+-..+||++|++| +|||+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence 46899999999999999999999999999999986543 2333445678999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~ 212 (436)
+|||+. ++.+.+... ..++...+..++.|++.|+.|+|++++|||||||+|||++. ++.+||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~---~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ---NGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec---CCcEEeccchhhHhhcCCc
Confidence 999976 666666654 45899999999999999999999999999999999999965 4559999999999887 77
Q ss_pred CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-------------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------------- 277 (436)
+.++..+.|.+|+|||.+-+ +|++.+||||+||++.||++|.+.|.+.++.+.+-.|.....++.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 88899999999999999865 699999999999999999999999999888766655544221111
Q ss_pred ------C--------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 ------R--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 ------~--------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
. ..++.++.-+.+|+++||+.||.+|++.+|+|.||||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 0 113456788899999999999999999999999999954
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=402.30 Aligned_cols=264 Identities=33% Similarity=0.548 Sum_probs=229.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-e
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-A 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~ 130 (436)
.+.++|.++++||.|+||.||+|+.+.+|..||||.++++-. ...+. .-.||++.|++|..|||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456899999999999999999999999999999999876543 33222 34679999999966999999999998887 9
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+|+|||||+. +|+++++.++ .+++..++.|+.||+.||+|+|.+|+.|||+||+|||+.. ...|||+|||+|+.+
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccccc
Confidence 9999999975 9999998764 5899999999999999999999999999999999999964 455999999999999
Q ss_pred CCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC------
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW------ 281 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~------ 281 (436)
.....++..+.|.+|+|||+|- +.|+.+.||||+|||++|+++-++.|.+.++.+.+-.|..-........|
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9888999999999999999975 56999999999999999999999999999888777777654333222222
Q ss_pred --------------------cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 282 --------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 282 --------------------~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+..+.++.++|.+||.+||.+||||.|+|+||||+.....
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 3468899999999999999999999999999999875443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-54 Score=400.84 Aligned_cols=260 Identities=32% Similarity=0.571 Sum_probs=235.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|+++..||+|+||.||+|+.+.||..+|+|++.++......+.+.++.|-.+|... ++|.||++|..|++..++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEE
Confidence 47899999999999999999999999999999999999887777888999999999996 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC--
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-- 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-- 211 (436)
||||++||++..+|...+.|++..++.++.+++.|+.-+|+.|+|||||||+|+||+ ..++|||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeeccccccchhhhhh
Confidence 999999999999999999999999999999999999999999999999999999994 677799999999853211
Q ss_pred --------------------C--C-----c-------------------ccccccCCcccchhccc-ccCCCCCchhHHH
Q 013816 212 --------------------G--E-----K-------------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAG 244 (436)
Q Consensus 212 --------------------~--~-----~-------------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG 244 (436)
. . . ..+.+|||-|+|||++. ..|+..+|.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0 0 01357999999999976 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC---CHHHHhcCcccccC
Q 013816 245 VILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (436)
Q Consensus 245 ~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 318 (436)
||+||||.|.+||.+.+..+....|.+....+..+.-..++++++|||.+||. ||++|. .+.||-.||||+..
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999999999999999887655555556789999999999999 999997 59999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=362.56 Aligned_cols=259 Identities=33% Similarity=0.574 Sum_probs=228.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|...+.||+|.||.||+|++.++|+.||+|+|......+..+ ....+||+.|+.+ +||||+.++++|...+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence 47899999999999999999999999999999998876654433 3567899999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
+||++. +|...++.+ ..++..++..++.+++.||+|||++.|+||||||.|+|+++ ++.+||+|||+|+.+.+..
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~---~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS---DGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC---CCcEEeecccchhccCCCC
Confidence 999976 898888765 45899999999999999999999999999999999999964 4559999999999886543
Q ss_pred -cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc-------
Q 013816 214 -KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------- 283 (436)
.....+-|.+|+|||.+. +.|+...||||.|||+.||+-|.+-|.+.++-+.+..|.+.........|++
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 334458899999999986 4699999999999999999999999999999998888888766655555543
Q ss_pred -----------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 284 -----------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 284 -----------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.++++.+|+.+||..||.+|+|+.|+|+|+||+...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 367789999999999999999999999999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=390.20 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=226.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~ 132 (436)
+.|+.+++||+|+||.||+|++..+|+.||+|++....... .......+||.||++| +||||+++.+...+. ..+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 56899999999999999999999999999999998765433 3455678999999999 999999999988766 7999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||+|||+. +|.-++... -.|++.++..+++||+.||.|||++||+|||||.+|||+++ .+.+||+|||+|+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn---~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN---NGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC---CCCEEeccccceeeccC
Confidence 99999976 888777653 36999999999999999999999999999999999999965 45599999999997765
Q ss_pred CC--cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCc-----
Q 013816 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP----- 282 (436)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 282 (436)
.. .++..+-|.+|+|||.|.+ .|+.+.|+||+||||.||++|++.|.+.++.+.+..|.+.........|+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 44 5678889999999999764 69999999999999999999999999999999999998866555555554
Q ss_pred --------------------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 283 --------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 283 --------------------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 246788899999999999999999999999999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=399.30 Aligned_cols=254 Identities=31% Similarity=0.586 Sum_probs=230.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... ...+.+.+.+|+++++.| +|||||.++++|+...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence 579999999999999999999999999999999987653 444678899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
.|||.| +|..++...+.++|+.+..++.+++.||.|||+.+|+|||+||.|||+. ..+++|+||||+|+....+..
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccCce
Confidence 999988 9999999999999999999999999999999999999999999999995 556699999999998765543
Q ss_pred -ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 215 -FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 215 -~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.+++.|||.|||||.+. +.|+..+|+||+|||+||+++|++||......+....|...... +....|..++.|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----PPSTASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----CcccccHHHHHHH
Confidence 36789999999999987 56999999999999999999999999988877777777765433 2347899999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccC
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+|.+||.+|.|..+++.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999999753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-53 Score=377.85 Aligned_cols=268 Identities=33% Similarity=0.543 Sum_probs=228.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
..+..+|..++.||+|+||.|+.|.++.+|+.||+|.+.. .+......++..+|+++|+.+ +|+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSR 95 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccc
Confidence 3566788889999999999999999999999999999864 356677888999999999999 89999999998854
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
-+.+|+|+|+| +-+|...++.+..+++..+..++.||+.||+|+|+.+|+||||||+|+|++ .++.+||+|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEeccccc
Confidence 46789999999 458999998887799999999999999999999999999999999999995 456689999999
Q ss_pred ccccCC---CCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc-----
Q 013816 206 SVFFKP---GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----- 275 (436)
Q Consensus 206 a~~~~~---~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----- 275 (436)
|+.... ...++..+.|.+|+|||++. ..|+.+.||||+|||+.||++|++.|.+.+....++.|..-...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998864 44567889999999999864 57999999999999999999999999887776555555432221
Q ss_pred ------------------CCCCC----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCC
Q 013816 276 ------------------FRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (436)
Q Consensus 276 ------------------~~~~~----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 324 (436)
.+..+ ++..++.+.+|+.+||..||.+|+|++|+|.|||+.........
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 11111 45788999999999999999999999999999999876554433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=369.53 Aligned_cols=254 Identities=28% Similarity=0.523 Sum_probs=218.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEE-EEEeC-Ce
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-TYEDD-TA 130 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~~-~~ 130 (436)
-..+|+|++.||+|+||+||++.+..+|..+|.|.+.-... +....+.+..|+.+|++| +|||||++++ .+.++ ..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchh
Confidence 34679999999999999999999999999999999974433 445677899999999999 9999999998 44444 44
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCceEeecCCCCCCeEEEe
Q 013816 131 VHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK--HG--VMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~--iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
++||||||.+|+|...++. +..++|..++.++.|++.||.++|+ .. |+||||||.||+++. ++.|||+|
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~---~gvvKLGD 171 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA---NGVVKLGD 171 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC---CCceeecc
Confidence 8999999999999998864 4569999999999999999999999 44 999999999999964 55699999
Q ss_pred eccccccCCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 203 FGLSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 203 fG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
||+++.+..... ..+.+|||+||+||.+. ..|+.+|||||+||++|||..-++||.+.+..+.-.+|.++.. ++-+
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~--~~~p 249 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY--PPLP 249 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC--CCCc
Confidence 999998875543 35789999999999987 5799999999999999999999999999988888888888743 2222
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
-...|.++..||..|+.+||+.||+. +|++.+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 24678999999999999999999987 5666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=382.00 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=214.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--eEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--AVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--~~~ 132 (436)
.+|...+.||+|+||.||++.+..+|...|||.+.... ....+.+.+|+.+|.+| +|||||++++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeE
Confidence 45888899999999999999999999999999987652 22267899999999999 6999999999754444 699
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+.|||++||+|.+++...+ .+++..++.+++||++||.|||++||+||||||+|||++.. ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999877 79999999999999999999999999999999999999652 34599999999987653
Q ss_pred ----CCcccccccCCcccchhccccc-C-CCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHccccCCCCCCccc
Q 013816 212 ----GEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 212 ----~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
........||+.|||||++... . .+++|||||||++.||+||..||... ......-.+..... .+.....+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~--~P~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS--LPEIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC--CCCCCccc
Confidence 1223467899999999998743 2 34999999999999999999999773 33333333333221 12333568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
|+++++||.+||..+|++||||.++|+|||.+....
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999999999999986543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=366.13 Aligned_cols=262 Identities=27% Similarity=0.458 Sum_probs=225.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 131 (436)
-+.|+.+..|++|+||.||+|+++.|++.||+|+++...-...-.+ .-.+||.+|.+. +|||||.+-++... -+.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~-~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKA-RHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhc-CCCCeeeeEEEEecccccee
Confidence 3579999999999999999999999999999999987654433333 346899999999 89999999998754 4679
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||||||+. +|...+..-+ ++...++..++.|++.|++|||.+.|+||||||+|+|+.. .+.+||+|||+|+.+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~---~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH---KGILKIADFGLAREYG 228 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc---CCcEEecccchhhhhc
Confidence 999999975 8888887654 7999999999999999999999999999999999999964 4559999999999886
Q ss_pred CC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc----
Q 013816 211 PG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK---- 283 (436)
Q Consensus 211 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 283 (436)
.. ..++..+-|.+|+|||.+-+ .|+.+.|+||+|||+.||+++++.|.+......+..|.+.........|+.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 54 45678899999999999764 599999999999999999999999999999988888887554444444432
Q ss_pred ------------------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 284 ------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 284 ------------------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+++...+|+..+|.+||.+|.||.|+|+|+||......
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 35778899999999999999999999999999985443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=377.63 Aligned_cols=261 Identities=29% Similarity=0.500 Sum_probs=227.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+.|++..+||.|..++||+|++..+++.||||++..+.+.+ +.+.+++|+..|+.+ +||||++++..|..+..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEE
Confidence 367999999999999999999999999999999999887654 478999999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||.||.+|++.++++.. ..++|..++.|+++++.||.|||++|.||||||+.|||++. ++.|||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~---dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS---DGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC---CCcEEEcCceeeeeecc
Confidence 99999999999999864 34899999999999999999999999999999999999965 45599999998765543
Q ss_pred C-Cc----ccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc------CC
Q 013816 212 G-EK----FSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------FR 277 (436)
Q Consensus 212 ~-~~----~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------~~ 277 (436)
. .. ....+||++|||||++. ..|+.|+||||||++..||.+|..||....+..++..-+++... .+
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 2 21 14568999999999964 36999999999999999999999999998888777666665442 11
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.......+..++.++..||++||.+||||+++|+|+||+..+.
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 2223456788999999999999999999999999999998654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=379.38 Aligned_cols=257 Identities=37% Similarity=0.682 Sum_probs=239.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.-+|++.+.||+|.||.|-+|++...|+.||||.|++..+.+..+.-.+++||+||..| +||||+.+|++|++.+.+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceE
Confidence 4567899999999999999999999999999999999999999998999999999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
.|||||..||.|+|++..++.+++.+++.+++||.+|+.|+|.++++|||||.+|||++.+ +.+||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N---~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN---NNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC---CCeeeeccchhhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999654 4489999999999988
Q ss_pred CCcccccccCCcccchhccccc-C-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
..-..+++|+|.|.+||++++. | ++..|-|||||+||.|+.|..||.+.+...+..+|.++...-+ .-+.++.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PSdA~ 280 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPSDAS 280 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCchHH
Confidence 8888999999999999999864 4 6899999999999999999999999999999999988866443 3467889
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
-||..||..||++|.|+.++..|-|++-
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeec
Confidence 9999999999999999999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=365.15 Aligned_cols=268 Identities=40% Similarity=0.723 Sum_probs=241.1
Q ss_pred ccccceeec-cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 52 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
.+.++|.+. ++||-|-.|.|..|.++.|++.+|+|++... ...++|+++--....|||||+++++|++
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 466788875 5699999999999999999999999987432 5567888887777799999999999864
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 -DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
...+.+|||.++||.|+..+..++. ++|+++..|++||..|+.|||+.+|.||||||+|+|+.....+..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678899999999999999998876 9999999999999999999999999999999999999998899999999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHccccCCCC
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~ 279 (436)
+|+.........+.+-||+|.|||++. ..|+..+|+||+||++|-|++|.+||+... ...+...|..+...|+.+
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 999877666777889999999999998 569999999999999999999999997653 346778899999999999
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCcc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~ 327 (436)
.|..+|+..+++|+++|..+|.+|.|+.++++|||+.....-+.+.+.
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 999999999999999999999999999999999999988777766654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=392.60 Aligned_cols=257 Identities=32% Similarity=0.532 Sum_probs=225.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
....|....+||+|+.|.||.|....+++.||+|++..... ...+-+.+|+.+|+.+ +|+|||.+++.|...+.+|
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeE
Confidence 34678889999999999999999999999999999976643 2457789999999999 9999999999998899999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++||+|.|.+... .++|.+++.|++.++.||.|||.+||+|||||.+|||++.++ .+||+|||++..+...
T Consensus 347 VVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g---~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG---SVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC---cEEEeeeeeeeccccc
Confidence 999999999999988665 599999999999999999999999999999999999996544 4999999999888655
Q ss_pred C-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. .-.+.+|||+|||||++. ..|+++.||||||++++||+-|.+||...+.-..+..|... .......+..+|+.+++
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKD 501 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHH
Confidence 4 557789999999999987 57999999999999999999999999876665555544433 23333445689999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
||.+||+.|+.+|++|.|+|+||||+.+
T Consensus 502 FL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=354.69 Aligned_cols=257 Identities=33% Similarity=0.601 Sum_probs=235.4
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.--++|++++.||+|-||.||+|+.++++-.||+|++.++.+....-..++.+|+++-..| +||||+++|++|.+...+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecccee
Confidence 3457899999999999999999999999999999999888776665667899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 132 HLVMELCEGGELFDRIV--ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
|+++||..+|+|+..|. ...++++..+..++.|++.||.|+|.++++||||||+|+|++..+. +||+|||++...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeec
Confidence 99999999999999998 5567999999999999999999999999999999999999966544 899999999876
Q ss_pred CCCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
. ...-.+.+||..|.|||+..+ .++...|+|++|++.||++.|.+||...+..+..+.|.+....++ ..++.++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a 249 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGA 249 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhH
Confidence 5 555577899999999999874 689999999999999999999999999999999999988776655 5789999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+|||.+||..+|.+|.+..|++.|||+..
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=377.22 Aligned_cols=267 Identities=34% Similarity=0.656 Sum_probs=229.2
Q ss_pred CCcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-----------hhhHHHHHHHHHHHHhCCCC
Q 013816 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------AVDIEDVRREVDIMRHLPKH 115 (436)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----------~~~~~~~~~E~~~l~~l~~h 115 (436)
..++...-+.|++++.||+|.||.|-+|++..+++.||+|++.+..... ....+..++||.+|++| .|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CC
Confidence 3455566688999999999999999999999999999999998765432 12356899999999999 99
Q ss_pred CceeEEEEEEEe--CCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 013816 116 QNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (436)
Q Consensus 116 ~niv~~~~~~~~--~~~~~lv~E~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~ 192 (436)
||||+|+++..+ .+.+|||+|||..|.+.. .-..+. +++.+++.+++.++.||.|||.+|||||||||+|+|++.
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~- 245 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS- 245 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC-
Confidence 999999999864 578999999999988843 333344 899999999999999999999999999999999999964
Q ss_pred CCCCCeEEEeeccccccCCC------CcccccccCCcccchhcccc-c----CCCCCchhHHHHHHHHHHhCCCCCCCCC
Q 013816 193 KETAPLKAIDFGLSVFFKPG------EKFSEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAET 261 (436)
Q Consensus 193 ~~~~~ikl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~l~~-~----~~~~~DiwSlG~il~~lltg~~pf~~~~ 261 (436)
.++|||+|||.+.....+ ......+|||.|+|||.+.+ . .+.+.||||+||+||.|+.|+.||.+..
T Consensus 246 --~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 246 --DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred --CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 466999999999866322 23345799999999998764 2 3567899999999999999999999999
Q ss_pred HHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..+....|.+..+.++.. +.+.+.+++||.+||++||++|++..++..|||......
T Consensus 324 ~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred HHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 999999999988877655 468899999999999999999999999999999976543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=376.27 Aligned_cols=258 Identities=30% Similarity=0.500 Sum_probs=218.8
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++++ +|+||+++++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78889999999999999999999999999998766544433445678999999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|++||+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++. ...+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD---RGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC---CCCEEEeeCCCcEEcCCCCe
Confidence 99999998887643 35899999999999999999999999999999999999964 44599999999987655545
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 55668999999999986 56899999999999999999999999876554333333332222233334568999999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+||+.||.+||+ ++++++||||...
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=379.63 Aligned_cols=253 Identities=30% Similarity=0.538 Sum_probs=223.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence 3689999999999999999999999999999999765443334456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEEecCcchhccCC--
Confidence 999999999999998888999999999999999999999999999999999999964 445999999999866432
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......++ ..+++.+++||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHH
Confidence 23457999999999986 4588999999999999999999999998888877777776654332 346899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCccccc
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
+||+.||.+||+ +.++++||||..
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=384.32 Aligned_cols=254 Identities=30% Similarity=0.592 Sum_probs=224.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEE
Confidence 46799999999999999999999999999999999766544444567789999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN---KGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC---CCCEEEeeccCceEcCCC-
Confidence 9999999999999998888999999999999999999999999999999999999964 445999999999876432
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+..+...++ ..++..+++||
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 246 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLV 246 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHH
Confidence 23457999999999986 4588999999999999999999999998887777777766544332 34789999999
Q ss_pred HHccCCCcCCCCC-----HHHHhcCccccc
Q 013816 293 RKMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 293 ~~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
.+||+.||.+||+ +.++++||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=386.82 Aligned_cols=259 Identities=28% Similarity=0.484 Sum_probs=220.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++.+.+...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 4699999999999999999999999999999999765444444556788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~---~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC---CCCEEEeeccCccccccccc
Confidence 999999999999998889999999999999999999999999999999999999964 4469999999987543211
Q ss_pred -----------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCC
Q 013816 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (436)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf 257 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012357999999999986 56899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcC---CCCCHHHHhcCcccccC
Q 013816 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK---RRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 258 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~---~Rps~~e~l~h~~~~~~ 318 (436)
.+.+..+....+.........+....++++++++|.+|+. +|. .||++.|+++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9888887777777643333333334578999999999775 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=381.91 Aligned_cols=250 Identities=30% Similarity=0.571 Sum_probs=218.8
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999865544444556788999999999 999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... .......+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC---CCCEEEeeCCCCcccccCCCccccee
Confidence 999999988888999999999999999999999999999999999999964 44599999999875422 23344567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999986 4689999999999999999999999988887777766665544332 46899999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccC
Q 013816 299 DPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=388.86 Aligned_cols=257 Identities=29% Similarity=0.523 Sum_probs=234.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|.++++||+|+||+|+++..+.+++.+|||++++..+-...+.+....|..++....+||.++.++..|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46899999999999999999999999999999999999888888899999999999999889999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~ 212 (436)
||||+.||++.. +...+.+++..++-++..++.||.|||++|||+||||.+|||++ ..+++||+|||+++..- .+
T Consensus 447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEecccccccccCCCC
Confidence 999999999544 33446799999999999999999999999999999999999996 45669999999998654 55
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
...++.+|||.|||||++. ..|+.++|.|||||+||||+.|..||.+.+++++...|+.....++ ..+|.++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----~~ls~ea~~i 598 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSKEAIAI 598 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CcccHHHHHH
Confidence 6778999999999999998 5699999999999999999999999999999999999998766554 3589999999
Q ss_pred HHHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+.++|.++|++|.- +.++..||||+..
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999999984 6899999999863
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=382.35 Aligned_cols=258 Identities=31% Similarity=0.539 Sum_probs=224.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999999866544444566788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA---SGHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCCEEEEeCcCCccccc--c
Confidence 999999999999988888999999999999999999999999999999999999964 44599999999986543 3
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC----cccCHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAK 289 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~ 289 (436)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+.........+.+ ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 34567999999999986 46899999999999999999999999988877776666554332222222 25689999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+||.+||..+|.+||++.++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=387.15 Aligned_cols=259 Identities=30% Similarity=0.540 Sum_probs=222.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|++..+|+.||+|++.............+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 3699999999999999999999999999999999765443444556788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999999999999999964 4459999999987543211
Q ss_pred --------------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCC
Q 013816 214 --------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV 254 (436)
Q Consensus 214 --------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~ 254 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 011246999999999976 56899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC---HHHHhcCcccccC
Q 013816 255 PPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (436)
Q Consensus 255 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps---~~e~l~h~~~~~~ 318 (436)
.||......+....+.........+....+++++++||.+||. +|.+|++ +.+++.||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999888777777776544333333334679999999999997 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=359.70 Aligned_cols=266 Identities=38% Similarity=0.648 Sum_probs=235.3
Q ss_pred cccceee-ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 53 IEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 53 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
+.+.|++ .+.||+|+|+.|-.|+...+|..||||+|.+.. .....++.+|++++.....|+||++++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4566766 466999999999999999999999999998764 335678999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+|||-+.||+|...|.++..++|.++..+++.|+.||.+||.+||.||||||+|||....+.-..||||||.+..-..-
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998877778899999988754322
Q ss_pred C--------CcccccccCCcccchhccc---c---cCCCCCchhHHHHHHHHHHhCCCCCCCCC---------------H
Q 013816 212 G--------EKFSEIVGSPYYMAPEVLK---R---NYGPEVDVWSAGVILYILLCGVPPFWAET---------------E 262 (436)
Q Consensus 212 ~--------~~~~~~~gt~~y~aPE~l~---~---~~~~~~DiwSlG~il~~lltg~~pf~~~~---------------~ 262 (436)
. ....+.+|+..|||||+.. + .|+.++|.||||||||-|++|.+||.+.. .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 1 1224567888999999753 2 48999999999999999999999996542 2
Q ss_pred HHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+.....|..+...|+...|..+|.+.+++++.+|..++.+|.++.++++|||++.....
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 45778889999999999999999999999999999999999999999999999875443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=386.05 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=219.9
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876554445567889999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-- 213 (436)
||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++. .+.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~---~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC---CCCEEEeeCcCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999964 4569999999875331000
Q ss_pred ----------------------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHH
Q 013816 214 ----------------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (436)
Q Consensus 214 ----------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~i 246 (436)
.....+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012357999999999986 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHcc--CCCcCCCCCHHHHhcCcccccC
Q 013816 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML--DPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 247 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l--~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+|+|+||..||......+....+.........+.+..+++++++||.+|+ ..+|..||++.++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999999888776666666544333334444568999999999965 4555569999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=374.27 Aligned_cols=249 Identities=28% Similarity=0.409 Sum_probs=214.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcE-EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-eEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDA-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~ 132 (436)
....+.+.||+|+||+||++.++ |+. ||+|++......... .+.|.+|+.+|.+| +|||||++++++.+.. ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceE
Confidence 34556677999999999999986 666 999999876554443 77999999999999 9999999999998887 799
Q ss_pred EEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 133 LVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+||||+++|+|.+++.. ...++...+..++.+|+.||.|||+++ ||||||||+|||++.+. .++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceee
Confidence 99999999999999987 578999999999999999999999999 99999999999996543 36999999999877
Q ss_pred CCC-CcccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPG-EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
... ...+...||+.|||||++.+ .|+.|+||||||+++|||+||..||.+.........+......... ...++
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~~ 272 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKECP 272 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCC
Confidence 654 44455799999999999984 4999999999999999999999999988886666666554433222 23489
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+..|+..||+.||.+||++.+++.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999876
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=381.04 Aligned_cols=255 Identities=30% Similarity=0.546 Sum_probs=223.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 467999999999999999999876655 68999999766544444567788999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK---DGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEecCCCCeecCC-
Confidence 99999999999999998888999999999999999999999999999999999999964 45699999999987543
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ +.+++++.++
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 258 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL 258 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 234567999999999986 4588999999999999999999999998888777777776654332 4578999999
Q ss_pred HHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
|.+||+.||++|+ ++.++++||||.+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999863
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=357.22 Aligned_cols=261 Identities=29% Similarity=0.503 Sum_probs=224.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEEEEEeCC---
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDT--- 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~--- 129 (436)
...|..+++||+|+||+||+|+.+.+|+.||+|+++...-.+. --....+|+.+|+.| +|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence 3568888999999999999999999999999999987643221 224567899999999 8999 999999998877
Q ss_pred ---eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 130 ---AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
..++|+||++. +|..++...+ .++...++.+++||+.||+|||+++|+||||||+|||+++ .+.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~---~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS---SGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC---CCcEeeec
Confidence 89999999975 8999987755 4788899999999999999999999999999999999975 55699999
Q ss_pred eccccccC-CCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 203 FGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 203 fG~a~~~~-~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
||+|+... +....+..++|.+|+|||++-+ .|+...||||+|||++||++++..|.+..+.+....|.+........
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999776 4455778899999999999764 59999999999999999999999999999988888887765554444
Q ss_pred CCcc--------------------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 280 PWPK--------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 280 ~~~~--------------------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.|+. .+++..+++.+||+.+|.+|.|+..+|.||||.....
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 4432 2357899999999999999999999999999987643
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=375.11 Aligned_cols=248 Identities=31% Similarity=0.566 Sum_probs=217.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++ +||||+++++++...+..|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999999765544445567788999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-CcccccccC
Q 013816 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (436)
Q Consensus 143 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~~~~~~gt 221 (436)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..... .......||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC---CCcEEEEECcccccCccCCCccccccCC
Confidence 9999988888999999999999999999999999999999999999964 445999999999754322 233456799
Q ss_pred Ccccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCc
Q 013816 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (436)
Q Consensus 222 ~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p 300 (436)
+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+ ...+++++++||.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF----PDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC----CCcCCHHHHHHHHHHcCCCH
Confidence 9999999986 468999999999999999999999999888777777766654333 24688999999999999999
Q ss_pred CCCC---CHHHHhcCcccccC
Q 013816 301 KRRL---TAQQVLEHPWLQNA 318 (436)
Q Consensus 301 ~~Rp---s~~e~l~h~~~~~~ 318 (436)
.+|| ++.++|+||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=385.65 Aligned_cols=258 Identities=31% Similarity=0.523 Sum_probs=221.6
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++.+.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999999765443344567889999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC---
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--- 212 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~--- 212 (436)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~---~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEeECCCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999964 456999999997532100
Q ss_pred ---------------------------------------------CcccccccCCcccchhccc-ccCCCCCchhHHHHH
Q 013816 213 ---------------------------------------------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (436)
Q Consensus 213 ---------------------------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~i 246 (436)
......+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012357999999999976 568999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC---HHHHhcCcccccC
Q 013816 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (436)
Q Consensus 247 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps---~~e~l~h~~~~~~ 318 (436)
+|+|++|..||...+..+....+.........+....+++++.++|.+|+ .+|.+|++ +.++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999988877766666654444444445678999999999987 59999997 9999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=376.12 Aligned_cols=273 Identities=28% Similarity=0.458 Sum_probs=229.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|...+.||+|+||.||+|.+..+++.||+|++...... ...+++.+|+.+|..+ +++||.++|+.|..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~-~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHH
Confidence 4688889999999999999999999999999999876543 3578899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||||.||++.+.+.....+.+..+..++++++.||.|||.++.+|||||+.|||+... +.+||+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechhh
Confidence 9999999999999888878999999999999999999999999999999999999654 5599999999987765433
Q ss_pred -ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 215 -FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 215 -~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
..+.+|||.|||||++.+ .|+.|+||||||++.+||++|.+|+....+..++..|-+.. ++..-...|+.+++||
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~---PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA---PPRLDGDFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC---CCccccccCHHHHHHH
Confidence 367899999999999985 79999999999999999999999998777643333332221 1111125789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHh
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSV 339 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (436)
..||++||+.||||.++|+|+|++...+ .+....+..+.+++..
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~k---~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKRAKK---TSELKELIDRYKRWRV 287 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHhcCC---chHHHHHHHHHHHHhh
Confidence 9999999999999999999999998432 2222344445554443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=385.26 Aligned_cols=258 Identities=28% Similarity=0.516 Sum_probs=218.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+++++.+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 3699999999999999999999999999999998765433344567788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~---~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEEeecccccccccccc
Confidence 999999999999988888999999999999999999999999999999999999964 4559999999986321100
Q ss_pred -----------------------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHH
Q 013816 214 -----------------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245 (436)
Q Consensus 214 -----------------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~ 245 (436)
.....+||+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 001246999999999986 56899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCC---CCHHHHhcCccccc
Q 013816 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQN 317 (436)
Q Consensus 246 il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R---ps~~e~l~h~~~~~ 317 (436)
++|+|++|..||......+....+.........+....++.++++||.+||. +|.+| +|+.+++.||||+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999998887776666666543333323334578999999999998 67665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=381.09 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=223.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence 46899999999999999999999999999999999765443334456678899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC---CCCEEEEeccceeeccCCC
Confidence 99999999999988654 6899999999999999999999999999999999999964 4559999999998664332
Q ss_pred --cccccccCCcccchhcccc-----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 214 --KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
......||+.|+|||++.. .++.++|||||||++|+|++|..||.+.........+.........+....+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2235679999999998752 378899999999999999999999999888777777776543333344446899
Q ss_pred HHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
++++||.+||+.+|.+ |+|+.++++||||+..
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 9999999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=385.47 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=220.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.+ +||||+++++.+.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999998765433333456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC--
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-- 212 (436)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|..+...
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC---CCCEEEEeCCCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999964 445999999997532100
Q ss_pred ------------------------------------------CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHH
Q 013816 213 ------------------------------------------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYI 249 (436)
Q Consensus 213 ------------------------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~ 249 (436)
......+||+.|+|||++. ..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0012357999999999986 468999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC---CHHHHhcCcccccC
Q 013816 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (436)
Q Consensus 250 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 318 (436)
|++|+.||.+....+....+.........+.+..+++++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 99999999988877666666554433333444578999999999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=382.38 Aligned_cols=259 Identities=35% Similarity=0.620 Sum_probs=225.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 4699999999999999999999999999999999876544444567789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~---~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA---DGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC---CCCEEeecCCCCccCcccCc
Confidence 999999999999988888999999999999999999999999999999999999964 4459999999997664332
Q ss_pred -----------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH
Q 013816 214 -----------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (436)
Q Consensus 214 -----------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 263 (436)
......||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 223457999999999987 46899999999999999999999999988877
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC-HHHHhcCcccccC
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQNA 318 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps-~~e~l~h~~~~~~ 318 (436)
.....+.........+....+++++.+||.+||. +|.+||+ +.++++||||+..
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777776633333333334579999999999997 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=374.82 Aligned_cols=249 Identities=28% Similarity=0.552 Sum_probs=217.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999866544444567788999999999 999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~---~~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK---DGHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC---CCcEEEecCcCCccCCCccccccccc
Confidence 999999988888999999999999999999999999999999999999964 44599999999875432 22334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......+ ...+++++.+||.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~----p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF----PRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC----CCCCCHHHHHHHHHHcCC
Confidence 999999999986 568999999999999999999999998887776666665544332 246889999999999999
Q ss_pred CcCCCC-----CHHHHhcCccccc
Q 013816 299 DPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 299 ~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
||++|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=373.82 Aligned_cols=250 Identities=30% Similarity=0.574 Sum_probs=217.8
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444556778899999999 999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC---CCCEEecccHHhccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999964 44599999999875422 22334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999986 5689999999999999999999999988887777666665544332 45789999999999999
Q ss_pred CcCCCC-----CHHHHhcCcccccC
Q 013816 299 DPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
||.+|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=378.91 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=222.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence 347899999999999999999999999999999999765443344456688999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~---~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK---HGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC---CCCEEEEecccceecccC
Confidence 999999999999988654 6899999999999999999999999999999999999964 455999999999876433
Q ss_pred C--cccccccCCcccchhcccc-----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 213 E--KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+.........+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 2 2245679999999999853 27889999999999999999999999888877777777654433333334679
Q ss_pred HHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
..+++++..||..++.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.77 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=211.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++++ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence 4699999999999999999999999999999998654321 2235678899999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||++| +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~---~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE---KGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEECcCcceeeccCCC
Confidence 999986 8988887654 4789999999999999999999999999999999999964 445999999999765432
Q ss_pred CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC-----------
Q 013816 213 EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 279 (436)
.......+|+.|+|||++. ..++.++||||+||++|+|+||+.||.+.+..+....+..........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2234457899999999875 358899999999999999999999998877766655554322111000
Q ss_pred ---------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 280 ---------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..+.+++++++||.+||++||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=372.81 Aligned_cols=251 Identities=31% Similarity=0.548 Sum_probs=218.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654433345567788999998876899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999654 4589999999875432 23334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|+.||...+.......+.......+ ..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence 999999999987 4689999999999999999999999998888877777766544322 35789999999999999
Q ss_pred CcCCCCCH------HHHhcCcccccC
Q 013816 299 DPKRRLTA------QQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~------~e~l~h~~~~~~ 318 (436)
||.+||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=358.33 Aligned_cols=258 Identities=33% Similarity=0.568 Sum_probs=232.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.|++++.||.|.-|+||+|..+.++..+|+|++.+..........++..|-+||+.+ +||.++.+|..|+.+...|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEE
Confidence 5799999999999999999999999999999999998887777778899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-
Q 013816 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP- 211 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~- 211 (436)
||||+||+|...++.+ +.+++..++-++..++.||+|||-.|||.|||||+||||. ++++|-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccccCCCC
Confidence 9999999999888765 4599999999999999999999999999999999999994 566799999998642210
Q ss_pred --------------------------------C------------------------CcccccccCCcccchhcccc-cC
Q 013816 212 --------------------------------G------------------------EKFSEIVGSPYYMAPEVLKR-NY 234 (436)
Q Consensus 212 --------------------------------~------------------------~~~~~~~gt~~y~aPE~l~~-~~ 234 (436)
. ....+.+||-.|.|||++.+ ..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 01134689999999999985 58
Q ss_pred CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC----HHHHh
Q 013816 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQVL 310 (436)
Q Consensus 235 ~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps----~~e~l 310 (436)
+.++|.|+|||++|||+.|..||.+.+..+...+|+.....++..+ .++..++|||+++|.+||.+|.. |+||-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 9999999999999999999999999999999999999888777653 78899999999999999999998 99999
Q ss_pred cCcccccC
Q 013816 311 EHPWLQNA 318 (436)
Q Consensus 311 ~h~~~~~~ 318 (436)
+||||+..
T Consensus 391 ~HpFF~gV 398 (459)
T KOG0610|consen 391 RHPFFEGV 398 (459)
T ss_pred cCccccCC
Confidence 99999863
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=371.28 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=221.6
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|+.++..+..|++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 48899999999999999999999999999999987654444456778899999999955567899999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~ 214 (436)
||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA---EGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC---CCCEEEeecCcceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999964 44599999999875322 223
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++|||||||++|+|+||+.||.+....+....+......+ ...+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY----PKSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHH
Confidence 34567999999999987 458999999999999999999999999888887777776654332 2457899999999
Q ss_pred HccCCCcCCCCCH-----HHHhcCcccccC
Q 013816 294 KMLDPDPKRRLTA-----QQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rps~-----~e~l~h~~~~~~ 318 (436)
+||+.||.+|+++ .++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=365.18 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=211.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence 3699999999999999999999999999999998765322 23456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++++.+..+......+++..+..++.|++.||.|||+.||+||||||+||+++. .+.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEEeeccCccccccccc
Confidence 999998777655544567999999999999999999999999999999999999964 3459999999998764332
Q ss_pred -cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc----------------
Q 013816 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---------------- 275 (436)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999976 46899999999999999999999999877655443333221100
Q ss_pred ---CCC---------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 ---FRR---------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 ---~~~---------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+. ..+..+|.++.+||.+||++||++|||+.++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-49 Score=375.77 Aligned_cols=259 Identities=30% Similarity=0.480 Sum_probs=222.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 3699999999999999999999999999999999876543444566788999999998 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR---TGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC---CCCEEeccCCCCeECCCCC
Confidence 9999999999999876 67999999999999999999999999999999999999964 4559999999998765433
Q ss_pred cc--cccccCCcccchhccc-------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 214 KF--SEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
.. ....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.........+..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 22 2347899999999874 34778999999999999999999999888877777777654332222333468
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++++.+||.+||+ +|.+|||+.++++||||...
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=356.84 Aligned_cols=259 Identities=32% Similarity=0.536 Sum_probs=219.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
...-.|.-.+.+|.|+||.||+|...++++.||||.+-.... --.+|+++|+.+ +|||||++..+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTES 92 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCC
Confidence 345578889999999999999999999999999998754432 224699999999 9999999999886432
Q ss_pred ---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 130 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
...+||||++. +|.+.++. +..++.-.++-+++||+.||.|||+.||+||||||+|+|++. .++.+||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~--~tg~LKicD 169 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP--DTGVLKICD 169 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC--CCCeEEecc
Confidence 34589999976 99988874 467888999999999999999999999999999999999974 567799999
Q ss_pred eccccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc-----
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----- 275 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~----- 275 (436)
||.|+.+..++...+..-|..|+|||.+. ..|+.+.||||.||++.||+-|++.|.+.+....+..|.+-...
T Consensus 170 FGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 170 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred CCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99999998888888888999999999876 46999999999999999999999999998888777777652211
Q ss_pred ---------------CCCCCC-----cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 276 ---------------FRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 276 ---------------~~~~~~-----~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+...+| ...++++.+|+.++|+++|.+|.++.|+|.||||......
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 111112 3468999999999999999999999999999999876543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=370.27 Aligned_cols=250 Identities=27% Similarity=0.525 Sum_probs=218.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|++..+++.||+|++.+.........+.+..|++++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999997765444445567788999998776899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA---EGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC---CCCEEEeecccceecccCCccccccc
Confidence 999999988888999999999999999999999999999999999999964 44599999999875432 22334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++ ..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence 999999999987 4689999999999999999999999999888888877776544322 34789999999999999
Q ss_pred CcCCCC-------CHHHHhcCccccc
Q 013816 299 DPKRRL-------TAQQVLEHPWLQN 317 (436)
Q Consensus 299 ~p~~Rp-------s~~e~l~h~~~~~ 317 (436)
||++|| ++.++++||||..
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999 9999999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=377.89 Aligned_cols=259 Identities=29% Similarity=0.522 Sum_probs=220.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++.+.+.+.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3689999999999999999999999999999999765444444567788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~---~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA---KGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEeeccCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999964 4569999999987542110
Q ss_pred -----------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCC
Q 013816 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (436)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf 257 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|+||..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 012357999999999976 56899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC---CHHHHhcCcccccC
Q 013816 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (436)
Q Consensus 258 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 318 (436)
...+.......+.........+....+++++++||.+|+. ||.+|+ ++.++++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 9888877777776533222222223578999999999874 999998 58999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=369.23 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=222.6
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+..||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999987654444445667788899888877999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~ 214 (436)
||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC---CCcEEEccCCCceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999964 44599999999975432 223
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++|||||||++|+|+||..||.+.........+......++ ..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence 34567999999999987 5689999999999999999999999999888888777776554332 357899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCccccc
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
+||+.+|.+|++ ..++++||||+.
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999999997 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=369.99 Aligned_cols=250 Identities=28% Similarity=0.522 Sum_probs=212.0
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999998765544555677889999999987899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc-CCCCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~-~~~~~~~~~~ 219 (436)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.. ..........
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA---EGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC---CCCEEECcCccccccccCCCcccccc
Confidence 999999988888999999999999999999999999999999999999964 445999999998753 2233445568
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||.... .....+.+....... ...++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCCCCHHHH
Confidence 999999999987 468999999999999999999999995321 112233333333222 235789999
Q ss_pred HHHHHccCCCcCCCCC------HHHHhcCccccc
Q 013816 290 DLVRKMLDPDPKRRLT------AQQVLEHPWLQN 317 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps------~~e~l~h~~~~~ 317 (436)
++|.+||+.||.+|+| +.++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999987 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=361.89 Aligned_cols=258 Identities=31% Similarity=0.510 Sum_probs=218.9
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.+ +||||+++++.+...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 388899999999999999999999999999999765444333445678899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ...++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD---YGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC---CCCEEEeeCCCceecCCCC
Confidence 999999999887653 45899999999999999999999999999999999999954 4559999999998765444
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............++..+.+|+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 445568899999999976 5688999999999999999999999987765544444433332223333456899999999
Q ss_pred HHccCCCcCCCC-----CHHHHhcCccccc
Q 013816 293 RKMLDPDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 293 ~~~l~~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
.+||+.||++|| ++.++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 9999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=371.78 Aligned_cols=249 Identities=30% Similarity=0.573 Sum_probs=216.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+++++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556778899999999 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEI 218 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~~~~~~~ 218 (436)
++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~---~~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK---DGHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC---CCCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 79999999999999964 3459999999987543 22333456
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|+||..||...+.......+......++ ..+++++.+||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 7999999999986 5689999999999999999999999988877766666655443332 3578999999999999
Q ss_pred CCcCCCC-----CHHHHhcCccccc
Q 013816 298 PDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 298 ~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
.||++|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 9999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=363.09 Aligned_cols=265 Identities=37% Similarity=0.657 Sum_probs=239.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.|.+-|.+.+.||+|.|++|-+|++--+|..||||+|.+.++... ....+.+|+.-|+.+ +|||||++|++......+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhcccceE
Confidence 467789999999999999999999999999999999998877543 456788999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+|+|+-+||+|+|+|.+. ..+.|..+..++.||+.|+.|+|+..+|||||||+|+++-. .-+.|||.|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeeccccccCC
Confidence 9999999999999999765 45999999999999999999999999999999999999864 34569999999999999
Q ss_pred CCCcccccccCCcccchhcccc-cC-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
++....+.+|+..|.|||++.+ .| .++.||||||||||.|++|++||...+..+.+-.|+......+ ..+|.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHH
Confidence 9999999999999999999875 45 4789999999999999999999999999999988887765543 4689999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 324 (436)
++||..||..||.+|.|.+++..|+|++.......+
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 999999999999999999999999999976555443
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=366.96 Aligned_cols=251 Identities=29% Similarity=0.493 Sum_probs=214.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999997654332334566778888888766899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999643 4599999999875322 22334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......+ ...++.++++||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHY----PRWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHHHHHHHHccC
Confidence 999999999987 468999999999999999999999999888777766665543322 234789999999999999
Q ss_pred CcCCCCCH-HHHhcCcccccC
Q 013816 299 DPKRRLTA-QQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~-~e~l~h~~~~~~ 318 (436)
||++||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999997 589999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=373.92 Aligned_cols=261 Identities=31% Similarity=0.491 Sum_probs=222.4
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++.+...+.+|
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence 347899999999999999999999999999999999765443344456688899999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~---~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC---CCCEEEEeCCceeEcCcC
Confidence 999999999999988654 5899999999999999999999999999999999999964 455999999999876433
Q ss_pred C--cccccccCCcccchhcccc-----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 213 E--KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+.........+....++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2235679999999999853 27889999999999999999999999988877777777654433334445789
Q ss_pred HHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
..++++|.+||..++.+ |+++.++++||||++.
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999854443 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=371.25 Aligned_cols=260 Identities=30% Similarity=0.569 Sum_probs=213.8
Q ss_pred ceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+..|+.++..+.+||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999998864 57899999999764332 2233467888999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||++||+|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---CCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999654 4599999999976533
Q ss_pred CC--cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.. ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...........+..............+++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 2335679999999999864 4788999999999999999999999643322111222222222222333468999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+.+++.+||+.||++|| ++.++++||||+..
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=364.36 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=207.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++.+....++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEE
Confidence 36799999999999999999999999999999998654322 2234677899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||+. ++|.+.+... +.+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD---TGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECCCCcceeccCC
Confidence 999996 4777777654 56899999999999999999999999999999999999964 445999999998754322
Q ss_pred -CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCC-----------
Q 013816 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFR----------- 277 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~----------- 277 (436)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 23345678999999998753 4788999999999999999999999765432 22222221110000
Q ss_pred ---CCC------------C--cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 ---RDP------------W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ---~~~------------~--~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
... | ...++++.+|+.+||+.||++|||+.|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 0 1245788999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=367.39 Aligned_cols=251 Identities=30% Similarity=0.540 Sum_probs=217.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444445667888999999887899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++..... .......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---CcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875322 22334457
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+......+ ...++.++.+||.+||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY----PRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC----CCcCCHHHHHHHHHHccC
Confidence 999999999986 468999999999999999999999998888777766666544332 235789999999999999
Q ss_pred CcCCCCCH-----HHHhcCcccccC
Q 013816 299 DPKRRLTA-----QQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~-----~e~l~h~~~~~~ 318 (436)
||.+|||+ .++++||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=366.08 Aligned_cols=251 Identities=32% Similarity=0.528 Sum_probs=214.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997654433344556677888887666899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Ccccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~~~~~~ 219 (436)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK---DGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC---CCCEEEccCcCCeECCCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999964 445999999999764332 2334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......+ ...++.++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF----PRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHccC
Confidence 999999999986 458999999999999999999999999888877776665543222 235789999999999999
Q ss_pred CcCCCCCH-HHHhcCcccccC
Q 013816 299 DPKRRLTA-QQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~-~e~l~h~~~~~~ 318 (436)
||.+||++ .++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=368.44 Aligned_cols=251 Identities=27% Similarity=0.510 Sum_probs=211.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++.++.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765555555677889999998877899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~~~~~~~~ 219 (436)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||+++... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~---~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC---CCCEEEeeCCccccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999964 4459999999987542 223344568
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+...... ....++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPRSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----CCCCCCHHHH
Confidence 999999999986 46889999999999999999999999521 111222333333222 2246789999
Q ss_pred HHHHHccCCCcCCCCC------HHHHhcCcccccC
Q 013816 290 DLVRKMLDPDPKRRLT------AQQVLEHPWLQNA 318 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps------~~e~l~h~~~~~~ 318 (436)
+||.+||+.||++||+ +.++++||||+..
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=358.95 Aligned_cols=252 Identities=31% Similarity=0.514 Sum_probs=209.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|+||+||+|.+..+++.||+|.+...........+.+..|+.+++.+ +||||+++.+++.....+++||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 79999999999999999999999999765544444456788899999999 99999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-ccc
Q 013816 143 LFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSE 217 (436)
Q Consensus 143 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~-~~~ 217 (436)
|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN---DGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCccceecCCCCccccc
Confidence 9887743 346899999999999999999999999999999999999964 44599999999976644322 234
Q ss_pred cccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHcc
Q 013816 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296 (436)
Q Consensus 218 ~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l 296 (436)
..||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++++.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 57899999999986 56889999999999999999999999765433222223322222222333468999999999999
Q ss_pred CCCcCCCC-----CHHHHhcCcccccC
Q 013816 297 DPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 297 ~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+.||++|| ++.++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.41 Aligned_cols=259 Identities=28% Similarity=0.468 Sum_probs=210.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC-----Ce
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TA 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----~~ 130 (436)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999986432 2233456788999999999 899999999987543 35
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCcEEEccCccccccc
Confidence 899999995 589999988888999999999999999999999999999999999999964 4459999999997543
Q ss_pred CCC----cccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc-----------
Q 013816 211 PGE----KFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----------- 272 (436)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~----------- 272 (436)
... ......||+.|+|||++. ..++.++|||||||++|+|+||+.||.+.+.......+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123457999999999875 35889999999999999999999999776543322221110
Q ss_pred ------------ccc----CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 273 ------------VLD----FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 273 ------------~~~----~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
... .....++.+++++.++|.+||+.||++|||+.++|+||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 001123457889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=366.38 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=216.4
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHH---hCCCCCceeEEEEEEEeCCeEEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR---HLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~---~l~~h~niv~~~~~~~~~~~~~l 133 (436)
|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++. .+ +||||+++++++...+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 678899999999999999999999999999997654333334566777776654 55 79999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~ 212 (436)
||||++|++|...+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CcEEeCcccCCccCCCCC
Confidence 9999999999887754 579999999999999999999999999999999999999654 4599999999875432 2
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 2334567999999999986 4688999999999999999999999998888777777766544322 4578999999
Q ss_pred HHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
|.+||+.||.+|| ++.++++||||++.
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=358.90 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=208.8
Q ss_pred cceeeccccccCCceEEEEEEEcC-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEE-----
Q 013816 55 ERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE----- 126 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~----- 126 (436)
++|++.+.||+|+||.||+|.+.. +++.||+|.+........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 468899999875443222 2345567877777663 6999999999885
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
....+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~---~~~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---CCEEEcccc
Confidence 3456899999997 4898888653 358999999999999999999999999999999999999654 459999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC----
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---- 279 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~---- 279 (436)
++.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+....+....+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 998765544445667999999999976 568999999999999999999999999888777776665432211111
Q ss_pred -------------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 280 -------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 280 -------------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..+.+++.+++|+.+||+.||++|||+.++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=380.02 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=209.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
...+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence 4568999999999999999999999999999999885431 2345799999999 999999999887432
Q ss_pred ----CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 129 ----TAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 129 ----~~~~lv~E~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
..+++||||+++ +|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cceee
Confidence 246799999976 7766664 345689999999999999999999999999999999999996432 35899
Q ss_pred EeeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---
Q 013816 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--- 275 (436)
Q Consensus 201 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--- 275 (436)
+|||+|+............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+....+.+....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987765555556788999999998753 5899999999999999999999999887766555555432110
Q ss_pred --------------CCCC--------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 --------------FRRD--------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 --------------~~~~--------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.. .....++++++||.+||++||.+|||+.|+|+||||....
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0000 0123678999999999999999999999999999997643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=371.27 Aligned_cols=261 Identities=31% Similarity=0.464 Sum_probs=218.9
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-----CceeEEEEE
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-----QNIVCLKDT 124 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-----~niv~~~~~ 124 (436)
++.+..+|.+.+.||+|+||.|.+|++..|++.||||+++... ....+...|+.+|..|.+| -|+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3566679999999999999999999999999999999997653 3456778899999999534 389999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 125 YEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 125 ~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
|...++.|||+|.++ -+|+++++.+. .++...++.++.||+.||.+||+.||||+||||+|||+...+.. .|||+|
T Consensus 257 F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVID 334 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVID 334 (586)
T ss_pred cccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEe
Confidence 999999999999995 59999999874 48899999999999999999999999999999999999876544 799999
Q ss_pred eccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC-----
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF----- 276 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~----- 276 (436)
||.|...... ..+.+.+..|+|||++- ..|+.+.||||||||+.||++|.+.|.+.++.+.+..|.+-....
T Consensus 335 FGSSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 335 FGSSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999876433 33778899999999865 589999999999999999999999999988877766664411100
Q ss_pred ----------CC-CC-------------------------------Cc------------ccCHHHHHHHHHccCCCcCC
Q 013816 277 ----------RR-DP-------------------------------WP------------KVSENAKDLVRKMLDPDPKR 302 (436)
Q Consensus 277 ----------~~-~~-------------------------------~~------------~~~~~~~~ll~~~l~~~p~~ 302 (436)
.. .. .+ .-...+.+||.+||.+||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 00 00 00 01235789999999999999
Q ss_pred CCCHHHHhcCcccccC
Q 013816 303 RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 303 Rps~~e~l~h~~~~~~ 318 (436)
|+|+.++|+||||...
T Consensus 493 R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 493 RITPAQALNHPFLTGT 508 (586)
T ss_pred cCCHHHHhcCcccccc
Confidence 9999999999999843
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=364.38 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=216.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|++..++..+|+|.+.... .....+.+.+|+++++.+ +||||+++++++..++.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999999999999999987542 233456799999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---CcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999654 45999999998765432
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc-----------------
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----------------- 274 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----------------- 274 (436)
......||+.|+|||++. ..++.++|||||||++|+|+||+.||......+....+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 234567999999999987 4589999999999999999999999976655443222211000
Q ss_pred -------------------------c--CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 275 -------------------------D--FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 275 -------------------------~--~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
. .+......+++++++||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 00111124678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=363.37 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=214.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+++.||+|++................|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997654332334456777888888765899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEccCCcceECCCCCCceeeec
Confidence 9999999887789999999999999999999999999999999999999653 4599999999875422 22334567
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+......+ ...++.+++++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCY----PRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CccCCHHHHHHHHHHhcc
Confidence 999999999986 468999999999999999999999998888777766665443222 234789999999999999
Q ss_pred CcCCCCCHH-HHhcCcccccC
Q 013816 299 DPKRRLTAQ-QVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~~-e~l~h~~~~~~ 318 (436)
||++||++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=364.18 Aligned_cols=250 Identities=32% Similarity=0.548 Sum_probs=214.9
Q ss_pred ccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 60 GRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.+ +||||+++++++..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence 367999999999999864 57899999999765332 223345678899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~ 214 (436)
||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA---QGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEeeCcCCeecccCCCc
Confidence 99999999999988888999999999999999999999999999999999999964 445999999998754322 22
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....... .+.+++++.+||.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~ 232 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL----PPYLTPEARDLLK 232 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHH
Confidence 34467999999999986 458899999999999999999999999888777777776654432 2457899999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCccccc
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
+||+.+|++|| ++.++++||||..
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=363.31 Aligned_cols=256 Identities=26% Similarity=0.477 Sum_probs=221.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|+.++..+.+|++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 37788999999999999999999999999999986544334455678889999998866788999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~ 214 (436)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999643 45999999998754322 22
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.......+.+......+ ...++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY----PKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CccCCHHHHHHHH
Confidence 34567999999999986 568999999999999999999999999888877777777654433 2457899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+||+.+|.+|++ ..++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 5799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=365.14 Aligned_cols=249 Identities=28% Similarity=0.540 Sum_probs=213.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
+.||+|+||+||+|++..+|+.||+|++.+...........+..|.. +++.+ +||||+++++.+...+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999997654433334455566655 45667 89999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~ 218 (436)
|++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS---QGHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC---CCcEEEeccCCCcccccCCCccccc
Confidence 9999999988888999999999999999999999999999999999999964 34599999999875432 2233456
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+....... .+.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhh
Confidence 7999999999986 468999999999999999999999999888877777776654332 34679999999999999
Q ss_pred CCcCCCCCH----HHHhcCccccc
Q 013816 298 PDPKRRLTA----QQVLEHPWLQN 317 (436)
Q Consensus 298 ~~p~~Rps~----~e~l~h~~~~~ 317 (436)
.||.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=363.29 Aligned_cols=260 Identities=29% Similarity=0.523 Sum_probs=217.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||++++..+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4699999999999999999999999999999999764433444556788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK---NGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC---CCCEEEEECCceeecCCCC
Confidence 999999999999976 457899999999999999999999999999999999999954 4459999999987654332
Q ss_pred cc--cccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCccc
Q 013816 214 KF--SEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKV 284 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 284 (436)
.. ....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+......+.. ...+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 22 2346999999999975 24788999999999999999999999888777666666554322221 223458
Q ss_pred CHHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
++.++++|.+||..++++ |+++.++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999998764443 7899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=364.59 Aligned_cols=255 Identities=33% Similarity=0.557 Sum_probs=230.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe-EEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA-VHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-~~l 133 (436)
+.|..++.+|+|+||.+++++++..+..+|+|.|........ ..+...+|+.+++++ .|||||.+.+.|+.++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 579999999999999999999999999999999987765544 345788999999999 99999999999998888 999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||+||+||+|.+.+...+ .++++.+..++.|++.|+.|||+++|+|||||++||+++.++ .|||.|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~---~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK---KVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---ceeecchhhhhhcCC
Confidence 999999999999997653 589999999999999999999999999999999999997544 389999999999887
Q ss_pred CC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ...+.+||+.||+||++. .+|+.|+|||||||++|||++-+.+|.+.+.......|.+...... ....+.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---CccccHHHH
Confidence 76 567889999999999998 4799999999999999999999999999999999999988874322 246789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.+|..||..+|..||++.++|.+|.+..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999998874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=369.88 Aligned_cols=253 Identities=23% Similarity=0.405 Sum_probs=206.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
..+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|++++++| +||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEE
Confidence 357999999999999999999999999999999743 23467899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||++. ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---GDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---CCEEEEeCCccccccccc
Confidence 999995 6899998888889999999999999999999999999999999999999643 45999999999754321
Q ss_pred -CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHcccc--------
Q 013816 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLD-------- 275 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~-------- 275 (436)
.......||+.|+|||++. ..++.++|||||||++|+|+||..||.... .......+......
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2234568999999999986 468999999999999999999998875432 11111111111000
Q ss_pred --------------------CCCCCC---cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 276 --------------------FRRDPW---PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 276 --------------------~~~~~~---~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.....| ..++.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 000111 134678999999999999999999999999999987543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=362.95 Aligned_cols=251 Identities=27% Similarity=0.489 Sum_probs=211.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++.+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998765544455677889999999987899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CCCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~~~~~~~~ 219 (436)
++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---CCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999654 459999999987532 233345568
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
||+.|+|||++. ..++.++|||||||++|+|++|..||.... .....+.+...... ....++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----IPRFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence 999999999976 568999999999999999999999995321 12233333332222 223578999999
Q ss_pred HHHccCCCcCCCCC------HHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLT------AQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps------~~e~l~h~~~~~~ 318 (436)
+.+||+.||.+|++ +.++++||||+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=366.56 Aligned_cols=250 Identities=31% Similarity=0.552 Sum_probs=213.3
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
||+|+||+||+|++..+++.||+|++.+..............|..++..+. +||||+++++++...+.+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997654433334445566777777654 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCcccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~~ 219 (436)
++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA---TGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999988888999999999999999999999999999999999999964 34599999999875432 22334567
Q ss_pred cCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 220 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 220 gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
||+.|+|||++.+ .++.++|||||||++|+|+||..||......+....+..+...++. ..+++++.+||.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999999753 4789999999999999999999999988887777777665443332 3478999999999999
Q ss_pred CCcCCCC----CHHHHhcCcccccC
Q 013816 298 PDPKRRL----TAQQVLEHPWLQNA 318 (436)
Q Consensus 298 ~~p~~Rp----s~~e~l~h~~~~~~ 318 (436)
.||.+|| ++.++++||||+..
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=353.92 Aligned_cols=257 Identities=31% Similarity=0.518 Sum_probs=213.6
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++ +|+||+.+++.+...+.+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEE
Confidence 77888999999999999999999999999998766544444445678899999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|++|++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++. ...++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~---~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD---HGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC---CCCEEEeeccceeecCCCcc
Confidence 99999999888654 35899999999999999999999999999999999999964 44589999999976654444
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||..........................+++++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 44567999999999986 56899999999999999999999999765432111111111111112233467899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCccccc
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
+||+.||++||| +.|+++||||+.
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.63 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=209.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|++..+++.||+|++.... .......+.+|+++++.+ +|+||+++++++...+.+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence 467899999999999999999999999999999986542 233456789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS---AKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCEEEcccccceeccccc
Confidence 9999999998643 34578888999999999999999999999999999999964 3459999999998764332
Q ss_pred -cccccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 214 -KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
......||..|+|||++.. ..+.++|||||||++|+|++|+.||...........+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2345679999999998742 235689999999999999999999974333222222211111222233356889
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
++++||.+||+.||++|||+.|+|+||||.....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 9999999999999999999999999999987643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=350.94 Aligned_cols=252 Identities=28% Similarity=0.466 Sum_probs=207.0
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|+||.||++.++.+|+.||+|.+.............+..|+++++.+ +||||++++++++.+..+++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999999765443333345567799999999 99999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccc
Q 013816 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (436)
Q Consensus 143 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~g 220 (436)
|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++. ...++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD---QGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC---CCCEEEeeceeeeecCCCceeeccCC
Confidence 988886543 4888999999999999999999999999999999999964 44589999999987655444455678
Q ss_pred CCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-CCCCcccCHHHHHHHHHccCC
Q 013816 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 221 t~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~ 298 (436)
|+.|+|||++. ..++.++|||||||++|+|++|..||...........+........ ......+++++++|+.+||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999976 4589999999999999999999999976443222222222221111 112246789999999999999
Q ss_pred CcCCCCCH----HHHhcCcccccC
Q 013816 299 DPKRRLTA----QQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps~----~e~l~h~~~~~~ 318 (436)
||++||++ .+++.||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 678899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=362.07 Aligned_cols=250 Identities=28% Similarity=0.542 Sum_probs=213.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-MRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|..+ ++.+ +||||+++++++...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999976544333344556666654 5667 99999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~ 218 (436)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~---~~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS---QGHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEeecCCcccCCCCCCCcccc
Confidence 9999999988888999999999999999999999999999999999999964 44599999999875422 2333456
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+....... .+..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhc
Confidence 7999999999987 468999999999999999999999999888877777776654332 24578999999999999
Q ss_pred CCcCCCCCH----HHHhcCcccccC
Q 013816 298 PDPKRRLTA----QQVLEHPWLQNA 318 (436)
Q Consensus 298 ~~p~~Rps~----~e~l~h~~~~~~ 318 (436)
.+|.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999976 599999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=350.72 Aligned_cols=258 Identities=32% Similarity=0.523 Sum_probs=220.2
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.+ +|+||+.+++.+..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 67788999999999999999999999999999766544444455678899999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|+.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ ..+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---CCEEEecCCcceecCCCCc
Confidence 99999998888653 358999999999999999999999999999999999999643 4599999999976654444
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....|+..|+|||++. ..++.++|+||||+++|+|++|..||...........+............+.++.++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 45567999999999976 56899999999999999999999999877665544444444333333444568899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+||+.||++||+ +.++++|+||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.10 Aligned_cols=259 Identities=27% Similarity=0.486 Sum_probs=218.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..+ +|+||+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999998764433334456688899999998 999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM---NGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC---CCCEEEEeccceeeccCCC
Confidence 999999999999977 467899999999999999999999999999999999999964 4459999999997664432
Q ss_pred cc--cccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-CCCCccc
Q 013816 214 KF--SEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 284 (436)
.. ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+......+. ...+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 23579999999998753 478899999999999999999999988877777766665433222 1223457
Q ss_pred CHHHHHHHHHccCCCcCC--CCCHHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~ 317 (436)
++++++++.+||...+.+ |+++.++++||||..
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 899999999999876654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=362.04 Aligned_cols=249 Identities=29% Similarity=0.523 Sum_probs=214.8
Q ss_pred cccccCCceEEEEEEE---cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 61 RELGRGEFGITYLCTD---RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+.||+|+||.||++++ ..+|+.||+|++.+.... ......+.+|+++++++ +||||+++++++...+.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 5799999999999886 357899999999765432 22345678899999999 899999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-Cccc
Q 013816 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFS 216 (436)
Q Consensus 138 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~~~ 216 (436)
++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---CcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999643 45999999998765433 2334
Q ss_pred ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHc
Q 013816 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (436)
Q Consensus 217 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~ 295 (436)
...||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+.......+ ..+++++.+||.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 567999999999986 4688999999999999999999999998887777777766544332 35789999999999
Q ss_pred cCCCcCCCCC-----HHHHhcCcccccC
Q 013816 296 LDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 296 l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
|+.||++||+ +.+++.||||+..
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999999 7789999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=359.72 Aligned_cols=260 Identities=29% Similarity=0.499 Sum_probs=218.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++.+..+++.+|+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 3699999999999999999999999999999998764433333455688899999998 999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~---~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC---CCCEEEeecchheecccCC
Confidence 999999999999976 467899999999999999999999999999999999999964 4459999999987653322
Q ss_pred c--ccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCccc
Q 013816 214 K--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKV 284 (436)
Q Consensus 214 ~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 284 (436)
. .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+......... .....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 23457999999999874 34788999999999999999999999988877777777654432221 223467
Q ss_pred CHHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 285 SENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
++++++|+.+||..++.+ |+++.++++||||...
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999999765544 6899999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=352.65 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=207.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEEe-----C
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED-----D 128 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~-----~ 128 (436)
+|++.+.||+|+||+||+|.++.+++.||+|.+........ ....+.+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875432221 2234566777776653 69999999998864 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 129 TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
..+++||||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccCcc
Confidence 468999999975 888888654 348999999999999999999999999999999999999644 45999999999
Q ss_pred cccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-------
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------- 278 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------- 278 (436)
.............||+.|+|||++. ..++.++|||||||++|+|++|.+||...........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765444445567899999999876 56899999999999999999999999887766655555432111000
Q ss_pred ----------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 279 ----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 279 ----------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
...+.++..+.+++.+||++||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=363.36 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=208.9
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence 45688999999999999999999999999999999986543 2333456788999999999 8999999999986543
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 130 ----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~---~~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEecCCC
Confidence 57999999976 5666654 34889999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc-----------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------- 273 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~----------- 273 (436)
++............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 98665444445668899999999986 468999999999999999999999998766543332222111
Q ss_pred -----------ccCCC----------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 274 -----------LDFRR----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 274 -----------~~~~~----------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..... ......++++++||.+||+.||++|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00000 001124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.35 Aligned_cols=249 Identities=27% Similarity=0.521 Sum_probs=211.3
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
+.||+|+||+||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999997654333333344555544 45667 99999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~ 218 (436)
|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~---~~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC---CCCEEEccCCCCcccccCCCCcccc
Confidence 9999999988888999999999999999999999999999999999999964 34599999999875432 2233456
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+...... ..+.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcc
Confidence 7999999999987 46889999999999999999999999988887777777665332 234689999999999999
Q ss_pred CCcCCCCCHH----HHhcCccccc
Q 013816 298 PDPKRRLTAQ----QVLEHPWLQN 317 (436)
Q Consensus 298 ~~p~~Rps~~----e~l~h~~~~~ 317 (436)
.+|.+||++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=360.11 Aligned_cols=262 Identities=32% Similarity=0.624 Sum_probs=236.0
Q ss_pred ccccceee--ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 52 EIEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 52 ~~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+..-|+| .+.||+|.||+||-|+++.+|+.||||+|.+..+... ....+++|+.||+.+ .||.||.+.--|+..+
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l-~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNL-HHPGIVNLECMFETPE 636 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhc-CCCCeeEEEEeecCCc
Confidence 34455666 4779999999999999999999999999999887654 347899999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 130 AVHLVMELCEGGELFDRIV--ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+++|||-+.| +..+.+. +.++++++...-++.||+.||.|||-++|+|.||||+|||+.+...-..+||||||+|+
T Consensus 637 rvFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 637 RVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred eEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccccee
Confidence 99999999976 5555554 34789999999999999999999999999999999999999887777789999999999
Q ss_pred ccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.+....-..+.+|||.|.|||++. +.|+.+-|+||+|||+|.-++|..||.. .+++.++|.+..+-++..+|..+++
T Consensus 716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH
Confidence 987666667899999999999987 6799999999999999999999999954 3456778888999999999999999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++.+||..+|+..-.+|.|..+.|.|||+++.
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999999975
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=358.01 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=210.8
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
+.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999997654433333455566655 56777 99999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CCccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~~~~~~ 218 (436)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEccCCCCccCCCCCCccccc
Confidence 99999999888889999999999999999999999999999999999999654 4599999999875322 2233456
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+....... .+..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQL----PGGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHcc
Confidence 7999999999986 468999999999999999999999999888777766666543322 24578899999999999
Q ss_pred CCcCCCCCH----HHHhcCccccc
Q 013816 298 PDPKRRLTA----QQVLEHPWLQN 317 (436)
Q Consensus 298 ~~p~~Rps~----~e~l~h~~~~~ 317 (436)
.+|.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999875 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=356.57 Aligned_cols=258 Identities=23% Similarity=0.394 Sum_probs=213.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.+ +||||+++++++..++.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEE
Confidence 478999999999999999999999999999999886542 233456789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---CCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999653 45999999998765322
Q ss_pred CcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--------------------- 270 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~--------------------- 270 (436)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999874 58899999999999999999999997654432221110
Q ss_pred -------------------HccccCCCC--CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 271 -------------------RSVLDFRRD--PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 271 -------------------~~~~~~~~~--~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
......... .....+.++++||.+||+.||++|||+.|++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000000000 011357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=372.87 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=205.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||+||+|++..+++.||||++.... .....+..|+.+++.+. .|++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999986421 12345566777777761 345689999988764
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCC------------
Q 013816 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE------------ 194 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~------------ 194 (436)
..+++|||++ |++|.+++...+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 77999999888889999999999999999999998 59999999999999976432
Q ss_pred -CCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc
Q 013816 195 -TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (436)
Q Consensus 195 -~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 272 (436)
...+||+|||.+.... ......+||+.|+|||++. ..++.++|||||||++|||++|+.||.+....+....+...
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2359999999876432 2334578999999999986 46999999999999999999999999877765544433322
Q ss_pred cccCCC-----------------------CC-------------Cc--ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 273 VLDFRR-----------------------DP-------------WP--KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 273 ~~~~~~-----------------------~~-------------~~--~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
...++. .. +. ..++.+.+||.+||++||++|||+.|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 111000 00 00 01456789999999999999999999999999
Q ss_pred cccCc
Q 013816 315 LQNAK 319 (436)
Q Consensus 315 ~~~~~ 319 (436)
|....
T Consensus 441 ~~~~~ 445 (467)
T PTZ00284 441 VLKYY 445 (467)
T ss_pred ccccC
Confidence 98743
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=384.32 Aligned_cols=265 Identities=29% Similarity=0.521 Sum_probs=219.6
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~- 127 (436)
.+....++|++++.||+|+||+||+|.+..++..+|+|++...... ......+..|+.+++.| +|||||+++++|..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence 3455667999999999999999999999999999999998765433 33457789999999999 89999999998854
Q ss_pred -CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCceEeecC---
Q 013816 128 -DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-------GVMHRDLKPENFLFANK--- 192 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-------~iiH~dlkp~NIl~~~~--- 192 (436)
...+||||||+++++|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+|||++..
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4678999999999999998865 25699999999999999999999985 49999999999999642
Q ss_pred -----------CCCCCeEEEeeccccccCCCCcccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCC
Q 013816 193 -----------KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFW 258 (436)
Q Consensus 193 -----------~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~ 258 (436)
+....+||+|||++.............||+.|+|||++. ..++.++||||||||||+|+||..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 123458999999998765444445668999999999874 347899999999999999999999997
Q ss_pred CCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 259 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
...........+... +..+....+.++.+||..||+.+|.+||++.|+|.|||++..
T Consensus 245 ~~~~~~qli~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 245 KANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCcHHHHHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 665443333333322 222334578999999999999999999999999999999754
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=353.47 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=212.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|.+.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++++ +||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence 5799999999999999999999999999999998754322 2234577899999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE---RGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECccccceecCCCc
Confidence 999976 888877654 34789999999999999999999999999999999999964 3459999999987653322
Q ss_pred -cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---------------
Q 013816 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------------- 275 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------------- 275 (436)
......+|+.|+|||++.+ .++.++|||||||++|+|+||..||.+.+..+....+.+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2234578999999998753 5788999999999999999999999887765554444332110
Q ss_pred ----CCC-------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 ----FRR-------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 ----~~~-------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++. ...+.+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 01235788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.05 Aligned_cols=244 Identities=26% Similarity=0.378 Sum_probs=209.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.+.+++.||+|-||.||+|.+. ....||+|.+..... ..+.|.+|+++|++| +|+|||++++++..+..+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEE
Confidence 34667889999999999999985 345899999876432 347788999999999 999999999999998899999
Q ss_pred EeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||++.|+|.++|.. ...+...+.+.++.||++|++||+++++|||||-..||||+ ++..+||+|||+|+...++
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCC
Confidence 999999999999987 45689999999999999999999999999999999999995 4456999999999965544
Q ss_pred Ccccccc--cCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 EKFSEIV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~~~~~~~--gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
......- -...|.|||.+. +.++.|||||||||+||||+| |+.||.+.+..++.+.+.++..- +..+.+|+++
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl---p~P~~CP~~v 433 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL---PRPEGCPDEV 433 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC---CCCCCCCHHH
Confidence 3322222 234699999987 779999999999999999998 99999999999999988887533 3335799999
Q ss_pred HHHHHHccCCCcCCCCCHHHHh
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVL 310 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l 310 (436)
.+++..||+.+|++|||+..+.
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999998654
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=359.14 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=211.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecccccc
Confidence 35678999999999999999999999999999999986543 2333456788999999999 899999999987543
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC---CCcEEEEeCCC
Confidence 457999999976 67776643 4889999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------- 277 (436)
++............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+........
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 98765544445668999999999986 4689999999999999999999999988776665555443211000
Q ss_pred -------------------------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 -------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 -------------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.......+..+++||.+||+.||.+|||+.++|+||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0001123567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=371.05 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=219.8
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
....++|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.++..+ +|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccc
Confidence 3445799999999999999999999999999999999976543 334566788999999999 9999999988765432
Q ss_pred -------eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 130 -------AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 130 -------~~~lv~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
.+++||||+++|+|.+++..+ ..+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~---~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC---CCCE
Confidence 368999999999999988653 46899999999999999999999999999999999999965 3459
Q ss_pred EEEeeccccccCCC---CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc
Q 013816 199 KAIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 199 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 274 (436)
||+|||+++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999765432 2234567999999999987 4689999999999999999999999998887777776665443
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
. ...+.+++++.+++.+||+.||.+||++.++++|||++.
T Consensus 263 ~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 D---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2 123468899999999999999999999999999999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=348.11 Aligned_cols=254 Identities=38% Similarity=0.702 Sum_probs=212.0
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++++ +||||+++++++......++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 7899999999999999999999999999999977643222 223345699999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc-CCCCcc
Q 013816 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~-~~~~~~ 215 (436)
|+.+++|.+++.....+++..+..++.||+.||.+||++|++|+||||+||+++. .+.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~---~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE---NGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST---TSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 9999999999987788999999999999999999999999999999999999964 344899999999763 333455
Q ss_pred cccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHccccCCCCCCcccCHHHHH
Q 013816 216 SEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
....+|+.|+|||++. ..++.++||||||+++|+|++|..||........ ...................++++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 6678899999999986 4688999999999999999999999987733322 2222222222222211223489999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+|.+||+.||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=369.45 Aligned_cols=254 Identities=29% Similarity=0.431 Sum_probs=217.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.+ +|||||++++++...+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998877 788999976433 333446788899999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+||||++||+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP---TGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC---CCcEEEEeCcCcee
Confidence 99999999999987754 346899999999999999999999999999999999999964 44599999999987
Q ss_pred cCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
...... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+..+.... ....+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence 654322 34567999999999986 568999999999999999999999998888877777776654321 22357
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+.++.++|.+||+.||++|||+.+++.|||++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=361.77 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=212.9
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-----e
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~ 130 (436)
+|++++.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.+ +||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence 3788999999999999999999999999999986432 2333456788999999999 8999999999998776 7
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC---CCCEEeccccceeecc
Confidence 899999996 588888887788999999999999999999999999999999999999964 4569999999998654
Q ss_pred CCC--cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc------------
Q 013816 211 PGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL------------ 274 (436)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~------------ 274 (436)
... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2334578999999998764 478999999999999999999999988776655444432110
Q ss_pred -----------cCCC-----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 275 -----------DFRR-----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 275 -----------~~~~-----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+. ......++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000 1113457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=365.87 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=223.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+-|.|+..||-|+||.||+|..+.++-..|.|+|.. .+....+++.-||+||..+ +||+||++++.|...+.++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEE
Confidence 4668999999999999999999999999999999854 3556788999999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-C
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-P 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~ 211 (436)
+.|||.||.+..++..- ..+++.++..+++|++.||.|||+++|||||||..|||++.+++ |+|+|||.+.... .
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKST 183 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhH
Confidence 99999999998877664 46999999999999999999999999999999999999987665 9999999875432 2
Q ss_pred CCcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 212 GEKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.....+++|||+|||||+.. .+|++++||||||++|.+|.-+.+|....+...++-.|.+.....-.. ....+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cchhh
Confidence 23446789999999999863 469999999999999999999999998888877777776654332211 23568
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+.||+.+||.+||..||+++++|+||||++..
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 8999999999999999999999999999999754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=358.62 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=209.9
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence 35678999999999999999999999999999999986543 2333456788999999999 899999999988643
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~---~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC---CCCEEEeeCcc
Confidence 357999999976 67666643 4889999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------- 275 (436)
++............||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 98765544445668999999999986 46899999999999999999999999877654443332221100
Q ss_pred -------------C----------------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 276 -------------F----------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 276 -------------~----------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
. ........+.++++||.+||+.||++|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 000112245678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.44 Aligned_cols=254 Identities=32% Similarity=0.619 Sum_probs=222.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..+++.+|+|++...........+.+.+|+++++++ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 3699999999999999999999999999999999766544444567889999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999999999999999999999654 45999999999876543
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+..+.... ...++..++++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF----PSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC----CccCCHHHHHHHH
Confidence 34457899999999876 457889999999999999999999998877666666665443322 2356899999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+||+.||.+|+ ++.++++||||+..
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 99999999999 99999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=338.34 Aligned_cols=255 Identities=28% Similarity=0.499 Sum_probs=215.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.|++.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+++++++ +||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 35899999999999999999999999999999986543221 22346788999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecccc
Confidence 999999999999999888889999999999999999999999999999999999999643 45999999998765432
Q ss_pred Ccc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 213 EKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 213 ~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
... ....|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+...... ......++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHH
Confidence 111 3356788999999987 45889999999999999999999999776555444444332221 2223467899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+++.+||..+|.+|||+.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.19 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=225.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.+..|.=++.||.|+||.||.|++..+.+.||||.++-+.-.......++..|+..|++| .|||++.+.++|-.+...|
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHH
Confidence 345688889999999999999999999999999999877666777788999999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+|||||-| +-.|++.- .+++.+..+..|+.+.+.||.|||+++.||||||..|||++ +++.|||+|||.|....
T Consensus 103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~- 177 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMA- 177 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcC-
Confidence 99999976 77777753 46799999999999999999999999999999999999995 56669999999987754
Q ss_pred CCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
...+++|||+|||||++- |.|+-++||||||++..||.-.++|+.+.+....+--|....... ......|..
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~~ 253 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDY 253 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHHH
Confidence 346789999999999862 679999999999999999999999999988877777776654321 122456889
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.|+..||++-|.+|||+.++|.|+|+....
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 99999999999999999999999999997643
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=355.99 Aligned_cols=260 Identities=27% Similarity=0.461 Sum_probs=210.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence 456789999999999999999999999999999999865422 223456678999999999 899999999987533
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+++|++ |++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~---~~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE---DCELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC---CCCEEEcCCcc
Confidence 4578999998 678887765 456999999999999999999999999999999999999964 34599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc--------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-------- 275 (436)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......
T Consensus 165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 986543 3345678999999999764 5889999999999999999999999876655444433321110
Q ss_pred ---------------CCCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 276 ---------------FRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 276 ---------------~~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+.. .+...++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 0000 01235677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=349.20 Aligned_cols=249 Identities=27% Similarity=0.485 Sum_probs=193.7
Q ss_pred ccccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeEEEEE
Q 013816 60 GRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHLVM 135 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~ 135 (436)
..+||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+++++ +||||+++++++.. ...+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999965 4678999999864422 24567899999999 99999999998854 46789999
Q ss_pred eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCeEEEeecc
Q 013816 136 ELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGL 205 (436)
Q Consensus 136 E~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~~~~ikl~DfG~ 205 (436)
||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+... ...+.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 99965 888777532 248899999999999999999999999999999999999643 3456799999999
Q ss_pred ccccCCCC----cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 013816 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 270 (436)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~i~ 270 (436)
++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764321 2345678999999998753 4889999999999999999999999643321 1111121
Q ss_pred HccccCC---------------------C-------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 271 RSVLDFR---------------------R-------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 271 ~~~~~~~---------------------~-------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
....... . ......+.++.+||.+||+.||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100000 0 0001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=344.83 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=212.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence 5799999999999999999999999999999998654322 2234677899999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ ..+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT 158 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---CcEEECcCcchhccCCCC
Confidence 999975 888888654 468999999999999999999999999999999999999653 459999999987653222
Q ss_pred -cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC------------
Q 013816 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------------ 278 (436)
......+++.|+|||++.+ .++.++|||||||++|+|+||++||...+..+....+.........
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2234567899999998753 4788999999999999999999999887765554443332111000
Q ss_pred --------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 279 --------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 279 --------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
...+.+++++++||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01135788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=349.25 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=203.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|++++.||+||.+.||++.. ...+.||+|.+..... +......+.+|+.+|.+|.+|.+||++|+|-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4699999999999999999985 4456777777654433 4456788999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||-+ .+|..+|.+.... +...++.+..|||.|++++|++||||.||||.|+|+. .+.+||+|||+|..+..+.
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCccc
Confidence 99864 5999999887654 3357889999999999999999999999999999995 4569999999999886554
Q ss_pred cc---cccccCCcccchhcccc------------cCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccCC
Q 013816 214 KF---SEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFR 277 (436)
Q Consensus 214 ~~---~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~ 277 (436)
.. .+.+||+.|||||.+.. ..++++||||||||||+|+.|+.||..... ..-+..|......
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~-- 591 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE-- 591 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc--
Confidence 32 46799999999998731 146789999999999999999999954432 1222222222111
Q ss_pred CCCCcccC--HHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 RDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 ~~~~~~~~--~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..++.++ .++.++++.||..||.+|||..++|+|||++.
T Consensus 592 -Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 -IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred -ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 1222222 34899999999999999999999999999985
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=337.30 Aligned_cols=257 Identities=29% Similarity=0.494 Sum_probs=217.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence 46899999999999999999999999999999986543 233456788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~ 213 (436)
+||+++++|.+++... ++++..+..++.|++.||.|||+.+++||||+|+||+++. .+.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEcccccceeeccccc
Confidence 9999999999998765 7899999999999999999999999999999999999965 445899999999876543 2
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......+++.|+|||.+. ..++.++||||||+++|+|+||..||...........+...... ......++..+.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHHHHH
Confidence 334557889999999976 45899999999999999999999999776655544444443221 111122788999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+||..+|++|||+.++++||||+....
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=354.42 Aligned_cols=256 Identities=36% Similarity=0.616 Sum_probs=233.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
...|.+...||+|.|+.|.+|++..++..||+|.|++...... ....+.+|+++|+.| +|||||+++.+.+....+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEE
Confidence 3579999999999999999999999999999999988765443 455699999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||+.||.+++++.+++...+..+..++.|+++|++|||+++|+|||||++|||++. ...+||+|||++..+..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~---~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE---NMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc---ccceeeeccccceeecccc
Confidence 9999999999999999999999999999999999999999999999999999999964 4449999999999999888
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
...+.+|++.|.|||+..+ ..++.+|+||+|++||.|+.|.+||.+.+..+.....+.+.+..+. .++.++.++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~l 285 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDL 285 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHHH
Confidence 8889999999999999874 3578999999999999999999999999888887777777665443 478999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
|.++|..+|.+|++.+++..|.|....
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchh
Confidence 999999999999999999999998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=337.02 Aligned_cols=254 Identities=30% Similarity=0.492 Sum_probs=212.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++.+...+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999986542 22345688899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++. .+.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~---~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD---NGHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECcceeeeEccCcc
Confidence 9999999999999988888999999999999999999999999999999999999964 3459999999987654321
Q ss_pred -cccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCcccCHH
Q 013816 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSEN 287 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 287 (436)
......|++.|+|||++. +.++.++|||||||++|+|++|..||..................... .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999873 34788999999999999999999999765544333333222221111 111246789
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
+.+++.+||+.+|++|||+.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=341.61 Aligned_cols=258 Identities=30% Similarity=0.517 Sum_probs=220.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+++++.+ +||||+++++.+..++.+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence 3689999999999999999999999999999998765443344556788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++. .+.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~---~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC---CCCEEEeeCCCccccCcCcc
Confidence 999999999999988888999999999999999999999999999999999999964 4458999999886421100
Q ss_pred ---------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 214 ---------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 214 ---------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
......++..|+|||.+. ..++.++||||||+++|+|++|..||.+....+....+.......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 011245788999999875 5689999999999999999999999998887777777666544433
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCC---HHHHhcCccccc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQN 317 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps---~~e~l~h~~~~~ 317 (436)
... ..++.++.++|.+||+.+|++||+ +.++|+||||..
T Consensus 237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 332 257899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=338.40 Aligned_cols=256 Identities=30% Similarity=0.587 Sum_probs=212.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++.....+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence 4799999999999999999999999999999998654321 22335678999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|..++.....+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---GQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---CcEEECccccceecCCCcc
Confidence 9999998888777666679999999999999999999999999999999999999654 459999999998765433
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc----------------
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---------------- 275 (436)
......++..|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567889999998753 4788999999999999999999999877665444333221100
Q ss_pred ---CCC--------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 ---FRR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 ---~~~--------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+. ..++.++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=349.27 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=200.5
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++..+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345789999986432 2234567899999999997899999999988754
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 013816 129 -TAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~--------------------------------------------------------- 150 (436)
..+++||||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCC
Q 013816 151 -----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSP 222 (436)
Q Consensus 151 -----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~ 222 (436)
.++++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++....... .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC---CCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23677888999999999999999999999999999999964 34589999999986543221 12335567
Q ss_pred cccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCc
Q 013816 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (436)
Q Consensus 223 ~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p 300 (436)
.|+|||++. ..++.++|||||||++|+|++ |..||.+....+............ .....+++++.+++.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCh
Confidence 899999876 568999999999999999997 999997755433332222222111 1224678999999999999999
Q ss_pred CCCCCHHHHhc
Q 013816 301 KRRLTAQQVLE 311 (436)
Q Consensus 301 ~~Rps~~e~l~ 311 (436)
.+|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.24 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=212.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++++ +||||+++++++..++.+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999886432 233456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---CcEEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999998 599999999999999654 45899999998765322
Q ss_pred cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC----------------
Q 013816 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------------- 276 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~---------------- 276 (436)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2244578999999999764 58889999999999999999999997655433222121110000
Q ss_pred ------------------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 277 ------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 277 ------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+..+...++.++++|+.+||..+|++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 001112367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.86 Aligned_cols=258 Identities=31% Similarity=0.551 Sum_probs=220.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..+++.||+|.+...........+.+.+|+++++.+ +||||+++++.+......|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence 3699999999999999999999999999999999876554434567889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---GHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---CCEEEeecchhhccccc
Confidence 9999999999998754 468999999999999999999999999999999999999653 45899999998754321
Q ss_pred C------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC
Q 013816 213 E------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (436)
Q Consensus 213 ~------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 261 (436)
. ......||..|+|||++. ..++.++||||||+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 112346889999999976 458889999999999999999999998887
Q ss_pred HHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC----HHHHhcCcccccC
Q 013816 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQVLEHPWLQNA 318 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps----~~e~l~h~~~~~~ 318 (436)
.......+......+.. ...++..+.+++.+||+.+|++||| +.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 237 RDETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred hHHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 77666666544433322 2237899999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.63 Aligned_cols=252 Identities=32% Similarity=0.509 Sum_probs=212.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999999999999987554332233344556666655544899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccc
Q 013816 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (436)
Q Consensus 141 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~g 220 (436)
++|.+++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++. ...+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ---TGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCcEEEeecccceeccc---cccCCC
Confidence 999999988888999999999999999999999999999999999999964 44599999998876432 234568
Q ss_pred CCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCC
Q 013816 221 SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (436)
Q Consensus 221 t~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~ 299 (436)
++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+..............+++++.+++.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999999764 4789999999999999999999999888777776666665555444444568999999999999999
Q ss_pred cCCCCC---HHHHhcCcccccC
Q 013816 300 PKRRLT---AQQVLEHPWLQNA 318 (436)
Q Consensus 300 p~~Rps---~~e~l~h~~~~~~ 318 (436)
|++||+ +.|+|+||||++.
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcC
Confidence 999994 5799999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=335.88 Aligned_cols=254 Identities=26% Similarity=0.467 Sum_probs=211.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
..+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++.+||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4577999999999999999999999999999999986542 23467889999999986799999999998653
Q ss_pred --CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 129 --TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||+|+||+++.+ ..++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~---~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC---CCEEEccCC
Confidence 4689999999999999998763 358999999999999999999999999999999999999654 459999999
Q ss_pred cccccCCC-CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
++...... .......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence 99765432 2234567899999999874 247889999999999999999999997665544443333221 12
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
......++.++.+|+.+||..+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.07 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=217.6
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+.........+.+.+|+++++++ +||||+++++.+......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 488999999999999999999999999999999876554444567899999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~ 215 (436)
||+.|++|.+.+....++++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---CCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999654 45899999999876554444
Q ss_pred cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHH
Q 013816 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~ 294 (436)
....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...... ....+............+..+..+.++|.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 5567889999999986 45789999999999999999999999876642 111111111112223334678999999999
Q ss_pred ccCCCcCCCCCH--HHHhcCccc
Q 013816 295 MLDPDPKRRLTA--QQVLEHPWL 315 (436)
Q Consensus 295 ~l~~~p~~Rps~--~e~l~h~~~ 315 (436)
||+.||.+||++ .++++||||
T Consensus 236 ~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HccCChhHcCCccHHHHhcCCCC
Confidence 999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=337.72 Aligned_cols=259 Identities=30% Similarity=0.509 Sum_probs=216.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...+|++.+.||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.+ +||||+++++.+......|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence 346899999999999999999999999999999998764432 346788999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++. +..+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~---~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC---CCCEEECccccchhcccc
Confidence 99999999999998865 46899999999999999999999999999999999999964 345899999998765433
Q ss_pred Cc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
.. .....|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.... .........++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHHH
Confidence 22 23457889999999876 457899999999999999999999998776544333333221 1111223467889999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
++.+||..+|++|||+.++++||||.....
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=330.57 Aligned_cols=252 Identities=25% Similarity=0.456 Sum_probs=216.5
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|.+.+.||+|++|.||+|++..+++.|++|.+...... ......+.+|+.+++.+ +||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence 478889999999999999999999999999998765433 34567889999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ ..++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---CCEEEcccccceeccCcc
Confidence 999999999998764 568999999999999999999999999999999999999654 458999999988765433
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....|++.|+|||++. +.++.++||||||+++|+|++|..||...........+....... ....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP---VSQMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 2 23457889999999976 568899999999999999999999998887666666655543221 112578999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+||+.+|++||++.+++.|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.10 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=207.4
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||+|++..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.+++.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence 488999999999999999999999999999998654322 22346788899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 136 ELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 136 E~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---CcEEECcccceeecCCC
Confidence 9997 5888887543 468999999999999999999999999999999999999654 45999999998765432
Q ss_pred C-cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC------------
Q 013816 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------ 277 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------------ 277 (436)
. ......+++.|+|||++.+ .++.++||||||+++|+|+||..||.+.........+........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467899999998753 478899999999999999999999987665443333222111000
Q ss_pred -------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 -------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 -------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
......++++++++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.58 Aligned_cols=251 Identities=33% Similarity=0.556 Sum_probs=211.2
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++...+.+|+||||++|++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999999999999999999765444344455678899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccccc
Q 013816 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (436)
Q Consensus 143 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~g 220 (436)
|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++. ...++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD---HGNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC---CCCEEEccCcchhhhccCCccccccC
Confidence 999997765 6899999999999999999999999999999999999964 34599999999876654444445578
Q ss_pred CCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCC
Q 013816 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (436)
Q Consensus 221 t~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~ 299 (436)
+..|+|||.+. +.++.++||||||+++|+|++|+.||...........+...............++++.++|.+||+.+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999976 45888999999999999999999999766542223333333333333334567999999999999999
Q ss_pred cCCCC-----CHHHHhcCccccc
Q 013816 300 PKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 300 p~~Rp-----s~~e~l~h~~~~~ 317 (436)
|.+|| ++.+++.||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=335.73 Aligned_cols=257 Identities=32% Similarity=0.501 Sum_probs=215.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.+ +||||+++++++...+..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence 4588999999999999999999999999999998543 234567788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||+++++|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---CCEEEccccccccccccc
Confidence 999999999887765 4568999999999999999999999999999999999999643 45999999998765322
Q ss_pred CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.......+|+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+....... ......++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence 2234457899999999873 236789999999999999999999998777665555554432211 112235789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.++|.+||+.+|.+|||+.++++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=336.87 Aligned_cols=241 Identities=18% Similarity=0.208 Sum_probs=205.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----CCeEEEEEe
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVME 136 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~E 136 (436)
..||+|++|.||+|.. +|+.||+|.+...........+.+.+|+.+|+++ +||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999987 6899999999765433333357788999999999 99999999999876 457899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc
Q 013816 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~ 215 (436)
|++||+|.+++.....+++.....++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++..... .
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~---~~~~kl~dfg~~~~~~~~--~ 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE---NYKLKIICHGLEKILSSP--P 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC---CCcEEEcccchHhhhccc--c
Confidence 999999999998888899999999999999999999985 9999999999999965 445899999999865432 2
Q ss_pred cccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 216 SEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.........+ ...++++++|+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 3456889999999986 368999999999999999999999999888777777766554333221 35789999999
Q ss_pred HHccCCCcCCCCCHHHHhc
Q 013816 293 RKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~ 311 (436)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999986
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=332.89 Aligned_cols=253 Identities=27% Similarity=0.495 Sum_probs=212.8
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh------hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+|.+...||.|++|.||+|.+..+++.+|+|.+........ ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence 47788999999999999999988999999998865433221 2235788999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++. ...++|+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~---~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC---CCCEEecccCCCccc
Confidence 99999999999999999988888999999999999999999999999999999999999964 445899999998766
Q ss_pred CCCC-------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 210 KPGE-------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 210 ~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
.... ......|+..|+|||.+. ..++.++||||||+++|+|++|..||...........+... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---ASPEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---CCCcCC
Confidence 4221 112345788999999986 45888999999999999999999999876654444443332 122223
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..++..+.++|.+||+.+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=334.88 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=216.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.++-|.++.+||+|+||.||+|.++++|+.+|+|.+... .+.+++..|+.+++++ +.|++|++|+.|-....+|
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceE
Confidence 356799999999999999999999999999999988533 3678999999999999 9999999999998899999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||||..|++.+++.. +.++++.++..+++..+.||+|||...-||||||..|||++.++ +.||+|||.|..+.+
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G---~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG---IAKLADFGVAGQLTD 181 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc---hhhhhhccccchhhh
Confidence 99999999999999875 46799999999999999999999999999999999999996544 479999999987653
Q ss_pred C-CcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC---CcccCH
Q 013816 212 G-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP---WPKVSE 286 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~ 286 (436)
. ...+++.|||.|||||++.. .|+.++||||||++..||..|++||.+..+...+-.|-. .+++. ....|.
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----KPPPTFKKPEEWSS 257 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----CCCCCCCChHhhhh
Confidence 2 23467899999999999984 799999999999999999999999976554322111111 11111 124578
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++-+|+++||.++|++|.|+.++++|||++++.
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 899999999999999999999999999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=345.59 Aligned_cols=255 Identities=19% Similarity=0.283 Sum_probs=204.0
Q ss_pred eccccccC--CceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 59 LGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 59 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
++++||+| +|++||++.++.+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 56889999 7899999999999999999998765332 23456788899999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-C
Q 013816 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (436)
Q Consensus 137 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~ 213 (436)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ ..++++||+.+...... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---CcEEEcccchhhccccccc
Confidence 99999999998653 458999999999999999999999999999999999999654 35899999865433211 1
Q ss_pred -------cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC------
Q 013816 214 -------KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (436)
Q Consensus 214 -------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 277 (436)
......++..|+|||++.+ .++.++|||||||++|+|++|..||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0122356778999999863 488999999999999999999999976554443333222211000
Q ss_pred ------------------------------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 ------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ------------------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
......+++++.+|+.+||+.||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00112356789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=356.13 Aligned_cols=267 Identities=28% Similarity=0.484 Sum_probs=222.5
Q ss_pred Ccccccccceeecc-----ccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEE
Q 013816 48 PTGREIEERYELGR-----ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122 (436)
Q Consensus 48 ~~~~~~~~~y~~~~-----~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 122 (436)
+.++.++-.|+..+ +||+|.||+||.|+|..+...+|||.|... .....+-+..||.+-++| +|.|||+++
T Consensus 563 ~ane~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~L-rHkNIVrYL 638 (1226)
T KOG4279|consen 563 PANEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTL-RHKNIVRYL 638 (1226)
T ss_pred CcccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHH-hhHhHHHHh
Confidence 44444555565433 499999999999999999999999998544 333556788999999999 999999999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 123 DTYEDDTAVHLVMELCEGGELFDRIVAR-GHY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 123 ~~~~~~~~~~lv~E~~~g~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
+.+..++.+-|.||-++||+|.+++... +++ .|.++..+.+||++||.|||++.|||||||-+|+|++. -.+.+|
T Consensus 639 Gs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlK 716 (1226)
T KOG4279|consen 639 GSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLK 716 (1226)
T ss_pred hccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEE
Confidence 9999999999999999999999999875 566 78899999999999999999999999999999999974 466799
Q ss_pred EEeeccccccCCCC-cccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 200 AIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 200 l~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
|+|||-++.+..-. -..++.||..|||||++. ..|+.++|||||||++.||.||++||........ ....-+.+.
T Consensus 717 ISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmyK 795 (1226)
T KOG4279|consen 717 ISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMYK 795 (1226)
T ss_pred ecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhccee
Confidence 99999998765433 345678999999999986 3599999999999999999999999976544322 122233444
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
..++....+|.+++.||.+|+.++|.+||+|.++|..||++...+.
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 4444456788999999999999999999999999999999876443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.78 Aligned_cols=255 Identities=24% Similarity=0.420 Sum_probs=206.0
Q ss_pred cccccceeeccccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..+..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+++++.+ +||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEeeC
Confidence 344568999999999999999999754 45678999987542 2346799999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..+++|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~---~~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE---PENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC---CCCEEEccCccccc
Confidence 99999999996 588898877778999999999999999999999999999999999999964 44589999999976
Q ss_pred cCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHcccc----CC
Q 013816 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLD----FR 277 (436)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~----~~ 277 (436)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+.+.... +.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 23467999999999987 46899999999999999999999999765422 122222211100 00
Q ss_pred ------------------CCC--C------cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 ------------------RDP--W------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ------------------~~~--~------~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
... + ..++.++.++|.+||+.||++|||+.++|.||||+..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000 0 1346788999999999999999999999999999864
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=339.41 Aligned_cols=262 Identities=30% Similarity=0.509 Sum_probs=217.4
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...+|.+++.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+..|
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEE
Confidence 45789999999999999999999999999999999865432 2346788999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++. .+.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~---~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEECcCccceEccCC
Confidence 99999999999998865 46899999999999999999999999999999999999964 345899999998765433
Q ss_pred Cc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
.. .....+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.... .........++..+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHH
Confidence 22 23457889999999976 458899999999999999999999997765433322222211 1111122457889999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCccCCC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~ 323 (436)
|+.+||+.+|++||++.++++||||+.....+.
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 999999999999999999999999997665444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=336.21 Aligned_cols=257 Identities=33% Similarity=0.523 Sum_probs=216.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+++++++ +||||+++++.+..+..+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEE
Confidence 46799999999999999999999889999999998643 344557788999999999 79999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++. .+.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~---~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC---CCCEEEccCccchhhccc
Confidence 99999999999988764 46899999999999999999999999999999999999964 445999999988655322
Q ss_pred -CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 213 -EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.......+|+.|+|||.+. ..++.++||||||+++|+|++|..||...........+...... .......++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP-TLDQPSKWS 235 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-CcCCcccCC
Confidence 2223457899999999874 23677999999999999999999999887766555555443221 111123578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.++.+++.+||+.+|.+|||+.++++||||.+.
T Consensus 236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=336.24 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=208.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++ +||||+++++.+...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence 35888999999999999999999999999999986542 233456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++. .+.++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~---~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT---RGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC---CCCEEEeeCCcceecccc-c
Confidence 999999988644 35789999999999999999999999999999999999965 445999999999765432 2
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHccccCCCCCCcccCH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.....||..|+|||++. ..++.++||||||+++|+|++|..||...... .....+.... .........++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCH
Confidence 34467899999999986 46899999999999999999999999643211 1112221111 11122345788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.+++.+||+.+|++||++.++++||||+...
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=332.33 Aligned_cols=255 Identities=28% Similarity=0.487 Sum_probs=215.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.+ +||||+++++.+.....+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence 46999999999999999999998899999999986544322 567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||+++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ ..++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccchHHHhcc
Confidence 9999999999999764 458999999999999999999999999999999999999653 4589999999876654
Q ss_pred CCcc-----cccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC--CCc
Q 013816 212 GEKF-----SEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD--PWP 282 (436)
Q Consensus 212 ~~~~-----~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 282 (436)
.... ....|+..|+|||++.. .++.++|+||||+++|+|++|+.||...+.......+.......... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3221 33468899999998763 58899999999999999999999998776655555554432211111 123
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=332.09 Aligned_cols=250 Identities=32% Similarity=0.572 Sum_probs=214.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||.|++|.||+|++..+++.+|+|++.+.........+.+.+|+.+++.+ +||||+++++.+.+...+++||||++|++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 79999999999999999999999999876554444567899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCC
Q 013816 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222 (436)
Q Consensus 143 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~ 222 (436)
|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---CCEEEeeCCcccccCcccccccccCCc
Confidence 99999887789999999999999999999999999999999999999653 459999999998775543344567899
Q ss_pred cccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCC
Q 013816 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (436)
Q Consensus 223 ~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~ 299 (436)
.|+|||.+. ..++.++|+||||+++|+|++|..||.... .......+........ .....++++.++|.+||+.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--FPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--CCcccCHHHHHHHHHHccCC
Confidence 999999876 458899999999999999999999998776 4445555543222211 12345899999999999999
Q ss_pred cCCCCC-----HHHHhcCcccccC
Q 013816 300 PKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 300 p~~Rps-----~~e~l~h~~~~~~ 318 (436)
|++||+ +.|+++||||++.
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.56 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=210.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.....+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEE
Confidence 467999999999999999999999999999999986442 22345688999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||+++++|.+++..++.+++..+..++.|++.||.|||+.||+||||+|+||+++. .+.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~---~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD---NGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCCEEECcCccceeecccc
Confidence 9999999999999988888999999999999999999999999999999999999964 3459999999998654322
Q ss_pred -cccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCcccCHH
Q 013816 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSEN 287 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 287 (436)
......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+......... .....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223457889999999873 34778999999999999999999999655443322222222111111 111346889
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
+.+|+.+||+.+|++|||+.++|+|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=336.45 Aligned_cols=259 Identities=30% Similarity=0.480 Sum_probs=216.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..+.|++++.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++.+..++.++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEE
Confidence 457899999999999999999999999999999998653 344567788999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||++|++|..++.+ ...+++..+..++.|++.+|.|||+.|++||||+|+||+++. .+.+||+|||++.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL---DGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC---CCCEEEccCccceeccc
Confidence 99999999999887754 456899999999999999999999999999999999999964 34599999998875432
Q ss_pred C-CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 212 G-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
. .......+++.|+|||++. ..++.++|||||||++|+|++|..||...........+...... .......+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence 2 2224456889999999873 23678999999999999999999999877665554444433221 11122357
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.++.+++.+||..+|++||++.++++||||....
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 88999999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=350.34 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=199.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|++++.||+|+||.||+|++..++..||+|+.... ....|+.+++++ +||||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999975332 234699999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND---VDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEEecCccccccccCc
Confidence 99996 488888765 356899999999999999999999999999999999999964 3458999999997644333
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHHcccc----CC-
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----------GVAQAIIRSVLD----FR- 277 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----------~~~~~i~~~~~~----~~- 277 (436)
......||+.|+|||++. ..++.++|||||||++|+|+++..|+...... .....+...... +.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 444567999999999976 56899999999999999999865555332111 111111111000 00
Q ss_pred -----------------CC--------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 -----------------RD--------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 -----------------~~--------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.. ....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 01145677888999999999999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=328.77 Aligned_cols=257 Identities=30% Similarity=0.598 Sum_probs=234.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
-++|..++.||+|.||.|-+|+.+.+++.+|+|++++..+-.......-..|-++|+.. +||.+..+...|+..+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 36799999999999999999999999999999999888776665666677899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc-cCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~-~~~~ 212 (436)
||||..||.|+-++.....+++..++-+...|++||.|||+++||.||||.+|.|++ .+++|||+|||+++. +..+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecccchhccccc
Confidence 999999999999998888899999999999999999999999999999999999995 556699999999974 3445
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
..+.+.+|||.|.|||++. ..|+.+.|.|.+||++|||++|++||+..+.......|+-..+.++. .++++++.|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence 6778899999999999998 56999999999999999999999999999999888888888777764 589999999
Q ss_pred HHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+..+|.+||.+|. .+.|+..|+||...
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999996 68999999999753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=340.32 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=206.0
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|+||.||+|++..+|+.+|+|.+...... ......+.+|+.+++++ +||||+++++++.+...+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence 588999999999999999999999999999998754322 22335677899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
||+.+ +|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---CcEEECccchhhccCCCCC
Confidence 99975 78887765 4678999999999999999999999999999999999999654 459999999998654332
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHcccc--------------C
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLD--------------F 276 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~--------------~ 276 (436)
......+++.|+|||++.+ .++.++|||||||++|+|+||..|+.. .+..+....+.+.... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567899999998764 378899999999999999999988643 3333333333221100 0
Q ss_pred C-----------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 277 R-----------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 277 ~-----------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
. ....+.+++++++||.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=336.77 Aligned_cols=260 Identities=29% Similarity=0.421 Sum_probs=214.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++++ +||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999999999999999886432 233456889999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||++|++|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++. ...+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC---CCCEEEeecCCccccc
Confidence 9999999998888663 368999999999999999999997 59999999999999965 4459999999987653
Q ss_pred CCCcccccccCCcccchhcccc-------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 211 PGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
.. ......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+............+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2234468889999998742 257899999999999999999999976555444333322211122223345
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+++++.+||.+||+.+|++||++.++++||||......
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 88999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=328.55 Aligned_cols=252 Identities=26% Similarity=0.515 Sum_probs=212.9
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-CCeEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHLV 134 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~lv 134 (436)
.|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+++++++ +|||++++++.+.. +..+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999865433 233456788999999999 89999999998764 4568999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+++++|.+++... ..+++.++..++.|++.||.+||+.|++||||+|+||+++. ...++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~---~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR---TNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec---CCcEEEecccceEEeccc
Confidence 9999999999998763 45899999999999999999999999999999999999964 445999999999766432
Q ss_pred C-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ......+++.|+|||++. ..++.++||||||+++|+|++|+.||...+.......+..+... ......++++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence 2 223456889999999976 45888999999999999999999999877766655555554331 122467899999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
++.+||+.+|++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=340.86 Aligned_cols=260 Identities=32% Similarity=0.529 Sum_probs=232.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.|+.-++||+||||.||-|..+.||+.+|+|.+.+..+..........+|-++|.++ ..+.||.+-..|+..+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEE
Confidence 4578889999999999999999999999999999888776666667788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|..|.||+|.-+|.+.+ .+++..+.-++.+|+.||.+||+.+||.|||||+|||++ +.++|+|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD---d~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD---DHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec---cCCCeEeeccceEEecCCC
Confidence 99999999988887765 699999999999999999999999999999999999995 5667999999999999888
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......+||.+|||||++. +.|+.+.|.|||||++|+|+.|+.||.......-..++-+.....+.......|++++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 8888889999999999987 569999999999999999999999998766654444555555555555567899999999
Q ss_pred HHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
...+|++||++|. .++++-+||||++.
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 9999999999997 67899999999863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=332.57 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=203.3
Q ss_pred cceeecccc--ccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 55 ERYELGREL--GRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 55 ~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.|.+.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.....+.+||||+++++.+...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 467776766 99999999999999999999999986543221 12223332337999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++..+..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ ..++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCC
Confidence 9999999999999998887899999999999999999999999999999999999997544 25999999998765422
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
....++..|+|||++. ..++.++||||||+++|+|++|..||.......................++..++.+.+|
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2346889999999986 468899999999999999999999997554433221222111222233445689999999
Q ss_pred HHHccCCCcCCCCC-HHHHhcCccccc
Q 013816 292 VRKMLDPDPKRRLT-AQQVLEHPWLQN 317 (436)
Q Consensus 292 l~~~l~~~p~~Rps-~~e~l~h~~~~~ 317 (436)
|.+||+.+|.+||+ +.++|+||||++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999996 599999999974
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=335.86 Aligned_cols=258 Identities=31% Similarity=0.526 Sum_probs=218.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
..+|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.....+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEE
Confidence 3679999999999999999999999999999999865432 2356788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|+||++|++|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++. .+.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~---~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccchhccccc
Confidence 99999999999888654 6899999999999999999999999999999999999964 4459999999987654432
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....++..|+|||.+. ..++.++|||||||++|+|++|..||...........+..... ........+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHH
Confidence 2 23457889999999886 4588999999999999999999999988776554444433221 1122234688999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
|.+||..+|++|||+.+++.||||+....
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 99999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=332.95 Aligned_cols=258 Identities=24% Similarity=0.453 Sum_probs=212.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+|+..+.||+|++|.||+|.+..+++.+|+|++....... ....+.+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999987543221 12356789999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||+.|++|.+++...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ ..+||+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999996432 34899999998766432
Q ss_pred C-----cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc-cCCCCCCcccC
Q 013816 213 E-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-DFRRDPWPKVS 285 (436)
Q Consensus 213 ~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~ 285 (436)
. ......||..|+|||.+. ..++.++||||+|+++|+|++|..||...........+..... .........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 112346888999999976 4688999999999999999999999965443322222222111 11122224578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
+++.+++.+||+.+|.+|||+.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=328.72 Aligned_cols=253 Identities=27% Similarity=0.478 Sum_probs=218.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence 589999999999999999999999999999999765433 33467899999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||++|++|.+++... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ ...+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEEccCCCceecCCCc
Confidence 999999999999764 348999999999999999999999999999999999999643 3348999999998775544
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......|+..|+|||.+. ..++.++||||||+++|+|++|..||...+.......+...... .....++.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence 444567899999999987 45788999999999999999999999887776666655544322 12235789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCccc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+||+.+|++|||+.+++.||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=333.42 Aligned_cols=271 Identities=26% Similarity=0.432 Sum_probs=221.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
...|+..+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.+ .||||+++++++.++..+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence 3568899999999999999999999999999999865432 33457889999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.+ ..++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---CCEEEcccccceeccCCc
Confidence 9999999999998865 578999999999999999999999999999999999999653 458999999997664332
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....++..|+|||++. ..++.++|+||||+++|+|+||..||...........+.... .......++..+.++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHH
Confidence 2 23346788999999976 458899999999999999999999998776654444332221 122223567889999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHh
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 336 (436)
+.+||+.+|++||++.+++.||||...... .+.....++++++
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~ 275 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKR 275 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHh
Confidence 999999999999999999999999765432 2233344444444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.72 Aligned_cols=261 Identities=32% Similarity=0.524 Sum_probs=214.5
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... .......+..|+.+++++ +||||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 488899999999999999999999999999999765433 122235677899999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.+ +.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---CCEEEccceeeeeccCC
Confidence 99999 889999997765 79999999999999999999999999999999999999653 45999999999876543
Q ss_pred -CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-----------
Q 013816 213 -EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----------- 278 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~----------- 278 (436)
.......+++.|+|||.+. ..++.++|||||||++|+|++|.+||.+....+....+.........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2233446788999999875 34788999999999999999998888776655544444332111000
Q ss_pred -------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 279 -------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
..+...+..+.++|.+||+++|++|||+.++|.||||++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 0123457889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=333.27 Aligned_cols=252 Identities=28% Similarity=0.461 Sum_probs=202.2
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC--CCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--PKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l--~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
.||+|+||.||++.+..+++.+|+|.+.+...........+.+|..+++.+ .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765443332233344454443332 279999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~ 219 (436)
|++|.+++..++.+++..+..++.|++.||.|||+++|+||||||+||+++. ...++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~---~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC---CCCEEEccCCcceeccccC-ccCcC
Confidence 9999999988888999999999999999999999999999999999999964 3459999999987554322 23457
Q ss_pred cCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 220 GSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 220 gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
||+.|+|||.+. ..++.++||||+||++|+|++|..||........ ..+............+.++.++.++|.+||+
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 899999999875 3478999999999999999999999975432211 1122222222223335688999999999999
Q ss_pred CCcCCCC-----CHHHHhcCcccccC
Q 013816 298 PDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 298 ~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
.||.+|| |++++++||||+..
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCC
Confidence 9999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=326.08 Aligned_cols=252 Identities=31% Similarity=0.503 Sum_probs=218.1
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+++++++ +|+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence 589999999999999999999999999999998755433 33456788999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||++|++|.+++... ..+++..+..++.|++.+|.|||+.|++||||+|+||+++.+ ..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---CCEEECcCcceEEccccc
Confidence 999999999999765 458999999999999999999999999999999999999654 459999999998664433
Q ss_pred -cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......|++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+..+.... ....++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 2345678999999998764 57889999999999999999999998877777666666544322 124678999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+||+.+|.+|||+.++|+|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=334.34 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=212.5
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++++ +||||+++++++.....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence 589999999999999999999999999999998765432 22356789999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
||+ |++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++. .+.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC---CCcEEEeeeeecccccCCCC
Confidence 999 9999998865 356899999999999999999999999999999999999965 4458999999988765432
Q ss_pred -cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC--------------
Q 013816 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------------- 276 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------------- 276 (436)
......|+..|+|||++.+ .++.++||||+|+++|+|+||.+||.+.........+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578999999998753 46889999999999999999988887766655544443321110
Q ss_pred -----CC-------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 277 -----RR-------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 277 -----~~-------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
.. ..++..+..+.++|.+||+.+|++|||+.++|+||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 01235678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=372.79 Aligned_cols=257 Identities=32% Similarity=0.524 Sum_probs=228.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|.|++.||+|+||.|.+++++.+++.||.|++++...-...+...|..|-.+|..- +.+=|++++..|+++.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence 47899999999999999999999999999999999886554444567788899999876 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++||+|..++.+..++++..++-++..|+.||.-||+.|+|||||||+|||++ ..++|||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchhHHhcCCCC
Confidence 999999999999999988999999999999999999999999999999999999994 66779999999887766333
Q ss_pred --cccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc--cccCCCCCCcc
Q 013816 214 --KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDPWPK 283 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 283 (436)
.....+|||-|.|||++. +.|++.||.||+||++|||+.|..||+..+..+.+..|++- .+.|+ .-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 335679999999999984 35899999999999999999999999999999999999876 45555 3346
Q ss_pred cCHHHHHHHHHccCCCcCCCCC---HHHHhcCccccc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQN 317 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps---~~e~l~h~~~~~ 317 (436)
+|+++++||.+++.. |+.|.. +.++-+||||.+
T Consensus 308 VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred cCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccC
Confidence 999999999999864 888988 999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=352.63 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=202.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
...|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++|++| +|||||++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999999999999999632 12356899999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~---~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC---CCCEEEcccCCceecccc
Confidence 999995 5888888664 46999999999999999999999999999999999999964 345899999999865432
Q ss_pred Cc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHcccc---C-
Q 013816 213 EK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--------EQGVAQAIIRSVLD---F- 276 (436)
Q Consensus 213 ~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~--------~~~~~~~i~~~~~~---~- 276 (436)
.. .....||+.|+|||++. ..++.++|||||||++|||++|..|+.... .....+.+...... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 22457999999999986 458999999999999999999887654321 12222222221110 0
Q ss_pred -----------------------CCCCCc---ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 277 -----------------------RRDPWP---KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 277 -----------------------~~~~~~---~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
....|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 011122 35678999999999999999999999999999974
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=314.54 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=217.8
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
.+++..||.|+.|+|++++.+.+|...|||.+.+.. +..+.++++..+.++....+.|+||+-+++|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 456788999999999999999999999999997653 455678888899888877679999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 137 LCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
.|. ..+..+++. .++++|..+-.+...++.||.||-.+ ||+|||+||+|||++ ..+.|||||||++..+-+...
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccceeecccc
Confidence 984 244444433 46799999999999999999999865 899999999999995 455699999999988877777
Q ss_pred ccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.+...|.+.|||||.+. ..|+-++||||||++|+||.||..||.+. ++-+++..+++... ...+.-...|+.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHHH
Confidence 77789999999999985 24888999999999999999999999874 44566667776443 22222235899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+|+..||++|+.+||...++|+|||++.....
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 99999999999999999999999999886543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.46 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=208.6
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 131 (436)
+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++++ +||||+++++++.. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 588899999999999999999999999999998654322 223456788999999999 89999999998875 4678
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++++||+++++|.+++.....+++..+..++.|++.||.|||+.+|+||||+|+||+++. ...+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~---~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC---CCCEEEccCCCcccccc
Confidence 899999999999999988778999999999999999999999999999999999999964 34589999999876532
Q ss_pred C----CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 G----EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. .......++..|+|||.+. ..++.++|||||||++|+|++|..||...........+..... .......+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPT--NPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCC--CCCCchhcCH
Confidence 1 1123356889999999986 4588999999999999999999999977655444433322211 1111235678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
.+++++ +||..+|++||++.|+++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 899998 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.69 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=211.0
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC---ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+...... .......+.+|+++++.+ +|+||+++++++.+.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 478899999999999999986 57899999988654321 122345688999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|+||++|++|.+++....++++..+..++.|++.||.|||+.+|+|+||+|+||+++. .+.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC---CCeEEeccchhhHhhhhc
Confidence 99999999999999988788999999999999999999999999999999999999964 345999999988754211
Q ss_pred -------CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 213 -------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 213 -------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
.......|+..|+|||++. ..++.++||||||+++|+|++|..||...........+...... .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CCCCCCCC
Confidence 1123456889999999986 45789999999999999999999999776655443333332111 12223467
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.++.+++.+||+.+|.+||++.+++.||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=334.35 Aligned_cols=258 Identities=29% Similarity=0.457 Sum_probs=209.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe----
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA---- 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~---- 130 (436)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+.+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3699999999999999999999999999999988654322 22345688899999999667999999999877665
Q ss_pred -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 131 -VHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 131 -~~lv~E~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||+++.+ ...+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence 8999999986 788887542 357999999999999999999999999999999999999752 3459999999
Q ss_pred cccccCCC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC---
Q 013816 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--- 278 (436)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--- 278 (436)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765322 22233467889999998753 4789999999999999999999999887766555444432111100
Q ss_pred ---------------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 279 ---------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 279 ---------------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
...+.+++++.+||.+||++||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01135788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=339.42 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=192.0
Q ss_pred ccccccCCceEEEEEEEcC--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE--eCCeEEEEE
Q 013816 60 GRELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--DDTAVHLVM 135 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~ 135 (436)
..+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.+ +||||+++++++. .+..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEE
Confidence 3579999999999999654 568899998865421 24577899999999 8999999999885 456789999
Q ss_pred eccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCeEEEeecc
Q 013816 136 ELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGL 205 (436)
Q Consensus 136 E~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~~~~ikl~DfG~ 205 (436)
||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+|||+..+ ...+.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 777776421 247899999999999999999999999999999999999643 3456799999999
Q ss_pred ccccCCCC----cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 013816 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 270 (436)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------~~~~~i~ 270 (436)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||.+||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98764322 2234578999999998753 4789999999999999999999999653321 1111111
Q ss_pred HccccCCC----------------------------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 271 RSVLDFRR----------------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 271 ~~~~~~~~----------------------------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
........ ......+..+.+|+.+||+.||.+|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 10000000 0001235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.12 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=210.9
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35678999999999999999999999999999999986432 12356788999999987899999999998653
Q ss_pred --CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 129 --TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
+.+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.+ ..+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~---~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEee
Confidence 368999999999999988753 3568999999999999999999999999999999999999654 4489999
Q ss_pred eccccccCCCC-cccccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 203 FGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 203 fG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
||++....... ......|+..|+|||.+.. .++.++|||||||++|+|++|+.||...........+.+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99987654322 2234578899999998752 2678999999999999999999999877665544444433221
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
........+..+.++|.+||+.+|++||++.++++||||+
T Consensus 252 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 -TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1111234678899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=327.29 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=215.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+.+.+|+.+++++ +||||+++++++.....+|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEE
Confidence 367999999999999999999999999999999986543 22567899999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---CCEEECccccchhhhhh
Confidence 99999999999988776 689999999999999999999999999999999999999653 45899999998765432
Q ss_pred C-cccccccCCcccchhccc-c---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCcccCH
Q 013816 213 E-KFSEIVGSPYYMAPEVLK-R---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSE 286 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~-~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 286 (436)
. ......++..|+|||.+. . .++.++||||||+++|+|+||..||...........+......... ......+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhH
Confidence 2 224457888999999875 3 5788999999999999999999999887765555444443222111 11234678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
++.+++.+||..+|.+|||+.+++.|||
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.08 Aligned_cols=254 Identities=22% Similarity=0.439 Sum_probs=221.2
Q ss_pred eeccccccCCceEEEEEEEcCCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe--EEEE
Q 013816 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA--VHLV 134 (436)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--~~lv 134 (436)
+...+||+|+|-+||+|.|..+|..||.-.++...+ +.+...++|..|+.+|+.| +||||+++|++|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeee
Confidence 456789999999999999999999999876654443 3455678999999999999 99999999999987655 8899
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|.+.+|+|..++++.+..+.+.+..|++||+.||.|||++ .|||||||-+||+|+ +..+.|||+|+|+|......
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 99999999999999999999999999999999999999998 499999999999997 56777999999999987654
Q ss_pred CcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
.. ...+|||.|||||+....|+...||||||+.++||+|+..||... +...++..+..+...-... .--.+++++|
T Consensus 200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--kV~dPevr~f 276 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--KVKDPEVREF 276 (632)
T ss_pred cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--ccCCHHHHHH
Confidence 43 348999999999999999999999999999999999999999654 5556777777766532222 1236899999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
|.+||.. .+.|||+.|+|+||||...
T Consensus 277 IekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999 9999999999999999874
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=335.08 Aligned_cols=256 Identities=27% Similarity=0.509 Sum_probs=211.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+++++.+ +||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence 36999999999999999999999899999999986543322 3346788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|..+......+++..+..++.|++.||.|||+.|++||||+|+||+++. ...++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCcEEEEeeeeeeeccCCcc
Confidence 999999888887766667999999999999999999999999999999999999965 4458999999988654332
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC---------------
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------------- 276 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------------- 276 (436)
......++..|+|||++.+ .++.++||||||+++|+|++|..||......+....+......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2334568899999998763 46789999999999999999999997665544333332211100
Q ss_pred ----CC--------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 277 ----RR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 277 ----~~--------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+. ..++.++..+.+|+.+||+.+|++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 0134578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=325.50 Aligned_cols=252 Identities=27% Similarity=0.555 Sum_probs=216.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence 589999999999999999999999999999998754332 23456889999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||+.+++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ ..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEEeeccceeecCcch
Confidence 9999999999887643 57899999999999999999999999999999999999643 458999999997664332
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....|++.|+|||++. +.++.++|+||||+++|+|++|..||......+....+..+.... ....++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence 2 23456888999999976 457889999999999999999999998877777666665544321 224578999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
|.+||+.+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.59 Aligned_cols=252 Identities=28% Similarity=0.485 Sum_probs=212.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+++.+++|.+.... ..+.+.+|+++++++ +||||+++++++.....+|+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEE
Confidence 367999999999999999999999889999999986432 257899999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||++......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---CcEEEcccccchhcccC
Confidence 9999999999999875 4568999999999999999999999999999999999999654 45899999999876543
Q ss_pred C-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ......++..|+|||++. ..++.++||||||+++|+|++|..||...........+..... ........++.++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHH
Confidence 3 233456889999999986 4588999999999999999999999977655443333222111 111112356789999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
++.+||+.+|++|||+.++|.||||
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.32 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=211.1
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 5888999999999999999999899999999886432111 11235688899999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+.+++||||++|++|.+++...+.+++..+..++.|++.||.|||+++++||||+|+||+++. .+.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~---~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC---CCeEEEeecccccc
Confidence 999999999999999999988888999999999999999999999999999999999999964 45599999999876
Q ss_pred cCCCC---cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc--ccCCCCC
Q 013816 209 FKPGE---KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--LDFRRDP 280 (436)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 280 (436)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||......+....+.... ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 53221 1234568899999998753 37889999999999999999999997655443333332221 1122223
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+.++.++.+++.+||.++|++|||+.++|+|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 34678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.50 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=211.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ....+.+.+|+++++++ +||||+++++++.....+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 4699999999999999999999999999999998654322 22345688899999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+++ +|.+.+..... +++..+..++.||+.||.|||+++++||||+|+||+++..+ ..+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIP 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCC
Confidence 999964 88888765443 57888999999999999999999999999999999997433 34899999999765332
Q ss_pred -CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC----------
Q 013816 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---------- 279 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 279 (436)
.......+++.|+|||.+.+ .++.++||||||+++|+|+||..||......+....+..........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22234567899999998753 47889999999999999999999998776655554443211110000
Q ss_pred ---------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 280 ---------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+.+++++.+++.+||+.+|++||++.+++.||||.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1235788999999999999999999999999999998653
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.22 Aligned_cols=252 Identities=29% Similarity=0.522 Sum_probs=206.6
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeEEEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~lv 134 (436)
|++.+.||+|+||.||+|.+..+++.||+|++..... .. ......+|+.++.++.+||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999865422 22 2234457899999996699999999999887 899999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence 999975 888887764 56899999999999999999999999999999999999975 569999999998765544
Q ss_pred cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc----------------
Q 013816 214 KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~---------------- 275 (436)
......+++.|+|||.+. +.++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444567899999999764 34788999999999999999999999877665544443321110
Q ss_pred --CCCC-------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 --FRRD-------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 --~~~~-------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
++.. ..+.++.++.++|.+||+++|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 012468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=328.75 Aligned_cols=263 Identities=30% Similarity=0.494 Sum_probs=213.9
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-----ceeEEEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-----NIVCLKD 123 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----niv~~~~ 123 (436)
.+..+..+|.+++.+|+|.||.|..+++..++..||+|+++.- ....+...-|+++|+++..+. -+|.+.+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 4567789999999999999999999999999999999998542 224566778999999994332 3788999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--------
Q 013816 124 TYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-------- 193 (436)
Q Consensus 124 ~~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~-------- 193 (436)
+|...++.+||+|.+ |.|+++++..++ +++..+++.+++|+++++.+||+.+++|.||||+|||+.+..
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 779999998865 588999999999999999999999999999999999996431
Q ss_pred ---------CCCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH
Q 013816 194 ---------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (436)
Q Consensus 194 ---------~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 263 (436)
.+..|+|+|||.|+... +..+.++.|..|+|||++. -+++..|||||+||||+|++||...|+.....
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 24569999999998743 4447789999999999876 58999999999999999999999999887765
Q ss_pred HHH---HHHHHccc-------------cCCCCCCcc--------------------------cCHHHHHHHHHccCCCcC
Q 013816 264 GVA---QAIIRSVL-------------DFRRDPWPK--------------------------VSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 264 ~~~---~~i~~~~~-------------~~~~~~~~~--------------------------~~~~~~~ll~~~l~~~p~ 301 (436)
+.+ +.|+.... .-....|++ ...++.+||.+||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 533 22221000 000111211 113578999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 013816 302 RRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 302 ~Rps~~e~l~h~~~~~~ 318 (436)
+|+|+.|+|.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=332.02 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=215.5
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+..+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.+ +||||+++.+++...+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe
Confidence 34557899999999999999999999999999999998755444444556789999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.|+||||+.| ++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. .+.++|+|||++...
T Consensus 90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~---~~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE---PGTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC---CCCEEEeecCcceec
Confidence 9999999975 77676654 456899999999999999999999999999999999999964 345999999998765
Q ss_pred CCCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
... ....+++.|+|||++. +.++.++||||||+++|+|+||..||...........+..... ........+
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence 432 3456888999999863 4588899999999999999999999987776555444433211 111123467
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+.++|.+||+.+|++||++.+++.||||....
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 8999999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=325.52 Aligned_cols=255 Identities=28% Similarity=0.490 Sum_probs=213.7
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.+ +||||+++++.+...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence 589999999999999999999989999999998765433 34678899999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~- 214 (436)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEcccccccccCCCCCc
Confidence 99999999999988777899999999999999999999999999999999999965 44599999999877643322
Q ss_pred ----ccccccCCcccchhcccc-c---CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 215 ----FSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 215 ----~~~~~gt~~y~aPE~l~~-~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.....+++.|+|||++.+ . ++.++||||||+++|++++|..||.....................+.+..+++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 123467889999999863 3 68899999999999999999999976533222222222222222233345689
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+.+++.+||+.+|.+|||+.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=331.88 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=207.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-----
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----- 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----- 126 (436)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 45688999999999999999999999999999999875422 123567889999999967999999999873
Q ss_pred eCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 127 DDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
..+.+++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEEEcc
Confidence 45678999999999999988753 3468899999999999999999999999999999999999654 4489999
Q ss_pred eccccccCCCC-cccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 203 FGLSVFFKPGE-KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 203 fG~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
||++....... ......|++.|+|||++. ..++.++|||||||++|+|++|..||...........+.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~- 246 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP- 246 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC-
Confidence 99987654322 223457899999999874 2378899999999999999999999987655433333222111
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.........+..+.+++.+||+.||++|||+.++++|+||
T Consensus 247 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1111112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.72 Aligned_cols=260 Identities=29% Similarity=0.461 Sum_probs=212.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 131 (436)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+........ ....+.+|+.+++++ +|+||+++++++... +.+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-CcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 3579999999999999999999999999999999875433221 223456799999999 899999999998755 568
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+||+++. .+.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD---KGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEECccceeeecC
Confidence 999999975 78888765 356899999999999999999999999999999999999964 4459999999998765
Q ss_pred CC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC-----------
Q 013816 211 PG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF----------- 276 (436)
Q Consensus 211 ~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~----------- 276 (436)
.. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43 22233456788999998753 47899999999999999999999998888777666665422111
Q ss_pred --------CCCC-------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 --------RRDP-------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 --------~~~~-------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.... ....++++.++|.+||+.||++|||+.++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0000 123578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=342.67 Aligned_cols=235 Identities=26% Similarity=0.425 Sum_probs=202.8
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
++=||.|+.|.||+|+.. ++.||||+++. .-..+|+-|++| +||||+.+.++|.....|+||||||.
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccc
Confidence 445999999999999854 89999998742 123588899999 99999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~ 219 (436)
.|.|...|+....++......+..+|+.|++|||.+.|||||||.-|||+..++. |||+|||-++.........+++
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~---VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV---VKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce---EEeccccchHhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999976544 9999999998877666667899
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
||..|||||+++ ...+.|+|||||||+|||||||..||.+.....++-.+-...+.+ +....+++.++-||++||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L--pvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL--PVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc--cCcccCchHHHHHHHHHHhc
Confidence 999999999998 568999999999999999999999997665543322222222222 22246788999999999999
Q ss_pred CcCCCCCHHHHhcC
Q 013816 299 DPKRRLTAQQVLEH 312 (436)
Q Consensus 299 ~p~~Rps~~e~l~h 312 (436)
.|..|||+.++|.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999999
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.20 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=209.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE------
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE------ 126 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~------ 126 (436)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++.+||||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3468999999999999999999999999999999985432 234678889999999877999999999984
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
....+|++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++. ...++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~---~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE---NAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCc
Confidence 356789999999999999988753 35888999999999999999999999999999999999964 4459999999
Q ss_pred cccccCCC-CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
++...... .......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--P 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--C
Confidence 98765322 2234467899999999874 2477899999999999999999999977655444333332211 1
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
......++.++.+||.+||+.||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=325.55 Aligned_cols=255 Identities=28% Similarity=0.516 Sum_probs=209.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--Ce
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~ 130 (436)
.+|++.+.||+|+||.||.|.+..++..||+|.+..... ......+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 468999999999999999999999999999998864321 1223456889999999999 999999999988763 56
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++++|||++|++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++. .+.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~---~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS---VGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC---CCCEEECcCccccccc
Confidence 8899999999999999988778999999999999999999999999999999999999964 3458999999987653
Q ss_pred CC----CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 211 PG----EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.. .......|+..|+|||++. ..++.++||||||+++|+|++|+.||...........+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence 21 1223456889999999876 4588999999999999999999999977655444433332211 111224577
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
..+.++|.+||. +|++||++.+++.|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999995 899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.18 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=203.8
Q ss_pred ccceeeccccccCCceEEEEEEE-----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|++ ..++..||+|++.... .....+.+.+|+.++..+.+||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 35799999999999999999974 3457789999986443 2234567889999999997899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 013816 129 TAVHLVMELCEGGELFDRIVARG--------------------------------------------------------- 151 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~--------------------------------------------------------- 151 (436)
+..++||||++||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886431
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 152 ------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 152 ------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
.+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH---GRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC---CCcEEEecCccceeccCcc
Confidence 3677888999999999999999999999999999999964 3458999999998664332
Q ss_pred cc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 214 KF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 214 ~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |..||................... ......+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--LSPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--CCCCCCCHHH
Confidence 21 1233456799999976 568999999999999999998 899997765444333333332221 1223467899
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+|+.+||+.||++|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.07 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=210.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC---
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~--- 129 (436)
..++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++.+||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 34789999999999999999999998999999999865432 34678999999999977999999999997644
Q ss_pred ---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 130 ---AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~---~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC---CeEEECC
Confidence 58999999999999988864 3578999999999999999999999999999999999999653 4599999
Q ss_pred eccccccCCCC-cccccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 203 FGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 203 fG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
||++....... ......|+..|+|||++.. .++.++||||||+++|+|++|..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 99987654322 2244568999999998742 3678899999999999999999999766555444444443221
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
. .......+.++++|+.+||..||++|||+.+++.|||+
T Consensus 237 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 T-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred C-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1 11112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=323.77 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=214.8
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
+|+..+.||+|++|.||+|.+..+++.|++|.+...... .....+.+.+|+.+++.+ +||||+++++++.....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 477889999999999999999889999999998654322 233456789999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
++||++|++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~---~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT---NGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccceeccccc
Confidence 9999999999999988878999999999999999999999999999999999999964 4459999999988765444
Q ss_pred cccccccCCcccchhccc-cc-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......|+..|+|||.+. .. ++.++|+||||+++|+|++|..||...........+.... ......+.+++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHH
Confidence 345567899999999875 34 7889999999999999999999997766444433333211 1122234678999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+||+.+|.+||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.40 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=203.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|++..+| ..||+|.+..... ....+.+.+|+.+++.+.+||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 467999999999999999999865443 5799999865432 234567889999999997899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 013816 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~---------------------------------------------------------- 150 (436)
+.+++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---
Q 013816 151 ------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (436)
Q Consensus 151 ------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~--- 215 (436)
.++++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~---~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD---GRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC---CCeEEEeeceeeeeccCCcceeec
Confidence 23678889999999999999999999999999999999964 445899999999765433221
Q ss_pred cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
....+++.|+|||++. ..++.++|||||||++|+|++ |..||...........+........ ....+++++.+++.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence 1233556799999876 568999999999999999997 9999977655443334443332222 12346899999999
Q ss_pred HccCCCcCCCCCHHHHhc
Q 013816 294 KMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 294 ~~l~~~p~~Rps~~e~l~ 311 (436)
+||+.||.+|||+.++++
T Consensus 350 ~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 350 MCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=329.05 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=205.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+..|+.++.+..+||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3689999999999999999999999999999998764322 22345666777644444899999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
|||++ ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++. ...+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~---~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR---NGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeeccccccc
Confidence 99997 578777654 24689999999999999999999997 9999999999999964 445999999999866
Q ss_pred CCCCcccccccCCcccchhccc-----ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..........|+..|+|||.+. ..++.++|+||||+++|+|++|..||.... ..+....+..... ...+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence 4333334457889999999874 246889999999999999999999996432 2222233332211 1111235
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+|.++.++|.+||..+|++||++.++++||||....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 789999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=332.36 Aligned_cols=255 Identities=28% Similarity=0.497 Sum_probs=209.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~ 132 (436)
++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++++... +..|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 4699999999999999999999999999999999755432 22234567899999999 899999999998877 8999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||+.+ +|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CcEEEeecCceeeccC
Confidence 99999975 8988887643 58999999999999999999999999999999999999654 4589999999987654
Q ss_pred C-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-----------
Q 013816 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR----------- 277 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~----------- 277 (436)
. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567899999998763 368899999999999999999999987776655544433211000
Q ss_pred ---------------CCCCcc--cCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 ---------------RDPWPK--VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 ---------------~~~~~~--~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
...++. +++.+.++|.+||+.+|++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011122 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=329.24 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=213.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||++.+..+|+.||+|++.... .....+.+.+|+++++.+ +||||+++++++...+.+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999886542 233457889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+++++|.+++...+.+++..+..++.+++.||.|||+ .+++||||+|+||+++. ...++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC---CCcEEEccCCcccchhhh-
Confidence 9999999999999887889999999999999999999997 69999999999999964 445899999998654322
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHccccCCCCCC
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----------GVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 281 (436)
......|+..|+|||++. +.++.++|||||||++|+|+||..||...... +....+.... ......
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCc
Confidence 223457899999999875 56889999999999999999999999765432 1222222211 111112
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..++.++.+|+.+||+.||++|||+.|+++||||.....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 237789999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.97 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=207.9
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++++.||.|++|.||+|++..+|+.||+|.+..... .......+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999999865432 222345788999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEeeccchhhcccCc
Confidence 9996 588888765 3468999999999999999999999999999999999999654 458999999987654322
Q ss_pred -cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC------------
Q 013816 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------------ 278 (436)
......+++.|+|||++.+ .++.++||||||+++|+|+||+.||...........+.+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2234467889999998763 3688999999999999999999999877655444433322111000
Q ss_pred -------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 279 -------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
...+.++++++++|.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=331.13 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=202.0
Q ss_pred ccceeeccccccCCceEEEEEEEcC----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 117 (436)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.++ +|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence 4689999999999999999998532 34579999986542 233456799999999999 9999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013816 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-------------------HYTERAAAAVTKTIVEVVQMCHKHGVM 178 (436)
Q Consensus 118 iv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~lH~~~ii 178 (436)
|+++++++.+.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886531 357788899999999999999999999
Q ss_pred ecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh--
Q 013816 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-- 252 (436)
Q Consensus 179 H~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-- 252 (436)
||||||+|||++. .+.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill~~---~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGE---NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcC---CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999964 44599999999986543322 12345578899999875 568999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHHcc----ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 253 GVPPFWAETEQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 253 g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+..||...........+.... ........+.+++.+.+|+.+||+.+|.+|||+.++..
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 667887766655544432211 11111122457899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.59 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=212.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++++ +||||+++++.+...+.++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEE
Confidence 358889999999999999999999999999999876532 23456789999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||++|++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++. .+.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~---~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC---CCCEEEeecccchhhHHH
Confidence 9999999999999876 778999999999999999999999 99999999999999965 445999999998765332
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHccccCCCCCCcccCH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.. ....++..|+|||.+. ..++.++||||||+++|+|++|..||.... .......+..... ...+...++.
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSP 231 (265)
T ss_pred Hh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhcCH
Confidence 22 2267889999999976 458899999999999999999999996542 2222222222211 1111112788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++.++|.+||..+|++|||+.+++.||||+..
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 99999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=330.67 Aligned_cols=256 Identities=31% Similarity=0.533 Sum_probs=211.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEE
Confidence 369999999999999999999999999999999865432 223456789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++. .+.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~---~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE---SGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEEeeecccccCCCcc
Confidence 999998777666666667999999999999999999999999999999999999964 4559999999988765443
Q ss_pred -cccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-------------
Q 013816 214 -KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------------- 277 (436)
......++..|+|||++. . .++.++||||||+++|+|++|..||.+....+....+........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 334567889999999976 4 578899999999999999999999987655443333222110000
Q ss_pred ------C---------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 ------R---------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 ------~---------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
. .....++.++++|+.+||..+|++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 0111348899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=340.57 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=209.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++++ +||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCc
Confidence 35678999999999999999999999999999999986532 2333456778899999999 999999999988643
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
...|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~---~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCcc
Confidence 357999999965 888877654 8999999999999999999999999999999999999654 4589999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------- 275 (436)
+.............+|+.|+|||++. ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 98765444444567889999999876 56899999999999999999999999876654433333221100
Q ss_pred -------------CCCC-----------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 276 -------------FRRD-----------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 276 -------------~~~~-----------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.... .....++.++++|.+||+.||++|||+.|+|.||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 01134567899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=330.89 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=206.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|+..+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++.+||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3577788999999999999999999999999998754322 34567889999999995699999999999999999999
Q ss_pred EeccCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 135 MELCEGGELFDRI---V--ARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 135 ~E~~~g~~L~~~l---~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
|||+.+ ++.++. . ....+++..+..++.|++.||+|||+. +++||||||+||+++. ...+||+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR---NGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc---CCcEEEeecchhHH
Confidence 999864 554432 2 235699999999999999999999985 9999999999999964 34589999999976
Q ss_pred cCCCCcccccccCCcccchhcccc----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHcc-ccCCCCCCc
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-LDFRRDPWP 282 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~ 282 (436)
...........|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... +....+.... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 654433344578999999999863 4789999999999999999999999654421 1112222111 111122223
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.++.++.+|+.+||+.+|++|||+.+++.||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 588999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=342.55 Aligned_cols=247 Identities=35% Similarity=0.553 Sum_probs=212.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+... +..+|+.++....+||||+++.+.+.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 456789999999999999999999999999999999977632 2345777777777999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+|||.+.|+-+.+.+.....+. ..+..|+.+|+.|+.|||++|++||||||+|||++ +..++++|+|||.++....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999999998887765555 78888999999999999999999999999999996 4556699999999987654
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. ....+-|..|.|||++. ..|+.+||+||||++||+|++|..||...... ++...+..+.+. ..+|.+++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AK 540 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAK 540 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHH
Confidence 4 44457788999999987 56999999999999999999999999877666 333333222221 57899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
+||.+||+.||.+||++.+++.||||.
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred HHHHHhccCChhhCcChhhhccCcchh
Confidence 999999999999999999999999993
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=326.60 Aligned_cols=257 Identities=30% Similarity=0.539 Sum_probs=213.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEEeCCeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~~~l 133 (436)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .|||++++++++.....+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999986542 2234567889999999993 39999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++. .+.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC---CCCEEEccCCceeecCCCc
Confidence 9999999999998865 47899999999999999999999999999999999999965 4459999999998765433
Q ss_pred -cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
......|+..|+|||.+.. .++.++|+||||+++|+|++|..||...........+... ..+.......+.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2344578999999998753 4688999999999999999999999776554433322221 1111112237889999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
++.+||+.||++||++.+++.||||+....
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=325.03 Aligned_cols=248 Identities=17% Similarity=0.251 Sum_probs=206.6
Q ss_pred cceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+|++.+.||+|+||.||+|++. ..+..||+|.+.... .......+.+|+.+++.+ +||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence 56999999999999999999865 446789999986542 233456788999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. +..+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~---~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC---CCcEEECCCccccccc
Confidence 9999999999999998764 56899999999999999999999999999999999999964 4458999999876543
Q ss_pred CCCccc--ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
...... ...++..|+|||.+. +.++.++|||||||++|++++ |..||+.....+....+..... .+....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---LPAPRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCH
Confidence 222111 234567899999876 568999999999999999775 9999998887776666654322 223356789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.+++.+||+.+|.+|||+.++++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.65 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=203.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.++.+++.||+|.+....... ....+.+|+++++.+ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence 67999999999999999999999899999999987543221 224567899999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---CCEEECccccccccCCCC
Confidence 999985 898888664 468999999999999999999999999999999999999654 45999999998754322
Q ss_pred CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHccccCCC-----------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRR----------- 278 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~----------- 278 (436)
.......++..|+|||++.+ .++.++||||+|+++|+|++|..||.... ..+....+.+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 12223456889999998753 47889999999999999999999997655 22222222211100000
Q ss_pred ---------------CCCcccC--HHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 279 ---------------DPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 279 ---------------~~~~~~~--~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..++.++ .++.+++.+||+.+|++|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0012334 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.55 Aligned_cols=261 Identities=31% Similarity=0.533 Sum_probs=217.1
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...+.|.....||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeE
Confidence 34566777788999999999999999999999999985432 33456788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+ ..++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEccCcchhhccc
Confidence 999999999999988754 468999999999999999999999999999999999999654 4589999999875532
Q ss_pred CC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ......|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.... ..........+..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHH
Confidence 22 223457899999999976 468899999999999999999999998777665555444322 112222235788999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
+++.+||..||.+|||+.++++||||.....+
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999999975543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=322.67 Aligned_cols=252 Identities=31% Similarity=0.549 Sum_probs=214.4
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~l 133 (436)
+|++.+.||.|+||.||+|.+..+++.+|+|.+..... .....+.+..|+++++.+ +||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999999876543 334567788999999999 99999999998753 456899
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCH-----KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-----~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+|||+++++|.+++.. ..++++..+..++.||+.||.||| +.+++|+||+|+||+++. .+.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~---~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA---NNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec---CCCEEEeccc
Confidence 9999999999999865 357899999999999999999999 889999999999999965 3459999999
Q ss_pred cccccCCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 205 LSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 205 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
++........ .....+++.|+|||++. ..++.++|+||||+++|+|++|..||...........+...... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---RIPY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC---CCcc
Confidence 9987754433 34557899999999986 45788999999999999999999999887766665555544321 1223
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..+..+.+++.+||+.+|++|||+.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=338.48 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=212.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
+.++|.+.+.||+|+||+||+|++..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence 45789999999999999999999999999999999865422 233445678899999999 899999999987643
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
...|+|+||+. ++|.+++...+++++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECcCcccc
Confidence 35899999996 5899999888889999999999999999999999999999999999999653 459999999998
Q ss_pred ccCCC-CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc-----------
Q 013816 208 FFKPG-EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------- 273 (436)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~----------- 273 (436)
..... .......++..|+|||.+. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76443 2234456889999999875 358899999999999999999999997665433222222110
Q ss_pred ------------ccCC----CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 274 ------------LDFR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 274 ------------~~~~----~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.... ...++.+++++.++|.+||+.+|++|||+.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 011346789999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.13 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=208.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence 4578999999999999999999999999999999986422 223446678899999999 899999999886543
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
...|+|+||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++. .+.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~---~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEECccccee
Confidence 358999999975 88777644 57999999999999999999999999999999999999964 4459999999987
Q ss_pred ccCCCCc----ccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc-------
Q 013816 208 FFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL------- 274 (436)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~------- 274 (436)
....... .....||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6543221 13357899999999864 3588899999999999999999999977654433222211100
Q ss_pred ----------------cCCCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 275 ----------------DFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 275 ----------------~~~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
..... ..+..++++.++|.+||+.+|++|||+.++++||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000 123467889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=354.95 Aligned_cols=246 Identities=33% Similarity=0.515 Sum_probs=206.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEE-EEEe------
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-TYED------ 127 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-~~~~------ 127 (436)
-+++|.+.|.+|||+.||+|.+...|..||+|++-.. +....+.+.+||++|+.|..|+|||.+++ ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4788999999999999999999888899999998543 55678899999999999988999999999 3321
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEee
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
.-.++|.||||.||.|.|++..+ ..|++.++++|+.++++|+.+||... |||||||-+|||+..++ .+|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCcc
Confidence 23678999999999999999854 45999999999999999999999997 99999999999996544 5899999
Q ss_pred ccccccCCCCcc----------cccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013816 204 GLSVFFKPGEKF----------SEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (436)
Q Consensus 204 G~a~~~~~~~~~----------~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 269 (436)
|.|...-..... -...-|+.|+|||++. ...+.|+|||||||+||-|+....||..... -.|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence 988644222111 1124589999999874 3589999999999999999999999976533 346
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+.++. .+..+..+++||..||+.||.+||++.+++.+
T Consensus 267 lng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 267 LNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred EeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 666665544 46899999999999999999999999999875
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=323.56 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=216.4
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+..+.++ +||||+++++++......++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEE
Confidence 588999999999999999999999999999998765321 3467899999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|+||+++. .+.++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~---~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS---KGEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC---CCCEEEccCccceecccCCC
Confidence 999999999999888889999999999999999999999 99999999999999965 44589999999987654333
Q ss_pred c-cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHccccCCCCCCcc-cCHHH
Q 013816 215 F-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPK-VSENA 288 (436)
Q Consensus 215 ~-~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-~~~~~ 288 (436)
. ....++..|+|||.+. ..++.++|+||||+++|+|+||..||.... ..+....+..... ...... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---PSLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---CCCCcccCCHHH
Confidence 2 2557889999999976 457889999999999999999999997663 3334444443221 111223 78999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.++|.+||..+|++|||+.++++|||++..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=323.35 Aligned_cols=252 Identities=28% Similarity=0.502 Sum_probs=208.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 4799999999999999999999999999999988764444444556788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---CCEEECccccceecc
Confidence 999999999888753 3458999999999999999999999999999999999999653 458999999988664
Q ss_pred CCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||..... ......+.... .+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 3322 23456889999999876 4588899999999999999999999965432 23333332221 22222335778
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=331.31 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=213.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+.|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++++ +||||+++++++..++.+|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence 3568889999999999999999999999999999864432 23456789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++|++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---CCEEEccccccccccCcc
Confidence 9999999999988754 568999999999999999999999999999999999999653 458999999997664332
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....|+..|+|||++. ..++.++||||||+++|+|++|..||...........+..... .......+.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHH
Confidence 2 23346888999999986 4588899999999999999999999976555444333322211 11113467899999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.+||+.+|++|||+.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 9999999999999999999999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.05 Aligned_cols=265 Identities=30% Similarity=0.498 Sum_probs=212.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-C
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-D 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~ 128 (436)
...|+++..||+|.||.||+|..+.++ ..+|+|.+..++-....+ ...-+|+.+++.| +|||++.+..+|-. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhccC
Confidence 357999999999999999999765554 368999987664433333 3566899999999 99999999998866 8
Q ss_pred CeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCeEEEe
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAID 202 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~~~~ikl~D 202 (436)
..+++++||.+. +|+.+++-. ..++...+.+|++||+.|++|||++-|+||||||.|||+..+ .+.+.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999976 898888642 358999999999999999999999999999999999999754 3457899999
Q ss_pred eccccccCCCC----cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 013816 203 FGLSVFFKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETE---------QGVAQ 267 (436)
Q Consensus 203 fG~a~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---------~~~~~ 267 (436)
||+++.+.+.- ....++-|.+|+|||.+- ..|+++.||||.|||+.||+|-.+.|.+... .....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886432 234567899999999875 4699999999999999999999888865322 23344
Q ss_pred HHHHccccCCCCCCcc---------------------------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 268 AIIRSVLDFRRDPWPK---------------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~---------------------------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
.|.+-........|+. -++...+|+.+||++||.+|.|+.++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 4544333333333321 1445779999999999999999999999999
Q ss_pred cccCccC
Q 013816 315 LQNAKKA 321 (436)
Q Consensus 315 ~~~~~~~ 321 (436)
|......
T Consensus 340 F~~d~lp 346 (438)
T KOG0666|consen 340 FTEDPLP 346 (438)
T ss_pred cccCCCC
Confidence 9876544
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=330.81 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=203.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 129 (436)
-++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+++++++ +||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhC-CCCCccceEEEEeccccccc
Confidence 357999999999999999999999999999999986543222 1234567899999999 9999999999886543
Q ss_pred ----eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 130 ----AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 130 ----~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++. .+.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg 164 (310)
T cd07865 89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK---DGILKLADFG 164 (310)
T ss_pred CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC---CCcEEECcCC
Confidence 45999999965 7887776543 6899999999999999999999999999999999999964 4458999999
Q ss_pred cccccCCCCc-----ccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 205 LSVFFKPGEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 205 ~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
++........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...........+.......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9976543221 123467889999998754 368899999999999999999999987766544433332111111
Q ss_pred CCC----------------------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 RDP----------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 ~~~----------------------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 00135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=288.79 Aligned_cols=257 Identities=30% Similarity=0.553 Sum_probs=218.7
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
.|...++||+|.||+||+|+.+.+++.||+|.++...-.+.. -....+||-+|+.| +|.|||+++++...+...-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkel-khknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeH
Confidence 467778999999999999999999999999999876543332 24578899999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||.. +|..+... ++.+..+.+++++.|++.||.++|++++.||||||.|.|++. ++.+||+|||+++.+.-.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~---ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR---NGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc---CCcEEecccchhhhcCCceE
Confidence 99965 77777755 567999999999999999999999999999999999999964 4559999999999875433
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc-------
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------- 283 (436)
-.+..+-|.+|++|.++-+ -|+.+.|+||.|||+.|+.. |++.|.+.+.......|.+.........|+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 3455677999999999864 49999999999999999986 7788888888888888877655545444443
Q ss_pred ------------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 284 ------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 284 ------------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++...++|+.++|..+|.+|++++++|+||||.+.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 34457899999999999999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=324.89 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=210.4
Q ss_pred ccceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence 4679999999999999999999877 77889999875432 233446789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 129 TAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
...++||||++|++|.+++.... .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999987643 48899999999999999999999999999999999999876655678999
Q ss_pred eeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccC
Q 013816 202 DFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 202 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
|||+++........ .....+..|+|||++. ..++.++|||||||++|+|++ |..||...+.......+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--- 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG--- 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence 99999866322211 1223356799999976 568999999999999999997 999998877766655544322
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......++..+.+++.+||+.+|++|||+.++++|
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 112234678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=327.13 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=209.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence 57999999999999999999976555 679999886432 233456789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
..+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~- 160 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG- 160 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC-
Confidence 999999999999999999764 347888999999999999999999999999999999999653
Q ss_pred CCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
..+||+|||++....... ......+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus 161 --~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 161 --LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred --CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 458999999997653322 123345678899999875 568999999999999999998 9999998887777666
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+...... .....+++++.+|+.+||+.||.+||++.+++++
T Consensus 239 i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6554322 2224688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=330.53 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=203.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
++|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++.++.+||||+++++++...+.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 5799999999999999999999877765 46666543 2233445678899999999978999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||++. ..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~---~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC---CC
Confidence 9999999999999987542 4788999999999999999999999999999999999964 34
Q ss_pred CeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccc
Q 013816 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 274 (436)
.+||+|||++.............++..|+|||.+. ..++.++|||||||++|+|+| |..||......+....+....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 58999999986432211112223456799999876 457899999999999999998 999998777666555443321
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......+++++.+|+.+||+.+|++||++.++|.+
T Consensus 241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122223578899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.41 Aligned_cols=259 Identities=29% Similarity=0.479 Sum_probs=207.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~ 132 (436)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++++ +||||+++++++.. .+.++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence 368899999999999999999999999999999875432 23457789999999999 89999999998864 44789
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.+ ..++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---CeEEEeecccccc
Confidence 99999999999887653 3458999999999999999999999999999999999999654 4499999999875
Q ss_pred cCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHccc-cCCCCCC
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVL-DFRRDPW 281 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-----~~~~~~~i~~~~~-~~~~~~~ 281 (436)
..... .....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+..... .......
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 53222 22446788999999876 568999999999999999999999997652 2223333322111 1111110
Q ss_pred --cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 282 --PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 282 --~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
...++.+.+++.+||+.+|.+|||+.|++.||||++...
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 134678999999999999999999999999999976433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=358.70 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=204.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|++..+|+.||+|++...........+++.+|+.+++++ +||||+++++++.+.+..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 5799999999999999999999999999999999765444444456799999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEee
Q 013816 135 MELCEGGELFDRIVAR-----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
|||++|++|.+++... ...+...+..++.||+.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d---g~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF---GEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC---CCEEEEec
Confidence 9999999999988642 234566788999999999999999999999999999999654 45899999
Q ss_pred ccccccCCCC-------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH
Q 013816 204 GLSVFFKPGE-------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (436)
Q Consensus 204 G~a~~~~~~~-------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 263 (436)
|++....... .....+||+.|+|||++. ..++.++|||||||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 112357999999999976 46899999999999999999999999775443
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....... ........++..+++.+.+++.+||+.||++||+..+.+.+
T Consensus 238 ki~~~~~-i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDV-ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhh-ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3222110 00111112234688999999999999999999887766644
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.89 Aligned_cols=257 Identities=31% Similarity=0.538 Sum_probs=215.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|...+.||+|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence 3466668899999999999999999999999988543 223346688999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
+||++|++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+++. .+.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC---CCcEEEcccccchhhccCCc
Confidence 999999999998877 67899999999999999999999999999999999999964 3459999999887553322
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+...... .......++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP-KLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC-CCcccccCCHHHHHHH
Confidence 223456899999999976 45889999999999999999999999877766555555544221 1112234789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+||+.+|++|||+.++++||||++...
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=325.91 Aligned_cols=253 Identities=29% Similarity=0.531 Sum_probs=208.5
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||.|++|.||+|++..+|..||+|++..... ......+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence 48899999999999999999999999999999875432 22345677899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 136 ELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 136 E~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CcEEEeecchhhhhcCC
Confidence 99986 888887654 358999999999999999999999999999999999999643 45899999999765432
Q ss_pred C-cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC----------
Q 013816 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---------- 279 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 279 (436)
. ......+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.+........
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 2234567889999998753 46889999999999999999999998777665555443321110000
Q ss_pred ---------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 280 ---------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..+..++.+++++.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.08 Aligned_cols=248 Identities=28% Similarity=0.474 Sum_probs=201.3
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHH---HHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD---IMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~---~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
.||+|+||.||+|.+..+++.||+|.+.+...........+..|.. .++.. .||+|+++++++...+.+++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999999999999999997654433222223334433 34444 7999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccc
Q 013816 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (436)
Q Consensus 139 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~ 218 (436)
.|++|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||+++. +..+||+|||++...... .....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~---~~~~kl~dfg~~~~~~~~-~~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFSKK-KPHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC---CCCEEEccCcCccccCcc-CCcCc
Confidence 99999999988888999999999999999999999999999999999999964 345999999998765432 22345
Q ss_pred ccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 219 VGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.|+..|+|||.+. + .++.++||||+|+++|+|++|..||..... ......... .....+..++.++.+++.
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MAVELPDSFSPELRSLLE 231 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----cCCCCCCcCCHHHHHHHH
Confidence 7899999999986 3 488999999999999999999999976532 222211111 122223357899999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+||..+|.+|| ++.++++||||+..
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=337.16 Aligned_cols=262 Identities=30% Similarity=0.479 Sum_probs=212.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE----eC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~ 128 (436)
+.++|++.+.||+|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCC
Confidence 45789999999999999999999999999999999875432 223456778899999999 8999999998875 34
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..+++||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~---~~~~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEeccccccee
Confidence 57899999996 589999887778999999999999999999999999999999999999964 44589999999876
Q ss_pred cCCCC-----cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc--------
Q 013816 209 FKPGE-----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-------- 273 (436)
Q Consensus 209 ~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~-------- 273 (436)
..... ......|+..|+|||.+.+ .++.++||||||+++|+|++|+.||.+.........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 54322 1134578999999998753 48899999999999999999999997765443332222110
Q ss_pred ---------------ccCCCCC----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 274 ---------------LDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 274 ---------------~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
....... .+..++++.++|.+||+.+|++|||+.+++.||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0001111 2456899999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.07 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=214.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+-|++.+.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.+++++ +||||+++++++..+..+++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence 458888999999999999999988999999998864432 23456788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---CCEEEeecccceecccchh
Confidence 999999999988764 468999999999999999999999999999999999999644 458999999987654322
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......++..|+|||.+. ..++.++|+|||||++|+|++|..||...........+..... ......++.++.+++
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHH
Confidence 223456888999999976 4578899999999999999999999977665544444433211 112235788999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+||+.+|.+||++.++++||||....
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 999999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=350.89 Aligned_cols=264 Identities=21% Similarity=0.298 Sum_probs=195.7
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCC-cEEEEEE--------------eeccccCChhhHHHHHHHHHHHHhCCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENG-DAFACKS--------------ISKKKLRTAVDIEDVRREVDIMRHLPK 114 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~--------------i~~~~~~~~~~~~~~~~E~~~l~~l~~ 114 (436)
+..+.++|++++.||+|+||+||+|..+... ...+.|. +.+...........+.+|+.+|+++ +
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~ 221 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-N 221 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-C
Confidence 3456678999999999999999998765332 2222221 1111111222345688999999999 9
Q ss_pred CCceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 013816 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (436)
Q Consensus 115 h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~ 189 (436)
|||||++++++...+..|+|+|++. ++|.+++... .......+..++.||+.||.|||++||+||||||+|||+
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 4777776542 223466788999999999999999999999999999999
Q ss_pred ecCCCCCCeEEEeeccccccCCCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC---HH
Q 013816 190 ANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQ 263 (436)
Q Consensus 190 ~~~~~~~~ikl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~ 263 (436)
+. .+.+||+|||++..+..... .....||+.|+|||++. ..++.++|||||||++|+|++|..|++... ..
T Consensus 301 ~~---~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 301 NC---DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CC---CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 64 44599999999987654322 23467999999999986 468999999999999999999886554322 22
Q ss_pred HHHHHHHHcccc----CCC------------------CC------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 264 GVAQAIIRSVLD----FRR------------------DP------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 264 ~~~~~i~~~~~~----~~~------------------~~------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.....+...... ++. .. ...++.++.++|.+||+.||.+|||+.|+|.||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 222222221100 000 00 01346678889999999999999999999999999
Q ss_pred ccC
Q 013816 316 QNA 318 (436)
Q Consensus 316 ~~~ 318 (436)
...
T Consensus 458 ~~~ 460 (501)
T PHA03210 458 SAE 460 (501)
T ss_pred hcC
Confidence 764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=323.82 Aligned_cols=249 Identities=34% Similarity=0.597 Sum_probs=213.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||.|+||.||+|++..+|+.+|+|.+...........+.+.+|+++++++ +||||+++++.+......|++|||++|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999989999999998765544445567899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC---------
Q 013816 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------- 213 (436)
Q Consensus 143 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~--------- 213 (436)
|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+ ..++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999654 458999999987543321
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......++..|+|||.+. ..++.++||||||+++|+|++|..||......+....+......++. ...++..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE--DVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc--cccCCHHHHHHH
Confidence 223456788999999876 45788999999999999999999999888877776666654333221 123489999999
Q ss_pred HHccCCCcCCCCCH---HHHhcCccccc
Q 013816 293 RKMLDPDPKRRLTA---QQVLEHPWLQN 317 (436)
Q Consensus 293 ~~~l~~~p~~Rps~---~e~l~h~~~~~ 317 (436)
.+||+.+|.+|||+ .++|+||||++
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=326.69 Aligned_cols=260 Identities=32% Similarity=0.570 Sum_probs=212.5
Q ss_pred ceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.|++.+.||.|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++.+.+||||+.++++++.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999874 47899999998754322 2223467888999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++. .+.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC---CCCEEEeeCccceeccc
Confidence 999999999999999988888999999999999999999999999999999999999964 44699999999976643
Q ss_pred CC--cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 GE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.. ......|+..|+|||.+.. .++.++||||||+++|+|++|..||...........+..............+++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 32 2234568999999998753 467899999999999999999999964333222222222222212222345789
Q ss_pred HHHHHHHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
.+.+++.+||+.+|++|| ++.+++.||||+..
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.07 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=202.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+|+.+++.+ +|+||+++++++...+..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEE
Confidence 367999999999999999999999999999999986543221 224567899999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---CcEEEeccccccccCCC
Confidence 999996 577666654 3567888999999999999999999999999999999999643 45999999998754322
Q ss_pred -CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccc--------------
Q 013816 213 -EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL-------------- 274 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~-------------- 274 (436)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... +....+.....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 22234567899999998753 4788999999999999999999999765432 11112111000
Q ss_pred cCCCC------------CCc--ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 275 DFRRD------------PWP--KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 275 ~~~~~------------~~~--~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+... .+. ..+.++.+++.+||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 001 125788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=326.51 Aligned_cols=253 Identities=29% Similarity=0.488 Sum_probs=208.3
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||.|++|.||+|.+..+|..||+|++....... .....+.+|+++++.+ +||||+++++++.+.+..|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence 677899999999999999999999999999987653222 2335678899999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++. .+.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---CCcEEEeecccccccCCCcc
Confidence 995 58999887765 6899999999999999999999999999999999999965 4459999999997653222
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC---------------
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------------- 276 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------------- 276 (436)
......+++.|+|||++.+ .++.++||||||+++|+|++|..||...........+.+.....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233466889999998753 46889999999999999999999998776654444433321100
Q ss_pred ----------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 277 ----------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 277 ----------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.....+.++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 011124577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=320.96 Aligned_cols=253 Identities=27% Similarity=0.538 Sum_probs=214.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+...... ....+.+.+|+.+++.+ +||||+++++.+.....+++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence 588999999999999999999999999999998765332 22456788999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ ..+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCc
Confidence 9999999999987643 478999999999999999999999999999999999996543 347999999987664432
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....|++.|+|||++. ..++.++|+||||+++|+|++|..||...........+...... ...+..+.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence 2 23346889999999876 45889999999999999999999999877666555554443321 2234678899999
Q ss_pred HHHccCCCcCCCCCHHHHhcCccc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=320.21 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=202.7
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
...||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++...+.+++|+||++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCC
Confidence 35799999999999999999999999988654 233456889999999999 89999999999999999999999999
Q ss_pred CCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-cc
Q 013816 140 GGELFDRIVAR-GHY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KF 215 (436)
Q Consensus 140 g~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-~~ 215 (436)
|++|.+++... ..+ ++..+..++.|++.||.|||++||+||||||+||+++.. ...++|+|||++....... ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCCCcc
Confidence 99999998764 445 788899999999999999999999999999999999642 3458999999987654322 22
Q ss_pred cccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 216 SEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
....|++.|+|||.+.+ .++.++||||||+++|+|++|..||............ .............+++++++++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHH
Confidence 34468899999998753 3788999999999999999999999654332111111 1111111122245788999999
Q ss_pred HHccCCCcCCCCCHHHHhcCccc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+||+.+|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=327.80 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=214.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|.....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEE
Confidence 345566789999999999999999999999999865432 2346788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---CcEEEeechhHhhcccccc
Confidence 999999999887654 568999999999999999999999999999999999999643 459999999987554322
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......|+..|+|||++. ..++.++||||||+++|+|++|+.||......+....+.... ......+..++..+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHH
Confidence 223457899999999986 468899999999999999999999998776655555443322 222223346789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+||+.+|++||++.++++||||.+...
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=334.71 Aligned_cols=259 Identities=31% Similarity=0.468 Sum_probs=209.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
+..+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+++++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence 45789999999999999999999999999999999865533 3456788999999999 999999999876543
Q ss_pred ----------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 129 ----------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 129 ----------~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
...|+||||+++ +|.+.+.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.. ...+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~--~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE--DLVL 154 (342)
T ss_pred ccccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC--CceE
Confidence 468999999974 88887754 468999999999999999999999999999999999999643 3358
Q ss_pred EEEeeccccccCCCC----cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc
Q 013816 199 KAIDFGLSVFFKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (436)
Q Consensus 199 kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 272 (436)
||+|||.+....... ......++..|+|||.+. ..++.++|||||||++|+|++|..||...........+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997653221 112346788999999864 34788999999999999999999999877665554444332
Q ss_pred cccC----------------------CCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 273 VLDF----------------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 273 ~~~~----------------------~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.... ... ..+.++.++.+||.+||+.||.+|||+.++|.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 1100 000 1235788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=326.27 Aligned_cols=254 Identities=31% Similarity=0.606 Sum_probs=218.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|.+.+.||+|++|.||+|.+..+++.||+|++.+...........+.+|+.+++++.+||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999987755544445678899999999993399999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++. .+.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~---~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK---DMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEecCCccccccCCccc
Confidence 999999999999988888999999999999999999999999999999999999964 3458999999987654322
Q ss_pred --------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc
Q 013816 214 --------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (436)
Q Consensus 214 --------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 272 (436)
......++..|+|||++. ..++.++||||||++++++++|..||.........+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112346788999999876 45888999999999999999999999887766555555543
Q ss_pred cccCCCCCCcccCHHHHHHHHHccCCCcCCCCCH----HHHhcCccc
Q 013816 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA----QQVLEHPWL 315 (436)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~----~e~l~h~~~ 315 (436)
...+ ...+++.+.+++.+||+.+|.+|||+ .++++||||
T Consensus 238 ~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3322 24568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=331.31 Aligned_cols=258 Identities=30% Similarity=0.525 Sum_probs=203.8
Q ss_pred ceeeccccccCCceEEEEEEEcC--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeE
Q 013816 56 RYELGRELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 131 (436)
+|++.+.||+|++|.||+|.+.. +++.||+|.+...........+.+.+|+.+++.+ +||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 8999999998764322222346678899999999 899999999999988 889
Q ss_pred EEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-CCCCCCeEEEeecc
Q 013816 132 HLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDFGL 205 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~-~~~~~~ikl~DfG~ 205 (436)
++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+++|+||||||+||+++. +...+.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 676666432 36899999999999999999999999999999999999975 22256799999999
Q ss_pred ccccCCCCc----ccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 013816 206 SVFFKPGEK----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------VAQAII 270 (436)
Q Consensus 206 a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---------~~~~i~ 270 (436)
+........ .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543221 234567899999998753 47889999999999999999999997554321 111111
Q ss_pred Hccc---------------------cCCCCCCc------------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 271 RSVL---------------------DFRRDPWP------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 271 ~~~~---------------------~~~~~~~~------------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.... .......+ ..+.++.+++.+||+.||++|||+.|+++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1000 00001111 466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.70 Aligned_cols=251 Identities=28% Similarity=0.527 Sum_probs=208.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..++..+|+|.+.............+.+|+.+++.+ +||||+++++++..++.++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 4688999999999999999999999999999988765444444567889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++. .+.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCCEEECcchhhhccc
Confidence 999999999998863 345899999999999999999999999999999999999964 3459999999987664
Q ss_pred CCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....|+..|+|||.+. ..++.++||||||+++|+|++|..||.+.... .....+... ..+...+...++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 3322 23457889999999986 45888999999999999999999999755432 222222221 222223345788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=317.57 Aligned_cols=248 Identities=29% Similarity=0.516 Sum_probs=211.1
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.+ +||||+++++.+...+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 4889999999999999999999999999999986543 233457788999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++. ...++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ---NGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC---CCcEEEcccCcceeecccc
Confidence 999999999988653 35899999999999999999999999999999999999964 4458999999987664322
Q ss_pred -cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......|++.|+|||++. ..++.++|+||||+++|+|++|..||...+.......+..+.... ....++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence 223457889999999986 458899999999999999999999998877766666555443321 223578899999
Q ss_pred HHHccCCCcCCCCCHHHHhcC
Q 013816 292 VRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h 312 (436)
+.+||+.||++|||+.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=323.89 Aligned_cols=253 Identities=31% Similarity=0.532 Sum_probs=209.9
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeEEEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~lv 134 (436)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +|||++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999999999999997654 2233346788999999999 899999999999888 899999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. .+.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~---~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN---DGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC---CCCEEEccccceeeccCCC
Confidence 999975 888888765 57899999999999999999999999999999999999965 4458999999998765433
Q ss_pred --cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC--------
Q 013816 214 --KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-------- 281 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 281 (436)
......++..|+|||.+.+ .++.++||||||+++|+|+||..||...+.......+...........|
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334567889999997653 4789999999999999999999999887766555555442211111111
Q ss_pred ------------------cc-cCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 282 ------------------PK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 282 ------------------~~-~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.. +++.+.+++.+||+.+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.09 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=216.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+...|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+++++.+ +|||++++++++..+...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeE
Confidence 3445688999999999999999999999999999998765444444556789999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++. ...+||+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~---~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE---PGQVKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC---CCCEEEecCCCccccC
Confidence 999999975 77777754 456899999999999999999999999999999999999964 3459999999887543
Q ss_pred CCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. .....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+...... .......++
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (317)
T cd06635 177 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEWSD 251 (317)
T ss_pred C---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCccccH
Confidence 2 23456889999999863 45888999999999999999999999887666655555554321 122235788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+.+++.+||+.+|.+||++.++++|+|+.....
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.95 Aligned_cols=258 Identities=31% Similarity=0.529 Sum_probs=213.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence 468999999999999999999998899999999985432 22346788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|+||+++++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++. ...++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~---~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC---CCCEEEccCcceecccccc
Confidence 99999999999988654 5889999999999999999999999999999999999964 3458999999887654332
Q ss_pred c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 214 ~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
. .....|++.|+|||.+. +.++.++||||||+++|++++|..||...........+.... ......+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence 2 23456889999999876 568899999999999999999999997665543322222111 11112233568899999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+.+||+.+|++||++.+++.||||+....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=316.81 Aligned_cols=254 Identities=29% Similarity=0.510 Sum_probs=210.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--Ce
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~ 130 (436)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ........+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 469999999999999999999999999999998754321 1233456889999999999 899999999998764 56
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++++||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ ..++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECccccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999643 458999999997653
Q ss_pred CC----CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 211 PG----EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.. .......|+..|+|||.+. ..++.++|+|||||++|+|++|+.||...........+.... ........++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccC
Confidence 21 1223456899999999986 458899999999999999999999998766555444433221 1222345688
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.+.+++.+||+ +|..||++.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.74 Aligned_cols=264 Identities=31% Similarity=0.465 Sum_probs=213.8
Q ss_pred ccccceee-ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh-----------hHHHHHHHHHHHHhCCCCCcee
Q 013816 52 EIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DIEDVRREVDIMRHLPKHQNIV 119 (436)
Q Consensus 52 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~-----------~~~~~~~E~~~l~~l~~h~niv 119 (436)
.+.++|.. .+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+++++.+ +||||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence 35677865 57799999999999999999999999998654322100 012577899999999 899999
Q ss_pred EEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 120 ~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~---~~~k 159 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICK 159 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC---CCEE
Confidence 99999999999999999997 5899999887889999999999999999999999999999999999999643 4589
Q ss_pred EEeeccccccCCC---------------CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCH
Q 013816 200 AIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (436)
Q Consensus 200 l~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 262 (436)
|+|||++...... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998765411 11223456889999998764 368899999999999999999999988777
Q ss_pred HHHHHHHHHccccCCCC------------------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 263 QGVAQAIIRSVLDFRRD------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 263 ~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+....+.......... ..+..+.++.++|.+||+.+|++|||+.++|.||||+..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 66555554322111110 012457889999999999999999999999999999876
Q ss_pred cc
Q 013816 319 KK 320 (436)
Q Consensus 319 ~~ 320 (436)
..
T Consensus 320 ~~ 321 (335)
T PTZ00024 320 PL 321 (335)
T ss_pred CC
Confidence 44
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.55 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=208.6
Q ss_pred cceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+++++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence 568999999999999999998753 36889999986542 222457899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
..++||||++|++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~--- 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--- 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC---
Confidence 9999999999999999997542 37888999999999999999999999999999999999654
Q ss_pred CCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 013816 196 APLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 270 (436)
..+||+|||++........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||......+....+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 5589999999876532221 12335578899999876 568999999999999999998 999998888777777666
Q ss_pred HccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.... ....++..+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 544322 22467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=324.48 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=214.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.+.|...+.||+|+||+||+|++..+++.||+|.+.............+.+|+.+++.+ +|||++++++++.+....
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEE
Confidence 3456688888999999999999999999999999998765544444556788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+||||+.| +|.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++. .+.+||+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~---~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE---PGQVKLADFGSASKSS 172 (313)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC---CCCEEEeecCCCcccC
Confidence 999999965 77777765 456899999999999999999999999999999999999964 3459999999886532
Q ss_pred CCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
......|+..|+|||++. +.++.++||||||+++|+|++|..||...........+..... +.......+.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD 247 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence 223457889999999873 4578899999999999999999999987766555554443322 2222245678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+++|+.+||+.+|.+||++.+++.||||...
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=315.83 Aligned_cols=252 Identities=28% Similarity=0.553 Sum_probs=216.7
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||.|++|.||++.+..++..+|+|++..... .......+.+|+++++.+ +|||++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999876543 234567789999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 136 ELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 136 E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||++|++|.+.+... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++. ...++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~---~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS---NGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC---CCcEEECCccceeeccc
Confidence 999999999998764 67999999999999999999999999999999999999965 34589999999977644
Q ss_pred CC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ......|++.|+|||.+. ..++.++|+||+|+++++|++|..||...........+....... ....++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 33 223457889999999876 458899999999999999999999998877666666555443221 1236789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+++.+||..+|++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=314.67 Aligned_cols=253 Identities=33% Similarity=0.556 Sum_probs=214.0
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~~l 133 (436)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.+++++ +||||+++++.+... ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999999999999998765432 34567899999999999 899999999999988 89999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
++||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++. .+.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC---CCCEEEcccccEEeccccc
Confidence 9999999999999988878999999999999999999999999999999999999975 3458999999998776544
Q ss_pred c---ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccCCCCCCcccCHHH
Q 013816 214 K---FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 214 ~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
. .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..... ......+... ..........+..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence 3 345678899999999874 488999999999999999999999977652 2222222110 11122224568999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+++.+||+.+|++||++.+++.||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=324.61 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=204.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
++|++.+.||+|+||.||+|++..++. .+++|.+... ......+.+.+|+.++.++.+||||+++++++...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 4688876532 233345678999999999977999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ..
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE---NL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC---CC
Confidence 9999999999999996532 4788999999999999999999999999999999999964 44
Q ss_pred CeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccc
Q 013816 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 274 (436)
.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|++ |..||...........+.....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 58999999986432221112223345799999876 468999999999999999997 9999988877766666554321
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
......++..+.+|+.+||+.+|.+|||+.++++.
T Consensus 237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12224588999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=312.57 Aligned_cols=251 Identities=32% Similarity=0.545 Sum_probs=212.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.+ +||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 47888999999999999999998999999999865432 3457889999999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 136 ELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||++|++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++. .+.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc---CCeEEEeecccccccccccc
Confidence 999999999998776 57899999999999999999999999999999999999965 44599999999987655433
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....++..|+|||.+. ..++.++||||||+++|+|++|..||...+.......+...... .......++..+.+++.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP-GLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCC-CcCcccccCHHHHHHHH
Confidence 34567889999999986 45788999999999999999999999877554444433332111 11111224889999999
Q ss_pred HccCCCcCCCCCHHHHhcCcc
Q 013816 294 KMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 294 ~~l~~~p~~Rps~~e~l~h~~ 314 (436)
+||+.||++|||+.++|.|||
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=317.59 Aligned_cols=247 Identities=21% Similarity=0.341 Sum_probs=208.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|.+.+.||+|++|.||+|.+..+++.||+|.+... ......+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEE
Confidence 4689999999999999999999999999999998643 22456789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. ...+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE---NHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCcEEeCCCccccccccc
Confidence 9999999999998764 35889999999999999999999999999999999999964 445999999999876543
Q ss_pred Ccc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+.... .......++.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHH
Confidence 221 1223456899999876 568899999999999999998 999998877766656554432 222335678999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=320.34 Aligned_cols=251 Identities=21% Similarity=0.337 Sum_probs=205.5
Q ss_pred cccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 4578999999999999999999864 235679999875432 223456788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 013816 128 DTAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ 197 (436)
...+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++. ...
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~---~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC---CCC
Confidence 999999999999999999986532 2567888999999999999999999999999999999964 445
Q ss_pred eEEEeeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHc
Q 013816 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (436)
Q Consensus 198 ikl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 272 (436)
++|+|||++......... ....+++.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998765432211 1234577899999986 568999999999999999999 78999887777666655544
Q ss_pred cccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
... .....++..+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 321 1124578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=330.26 Aligned_cols=260 Identities=28% Similarity=0.500 Sum_probs=212.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++++.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 46788999999999999999999999999999999986532 2233345788999999999 9999999999987553
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 130 ----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+++||||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++. .+.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~---~~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEeeccc
Confidence 468999999 6788877754 57999999999999999999999999999999999999964 34599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc--------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-------- 275 (436)
+..... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 976542 2234567899999998763 4788999999999999999999999877655444443321111
Q ss_pred ---------------CCC----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 276 ---------------FRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 276 ---------------~~~----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
... ..++.+++.+.++|.+||+.||++|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000 112457888999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=319.92 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=218.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...+.|++...||+|++|.||+|.+..++..+++|++..... ..+.+.+|+++++.+ +|+||+++++.+......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEE
Confidence 345679999999999999999999998999999999865432 457788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++. .+.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK---DGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC---CCCEEECccchhhhhc
Confidence 99999999999999998876 7999999999999999999999999999999999999964 3458999999887554
Q ss_pred CCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 211 PGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 211 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
... ......++..|+|||.+. ..++.++||||||+++|+|++|..||...........+...... .......++.++
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 322 223446788999999876 45889999999999999999999999877665544444333221 112223478999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.++|.+||+.+|.+|||+.+++.||||+..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.54 Aligned_cols=261 Identities=33% Similarity=0.522 Sum_probs=218.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-----e
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~ 130 (436)
+|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.+ +||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999999899999999986542 2234457789999999999 8999999999987765 7
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+||||+.+ +|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.+ +.++|+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---CDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccCceEeec
Confidence 8999999974 899998887789999999999999999999999999999999999999654 569999999998765
Q ss_pred CCC----cccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC-----
Q 013816 211 PGE----KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (436)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 279 (436)
... ......+|+.|+|||++. . .++.++||||||+++|+|++|..||...+..+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 234557889999999976 3 57889999999999999999999998887766555554422111110
Q ss_pred ----------------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCC
Q 013816 280 ----------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (436)
Q Consensus 280 ----------------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 322 (436)
..+.++.++.++|.+||+.+|.+|||+.+++.||||+.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 0134678999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=316.06 Aligned_cols=251 Identities=26% Similarity=0.521 Sum_probs=208.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...........+.+.+|+++++++ +|+||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 5799999999999999999999999999999998765444444567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---CcEEEeccceeeecc
Confidence 999999999998864 2458999999999999999999999999999999999999643 458999999987654
Q ss_pred CCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
... ......+++.|+|||.+. ..++.++||||||+++|+|++|..||..... ......+..+.. ...+....+.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence 332 223456889999999876 4588999999999999999999999965432 223333333222 2222235788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=320.85 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=206.6
Q ss_pred cceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 57999999999999999999852 34567999988643 233456789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 130 AVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
.+++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++. .+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~---~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE---NL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc---CC
Confidence 9999999999999999987543 3899999999999999999999999999999999999964 44
Q ss_pred CeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 013816 197 PLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 271 (436)
.+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 589999999976543221 12334577899999886 568999999999999999998 9999988877777676665
Q ss_pred ccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.... .....+.++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54321 12357889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.57 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=202.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||.||+|++... +..||+|++.... .....+.+.+|+++++++..||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 46799999999999999999987433 3479999986542 2334567899999999995599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 013816 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~---------------------------------------------------------- 150 (436)
..+|+|||||++|+|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999888542
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 013816 151 --------------------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (436)
Q Consensus 151 --------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~ 192 (436)
..+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~- 272 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ- 272 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC-
Confidence 13677788899999999999999999999999999999965
Q ss_pred CCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 013816 193 KETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (436)
Q Consensus 193 ~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 267 (436)
...+||+|||+++....... .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||..........
T Consensus 273 --~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 273 --GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred --CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 34589999999986543221 12345678899999876 568999999999999999997 999997755443333
Q ss_pred HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
......... .....++.++.+++.+||+.+|++|||+.++.+
T Consensus 351 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333322222 222467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.41 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=201.7
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~- 127 (436)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 468999999999999999999753 345789999986432 233456788899999999789999999998764
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~--------------------------------------------------------- 150 (436)
...++++|||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46788999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCc
Q 013816 151 ----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY 223 (436)
Q Consensus 151 ----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~ 223 (436)
.++++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~---~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC---CCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788999999999999999999999999999999999974 34599999999987643221 123455678
Q ss_pred ccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcC
Q 013816 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 224 y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~ 301 (436)
|+|||++. ..++.++|||||||++|+|++ |..||.+....+............. .....++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChh
Confidence 99999876 568999999999999999998 9999977544333333332222111 1235688999999999999999
Q ss_pred CCCCHHHHhcC
Q 013816 302 RRLTAQQVLEH 312 (436)
Q Consensus 302 ~Rps~~e~l~h 312 (436)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=315.26 Aligned_cols=245 Identities=25% Similarity=0.398 Sum_probs=205.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++.+. .+..+|+|.+..... ....+.+|+.+++++ +||||+++++++...+.+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence 46889999999999999999875 456899998764322 246788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||+|+||+++. ...+||+|||.++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS---TGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC---CCeEEECCCCCccccCCCc
Confidence 9999999999998753 46899999999999999999999999999999999999964 3458999999987654322
Q ss_pred cc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |+.||...+..+....+.++..... ....+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence 22 2234556899999986 568899999999999999999 9999988887777777765432211 234678999
Q ss_pred HHHHHccCCCcCCCCCHHHHhc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++.+||+.+|++|||+.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=332.05 Aligned_cols=262 Identities=28% Similarity=0.499 Sum_probs=214.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe-
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 130 (436)
.+.++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++.+++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence 45678999999999999999999999999999999886532 2233446678899999999 99999999988766554
Q ss_pred -----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 131 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 131 -----~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.++|+||+ |++|.+++.. .++++..+..++.|++.||.|||+.||+||||+|+||+++. .+.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~---~~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE---DCELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEccccc
Confidence 89999999 6699888865 47999999999999999999999999999999999999965 34599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------ 277 (436)
+...... .....++..|+|||.+.+ .++.++||||||+++|+|++|+.||.+.........+........
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9865432 344578899999998753 578899999999999999999999987776655554443211100
Q ss_pred -----------------C----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCC
Q 013816 278 -----------------R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (436)
Q Consensus 278 -----------------~----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 322 (436)
. ..+...++.+.++|.+||+.+|++|||+.+++.||||+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 0 01124688999999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=311.73 Aligned_cols=252 Identities=32% Similarity=0.573 Sum_probs=216.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ....+.+.+|+++++++ +|||++++++++.+.+.++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence 588899999999999999999989999999999766432 24567899999999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~- 214 (436)
||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++. .+.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC---CCCEEEeccccceecCCCccc
Confidence 99999999999988888999999999999999999999999999999999999965 45699999999987654332
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....++..|+|||.+. ..++.++||||+|+++|+|++|..||...........+.... .......+++.+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CCCCCCCCCHHHHHHHH
Confidence 23456889999999876 347889999999999999999999998766544443333221 22233467899999999
Q ss_pred HccCCCcCCCCCHHHHhcCccc
Q 013816 294 KMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 294 ~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+||..+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=346.05 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=213.9
Q ss_pred cceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+.+..+.||+|+||+||+|... +..+.||||.++... +.....+|++|++++..| +|||||+++|+|..++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCC
Confidence 45677899999999999999854 334679999986543 444678999999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
..++|+|||..|+|.++|..++ +++..+.+.|+.||+.|+.||-++.+|||||-..|+|| ++.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccc
Confidence 9999999999999999996431 27888999999999999999999999999999999999 566
Q ss_pred CCeEEEeeccccccCCCCccc---ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 013816 196 APLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 270 (436)
..|||+|||+++.+-..+.+. ...-..+|||||.+. +.||.+|||||+||+|||+++ |+.||.+...+++++.|.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 779999999998765444332 222346899999765 889999999999999999987 999999999999999999
Q ss_pred HccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.. ... ...+|.++.+||..||+.+|.+||+++||-.
T Consensus 720 ~g~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 720 AGQL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cCCc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8876 332 3579999999999999999999999999843
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.25 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=207.0
Q ss_pred ccceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC
Confidence 4789999999999999999997642 35589999876432 222345678899999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 129 TAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
+..++||||+++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+||+++. ...+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~---~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC---CCcE
Confidence 9999999999999999999653 23456788899999999999999999999999999999964 4458
Q ss_pred EEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc
Q 013816 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 199 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 273 (436)
+|+|||+++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876533221 12234567899999976 568999999999999999998 789998877766665555432
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc------Cccccc
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE------HPWLQN 317 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~------h~~~~~ 317 (436)
... .....++.+.+++.+||+.+|++|||+.++++ ||||..
T Consensus 239 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 239 YLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 211 12346789999999999999999999999987 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=330.02 Aligned_cols=255 Identities=17% Similarity=0.281 Sum_probs=202.0
Q ss_pred cccccC--CceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
..||+| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence 457766 999999999999999999999875432 233457889999999999 8999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-c
Q 013816 139 EGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-F 215 (436)
Q Consensus 139 ~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~-~ 215 (436)
.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++++||+.+........ .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCccc
Confidence 999999988764 348999999999999999999999999999999999999654 4589999986543221110 0
Q ss_pred -------cccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC---------
Q 013816 216 -------SEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------- 276 (436)
Q Consensus 216 -------~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------- 276 (436)
....++..|+|||++.+ .++.++|||||||++|+|++|..||...................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 11234567999999864 37889999999999999999999997766544433332211100
Q ss_pred ----------------------------------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 277 ----------------------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 277 ----------------------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.......+++.+.+|+.+||+.||++|||+.++|+||||.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00111235678999999999999999999999999999987544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=323.64 Aligned_cols=259 Identities=31% Similarity=0.548 Sum_probs=209.8
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
....++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence 34567899999999999999999999999999999998754322 22335677899999999 8999999999887654
Q ss_pred ---------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 130 ---------AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 130 ---------~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.+++|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+.||+||||+|+||+++. ...+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~---~~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN---KGQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCcEE
Confidence 89999999986 677776654 46899999999999999999999999999999999999964 44599
Q ss_pred EEeeccccccCCCC--cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 200 AIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 200 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
|+|||++....... ......++..|+|||.+.+ .++.++|||||||++|+|++|+.||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998764332 2223456788999998753 4788999999999999999999999877665555444432111
Q ss_pred CCC--------------------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 276 FRR--------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 276 ~~~--------------------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
... ..+..++..+.+++.+||+.+|.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 100 1123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=320.47 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=213.9
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
....|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+++++.+ +|||++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence 346688899999999999999999999999999998754444444556788999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||+. ++|.+.+.. ..++++..+..++.|++.||.|||+++++||||+|+||+++. .+.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC---CCcEEECCcccceeecC
Confidence 9999997 478777654 456899999999999999999999999999999999999964 34599999999876543
Q ss_pred CCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
. ....+++.|+|||.+. +.++.++|||||||++|+|++|..||...........+...... .......+..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccHH
Confidence 2 3456889999999863 35788999999999999999999999876655544444443321 1112357889
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.+||.+||+.+|++||++.++++|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=333.16 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=213.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc---E-EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD---A-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+++-.+.++||+|+||.||+|..+..+. . ||+|....+.........++.+|+++|+.+ +|||||++||+.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCC
Confidence 3556677999999999999999765432 3 899998764445566788999999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.+++|||+|.||+|.++|...+ .++..+...++.+.+.||+|||++++|||||-..|+|++.+ ..+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~---~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK---GVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC---CeEEeCccccccC
Confidence 9999999999999999999886 49999999999999999999999999999999999999643 3479999999886
Q ss_pred cCCCCccc-ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 209 FKPGEKFS-EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 209 ~~~~~~~~-~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
...-.... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....++...|.......+.+ ...+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~--~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP--SKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC--CCCH
Confidence 53111111 112346899999987 679999999999999999998 889999999999888886654433333 4678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.++..++.+|+..+|++|||+.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 89999999999999999999999976
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=319.11 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=208.1
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEEeCCe----
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTA---- 130 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~~~~---- 130 (436)
|++.+.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++++. +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999998889999999987543322 22345667888777663 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 131 -VHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 131 -~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcce
Confidence 9999999975 8888887643 48999999999999999999999999999999999999654 569999999998
Q ss_pred ccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC---------
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--------- 277 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--------- 277 (436)
............++..|+|||++. ..++.++|||||||++|+|++|.+||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 775544445556889999999876 4688999999999999999999999988777666665544221100
Q ss_pred --------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 278 --------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 278 --------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
....+.+++.+.+++.+||+.||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00012456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=332.48 Aligned_cols=248 Identities=23% Similarity=0.403 Sum_probs=206.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+...+...||+|.||+||+|.|. ..||||++..... .+...+.|++|+.++++- +|.||+=+.|++..+.. .||
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AII 465 (678)
T ss_pred HHhhccceeccccccceeecccc---cceEEEEEecCCC-CHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-eee
Confidence 45678899999999999999986 4599999987654 455889999999999999 99999999999988877 999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC---
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--- 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~--- 210 (436)
+.+|+|-+|+.++... ..|.....+.|++||+.|+.|||.++|||||||..||++.+ ...|||+|||++....
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~---~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE---DLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc---CCcEEEecccceeeeeeec
Confidence 9999999999999754 45888999999999999999999999999999999999964 3569999999986432
Q ss_pred CCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCcccC
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVS 285 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~ 285 (436)
.........|...|||||++. ..|++.+||||||+++|||+||..||.....+.++-.+-++...... ......+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 223344556778899999985 25899999999999999999999999866665554444444332222 1234567
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.++++|+..||.+++++||.+.++|.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 79999999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=303.23 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=203.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC-----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD----- 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----- 128 (436)
.+||++.+.||+|||+.||++....+++.||+|++... +..+.+...+|++..+++ +|||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence 57999999999999999999999999999999999655 345678899999999999 999999999876433
Q ss_pred CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEe
Q 013816 129 TAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
...||++.|...|+|.+.+... ..++|.++..|+.+++.||.+||+.. ++||||||.|||+.. .+.++|.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~---~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD---SGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC---CCceEEEe
Confidence 4589999999999999988653 36899999999999999999999998 999999999999965 44589999
Q ss_pred eccccccCCC----------CcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH--HHH
Q 013816 203 FGLSVFFKPG----------EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVA 266 (436)
Q Consensus 203 fG~a~~~~~~----------~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--~~~ 266 (436)
||.++...-. ....+...|..|+|||.+. ...+.++|||||||+||.|+.|..||...-.+ .+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9988754311 0112235688999999875 23688999999999999999999999422111 011
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
-++.+....++.. ..+|+.+.++|++||+.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2233333344433 2489999999999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=313.55 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=199.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|++..+++.+|+|.+.... .......+.+|+++++.+ +||||+++++++.....+++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999999999999999875432 233456789999999999 899999999999999999999999999
Q ss_pred CchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccc---
Q 013816 141 GELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--- 216 (436)
Q Consensus 141 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~--- 216 (436)
++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++. ...+||+|||++..........
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE---KNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC---CCcEEECccccCcccccccccccCC
Confidence 99999987644 5899999999999999999999999999999999999964 3458999999987654321111
Q ss_pred ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHH
Q 013816 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (436)
Q Consensus 217 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~ 294 (436)
...++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.... ........+..+.+++.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC---CCCCcccCCHHHHHHHHH
Confidence 112245699999876 568899999999999999998 899997766655544444322 112234578999999999
Q ss_pred ccCCCcCCCCCHHHHhc
Q 013816 295 MLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 295 ~l~~~p~~Rps~~e~l~ 311 (436)
||+.+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.53 Aligned_cols=249 Identities=21% Similarity=0.366 Sum_probs=205.6
Q ss_pred cceeeccccccCCceEEEEEEEc----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++|++.+.||+|+||+||+|.+. .++..+|+|.+... ........+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence 46899999999999999999853 45678999998643 2334456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 131 VHLVMELCEGGELFDRIVAR-----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
.|+||||+++++|.+++..+ ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~- 160 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ- 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC-
Confidence 99999999999999998532 237888899999999999999999999999999999999643
Q ss_pred CCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
..+||+|||+++...... ......++..|+|||++. +.++.++||||||+++|+|++ |..||.+.........
T Consensus 161 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 161 --LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred --CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 458999999997654322 123344567899999876 568999999999999999998 9999988776655555
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+..... ......+++.+.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 544322 12234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.86 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=201.9
Q ss_pred ccCCcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE
Q 013816 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (436)
Q Consensus 45 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 124 (436)
+...+....++.|.-...||+|+||.||+|... +|..||||++....... ..+|.+|+.++.++ +|||+|+++||
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~LlGy 139 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKLLGY 139 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccEEEE
Confidence 333444556688998899999999999999964 45999999876543221 45699999999999 79999999999
Q ss_pred EEeCC-eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceEeecCCCCCCe
Q 013816 125 YEDDT-AVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 125 ~~~~~-~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~NIl~~~~~~~~~i 198 (436)
|.+.+ ..+||+||+++|+|.+++.... +++|....+|+.+++.||+|||... ||||||||+|||++.+. ..
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~---~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF---NA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC---CE
Confidence 99988 5999999999999999998765 8999999999999999999999853 99999999999997544 47
Q ss_pred EEEeeccccccCC-CCccccc-ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC---HHHHHH---HH
Q 013816 199 KAIDFGLSVFFKP-GEKFSEI-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQ---AI 269 (436)
Q Consensus 199 kl~DfG~a~~~~~-~~~~~~~-~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~---~i 269 (436)
||+|||+|+.... ....... .||.+|+|||++. +..+.|+|||||||+|+||+||+.|..... ...... ..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999976544 3333333 8999999999986 679999999999999999999998876432 111111 11
Q ss_pred H-H----ccccCCCCCCcccC-----HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 270 I-R----SVLDFRRDPWPKVS-----ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 270 ~-~----~~~~~~~~~~~~~~-----~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+ + ...+..... ...+ ..+..+...|++.+|.+||++.|+++
T Consensus 297 ~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1 1 111111100 1222 23567888999999999999999755
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.55 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=206.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC----------------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG----------------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 117 (436)
.++|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++++ +|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCC
Confidence 367999999999999999999876544 458999886543 234567889999999999 8999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013816 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (436)
Q Consensus 118 iv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 186 (436)
|+++++++..++.++++|||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 68999999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh--CCCCCCCC
Q 013816 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (436)
Q Consensus 187 Il~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt--g~~pf~~~ 260 (436)
|+++.+ ..++|+|||+++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKN---YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCC---CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999654 5589999999876543321 22345677899999876 478999999999999999998 78888776
Q ss_pred CHHHHHHHHHHcc----ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 261 TEQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 261 ~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
........+.... ........+..+.++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6666555554321 11111122356789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=314.08 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=205.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||+||+|.+. .+..+|+|.+..... ..+.+.+|+.+++.+ +||||+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence 46999999999999999999865 355699998864332 246789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +..+||+|||.++......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~---~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---CCCEEECCCccceecCCCc
Confidence 9999999999998764 46899999999999999999999999999999999999964 3459999999987654332
Q ss_pred cc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+........ ....+..++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence 21 1234567899999986 568899999999999999998 9999987777666666655433221 234689999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+||+.+|.+|||+.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=328.98 Aligned_cols=263 Identities=32% Similarity=0.513 Sum_probs=212.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--C
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~ 129 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++++.+||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 46789999999999999999999999899999999886432 22234456778999999997899999999988643 4
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||+|+||+++. .+.+||+|||++...
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~---~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEEeeccchhcc
Confidence 68999999975 998888765 7889999999999999999999999999999999999964 445999999999766
Q ss_pred CCCC------cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc------
Q 013816 210 KPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------ 275 (436)
Q Consensus 210 ~~~~------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------ 275 (436)
.... ......||+.|+|||.+. ..++.++||||||+++|+|+||+.||.+.........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 4322 223456899999999874 34788999999999999999999999776554443333222110
Q ss_pred -----------------CC----CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 276 -----------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 276 -----------------~~----~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.. ....+.++.++.++|.+||+.+|++|||+.++++|||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 00 1112346889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=313.52 Aligned_cols=245 Identities=35% Similarity=0.647 Sum_probs=212.8
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|+||.||++.+..+++.+|+|++.............+..|+.+++++ +||||+++++.++.+..+++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 79999999999999889999999999877655555667899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-CcccccccC
Q 013816 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (436)
Q Consensus 143 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-~~~~~~~gt 221 (436)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ ..++|+|||.+...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---CcEEEeecCcceecccCCCcccCCcCC
Confidence 99999888789999999999999999999999999999999999999654 45899999998776443 233456788
Q ss_pred Ccccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCc
Q 013816 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (436)
Q Consensus 222 ~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p 300 (436)
..|+|||... ...+.++|+||||+++|+|++|..||...........+..... ......+..+.+++.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL----RFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHhcCCH
Confidence 9999999876 4578899999999999999999999987776555555554322 2223468999999999999999
Q ss_pred CCCCCH---HHHhcCccc
Q 013816 301 KRRLTA---QQVLEHPWL 315 (436)
Q Consensus 301 ~~Rps~---~e~l~h~~~ 315 (436)
++||++ .++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=347.35 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=203.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
....+|+.++.||+||||.||+|+.+-+|+.||||+|.... +......+.+|+..|++| +|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence 34567889999999999999999999999999999997654 344567799999999999 999999998533110
Q ss_pred --------------------------------------------------------------------------------
Q 013816 129 -------------------------------------------------------------------------------- 128 (436)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (436)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHH
Q 013816 129 ------------------------------------TAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171 (436)
Q Consensus 129 ------------------------------------~~~~lv~E~~~g~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~ 171 (436)
..+||-||||+.-+|.+++..+... ....+++++++|++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 1268999999986666666555433 477899999999999999
Q ss_pred HHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-------------------CCCcccccccCCcccchhccc-
Q 013816 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------------------PGEKFSEIVGSPYYMAPEVLK- 231 (436)
Q Consensus 172 lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~l~- 231 (436)
+|+.|||||||||.||+++. ...|||+|||+|+... +....+..+||.-|+|||++.
T Consensus 713 IH~~giIHRDLKP~NIFLd~---~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDS---RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCceeeccCCcceeEEcC---CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999999999999999974 4449999999998721 011345679999999999986
Q ss_pred -c--cCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHH
Q 013816 232 -R--NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (436)
Q Consensus 232 -~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~ 307 (436)
. .|+.|+|||||||||+||+ .||....+ ...+..+.++.+..+...+..--+.-..+|.+||+.||.+||||.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 2 5999999999999999999 46754433 334455555555444323344456678899999999999999999
Q ss_pred HHhcCccccc
Q 013816 308 QVLEHPWLQN 317 (436)
Q Consensus 308 e~l~h~~~~~ 317 (436)
|+|++.||..
T Consensus 867 eLL~s~llpp 876 (1351)
T KOG1035|consen 867 ELLNSELLPP 876 (1351)
T ss_pred HHhhccCCCc
Confidence 9999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=334.42 Aligned_cols=258 Identities=30% Similarity=0.535 Sum_probs=236.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+++++..||-||||.|-++........+|+|++++.++-...+.+.+..|-.+|..+ +.|.||++|..|.++.++|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhh
Confidence 4577888899999999999987665566999999999888877888999999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||-|-||.|+..+..++.+.+..++-++..+++|+.|||++|||.|||||+|.+++. .+.+||.|||+|+.+..+..
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~---~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN---RGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc---CCceEEeehhhHHHhccCCc
Confidence 999999999999999999999999999999999999999999999999999999964 45589999999999999999
Q ss_pred ccccccCCcccchhcc-cccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
+.+.+|||.|.|||++ ++..+.++|.||||+++|||++|.+||.+.++...++.|+++.-....+ ..++..+.+||+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence 9999999999999985 5778999999999999999999999999999999999999987544333 468899999999
Q ss_pred HccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 294 KMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
++...+|.+|.. +.++-+|.||...
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 999999999985 8999999999753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=324.87 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=203.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..+|++.+.||+|+||.||+|.+..++.. ||+|.+... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-
Confidence 35799999999999999999998766654 899988543 2233456788999999999 999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~---~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC---CCcEEEcccccccc
Confidence 577999999999999999874 45889999999999999999999999999999999999964 34589999999987
Q ss_pred cCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
....... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+... +.......+ ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~--~~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLP--QPPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCC--CCCC
Confidence 6543322 1223466899999876 568999999999999999997 999998776655433 333322222 2245
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.++.+++.+||..+|.+|||+.+++.+
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 78899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.02 Aligned_cols=246 Identities=22% Similarity=0.373 Sum_probs=206.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|+++++||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++.+...+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEE
Confidence 367999999999999999999864 56789999875432 2357889999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ...++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE---SLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC---CCcEEECCCccceecCC
Confidence 99999999999998653 45788999999999999999999999999999999999964 44589999999987643
Q ss_pred CCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... ....++..|+|||.+. +.++.++||||||+++|+|+| |..||...........+.... ..+....++.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPDE 232 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence 3211 2234567899999876 568889999999999999998 999998877766666655432 22233467899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+++.+||..+|++|||+.++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.41 Aligned_cols=257 Identities=31% Similarity=0.537 Sum_probs=213.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|.....||+|+||.||++.+..+++.||+|.+... .......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEE
Confidence 3455567899999999999999999999999987543 223456789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 96 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEcccccceecccccc
Confidence 999999999887644 468999999999999999999999999999999999999643 458999999887654322
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...........+..... ........++..+.+++
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 250 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFL 250 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHH
Confidence 223456889999999876 4678999999999999999999999987766555444433222 12222346789999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+||+.+|.+||++.+++.||||.....
T Consensus 251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 251 DRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 9999999999999999999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=313.41 Aligned_cols=243 Identities=25% Similarity=0.386 Sum_probs=208.3
Q ss_pred cccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 61 RELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.+ +|+||+++++++.....+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence 4699999999999998866 8999999987653322 467899999999999 799999999999999999999999
Q ss_pred cCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 138 CEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 138 ~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---LVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---CcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999654 5589999999987
Q ss_pred cCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+.... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY---RLPKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCcc
Confidence 65432 223456788999999876 468899999999999999999 699998887777766666532 1222346
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++++.+++.+||+.+|.+|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 78999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=324.47 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=205.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC-----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD----- 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~----- 128 (436)
.++|++.+.||+|+||.||+|.+..+++.+|+|++........ ....+.+|+++++.+ +||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 4789999999999999999999999999999999865433222 234567899999999 899999999887443
Q ss_pred ---CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 129 ---TAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..+++||||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++. .+.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~---~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN---QGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEECcCc
Confidence 357999999975 67666654 347999999999999999999999999999999999999965 4458999999
Q ss_pred cccccCCCCc------------ccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 013816 205 LSVFFKPGEK------------FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (436)
Q Consensus 205 ~a~~~~~~~~------------~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~ 270 (436)
++........ .....+++.|+|||.+.+ .++.++||||||+++|+|++|++||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976543211 123467889999998753 47889999999999999999999998777765555544
Q ss_pred HccccCCCC--------------------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 271 RSVLDFRRD--------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 271 ~~~~~~~~~--------------------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
......... .+...++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 322111100 012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.43 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=209.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+.|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+..|+.++.++.+||||+++++++......|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3679999999999999999999998899999999875432 22345667788877777579999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++. +..+||+|||++.....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~---~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA---SGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC---CCCEEECccccchhccC
Confidence 9999854 67666654 4578999999999999999999997 59999999999999964 44599999999976654
Q ss_pred CCcccccccCCcccchhcccc-----cCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccCCCCCCcccC
Q 013816 212 GEKFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
........+++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .+....+....... ......++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 246 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS-LPPNEGFS 246 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC-CCCCCCCC
Confidence 443444567889999998753 278899999999999999999999965432 23333333332111 11122478
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.++.+|+.+||+.||.+||++.+++.||||.....
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 89999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.78 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=208.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
-.++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 357899999999999999999997643 3789999886532 233456788999999999779999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~ 191 (436)
.+.++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 99999999999999999998642 35789999999999999999999999999999999999964
Q ss_pred CCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 013816 192 KKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVA 266 (436)
Q Consensus 192 ~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 266 (436)
...+||+|||+++....... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 168 ---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 168 ---DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred ---CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 44589999999987644321 12233457899999875 568999999999999999997 99999888777666
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+..... .......+.++.+|+.+||..||++|||+.+++++
T Consensus 245 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 66554432 12224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.06 Aligned_cols=149 Identities=31% Similarity=0.501 Sum_probs=136.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.++..+ +||||+++++++.....+|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999766554555567889999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
|||+.|++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++. .+.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~---~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN---EGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC---CCCEEEEeCCCCc
Confidence 999999999999988888999999999999999999999999999999999999964 4469999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=327.09 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=209.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 45688999999999999999999999999999999986532 2223356788899999999 899999999988543
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|++++++ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGL 166 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---CCEEEecccc
Confidence 4578888887 7799877754 469999999999999999999999999999999999999654 4599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc---------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--------- 274 (436)
+..... ......+|..|+|||.+.+ .++.++|||||||++|+|++|..||...........+.....
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 876532 3344578899999998753 578899999999999999999999977665444333322110
Q ss_pred --------------cCCC----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 275 --------------DFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 275 --------------~~~~----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..+. ..+...++++.++|.+||+.||.+|||+.+++.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 011235788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.44 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=207.7
Q ss_pred cceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.+ +||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence 5799999999999999999998654 4579999886542 233456788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++. ...++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~---~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC---CCCEEECccchhhccc
Confidence 9999999999999998764 46899999999999999999999999999999999999964 4458999999998764
Q ss_pred CCCc-c--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 211 PGEK-F--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 211 ~~~~-~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.... . ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..... .+....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR---LPPPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 2211 1 1223457899999886 568999999999999999998 9999988777766666654321 12224578
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=324.95 Aligned_cols=259 Identities=32% Similarity=0.488 Sum_probs=207.9
Q ss_pred ceeeccccccCCceEEEEEEEcCC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----CC
Q 013816 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 129 (436)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ......+.+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986432 2222356778899999999679999999987532 25
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+++||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---CCEEeCcCCCceec
Confidence 6789999986 5899999888889999999999999999999999999999999999999653 45899999999865
Q ss_pred CCCC-----cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc--------
Q 013816 210 KPGE-----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------- 274 (436)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-------- 274 (436)
.... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 1234578999999998653 578999999999999999999999977654443333222110
Q ss_pred ---------------cCC----CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 275 ---------------DFR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 275 ---------------~~~----~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+ ...++..+..+.+++.+||+.||++|||+.+++.|||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000 011235688999999999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.57 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=214.8
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+|++.+.||+|++|.||++.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++.+++.....+++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence 588999999999999999999999999999998765432 33456788899999999 8999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 136 ELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 136 E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~---~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec---CCcEEEeeccchhhhcc
Confidence 99999999998866 356899999999999999999999999999999999999975 34589999999987654
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ......+++.|+|||.+. ..++.++|+||||+++|+|++|+.||...+.......+....... .....+.++++
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---IPPIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---CchhhCHHHHH
Confidence 4 333456889999999976 457889999999999999999999998887766655554433221 12357889999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCccc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
++.+||+.+|++|||+.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.30 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=206.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence 46899999999999999999997644 3789999975432 223446788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 129 TAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~---~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED---LTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC---CCE
Confidence 99999999999999999986532 36778899999999999999999999999999999999654 458
Q ss_pred EEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc
Q 013816 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 199 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 273 (436)
||+|||+++....... .....++..|+|||.+. +.++.++|||||||++|+++| |..||...+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 22345678899999876 568999999999999999998 999998877776666555332
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
. .......+.++.+++.+||+.+|++|||+.++++
T Consensus 239 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 H---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 1122346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=320.37 Aligned_cols=260 Identities=33% Similarity=0.564 Sum_probs=209.1
Q ss_pred ceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
+|++.+.||+|++|.||+|++. .++..||+|++.+.... .....+.+.+|+.++.++.+||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 46789999998754322 1223456889999999997799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||+.|++|.+.+.....+++..+..++.|++.+|.|||+.+++||||+|+||+++. ...++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS---EGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC---CCCEEEEECcccccccc
Confidence 999999999999999988778999999999999999999999999999999999999964 34589999999876543
Q ss_pred CCc--ccccccCCcccchhccccc---CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 GEK--FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
... .....|+..|+|||.+.+. .+.++||||||+++|+|++|..||...........+.+............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 1234688999999987632 67899999999999999999999964332211122222211222223345789
Q ss_pred HHHHHHHHccCCCcCCCCC---HHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLT---AQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps---~~e~l~h~~~~~~ 318 (436)
.+.+++.+||+.+|++||| +.++|+||||+..
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 9999999999999999998 5677999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=312.15 Aligned_cols=241 Identities=24% Similarity=0.319 Sum_probs=199.7
Q ss_pred ccccCCceEEEEEEE--cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 62 ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
+||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++. ...+++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCC
Confidence 689999999999965 4567899999986443 2334567889999999999 9999999999875 456789999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc----
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---- 215 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~---- 215 (436)
+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC---CCeEEECCCccccccCCCCCeeeec
Confidence 9999999988788999999999999999999999999999999999999964 345899999999866433221
Q ss_pred cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.++.. ......+++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHH
Confidence 2223457899999876 468889999999999999998 9999988777666666554322 1223468999999999
Q ss_pred HccCCCcCCCCCHHHHhc
Q 013816 294 KMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 294 ~~l~~~p~~Rps~~e~l~ 311 (436)
+||+.||++||++.++..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.07 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=206.9
Q ss_pred ccccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
...++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 34578999999999999999999852 345689999886542 23345678999999999977999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+++|+|+||||+||+++. ...++|+|||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~dfg 186 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---GKIVKICDFG 186 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC---CCeEEECCCc
Confidence 9999999999999999999987643 3899999999999999999999999999999999999964 4458999999
Q ss_pred cccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 205 LSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 205 ~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
++........ .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||................... .
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~ 264 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--A 264 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--C
Confidence 9976543221 12234577899999876 568899999999999999998 999998766555444444332221 2
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.....++++.+++.+||+++|++|||+.+++.
T Consensus 265 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 22357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.26 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=205.8
Q ss_pred ccceeeccccccCCceEEEEEEEcC-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4789999999999999999998643 23579999986542 23345678899999999978999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
..+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999997642 378889999999999999999999999999999999996
Q ss_pred cCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
.+ ..+||+|||++........ .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+.
T Consensus 175 ~~---~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 175 ED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred CC---CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 43 4599999999876543221 11223456899999876 458899999999999999998 8899987776665
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
...+.... .......++.++.+++.+||..+|++|||+.+++++
T Consensus 252 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 252 FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55554432 112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=319.36 Aligned_cols=253 Identities=32% Similarity=0.548 Sum_probs=209.7
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++...+.+++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence 56788999999999999999989999999998765432 23456788999999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 013816 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-~ 214 (436)
|+++ +|.+.+... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++. .+.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT---EGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC---CCcEEEeeeeeeEecCCCccc
Confidence 9976 888877664 57899999999999999999999999999999999999964 3459999999997765443 2
Q ss_pred ccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC--------------
Q 013816 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 278 (436)
.....++..|+|||.+. . .++.++||||||+++|+|+||+.||...+..+....+.........
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 33456888999999875 3 5788999999999999999999999877765544444332111000
Q ss_pred ------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 279 ------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..++.++.++.++|.+||++||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=318.07 Aligned_cols=249 Identities=21% Similarity=0.335 Sum_probs=206.7
Q ss_pred cceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++..+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence 4688999999999999999987543 5789999986442 223356788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~-- 159 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD-- 159 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC--
Confidence 999999999999999988532 24788889999999999999999999999999999999964
Q ss_pred CCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
...+||+|||+++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus 160 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 -KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred -CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 34589999999876543221 22345678999999875 668999999999999999998 8889988877777666
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+....... ....++..+.+|+.+||+.+|.+||++.+++..
T Consensus 239 i~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IRNRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHcCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66554321 224688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=312.03 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=203.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEE
Confidence 35889999999999999999875 567899999864332 235688899999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++..+ ..+++..+..++.|++.||.|||+.|++||||||+||+++. .+.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE---DNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC---CCcEEECCcccceeccccc
Confidence 9999999999998764 46899999999999999999999999999999999999964 4458999999987654322
Q ss_pred cc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+..... .......+.++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR---LYRPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCCHHHH
Confidence 11 1122345799999876 568999999999999999999 8999987776666555544321 122245789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+||..+|++|||+.++++.
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=316.16 Aligned_cols=245 Identities=28% Similarity=0.454 Sum_probs=200.0
Q ss_pred eeccccccCCceEEEEEEEc----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 58 ELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|++.++++ +||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 45688999999999999987 45678999998442 3344578899999999999 99999999999998888999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++|+|.+++... ..+++..+..|+.||+.||.|||+++++|+||+++||+++.++ .+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~---~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG---QVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT---EEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc
Confidence 99999999999999886 6799999999999999999999999999999999999997544 599999999987632
Q ss_pred CCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 GEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
... .....+...|+|||.+. ..++.++||||||+++||+++ |..||......+....+.+... ......++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---LPIPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---TTSBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ceeccchhH
Confidence 221 13345667899999986 458999999999999999999 7899988888777777744432 122245789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.++|..||..+|++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=326.97 Aligned_cols=258 Identities=29% Similarity=0.514 Sum_probs=208.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
+.++|.+...||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence 45789999999999999999999999999999999865422 222345678999999999 999999999998654
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
..+++|+||+.+ +|...+ ...+++..+..++.|++.||.|||+.|++||||||+||+++. .+.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~---~~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE---DCELKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCCCC
Confidence 356999999964 676654 236899999999999999999999999999999999999965 445999999998
Q ss_pred cccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc----------
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------- 274 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---------- 274 (436)
..... ......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 76532 2334577899999998753 478899999999999999999999987765544443332110
Q ss_pred -------------cCCCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 275 -------------DFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 275 -------------~~~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..... .++..++++.+||.+||+.||++||++.+++.||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00111 12356788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.85 Aligned_cols=253 Identities=33% Similarity=0.553 Sum_probs=208.1
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||+|++|+||+|....+++.||+|.+...... .......+|+..++++.+||||+++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999889999999998654321 1233456799999999339999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++. .+.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~---~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC---CCCEEEeecccceeccCCCC
Confidence 99 779999887764 6899999999999999999999999999999999999965 45589999999987765444
Q ss_pred ccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC--------------
Q 013816 215 FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 278 (436)
.....++..|+|||++. ..++.++|+||||+++++|++|..||...........+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567899999999874 34789999999999999999999999777655544433321111000
Q ss_pred ------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 279 ------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
...+..+.++.+++.+||+.+|++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0012346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=313.12 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=197.4
Q ss_pred cccccCCceEEEEEEEcCCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.++.++.+||||+++++++...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 4677877532 223345678899999999978999999999999999999999999
Q ss_pred CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 139 EGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 139 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. ...+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~---~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC---CCeEEECC
Confidence 9999999987542 3788999999999999999999999999999999999964 44589999
Q ss_pred eccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||.+.+..+....+.... ....
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence 99986432111112223356799999876 568899999999999999997 999998777666655554321 1122
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...++.++.+++.+||+.+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=321.03 Aligned_cols=261 Identities=32% Similarity=0.515 Sum_probs=209.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-CCe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTA 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~ 130 (436)
.+.++|++.+.||.|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCc
Confidence 457889999999999999999999999999999998865432 223456788999999999 89999999999865 567
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.++||||+ +++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||+++. .+.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~---~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE---NCDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC---CCCEEeCccccccccC
Confidence 89999999 5688877754 46889999999999999999999999999999999999964 4559999999987543
Q ss_pred CCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc--------------
Q 013816 211 PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------------- 274 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~-------------- 274 (436)
. ......+++.|+|||.+.+ .++.++||||||+++|+|+||..||...........+.+...
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 2234567889999998753 588999999999999999999999977654332221111000
Q ss_pred ------cC---CC----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccC
Q 013816 275 ------DF---RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321 (436)
Q Consensus 275 ------~~---~~----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 321 (436)
.. .. ...+.+++++.++|.+||+.+|++|||+.+++.||||......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00 00 1123568899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.75 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 61 RELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.+ +||||+++++++. .+.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEe
Confidence 46999999999999876555 78999998765432 3456789999999999 8999999999876 4568999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc--
Q 013816 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF-- 215 (436)
Q Consensus 138 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~-- 215 (436)
+++++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.+ ..+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---CcEEeccccccceeecCCcccc
Confidence 9999999999888789999999999999999999999999999999999999654 45899999999866443321
Q ss_pred --cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 216 --SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 216 --~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
....++..|+|||.+. ..++.++||||||+++|+|++ |..||......+....+..... ......++..++++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence 1112346799999876 568899999999999999998 9999987776655555544321 22334678999999
Q ss_pred HHHccCCCcCCCCCHHHHhc
Q 013816 292 VRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+||..+|++|||+.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=318.42 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=205.2
Q ss_pred ccceeeccccccCCceEEEEEEEcC-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 4689999999999999999998632 34579999886432 23345678899999999967999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
..+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999653 2478889999999999999999999999999999999996
Q ss_pred cCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
.+ +.+||+|||+++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.+....+.
T Consensus 169 ~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 ED---NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CC---CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 43 4599999999986543221 11223446799999876 568899999999999999999 8999988777666
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+..... ......++.++++++.+||+.+|++|||+.++++
T Consensus 246 ~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 665554321 1223467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=316.26 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=205.6
Q ss_pred cceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence 46899999999999999999854 34567889887543 233456789999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 130 AVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
..++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~- 159 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN- 159 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence 9999999999999999997542 37889999999999999999999999999999999999653
Q ss_pred CCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
..++|+|||++........ .....++..|+|||++. ..++.++||||||+++|+|+| |..||......+....
T Consensus 160 --~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 160 --LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred --CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4599999999976543221 12345678899999876 568899999999999999999 9999988777666665
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+..+.... .....+..+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55443321 223568899999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=313.82 Aligned_cols=248 Identities=20% Similarity=0.273 Sum_probs=203.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.++|++.+.||+|+||+||+|.+..+++ .||+|.+.... .......+.+|+.+++.+ .||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-C
Confidence 3579999999999999999999877776 48999886432 233456788999999999 89999999999875 4
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++++||+++|+|.+.+... +.+++..+..++.|++.||.|||+++|+||||||+|||++++ ..+||+|||+++.
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~---~~~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP---NHVKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCCCceee
Confidence 577999999999999999764 568999999999999999999999999999999999999643 4489999999987
Q ss_pred cCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
....... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||...........+.... .. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RL--PQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cC--CCCcc
Confidence 6533221 1223467899999876 568999999999999999998 899997766655544443322 11 22346
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.++.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=313.00 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=203.0
Q ss_pred eeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe---
Q 013816 57 YELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA--- 130 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~--- 130 (436)
|++.+.||+|+||.||+|.+..+ +..||+|.+..... .......+.+|+..++.+ +||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 56789999999999999997653 47899999875432 334567899999999999 89999999998765544
Q ss_pred ---EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 131 ---VHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 131 ---~~lv~E~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ...+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE---DMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC---CCeEEEC
Confidence 79999999999999888542 35899999999999999999999999999999999999964 3458999
Q ss_pred eeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccC
Q 013816 202 DFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 202 DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
|||+++........ ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL- 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 99999866433221 1223467899999986 468899999999999999999 99999887777666666544321
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.....++.++.+++.+||+.||++|||+.+++++
T Consensus 235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=310.25 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=205.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence 467999999999999999999964 467899999865432 346788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+.|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN---NICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---CCEEECCcceEEEccC
Confidence 999999999999997654 68999999999999999999999999999999999999654 4589999999987653
Q ss_pred CCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... .....+..|+|||.+. ..++.++||||||+++|+|+| |+.||.+.........+..... .......+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR---MPCPPGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHH
Confidence 2111 1122245799999876 568899999999999999999 9999988777666665544321 1223457899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.62 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=208.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
..+|++.+.||.|+||.||+|.+.. +..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence 4579999999999999999999877 8999999986543 22356788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---LVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---ceEEEccccchhhcCC
Confidence 99999999999999753 358999999999999999999999999999999999999653 4589999999976643
Q ss_pred CCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 212 GEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 212 ~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.... ........++.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 233 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY---RMPCPAKCPQEI 233 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC---cCCCCCCCCHHH
Confidence 221 12334567899999876 568899999999999999998 899998877776666665432 222235688999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+++.+||+.+|.+|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=316.36 Aligned_cols=253 Identities=30% Similarity=0.540 Sum_probs=209.9
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|++.+.||+|++|.||+|++..+++.+|+|.+..... .....+.+.+|+.+++.+ +||||+++++++.+.+.+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence 5677889999999999999999999999999876542 222346778899999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-c
Q 013816 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (436)
Q Consensus 137 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-~ 214 (436)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++. .+.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~---~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---CCCEEEecCCcccccCCCccc
Confidence 9975 899999876 57999999999999999999999999999999999999965 4558999999987664332 2
Q ss_pred ccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC----------------
Q 013816 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------------- 276 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~---------------- 276 (436)
.....++..|+|||.+. . .++.++||||||+++|+|++|..||......+....+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 33445678899999875 3 68889999999999999999999998877655544443311100
Q ss_pred --C-------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 277 --R-------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 277 --~-------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+ ...++..+..+.++|.+||+.+|++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 01123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=316.34 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=201.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC--------------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCcee
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG--------------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--------------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv 119 (436)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+++++++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~ 80 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNII 80 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcC
Confidence 368999999999999999999875432 358999986542 233456789999999999 999999
Q ss_pred EEEEEEEeCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 013816 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARG------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (436)
Q Consensus 120 ~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NI 187 (436)
++++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886532 367888999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh--CCCCCCCCC
Q 013816 188 LFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAET 261 (436)
Q Consensus 188 l~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt--g~~pf~~~~ 261 (436)
+++. ...+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++ |..||....
T Consensus 161 ll~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVGN---HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEcC---CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9964 34589999999976543221 12234567899999875 568999999999999999988 678887766
Q ss_pred HHHHHHHHHHcc----ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 262 EQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 262 ~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.......+.... ........+..++.+.+|+.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 655544433211 11111223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=313.05 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=200.8
Q ss_pred eeeccccccCCceEEEEEEEcCCCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe------C
Q 013816 57 YELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------D 128 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------~ 128 (436)
|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+.+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 3567889999999999999877775 68999886542 2344567889999999999 89999999997642 2
Q ss_pred CeEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 129 TAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
...+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ...+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE---NMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC---CCCEEECC
Confidence 3578999999999999887431 34789999999999999999999999999999999999954 45589999
Q ss_pred eccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCC
Q 013816 203 FGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 203 fG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
||+++........ ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..+..
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 232 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--- 232 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 9999876433221 2234567899999986 468999999999999999999 8999988777666665554332
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....+.++..+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=310.95 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=206.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 579999999999999999999865543 79999886532 233456889999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++. ...++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~---~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC---CCeEEeCCCCcccccc
Confidence 9999999999999999765 46899999999999999999999999999999999999964 4458999999998764
Q ss_pred CCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+.+.. . .+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-R--LPAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-c--CCCCCCC
Confidence 33211 1122356899999987 568999999999999999886 999998877766666665432 1 2223457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=310.20 Aligned_cols=245 Identities=23% Similarity=0.329 Sum_probs=202.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+++++.+ +||||+++++.+. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEE
Confidence 46799999999999999999998655 4699999865332 235789999999999 8999999999875 456899
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ...++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~---~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC---CCcEEeccCCceeeccc
Confidence 99999999999999763 35789999999999999999999999999999999999964 44589999999976643
Q ss_pred CCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... ....++..|+|||++. +.++.++||||||+++|+|+| |..||.+....+....+..... ......++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHH
Confidence 3221 2334567899999875 568999999999999999999 8889987777666655544321 1222467899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+++.+||+.+|++||++.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.03 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=204.8
Q ss_pred cceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.+|++.++||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.+ +||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence 57889999999999999999743 34678999987543 234457899999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC
Q 013816 130 AVHLVMELCEGGELFDRIVARG---------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~ 194 (436)
.++++|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~--- 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ--- 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC---
Confidence 9999999999999999987642 4788999999999999999999999999999999999964
Q ss_pred CCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 013816 195 TAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 269 (436)
Q Consensus 195 ~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i 269 (436)
...+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 45599999999875543221 12234567899999876 568999999999999999998 99999877776666655
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
..... ......+++.+.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCcc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54432 1222467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=323.74 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=199.2
Q ss_pred ccceeeccccccCCceEEEEEEE-----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-
Q 013816 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~- 127 (436)
.++|++.+.||+|+||.||+|.+ ..+++.||||.+.... .......+.+|+.++.++.+||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 36899999999999999999985 3567899999986543 223456788999999999778999999998765
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~--------------------------------------------------------- 150 (436)
...+++||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45678999999999999988642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccc
Q 013816 151 ----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSE 217 (436)
Q Consensus 151 ----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~ 217 (436)
..+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC---CCcEEEEecccccccccCcchhhcCC
Confidence 13567788899999999999999999999999999999964 44599999999876532221 122
Q ss_pred cccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHc
Q 013816 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (436)
Q Consensus 218 ~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~ 295 (436)
..+++.|+|||.+. ..++.++||||||+++|+|++ |..||..................... ....++++.+++..|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC--CCCCCHHHHHHHHHH
Confidence 34567899999875 568999999999999999997 99999765433322222222222111 124678999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 013816 296 LDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 296 l~~~p~~Rps~~e~l~h 312 (436)
|+.+|++|||+.++++|
T Consensus 319 l~~~p~~Rps~~eil~~ 335 (343)
T cd05103 319 WHGEPSQRPTFSELVEH 335 (343)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=320.13 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=199.1
Q ss_pred eeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
.+++.+|.| |.||.+++..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..+++|||
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEec
Confidence 344444444 5566666667899999999976532 334667899999999999 899999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 013816 138 CEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (436)
Q Consensus 138 ~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-- 213 (436)
+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeecccccc
Confidence 9999999998763 458999999999999999999999999999999999999754 458999999886553221
Q ss_pred ------cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC--------
Q 013816 214 ------KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------- 276 (436)
Q Consensus 214 ------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------- 276 (436)
......++..|+|||++.. .++.++|||||||++|+|++|..||..............+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 1133457788999999853 47889999999999999999999997665443332222211000
Q ss_pred ----------------------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 ----------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 ----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.......++.++.+|+.+||+.||++|||+.++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000012346788999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=311.62 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=200.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++|++.+.||+|+||+||+|.+..+++. +++|.+.... ......++..|+..++++ +||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCc
Confidence 5799999999999999999999877764 6677664321 223346788888899999 8999999999875 455
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++++||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++. ...+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~---~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEEcCCccceec
Confidence 78999999999999999764 56899999999999999999999999999999999999964 445899999999865
Q ss_pred CCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.+.........+..+.. .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LA--QPQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CC--CCCCC
Confidence 43321 23345677899999976 568999999999999999998 9999987776655444433221 11 12346
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.++.+++.+||..+|++|||+.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7889999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=316.24 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=207.9
Q ss_pred ccccceeeccccccCCceEEEEEEEc-------CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 124 (436)
...++|.+.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+++.+.+||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 34578999999999999999999753 234579999886432 233457789999999999789999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 013816 125 YEDDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (436)
Q Consensus 125 ~~~~~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl 188 (436)
+......|+||||+++++|.+++... ..++...+..++.||+.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998764 23677889999999999999999999999999999999
Q ss_pred eecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHH
Q 013816 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (436)
Q Consensus 189 ~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 263 (436)
++. .+.+||+|||+++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.+..
T Consensus 170 i~~---~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 170 VTE---NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EcC---CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 964 44589999999986643221 12234567899999876 458999999999999999998 88999888777
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+....+..... ......++.++.+++.+||+.+|.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 76666554322 11224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=313.85 Aligned_cols=258 Identities=28% Similarity=0.492 Sum_probs=231.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
..+|..+.+||+|+||.|-+|..+.+.+.+|||++++..+-...+.+--..|-++|....+.|.++++..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 35789999999999999999999999999999999888776666666667788888888788999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc-CCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~-~~~ 212 (436)
||||+.||+|--.+++-+.+.|..+.-++..|+.||-+||++|||.||||.+|||++. .++|||+|||+++.- -.+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~---eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc---CCceEeeecccccccccCC
Confidence 9999999999999999999999999999999999999999999999999999999964 456999999999743 334
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
....+.+|||.|+|||++. ++|+.++|.||+||+||||+.|++||.+.++.++.+.|......++ ..+|.++.++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHH
Confidence 5567889999999999986 7899999999999999999999999999999999999998776654 4689999999
Q ss_pred HHHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
.+.+|.+.|.+|.. -.++-.||||+..
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 99999999999974 4789999999753
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=313.62 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=202.0
Q ss_pred ceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 56 RYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence 47889999999999999998753 23568888876432 233457889999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013816 131 VHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 186 (436)
.+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 247788999999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCC
Q 013816 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (436)
Q Consensus 187 Il~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 261 (436)
|+++. ...+||+|||+++....... .....++..|+|||.+. ..++.++||||||+++|+|+| |..||.+..
T Consensus 158 ill~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAE---GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcC---CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99964 34599999999976533221 12234567899999875 458899999999999999998 999998877
Q ss_pred HHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.......+... . .......++.++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~-~--~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTG-Y--RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCC-C--CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655544332 2 12223467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=308.63 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=202.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.+++++ +||||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcE
Confidence 3468999999999999999999865 567799999865432 235789999999999 8999999999875 45688
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ...++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~---~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC---CceEEeCCceeeeecc
Confidence 999999999999998753 35899999999999999999999999999999999999964 4458999999997654
Q ss_pred CCCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+.... ..+.....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCH
Confidence 33221 1234556799999876 568899999999999999999 899998877766666655432 1222345789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.+|+.+||..+|++|||+.++++
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=307.66 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=205.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEE
Confidence 56899999999999999999864 89999999865422 457889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. .+.+||+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~---~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE---DLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC---CCCEEEcccccccccccc
Confidence 99999999999998765 6899999999999999999999999999999999999964 445899999999876322
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.... ........++++.+
T Consensus 156 ~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 230 (256)
T cd05039 156 Q--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---RMEAPEGCPPEVYK 230 (256)
T ss_pred c--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CCCCccCCCHHHHH
Confidence 2 2334456799999876 568889999999999999997 999998877766555554432 12222457899999
Q ss_pred HHHHccCCCcCCCCCHHHHhcC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.+||..+|++|||+.++++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=312.16 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=195.5
Q ss_pred cce-eeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--
Q 013816 55 ERY-ELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-- 127 (436)
Q Consensus 55 ~~y-~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 127 (436)
++| ++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+++++++ +||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 455 999999999999998765 34568899999986542 223456788999999999 99999999998765
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN---DRLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC---CCcEEEeeccccc
Confidence 34689999999999999988764 5999999999999999999999999999999999999964 3458999999998
Q ss_pred ccCCCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH--H------------HHH
Q 013816 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--V------------AQA 268 (436)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~--~------------~~~ 268 (436)
........ ....++..|+|||.+. ..++.++||||||+++|+|+||..||......- . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 66433221 1234566799999876 568999999999999999999999985433210 0 000
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...... ........+.++.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011111 11112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=325.00 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=203.5
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|.+.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+|.++..||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 467999999999999999999964 345789999996542 2223457889999999994499999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 013816 129 TAVHLVMELCEGGELFDRIVARG--------------------------------------------------------- 151 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~--------------------------------------------------------- 151 (436)
+..++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986431
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 152 -----------------------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 152 -----------------------------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
.+++..+..++.||+.||.|||+.+++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256667888999999999999999999999999999996
Q ss_pred cCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
. ...+||+|||+++....... .....+++.|+|||.+. ..++.++||||||+++|||++ |..||......+.
T Consensus 274 ~---~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 274 E---GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred C---CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 4 44589999999976532221 12345678899999876 458899999999999999998 8999976655554
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......... ......++.++.+|+.+||+.+|.+||++.++++.
T Consensus 351 ~~~~~~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 351 FYNAIKRGYR--MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4443333222 22234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=309.84 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=205.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
..|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+..|+.+++.+ +||||+++++++..+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence 458999999999999999999877664 69999986532 333457899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++. ...+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~---~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC---CCcEEECCCccccccc
Confidence 9999999999999988764 56899999999999999999999999999999999999954 4459999999987654
Q ss_pred CCCcc---cccc---cCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 211 PGEKF---SEIV---GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 211 ~~~~~---~~~~---gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
..... .... .+..|+|||.+. +.++.++||||||+++|+|++ |..||+..........+... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---YRLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CcCCCcc
Confidence 32211 1111 235799999986 568999999999999999886 99999888777666665432 1222335
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.++..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.58 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=205.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.+ +||||+++.+++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCc
Confidence 468889999999999999999876654 79999886432 233456789999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++. ...+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC---CCcEEECCCccceecc
Confidence 9999999999999998764 56899999999999999999999999999999999999964 4458999999987654
Q ss_pred CCCcc--c--ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEKF--S--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~~--~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... . ....++.|+|||++. +.++.++|||||||++|+|++ |..||+..........+.... ..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCCC
Confidence 32211 1 112345799999876 568899999999999999997 999998887776666665432 22223457
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.++.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.92 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=219.8
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.-+++-...||.|.||.||.|.+..+|...|+|.|...... ....+.+.+|+.+|..+ +|||+|++|++-.+.+.
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHH
Confidence 34566788889999999999999999999999999998765544 34567789999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.+|.||||+||+|.+.+...+-.+|.....+..|+++|+.|||++|||||||||+||+++.++ .||++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---LIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC---cEEeecccceeEec
Confidence 999999999999999998777788889999999999999999999999999999999997544 69999999998876
Q ss_pred CCC-----cccccccCCcccchhcccc----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 211 PGE-----KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 211 ~~~-----~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
++. ......||+.|||||++.+ +...++|||||||++.||+||+.||...+.+-.+.--.... . .+...
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g-h-~Pq~P 1463 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG-H-KPQIP 1463 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-C-CCCCc
Confidence 542 2245789999999999863 35678999999999999999999997665543322211111 1 11222
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+|++.++||..||+.||++|.++.|+|+|.|-+..
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 3589999999999999999999999999999987654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.14 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=204.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|+++++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++++ +||||+++++++. .+.++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcE
Confidence 4578999999999999999999864 678899999865432 346788999999999 8999999999874 56789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ...++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE---TLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC---CCCEEEccCcceeecC
Confidence 999999999999988653 35889999999999999999999999999999999999964 4458999999997665
Q ss_pred CCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....++..|+|||++. ..++.++||||||+++|+|++ |+.||.+.+..+....+.... ........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---RMPRPDNCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC---CCCCCCCCCH
Confidence 3221 12334567899999986 568899999999999999999 999998877766655554432 1222345788
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.34 Aligned_cols=241 Identities=24% Similarity=0.316 Sum_probs=196.4
Q ss_pred ccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 62 ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++++ +||||++++++++ ...+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 4899999999999865 445679999886542 233456789999999999 9999999999886 457899999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---
Q 013816 140 GGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (436)
Q Consensus 140 g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~--- 215 (436)
+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++. ...+||+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN---QHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC---CCcEEeccCCccccccCCccceec
Confidence 9999998875 456899999999999999999999999999999999999964 445899999999765433221
Q ss_pred -cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 216 -SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 216 -~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
....+++.|+|||.+. +.++.++||||||+++|++++ |..||...........+..+.. .......++++.+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR---LDCPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHH
Confidence 1122357899999876 568899999999999999996 9999988877666555544332 122245789999999
Q ss_pred HHccCCCcCCCCCHHHHhcC
Q 013816 293 RKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h 312 (436)
.+||..+|++||++.++.+.
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999663
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.43 Aligned_cols=260 Identities=29% Similarity=0.534 Sum_probs=217.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-------
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE------- 126 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~------- 126 (436)
.+.|+-..+||+|.||.||+|+.+.+|+.||+|++-...-..... ....+|+++|..| +|+|++.+++.|.
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 356888899999999999999999999999999775433222222 3467899999999 9999999988764
Q ss_pred -eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 -DDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 -~~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+...+|+|+.+|+. +|.-++.+. -+++..++..++.+++.||.|+|+..|+|||+||+|+|++ ..+.+||+|||
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFG 169 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFG 169 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeeccc
Confidence 23568999999975 888888765 5699999999999999999999999999999999999995 44569999999
Q ss_pred cccccCCC-----CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 205 LSVFFKPG-----EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 205 ~a~~~~~~-----~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
+++.+... ..++..+-|.+|++||.+- ..|+++.|||..|||+.+|.||.+.+.+.+++..+..|..-.....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99766432 2345567799999999875 4699999999999999999999999999999988888876555555
Q ss_pred CCCCccc-------------------------------CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 278 RDPWPKV-------------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 278 ~~~~~~~-------------------------------~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+.||++ ++++.+|+.++|..||.+|+++.++|+|.||....
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 5555542 34778999999999999999999999999998643
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.92 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=206.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
...+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+++++++.+||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346799999999999999999986432 2368999876432 2334578899999999997799999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~ 189 (436)
...+..+++|||+++++|.+++.... .++...+..++.|++.||.|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999987532 36778889999999999999999999999999999999
Q ss_pred ecCCCCCCeEEEeeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHH
Q 013816 190 ANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (436)
Q Consensus 190 ~~~~~~~~ikl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 264 (436)
+.+ ..+||+|||+++........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 168 ~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 168 TED---NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred cCC---CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 643 45899999999865432211 2223456799999876 568899999999999999998 899998887777
Q ss_pred HHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....+..... .......+.++.+++.+||+.+|++|||+.+++++
T Consensus 245 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6666654322 12224578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.62 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=202.2
Q ss_pred cccccCCceEEEEEEEcC-CCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 61 RELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+.||+|++|.||+|.+.. +++ .||+|.+...... ...+.+.+|+.+++++ +||||+++++.+.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 333 6999998765443 4567899999999999 89999999999988 889999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-
Q 013816 138 CEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (436)
Q Consensus 138 ~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~- 214 (436)
+++++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccc
Confidence 99999999997764 68999999999999999999999999999999999999754 4599999999987644221
Q ss_pred ---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 215 ---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 215 ---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+........ .....+..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 12345678899999886 568999999999999999998 9999987777766666554222221 1235789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++.+||+.+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=311.09 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=207.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
+|.+.+.||+|+||.||++.+..++..+++|.+...... .......+.+|+.+++.+ +||||+++++++.+...+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 589999999999999999999887777777766543221 122334577899999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
||||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ..++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999988753 346899999999999999999999999999999999999963 24899999998766
Q ss_pred CCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
..... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+...... .....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence 43322 23456889999999876 45788999999999999999999999776665555544433211 112357889
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
+.++|.+||+.+|++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.22 Aligned_cols=241 Identities=24% Similarity=0.373 Sum_probs=200.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE-EeCCeEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY-EDDTAVHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~~~~~l 133 (436)
.+|++.+.||+|+||.||++... |..+|+|.+.... ..+.+.+|+.+++++ +|||++++++++ ...+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999754 8889999875331 346788999999999 899999999975 45567899
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC---CCcEEecCCccceeccc
Confidence 999999999999997654 3789999999999999999999999999999999999964 34589999999876533
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |..||...........+.... .....+.+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCCHHHH
Confidence 22 2334566899999876 458899999999999999997 999998777766655554432 2223356789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++.+||+.+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=306.13 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=201.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.+ +|||++++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEE
Confidence 36799999999999999999987654 4699998764322 236788999999999 8999999999875 456889
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~---~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD---NLVCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCeEEECCCccceEccC
Confidence 999999999999997642 4789999999999999999999999999999999999964 44589999999976543
Q ss_pred CCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... ....++..|+|||.+. +.++.++||||||+++|+|+| |..||.+....+....+.... ........+..
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---RMPCPQGCPES 231 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHH
Confidence 3211 2234567899999876 568899999999999999999 999998877766666554432 12223467899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+++.+||+.||++||++.++++
T Consensus 232 ~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 232 LHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.83 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=205.2
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence 467999999999999999999874 367899999986432 233456789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013816 129 TAVHLVMELCEGGELFDRIVARG----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 186 (436)
..+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36788899999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCC
Q 013816 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (436)
Q Consensus 187 Il~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~ 261 (436)
|+++. .+.++|+|||++........ .....++..|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGE---NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecC---CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99964 44589999999876532221 12234466799999876 568999999999999999997 889998877
Q ss_pred HHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
..+....+..+... .....++.++.+|+.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77666665544321 112357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=312.02 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=200.6
Q ss_pred ccceeeccccccCCceEEEEEEEcC----------------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 117 (436)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence 4679999999999999999986432 34578999986542 233456889999999999 8999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013816 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (436)
Q Consensus 118 iv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 186 (436)
|+++++++...+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999987642 36678899999999999999999999999999999
Q ss_pred eEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh--CCCCCCCC
Q 013816 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (436)
Q Consensus 187 Il~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt--g~~pf~~~ 260 (436)
|+++. ...++|+|||++........ .....+++.|+|||... +.++.++|||||||++|+|++ |..||...
T Consensus 161 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGK---NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcC---CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99964 44589999999976543221 12233467899999754 678999999999999999998 78899776
Q ss_pred CHHHHHHHHHH---cc-ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 261 TEQGVAQAIIR---SV-LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 261 ~~~~~~~~i~~---~~-~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+....... .. .....+....+++.+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 66554433321 10 11111122457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.44 Aligned_cols=246 Identities=27% Similarity=0.398 Sum_probs=207.5
Q ss_pred eeeccccccCCceEEEEEEEcCCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+++.+.||.|+||.||+|.+..++ ..||+|.+..... ....+.+..|+.++..+ +||||+++++++.+.+.++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 356788999999999999998766 8999999865422 22567899999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++|||+++++|.+++..... +++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~---~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC---CeEEEcccCCceecc
Confidence 99999999999999976544 8999999999999999999999999999999999999654 359999999998765
Q ss_pred CCCccc--ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~--~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
...... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... ......+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL---PKPENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCcCCH
Confidence 432222 233678999999885 568999999999999999998 88999877777666666554332 22234789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+++.+||..+|++|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.02 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=207.2
Q ss_pred cceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
++|++++.||+|+||.||+|+++.+ .+.+++|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence 6799999999999999999997543 4679999875432 222456799999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 130 AVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.+ ..++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---REVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC---CcEEE
Confidence 9999999999999999997655 68999999999999999999999999999999999999654 45899
Q ss_pred EeeccccccCCCC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccC
Q 013816 201 IDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 201 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
+|||++....... ......++..|+|||.+. ..++.++||||||+++|+|++ |..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999987543221 223445677899999875 567889999999999999998 889997776666655555443332
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
. ....++..+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 P--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 2 224678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=308.23 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=205.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..+|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-C
Confidence 3679999999999999999999876665 58999876543 234557789999999999 89999999999887 7
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ ..+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---CeEEECCCccccc
Confidence 889999999999999998764 468999999999999999999999999999999999999643 4589999999987
Q ss_pred cCCCCccc---ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
........ ...++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER---LPQPPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC---CCCCCC
Confidence 65433221 122356799999876 568899999999999999998 9999988877776666654322 111234
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+.++.+++.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.01 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=206.7
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+. .++.+|+|.+..... ..+.+.+|+.+++++ +||||+++++++......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceE
Confidence 3578999999999999999999975 568899999865432 346789999999999 8999999999999989999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ ..+||+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC---CCEEECccccceecc
Confidence 9999999999999997643 58999999999999999999999999999999999999654 558999999987664
Q ss_pred CCCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |+.||.+.........+.... ........+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPE 231 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCH
Confidence 32111 1223456899999876 468899999999999999998 999998877776666665432 1222245689
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+++.+||+.+|++||++.+++.
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=309.44 Aligned_cols=240 Identities=19% Similarity=0.266 Sum_probs=192.9
Q ss_pred cccccCCceEEEEEEEcCCCc-------EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 61 RELGRGEFGITYLCTDRENGD-------AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
+.||+|+||.||+|.+...+. .+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence 469999999999999865544 38888775432 23456788899999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-----CCCeEEEeecccc
Q 013816 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-----TAPLKAIDFGLSV 207 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~-----~~~ikl~DfG~a~ 207 (436)
||||+++|+|.+++..++ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 5899999999999999999999999999999999999976532 2347999999987
Q ss_pred ccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... ....+++.|+|||++.+ .++.++||||||+++|+|++|. .||........ ..+....... ....
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~----~~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQL----PAPK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccC----CCCC
Confidence 65432 33467889999999864 4788999999999999999995 66655444332 2233322222 1245
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.++.+++.+||+.+|++|||+.++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.25 Aligned_cols=239 Identities=17% Similarity=0.206 Sum_probs=191.3
Q ss_pred ccccCCceEEEEEEEcCC------------------------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc
Q 013816 62 ELGRGEFGITYLCTDREN------------------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n 117 (436)
.||+|+||.||+|....+ ...||+|.+.... ......+.+|+.+++.+ +|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence 699999999999975322 2358888875432 22345788899999999 8999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC---
Q 013816 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--- 193 (436)
Q Consensus 118 iv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--- 193 (436)
|+++++++......++||||+++++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988865 46789999999999999999999999999999999999997532
Q ss_pred -CCCCeEEEeeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHH-HhCCCCCCCCCHHHHHHHH
Q 013816 194 -ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYIL-LCGVPPFWAETEQGVAQAI 269 (436)
Q Consensus 194 -~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~l-ltg~~pf~~~~~~~~~~~i 269 (436)
....+|++|||++...... ....++..|+|||.+.+ .++.++||||||+++|+| ++|..||......+....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~- 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF- 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence 2334899999988654221 23457888999998753 478999999999999998 579999987665544332
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......+ ...++++.+++.+||+.+|++|||+.++|++
T Consensus 234 ~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222111 2356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=302.95 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=204.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+++++.+ +||||+++++++.....+++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence 36889999999999999999875 477899998865432 235788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+.+++|.+++... +.+++..+..++.|++.+|.|||+.+++||||+|+||+++. +..+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE---NQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC---CCeEEECCCcceeecccCc
Confidence 9999999999998764 46899999999999999999999999999999999999964 4458999999987653322
Q ss_pred c--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+........ ....+..+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHH
Confidence 1 11233457899999876 568889999999999999998 9999988777766666654322211 234689999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+|+.+||+.+|++|||+.+++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.38 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=204.7
Q ss_pred ccceeeccccccCCceEEEEEEEcC----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-C
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-D 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~ 128 (436)
.++|++.+.||+|+||.||+|.+.. ++..|++|++... ......+.+.+|+.+++++ +||||+++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4689999999999999999999875 3688999987533 2344567789999999999 99999999998765 5
Q ss_pred CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.+ ..+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE---LQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC---CcEEE
Confidence 7789999999999999998653 358899999999999999999999999999999999999643 55899
Q ss_pred EeeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcccc
Q 013816 201 IDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 201 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
+|||+++.+...... ....++..|+|||++. ..++.++||||||+++|++++ |..||......+....+... ..
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CC
Confidence 999999865433211 2234567899999876 458899999999999999999 99999877666555444432 22
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
. .....+++++.+++.+||..+|++|||+.++++
T Consensus 238 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 222457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.18 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=198.0
Q ss_pred ceeeccccccCCceEEEEEEE----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--C
Q 013816 56 RYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T 129 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~ 129 (436)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+ +||||+++.+++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 478999999999999999974 4568899999986442 233456799999999999 999999999998775 6
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.+++||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. .+.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~---~~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES---EHQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC---CCCEEECCCccccc
Confidence 789999999999999998665 35899999999999999999999999999999999999965 34589999999987
Q ss_pred cCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHH
Q 013816 209 FKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--------------GVAQAI 269 (436)
Q Consensus 209 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--------------~~~~~i 269 (436)
...... .....++..|+|||++. ..++.++||||||+++|+|+|+..|+...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643322 12345677899999876 56889999999999999999987765321110 001111
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..... ..+.+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11111 122235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=300.33 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 3699999999999986 468899999886542 223345788999999999 999999999999999999999999999
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc--cc
Q 013816 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SE 217 (436)
Q Consensus 141 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~--~~ 217 (436)
++|.+++... ..+++..+..++.|++.||.|+|++|++||||+|+||+++. ...+||+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE---NNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC---CCeEEECCCccceeccccccccCCC
Confidence 9999988654 45789999999999999999999999999999999999964 445899999998754332211 12
Q ss_pred cccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHc
Q 013816 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (436)
Q Consensus 218 ~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~ 295 (436)
..+++.|+|||++. +.++.++||||||+++|++++ |..||...........+.... .......++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY---RMSCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHHHHHHHHH
Confidence 23456799999986 568899999999999999998 999998877666555554432 1222346789999999999
Q ss_pred cCCCcCCCCCHHHHhcC
Q 013816 296 LDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 296 l~~~p~~Rps~~e~l~h 312 (436)
|+.+|++|||+.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.22 Aligned_cols=228 Identities=25% Similarity=0.380 Sum_probs=187.9
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCchHH
Q 013816 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD 145 (436)
Q Consensus 66 G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~ 145 (436)
|.+|.||+|++..+++.||+|.+.... ...+|...+... .||||+++++++...+.+++||||++|++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986542 123344445555 79999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCccc
Q 013816 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225 (436)
Q Consensus 146 ~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~ 225 (436)
++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++++|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999654 44899999987655432 23345677899
Q ss_pred chhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC
Q 013816 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (436)
Q Consensus 226 aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp 304 (436)
|||.+. +.++.++||||+|+++|+|++|..|+...... + ...... ...+.+++.++++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-NTHTTL--NIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-cccccc--CCcccCCHHHHHHHHHHccCCHHHhc
Confidence 999986 46889999999999999999999887543321 0 000111 11235789999999999999999999
Q ss_pred CH-----HHHhcCccc
Q 013816 305 TA-----QQVLEHPWL 315 (436)
Q Consensus 305 s~-----~e~l~h~~~ 315 (436)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=304.51 Aligned_cols=252 Identities=29% Similarity=0.509 Sum_probs=208.6
Q ss_pred ceeeccccccCCceEEEEEEEcC-CCcEEEEEEeecccc-------CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 56 RYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL-------RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37889999999999999999887 688999998864321 1223455678899988764489999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 128 DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
++..++||||++|++|.+++.. ...+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.+ ..+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~---~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC---CcEEEec
Confidence 9999999999999999888743 3468999999999999999999996 789999999999999654 4589999
Q ss_pred eccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
||.+.............|+..|+|||.+. +.++.++||||||+++|+|++|..||...........+....... ...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--LPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--CCc
Confidence 99998765544445667899999999986 458899999999999999999999998777666665555543321 122
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
...++++.+++.+||+.||++||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3578999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.77 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+++++++ +||||+++++++......++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999877 999999988654322 3456899999999999 899999999999999999999999999
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc---c
Q 013816 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---S 216 (436)
Q Consensus 141 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~---~ 216 (436)
++|.+++... ..+++..+..++.+++.+|.|||+++++||||+|+||+++. ...+||+|||++......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~---~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE---NNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC---CCcEEEeeccccccccCCcceeccc
Confidence 9999998653 46889999999999999999999999999999999999964 445999999998765422111 1
Q ss_pred ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHH
Q 013816 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (436)
Q Consensus 217 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~ 294 (436)
...++..|+|||.+. +.++.++||||||+++|+|+| |..||...........+.... .......++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---RMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC---CCCCCccCCHHHHHHHHH
Confidence 123356799999876 568999999999999999999 889997777665555544321 112234678999999999
Q ss_pred ccCCCcCCCCCHHHHhc
Q 013816 295 MLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 295 ~l~~~p~~Rps~~e~l~ 311 (436)
||+.+|.+|||+.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=304.25 Aligned_cols=240 Identities=20% Similarity=0.211 Sum_probs=191.0
Q ss_pred cccccCCceEEEEEEEcCC------------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 61 RELGRGEFGITYLCTDREN------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
+.||+|+||.||+|+.... ...+|+|.+.... ......+.+|+.+++.+ +||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 3689999999999985322 2358888875432 22345788899999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC----CCCeEEEee
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE----TAPLKAIDF 203 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~----~~~ikl~Df 203 (436)
...++||||+++++|..++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998887653 56899999999999999999999999999999999999975432 123899999
Q ss_pred ccccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 204 G~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
|++..... .....++..|+|||.+. ..++.++|||||||++|+|+ +|..||......+.. ........ .
T Consensus 157 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----~ 228 (262)
T cd05077 157 GIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----L 228 (262)
T ss_pred CCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----C
Confidence 98875432 23346788999999875 45889999999999999997 588888765544332 22222221 1
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....++++.+|+.+||+.||.+||++.+++++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 22346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=312.69 Aligned_cols=265 Identities=31% Similarity=0.456 Sum_probs=220.2
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC----hhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
..+.++|-++.+||+|||+.||+|.|....++||||+-...+.-. ....+..-+|..|-+.| +||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeee
Confidence 356689999999999999999999999999999999865433211 12344567899999999 9999999999996
Q ss_pred -eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceEeecCCCCCCeEEEee
Q 013816 127 -DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 127 -~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
+.+.+|-|+|||+|.+|.-+|+.+..+++.+++.|+.||+.||.||... .|||-||||.|||+.+....+.|||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 5578899999999999999999999999999999999999999999987 5999999999999998888888999999
Q ss_pred ccccccCCCC--------cccccccCCcccchhccc-c----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHH--
Q 013816 204 GLSVFFKPGE--------KFSEIVGSPYYMAPEVLK-R----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQ-- 267 (436)
Q Consensus 204 G~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~-- 267 (436)
|+++.+.... -.+...||.+|++||.+- + ..+.|+||||+|||+|..+.|+.||...-.+ .+++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999886432 224568999999999763 2 3688999999999999999999999654332 2221
Q ss_pred HHH-HccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 268 AII-RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 268 ~i~-~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.|+ .....|+.. |.+++++++||++||++.-++|....++..||||...
T Consensus 698 TIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 698 TILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred chhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 111 223344433 5799999999999999999999999999999999753
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=303.25 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=191.8
Q ss_pred cccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++++ +||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence 36999999999999864 345679999886543 223345788899999999 8999999999999999999999999
Q ss_pred CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 139 ~g~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
++++|.+++.... ..++..+..++.|++.||.|||+++++||||||+||+++. ...+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~---~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEECCccccccccCcc
Confidence 9999999986532 3567788899999999999999999999999999999964 4559999999987543222
Q ss_pred c---ccccccCCcccchhcccc--------cCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHc-cccCCCCC
Q 013816 214 K---FSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS-VLDFRRDP 280 (436)
Q Consensus 214 ~---~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 280 (436)
. .....++..|+|||++.+ .++.++||||||+++|+|++ |..||......+........ ......+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1 123457788999998752 25789999999999999996 99999776655543333222 22222222
Q ss_pred C-cccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 281 W-PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 281 ~-~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
. ...++.+.+++..|+ .+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1 246788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=304.13 Aligned_cols=249 Identities=26% Similarity=0.340 Sum_probs=203.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CC
Confidence 35689999999999999999987644 3568999875432 233456889999999999 89999999998875 55
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++. ...+||+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec---CCCeEEccCceeeec
Confidence 789999999999999997644 5899999999999999999999999999999999999965 345899999998766
Q ss_pred CCCCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
...... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+.+... ......++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER---LPMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc---CCCCCCCC
Confidence 433221 1223456799999876 568899999999999999986 9999988777666655544322 12335678
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.++.+++.+||..+|.+|||+.+++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=305.46 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=199.5
Q ss_pred cccccCCceEEEEEEEcCCC------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 61 RELGRGEFGITYLCTDRENG------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.||+|+||.||+|++.... +.+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999976544 689999875432 123456788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeecc
Q 013816 135 MELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGL 205 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~ 205 (436)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2378899999999999999999999999999999999997654 233699999999
Q ss_pred ccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 206 SVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 206 a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
+........ .....++..|+|||.+. +.++.++||||||+++|+|+| |..||......+....+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---RLQK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---ccCC
Confidence 876543221 12234567899999876 568999999999999999998 999998777665555443322 1122
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...++..+.+++.+||..+|.+||++.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3467899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.34 Aligned_cols=246 Identities=22% Similarity=0.362 Sum_probs=202.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.+ +|+||+++++.+.. ..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeE
Confidence 3578999999999999999999854 56679999876432 2346788999999999 89999999999887 7789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ...+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCCcceeecc
Confidence 999999999999999763 35788889999999999999999999999999999999964 4459999999987654
Q ss_pred CCCcc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
..... ....++..|+|||++. +.++.++||||||+++|+++| |..||...+.......+.... ........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---CCCCcccCCH
Confidence 33221 2234567799999986 468889999999999999999 999998877666655554432 2222356789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=303.29 Aligned_cols=237 Identities=18% Similarity=0.211 Sum_probs=190.8
Q ss_pred cccccCCceEEEEEEEcCCC----------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 61 RELGRGEFGITYLCTDRENG----------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence 46999999999999998776 3577787654321 157888999999999 89999999999887 77
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC----CCCCeEEEeecc
Q 013816 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK----ETAPLKAIDFGL 205 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~----~~~~ikl~DfG~ 205 (436)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 789999999999999999999999999999999999997654 223599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
+..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||......+...... .....+
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~---- 226 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLP---- 226 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCC----
Confidence 986543 223456778999999863 47889999999999999999 578886664333322222 111111
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+..+.+++.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.45 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=191.2
Q ss_pred cccccCCceEEEEEEEcC--CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.+ +||||+++++.+.....+++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence 369999999999996432 34578888775432 233346788999999999 8999999999999999999999999
Q ss_pred CCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 139 ~g~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
++|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC---CCcEEEeccccccccccch
Confidence 9999999987642 2467788999999999999999999999999999999965 4459999999986543221
Q ss_pred c---ccccccCCcccchhccc--------ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc-ccCCCCC
Q 013816 214 K---FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-LDFRRDP 280 (436)
Q Consensus 214 ~---~~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 280 (436)
. .....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+....+.... ...+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12334567899999864 236789999999999999999 788987776665555544332 2222221
Q ss_pred -CcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 281 -~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+++.+.+++..|+ .||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 2357888999999998 59999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.72 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=212.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..-++.+.||+|+||.||.|.-..... .||+|.+.+ ..+.....+|.+|+.+|+.+ +|||||++++++-+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence 567788999999999999998654333 388888754 34667788999999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 130 AVHLVMELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
.++|++|||+||+|..+|.+. ..++......++.+|+.|++||+++++|||||...|+|++. ...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~---~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE---RRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc---cCcEEEcc
Confidence 999999999999999999875 34888999999999999999999999999999999999964 46799999
Q ss_pred eccccccCCCCcccc---cccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCC
Q 013816 203 FGLSVFFKPGEKFSE---IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 203 fG~a~~~~~~~~~~~---~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
||+|+.+-..+.+.. ..-...|||||.+. +.++.++|||||||+|||++| |..||.+.+..++..-+.++. +
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence 999995543332211 12235799999987 779999999999999999998 899999999988888777766 3
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.++...++..+.++|..||+.+|++||++..+++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 4444679999999999999999999999999988
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.86 Aligned_cols=260 Identities=20% Similarity=0.266 Sum_probs=211.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++.+-+..||.|+||+|++..++.+|+..|||+|+.... ..+..+++.|.+...+-.+.||||++|+..-.++..||.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 345557889999999999999999999999999976543 345678999999888877999999999999889999999
Q ss_pred EeccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 135 MELCEGGELFDRIV-----ARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 135 ~E~~~g~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
||+|+ .||..+.+ ++..++|..+..|....+.||.||-. ..|||||+||+|||++. .+.|||||||++..
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr---~G~vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR---HGDVKLCDFGICGQ 217 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec---CCCEeeecccchHh
Confidence 99995 46644332 34679999999999999999999986 48999999999999964 55599999999987
Q ss_pred cCCCCcccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccCCCCC--Cc
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDP--WP 282 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~--~~ 282 (436)
+.++-..+.-.|...|||||.+. ..|+-+|||||||++|||+.||..||..-+. .+.+..+..+....-... .-
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 76655556678999999999985 3489999999999999999999999965443 233333444332211111 12
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.++..++.+|..||.+|...||+..+++++||++....
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 47889999999999999999999999999999987544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=283.38 Aligned_cols=254 Identities=28% Similarity=0.549 Sum_probs=210.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 131 (436)
.++|++.+++|+|.|+.||.|....+++.+++|++++ ...+.+.+|+.+|..|..||||++++++..+. ..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4689999999999999999999999999999999853 34578999999999998899999999998654 567
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
.+|+||+.+.+...+. ..++...+..++.+++.||.|+|+.||+|||+||.|++++... ..++|+|+|+|..+.+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--ceeeeeecchHhhcCC
Confidence 8999999886554433 4578889999999999999999999999999999999998543 4589999999999998
Q ss_pred CCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHc-------------cc-
Q 013816 212 GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRS-------------VL- 274 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~-------------~~- 274 (436)
+...+..+.+..|--||.+- +.|+.+-|+|||||+|..|+..+-||... +....+..|.+- ..
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 88888888999999999875 56999999999999999999999998543 333322222210 00
Q ss_pred ----------cCCCCCCc---------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 275 ----------DFRRDPWP---------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 275 ----------~~~~~~~~---------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.....+|. -+++++.+|+.++|..|..+|+||.|++.||||...
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11112221 247999999999999999999999999999999754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=300.54 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=200.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||++. .+++.||+|.+.... ..+.+.+|+.+++++ +||||+++++++..+ ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence 569999999999999999986 468899999985432 236788999999999 999999999998755 47899
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---GVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CcEEECCCccceecccc
Confidence 99999999999997653 47899999999999999999999999999999999999643 45899999998764322
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
......+..|+|||.+. +.++.++||||||+++|+|++ |..||......+....+.+.. .......++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHHHHH
Confidence 22234457899999876 568899999999999999997 999998887776666554432 22233567899999
Q ss_pred HHHHccCCCcCCCCCHHHHhc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+||+.+|++||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=303.70 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=195.8
Q ss_pred cceeeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--C
Q 013816 55 ERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~ 128 (436)
.+|++.+.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+++++.+ +||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence 479999999999999999997 3467899999998643 233457889999999999 89999999997643 4
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
..+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~---~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES---ENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC---CCeEEECCCcccc
Confidence 5789999999999999998764 46899999999999999999999999999999999999964 3458999999998
Q ss_pred ccCCCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH---------------HHH
Q 013816 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------------VAQ 267 (436)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---------------~~~ 267 (436)
........ ....++..|+|||++. ..++.++||||||+++|+|++|..|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence 76433221 1122345699999976 468899999999999999999877754332110 001
Q ss_pred HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+..... .......++.++.+|+.+||..+|++|||+.++++
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 237 ELLKNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHhcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111111 11222457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=318.26 Aligned_cols=259 Identities=30% Similarity=0.507 Sum_probs=222.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|..++.||-|+||.|.++....|...||.|.+.+...-........+.|-.||..- +.+-||+||..|++++.+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEE
Confidence 4588899999999999999998899999999999887766666677788899999998 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC----
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK---- 210 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~---- 210 (436)
|+|++||++-.+|.+-+-|+|..++-++..+..|+++.|..|+|||||||+|||++ .+++|||+|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID---rdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---cCCceeeeeccccccceeccc
Confidence 99999999999999999999999999999999999999999999999999999995 55679999999986331
Q ss_pred -----CCC----------------------------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHH
Q 013816 211 -----PGE----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYIL 250 (436)
Q Consensus 211 -----~~~----------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~l 250 (436)
.++ .....+||+.|+|||++. ..|+..||.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 100 001347999999999986 5799999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC---CHHHHhcCcccccC
Q 013816 251 LCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLEHPWLQNA 318 (436)
Q Consensus 251 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp---s~~e~l~h~~~~~~ 318 (436)
+.|+.||...+.-+....+++....+...+..++|.++.++|.++. .+++.|. -+.++-.||||+..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 9999999988887776666655444444455689999999999876 4577886 47789999999853
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=325.59 Aligned_cols=201 Identities=32% Similarity=0.534 Sum_probs=178.0
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC------C
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD------T 129 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~------~ 129 (436)
-+...+.||+||||.||+++++.+|+.||||.+.+.. .....+..-+|+++|++| +|||||+++++-+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence 4666788999999999999999999999999997754 333567889999999999 799999999986544 3
Q ss_pred eEEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCeEEEeecc
Q 013816 130 AVHLVMELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGL 205 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~ 205 (436)
...+|||||.||+|...+..- ..+++.+.+.++..+..||.|||++||+||||||.||++.... .....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 568999999999999999642 4599999999999999999999999999999999999986543 344579999999
Q ss_pred ccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCC
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWA 259 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~ 259 (436)
|+.+.++....+.+||+.|.+||++. +.|+..+|.|||||++|+++||..||..
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99999999999999999999999987 5688899999999999999999999943
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.03 Aligned_cols=255 Identities=13% Similarity=0.155 Sum_probs=188.3
Q ss_pred cccccceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhh--------HHHHHHHHHHHHhCCCCCcee
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVD--------IEDVRREVDIMRHLPKHQNIV 119 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~--------~~~~~~E~~~l~~l~~h~niv 119 (436)
+...++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+ +|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence 45567899999999999999999998877 6677777643222110000 01122333445566 899999
Q ss_pred EEEEEEEeCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 120 CLKDTYEDDT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 120 ~~~~~~~~~~----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
++++++.... ..++++|++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++. .
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~---~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG---N 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---C
Confidence 9998765443 44788888744 67676666555788999999999999999999999999999999999964 3
Q ss_pred CCeEEEeeccccccCCCC--------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HH
Q 013816 196 APLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GV 265 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~ 265 (436)
..++|+|||+|+...... ......||+.|+|||+.. ..++.++|||||||++|+|++|..||.+.... ..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 458999999997653221 112346999999999976 45899999999999999999999999776322 21
Q ss_pred HHH----HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 AQA----IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 ~~~----i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
... ....... .....+..++++.+++..|+..+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111 1111111 11123456899999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=306.30 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=201.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.++|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence 3578999999999999999999887776 46888775432 222345688999999999 999999999998654
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~---~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS---PNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC---CCceEEcccccccc
Confidence 4679999999999999987654 5899999999999999999999999999999999999964 34589999999987
Q ss_pred cCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
...... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+ ...... ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL--PQPPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC--CCCCC
Confidence 643322 12234567899999876 568899999999999999997 99999776655444433 322222 22345
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+..+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=295.83 Aligned_cols=256 Identities=27% Similarity=0.525 Sum_probs=227.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|.+++.||+|+|+.|.++++++|.+.+|+|+++++-+....+++-...|-.+..+-.+||.+|.+..+|+....+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57999999999999999999999999999999999998888888888899999999988999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc-cCCCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~-~~~~~ 213 (436)
.||++||+|--.+.++..++++.++-+...|+.||+|||++|||.||||.+|+|++. .+++||+|+|+++. +.++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda---eghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA---EGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc---CCceeecccchhhcCCCCCc
Confidence 999999999888888889999999999999999999999999999999999999964 45699999999864 45667
Q ss_pred cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHccccCCCCCCccc
Q 013816 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA--------ETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~--------~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..++.+|||.|.|||++.+ .|+.+.|.|+|||+++||+.|+.||.- ++..-..+.|+...+..++ .+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence 7889999999999999985 699999999999999999999999942 2233345566665554433 57
Q ss_pred CHHHHHHHHHccCCCcCCCC------CHHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKRRL------TAQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rp------s~~e~l~h~~~~~ 317 (436)
|-.+..+++..|++||.+|. ..+++-.|+||+.
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 78888999999999999995 4788999999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.63 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=192.4
Q ss_pred cccccCCceEEEEEEEcC---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-eCCeEEEEEe
Q 013816 61 RELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVME 136 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~~~lv~E 136 (436)
+.||+|+||.||+|.+.. .+..+|+|.+... ......+.+.+|+.+++.+ +||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998653 3467999987532 2334467888999999999 9999999999765 4567899999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 013816 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (436)
Q Consensus 137 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-- 213 (436)
|+.+++|.+++... ...++..+..++.|++.||.|||+.+++||||||+|||++. ...+||+|||+++......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~---~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE---SFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCccccccccCCcce
Confidence 99999999998764 34677888899999999999999999999999999999964 4458999999997653221
Q ss_pred ---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 214 ---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 214 ---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
......++..|+|||.+. ..++.++||||||+++|+|++ |.+||...........+..... .......++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR---LLQPEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---CCCCCcCCHHH
Confidence 112334567899999875 568899999999999999999 4667766665555554443321 11123468899
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+||+.+|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=324.93 Aligned_cols=338 Identities=19% Similarity=0.252 Sum_probs=209.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCC----CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE-----
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT----- 124 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~----- 124 (436)
.++|++.+.||+|+||.||+|++..+ +..||+|++..... .+....+ .+... .+.+++.+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhccc
Confidence 46899999999999999999999988 99999998753221 1111111 11221 22222222211
Q ss_pred -EEeCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013816 125 -YEDDTAVHLVMELCEGGELFDRIVARGH--------------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLK 183 (436)
Q Consensus 125 -~~~~~~~~lv~E~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk 183 (436)
......+++||||+.+++|.+++..... ..+..+..++.||+.||.|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456789999999999999998865421 1234567899999999999999999999999
Q ss_pred CCceEeecCCCCCCeEEEeeccccccCCCC--cccccccCCcccchhccc-c----------------------cCCCCC
Q 013816 184 PENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-R----------------------NYGPEV 238 (436)
Q Consensus 184 p~NIl~~~~~~~~~ikl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~----------------------~~~~~~ 238 (436)
|+|||++.+ ...+||+|||+|+...... ......+|+.|+|||.+. . +++.++
T Consensus 283 P~NILl~~~--~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 283 PQNIIFSEG--SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHHEEEeCC--CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999742 3459999999998654322 234568899999999652 1 134467
Q ss_pred chhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC-------CC----------CCCcccCHHHHHHHHHccCCCcC
Q 013816 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------RR----------DPWPKVSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 239 DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~~~~~~~ll~~~l~~~p~ 301 (436)
|||||||+||||+++..|+... .......+....... .. ..+...+...++||.+||++||+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999999987765321 111111111111000 00 00111234566999999999999
Q ss_pred CCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHH
Q 013816 302 RRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINID 381 (436)
Q Consensus 302 ~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~ 381 (436)
+|||+.++|+||||+........ ..+.+. +..+... .+. ..+-..-+......-+.+.+|-++-.
T Consensus 440 kR~ta~e~L~Hpff~~~~~~~~~-~~~~~~--~~~~~~~-----------~~~-~~~~~~~~~~~~~~~~~~~~~~~~e~ 504 (566)
T PLN03225 440 QRISAKAALAHPYFDREGLLGLS-VMQNLR--LQLFRAT-----------QQD-YGEAAAWVVFLMAKSGTEKEGGFTEA 504 (566)
T ss_pred cCCCHHHHhCCcCcCCCCccccc-cccccc--cccchhh-----------HHH-HHHHHHHHHHHHHhcCCCCCCCccHH
Confidence 99999999999999875332111 111100 0000000 000 00011122233334455667788888
Q ss_pred HHHHHHHHcCCCCCHHHHH--HHHHHHhcCCC--cCHhhHHH
Q 013816 382 ELRVGLHKLGHQIPDTDVQ--ILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 382 el~~~l~~lg~~~~~~e~~--~~~~~~d~~~~--i~~~ef~~ 419 (436)
+|+..... +. -.+++.+ .|....+.... ..+++++.
T Consensus 505 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (566)
T PLN03225 505 QLQELREK-EP-KKKGSAQRNALASALRLQRKGVKTVARTVD 544 (566)
T ss_pred HHHHhhhh-cC-cchhhhhhhhHHHHHhhhhhhhhhhhhhhh
Confidence 88755543 32 1233333 36666666544 66777643
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=302.02 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=200.2
Q ss_pred cceeeccccccCCceEEEEEEEc----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--C
Q 013816 55 ERYELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~ 128 (436)
+.|++.+.||+|+||.||+|.+. .++..+|+|.+...... ...+.+.+|+++++.+ .||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence 46888899999999999999864 34789999998754322 3467899999999999 99999999999877 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ ..++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---DLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEccccccc
Confidence 68999999999999999997654 58999999999999999999999999999999999999654 558999999998
Q ss_pred ccCCCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 013816 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA 268 (436)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~--------------~~~~ 268 (436)
........ ....++..|+|||.+. ..++.++||||||+++|+|+||..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532221 1224456799999876 568899999999999999999999986543221 1112
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
........ .....++.++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 238 LLKEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHcCCcC--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22222211 222456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=296.80 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=190.3
Q ss_pred cccccCCceEEEEEEEcCC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
++||+|+||.||++..... ...+++|.+.... .....+.+.+|+.+++.+ +||||+++++.+......|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecC
Confidence 3699999999999975433 2346667664432 223457899999999999 9999999999999999999999999
Q ss_pred CCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 139 EGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 139 ~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
++++|.+++... ...++..+..++.||+.||.|||+.+++||||||+|||++. ...+||+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~---~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC---CccEEecccccccccCcchh
Confidence 999999998754 23567788899999999999999999999999999999964 4459999999886432211
Q ss_pred --cccccccCCcccchhcccc--------cCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc-ccCCCC-C
Q 013816 214 --KFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-LDFRRD-P 280 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~-~~~~~~-~ 280 (436)
......++..|+|||++.. .++.++||||||+++|+|++ |..||......+....+.... .....+ .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 1234567889999998742 35778999999999999997 577887777666666554432 221222 2
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+++.+.+++..|| .+|++||++.++++
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 2357889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=299.06 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=199.2
Q ss_pred eeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC----
Q 013816 57 YELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 129 (436)
|.+.+.||+|+||.||+|.+. .+++.||+|++.... ......+.+.+|+++++.+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence 667889999999999999864 357899999986543 3334567789999999999 8999999999886532
Q ss_pred --eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 130 --AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 130 --~~~lv~E~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. ...+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~---~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE---NMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC---CCCEEEC
Confidence 347899999999998877532 24788999999999999999999999999999999999954 4458999
Q ss_pred eeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccC
Q 013816 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 202 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
|||+++....... .....+++.|++||.+. +.++.++||||||+++|+|++ |..||......+....+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL- 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 9999986543321 12334567899999876 457889999999999999999 89999877766655555443211
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
...+..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.47 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=215.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-----e
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-----D 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-----~ 127 (436)
..+.|++.+.||.|.+|.||+++.+.+++..|+|+.....- ..+++..|.++|+.+..|||++.+|++|. .
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34669999999999999999999999999999999865432 34678889999999999999999999985 4
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
++.+|||||||.|||..|++++- ..+.|..++.|++.++.||.+||...++|||||=.|||++.++. |||+|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeee
Confidence 67899999999999999999764 46899999999999999999999999999999999999976544 99999999
Q ss_pred ccccCCC-CcccccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC
Q 013816 206 SVFFKPG-EKFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (436)
Q Consensus 206 a~~~~~~-~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 278 (436)
+..+... ....+.+|||.|||||++.. .|+.++|+||||++..||.-|.+|+-+......+-.|.+. .....
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkL 248 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKL 248 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccc
Confidence 9877543 23466799999999999852 2677899999999999999999999777665433332221 11111
Q ss_pred CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 279 ~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..|...+.++.+||+.||.+|-++||+..++|.|||++.
T Consensus 249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 223456889999999999999999999999999999983
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=299.12 Aligned_cols=266 Identities=27% Similarity=0.493 Sum_probs=203.9
Q ss_pred cccccc-cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-------ceeE
Q 013816 49 TGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-------NIVC 120 (436)
Q Consensus 49 ~~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-------niv~ 120 (436)
.|+.+. .||.+.++||.|.|++||+|+|.++.+.||+|+++.. ....+....||++|+++..+. .||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 356666 8999999999999999999999999999999998643 234567888999999985332 6999
Q ss_pred EEEEEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCC
Q 013816 121 LKDTYE----DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK 193 (436)
Q Consensus 121 ~~~~~~----~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~ 193 (436)
|++.|. +..+++||+|++ |.+|..+|... ..++...++.|++|||.||.|||.. ||||.||||+|||+....
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence 999996 456899999999 77999999875 3489999999999999999999975 999999999999985320
Q ss_pred C-------------------------------------------------------------------------------
Q 013816 194 E------------------------------------------------------------------------------- 194 (436)
Q Consensus 194 ~------------------------------------------------------------------------------- 194 (436)
.
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------C-----------------------------------------------
Q 013816 195 --------------------------------T----------------------------------------------- 195 (436)
Q Consensus 195 --------------------------------~----------------------------------------------- 195 (436)
.
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence 0
Q ss_pred -----CCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC------HH
Q 013816 196 -----APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------EQ 263 (436)
Q Consensus 196 -----~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~------~~ 263 (436)
..|||+|||-|.... ...+.-+.|..|+|||++- ..|++.+||||++|++|||+||...|.... ++
T Consensus 386 ~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred CCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 015666666665542 3345556799999999976 579999999999999999999999884221 11
Q ss_pred HHHHHHHHccccC-------------------------CCCCCc-------------ccCHHHHHHHHHccCCCcCCCCC
Q 013816 264 GVAQAIIRSVLDF-------------------------RRDPWP-------------KVSENAKDLVRKMLDPDPKRRLT 305 (436)
Q Consensus 264 ~~~~~i~~~~~~~-------------------------~~~~~~-------------~~~~~~~~ll~~~l~~~p~~Rps 305 (436)
..+..|+.-.... ...+|+ .-..++.+||.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 1122221110000 011232 11356789999999999999999
Q ss_pred HHHHhcCcccccCccC
Q 013816 306 AQQVLEHPWLQNAKKA 321 (436)
Q Consensus 306 ~~e~l~h~~~~~~~~~ 321 (436)
|.++|+|||+......
T Consensus 544 A~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 544 AAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHhcCccccCCCCC
Confidence 9999999999976553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.41 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=211.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+..||.-++.+|.|+- .|..|.|.-+++.||+|.+... +......++..+|..++..+ .|+||++++.+|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCccccH
Confidence 45678999999999998 8888999999999999998776 55666788899999999999 999999999998533
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+|||++.. +|...+.. .+....+..|..|++.|++|||+.||+||||||+||++. ..+.+||.|||+
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFGL 164 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccchh
Confidence 467999999965 88887763 477889999999999999999999999999999999994 566799999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--------- 275 (436)
|+.....-.++..+.|..|+|||++- -.|...+||||+||++.||++|+..|.+.+.-.....+.+....
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 99876655667889999999999865 45999999999999999999999999776554433333221110
Q ss_pred ----------------------CCCCCCc-------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 276 ----------------------FRRDPWP-------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 276 ----------------------~~~~~~~-------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
++...|+ .-+..+++++.+||..||++|.|+.++|+|||++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111111 1234689999999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=318.83 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=216.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
....|.++||.|.||.||+|+.+..| ..||||.++... ......+|+.|+.||.++ +||||++|.++......+
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCcee
Confidence 34678899999999999999987666 469999986543 344567899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.||+|||++|+|..+|..+ +.++..+...+++.|++|++||-+.|+|||||-..|||+++ +..+|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs---nLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc---ceEEEeccccceeecc
Confidence 9999999999999999765 67999999999999999999999999999999999999954 5568999999999886
Q ss_pred CCC-c-cccccc--CCcccchhccc-ccCCCCCchhHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGE-K-FSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~-~-~~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
++. . +++.-| ...|.|||.+. +.++.+|||||+|+++||.+ .|..|||+.+.++++..|..+. +.++...+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCC
Confidence 543 2 222223 35899999987 78999999999999999855 5999999999999999998754 44555689
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
|..+.+|+..||++|-.+||.+.|++.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9999999999999999999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=284.79 Aligned_cols=242 Identities=44% Similarity=0.753 Sum_probs=204.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCchHHH
Q 013816 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR 146 (436)
Q Consensus 67 ~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~ 146 (436)
+||.||+|.+..+|+.+|+|++........ .+.+.+|++.++++ +|+||+++++.+......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999998999999999876543221 57899999999999 999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccc
Q 013816 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226 (436)
Q Consensus 147 l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~a 226 (436)
+.....+++..+..++.+++.++.+||+.+++|+||+|+||+++.+ ..++|+|||.+.............++..|+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCC
Confidence 9877668999999999999999999999999999999999999754 4589999999987765545556678899999
Q ss_pred hhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCC
Q 013816 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (436)
Q Consensus 227 PE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rp 304 (436)
||.+. ..++.++||||||+++++|++|..||.. .........+...... .......++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCCchhcc
Confidence 99876 5688899999999999999999999977 4444333333332222 1222222789999999999999999999
Q ss_pred CHHHHhcCccc
Q 013816 305 TAQQVLEHPWL 315 (436)
Q Consensus 305 s~~e~l~h~~~ 315 (436)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=307.17 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=213.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++...+.++||+|.||+|+.|.|..-+ ..||||++....... ...+|.+|+.+|.+| +|||++++|++..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-ch
Confidence 356778899999999999999987543 458999997665432 578999999999999 99999999999876 67
Q ss_pred EEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 131 VHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..+|||++++|+|.+.|.. +..|.......++.||+.|+.||.++++|||||-..|+|+.+ ...|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceec
Confidence 8899999999999999987 345888889999999999999999999999999999999964 45699999999999
Q ss_pred cCCCCcccccc----cCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 209 FKPGEKFSEIV----GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 209 ~~~~~~~~~~~----gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
+..++.+.... -...|+|||.++ +.++.++|||++||++|||+| |..||.+.....+++.|-.+..-.+ .+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PK 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CC
Confidence 87766543222 235799999998 679999999999999999998 7899999999888888875443222 24
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+++++.+++..||..+|++|||+..+.+.-+.
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 689999999999999999999999998754333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=298.17 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=207.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+...+.++||+|-||.|.+|.- ..+..||||.++..... ....+|.+|+++|.+| +|||||++.++|..++.+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATK--NARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccch--hHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence 46788999999999999999984 44799999999766433 3458899999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||+++|+|.+++..+. .+......+|+.||++|++||.+.++|||||.+.|+|++ ...++||+|||+++.+-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCccccccccc
Confidence 999999999999998773 234455678999999999999999999999999999995 556699999999997765
Q ss_pred CCccc---ccccCCcccchhcc-cccCCCCCchhHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHccccCCC----CCC
Q 013816 212 GEKFS---EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILL--CGVPPFWAETEQGVAQAIIRSVLDFRR----DPW 281 (436)
Q Consensus 212 ~~~~~---~~~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~~ll--tg~~pf~~~~~~~~~~~i~~~~~~~~~----~~~ 281 (436)
++.+. ..+-...|||||.+ .+.++.++|+|+||+++||++ +...||...+.+...++.-.-...... ...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 54432 33456789999975 589999999999999999965 578999888777666554432222111 112
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.++..+.++|..||..+.++|||++++..
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 457889999999999999999999999854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.19 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=205.1
Q ss_pred ceeeccccccCCceEEEEEEEcC--CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 56 RYELGRELGRGEFGITYLCTDRE--NG--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~--~~--~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...+.+.||.|-||.||+|.... .| -.||||+.+.. ....+.+.|..|+-+|+.+ +||||++++|++.+ ...
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhC-CCcchhheeeeeec-cce
Confidence 34556779999999999998432 23 45888887654 2445678999999999999 99999999999964 468
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||||.++-|.|..+++.++ .++......++.||+.||.|||+..+|||||-..|||+.+ +..|||+|||+++.+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS---p~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS---PQCVKLADFGLSRYLE 542 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC---cceeeecccchhhhcc
Confidence 99999999999999998764 5899999999999999999999999999999999999965 3349999999999988
Q ss_pred CCCccccccc--CCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
+...+....| ..-|||||-++ +.++.++|||-|||.+||+++ |..||.+-...+++-.+.++.. .+..+++|+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCPp 619 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCPP 619 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCCh
Confidence 7665544344 34699999988 789999999999999999765 9999999887776666655542 333468999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHh
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVL 310 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l 310 (436)
.+..|+.+||.++|.+||.+.++.
T Consensus 620 ~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHH
Confidence 999999999999999999987764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=300.50 Aligned_cols=244 Identities=22% Similarity=0.376 Sum_probs=209.5
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+.....+||-|.||.||.|.|+.....||||.++.. ....++|+.|+.+|+.+ +|||+|+++++|.....+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence 345567899999999999999999999999998643 44678999999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||..|+|.++|.... .++.-....++.||.+|+.||..+++|||||-..|+|+ +++..||++|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgD- 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGD- 418 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCC-
Confidence 9999999999998754 36777788999999999999999999999999999999 56667999999999988643
Q ss_pred ccccccc---CCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 214 KFSEIVG---SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 214 ~~~~~~g---t~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.++.-.| ..-|.|||-+. ..++.|+|||+|||+|||+.| |-.||.+.+...++..+.++ + +......+++..
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-y--RM~~PeGCPpkV 495 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-Y--RMDGPEGCPPKV 495 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-c--cccCCCCCCHHH
Confidence 3333333 35699999887 569999999999999999987 88999998887776655543 3 333346899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+|+..||+++|.+||+++|+-+
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHH
Confidence 99999999999999999999844
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.99 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=186.8
Q ss_pred ccccceeeccccccCCceEEEEEEEc----------------CCCcEEEEEEeeccccCCh-----------hhHHHHHH
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR----------------ENGDAFACKSISKKKLRTA-----------VDIEDVRR 104 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~i~~~~~~~~-----------~~~~~~~~ 104 (436)
.-.++|++.++||+|+||+||+|.+. ..++.||||++........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34578999999999999999999752 3456899999864321100 01122345
Q ss_pred HHHHHHhCCCCCce-----eEEEEEEEe--------CCeEEEEEeccCCCchHHHHHhc---------------------
Q 013816 105 EVDIMRHLPKHQNI-----VCLKDTYED--------DTAVHLVMELCEGGELFDRIVAR--------------------- 150 (436)
Q Consensus 105 E~~~l~~l~~h~ni-----v~~~~~~~~--------~~~~~lv~E~~~g~~L~~~l~~~--------------------- 150 (436)
|+.++.++ +|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 222 E~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 77777777 45543 566776643 45689999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccc--cccCCccc
Q 013816 151 ---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYM 225 (436)
Q Consensus 151 ---~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~--~~gt~~y~ 225 (436)
..+++..+..++.|++.+|.|||+.+|+||||||+|||++.+ ..+||+|||++........... ..+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC---CcEEEEeCcCccccccCCccCccccCCCccee
Confidence 123456788999999999999999999999999999999654 4589999999976543332222 23478999
Q ss_pred chhccccc---------------------C--CCCCchhHHHHHHHHHHhCCC-CCCCCCHHHH-----------HHHHH
Q 013816 226 APEVLKRN---------------------Y--GPEVDVWSAGVILYILLCGVP-PFWAETEQGV-----------AQAII 270 (436)
Q Consensus 226 aPE~l~~~---------------------~--~~~~DiwSlG~il~~lltg~~-pf~~~~~~~~-----------~~~i~ 270 (436)
|||.+... + ..+.||||+||++|+|++|.. ||........ ...+.
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99986421 1 134799999999999999986 6643211110 01111
Q ss_pred HccccCCCCCCcccCHHHHHHHHHccCCCc---CCCCCHHHHhcCccccc
Q 013816 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDP---KRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p---~~Rps~~e~l~h~~~~~ 317 (436)
.. ......+...++..++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 458 ~~--~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQ--KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cc--CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 11 22233466789999999999999866 68999999999999964
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=314.46 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=200.3
Q ss_pred eeeccccccCCceE-EEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 57 YELGRELGRGEFGI-TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 57 y~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
|.-.+.+|.|+.|+ ||+|.- .|+.||||++-.. ..+-..+|+..|+.-.+|||||++|+.-.++...||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34456799999986 889985 4889999998543 23567899999999989999999999999999999999
Q ss_pred eccCCCchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC--CCCCCeEEEeecccccc
Q 013816 136 ELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK--KETAPLKAIDFGLSVFF 209 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~--~~~~~ikl~DfG~a~~~ 209 (436)
|.|.. +|.+++..... ...-..+.++.|+++||++||+.+||||||||.|||+... .....++|+|||+++.+
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99965 99999987411 1113457889999999999999999999999999999864 23456899999999988
Q ss_pred CCCCc----ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..+.. .....||-+|+|||++.. ..+.++||+|+||++|+.++| ..||..... ...+|+.+........ +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLE-PL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeec-cC
Confidence 65532 356789999999999974 456789999999999998886 899954433 2345665554332211 11
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
...++.+||.+||+++|..||+|.++|+||+|.+..+
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek 775 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK 775 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence 1228999999999999999999999999999987543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=302.06 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=215.0
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCceeEEEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKD 123 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~ 123 (436)
.|+.+..+|.+....|+|-|++|..|.+...|+.||||+|...... .+.=+.|+++|++|. +--++++++.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 4567778999999999999999999999999999999999876443 345578999999994 2447899999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 124 TYEDDTAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 124 ~~~~~~~~~lv~E~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
.|...+++|||+|.+. .+|.+.|+..+. +....+..++.|++.||..|-.+||+|.||||.|||++.. ...+||
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~--k~iLKL 578 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES--KNILKL 578 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC--cceeee
Confidence 9999999999999984 599999987653 7888999999999999999999999999999999999743 456999
Q ss_pred EeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 201 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
||||.|.....++. +.+.-+..|.|||++. -.|+...|+||+||+||||+||+..|.+.+...++...+.-...++..
T Consensus 579 CDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 579 CDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 99999987765443 3445567899999876 579999999999999999999999999988877766554422222211
Q ss_pred CC-------------------------------------------------ccc-------CHHHHHHHHHccCCCcCCC
Q 013816 280 PW-------------------------------------------------PKV-------SENAKDLVRKMLDPDPKRR 303 (436)
Q Consensus 280 ~~-------------------------------------------------~~~-------~~~~~~ll~~~l~~~p~~R 303 (436)
-+ +.+ -..+++||.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 00 001 1357899999999999999
Q ss_pred CCHHHHhcCccccc
Q 013816 304 LTAQQVLEHPWLQN 317 (436)
Q Consensus 304 ps~~e~l~h~~~~~ 317 (436)
.|..++|.||||..
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=257.12 Aligned_cols=213 Identities=23% Similarity=0.349 Sum_probs=177.9
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..+....+..||+|++|.|-+.++..+|+..|+|.+.... +....+++.+|+.+..+...+|.+|.+|+.+.....++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3456777889999999999999999999999999997543 34456788999999988889999999999999999999
Q ss_pred EEEeccCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 133 LVMELCEGGELFDR----IVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 133 lv~E~~~g~~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
|.||.|.- ||..+ ++..+.++|..+-+|+..++.||.|||++ .+||||+||+|||++ ..+.||+||||++.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGISG 197 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccce
Confidence 99999953 66543 34567899999999999999999999987 899999999999995 45569999999998
Q ss_pred ccCCCCcccccccCCcccchhccc-----ccCCCCCchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIR 271 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~ 271 (436)
.+.++-..+...|...|||||.+. ..|+-++||||||++++||.+++.||.. .++-+.+.++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 876555445567889999999875 2588899999999999999999999943 334444444444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=278.07 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=211.1
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-----e
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-----~ 130 (436)
+.+-.+.||-|+||+||.++|..+|+.||+|++.. .+.+-...+.+.+|+++|..+ +|.|++..+++.+-.. .
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence 45556889999999999999999999999998743 344555678899999999999 9999999998876443 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+++|.+.. +|..++..-..++...+.-++.||+.||+|||+.+|.||||||.|.|+ +.++.+||||||+++...
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccc
Confidence 6788999965 888888888889999999999999999999999999999999999999 457789999999999876
Q ss_pred CCC--cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC---------
Q 013816 211 PGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--------- 277 (436)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--------- 277 (436)
..+ .++..+-|.+|+|||++.+ .|+.+.||||+|||+.||+..+..|...+..+.++.|..-.....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 543 3455677899999999874 699999999999999999999999988777666655543211100
Q ss_pred ------------CCCCc---------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 ------------RDPWP---------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ------------~~~~~---------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+..+ ....+...++.++|..||.+|.+..+++.|++....
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 01111 123467889999999999999999999999998653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=297.12 Aligned_cols=260 Identities=28% Similarity=0.501 Sum_probs=224.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|+++..+|.|+||.||+++++.+++..|+|+++... ..+..-+.+|+-+++.. +|||||.+++.|...+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecC-CCcChHHHHhhhhhhcCc
Confidence 45678999999999999999999999999999999997654 34567788999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+++||||.||+|.+...-.+++++.++..+++..+.+|+|||+.|=+|||||=.|||+++.++ +|+.|||.+..+..
T Consensus 88 wicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhh
Confidence 999999999999999888899999999999999999999999999999999999999976554 89999999876543
Q ss_pred C-CcccccccCCcccchhcc----cccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCCcccC
Q 013816 212 G-EKFSEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVS 285 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l----~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~ 285 (436)
. .+..+..||++|||||+. ++.|...||||++|++..|+---++|............+.+..+..+. ..-...+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 2 234568999999999975 267999999999999999999989997776666555555554443332 2334568
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.+-+|++.+|.++|++||++..+|.|||....
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 899999999999999999999999999998754
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=324.66 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=184.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|.....||+|+||.||+|++..++..||+|.+..... ....|++.++++ +|||||++++++.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEE
Confidence 456677889999999999999999999999998854321 113468899999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|||++||+|.+++. .+++..+..++.|++.||.||| +.+|+||||||+||+++.+.. .++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-ecccccccc
Confidence 99999999999985 3889999999999999999999 669999999999999975443 4544 665543321
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHc---------cccCCC--
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRS---------VLDFRR-- 278 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~---------~~~~~~-- 278 (436)
.....||+.|+|||++. ..++.++|||||||++|||+||+.||...... .......+. ..+...
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12346889999999976 56999999999999999999999998532110 000011000 000000
Q ss_pred --CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 279 --DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 279 --~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
........++.+++.+||+.+|++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0001122357789999999999999999999885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=278.05 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=202.7
Q ss_pred cccccceeeccccccCCceEEEEEEEcC---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..+.+.|.++.+||+|+|++||++.+.. .++.||+|.+.... ....+.+|++.|..++.+.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 4566789999999999999999999887 78999999986432 336789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++...+|+||++.....++.. .++...+..+++.++.||.++|.+|||||||||+|+|++.... .-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhHH
Confidence 999999999998877766664 3678999999999999999999999999999999999975443 45899999987
Q ss_pred ccC-----------------C--CC--------------------------cccccccCCcccchhccc--ccCCCCCch
Q 013816 208 FFK-----------------P--GE--------------------------KFSEIVGSPYYMAPEVLK--RNYGPEVDV 240 (436)
Q Consensus 208 ~~~-----------------~--~~--------------------------~~~~~~gt~~y~aPE~l~--~~~~~~~Di 240 (436)
..+ + +. ..-...||++|+|||++. ...+++.||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 221 0 00 001236999999999986 467889999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH--------------Hcc-------------------ccC----------
Q 013816 241 WSAGVILYILLCGVPPFWAETEQ-GVAQAII--------------RSV-------------------LDF---------- 276 (436)
Q Consensus 241 wSlG~il~~lltg~~pf~~~~~~-~~~~~i~--------------~~~-------------------~~~---------- 276 (436)
||.|+|+..++++..||...... .....+. .+. ...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999999543221 0000000 000 000
Q ss_pred ---CCCCC-cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 277 ---RRDPW-PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 277 ---~~~~~-~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
....| ...+..+.+|+.+||..||.+|.||+++|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00111 1234578999999999999999999999999999843
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=292.96 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred cceeeccccccCCceEEEEEEEc---C----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 55 ERYELGRELGRGEFGITYLCTDR---E----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
++..+.+.||+|+||.|++|.-. . ....||||........ .+.+.+..|+++|..++.||||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 44567779999999999998732 1 1467999998665432 5678999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 013816 128 DTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~ 191 (436)
.+.+++|+||+..|+|.+++..++ .++......++.||+.|++||++..++||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3888899999999999999999999999999999999954
Q ss_pred CCCCCCeEEEeeccccccCCCCccc--ccccC--Ccccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCC-HHH
Q 013816 192 KKETAPLKAIDFGLSVFFKPGEKFS--EIVGS--PYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET-EQG 264 (436)
Q Consensus 192 ~~~~~~ikl~DfG~a~~~~~~~~~~--~~~gt--~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~-~~~ 264 (436)
+..+||+|||+|+......... ...|+ ..|||||.+. ..|+.++|||||||+|||++| |..||.+.. ..+
T Consensus 454 ---~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 454 ---NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ---CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 4569999999999665444332 12222 3599999987 469999999999999999988 889998755 445
Q ss_pred HHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
..+.+..+ ..... ...+++++.+++..||+.+|++||++.++.+
T Consensus 531 l~~~l~~G-~r~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 531 LLEFLKEG-NRMEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHhcC-CCCCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 54433333 32222 2457999999999999999999999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.86 Aligned_cols=200 Identities=33% Similarity=0.547 Sum_probs=175.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCC---CCceeEEEEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPK---HQNIVCLKDTYE 126 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~---h~niv~~~~~~~ 126 (436)
..|..++.+|+|+||.|++|.++.+...|++|.|.++.+-.. ...-.+-.||+||..| + |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheee
Confidence 359999999999999999999999999999999988765211 1223456799999999 5 999999999999
Q ss_pred eCCeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 127 DDTAVHLVMELC-EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 127 ~~~~~~lv~E~~-~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
+++++||+||.- +|.+|++++.-+..++|.++..|++|++.|+++||+.||||||||-+|+.++. ++.+||+|||.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~---~g~~klidfgs 716 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS---NGFVKLIDFGS 716 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEec---CCeEEEeeccc
Confidence 999999999975 57799999999999999999999999999999999999999999999999964 45589999998
Q ss_pred ccccCCCCcccccccCCcccchhccccc--CCCCCchhHHHHHHHHHHhCCCCCCC
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWA 259 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~ 259 (436)
|..... ......+||..|.|||++.+. .+..-|||++|++||.++....||++
T Consensus 717 aa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 877653 455778999999999999864 46779999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=284.26 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=206.0
Q ss_pred eeeccccccCCceEEEEEEEcCCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.+..++||+|+||+||+|.+-..|+ +||+|++.... ......++.+|+-+|.+| +|||++++++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence 4556789999999999999876664 58888876543 333457899999999999 9999999999998776 78
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||++|+++|+|.++++.+ ..+..+..+.|..||+.|+.|||.++++||||-..||||. ...++||.|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccCc
Confidence 999999999999999864 5688999999999999999999999999999999999995 455699999999998876
Q ss_pred CCcccc-cc--cCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 GEKFSE-IV--GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~~~~~~-~~--gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
....-. .. -.+.|||=|.+. ..|+.++|||||||++||++| |..|+.+....++...+..+.. . ...+..+.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-L--sqPpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-L--SQPPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-C--CCCCCccH
Confidence 543322 22 235689999876 679999999999999999988 9999999988877776665543 3 33357899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.-++.+||..|+..||+++++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999999865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=263.40 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=186.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEEEEEEeCC----e
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLKDTYEDDT----A 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~~----~ 130 (436)
..++.+.||+|.||.||+|.. +++.||||++.. .+.+.+.+|-+|.+... +|+||+++++.-+... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 466788999999999999985 479999999843 34567888888777532 8999999998876555 8
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceEeecCCCCCCeEEE
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------GVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
++||+||.+.|+|.++|+.+ .+++....+|+..|+.||+|||+- .|+|||||..|||+.+ +.+..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~---DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN---DLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc---CCcEEee
Confidence 99999999999999999876 689999999999999999999962 5999999999999954 4557999
Q ss_pred eeccccccCCCCc---ccccccCCcccchhccccc--CC-----CCCchhHHHHHHHHHHhCC------------CCCC-
Q 013816 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKRN--YG-----PEVDVWSAGVILYILLCGV------------PPFW- 258 (436)
Q Consensus 202 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~-----~~~DiwSlG~il~~lltg~------------~pf~- 258 (436)
|||+|..+.++.. ....+||.+|||||++.+. +. .+.||||+|.+||||++.. .||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999998876533 2347999999999999764 22 2589999999999999863 2332
Q ss_pred ----CCCHHHHHHHHHHccccC-CCCCCcc--cCHHHHHHHHHccCCCcCCCCCHHHH
Q 013816 259 ----AETEQGVAQAIIRSVLDF-RRDPWPK--VSENAKDLVRKMLDPDPKRRLTAQQV 309 (436)
Q Consensus 259 ----~~~~~~~~~~i~~~~~~~-~~~~~~~--~~~~~~~ll~~~l~~~p~~Rps~~e~ 309 (436)
..+..++...+.+..... -+..|.. -..-+++.+.-||..||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 122333333343332211 1122222 23457899999999999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=260.30 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=189.3
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEEEEEeC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYEDD- 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l-~~h~niv~~~~~~~~~- 128 (436)
+.+..+..+.+.||+|.||.||+|.++ |+.||||++... +...+.+|.++.+.+ -+|+||+.+++.=..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 456788999999999999999999986 999999998543 446788898888752 3899999999764322
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCCCC
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETAP 197 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiH~dlkp~NIl~~~~~~~~~ 197 (436)
..+|||++|.+.|||+|+|.. ..++.....+++..++.||.|||-. .|.|||||..|||+.+ ++.
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk---n~~ 354 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGT 354 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc---CCc
Confidence 368999999999999999987 5799999999999999999999953 4999999999999954 455
Q ss_pred eEEEeeccccccCCCC-----cccccccCCcccchhcccccC------C-CCCchhHHHHHHHHHHhC----------CC
Q 013816 198 LKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRNY------G-PEVDVWSAGVILYILLCG----------VP 255 (436)
Q Consensus 198 ikl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~------~-~~~DiwSlG~il~~lltg----------~~ 255 (436)
.-|+|+|+|....... ..+..+||..|||||++.... + ..+||||||.++||+... .+
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 8999999997665432 235679999999999996432 2 258999999999998753 57
Q ss_pred CCCCCC-----HHHHHHHHHHcccc-CCCCCCcccC--HHHHHHHHHccCCCcCCCCCHHHHh
Q 013816 256 PFWAET-----EQGVAQAIIRSVLD-FRRDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVL 310 (436)
Q Consensus 256 pf~~~~-----~~~~~~~i~~~~~~-~~~~~~~~~~--~~~~~ll~~~l~~~p~~Rps~~e~l 310 (436)
||++.. .+++..-+.-.... ..+..|...+ ..+..+++.||..||.-|.||-.+-
T Consensus 435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 885432 22222222211111 1122233222 3467899999999999999886553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.35 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=202.1
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE-EEeCCe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDTA 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~-~~~~~~ 130 (436)
.+.+.|.|.+.||+|.||.+-+|.++.+++.+|+|.+.+.. ....+|.+|...--.|+.|.||+.-|++ |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 46688999999999999999999999999999999986543 3467899999888888889999988875 788889
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++++||++.|+|..-+... .+.|.....++.|+++|+.|+|++++||||||.+|||+-..+- .+|||||||.++...
T Consensus 97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df-~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF-YRVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc-cEEEeeecccccccC
Confidence 99999999999998877654 4889999999999999999999999999999999999965433 379999999887643
Q ss_pred CCCcccccccCCcccchhccc----c--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHccccCCCCC
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK----R--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~----~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~~ 280 (436)
. .....-.+..|.+||.+. + ...+.+|||.||+++|.++||.+||+..... ........+.-.--+..
T Consensus 175 ~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 T--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred c--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 2 222223456799999753 2 2578899999999999999999999643211 11122222222222233
Q ss_pred CcccCHHHHHHHHHccCCCcCCC---CCHHHHhcCccccc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQN 317 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~R---ps~~e~l~h~~~~~ 317 (436)
+..+++.+..+.++-|..+|++| -+++.....-|...
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 45689999999999999999999 45555555566543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=239.31 Aligned_cols=211 Identities=43% Similarity=0.750 Sum_probs=184.6
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCc
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~ 142 (436)
||+|++|.||++.+..+++.+++|++....... ..+.+.+|+..++.+ .|++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999986553221 346799999999999 89999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-ccccccc
Q 013816 143 LFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVG 220 (436)
Q Consensus 143 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-~~~~~~g 220 (436)
|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|.||+++.. ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99998775 468999999999999999999999999999999999999752 3458999999998664432 1334567
Q ss_pred CCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 221 SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 221 t~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
+..|++||.+.. .++.++|+||+|++++++ ..+.+++.+|++.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 889999999874 678899999999999999 6788999999999
Q ss_pred CcCCCCCHHHHhcCc
Q 013816 299 DPKRRLTAQQVLEHP 313 (436)
Q Consensus 299 ~p~~Rps~~e~l~h~ 313 (436)
+|++||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-31 Score=236.13 Aligned_cols=210 Identities=41% Similarity=0.725 Sum_probs=179.0
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++++ +|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence 56778999999999999999888999999998765432 2467899999999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC--
Q 013816 137 LCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-- 213 (436)
++++++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|+||+++.+ ..++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCcccc
Confidence 9999999999987766 8999999999999999999999999999999999999654 569999999998765442
Q ss_pred cccccccCCcccchhcc-c-ccCCCCCchhHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHHc
Q 013816 214 KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQ-GVAQAIIRS 272 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~-~~~~~i~~~ 272 (436)
......++..|++||.+ . ..++.++|+||||+++++|++|+.||.. .... .+.+.+..+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 33455778899999997 4 4577899999999999999999999977 3443 444444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=290.08 Aligned_cols=199 Identities=20% Similarity=0.264 Sum_probs=148.7
Q ss_pred CC-CceeEEEEEE-------EeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013816 114 KH-QNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (436)
Q Consensus 114 ~h-~niv~~~~~~-------~~~~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp 184 (436)
.| +||+++++++ .....++.++|++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 45 5777777776 3345677889988 5699999965 34599999999999999999999999999999999
Q ss_pred CceEeecC----------------CCCCCeEEEeeccccccCCCC-----------------cccccccCCcccchhccc
Q 013816 185 ENFLFANK----------------KETAPLKAIDFGLSVFFKPGE-----------------KFSEIVGSPYYMAPEVLK 231 (436)
Q Consensus 185 ~NIl~~~~----------------~~~~~ikl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l~ 231 (436)
+|||++.. +....+|++|||+++...... .....+||++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 99999531 233457888888876432100 011246899999999976
Q ss_pred -ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHh
Q 013816 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310 (436)
Q Consensus 232 -~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l 310 (436)
..++.++|||||||+||||++|..|+.... .....+..... + .......+...+++.+||+++|.+||++.|+|
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--P-PQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--C-hhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 569999999999999999999988874321 12222222211 1 11112345678999999999999999999999
Q ss_pred cCcccccC
Q 013816 311 EHPWLQNA 318 (436)
Q Consensus 311 ~h~~~~~~ 318 (436)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=231.93 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=202.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-eC
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DD 128 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~ 128 (436)
.|+++...+-+|.||.||.|.+++.. +.|-+|.+... .++.+...+..|...+..+ .|||+..+.++.. +.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence 57888889999999999999876443 34666776543 2455677899999999999 7999999999874 55
Q ss_pred CeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
...++++.+..-|+|..++... ..++..+...++.|++.|+.|||++|+||.||-..|.++++ ...|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd---~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD---QLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh---heeEEe
Confidence 6788899999889999998732 23667788899999999999999999999999999999964 466999
Q ss_pred EeeccccccCCCCccc---ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcccc
Q 013816 201 IDFGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 201 ~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
+|=.+++.+.+.+... ..--...|||||.+. ..|+.++|+||||++||||+| |+.|+...++.++..-+..+..-
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL 517 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence 9999998776554321 111235799999987 569999999999999999987 99999999998888777765432
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...-++|+++..++.-||...|++||+.+|+..
T Consensus 518 ---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 ---AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222478999999999999999999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-28 Score=227.64 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=194.8
Q ss_pred ceeeccccccCCceEEEEEEEcCCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEEEE-EeCCe
Q 013816 56 RYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTY-EDDTA 130 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---h~niv~~~~~~-~~~~~ 130 (436)
+|.+.+.||+|+||.||.|.+..++ ..+|+|.......... ..+..|..++..+.. -+++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987765 6789888765432211 267789999998842 36899999999 57888
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--CCCeEEEeeccc
Q 013816 131 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLS 206 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~--~~~ikl~DfG~a 206 (436)
.|+||+.+ |.+|.++.... +.++..++..|+.|++.+|.+||+.|++||||||+|+++..... ...+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 78999988654 47999999999999999999999999999999999999976532 256999999999
Q ss_pred cccC---CCC-------c-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc
Q 013816 207 VFFK---PGE-------K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 207 ~~~~---~~~-------~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 274 (436)
+... ... . .....||..|+++.+.. ...+++.|+||++.++.+++.|..||.+.........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 111 1 12345999999999866 5689999999999999999999999976654333333332222
Q ss_pred cCCCC-CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 275 DFRRD-PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 275 ~~~~~-~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..... .....+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223355777888777777888888888777654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=214.21 Aligned_cols=162 Identities=26% Similarity=0.332 Sum_probs=126.6
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccc
Q 013816 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (436)
Q Consensus 141 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~ 219 (436)
|+|.+++..+ ..+++..++.++.|++.||.|||+.+ ||+|||++. ++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~---~~~~~~--fG~~~~~~~~----~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW---DGLLKL--DGSVAFKTPE----QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC---ccceee--ccceEeeccc----cCC
Confidence 6899999874 45999999999999999999999998 999999964 344787 9998865432 226
Q ss_pred cCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCC---CCCcccCH--HHHHHH
Q 013816 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRR---DPWPKVSE--NAKDLV 292 (436)
Q Consensus 220 gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~~~--~~~~ll 292 (436)
||+.|+|||++. ..++.++|||||||++|+|+||..||...... .....+......... .....++. ++++++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999986 56899999999999999999999999765432 233333333222111 11122333 699999
Q ss_pred HHccCCCcCCCCCHHHHhcCccccc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.+||..+|.+||++.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=255.59 Aligned_cols=257 Identities=29% Similarity=0.491 Sum_probs=197.5
Q ss_pred eeccccccCCceEEEEEEEcCCCcEEEEEEeecc--ccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKK--KLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~--~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.....+|.|++|.|+.+........++.|..... .... ......+..|+-+-..| .|||++..+..+.+....+-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence 4567899999999998887776776777655421 1111 11112266677777788 899998887777766666666
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC--
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-- 212 (436)
||||++ +|+.++...+.++...+..++.|++.|++|+|+.||.||||||+|+++... +.+||+|||.+......
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeeccCcc
Confidence 999999 999999988889999999999999999999999999999999999999654 46999999988765432
Q ss_pred ---CcccccccCCcccchhccc-ccCCC-CCchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHH---HHccccCCCCCCc
Q 013816 213 ---EKFSEIVGSPYYMAPEVLK-RNYGP-EVDVWSAGVILYILLCGVPPFWAETEQGVA--QAI---IRSVLDFRRDPWP 282 (436)
Q Consensus 213 ---~~~~~~~gt~~y~aPE~l~-~~~~~-~~DiwSlG~il~~lltg~~pf~~~~~~~~~--~~i---~~~~~~~~~~~~~ 282 (436)
......+|+..|+|||++. ..|.+ ..||||.|++++.|++|+.||......... ... .......+...+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 1235678999999999987 45766 489999999999999999999654433221 111 0111111222344
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.++.+.+.+|.+||+++|.+|.|+.+|++.+||+...
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 6788999999999999999999999999999998653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=225.97 Aligned_cols=176 Identities=20% Similarity=0.254 Sum_probs=134.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcC-CCcEEEEEEeecccc--CChhhHHHHHHHHHHHHhCCCCCceeE-EEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC-LKDTYE 126 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~-~~~~~~ 126 (436)
+.+.++|.+.+.||+|+||+||+|++.. +++.+|||++..... ........+.+|+++|+++ +|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc--
Confidence 4567889999999999999999999876 678889998753211 1223456799999999999 8999884 5442
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceEeecCCCCCCeEEEeecc
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl-kp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
+..|+||||++|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.+ +.+||+|||+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~---~~ikLiDFGl 158 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD---GEAAVIDFQL 158 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC---CCEEEEECcc
Confidence 45799999999999963 211 11 1467899999999999999999999 9999999543 4599999999
Q ss_pred ccccCCCC---------cccccccCCcccchhccccc-------CCCCCchh
Q 013816 206 SVFFKPGE---------KFSEIVGSPYYMAPEVLKRN-------YGPEVDVW 241 (436)
Q Consensus 206 a~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-------~~~~~Diw 241 (436)
|+.+.... ......+++.|+|||.+... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 98665432 12356788899999998521 23447777
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=201.63 Aligned_cols=250 Identities=20% Similarity=0.247 Sum_probs=199.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.+.|+++++||+|+||.+|+|....+|..||+|.-+.... ...+..|..+.+.|..-..|+.+..+..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 346789999999999999999999999999999998765432 245778999999997778899999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.+||+.+ |.||.+++.-. ..++..+++.++-|++.-++|+|.+++|||||||+|+|..-+.....+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 88999888643 469999999999999999999999999999999999999765556679999999998775
Q ss_pred CCC--------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHccccCCC
Q 013816 211 PGE--------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---VAQAIIRSVLDFRR 278 (436)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~~~~~ 278 (436)
+.. .-....||..|.+-.... -..+.+.|+-|+|.+|.++.-|..||++..... -...|.+.....+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 432 124568999999988754 457888999999999999999999998865543 33344443332222
Q ss_pred C-CCcccCHHHHHHHHHccCCCcCCCCCHH
Q 013816 279 D-PWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (436)
Q Consensus 279 ~-~~~~~~~~~~~ll~~~l~~~p~~Rps~~ 307 (436)
. .....|.++.-.+.-|-..--++-|...
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 1 1245678888888888666555666543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-26 Score=217.71 Aligned_cols=256 Identities=37% Similarity=0.593 Sum_probs=207.7
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEEEEEeCCeEEEEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~ 135 (436)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+ .|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999986 88999998876654433567899999999999 666 8999999998888889999
Q ss_pred eccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+++.++++.+.+.... .+++.....++.|++.++.|+|+.+++|||+||+||+++..+. .++++|||.+......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP 155 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence 9999999997777664 6899999999999999999999999999999999999965432 4899999999755433
Q ss_pred C-------cccccccCCcccchhcccc----cCCCCCchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHcccc-C
Q 013816 213 E-------KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLD-F 276 (436)
Q Consensus 213 ~-------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~-~ 276 (436)
. ......||..|+|||.+.+ .++...|+||+|++++++++|..||..... ......+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 2466789999999999864 578899999999999999999999876653 3444444443322 1
Q ss_pred CCCCCccc----CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 277 RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 277 ~~~~~~~~----~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
........ ...+.+++..++..+|..|.+..+...++|....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21111111 2578999999999999999999999998776543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=207.76 Aligned_cols=205 Identities=22% Similarity=0.399 Sum_probs=176.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.-.|+++++||+|+||+.+.|+..-++++||||.-.... ...+++.|....+.|...++|..+|.+..+..+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 34557999999999999999999999999999999764332 3467888999999998999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeeccccc
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~a~~ 208 (436)
.||+|++ |.||.|+..-+ ..++..+++.++.|++.-++|+|++.+|.|||||+|+||...+ ....|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999998 88999988755 4599999999999999999999999999999999999996532 344699999999998
Q ss_pred cCCCCc--------ccccccCCcccchhc-ccccCCCCCchhHHHHHHHHHHhCCCCCCCCCH
Q 013816 209 FKPGEK--------FSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (436)
Q Consensus 209 ~~~~~~--------~~~~~gt~~y~aPE~-l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 262 (436)
+.+... ..+..||..||+-.. +....+.+.|+-|||-++++.|-|.+||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 765432 245789999999887 446688999999999999999999999987544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-27 Score=227.68 Aligned_cols=241 Identities=27% Similarity=0.460 Sum_probs=203.1
Q ss_pred ccccCCceEEEEEE---EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 62 ELGRGEFGITYLCT---DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~---~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
.+|.|+||.|+++. -...|.-+|.|+..+......... .-..|..++..+..||.+|++...++.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999765 235578899998877665443322 45568888888867999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCccccc
Q 013816 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (436)
Q Consensus 139 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~ 218 (436)
.||.|...+.....+.+.....+...++-++.++|+.+|+|||+|++||+++ ..+++++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHhhhhc---
Confidence 9999999998888889999999999999999999999999999999999995 4556899999999876433332
Q ss_pred ccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCC
Q 013816 219 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (436)
Q Consensus 219 ~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 298 (436)
+||..|||||+++ .....+|.||||+++++|+||..||.. +....|.+.....+ ..++..+++++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----RELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhh
Confidence 8999999999998 667899999999999999999999977 56666666555443 35788999999999999
Q ss_pred CcCCCCC-----HHHHhcCcccccC
Q 013816 299 DPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 299 ~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+|..|.- +.++++|+||+..
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred CHHHHhccCcchhHHHhccchheee
Confidence 9999974 5799999999753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=197.47 Aligned_cols=176 Identities=19% Similarity=0.208 Sum_probs=135.3
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHH------HHHHHHHHHhCCCCCceeEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED------VRREVDIMRHLPKHQNIVCLKDT 124 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~------~~~E~~~l~~l~~h~niv~~~~~ 124 (436)
..+.++|++++.||.|+||.||++.+ ++..+|+|.+............. +.+|+..+.++ .||+|..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence 35678999999999999999999754 47789999997655444333333 68999999999 99999999988
Q ss_pred EEeC--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 125 YEDD--------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 125 ~~~~--------~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
+... +..++||||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||++|+||+++.+ +
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C
Confidence 6643 3588999999999997763 2333 346699999999999999999999999999643 3
Q ss_pred CeEEEeeccccccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHH
Q 013816 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILL 251 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~ll 251 (436)
++|+|||.+........... =++...+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 89999998765432211110 012345778999999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=189.95 Aligned_cols=142 Identities=20% Similarity=0.228 Sum_probs=110.5
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhh-----------------------HHHHHHHHHHHHhCCCCC
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-----------------------IEDVRREVDIMRHLPKHQ 116 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~-----------------------~~~~~~E~~~l~~l~~h~ 116 (436)
...||+|++|.||+|.+. +|+.||+|++.......... .....+|++++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 467999999999999986 89999999997653211110 11234599999999 777
Q ss_pred ceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceEeecCCCC
Q 013816 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 117 niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
++.....+... . .+|||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+|||+++
T Consensus 80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---- 153 (190)
T cd05147 80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---- 153 (190)
T ss_pred CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence 76443333222 2 379999999987766555556799999999999999999999 7999999999999999963
Q ss_pred CCeEEEeecccccc
Q 013816 196 APLKAIDFGLSVFF 209 (436)
Q Consensus 196 ~~ikl~DfG~a~~~ 209 (436)
..++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 35999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=197.27 Aligned_cols=234 Identities=27% Similarity=0.426 Sum_probs=153.3
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---------CCceeEEEEEE-
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---------HQNIVCLKDTY- 125 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---------h~niv~~~~~~- 125 (436)
.+...+.||.|+++.||.+++..||+.+|+|+............+.+++|.-....+.. |-.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778889999999999999999999999999876654444567778887765555422 22333333322
Q ss_pred --------EeC---C-----eEEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 013816 126 --------EDD---T-----AVHLVMELCEGGELFDRIV---ARGH----YTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182 (436)
Q Consensus 126 --------~~~---~-----~~~lv~E~~~g~~L~~~l~---~~~~----~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl 182 (436)
... . +.+++|+-+.+ +|.+.+. .... +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 34678888754 8877653 2222 222334566789999999999999999999
Q ss_pred CCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhcccc---------cCCCCCchhHHHHHHHHHHhC
Q 013816 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR---------NYGPEVDVWSAGVILYILLCG 253 (436)
Q Consensus 183 kp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DiwSlG~il~~lltg 253 (436)
+|+|++++. ++.+.|+||+...... ........+..|.|||.... .++.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~---~G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQ---DGGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-T---TS-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcC---CCCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999965 4559999998776543 22222345578999997632 368889999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCC
Q 013816 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303 (436)
Q Consensus 254 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 303 (436)
..||........... .+.. ...+|+.++.||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~--C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSR--CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTT--SS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchh--cCCcCHHHHHHHHHHccCCcccC
Confidence 999965543311110 2222 23789999999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-25 Score=220.55 Aligned_cols=221 Identities=30% Similarity=0.536 Sum_probs=176.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...+|..++.|..|+||.||+++|+.+.+.+|.| +.+..+ +.+- ++... ..|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--ccccc-CCccee-------------
Confidence 3578999999999999999999999999999994 433321 1111 33333 555555
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|+-...++.-++++... +.+++|||+.||+|||+||+|.+++. -+++|+.|||+++..-..
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~---mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee---cccccccchhhhhhhhhh
Confidence 34445555555666544 77899999999999999999999964 455899999998643211
Q ss_pred C----------------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 213 E----------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 213 ~----------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
. .....+|||.|+|||++. +.|+..+|.|++|+|+|+.+.|..||.+.+.++....++...+.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0 013468999999999865 77999999999999999999999999999999999999998888
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCC---CCHHHHhcCcccccC
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQNA 318 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R---ps~~e~l~h~~~~~~ 318 (436)
++... ..+++++++++.++|+.+|..| +.+.++.+|+||+..
T Consensus 277 wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 277 WPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 87774 4688999999999999999999 478899999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=194.28 Aligned_cols=192 Identities=29% Similarity=0.448 Sum_probs=142.5
Q ss_pred CCCCCceeEEEEEEEe---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHH
Q 013816 112 LPKHQNIVCLKDTYED---------------------------DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164 (436)
Q Consensus 112 l~~h~niv~~~~~~~~---------------------------~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~q 164 (436)
|.+|||||++...|.+ ....|+||-..+. +|..++..+ ..+.....-++.|
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQ 349 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHH
Confidence 3579999999887643 3468999988864 999988765 5778888999999
Q ss_pred HHHHHHHHHHCCceecCCCCCceEeecCC-CCCCeEEEeeccccccCCC-------CcccccccCCcccchhcccccCC-
Q 013816 165 IVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPG-------EKFSEIVGSPYYMAPEVLKRNYG- 235 (436)
Q Consensus 165 i~~~l~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~- 235 (436)
+++|+.|||++||.|||+|.+|||+.-++ ....+.|+|||.+-.-+.. ......-|.-.-||||+.....+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999997543 3346889999976433221 11123456778999999753222
Q ss_pred ------CCCchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHH
Q 013816 236 ------PEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ 308 (436)
Q Consensus 236 ------~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e 308 (436)
.|+|.|+.|.+.||+++...||+...+..... ...+.. . +.-...+++.+++++..+|+.||++|+|+.-
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q--L-Palp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ--L-PALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh--C-CCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 37999999999999999999998744321111 111111 1 1112468899999999999999999998543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=179.95 Aligned_cols=188 Identities=21% Similarity=0.273 Sum_probs=141.1
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEec
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+...|++|+||+||.+.. .+..++.+.+.....-. ......+.+|+++|++|..|+++++++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 457799999999998764 57888877665443211 11223588999999999767899999986 346899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceEeecCCCCCCeEEEeeccccccCCCCccc
Q 013816 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216 (436)
Q Consensus 138 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl-kp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~ 216 (436)
+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++. .+.++|+|||+|..........
T Consensus 80 I~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~---~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE---DGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC---CCCEEEEECCCceecCCcchHH
Confidence 999988654321 1 2357889999999999999999999 799999964 3459999999998655433210
Q ss_pred --------------ccccCCcccchhccc--ccCC-CCCchhHHHHHHHHHHhCCCCCCCCCH
Q 013816 217 --------------EIVGSPYYMAPEVLK--RNYG-PEVDVWSAGVILYILLCGVPPFWAETE 262 (436)
Q Consensus 217 --------------~~~gt~~y~aPE~l~--~~~~-~~~DiwSlG~il~~lltg~~pf~~~~~ 262 (436)
-...++.|++|+.-. ...+ ...+.++.|.-+|.++|+..|++...+
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 113578888888543 2333 567889999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=181.03 Aligned_cols=144 Identities=17% Similarity=0.193 Sum_probs=112.7
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----------------------hhHHHHHHHHHHHHhCCCC
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----------------------VDIEDVRREVDIMRHLPKH 115 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~~h 115 (436)
+.+.||+|++|.||+|.+. +|+.||||++........ .....+.+|+..+.++ .|
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 78 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YE 78 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-Hh
Confidence 3578999999999999987 899999999986531100 0012346799999999 88
Q ss_pred CceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCC
Q 013816 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE 194 (436)
Q Consensus 116 ~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~ 194 (436)
+++.....+.... .++||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+||+++
T Consensus 79 ~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~---- 152 (190)
T cd05145 79 AGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH---- 152 (190)
T ss_pred CCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----
Confidence 8875444433332 47999999988665443445678889999999999999999999 9999999999999996
Q ss_pred CCCeEEEeeccccccC
Q 013816 195 TAPLKAIDFGLSVFFK 210 (436)
Q Consensus 195 ~~~ikl~DfG~a~~~~ 210 (436)
.+.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 3458999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-24 Score=213.29 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=176.8
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.|...+.||++.|=.|.+|++. .|. |+||++-+... -+-....+...|++ .. +.+|||.+.+.-+.+.+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHHHH
Confidence 5788899999999999999875 354 99999866542 12223344444555 33 34899999998888888889999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc--CCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~--~~~ 212 (436)
-+|... +|+|.+..+..+..-+.+-|+.|++.||..+|..||+|||||.+|||+++.+- +.|+||..-+.. ..+
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW---~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW---LYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech---hhhhcccccCCccCCCC
Confidence 999964 99999999888899999999999999999999999999999999999987543 789999755422 111
Q ss_pred --Cccccc----ccCCcccchhcccc-----------c-CCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc
Q 013816 213 --EKFSEI----VGSPYYMAPEVLKR-----------N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 213 --~~~~~~----~gt~~y~aPE~l~~-----------~-~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 273 (436)
...+-+ .--..|.|||.+.. . .+++-||||+||++.||++ |.+||.-. .+-+..++.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC
Confidence 111111 12246999997521 1 4678999999999999987 68888211 111111111
Q ss_pred ccCCCCCCcc-cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 274 LDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 274 ~~~~~~~~~~-~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
...+..-+.. -+..++.+|..|++.||.+|.||.+.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000000 13468999999999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=173.79 Aligned_cols=139 Identities=18% Similarity=0.199 Sum_probs=109.4
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----CCCceeEEEEEEEeCC---e-E
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQNIVCLKDTYEDDT---A-V 131 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~---~-~ 131 (436)
...||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+. .||||++++++++++. . +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 6777666 6898865432 23467999999999993 4799999999998874 4 3
Q ss_pred EEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCceEeecCC-CCCCeEEEeecccc
Q 013816 132 HLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVV-QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSV 207 (436)
Q Consensus 132 ~lv~E~--~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~a~ 207 (436)
.+|+|| +.+++|.+++.+. .+++. ..++.|++.++ .|||+++|+||||||+|||++..+ ....++|+||+.+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 478999 5579999999664 56665 35678888777 999999999999999999997643 33479999955443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=178.45 Aligned_cols=242 Identities=18% Similarity=0.231 Sum_probs=189.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
...++-+|.+...|..|+|++. |..+++|++........ -..+|..|.-.|+-+ .||||+.+++.|....+..++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~r-isrdfneefp~lrif-shpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTAR-ISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchh-hcchhhhhCcceeee-cCCchhhhhhhccCCCCceEee
Confidence 3556677999999999999986 66677788765544322 235788899999988 8999999999999999999999
Q ss_pred eccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 136 ELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
.|++.|+|+..+..... ....++.+++..|+.|+.|||+.. |.--.|....++++.+- ...+..+|-.++...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfqe-- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQE-- 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeeec--
Confidence 99999999999987644 567889999999999999999974 44456888889996543 334555554433221
Q ss_pred CCcccccccCCcccchhcccccC----CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLKRNY----GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~~~----~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
......|.|||||.+.... -.++|+|||++++|||.|...||......+.-..|.-..+. ....+.++..
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~h 417 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRH 417 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHH
Confidence 1223468899999987432 24689999999999999999999888887776666554443 3334689999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHh
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVL 310 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l 310 (436)
+..|+.-|+..||.+||.+..++
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999887653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=201.21 Aligned_cols=193 Identities=24% Similarity=0.383 Sum_probs=158.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---h~niv~~~~~~~~~~~~ 131 (436)
..|.|.+.||+|+||.||.|.+.. |+.||+|+-..... -+|.--.+++.+| + -+-|..+...+...+.-
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~------WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP------WEFYICLQVMERL-KPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc------eeeeehHHHHHhh-chhhhcchHHHHHHHccCCcc
Confidence 579999999999999999999876 99999998654432 2233344555666 3 23455555666677778
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec----CCCCCCeEEEeecccc
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN----KKETAPLKAIDFGLSV 207 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~----~~~~~~ikl~DfG~a~ 207 (436)
++|+||.+.|+|.+++...+..++..+..++.||+..+.+||..+||||||||+|+|+.. +....-++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998888999999999999999999999999999999999999953 2234569999999885
Q ss_pred cc---CCCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCC
Q 013816 208 FF---KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVP 255 (436)
Q Consensus 208 ~~---~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~ 255 (436)
.+ .++......++|-.+-.+|+..+ .|++..|.|.|+.+++.||.|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 43 34556677899999999999874 69999999999999999999964
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=172.64 Aligned_cols=146 Identities=20% Similarity=0.135 Sum_probs=114.4
Q ss_pred ceeeccccccCCceEEEEEE-EcCCCcEEEEEEeeccccCC-------------------hh--hHHHHHHHHHHHHhCC
Q 013816 56 RYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRT-------------------AV--DIEDVRREVDIMRHLP 113 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~i~~~~~~~-------------------~~--~~~~~~~E~~~l~~l~ 113 (436)
-|.+.+.||+|++|.||+|. +..+|+.||+|++....... .. ....+.+|+.++.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 48899999999999999999 67889999999987543210 00 112467899999999
Q ss_pred CCC--ceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCceEee
Q 013816 114 KHQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFA 190 (436)
Q Consensus 114 ~h~--niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-iiH~dlkp~NIl~~ 190 (436)
.+. .+++++++ . ..++||||++|.+|.........+....+..++.|++.++.+||+.| |+||||||+||+++
T Consensus 108 ~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 543 34455543 2 34799999999888766545556677778899999999999999999 99999999999996
Q ss_pred cCCCCCCeEEEeeccccccC
Q 013816 191 NKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~ 210 (436)
...++|+|||.+....
T Consensus 184 ----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 ----DGKVVIIDVSQSVELD 199 (237)
T ss_pred ----CCCEEEEEChhhhccC
Confidence 3458999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-22 Score=186.90 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=165.1
Q ss_pred cceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEE-------E
Q 013816 55 ERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-------T 124 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~-------~ 124 (436)
..+.+.+..+..+++.+....-..+ ...++-+...... ........+++-.+.....|+..+ +.+ .
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~---~~~~~~~~r~~~~l~~~~~~~~s~-~~d~~~s~~~~ 319 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDS---LCACKYTFRQLGVLVDSSHSNRSI-LEDLRPSLFES 319 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccc---hhhhhhhhhhhhheeccccCCccc-ccCCCCchhhh
Confidence 3455666677777777665543222 2334433332221 112233444555554443444433 222 1
Q ss_pred EE-----eCCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 125 YE-----DDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 125 ~~-----~~~~~~lv~E~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
+. ...++||.|++|.-.+|.+++..+. ..+....+.++.|+..|+.| ++.+|+|+||.||++..+.
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--- 393 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--- 393 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch---
Confidence 11 1236889999999999999997553 35677889999999999999 9999999999999996544
Q ss_pred CeEEEeeccccccCCCC-------cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 013816 197 PLKAIDFGLSVFFKPGE-------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 267 (436)
.+||.|||+........ ..+..+||.+||+||.+. ..|+.++||||||+||+||++ =..+|. ......
T Consensus 394 q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~ 470 (516)
T KOG1033|consen 394 QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLT 470 (516)
T ss_pred hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhh
Confidence 48999999988776554 557789999999999998 569999999999999999997 222221 111222
Q ss_pred HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
.+..+.+. +..+.. .++-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 471 d~r~g~ip--~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIP--PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCC--hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22233221 111222 2455789999999999999988888777775
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=161.69 Aligned_cols=137 Identities=28% Similarity=0.374 Sum_probs=113.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
+.||+|++|.||+|.+ .|..+++|+......... .....+.+|+.++..+ .|++|+....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999986 678899998654433221 1234678899999999 8998877777777778889999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
||++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ...++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 99999999998865432 7889999999999999999999999999999997 34589999998875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=177.20 Aligned_cols=199 Identities=22% Similarity=0.321 Sum_probs=155.8
Q ss_pred HhCCCCCceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCce
Q 013816 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGV-MHRDLKPENF 187 (436)
Q Consensus 110 ~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i-iH~dlkp~NI 187 (436)
+.+ .|.|+.++++.+.+....++|.+||..|+|.|.+... -.+++.....+++.|+.||.|+|+..| .|+.|+++|.
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 456 8999999999999999999999999999999999873 457888899999999999999999876 9999999999
Q ss_pred EeecCCCCCCeEEEeeccccccCCC---CcccccccCCcccchhccccc--------CCCCCchhHHHHHHHHHHhCCCC
Q 013816 188 LFANKKETAPLKAIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLKRN--------YGPEVDVWSAGVILYILLCGVPP 256 (436)
Q Consensus 188 l~~~~~~~~~ikl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~--------~~~~~DiwSlG~il~~lltg~~p 256 (436)
+++. ...+||+|||+....... .......-...|.|||.+... .+.+.||||||++++|+++...|
T Consensus 81 lvd~---~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDS---RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeee---eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9964 455999999998766421 111222334579999998642 46779999999999999999999
Q ss_pred CCCCCH----HHHHHHHHH-ccccCCCCCC--cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 257 FWAETE----QGVAQAIIR-SVLDFRRDPW--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 257 f~~~~~----~~~~~~i~~-~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
|..... .+....+.+ +...+.+..+ ...++++..++..||..+|..||++.++-..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 965322 234444444 2222222222 1456679999999999999999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-22 Score=199.98 Aligned_cols=261 Identities=30% Similarity=0.525 Sum_probs=208.9
Q ss_pred ccceeeccccccCCceEEEEEEEc-CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...|.+.+.||+|+|+.|-.+... .....+|+|.+.... ......+....|..+-..+.+|+|++.+++...+....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 346888889999999999988753 334567777765543 223344566668888888856999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 133 LVMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 133 lv~E~~~g~~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
++++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+|+||+|.+++..+. .+++.|||+|..+
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~ 175 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAY 175 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhccc
Confidence 999999999999988 5544 5777888999999999999999 999999999999999976543 5899999999877
Q ss_pred CC-CC---ccccccc-CCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHccccCCCCCC
Q 013816 210 KP-GE---KFSEIVG-SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPW 281 (436)
Q Consensus 210 ~~-~~---~~~~~~g-t~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 281 (436)
.. .. .....+| ++.|+|||...+ ...+..|+||.|+++.-+++|..|+......... .........+...+|
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence 65 22 2245678 999999999765 4578899999999999999999998654433211 122222223345678
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..++....+++.++|..+|..|.+..++-.+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 889999999999999999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-19 Score=155.52 Aligned_cols=134 Identities=26% Similarity=0.319 Sum_probs=106.1
Q ss_pred ccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
.||+|++|.||+|.+ +|..+++|.......... .....+.+|++++..+ .|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999984 578899998654332221 1235678899999999 77766554445556667789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
|++|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ ...++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 7899999999999999999999999999996 345899999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=154.20 Aligned_cols=139 Identities=24% Similarity=0.298 Sum_probs=107.0
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-------------------hhHHHHHHHHHHHHhCCCCC-
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-------------------VDIEDVRREVDIMRHLPKHQ- 116 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-------------------~~~~~~~~E~~~l~~l~~h~- 116 (436)
|.+.+.||+|+||.||++.+. +|+.||||++........ .......+|+.++..+ .|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 788899999999999999874 799999998765321000 0112367789999998 676
Q ss_pred -ceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 117 -NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 117 -niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
.++..++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||+|+||+++. .
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~---~ 161 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD---D 161 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC---C
Confidence 4455544 245589999999998866432 1345678899999999999999999999999999964 4
Q ss_pred CCeEEEeeccccccC
Q 013816 196 APLKAIDFGLSVFFK 210 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~ 210 (436)
..++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 458999999996654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=175.71 Aligned_cols=141 Identities=23% Similarity=0.276 Sum_probs=112.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
...|...+.||+|+||+||++.+.. ..+++|+....... .....+.+.+|++++..+ +|++++....++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC
Confidence 4456778999999999999998653 34444443222211 112345688999999999 899998888777777
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ...++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCccccc
Confidence 78899999999999998875 3567899999999999999999999999999993 23489999999976
Q ss_pred c
Q 013816 209 F 209 (436)
Q Consensus 209 ~ 209 (436)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=148.46 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=98.4
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHH---------------------HHHHHHHHHHhCCCCC--
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE---------------------DVRREVDIMRHLPKHQ-- 116 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~h~-- 116 (436)
.+.||+|+||+||+|.+. +|+.||+|++............ ....|...+..+ .+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence 567999999999999976 8999999998754321111111 113566666666 332
Q ss_pred ceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCC
Q 013816 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 117 niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~ 195 (436)
.+++.++. ...++||||++|+++........... ..+..++.+++.++.++|+ .||+||||||+||+++ .
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence 24455543 23589999999854432111111111 6678999999999999999 9999999999999997 3
Q ss_pred CCeEEEeeccccccC
Q 013816 196 APLKAIDFGLSVFFK 210 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~ 210 (436)
..++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 458999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.7e-17 Score=145.28 Aligned_cols=138 Identities=19% Similarity=0.269 Sum_probs=103.4
Q ss_pred cccc-cCCceEEEEEEEcCCCcEEEEEEeecccc-----C-----ChhhHHHHHHHHHHHHhCCCCCce--eEEEEEEEe
Q 013816 61 RELG-RGEFGITYLCTDRENGDAFACKSISKKKL-----R-----TAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED 127 (436)
Q Consensus 61 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-----~-----~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~ 127 (436)
..|| .||.|+||.+... +..++||.+..... . .......+.+|+.++.+| .|++| +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 8888999988753 78899998854221 0 112345688899999999 78775 677766433
Q ss_pred C-Ce---EEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 128 D-TA---VHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 128 ~-~~---~~lv~E~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
. .. .++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||+.||+||||||.|||++.++ .++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEE
Confidence 2 22 2599999997 688887754 3555543 57899999999999999999999999996533 599999
Q ss_pred ecccccc
Q 013816 203 FGLSVFF 209 (436)
Q Consensus 203 fG~a~~~ 209 (436)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.2e-18 Score=163.84 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=200.4
Q ss_pred cccceeecccccc--CCceEEEEEEE--cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 53 IEERYELGRELGR--GEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
+...+.+...+|. |.+|.||.+.. ..++..+|+|.-... ...+.....=.+|+...+.+..|+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence 3456788899999 99999999998 888999999973322 222223334456787888888899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCceEeecCCCCCCeEEEee
Q 013816 129 TAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVE----VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
+..|+-+|+|. .+|..+...... ++...++....+... ||.++|+.+++|-|+||.||+...+. ...+++||
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTDF 267 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCCc
Confidence 99999999995 688777766544 889999999999999 99999999999999999999997653 45799999
Q ss_pred ccccccCCCCcc------cccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 204 GLSVFFKPGEKF------SEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 204 G~a~~~~~~~~~------~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
|+...+.++.-. ....|...|++||.+++-++...||||+|.+..+..++..+........ ...+.+.. .+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~--ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGY--IP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccccccc--Cc
Confidence 999887655422 1225778899999999999999999999999999988866653321110 00011111 12
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.+.....+..+...+..|++.+|-.|++++.+++|+++..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2233456677778999999999999999999999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=135.78 Aligned_cols=133 Identities=23% Similarity=0.295 Sum_probs=109.9
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CceeEEEEEEEeCCeEEEEEec
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~lv~E~ 137 (436)
+++.||+|.++.||++... +..+++|....... ...+.+|+.+++.+..+ +++++++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4577999999999999974 37899998754321 35788999999999433 6899999988888899999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 138 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+.|+++... +......++.+++.++.++|.. +++|+|++|+||+++. ...++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence 998877543 5566778899999999999985 6999999999999975 34589999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7e-17 Score=163.84 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=202.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
-+.+.+.+.+-+|+++.++.+.-..+|...+.|+......-...+.+....+-.++-.. .+|-++...-.+......++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcch
Confidence 35678888999999999999988788877777765433222222334444444443333 56777766555666788899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC---
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--- 210 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~--- 210 (436)
+++|+.|++|...+...+..++..++..+..+..++++||+..+.|+|++|.|++... .++.++.|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~---~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY---DGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcc---cCCcccCcccccccccccc
Confidence 9999999999999988888888889999999999999999999999999999999854 4557999998332110
Q ss_pred ---C---------------C-----------CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC
Q 013816 211 ---P---------------G-----------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (436)
Q Consensus 211 ---~---------------~-----------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~ 260 (436)
. . .......||+.|.+||.+. ......+|.|++|+++++.++|..||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 0112357899999999876 56788999999999999999999999999
Q ss_pred CHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHH---HHhcCcccccC
Q 013816 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLEHPWLQNA 318 (436)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~---e~l~h~~~~~~ 318 (436)
..+...+++.+....++.-+ ...+.++.+++..+|..+|.+|..+. ++-.||||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 99988888887665544332 35788999999999999999999887 99999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.4e-16 Score=139.22 Aligned_cols=234 Identities=19% Similarity=0.230 Sum_probs=156.0
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccCChhh-HHHHHHHHHHHHhCCCCCceeEEEEEEEeC-----CeEEEEEeccCCCch
Q 013816 70 ITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TAVHLVMELCEGGEL 143 (436)
Q Consensus 70 ~Vy~~~~~~~~~~vavK~i~~~~~~~~~~-~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~E~~~g~~L 143 (436)
.||++-+...|..|+...+.-...++... .+....-...|-.+ .|.|||+++.||.+. ....++.||++.|++
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 46677677777766655443222222111 11222223344455 699999999988544 457899999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceEeecCCCCCCeEEEeeccccc--cCCC---
Q 013816 144 FDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF--FKPG--- 212 (436)
Q Consensus 144 ~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~--~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~--~~~~--- 212 (436)
..+|++- ..+......+++-||+.||.|||+. -|+|+++....|++.. ++.||+. .+.. ..+.
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~---ngLIkig---~~ap~s~h~s~~~ 233 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQH---NGLIKIG---SVAPDSTHPSVNS 233 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecC---CceEEec---ccCccccchhhhh
Confidence 9999753 3578888999999999999999998 4999999999999963 3335543 2221 1110
Q ss_pred ---CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 213 ---EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 213 ---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.......+-++|.|||.=. .+.+..+|||+||+...+|..+..--.. .........+.+-.+... ...
T Consensus 234 ~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~l 306 (458)
T KOG1266|consen 234 TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGL 306 (458)
T ss_pred hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------Ccc
Confidence 0112234568899999743 4567789999999999999888654322 222222223333222211 123
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
-++++.+||+..|..||++.++|-||.+-+
T Consensus 307 qr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 307 QRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 367899999999999999999999998654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-13 Score=119.00 Aligned_cols=143 Identities=13% Similarity=0.116 Sum_probs=102.8
Q ss_pred ccccccCCceEEEEEEEcC------CCcEEEEEEeecccc--CC-----------------hhhHHHHH----HHHHHHH
Q 013816 60 GRELGRGEFGITYLCTDRE------NGDAFACKSISKKKL--RT-----------------AVDIEDVR----REVDIMR 110 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~i~~~~~--~~-----------------~~~~~~~~----~E~~~l~ 110 (436)
...||.|--+.||.|.... .+..+|||+.+.... +. ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 357999998754321 00 11122333 8999999
Q ss_pred hCCCC-CceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceE
Q 013816 111 HLPKH-QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFL 188 (436)
Q Consensus 111 ~l~~h-~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~l-H~~~iiH~dlkp~NIl 188 (436)
++... -++++++++ ...+|||||+.+..+.........+++.....+..+++.+|..+ |+.||+||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98433 466777764 45679999997754432222333466667788899999999998 8999999999999999
Q ss_pred eecCCCCCCeEEEeeccccccC
Q 013816 189 FANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 189 ~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+.. +.+.|+|||.+....
T Consensus 158 ~~~----~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD----GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEC----CcEEEEECCCceeCC
Confidence 953 348999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.5e-14 Score=140.93 Aligned_cols=148 Identities=20% Similarity=0.322 Sum_probs=96.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--------------------------C-h----hhHH---
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--------------------------T-A----VDIE--- 100 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------------------------~-~----~~~~--- 100 (436)
..|.. +.||+|++|.||+|+.+.+|+.||||++++.... . . .-.+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 7899999999999999888999999999754210 0 0 0011
Q ss_pred ---HHHHHHHHHHhCC---CCCceeEEEEEEE-eCCeEEEEEeccCCCchHHH--HHhcC----CCCHHHHHHHHHHHHH
Q 013816 101 ---DVRREVDIMRHLP---KHQNIVCLKDTYE-DDTAVHLVMELCEGGELFDR--IVARG----HYTERAAAAVTKTIVE 167 (436)
Q Consensus 101 ---~~~~E~~~l~~l~---~h~niv~~~~~~~-~~~~~~lv~E~~~g~~L~~~--l~~~~----~~~~~~~~~i~~qi~~ 167 (436)
++.+|+..+.++. .+.+.+.+-.+|. -....+|||||+.|+++.+. +...+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2344554444442 2333333333332 24567899999999999764 33332 13333334444444
Q ss_pred HHHHHHHCCceecCCCCCceEeecCC-CCCCeEEEeeccccccC
Q 013816 168 VVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 168 ~l~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~a~~~~ 210 (436)
...|++|+|++|.||+++.++ ..+.++++|||++..+.
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 468999999999999997643 23469999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-13 Score=136.12 Aligned_cols=143 Identities=19% Similarity=0.257 Sum_probs=96.2
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh-----------------------h--------------HHHHH
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------------------D--------------IEDVR 103 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~-----------------------~--------------~~~~~ 103 (436)
+.||+|++|.||+|+.+ +|+.||||+........-. + .-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999964 7999999998653210000 0 00244
Q ss_pred HHHHHHHhCC----CCCceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 013816 104 REVDIMRHLP----KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGV 177 (436)
Q Consensus 104 ~E~~~l~~l~----~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~lH~~~i 177 (436)
+|+..+.++. +++++.-..-+....+..++||||++|++|.+..... .... ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5555555542 3454432222223345578999999999998876432 1122 3345566655 4788999999
Q ss_pred eecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 178 iH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+|++|.||++..+ +.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~---g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD---GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC---CcEEEEeCCCeeECC
Confidence 999999999999543 459999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.4e-15 Score=141.78 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=186.8
Q ss_pred cccceeeccccccCCceEEEEEEEc-CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...+|..+..||.|.|+.|+.+.-. .++..|++|.+.+.......+ ..-..|+-+...+.-|.++++.+..|......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3457888999999999999988755 678899999887655443333 23345777777787899999999988888888
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++ +..++.|||....+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~- 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA- 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc-
Confidence 89999999998876664445578888999999999999999999999999999999997653 456899999876421
Q ss_pred CCcccccccCCccc-chhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 212 GEKFSEIVGSPYYM-APEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 212 ~~~~~~~~gt~~y~-aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
-......++-+++ .+|++. ..+..+.|++|||..+.+.++|...-+.... ...+..+.. ...+....++
T Consensus 419 -~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~----p~~~~~~~~~ 490 (524)
T KOG0601|consen 419 -FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDT----PNLPGLKLQL 490 (524)
T ss_pred -eecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccc----cCCCchHHhh
Confidence 1111222333455 356554 3477899999999999999998654322221 111222211 1123345788
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
..+.+.++.+++..||.+.++..|+=|-
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 8899999999999999999998886543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.7e-13 Score=111.54 Aligned_cols=147 Identities=20% Similarity=0.258 Sum_probs=111.6
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+..|-+|+-+.|+.+.+ .|+.+.||.=..+.... .....+..+|+++|.++ .--.|.-..-++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 456788999999999986 48887887543333332 23455678899999988 44455544555666777789
Q ss_pred EEeccCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 134 VMELCEG-GELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 134 v~E~~~g-~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+|||++| .++.+++.... .........+++.|-+.+.-||..+|+|+||..+||++.+++....+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999988 46777776542 233333478899999999999999999999999999999888888889999998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-13 Score=116.80 Aligned_cols=129 Identities=18% Similarity=0.172 Sum_probs=94.9
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccC
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
++.|+.|.++.||++... +..+++|....... ....+..|+.+++.+.+...+++++.+.. ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 356889999999999864 78899998754321 12345789999998843333456665543 34579999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV-----MHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 140 g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i-----iH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
|.++.+. ......++.+++.+|..||+.++ +|+|++|+||+++ + ..++++|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~---~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D---GRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C---CeEEEEecccccC
Confidence 9887543 11123457899999999999985 9999999999997 2 2489999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.5e-12 Score=107.30 Aligned_cols=135 Identities=26% Similarity=0.323 Sum_probs=99.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh-----hHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEE
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~-----~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 135 (436)
..+++|+-+.+|.+.+. |..+++|.=.++....+. ..++-.+|+.++.++ .--.|...+=+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence 45789999999998663 555666653333333322 233567799999987 4445554444556677778999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
||++|..|.+.+... ...+++.+-..+.-||..||+|+||+++||++...+ +.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCccccc
Confidence 999998888888654 256677777788899999999999999999996432 899999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.9e-11 Score=113.55 Aligned_cols=313 Identities=16% Similarity=0.172 Sum_probs=199.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE----eCCeEEEEEeccCC-C
Q 013816 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DDTAVHLVMELCEG-G 141 (436)
Q Consensus 67 ~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~~~~lv~E~~~g-~ 141 (436)
-..+.|+|....+|..|++|+++....... ...-.-+++++++ .|+|+|.+.++|. .+..+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 446899999999999999999954433332 1223457789999 8999999999886 45678999999986 5
Q ss_pred chHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 142 ELFDRIVA---------------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 142 ~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
+|.+..-. ....+|..++.++.|+..||.++|+.|+.-+-|.|.+||++.+ .+|+|+..|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---MRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---ceEEEecccce
Confidence 77776532 1236789999999999999999999999999999999999643 35899988877
Q ss_pred cccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCC-HHHH-HHHHHHccccCCCCCCccc
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGV-AQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~-~~~i~~~~~~~~~~~~~~~ 284 (436)
..+..+.. |-+. --.+-|.=.||.+++.|.||..--+..+ .++. ...|. +.+
T Consensus 441 Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y 494 (655)
T KOG3741|consen 441 DVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY 494 (655)
T ss_pred eeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence 66554330 1111 1124688899999999999965432222 2222 22221 357
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCc---ccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHH--hhc----
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHP---WLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA--QHL---- 355 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~--~~~---- 355 (436)
|.+++++|.-+...++++ -++.+++.|- ||....... ...+.....+.+--...++.+...++.. .+.
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q--~~~d~mE~~Ls~emENGRLfRll~Kln~I~dR~e~~~ 571 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQ--LKTDVMETELSREMENGRLFRLLLKLNFIDDRPEYVD 571 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHH--HHHHHHHHHHHHHHhcchHHHHHHHHhhhccCccccc
Confidence 889999999999999887 7888888762 332211100 0001111111111122233333333221 111
Q ss_pred ----hhhhhhhhh-----hhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC----cCHhhHHHH
Q 013816 356 ----SVEEVAGIK-----EGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH----LDLAFFREK 420 (436)
Q Consensus 356 ----~~~~~~~l~-----~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~----i~~~ef~~~ 420 (436)
+.....-+. -.|...|.|+.--++...+-++|.+|..-.. +-|.-+..|+. |+|.|....
T Consensus 572 D~~WSesG~~fmi~LFRDYlFHqvtedg~p~lDlaHvl~CLNKLDAG~~-----EkI~LvSrDE~t~IIvSY~ELK~~ 644 (655)
T KOG3741|consen 572 DPDWSESGDRFMIKLFRDYLFHQVTEDGKPWLDLAHVLQCLNKLDAGIQ-----EKILLVSRDELTCIIVSYKELKTI 644 (655)
T ss_pred CCcchhccceehHHHHHHhhheEeccCCChhhhHHHHHHHhhhccccch-----hheeEeccCCCcEEEEEHHHHHHH
Confidence 111111122 3455667777777899999999999854321 22222333443 899998663
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.2e-12 Score=122.84 Aligned_cols=169 Identities=17% Similarity=0.201 Sum_probs=127.2
Q ss_pred EEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCC
Q 013816 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152 (436)
Q Consensus 73 ~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~ 152 (436)
.|..+.++.+|.|.....+.- .......+-++-|+.+ +||||+++++.++.++..|||+|.+. .|..++++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-
Confidence 456678899999988865532 2345677888899999 99999999999999999999999985 6666676543
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc-ccccccCCcccchhcc
Q 013816 153 YTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEIVGSPYYMAPEVL 230 (436)
Q Consensus 153 ~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l 230 (436)
...+.--+.||+.||.+|| +.+++|++|..+.|+|+. .+..||++|-++........ ......-..|..|+.+
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~---~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE---SGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC---CCcEEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 6677778899999999998 568999999999999964 45589999988765432221 1111112246666654
Q ss_pred cccCCCCCchhHHHHHHHHHHhCC
Q 013816 231 KRNYGPEVDVWSAGVILYILLCGV 254 (436)
Q Consensus 231 ~~~~~~~~DiwSlG~il~~lltg~ 254 (436)
... +-..|.|-|||++++++.|.
T Consensus 178 ~~s-~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPS-EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Ccc-ccchhhhhHHHHHHHHhCcc
Confidence 311 13469999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.3e-11 Score=107.38 Aligned_cols=143 Identities=24% Similarity=0.380 Sum_probs=103.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEEEEEeC---CeEEEEEe
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDD---TAVHLVME 136 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~---~~~~lv~E 136 (436)
+.|+.|..+.||++... +|..+++|........ .....+.+|+++++.+.. +.++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999864 3688999987544321 124568899999999843 23467777776554 36789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013816 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK------------------------------------------ 174 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------------ 174 (436)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666666777777777777763
Q ss_pred --------------CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 175 --------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 175 --------------~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++|+|+.|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236999999999999753 123478999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.7e-11 Score=99.41 Aligned_cols=83 Identities=22% Similarity=0.357 Sum_probs=75.4
Q ss_pred HhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------
Q 013816 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE---------- 419 (436)
Q Consensus 352 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~---------- 419 (436)
...++.++.++++++|..+|.+++|.|+.++|..+|+.+|..++++++.+|+..+|. |. |+|.+|..
T Consensus 11 ~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~-~~~~idf~~Fl~~ms~~~~~~~ 89 (160)
T COG5126 11 FTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA-GNETVDFPEFLTVMSVKLKRGD 89 (160)
T ss_pred cccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccC-CCCccCHHHHHHHHHHHhccCC
Confidence 345688999999999999999999999999999999999999999999999999998 44 99999943
Q ss_pred -HHHHHHhHHhhhhcCC
Q 013816 420 -KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -~~~~~~~f~~~d~~~~ 435 (436)
..++..||+.||+|++
T Consensus 90 ~~Eel~~aF~~fD~d~d 106 (160)
T COG5126 90 KEEELREAFKLFDKDHD 106 (160)
T ss_pred cHHHHHHHHHHhCCCCC
Confidence 4578899999999985
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.9e-11 Score=101.29 Aligned_cols=80 Identities=26% Similarity=0.436 Sum_probs=72.5
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH--------------
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-------------- 419 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-------------- 419 (436)
+.++...++++|..+|.+++|+|+..||..+++.+|..+++.|+..++.++|.+|+ |+|+||..
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~~l~~~~~~~~~~~~~ 82 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFLDLMEKLGEEKTDEEA 82 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHhhhcccccccc
Confidence 45667889999999999999999999999999999999999999999999999877 99999933
Q ss_pred -HHHHHHhHHhhhhcCC
Q 013816 420 -KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -~~~~~~~f~~~d~~~~ 435 (436)
...++.||++||+||+
T Consensus 83 ~~~el~eaF~~fD~d~~ 99 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGD 99 (151)
T ss_pred cHHHHHHHHHHHccCCC
Confidence 2278899999999975
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.4e-10 Score=95.50 Aligned_cols=130 Identities=22% Similarity=0.227 Sum_probs=82.2
Q ss_pred EEEEEEEcCCCcEEEEEEeeccccC-----------------------ChhhHHHHHHHHHHHHhCCCC-CceeEEEEEE
Q 013816 70 ITYLCTDRENGDAFACKSISKKKLR-----------------------TAVDIEDVRREVDIMRHLPKH-QNIVCLKDTY 125 (436)
Q Consensus 70 ~Vy~~~~~~~~~~vavK~i~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~ 125 (436)
.||.|.. ..|..+|+|+....... .........+|.+.|.++... -++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3899886 46889999987542110 011234578899999999433 2577777553
Q ss_pred EeCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 126 EDDTAVHLVMELCE--GGELFDRIVARGHYTERAAAAVTKTIVEVVQM-CHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 126 ~~~~~~~lv~E~~~--g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
..+|||||++ |..+..+. .. .++......++.+++..+.. +|+.||+||||++.||+++.+ .+.|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred ----CCEEEEEecCCCccchhhHH-hc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence 2359999998 65664433 22 12244566777888885554 679999999999999999753 489999
Q ss_pred eccccccC
Q 013816 203 FGLSVFFK 210 (436)
Q Consensus 203 fG~a~~~~ 210 (436)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.6e-09 Score=99.12 Aligned_cols=135 Identities=18% Similarity=0.147 Sum_probs=92.1
Q ss_pred EEEEEEcCCCcEEEEEEeeccccC----C----hhhHHHHHHHHHHHHhCCCCCce--eEEEEEEEe-----CCeEEEEE
Q 013816 71 TYLCTDRENGDAFACKSISKKKLR----T----AVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED-----DTAVHLVM 135 (436)
Q Consensus 71 Vy~~~~~~~~~~vavK~i~~~~~~----~----~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~-----~~~~~lv~ 135 (436)
|+.+.. .|+.|.||........ . ......+.+|...+.+| ..-+| +.+..+.+. ...-++||
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 445543 4667888865332210 0 01112467888888776 22222 333444432 23467999
Q ss_pred eccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC----CCCCCeEEEeeccccc
Q 013816 136 ELCEGG-ELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----KETAPLKAIDFGLSVF 208 (436)
Q Consensus 136 E~~~g~-~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~----~~~~~ikl~DfG~a~~ 208 (436)
|+++|- +|.+++.. ....+......++.+++..+.-||+.||+|+|++++|||++.+ .+...+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999885 78888754 3446677888999999999999999999999999999999752 3356799999998753
|
|
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4e-10 Score=89.52 Aligned_cols=86 Identities=20% Similarity=0.333 Sum_probs=74.6
Q ss_pred HHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHH---------
Q 013816 348 LKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFR--------- 418 (436)
Q Consensus 348 l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~--------- 418 (436)
...+-..+.+.++++++++|+.+|.|.||.|..++|+..|.+||...+++|++.|+.++. |.|||.-|.
T Consensus 19 sSnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea~--gPINft~FLTmfGekL~g 96 (171)
T KOG0031|consen 19 SSNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEAP--GPINFTVFLTMFGEKLNG 96 (171)
T ss_pred cchHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhCC--CCeeHHHHHHHHHHHhcC
Confidence 334445567889999999999999999999999999999999999999999999998854 679999994
Q ss_pred --HHHHHHHhHHhhhhcCC
Q 013816 419 --EKVRLKISFFRWYEIGG 435 (436)
Q Consensus 419 --~~~~~~~~f~~~d~~~~ 435 (436)
+...+..||+.||.+|.
T Consensus 97 tdpe~~I~~AF~~FD~~~~ 115 (171)
T KOG0031|consen 97 TDPEEVILNAFKTFDDEGS 115 (171)
T ss_pred CCHHHHHHHHHHhcCccCC
Confidence 35567789999999963
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.9e-09 Score=97.30 Aligned_cols=238 Identities=16% Similarity=0.183 Sum_probs=155.8
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE------EEeC-CeE
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT------YEDD-TAV 131 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~------~~~~-~~~ 131 (436)
..+.||+|+-+.+|..-. -...+.|++......- -.+-+..|.....||-+-.=+.+ ..+. ..+
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 457799999999996532 2234558876553221 12234455666677765431111 1122 236
Q ss_pred EEEEeccCCCc-hHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 132 HLVMELCEGGE-LFDRIV------ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 132 ~lv~E~~~g~~-L~~~l~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
-+.|..++|.. +..++. ......+....+.++.++.+...||..|.+-+|+.++|+|+.+ +..|.|+|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd---~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSD---DSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeec---CceEEEEccc
Confidence 78888887752 222221 1234678889999999999999999999999999999999954 4458888855
Q ss_pred cccccCCCCcccccccCCcccchhccc-c-----cCCCCCchhHHHHHHHHHHhC-CCCCCCCCHH----H-HHHHHHHc
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----NYGPEVDVWSAGVILYILLCG-VPPFWAETEQ----G-VAQAIIRS 272 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-----~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~----~-~~~~i~~~ 272 (436)
.-....++....-.+|...|.+||.-. + .-+...|-|.||+++++++.| +.||.+.... . ....|..+
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 433333444445568899999999753 2 346789999999999999887 9999653211 0 01122222
Q ss_pred cc------------cCCCCCCcccCHHHHHHHHHccCC--CcCCCCCHHH
Q 013816 273 VL------------DFRRDPWPKVSENAKDLVRKMLDP--DPKRRLTAQQ 308 (436)
Q Consensus 273 ~~------------~~~~~~~~~~~~~~~~ll~~~l~~--~p~~Rps~~e 308 (436)
.+ .....+|.-+++.+..|..+|+.. ++.-|||++.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11 112234556889999999999864 3568998754
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.1e-10 Score=91.49 Aligned_cols=78 Identities=26% Similarity=0.433 Sum_probs=67.2
Q ss_pred HHHHHHHHHhhc-hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 344 KKRALKVIAQHL-SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 344 ~~~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
...++..|+... ..+..++++.+|+.||.|++|+|+.++|+.+++.+|+.++++|+++|++.+|.|++ |+|++|...
T Consensus 74 f~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~~~ 153 (160)
T COG5126 74 FPEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFKKL 153 (160)
T ss_pred HHHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHHHH
Confidence 345566666666 44557789999999999999999999999999999999999999999999998776 999999764
Q ss_pred H
Q 013816 421 V 421 (436)
Q Consensus 421 ~ 421 (436)
.
T Consensus 154 ~ 154 (160)
T COG5126 154 I 154 (160)
T ss_pred H
Confidence 3
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.4e-10 Score=84.48 Aligned_cols=63 Identities=19% Similarity=0.342 Sum_probs=57.7
Q ss_pred hhhhhhhccccCC-CCCCcccHHHHHHHHHH-cCCCCCH-HHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDI-GNRGKINIDELRVGLHK-LGHQIPD-TDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~-~~~G~i~~~el~~~l~~-lg~~~~~-~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+..+..+|+.+|. +++|+|+.+||+.++++ +|..++. +++++||+.+|.|++ |+|+||...+.
T Consensus 7 i~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~~l~~ 74 (89)
T cd05022 7 IETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFWELIG 74 (89)
T ss_pred HHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 4578899999999 99999999999999999 9988998 999999999999988 99999976553
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.3e-09 Score=93.83 Aligned_cols=110 Identities=18% Similarity=0.221 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHHhCCCCC--ceeEEEEEEEeC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 013816 99 IEDVRREVDIMRHLPKHQ--NIVCLKDTYEDD----TAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVEVVQM 171 (436)
Q Consensus 99 ~~~~~~E~~~l~~l~~h~--niv~~~~~~~~~----~~~~lv~E~~~g~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~ 171 (436)
.....+|...+..| ..- ..++.+.+.+.. ...++|+|+++|. +|.+++......+......++.++...+.-
T Consensus 55 ~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 34677787777766 222 234555555442 2458999999984 788888775557777888999999999999
Q ss_pred HHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 172 lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
||+.||+|+|++|.|||+..++....+.|+||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999987765667999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-10 Score=113.59 Aligned_cols=151 Identities=20% Similarity=0.350 Sum_probs=108.1
Q ss_pred HHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcc-----c-----ccccCCcccchhcccc
Q 013816 164 TIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF-----S-----EIVGSPYYMAPEVLKR 232 (436)
Q Consensus 164 qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~-----~-----~~~gt~~y~aPE~l~~ 232 (436)
++..|+.|+|.. ++||++|.|++|.++. .+..||+.|+++....++..+ . -..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na---~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNA---NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeecc---CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 334899999976 8999999999999964 445899999988766542211 1 1123467999999875
Q ss_pred -cCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCC-CCCCcccCHHHHHHHHHccCCCcCCCCCHHHH
Q 013816 233 -NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (436)
Q Consensus 233 -~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~ 309 (436)
..+.++|++|+|+++|.+.. |+..+...... ..........+.. ......+++++++=|.++|..++.-||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 46789999999999999994 54444333221 1111111111111 11225789999999999999999999999999
Q ss_pred hcCcccccC
Q 013816 310 LEHPWLQNA 318 (436)
Q Consensus 310 l~h~~~~~~ 318 (436)
+..|||.+.
T Consensus 263 ~~~~ff~D~ 271 (700)
T KOG2137|consen 263 LSIPFFSDP 271 (700)
T ss_pred hcccccCCc
Confidence 999999874
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.8e-09 Score=90.40 Aligned_cols=64 Identities=22% Similarity=0.375 Sum_probs=59.8
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++++|+.+|.|++|+|+.+||+.+|+.+|.+.+.+++++|++.+|.||+ |+|+||+..+.
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~~~m~ 148 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFVKMMS 148 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHh
Confidence 35689999999999999999999999999999999999999999999999887 99999987764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.6e-09 Score=91.82 Aligned_cols=138 Identities=23% Similarity=0.318 Sum_probs=100.4
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccc--cC---------------C--hhhHHHHHHHHHHHHhCCCC-C
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKK--LR---------------T--AVDIEDVRREVDIMRHLPKH-Q 116 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~--~~---------------~--~~~~~~~~~E~~~l~~l~~h-~ 116 (436)
+.++..||.|--+.||.|.+. .|.++|+|.=+... +. + -.......+|.++|.+|..+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 557788999999999999964 79999999542110 00 0 12344678899999999333 2
Q ss_pred ceeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 117 niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
.+++.+++ +...+|||+++|..|...- ++......++..|+.-+.-+-..|+||+|+++-||+++.++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 57777654 3457999999997775432 235556667777777777777999999999999999976444
Q ss_pred CeEEEeecccc
Q 013816 197 PLKAIDFGLSV 207 (436)
Q Consensus 197 ~ikl~DfG~a~ 207 (436)
+.++||--+.
T Consensus 241 -~~vIDwPQ~v 250 (304)
T COG0478 241 -IVVIDWPQAV 250 (304)
T ss_pred -EEEEeCcccc
Confidence 8999996554
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-08 Score=81.60 Aligned_cols=66 Identities=18% Similarity=0.333 Sum_probs=61.0
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+...+++.+|+.+|.|.+|+|+..+|+.+.+.||++++++|+.+||+++|.|++ |+-+||..++.
T Consensus 102 ~dt~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF~~imk 169 (172)
T KOG0028|consen 102 RDTKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEFIRIMK 169 (172)
T ss_pred cCcHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHHHHHHh
Confidence 3466789999999999999999999999999999999999999999999999887 99999987764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.2e-10 Score=111.77 Aligned_cols=250 Identities=17% Similarity=0.175 Sum_probs=173.0
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEEEEE
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYE 126 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~ 126 (436)
|..+.-...|.....+++|+++.+++.+...+...+ .+.+... ....-++++|.++ +||| .+..++-++
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYD 304 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCC
Confidence 333444455777788999999999998866555544 6665432 3456688999999 9999 777777788
Q ss_pred eCCeEEEEEeccCCC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 DDTAVHLVMELCEGG-ELFDRI-VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~-~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
.++..+++|+++.++ +..... ...-.+.+-+...+.+.-+.+++++|+..=+|+| ||+..+ ...|..||+
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~ 376 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFA 376 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc----ccccccccc
Confidence 888999999999887 222211 1112244455666777788899999998778998 888754 336999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC--C-CC
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--R-DP 280 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--~-~~ 280 (436)
....+..........+|+.++|||+.. ..+....|.||+|+-..++.-|.+|-..... ....+-.+...+. . ..
T Consensus 377 v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~a 454 (829)
T KOG0576|consen 377 VPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSA 454 (829)
T ss_pred CCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhh
Confidence 988877665667788999999999876 5688899999999888888877776432110 0000000000000 0 11
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
|.. ..-.++...|+...|..|+....++-|.+|....
T Consensus 455 w~~--~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 455 WSP--VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred cCc--ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence 111 1112578889999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.4e-08 Score=83.62 Aligned_cols=142 Identities=14% Similarity=0.126 Sum_probs=100.5
Q ss_pred cccCCceEEEEEEEcCCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCc--eeEEEEEEEe----CCeEEE
Q 013816 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQN--IVCLKDTYED----DTAVHL 133 (436)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~h~n--iv~~~~~~~~----~~~~~l 133 (436)
-|+||-+-|+..... |+.+-+|.-......+ +.....|.+|+..|.+|. .-+ ++++...... .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~-~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELE-RAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHH-HcCCCCCccceeeeeccCCceEEEE
Confidence 356888888886643 4468888764222211 345678999999998873 222 4444422111 123579
Q ss_pred EEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 134 VMELCEG-GELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 134 v~E~~~g-~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
|+|-+.| .+|.+++.+. .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.++ ...++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 9998764 5788887653 3467788889999999999999999999999999999997544 34599999986653
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.6e-09 Score=76.88 Aligned_cols=62 Identities=18% Similarity=0.204 Sum_probs=56.2
Q ss_pred hhhhhhhccccC-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..++++|+.+| .+++| +|+.+||+.+|+. +|...++++++++++.+|.|++ |+|+||...+
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~~li 77 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFV 77 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 457889999998 79999 5999999999999 8999999999999999999887 9999996654
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=9.3e-09 Score=82.52 Aligned_cols=80 Identities=28% Similarity=0.436 Sum_probs=71.1
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------HH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-----------KV 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-----------~~ 421 (436)
+.+++.+.++.+|..||.+++|+|+..||..+++.+|..+..+|+.+|+..+|.+|. |+|++|.. ..
T Consensus 27 l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~~~mt~k~~e~dt~e 106 (172)
T KOG0028|consen 27 LTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFRRVMTVKLGERDTKE 106 (172)
T ss_pred ccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHHHHHHHHHhccCcHH
Confidence 355667899999999999999999999999999999999999999999999999887 99999943 44
Q ss_pred HHHHhHHhhhhcC
Q 013816 422 RLKISFFRWYEIG 434 (436)
Q Consensus 422 ~~~~~f~~~d~~~ 434 (436)
+++.+|+.+|-|+
T Consensus 107 Ei~~afrl~D~D~ 119 (172)
T KOG0028|consen 107 EIKKAFRLFDDDK 119 (172)
T ss_pred HHHHHHHcccccC
Confidence 7888999886654
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.81 E-value=7.6e-09 Score=80.90 Aligned_cols=80 Identities=19% Similarity=0.249 Sum_probs=70.6
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCC----CcCHhhHHH------------
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTL----HLDLAFFRE------------ 419 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~----~i~~~ef~~------------ 419 (436)
++++..+++++|..||..+||+|+..+...+|+.+|.++|++|+.+.+...+.+. .|+|++|.+
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fLpm~q~vaknk~q~ 85 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFLPMYQQVAKNKDQG 85 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHHHHHHHHHhccccC
Confidence 4566789999999999999999999999999999999999999999999988884 299999943
Q ss_pred -HHHHHHhHHhhhhcCC
Q 013816 420 -KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -~~~~~~~f~~~d~~~~ 435 (436)
.....+.+++||++|+
T Consensus 86 t~edfvegLrvFDkeg~ 102 (152)
T KOG0030|consen 86 TYEDFVEGLRVFDKEGN 102 (152)
T ss_pred cHHHHHHHHHhhcccCC
Confidence 3356678999999986
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.7e-08 Score=83.47 Aligned_cols=143 Identities=22% Similarity=0.286 Sum_probs=90.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHH------HHHHHHHHHHhCC--CCCceeEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE------DVRREVDIMRHLP--KHQNIVCLKD 123 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~------~~~~E~~~l~~l~--~h~niv~~~~ 123 (436)
.+..+|.+.+.+-......|.+.. -+|+.+++|..+........... ...+++..+.++. .-...+.++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 345678888888877777666654 46899999987554321111111 1233333333331 1222222222
Q ss_pred -----EEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 124 -----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 124 -----~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
.+.-....+++|||++|..|.+... +++ .+...+.+++.-+|+.|+.|+|..|.|++++.++ +
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----I 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----E
Confidence 2223355679999999988866431 333 3456677889999999999999999999997432 8
Q ss_pred EEEeeccccc
Q 013816 199 KAIDFGLSVF 208 (436)
Q Consensus 199 kl~DfG~a~~ 208 (436)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-08 Score=78.27 Aligned_cols=74 Identities=20% Similarity=0.303 Sum_probs=65.2
Q ss_pred HHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHH-HHhcCCCcCHhhHHHH
Q 013816 347 ALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD-AVSHTLHLDLAFFREK 420 (436)
Q Consensus 347 ~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~-~~d~~~~i~~~ef~~~ 420 (436)
++..++++-.+...+.+.+.++.||++++|.|...||+.+|+.+|+.++++|+++++. ..|.+|.|+|+.|++.
T Consensus 74 m~q~vaknk~q~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~eD~nG~i~YE~fVk~ 148 (152)
T KOG0030|consen 74 MYQQVAKNKDQGTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQEDSNGCINYEAFVKH 148 (152)
T ss_pred HHHHHHhccccCcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccccccCCcCcHHHHHHH
Confidence 4445556666677888999999999999999999999999999999999999999998 6788899999999765
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.77 E-value=1e-08 Score=72.73 Aligned_cols=59 Identities=24% Similarity=0.396 Sum_probs=50.8
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHH----HHHHHHhcCCC--cCHhhHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQ----ILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~----~~~~~~d~~~~--i~~~ef~~~ 420 (436)
.++++|+.+|.|++|+|+.+||..+++.++...+..+++ .+++.+|.|++ |+|+||...
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~ 65 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFLNF 65 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHhcc
Confidence 367889999999999999999999999999777665554 45899999987 999999764
|
... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.3e-08 Score=101.06 Aligned_cols=205 Identities=21% Similarity=0.218 Sum_probs=147.1
Q ss_pred HHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE----EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 013816 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174 (436)
Q Consensus 99 ~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~----~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~ 174 (436)
+.....|+..+.+. .|+|++.++.|....... .+..|+|.+-++...+..-+..+....+.+..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44455677778888 899999999886544322 2445889999999999888899999999999999999999999
Q ss_pred CCceecCCCCCceEeecCCCCCCeEEE--eeccccccCCCCcccccccCCcccchhcccccC---CCCCchhHHHHHHHH
Q 013816 175 HGVMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY---GPEVDVWSAGVILYI 249 (436)
Q Consensus 175 ~~iiH~dlkp~NIl~~~~~~~~~ikl~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~DiwSlG~il~~ 249 (436)
..+.|.-|..+-..-......+.+.++ ||+.+.............-+..+.+||....+. ....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 976666655553332222334445555 888887776555555555567788888876443 334699999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC-HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS-ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 250 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+..|..+-... .....+ .+..+ ....+.+.+|+.-++++|+++.+++.|||.+..
T Consensus 385 ~~~~~~i~~~~---~~~~~~-----------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSL-----------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccc---cchhhh-----------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99886552111 011111 11122 267889999999999999999999999998754
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=5e-08 Score=74.82 Aligned_cols=68 Identities=22% Similarity=0.242 Sum_probs=60.0
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
++.++...++.+|..+|.+++|.|+.+|+..+++.+| ++++++++|+..+|.+++ |+|+||...+...
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~~~~~~~ 73 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFALAMHLI 73 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHH
Confidence 4567888999999999999999999999999999976 689999999999998766 9999997766544
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2e-07 Score=79.30 Aligned_cols=76 Identities=22% Similarity=0.255 Sum_probs=68.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC--CCcCHhhH----HHHHHHHHhHHhhhh
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT--LHLDLAFF----REKVRLKISFFRWYE 432 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--~~i~~~ef----~~~~~~~~~f~~~d~ 432 (436)
.+..++.+|+.+|.|++|.|+..||+.+|..+|..++++-++.++++.|.. |+|.|++| +....|.++|+..|.
T Consensus 122 ~i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~FI~ccv~L~~lt~~Fr~~D~ 201 (221)
T KOG0037|consen 122 YINQWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDFIQCCVVLQRLTEAFRRRDT 201 (221)
T ss_pred HHHHHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHHHHHHHHHHHHHHHHHHhcc
Confidence 356788999999999999999999999999999999999999999999954 45999999 457788999999998
Q ss_pred cC
Q 013816 433 IG 434 (436)
Q Consensus 433 ~~ 434 (436)
+.
T Consensus 202 ~q 203 (221)
T KOG0037|consen 202 AQ 203 (221)
T ss_pred cc
Confidence 75
|
|
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.68 E-value=6e-08 Score=74.04 Aligned_cols=68 Identities=16% Similarity=0.153 Sum_probs=58.5
Q ss_pred hhhhhhhccccCC-CC-CCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHHhH
Q 013816 360 VAGIKEGFHMMDI-GN-RGKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKISF 427 (436)
Q Consensus 360 ~~~l~~~F~~~D~-~~-~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~~f 427 (436)
...+..+|..+|. ++ +|+|+.+||+.+++. +|..+++++++++++.+|.+++ |+|+||...+.-..+|
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~~l~~~~~~~ 83 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFVSLVAGLSIA 83 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHH
Confidence 4568899999997 87 699999999999987 5778899999999999999876 9999998776655444
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.6e-08 Score=71.72 Aligned_cols=67 Identities=15% Similarity=0.306 Sum_probs=56.5
Q ss_pred hhhhhhhccccCC-CC-CCcccHHHHHHHHHH---cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-HHHHh
Q 013816 360 VAGIKEGFHMMDI-GN-RGKINIDELRVGLHK---LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-RLKIS 426 (436)
Q Consensus 360 ~~~l~~~F~~~D~-~~-~G~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-~~~~~ 426 (436)
+..+...|+.+|. ++ +|+|+.+||+.++++ +|.+++++|+++|++.+|.|++ |+|+||...+ .+..|
T Consensus 9 ~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv~lm~~l~~~ 83 (88)
T cd05029 9 IGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYVTFLGALALI 83 (88)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHHHHHHH
Confidence 4567888999998 66 899999999999973 7999999999999999999887 9999996544 34433
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.6e-08 Score=80.41 Aligned_cols=82 Identities=24% Similarity=0.408 Sum_probs=71.1
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
.++.++...++..|..+|.+++|.|+.+|+..++..+|..++.+++..++..+|.+++ |+|+||...+
T Consensus 4 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~l~~~~~~~~~~ 83 (149)
T PTZ00184 4 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTLMARKMKDTDSE 83 (149)
T ss_pred ccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHHHHHHHhccCCcHH
Confidence 3456677889999999999999999999999999999998999999999999998876 9999995432
Q ss_pred -HHHHhHHhhhhcCC
Q 013816 422 -RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -~~~~~f~~~d~~~~ 435 (436)
.+..+|..+|++|.
T Consensus 84 ~~~~~~F~~~D~~~~ 98 (149)
T PTZ00184 84 EEIKEAFKVFDRDGN 98 (149)
T ss_pred HHHHHHHHhhCCCCC
Confidence 45679999998874
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-07 Score=80.04 Aligned_cols=82 Identities=20% Similarity=0.355 Sum_probs=71.2
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------- 420 (436)
.+++++...+..+|..+|.+++|.|+.+|+..+++.+|..++..+++.++..+|.+++ |+|+||...
T Consensus 10 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 89 (158)
T PTZ00183 10 GLTEDQKKEIREAFDLFDTDGSGTIDPKELKVAMRSLGFEPKKEEIKQMIADVDKDGSGKIDFEEFLDIMTKKLGERDPR 89 (158)
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHhcCCCcH
Confidence 3566778889999999999999999999999999999988899999999999998877 999999542
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|++|.
T Consensus 90 ~~l~~~F~~~D~~~~ 104 (158)
T PTZ00183 90 EEILKAFRLFDDDKT 104 (158)
T ss_pred HHHHHHHHHhCCCCC
Confidence 256788999998874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.4e-07 Score=90.82 Aligned_cols=144 Identities=18% Similarity=0.217 Sum_probs=93.9
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCC---------------------------hhh----------HHHHH
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---------------------------AVD----------IEDVR 103 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---------------------------~~~----------~~~~~ 103 (436)
..|+.++-|.||+|+.+ +|+.||||+.++.-... ..- .-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999975 59999999986532110 000 01244
Q ss_pred HHHHHHHhC----CCCCceeEEEEEEEeCCeEEEEEeccCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 013816 104 REVDIMRHL----PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHKHGV 177 (436)
Q Consensus 104 ~E~~~l~~l----~~h~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 177 (436)
+|+..+.++ .+.|++.-..=+++-.+.-.|+|||++|..+.+.. .. ...+...+.....++ -+..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 455555543 34555543343445556678999999999988874 33 334433332222221 1334445899
Q ss_pred eecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 178 iH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
.|.|.+|.||++..+ +.+-+.|||+...+.+
T Consensus 287 fHaDpHpGNi~v~~~---g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSD---GRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecC---CcEEEEcCcceecCCH
Confidence 999999999999754 5589999999877653
|
|
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.2e-07 Score=72.10 Aligned_cols=63 Identities=21% Similarity=0.213 Sum_probs=53.0
Q ss_pred hhhhhhhccccC-CCCCC-cccHHHHHHHHHH-c----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-L----GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-l----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+..++++|+.+| .|++| +|+.+||+.++.. + +...+..++++|++++|.|++ |+|+||...+.
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~~l~~ 80 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFVVLVA 80 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 456788899999 78998 5999999999977 3 344578899999999999877 99999977553
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=70.91 Aligned_cols=62 Identities=19% Similarity=0.187 Sum_probs=53.6
Q ss_pred hhhhhhccccC-CCCCCc-ccHHHHHHHHHH-cCC----CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 361 AGIKEGFHMMD-IGNRGK-INIDELRVGLHK-LGH----QIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 361 ~~l~~~F~~~D-~~~~G~-i~~~el~~~l~~-lg~----~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
..++++|+.+| .+++|+ |+..||+.+|+. +|. .++.++++++++.+|.|++ |+|+||...+.
T Consensus 9 ~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~~l~~ 79 (92)
T cd05025 9 ETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFVVLVA 79 (92)
T ss_pred HHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 56889999997 999994 999999999986 543 5689999999999999876 99999976554
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.7e-06 Score=73.17 Aligned_cols=134 Identities=21% Similarity=0.275 Sum_probs=97.8
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeecccc-------------CChhhHHHHHHHHHHHHhCC-----CCCceeEEE
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKL-------------RTAVDIEDVRREVDIMRHLP-----KHQNIVCLK 122 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-------------~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~ 122 (436)
..||+|+.-.||. ........||+...... ......++..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 5699999999996 34566778898876550 01112456677777666662 378899999
Q ss_pred EEEEeCCeEEEEEeccCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 123 DTYEDDTAVHLVMELCEG------GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 123 ~~~~~~~~~~lv~E~~~g------~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
|+.+.+...-+|+|.+.. .+|.+++... .+++ .+...+-+-..||-+.+|+.+||+|+||++.......
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998742 4677777443 4555 3344445566788999999999999999998766555
Q ss_pred -CeEEEe
Q 013816 197 -PLKAID 202 (436)
Q Consensus 197 -~ikl~D 202 (436)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 678888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.3e-07 Score=65.08 Aligned_cols=58 Identities=28% Similarity=0.282 Sum_probs=51.5
Q ss_pred hhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHH
Q 013816 364 KEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRL 423 (436)
Q Consensus 364 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~ 423 (436)
+++|..+|.+++|.|+.+|+..+++.+|. +++++++++..+|.+++ |+|+||...+..
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~~~g~i~~~ef~~~~~~ 61 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTDKDGKLDKEEFAIAMHL 61 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHH
Confidence 56899999999999999999999999875 88999999999998866 999999776543
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.7e-07 Score=69.56 Aligned_cols=66 Identities=18% Similarity=0.255 Sum_probs=56.2
Q ss_pred hhhhhhhhhhccccCC--CCCCcccHHHHHHHHHH-cCCCC----CHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 357 VEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHK-LGHQI----PDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~-lg~~~----~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.++...++.+|..+|. +++|.|+.+|+..+++. +|..+ +.++++.|+..+|.+++ |+|+||...+.
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~~~~~ 78 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFLVLIG 78 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHH
Confidence 3456789999999999 89999999999999987 56544 59999999999999865 99999976543
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-06 Score=76.42 Aligned_cols=73 Identities=25% Similarity=0.265 Sum_probs=54.4
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEEEEEeCCeEEEEEeccC
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVMELCE 139 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~lv~E~~~ 139 (436)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+.... .+++++.+.+..+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 25567888865321 2355788999999884332 25788888888888899999999
Q ss_pred CCc
Q 013816 140 GGE 142 (436)
Q Consensus 140 g~~ 142 (436)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 963
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.8e-06 Score=71.37 Aligned_cols=129 Identities=19% Similarity=0.254 Sum_probs=92.2
Q ss_pred cceeeccccccCCc-eEEEEEEEcCCCcEEEEEEeeccccCCh------------------hhHHHHHHHHHHHHhCCC-
Q 013816 55 ERYELGRELGRGEF-GITYLCTDRENGDAFACKSISKKKLRTA------------------VDIEDVRREVDIMRHLPK- 114 (436)
Q Consensus 55 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~vavK~i~~~~~~~~------------------~~~~~~~~E~~~l~~l~~- 114 (436)
..++.++.||.|.- |.||++.. .|+.||+|....-..... .....|..|.++..+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67999999999999 99999985 588999999322111100 223468889998888732
Q ss_pred -CCce--eEEEEEEEeC------------------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013816 115 -HQNI--VCLKDTYEDD------------------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173 (436)
Q Consensus 115 -h~ni--v~~~~~~~~~------------------~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH 173 (436)
+.++ |+.++|..-. ....||.||++... .+ ...-+.+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence 3344 8888886322 12457888876643 12 2234567888889999
Q ss_pred HCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 174 ~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
..||+-+|+++.|.. +. ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G----~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GG----KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CC----EEEecccC
Confidence 999999999999998 22 89999854
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.9e-06 Score=77.31 Aligned_cols=75 Identities=16% Similarity=0.155 Sum_probs=55.0
Q ss_pred cccCCc-eEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCC
Q 013816 63 LGRGEF-GITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG 141 (436)
Q Consensus 63 lg~G~~-g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~ 141 (436)
|-.|.+ +.||++.. .+..+.+|+..... ...+.+|+++++.+..+--+++++.+....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 445555 78999864 24678888764321 2456789999998866656778888887777789999999997
Q ss_pred chHH
Q 013816 142 ELFD 145 (436)
Q Consensus 142 ~L~~ 145 (436)
++..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.2e-06 Score=73.87 Aligned_cols=140 Identities=19% Similarity=0.156 Sum_probs=91.7
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh----------------hHH-----HHHHHHHHHHhCC-CCCce
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV----------------DIE-----DVRREVDIMRHLP-KHQNI 118 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~----------------~~~-----~~~~E~~~l~~l~-~h~ni 118 (436)
..|+.|--+.||+|.. .++..+|+|++......... +.. -...|...|+++. .+-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3577788889999984 56899999998654321110 111 1345666666652 13344
Q ss_pred eEEEEEEEeCCeEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCC
Q 013816 119 VCLKDTYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 119 v~~~~~~~~~~~~~lv~E~~~g~~L-~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
++.+.+. .-.|||||+..... .-.|+ .-++....+..+..+++..+.-|-. .++||+||+.-|||+. .+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~ 203 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DG 203 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CC
Confidence 5555544 24599999954311 11111 1223444788888899999888777 8999999999999996 23
Q ss_pred CeEEEeeccccccC
Q 013816 197 PLKAIDFGLSVFFK 210 (436)
Q Consensus 197 ~ikl~DfG~a~~~~ 210 (436)
.+.++|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 37999999887554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.1e-06 Score=70.60 Aligned_cols=130 Identities=22% Similarity=0.314 Sum_probs=89.8
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCce-eEEEEEEEeCCeEEEEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-VCLKDTYEDDTAVHLVM 135 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-v~~~~~~~~~~~~~lv~ 135 (436)
.++.+.||+|.+|.||++.+. |..+|+|+-... .....+..|+++|..+ .-.++ .++|.+-++ ++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil-~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEIL-AGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHh-hhcCCCceEEEechh----hhhh
Confidence 456788999999999999875 779999986433 2457789999999998 44443 566655433 3559
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-C-CceEeecCCCCCCeEEEeecccccc
Q 013816 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLK-P-ENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 136 E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlk-p-~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
||+.|.+|.+.-... . ..-+..+++.-.-|-..||-|+.|. | .||++.. . .+.|+||..|+..
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~---~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-R---DVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-C---cEEEEEccchhhc
Confidence 999998886544221 2 2233445555556777899999886 3 3555532 2 3799999988744
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=6e-06 Score=74.45 Aligned_cols=79 Identities=25% Similarity=0.239 Sum_probs=56.3
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CceeEEEEEE---EeCCeEEEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTY---EDDTAVHLVM 135 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~---~~~~~~~lv~ 135 (436)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|..+ ..+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 3568999999999998654 58999986432 3456788898888887433 2356777644 3345679999
Q ss_pred eccCCCchHH
Q 013816 136 ELCEGGELFD 145 (436)
Q Consensus 136 E~~~g~~L~~ 145 (436)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.6e-06 Score=69.37 Aligned_cols=77 Identities=22% Similarity=0.296 Sum_probs=65.7
Q ss_pred HHHHHHHhhc-hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc--CCCcCHhhHHHHHH
Q 013816 346 RALKVIAQHL-SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH--TLHLDLAFFREKVR 422 (436)
Q Consensus 346 ~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~--~~~i~~~ef~~~~~ 422 (436)
.++.++...+ ..+..+.+..+|..||.++.|+|..+.|+..|...|..++++||++|++.... .|.++|.+|...+.
T Consensus 85 ~FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~~~it 164 (171)
T KOG0031|consen 85 VFLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFTYIIT 164 (171)
T ss_pred HHHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHHHHHH
Confidence 3556666666 34556789999999999999999999999999999999999999999998766 66799999977653
|
|
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-06 Score=59.23 Aligned_cols=49 Identities=24% Similarity=0.412 Sum_probs=44.7
Q ss_pred CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 374 NRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 374 ~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+|.|+.++|+.++..+|.. ++++|+..++..+|.|++ |+|+||...+.
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~~~~~ 52 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFISMMQ 52 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence 36999999999999889999 999999999999999988 99999976553
|
... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.1e-06 Score=88.76 Aligned_cols=148 Identities=21% Similarity=0.369 Sum_probs=92.3
Q ss_pred ccccccCCceEEEEEEEcCCC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCce--eEEEEEEEeC---CeEE
Q 013816 60 GRELGRGEFGITYLCTDRENG--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYEDD---TAVH 132 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~--~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni--v~~~~~~~~~---~~~~ 132 (436)
+..|+.|.++.+|+......+ ..+++|+....... .....+.+|+.+|+.|..|+++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 466899999999998765332 46777775432211 1235688999999999546655 7888877654 4678
Q ss_pred EEEeccCCCchHH--------------------HH---HhcC-----------C--CCHHHHHHHHHH------------
Q 013816 133 LVMELCEGGELFD--------------------RI---VARG-----------H--YTERAAAAVTKT------------ 164 (436)
Q Consensus 133 lv~E~~~g~~L~~--------------------~l---~~~~-----------~--~~~~~~~~i~~q------------ 164 (436)
+||||++|..+.+ .+ +.-. + +...++..+..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864321 11 1100 0 011223222221
Q ss_pred ---HHHHHHHHHH-----------CCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 165 ---IVEVVQMCHK-----------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 165 ---i~~~l~~lH~-----------~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+...+.+|.. ..+||+|++|.||+++.++ ...+-|+||+++..-.
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~-~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTE-DRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCC-CeEEEEEeeeccccCC
Confidence 2234556632 2499999999999997432 2235799999887543
|
|
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.6e-06 Score=65.02 Aligned_cols=62 Identities=11% Similarity=0.123 Sum_probs=52.7
Q ss_pred hhhhhhhccc-cCCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHM-MDIGNRG-KINIDELRVGLHKL-----GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~-~D~~~~G-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..+..+|+. +|.+++| +|+.+||+..+... +...++.+++++++.+|.|++ |+|+||...+
T Consensus 8 i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~~l~ 78 (89)
T cd05023 8 IESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFLNLI 78 (89)
T ss_pred HHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 4578889999 7888886 99999999999875 445678999999999999877 9999997654
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.1e-06 Score=59.09 Aligned_cols=59 Identities=15% Similarity=0.287 Sum_probs=54.3
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHHhcCCC---cCHhhHHHHHHH
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGH-QIPDTDVQILMDAVSHTLH---LDLAFFREKVRL 423 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~~~---i~~~ef~~~~~~ 423 (436)
.+|..+|.++.|.|...+|...|+.++. .+++.+++.+..++|++|. |+|+.|..+|..
T Consensus 2 ~~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~g~~~~v~~d~F~~iM~~ 64 (66)
T PF14658_consen 2 TAFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPEGRDGSVNFDTFLAIMRD 64 (66)
T ss_pred cchhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCCCCCceEeHHHHHHHHHH
Confidence 3699999999999999999999999988 8999999999999999876 999999887753
|
|
| >PLN02964 phosphatidylserine decarboxylase | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.5e-06 Score=87.63 Aligned_cols=73 Identities=15% Similarity=0.160 Sum_probs=40.3
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC-CCCCHHH---HHHHHHHHhcCCC--cCHhhHHH----------HH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTD---VQILMDAVSHTLH--LDLAFFRE----------KV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-~~~~~~e---~~~~~~~~d~~~~--i~~~ef~~----------~~ 421 (436)
.+..++.++|..+|.|++|++ +..+++.+| ..++++| ++++++.+|.|++ |+|+||.. ..
T Consensus 140 kqi~elkeaF~lfD~dgdG~i----Lg~ilrslG~~~pte~e~~fi~~mf~~~D~DgdG~IdfdEFl~lL~~lg~~~seE 215 (644)
T PLN02964 140 QEPESACESFDLLDPSSSNKV----VGSIFVSCSIEDPVETERSFARRILAIVDYDEDGQLSFSEFSDLIKAFGNLVAAN 215 (644)
T ss_pred HHHHHHHHHHHHHCCCCCCcC----HHHHHHHhCCCCCCHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhccCCCHH
Confidence 344555555666666666654 555555565 3555554 5566666655554 66666632 12
Q ss_pred HHHHhHHhhhhcC
Q 013816 422 RLKISFFRWYEIG 434 (436)
Q Consensus 422 ~~~~~f~~~d~~~ 434 (436)
++..+|+.||+||
T Consensus 216 EL~eaFk~fDkDg 228 (644)
T PLN02964 216 KKEELFKAADLNG 228 (644)
T ss_pred HHHHHHHHhCCCC
Confidence 3455666666554
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=6e-06 Score=69.63 Aligned_cols=62 Identities=23% Similarity=0.397 Sum_probs=56.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
..+..+|..+|.+++|.|+.+|+...+..+|..++.+++++++..+|.+++ |+|+||...+.
T Consensus 90 ~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~ 153 (158)
T PTZ00183 90 EEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFYRIMK 153 (158)
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 567889999999999999999999999999999999999999999998766 99999976654
|
|
| >cd00051 EFh EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Probab=98.16 E-value=6.3e-06 Score=57.03 Aligned_cols=58 Identities=26% Similarity=0.534 Sum_probs=52.8
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
+..+|..+|.+++|.|+..|+..+++.++...+.+++..+++.+|.+++ |+|+||...
T Consensus 2 ~~~~f~~~d~~~~g~l~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ef~~~ 61 (63)
T cd00051 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFLEL 61 (63)
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHH
Confidence 5677999999999999999999999999999999999999999998765 999999653
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. |
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.6e-06 Score=68.18 Aligned_cols=61 Identities=25% Similarity=0.401 Sum_probs=55.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..+..+|..+|.+++|+|+.+|+..++..+|..++.+++..++..+|.+++ |+|+||...+
T Consensus 84 ~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~ 146 (149)
T PTZ00184 84 EEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFVKMM 146 (149)
T ss_pred HHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHHHHH
Confidence 467888999999999999999999999999999999999999999998776 9999997654
|
|
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.1e-06 Score=68.55 Aligned_cols=66 Identities=20% Similarity=0.296 Sum_probs=59.3
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
.++..+++.+...|..+|.+.||+|++.||+.+|.+||..-|.=-++.||.++|.|.+ |+|-||.-
T Consensus 92 eFsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVded~dgklSfreflL 159 (244)
T KOG0041|consen 92 EFSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVDEDFDGKLSFREFLL 159 (244)
T ss_pred HHHHHHHHHHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhhcccccchhHHHHHH
Confidence 3456677888899999999999999999999999999999899889999999999876 99999943
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.4e-05 Score=77.62 Aligned_cols=156 Identities=18% Similarity=0.184 Sum_probs=95.4
Q ss_pred cccccccceeec--cccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-hh---------------------------
Q 013816 49 TGREIEERYELG--RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-VD--------------------------- 98 (436)
Q Consensus 49 ~~~~~~~~y~~~--~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-~~--------------------------- 98 (436)
-|..+++-|... +.||.-+.|.||+|+.+. |+.||||+-++.-.... .+
T Consensus 153 lG~~ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~ 231 (538)
T KOG1235|consen 153 LGAPIEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI 231 (538)
T ss_pred hCCCHHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence 344555555433 569999999999999765 99999998754321110 00
Q ss_pred HH------HHHHHHHHHHhCC---CCCc------eeEEEEEEEeCCeEEEEEeccCCCchHHH--HHhcCCCCHHHHHHH
Q 013816 99 IE------DVRREVDIMRHLP---KHQN------IVCLKDTYEDDTAVHLVMELCEGGELFDR--IVARGHYTERAAAAV 161 (436)
Q Consensus 99 ~~------~~~~E~~~l~~l~---~h~n------iv~~~~~~~~~~~~~lv~E~~~g~~L~~~--l~~~~~~~~~~~~~i 161 (436)
.+ +|.+|++...+.. .|-+ |+++|-. ......|+||||+|..+.|. +.+. .++...+..-
T Consensus 232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~ 308 (538)
T KOG1235|consen 232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNK 308 (538)
T ss_pred HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHH
Confidence 01 2334443333221 3444 4444432 33456799999999877654 3343 3555443333
Q ss_pred HHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCeEEEeeccccccC
Q 013816 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 162 ~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~~~~ikl~DfG~a~~~~ 210 (436)
+.+... ..+=..|++|+|=.|.||++..+ .....+.+-|||+...+.
T Consensus 309 l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 309 LVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 332222 23335689999999999999854 245679999999887654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.07 E-value=0.00013 Score=70.58 Aligned_cols=81 Identities=19% Similarity=0.284 Sum_probs=56.8
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeecccc---CC-hhhHHHHHHHHHHHHhCCCC--CceeEEEEEEEeCCeEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RT-AVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~---~~-~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~l 133 (436)
.+.||.|.+..||++.....++.++||.-..... .. +...++...|.+.|..+..+ .++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 3679999999999999764336899998532111 10 23456778888888886443 457788876 4466789
Q ss_pred EEeccCCCc
Q 013816 134 VMELCEGGE 142 (436)
Q Consensus 134 v~E~~~g~~ 142 (436)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >cd05030 calgranulins Calgranulins: S-100 domain found in proteins belonging to the Calgranulin subgroup of the S100 family of EF-hand calcium-modulated proteins, including S100A8, S100A9, and S100A12 | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.5e-05 Score=59.86 Aligned_cols=63 Identities=13% Similarity=0.215 Sum_probs=52.4
Q ss_pred hhhhhhhccccCCC--CCCcccHHHHHHHHH-HcCCCCC----HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIG--NRGKINIDELRVGLH-KLGHQIP----DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~--~~G~i~~~el~~~l~-~lg~~~~----~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+..+...|+.++.. ++|+|+.+||+.+|. .+|..++ +++++++++.+|.+++ |+|+||...+.
T Consensus 7 i~~~~~~f~~y~~~~~~~~~Is~~El~~ll~~~~g~~~t~~~~~~~v~~i~~~~D~d~dG~I~f~eF~~~~~ 78 (88)
T cd05030 7 IETIINVFHQYSVRKGHPDTLYKKEFKQLVEKELPNFLKKEKNQKAIDKIFEDLDTNQDGQLSFEEFLVLVI 78 (88)
T ss_pred HHHHHHHHHHHhccCCCcccCCHHHHHHHHHHHhhHhhccCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHH
Confidence 45677788888865 579999999999997 5677677 9999999999998776 99999976554
|
Note that the S-100 hierarchy, to which this Calgranulin group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. These proteins are expressed mainly in granulocytes, and are involved in inflammation, allergy, and neuritogenesis, as well as in host-parasite response. Calgranulins are modulated not only by calcium, but also by other metals such as zinc and copper. Structural data suggested that calgranulins may exist in multiple structural forms, homodimers, as well as hetero-oligomers. For example, the S100A8/S100A9 complex called calprotectin plays important roles in the regulation of inflammatory processes, wound repair, and regulating zinc-dependent enzymes as well as microbial growth. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 436 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-63 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-60 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-60 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-60 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-60 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-60 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-58 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-58 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-58 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-57 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-56 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-55 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-55 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-55 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-55 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-54 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-54 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-54 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-53 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-53 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-53 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-53 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-52 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-52 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-52 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-52 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-52 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-52 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-52 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-52 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-52 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-52 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-49 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-49 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-49 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-48 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-48 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-47 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-47 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-46 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-46 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-46 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-46 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-45 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-45 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-45 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-45 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-45 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-45 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-45 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-45 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-45 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-45 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-45 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-45 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-45 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-45 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-45 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-45 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-44 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-44 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-44 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-44 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-44 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-42 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-42 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-42 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-42 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-42 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-41 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-41 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-41 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-41 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-41 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-41 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-41 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-41 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-40 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-40 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-40 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-40 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-40 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-40 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-40 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-39 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-39 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-39 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-39 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-38 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-37 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-37 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-37 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-37 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-36 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-36 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-36 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-36 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-36 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-35 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-35 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-35 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-35 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-35 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-35 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-35 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-34 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-34 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-34 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-34 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-34 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-34 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-34 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-34 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-34 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-34 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-34 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-34 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-33 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-33 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-32 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-32 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-31 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-30 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-30 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-30 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-29 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-29 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-28 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-28 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-26 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-26 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-26 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-26 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-26 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-26 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-26 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-26 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-26 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-26 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-26 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-26 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-26 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-26 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-26 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-26 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-25 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-24 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-24 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-24 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-24 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-24 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-24 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-24 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-24 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-24 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-24 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-24 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-24 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-24 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-22 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-22 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-22 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-22 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-22 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-22 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-22 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-22 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-22 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-22 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-22 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-22 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-22 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-22 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-22 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-22 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-22 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-22 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-22 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-18 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-18 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-18 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-18 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-16 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-16 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-16 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-16 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-16 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-16 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-16 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-16 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-16 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-15 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-15 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-15 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-13 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-13 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-13 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-12 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 7e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 8e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 1s6j_A | 87 | N-Terminal Region Of The Ca2+-Saturated Calcium Reg | 8e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 1s6i_A | 188 | Ca2+-Regulatory Region (Cld) From Soybean Calcium-D | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3pm8_A | 197 | Cad Domain Of Pff0520w, Calcium Dependent Protein K | 4e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 7e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-04 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1S6J|A Chain A, N-Terminal Region Of The Ca2+-Saturated Calcium Regulatory Domain (Cld) From Soybean Calcium-Dependent Protein Kinase- Alpha (Cdpk) Length = 87 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1S6I|A Chain A, Ca2+-Regulatory Region (Cld) From Soybean Calcium-Dependent Protein Kinase-Alpha (Cdpk) In The Presence Of Ca2+ And The Junction Domain (Jd) Length = 188 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PM8|A Chain A, Cad Domain Of Pff0520w, Calcium Dependent Protein Kinase Length = 197 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 563 bits (1454), Expect = 0.0
Identities = 137/393 (34%), Positives = 204/393 (51%), Gaps = 25/393 (6%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQGT----FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN----AKKAPNVSLGE 328
F W +S++AKDL+RKML P R+TA Q LEHPW+Q ++ E
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
Query: 329 TVKARLKQFSVMNKLKKRALKVIAQHLS-VEEVAGIKEGFHMMDIGNRGKINIDELRVGL 387
+ ++QF KL + AL +A L+ ++E + E F +D N G ++ DEL G
Sbjct: 298 SAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGY 357
Query: 388 HKL--------------GHQIPDTDVQILMDAV 406
H+ + + LM +
Sbjct: 358 HEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLL 390
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 562 bits (1449), Expect = 0.0
Identities = 136/378 (35%), Positives = 206/378 (54%), Gaps = 17/378 (4%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
++ T +RY+ R LG+G FG LC D+ G A K ISK++++ D E +
Sbjct: 16 FVQHSTAI-FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L H NI+ L + +ED +LV E+ GGELFD I++R ++E AA + +
Sbjct: 75 REVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ + HK+ ++HRDLKPEN L +K + A ++ IDFGLS F+ +K + +G+ Y
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVL Y + DVWS GVILYILL G PPF E + + + + F W K
Sbjct: 194 YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK---APNVSLGETVKARLKQFSVM 340
VSE+AKDL+RKML P R++A+ L+H W+Q K + +V + ++QF
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313
Query: 341 NKLKKRALKVIAQHL-SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHK---------- 389
KL + AL + L S +E + FH MD G+++ EL G +
Sbjct: 314 QKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDAS 373
Query: 390 -LGHQIPDTDVQILMDAV 406
L + +V ++DAV
Sbjct: 374 MLDASAVEHEVDQVLDAV 391
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 124/414 (29%), Positives = 205/414 (49%), Gaps = 31/414 (7%)
Query: 15 KKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLC 74
+ ++N + QG + +++ G+ I E Y R+LG G +G LC
Sbjct: 4 HHHHSSGRENLY-------FQGIAINPGMYVRKKEGK-IGESYFKVRKLGSGAYGEVLLC 55
Query: 75 TDRENGDAFACKSISKKKLRTAV----------DIEDVRREVDIMRHLPKHQNIVCLKDT 124
++ A K I K + E++ E+ +++ L H NI+ L D
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDV 114
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
+ED +LV E EGGELF++I+ R + E AA + K I+ + HKH ++HRD+KP
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAG 244
EN L NK +K +DFGLS FF K + +G+ YY+APEVLK+ Y + DVWS G
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG 234
Query: 245 VILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
VI+YILLCG PPF + +Q + + + + F + W +S+ AK+L++ ML D +R
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 305 TAQQVLEHPWLQNAKK---APNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLS-VEEV 360
TA++ L W++ + + +++F KL + A+ I L+ +EE
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEER 354
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGH--------QIPDTDVQILMDAV 406
+ + F +D G+++ EL G + L + + + +V ++ V
Sbjct: 355 KELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEV 408
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 553 bits (1427), Expect = 0.0
Identities = 135/407 (33%), Positives = 209/407 (51%), Gaps = 22/407 (5%)
Query: 13 QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY 72
+ ++N + G + G + E Y+ ++LG G +G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGM------FITSKKGH-LSEMYQRVKKLGSGAYGEVL 54
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
LC D+ A K I K + T+ + EV +++ L H NI+ L D +ED +
Sbjct: 55 LCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYY 112
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LVME +GGELFD I+ R + E AA + K ++ V HKH ++HRDLKPEN L +K
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLC 252
++ A +K +DFGLS F+ +K E +G+ YY+APEVL++ Y + DVWS GVIL+ILL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLA 232
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
G PPF +T+Q + + + + F W VSE AKDL+++ML D +RR++AQQ LEH
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
Query: 313 PWLQNAKKAP----NVSLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKEGF 367
PW++ + +++F KL + AL +A L S EE + + F
Sbjct: 293 PWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIF 352
Query: 368 HMMDIGNRGKINIDELRVGLHKLGHQ--------IPDTDVQILMDAV 406
+D G+++ EL G KL + +++V ++ A
Sbjct: 353 RHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAA 399
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 539 bits (1391), Expect = 0.0
Identities = 128/362 (35%), Positives = 196/362 (54%), Gaps = 8/362 (2%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E Y+L ELG+G F + C G +A I+ KKL +A D + + RE I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
R L KH NIV L D+ ++ +L+ +L GGELF+ IVAR +Y+E A+ + I+E
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAP 227
V CH+ GV+HR+LKPEN L A+K + A +K DFGL++ + + + G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
EVL+++ YG VD+W+ GVILYILL G PPFW E + + Q I DF W V+
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 346
AKDL+ KML +P +R+TA + L+HPW+ + + + LK+F+ KLK
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
Query: 347 ALKVIA--QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
L V+ ++ SV + IK +++ + G + + + L++
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNG--DFESYTKMCDPGMTAFEPEALGNLVE 360
Query: 405 AV 406
+
Sbjct: 361 GL 362
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 531 bits (1371), Expect = 0.0
Identities = 120/363 (33%), Positives = 185/363 (50%), Gaps = 7/363 (1%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
+ G + + + Y++ ELG+G F + C + G FA K I+
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR 150
KKL +A D + + RE I R L +H NIV L D+ ++++ +LV +L GGELF+ IVAR
Sbjct: 65 KKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
Y+E A+ + I+E + CH +G++HR+LKPEN L A+K + A +K DFGL++
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 211 PGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
E + G+P Y++PEVLK++ Y VD+W+ GVILYILL G PPFW E + + I
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET 329
D+ W V+ AK L+ ML +PK+R+TA Q L+ PW+ N ++ + +
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
Query: 330 VKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHK 389
LK+F+ KLK L + ++ + I E
Sbjct: 303 TVDCLKKFNARRKLKGAILTTMIATRNLSN---LGRNLLNKKEQGPPST-IKESSESSQT 358
Query: 390 LGH 392
+
Sbjct: 359 IDD 361
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 520 bits (1341), Expect = 0.0
Identities = 114/328 (34%), Positives = 172/328 (52%), Gaps = 10/328 (3%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIM 109
E+ YEL +G+G F + C +RE G FA K + K + ED++RE I
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTI 165
L KH +IV L +TY D +++V E +G +L IV R Y+E A+ + I
Sbjct: 81 HML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+E ++ CH + ++HRD+KP L A+K+ +AP+K FG+++ + G VG+P++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
MAPEV+KR YG VDVW GVIL+ILL G PF+ T++ + + II+ W
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSH 258
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 343
+SE+AKDLVR+ML DP R+T + L HPWL+ + +L++F+ KL
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318
Query: 344 KKRALKVIAQHLSVEEVAGIKEGFHMMD 371
K L ++ H E
Sbjct: 319 KGAVLAAVSSHKFNSFYGDPPEELPDFS 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = 0.0
Identities = 110/325 (33%), Positives = 168/325 (51%), Gaps = 16/325 (4%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 69 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ +K IDFGL+ G +F I G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
AKD +R++L DPK+R+T Q L+HPW++ +S R M K KK A
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-------RKASAVNMEKFKKFA 300
Query: 348 LKVIAQHLSVEEVAGIKEGFHMMDI 372
+ + + S G+ + F I
Sbjct: 301 ARKKSNNGS---GGGLNDIFEAQKI 322
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-180
Identities = 130/313 (41%), Positives = 181/313 (57%), Gaps = 11/313 (3%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
+ + + +E+ ELGRG I Y C + +A K + K D + VR
Sbjct: 43 IDGSNRD-ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVR 96
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+ ++ L H NI+ LK+ +E T + LV+EL GGELFDRIV +G+Y+ER AA K
Sbjct: 97 TEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK 155
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+E V H++G++HRDLKPEN L+A APLK DFGLS + + G+P
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 224 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPW 281
Y APE+L+ YGPEVD+WS G+I YILLCG PF+ E +Q + + I+ F W
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 341
+VS NAKDLVRK++ DPK+RLT Q L+HPW+ KA N +T + +L++F+
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARR 333
Query: 342 KLKKRALKVIAQH 354
KLK V+A
Sbjct: 334 KLKAAVKAVVASS 346
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 495 bits (1278), Expect = e-177
Identities = 113/281 (40%), Positives = 168/281 (59%), Gaps = 4/281 (1%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y++ ELG+G F + C + G FA K I+ KKL +A D + + RE I R
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRK 61
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H NIV L D+ ++++ +LV +L GGELF+ IVAR Y+E A+ + I+E +
Sbjct: 62 L-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
CH +G++HR+LKPEN L A+K + A +K DFGL++ E + G+P Y++PEVLK
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ Y VD+W+ GVILYILL G PPFW E + + I D+ W V+ AK
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQN-AKKAPNVSLGETV 330
L+ ML +PK+R+TA Q L+ PW+ N + A + +TV
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 496 bits (1279), Expect = e-177
Identities = 90/317 (28%), Positives = 163/317 (51%), Gaps = 12/317 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ + ++ +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 348
D V ++L + K R+TA + L+HPWL+ + + V LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK----VIRTLKHRRYYHTLIKKDL 290
Query: 349 KVIAQHLSVEEVAGIKE 365
++ + I+
Sbjct: 291 NMVVSAARISCGGAIRS 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-175
Identities = 115/285 (40%), Positives = 164/285 (57%), Gaps = 6/285 (2%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQG----TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
F W +S++AKDL+RKML P R+TA Q LEHPW+Q
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 488 bits (1259), Expect = e-174
Identities = 118/278 (42%), Positives = 167/278 (60%), Gaps = 4/278 (1%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T +I + Y L +GRG +G + + A K I K + D++ ++E++I
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ L H NI+ L +T+ED+T ++LVMELC GGELF+R+V + + E AA + K ++
Sbjct: 60 MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
V CHK V HRDLKPENFLF +PLK IDFGL+ FKPG+ VG+PYY++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 229 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
VL+ YGPE D WSAGV++Y+LLCG PPF A T+ V I F W VS A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
+ L+R++L PK+R+T+ Q LEH W + + +L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-174
Identities = 85/324 (26%), Positives = 153/324 (47%), Gaps = 10/324 (3%)
Query: 33 HHQGNGGHKLCVLKEP----TGREIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKS 87
HH + + + E + Y L +ELGRG+F + C + G +A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 88 ISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
+ K++ ++ E+ ++ ++ L + YE+ + + L++E GGE+F
Sbjct: 62 LKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 148 VAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ +E + K I+E V H++ ++H DLKP+N L ++ +K +DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
S + EI+G+P Y+APE+L + D+W+ G+I Y+LL PF E Q
Sbjct: 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
I + +D+ + + VS+ A D ++ +L +P++R TA+ L H WLQ
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
Query: 325 SLGET-VKARLKQFSVMNKLKKRA 347
ET ++ + SV + K +
Sbjct: 301 HPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-174
Identities = 116/347 (33%), Positives = 173/347 (49%), Gaps = 10/347 (2%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDI 108
++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 69 LRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
E++ G E D+WS GVI YILL G PF +T+Q I DF + + + SE
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKLK 344
AKD +RK+L + ++RLT Q+ L HPW+ + E K+ V + K
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWK 307
Query: 345 KRALKVIA-QHLSVEEVAGIKEG-FHMMDIGNRGKINIDELRVGLHK 389
V HL+ + + + R LH
Sbjct: 308 LSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHP 354
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 486 bits (1254), Expect = e-173
Identities = 104/330 (31%), Positives = 161/330 (48%), Gaps = 19/330 (5%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H + + + YE+ ++G G + + C + FA K I K K
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----- 59
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA 157
D E++I+ +H NI+ LKD Y+D V++V EL +GGEL D+I+ + ++ER
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE 117
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA-PLKAIDFGLSVFFKPGEK-F 215
A+AV TI + V+ H GV+HRDLKP N L+ ++ ++ DFG + +
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 216 SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIR 271
+ ++APEVL+R Y D+WS GV+LY +L G PF +T + + I
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
Query: 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
W VS+ AKDLV KML DP +RLTA VL HPW+ + + P L
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDA 297
Query: 332 ARLKQ------FSVMNKLKKRALKVIAQHL 355
L + +S +N+ + L+ + +
Sbjct: 298 PHLVKGAMAATYSALNRNQSPVLEPVGRST 327
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-172
Identities = 110/315 (34%), Positives = 170/315 (53%), Gaps = 11/315 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVD 107
+++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
I+R + H N++ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 68 ILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE++ G E D+WS GVI YILL G PF +T+Q I DF + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKL 343
E AKD +RK+L + ++RLT Q+ L HPW+ + E ++ V +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRW 306
Query: 344 KKRALKVIA--QHLS 356
K + +++ HL+
Sbjct: 307 KL-SFSIVSLCNHLT 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 486 bits (1253), Expect = e-172
Identities = 108/381 (28%), Positives = 168/381 (44%), Gaps = 23/381 (6%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
PA A + T P Q H L+ I++ + LG G
Sbjct: 14 FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
G ++ + FA K + RREV++ + +IV + D YE
Sbjct: 74 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125
Query: 127 D----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + +VME +GGELF RI RG +TER A+ + K+I E +Q H + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
D+KPEN L+ +K+ A LK DFG + + +PYY+APEVL Y D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 240 VWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
+WS GVI+YILLCG PPF++ G+ I +F W +VSE K L+R +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHL 355
L +P +R+T + + HPW+ + K P L + + + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365
Query: 356 SVEEVAGIKEGFHMMDIGNRG 376
E++ + + D N
Sbjct: 366 DYEQI----KIKKIEDASNPL 382
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 483 bits (1245), Expect = e-172
Identities = 102/322 (31%), Positives = 156/322 (48%), Gaps = 28/322 (8%)
Query: 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y+L + LG G F I C +++ AFA K ISK+ + ++E+ +
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITAL 59
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ H NIV L + + D LVMEL GGELF+RI + H++E A+ + + +V V
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPE 228
H GV+HRDLKPEN LF ++ + +K IDFG + P + + +Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVLDFRRDP 280
+L +N Y D+WS GVILY +L G PF + + + I + F +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL---------GETVK 331
W VS+ AKDL++ +L DP +RL + + WLQ+ + + L G V
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
Query: 332 ARLK-QFSVMNKLKKRALKVIA 352
+K F NK K+ +
Sbjct: 300 TCVKATFHAFNKYKREGFCLQN 321
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-170
Identities = 101/322 (31%), Positives = 157/322 (48%), Gaps = 16/322 (4%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
P+ + + K + Q G E ++Y+ +GRG
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFYQKYDPKDVIGRG 105
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVD-----IEDVRREVDIMRHLPKHQNIVCL 121
+ C R G FA K + R + + E RRE I+R + H +I+ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
D+YE + + LV +L GELFD + + +E+ ++ ++++E V H + ++HRD
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-------RNY 234
LKPEN L + ++ DFG S +PGEK E+ G+P Y+APE+LK Y
Sbjct: 226 LKPENILLDDN---MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G EVD+W+ GVIL+ LL G PPFW + + + I+ F W S KDL+ +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISR 342
Query: 295 MLDPDPKRRLTAQQVLEHPWLQ 316
+L DP+ RLTA+Q L+HP+ +
Sbjct: 343 LLQVDPEARLTAEQALQHPFFE 364
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-170
Identities = 101/290 (34%), Positives = 162/290 (55%), Gaps = 12/290 (4%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + I++ + R+LG G FG +L +R +G K+I+K +
Sbjct: 4 HHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-- 150
+ V +E + E+++++ L H NI+ + + +ED +++VME CEGGEL +RIV+
Sbjct: 60 SQ--VPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+E A + K ++ + H V+H+DLKPEN LF + +P+K IDFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 268
FK E + G+ YMAPEV KR+ + D+WSAGV++Y LL G PF + + V Q
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
++ + P ++ A DL+++ML DP+RR +A QVL H W + A
Sbjct: 237 ATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-170
Identities = 109/275 (39%), Positives = 157/275 (57%), Gaps = 6/275 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+E+ YE+G ELG G+F I C + G +A K I K++L R V E++ REV+I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R + +H NI+ L D +E+ T V L++EL GGELFD + + TE A K I++ V
Sbjct: 63 REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + +K +K IDFG++ + G +F I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF ET+Q I DF + + SE
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
AKD +R++L DPKRR+T Q LEH W++ ++
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 468 bits (1207), Expect = e-166
Identities = 101/285 (35%), Positives = 149/285 (52%), Gaps = 16/285 (5%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVR----RE 105
E YE LGRG + C + +A K I +A +++++R +E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
VDI+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+EV+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 226 APEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
APE+++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
W S+ KDLV + L P++R TA++ L HP+ Q
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 476 bits (1226), Expect = e-165
Identities = 100/395 (25%), Positives = 166/395 (42%), Gaps = 11/395 (2%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
++ + + S +Y + E + + Y++ ELG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+ + T+R G+ FA K + D E VR+E+ M L +H +V L D +ED
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDAFED 225
Query: 128 DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D + ++ E GGELF+++ +E A + + + + H++ +H DLKPEN
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245
+F K+ LK IDFGL+ P + G+ + APEV + + G D+WS GV
Sbjct: 286 IMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ YILL G+ PF E + + + + + +SE+ KD +RK+L DP R+T
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404
Query: 306 AQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKE 365
Q LEHPWL S + +R + K K A + ++
Sbjct: 405 IHQALEHPWLTPGNAPGRDS--QIPSSRYTKIRDSIKTKYDAWPEPL--PPLGRISNYSS 460
Query: 366 GFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQ 400
+ + + + T+V
Sbjct: 461 LRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVG 495
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 466 bits (1201), Expect = e-165
Identities = 103/319 (32%), Positives = 157/319 (49%), Gaps = 18/319 (5%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A K ISK+K R A +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 340
W +VSE A DLV+K+L DPK R T ++ L HPWLQ+ + L + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENES 297
Query: 341 NKLKKRALKVIAQHLSVEE 359
L + + E
Sbjct: 298 TALPQVLAQPSTSRKRPRE 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-165
Identities = 113/333 (33%), Positives = 162/333 (48%), Gaps = 22/333 (6%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISK 90
HH +G L EP + + Y+L ++ LG G G C R G A K +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDR 146
R+EVD +IVC+ D YE+ + ++ME EGGELF R
Sbjct: 65 SP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 147 IVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
I RG +TER AA + + I +Q H H + HRD+KPEN L+ +K++ A LK DFG
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +PYY+APEVL Y D+WS GVI+YILLCG PPF++ T Q
Sbjct: 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235
Query: 264 GVAQAIIRSVL----DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
++ + R + F W +VSE+AK L+R +L DP RLT Q + HPW+ +
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295
Query: 320 KAPNVSLGETVKARLKQFSVMNKLKKRALKVIA 352
P L + + +++K+ +A
Sbjct: 296 VVPQTPLHTARVLQ-EDKDHWDEVKEEMTSALA 327
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 468 bits (1205), Expect = e-165
Identities = 100/369 (27%), Positives = 165/369 (44%), Gaps = 28/369 (7%)
Query: 16 KKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCT 75
K K P DY ++ + E + + Y++ ELG G FG+ + C
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ G F K I+ +D V+ E+ IM L H ++ L D +ED + L++
Sbjct: 72 EKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLIL 127
Query: 136 ELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
E GGELFDRI A + +E + E ++ H+H ++H D+KPEN + K +
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-K 186
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
+ +K IDFGL+ P E + + APE++ R G D+W+ GV+ Y+LL G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ PF E + Q + R +F D + VS AKD ++ +L +P++RLT LEHP
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
Query: 314 WLQNAKKAPNVSLGETVK---------------------ARLKQFSVMNKLKKRALKVIA 352
WL+ + + R+ FS + K + + ++
Sbjct: 307 WLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYD 366
Query: 353 QHLSVEEVA 361
+ +E
Sbjct: 367 SYFDRKEAV 375
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-161
Identities = 98/304 (32%), Positives = 142/304 (46%), Gaps = 35/304 (11%)
Query: 53 IEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y+L + LG G C + +A K I K+ V REV+++
Sbjct: 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQ 66
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
H+N++ L + +E++ +LV E GG + I R H+ E A+ V + + +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H G+ HRDLKPEN L + + +P+K DF L K S I GS
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 224 YMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE---------------TE 262
YMAPEV++ Y D+WS GVILYILL G PPF +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+ ++I +F W +S AKDL+ K+L D K+RL+A QVL+HPW+Q AP
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--CAP 304
Query: 323 NVSL 326
+L
Sbjct: 305 ENTL 308
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-156
Identities = 96/300 (32%), Positives = 152/300 (50%), Gaps = 15/300 (5%)
Query: 52 EIEERYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y + + LG G FG + C + G A K I + ++ D E+V+ E+ +M
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVM 140
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
L H N++ L D +E + LVME +GGELFDRI+ + TE K I E
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
++ H+ ++H DLKPEN L N+ + +K IDFGL+ +KP EK G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
V+ + D+WS GVI Y+LL G+ PF + + I+ D + + +SE
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
AK+ + K+L + R++A + L+HPWL + K +S A+ K+ +
Sbjct: 319 AKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS------AQKKKNRGSDAQDFVT 372
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-153
Identities = 97/345 (28%), Positives = 161/345 (46%), Gaps = 53/345 (15%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + G + + + E++++Y L +G+G +G+ + + + A K ++K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 92 KLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K+R D+E ++ EV +M+ L H NI L + YED+ + LVMELC GG L D++
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 150 RGH----------------------------------------YTERAAAAVTKTIVEVV 169
E+ + + + I +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYY 224
H G+ HRD+KPENFLF+ ++ +K +DFGLS F + G+PY+
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 225 MAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+APEVL +YGP+ D WSAGV+L++LL G PF + ++ L F +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL-QNAKKAPNVS 325
+S A+DL+ +L+ + R A + L+HPW+ Q + K +S
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-153
Identities = 96/326 (29%), Positives = 145/326 (44%), Gaps = 39/326 (11%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H L+ I++ + LG G G ++ + FA K +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------ 54
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH- 152
RREV++ + +IV + D YE+ + +VME +GGELF RI RG
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+TER A+ + K+I E +Q H + HRD+KPEN L+ +K+ A LK DFG
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQ 267
A E Y D+WS GVI+YILLCG PPF++ G+
Sbjct: 167 --------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327
I +F W +VSE K L+R +L +P +R+T + + HPW+ + K P L
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272
Query: 328 ETVKARLKQFSVMNKLKKRALKVIAQ 353
+ + + +K+ +A
Sbjct: 273 TSRVLKEDKER-WEDVKEEMTSALAT 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-152
Identities = 99/277 (35%), Positives = 149/277 (53%), Gaps = 12/277 (4%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A + ISK+K R A +V E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 191 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
W +VSE A DLV+K+L DPK R T ++ L HPWLQ+
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 341 bits (877), Expect = e-114
Identities = 80/366 (21%), Positives = 149/366 (40%), Gaps = 29/366 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ + LG G G T + + A K I + REV ++R
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
+H N++ T +D ++ +ELC L + + + + + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGE----KFSEIVGSPYYMA 226
H ++HRDLKP N L + +KA+ DFGL G + S + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 227 PEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
PE+L K N VD++SAG + Y ++ G PF ++ + LD P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 341
A++L+ KM+ DP++R +A+ VL+HP+ + +K + + V R+++ S+
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK--QLQFFQDVSDRIEKESLDG 311
Query: 342 KLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINI----DELRVGLHKLGHQIPDT 397
+ K+ + + ++ I D+ D LR +K H +
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPL-QTDLRKFRTYKGGSVRDLLRAMRNKKHH-YREL 369
Query: 398 DVQILM 403
++
Sbjct: 370 PAEVRE 375
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-110
Identities = 81/401 (20%), Positives = 144/401 (35%), Gaps = 61/401 (15%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ ++ + LG G G G A K + + E+ ++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------TERAAAAVTK 163
H N++ + D +++ +ELC L D + ++ E ++ +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKK----------ETAPLKAIDFGLSVFFKPGE 213
I V H ++HRDLKP+N L + E + DFGL G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 214 -----KFSEIVGSPYYMAPEVL--------KRNYGPEVDVWSAGVILYILLC-GVPPFWA 259
+ G+ + APE+L KR +D++S G + Y +L G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 260 ETEQGVAQAIIRSVLDF---RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ + IIR + + + A DL+ +M+D DP +R TA +VL HP
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 317 NAKKAPN----VSLGETVKARLKQFSVMNKLKKRALKVIAQ-----HLSVEEVAGIKE-- 365
K VS ++ R +++ K + VI + ++
Sbjct: 301 PKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYR 360
Query: 366 ---GFHMMDI--GNRGKIN-IDELRVGLHKLGHQIPDTDVQ 400
+MD+ R K + +L + +L +PD
Sbjct: 361 KYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPDGFYD 401
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 7e-99
Identities = 62/312 (19%), Positives = 116/312 (37%), Gaps = 43/312 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKR---------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVLEH 312
+S + L+ +L+ D ++ Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 313 PWLQNAKKAPNV 324
+ +
Sbjct: 304 TSDILHRGNSHH 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-94
Identities = 67/341 (19%), Positives = 123/341 (36%), Gaps = 43/341 (12%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKRN---------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVLEH 312
+S + L+ +L+ D ++ Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 313 PWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQ 353
+ +V + + A N V Q
Sbjct: 304 TSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 9e-94
Identities = 87/265 (32%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 246
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317
+KML DP R T ++L + +
Sbjct: 247 QKMLQTDPTARPTINELLNDEFFTS 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-93
Identities = 87/264 (32%), Positives = 128/264 (48%), Gaps = 10/264 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 272
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQ 316
+KML DP R T ++L +
Sbjct: 273 QKMLQTDPTARPTINELLNDEFFT 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 7e-93
Identities = 77/321 (23%), Positives = 135/321 (42%), Gaps = 32/321 (9%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSI 88
HH + + + E + Y + +++G G + + E +A K +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 89 SKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDTAVHLVMELCEGGELFDR 146
+ ++ ++ R E+ + L + + I+ L D D +++VME C +L
Sbjct: 61 NLEEADNQ-TLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ + + K ++E V H+HG++H DLKP NFL + LK IDFG++
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIA 173
Query: 207 VFFKPGEKFSE---IVGSPYYMAPEVLKRN------------YGPEVDVWSAGVILYILL 251
+P VG+ YM PE +K P+ DVWS G ILY +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 252 CGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G PF Q AII + + ++ +D+++ L DPK+R++ ++L
Sbjct: 234 YGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
Query: 311 EHPWLQNAKKAPNVSLGETVK 331
HP++Q N T +
Sbjct: 292 AHPYVQIQTHPVNQMAKGTTE 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 2e-92
Identities = 80/328 (24%), Positives = 136/328 (41%), Gaps = 32/328 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP- 113
Y + +++G G + + E +A K ++ ++ ++ R E+ + L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQ 66
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
I+ L D D +++VME C +L + + + K ++E V H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEVL 230
+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE +
Sbjct: 126 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 231 KR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFR 277
K P+ DVWS G ILY + G PF Q AII +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 239
Query: 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET------VK 331
+ ++ +D+++ L DPK+R++ ++L HP++Q N T V
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299
Query: 332 ARLKQFSVMNKLKKRALKVIAQHLSVEE 359
+L + N + K A + + E
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 9e-92
Identities = 90/276 (32%), Positives = 138/276 (50%), Gaps = 11/276 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++G LG+G F Y G A K I KK + A ++ V+ EV I L K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-K 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMCH 173
H +I+ L + +ED V+LV+E+C GE+ + R +E A I+ + H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR 232
HG++HRDL N L +K DFGL+ K P EK + G+P Y++PE+ R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+ +G E DVWS G + Y LL G PPF +T + ++ + + P +S AKDL
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDL 242
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLG 327
+ ++L +P RL+ VL+HP++ + G
Sbjct: 243 IHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 3e-91
Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 41/299 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+E LG+G FG + + +A K I + + + EV ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59
Query: 113 PKHQNIVCLKDTYEDD-------------TAVHLVMELCEGGELFDRIVARGHYTERAAA 159
HQ +V + + + + + ME CE G L+D I + +R
Sbjct: 60 -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 160 A-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------- 210
+ + I+E + H G++HRDLKP N + +K DFGL+
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKL 175
Query: 211 -------PGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ + +G+ Y+A EVL +Y ++D++S G+I + ++ P
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ + + ++F D + K ++R ++D DP +R A+ +L WL +
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 279 bits (714), Expect = 1e-90
Identities = 80/328 (24%), Positives = 138/328 (42%), Gaps = 34/328 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
Y + +++G G + + E +A K ++ ++ ++ R E+ + L +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-Q 112
Query: 115 HQN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ I+ L D D +++VME C +L + + + K ++E V
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEV 229
H+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE
Sbjct: 172 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 230 LKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDF 276
+K P+ DVWS G ILY + G PF Q AII +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NH 285
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGET------V 330
+ ++ +D+++ L DPK+R++ ++L HP++Q N T V
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYV 345
Query: 331 KARLKQFSVMNKLKKRALKVIAQHLSVE 358
+L + N + K A + + E
Sbjct: 346 LGQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-90
Identities = 52/310 (16%), Positives = 92/310 (29%), Gaps = 44/310 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
+ +L L G+ + +L D E + FA K + + ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 113 --------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG------GELF 144
L +D + L+M L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
V RG A +T ++ + G++H P+N L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAET 261
K G + Y E L + + ++ W G+ +Y + C PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 262 EQGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S+ D + + K L+ + L+ D +RRL + +E P
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 317 NAKKAPNVSL 326
+ + SL
Sbjct: 358 QLQNEISSSL 367
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 9e-90
Identities = 95/278 (34%), Positives = 151/278 (54%), Gaps = 11/278 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
V+HRD+KPEN L + E LK DFG SV P + +++ G+ Y+ PE+++
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R +F + V+E A+DL+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLIS 239
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ-NAKKAPNVSLGETV 330
++L +P +R ++VLEHPW+ N+ K N E+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 5e-88
Identities = 93/292 (31%), Positives = 149/292 (51%), Gaps = 11/292 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L + +G+G F L G A K I K +L ++ + REV IM+ L H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV L + E + ++L+ME GGE+FD +VA G E+ A + + IV VQ CH+
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLK EN L +K DFG S F G K G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS GVILY L+ G PF + + + + ++R +R + +S + ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 345
+ L +P +R T +Q+++ W+ + + + + ++ +
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVG 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 2e-87
Identities = 86/280 (30%), Positives = 156/280 (55%), Gaps = 10/280 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++GR LG+G+FG YL +++N A K + K +L +RRE++I HL +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-R 72
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ + + + D ++L++E GEL+ + G + E+ +A + + + + CH+
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRN 233
V+HRD+KPEN L K E LK DFG SV P + + G+ Y+ PE++ +
Sbjct: 133 RKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+W AGV+ Y L G+PPF + + + I+ D + P+ +S+ +KDL+
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLIS 244
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKAR 333
K+L P +RL + V+EHPW++ + + ++ +++
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-86
Identities = 96/269 (35%), Positives = 133/269 (49%), Gaps = 10/269 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + + G A K ++++K+R+ + ++RE+ ++ +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L T +VME GGELFD I G E A + + I+ V CH+H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS GVILY LLCG PF E + + I F + ++ + L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
ML DP +R T + + EH W + +
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-85
Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 11/275 (4%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
P + + RY+ +++G G FG+ L D+ + A K I + E+V+RE
Sbjct: 12 DMPIMHDSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ R L +H NIV K+ T + ++ME GGEL++RI G ++E A + +
Sbjct: 67 IINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ V CH + HRDLK EN L + LK DFG S + VG+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 226 APEVL-KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--DFRRDPW 281
APEVL ++ Y G DVWS GV LY++L G PF E + I+ +L +
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
++S L+ ++ DP R++ ++ H W
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 1e-85
Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 14/268 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
L+ K+L +P R+T + + W
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 274 bits (701), Expect = 1e-85
Identities = 71/340 (20%), Positives = 128/340 (37%), Gaps = 35/340 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+E+ LG G FG ++ G+ A K ++ + + E E+ IM+ L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NH 71
Query: 116 QNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIV 166
N+V ++ + + L ME CEGG+L + + E + I
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
++ H++ ++HRDLKPEN + + K ID G + GE +E VG+ Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE+L+ + Y VD WS G + + + G PF + +R + + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 286 EN--------------------AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
+ ++ ML ++R T Q Q ++
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
Query: 326 LGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKE 365
L + + V + +++ GI E
Sbjct: 312 LLSVMN--MVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-85
Identities = 52/335 (15%), Positives = 104/335 (31%), Gaps = 66/335 (19%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E E G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 107 DIMRHL------------------------PKHQNIVCLKDTYEDDTA--VHLVMELCE- 139
+R L P+ + ++ ++ D + +
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 140 -----GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
G L A +T ++ ++ H +G++H L+P + + +
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQ 241
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN------------YGPEVDVWS 242
+ F V S + PE+ R D W+
Sbjct: 242 RGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
G+++Y + C P + G ++ I RS + + + + L+ L +
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKED 350
Query: 303 RLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337
RL Q +E P + L + A L +
Sbjct: 351 RLLPLQAMETPEYEQ--------LRTELSAALPLY 377
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 4e-85
Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 14/268 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
L+ K+L +P R+T + + W
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 6e-85
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 26/295 (8%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED----- 101
E ++Y LG G FG + D+E K I K+K+ IED
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAA 160
V E+ I+ + +H NI+ + D +E+ LVME G +LF I E A+
Sbjct: 76 VTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + +V V ++HRD+K EN + A +K IDFG + + + G+ F G
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCG 191
Query: 221 SPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDF 276
+ Y APEVL N Y GPE+++WS GV LY L+ PF ET +
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA----------AI 241
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
VS+ LV +L P P+RR T ++++ PW+ + + E +
Sbjct: 242 HPPYL--VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-84
Identities = 79/294 (26%), Positives = 124/294 (42%), Gaps = 22/294 (7%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVD 107
E Y LG LG+G FG + + A K I + ++ + D EV
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 108 IMRHL---PKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTK 163
++ + H ++ L D +E LV+E +LFD I +G E +
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V +Q CH GV+HRD+K EN L K IDFG +++ G+
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRV 203
Query: 224 YMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y PE + Y VWS G++LY ++CG PF + E I+ + L F
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP---- 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
VS + L+R+ L P P R + +++L PW+Q + ++ + A L
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 5e-84
Identities = 94/269 (34%), Positives = 135/269 (50%), Gaps = 10/269 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + G A K ++++K+R+ + +RRE+ ++ +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L + + +VME GGELFD I G E+ + + + I+ V CH+H
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS+GVILY LLCG PF + + + I F + ++ + L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
ML DP +R T + + EH W +
Sbjct: 249 HMLQVDPMKRATIKDIREHEWFKQDLPKY 277
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 5e-83
Identities = 91/263 (34%), Positives = 136/263 (51%), Gaps = 11/263 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y + LG G FG L T + A K IS++ L+ + V RE+ ++ L +H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L D T + +V+E GGELFD IV + TE + I+ ++ CH+H
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLKPEN L + +K DFGLS G GSP Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS G++LY++L G PF E + + + + + +S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
+M+ DP +R+T Q++ PW
Sbjct: 241 RMIVADPMQRITIQEIRRDPWFN 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 1e-82
Identities = 85/292 (29%), Positives = 134/292 (45%), Gaps = 22/292 (7%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N H + +E +Y++G LG G FG Y + A K + K ++
Sbjct: 22 APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81
Query: 94 RTAVDIED---VRREVDIMRHLPKHQ--NIVCLKDTYEDDTAVHLVMELCEG-GELFDRI 147
++ + V EV +++ + ++ L D +E + L++E E +LFD I
Sbjct: 82 SDWGELPNGTRVPMEVVLLKKV-SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 140
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
RG E A + ++E V+ CH GV+HRD+K EN L LK IDFG
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGA 198
Query: 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
K +++ G+ Y PE ++ Y G VWS G++LY ++CG PF + E
Sbjct: 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
IIR + FR +VS + L+R L P R T +++ HPW+Q+
Sbjct: 255 ---IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-82
Identities = 85/291 (29%), Positives = 138/291 (47%), Gaps = 37/291 (12%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD----------------- 98
+Y L E+G+G +G+ L + + +A K +SKKKL
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 99 ------IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVAR 150
IE V +E+ I++ L H N+V L + +D HL V EL G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+E A + +++ ++ H ++HRD+KP N L +K DFG+S FK
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFK 188
Query: 211 PGEKF-SEIVGSPYYMAPEVL---KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
+ S VG+P +MAPE L ++ + G +DVW+ GV LY + G PF E +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
I L+F P ++E+ KDL+ +MLD +P+ R+ ++ HPW+
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 8e-82
Identities = 71/265 (26%), Positives = 112/265 (42%), Gaps = 13/265 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ ++ LG G +G + +E+G +A K S R D EV +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
+H V L+ +E+ ++L ELC G L A G E + + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H G++H D+KP N + K DFGL V G P YMAPE+L+
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 233 NYGPEVDVWSAGVILYILLCGVP-PFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+YG DV+S G+ + + C + P E Q + Q + +S + +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSV 284
Query: 292 VRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ ML+PDPK R TA+ +L P L+
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-80
Identities = 60/334 (17%), Positives = 113/334 (33%), Gaps = 49/334 (14%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------ 99
+ Y + R L +G+F LC ++ +A K K L D
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 100 --------EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
+D + E+ I+ + K++ + + + V+++ E E +
Sbjct: 80 KISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 152 H--------YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAID 202
+ + K+++ H + HRD+KP N L +K D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSD 195
Query: 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWA 259
FG S + +K G+ +M PE G +VD+WS G+ LY++ V PF
Sbjct: 196 FGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 260 ETEQ----------------GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ + +S D ++ L +P R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 304 LTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337
+T++ L+H WL + + + + K+
Sbjct: 315 ITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-78
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 25/278 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 63
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 169 VQMCHK-----HGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGS 221
++ CH+ H V+HRDLKP N FL + +K DFGL+ F++ VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGT 179
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
PYYM+PE + +Y + D+WS G +LY L +PPF A +++ +A I +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRR 235
Query: 281 WPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
P S+ +++ +ML+ R + +++LE+P +
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 5e-77
Identities = 71/272 (26%), Positives = 139/272 (51%), Gaps = 16/272 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y +++G G FG L E+G + K I+ ++ ++ + E+ RREV ++ ++ K
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H NIV ++++E++ ++++VM+ CEGG+LF RI A+ + E I ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 173 HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVL 230
H ++HRD+K +N FL + ++ DFG++ + + +G+PYY++PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENA 288
+ Y + D+W+ G +LY L F A + + + II P S +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHYSYDL 253
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ LV ++ +P+ R + +LE ++ +
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-76
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 20/272 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPK 114
+Y +G LG G +G D E A K + KKKLR + E V++E+ ++R L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 115 HQNIVCLKD--TYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+N++ L D E+ +++VME C G E+ D + + A +++ ++
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF---FKPGEKFSEIVGSPYYMAP 227
H G++H+D+KP N L LK G++ F + GSP + P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 228 EVL--KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
E+ + G +VD+WSAGV LY + G+ PF + + + I + +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
DL++ ML+ +P +R + +Q+ +H W +
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-73
Identities = 69/312 (22%), Positives = 113/312 (36%), Gaps = 38/312 (12%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
HH +G L G + + Y ++LG G F L +G +A K I
Sbjct: 8 HHHSSGRENL----YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFD 145
+ + D E+ +RE D+ R H NI+ L + L++ + G L++
Sbjct: 64 CHEQQ---DREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 146 RIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201
I TE + I ++ H G HRDLKP N L ++ + +
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLM 176
Query: 202 DFGLSVFFKPG----------EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVIL 247
D G + ++ + Y APE+ DVWS G +L
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
Y ++ G P+ ++G + A+ P+ S L+ M+ DP +R
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 308 QVLEHPW-LQNA 318
+L LQ
Sbjct: 296 LLLSQLEALQPP 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 9e-72
Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 38/293 (12%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ ++ +G G FG + R +G + K + E REV
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREV 55
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTA----------------VHLVMELCEGGELFDRIVAR 150
+ L H NIV ++ + + ME C+ G L I R
Sbjct: 56 KALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ A + + I + V H +++RDLKP N + K+ +K DFGL
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTS 171
Query: 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K K + G+ YM+PE + ++YG EVD+++ G+IL LL
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFT 229
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ ++ + K L++K+L P+ R ++L +
Sbjct: 230 DLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-71
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 16/289 (5%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L+ G + + +++GRG+F Y +G A K + L A D +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 105 EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG----HYTERAAAA 160
E+D+++ L H N++ ++ +D +++V+EL + G+L I ER
Sbjct: 82 EIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEI 218
+ ++ H VMHRD+KP N F+ A +K D GL F +
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL 196
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLD 275
VG+PYYM+PE + N Y + D+WS G +LY + PF+ + + + I + D
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--D 254
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
+ P SE + LV ++PDP++R V + +A A ++
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-68
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 41/306 (13%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
GR + + +E + LGRG FG+ + ++ + +A K I + E V REV +
Sbjct: 1 GRYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKAL 57
Query: 110 RHLPKHQNIVCLKDTYEDDTA------------VHLVMELCEGGELFDRIVARGHYTERA 157
L +H IV + + + +++ M+LC L D + R ER
Sbjct: 58 AKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 158 AAAVTKT---IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------- 206
+ I E V+ H G+MHRDLKP N F +K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEE 173
Query: 207 -----VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260
+ + VG+ YM+PE + +Y +VD++S G+IL+ LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
E+ +R+ L F + +V+ ML P P R A ++E+ ++
Sbjct: 231 MERVRTLTDVRN-LKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
Query: 321 APNVSL 326
L
Sbjct: 289 PGKTVL 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 5e-67
Identities = 72/301 (23%), Positives = 111/301 (36%), Gaps = 41/301 (13%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E R + R L G F Y D +G +A K + + + +EV M+ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLS 83
Query: 114 KHQNIVCLKDTYEDDTA--------VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTK 163
H NIV L+ ELC+G E ++ +RG + +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 164 TIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----- 216
VQ H+ ++HRDLK EN L +N+ +K DFG + +S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQR 200
Query: 217 --------EIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
+P Y PE++ G + D+W+ G ILY+L PF E G
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDG 256
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
I+ + P L+R ML +P+ RL+ +V+ A + N
Sbjct: 257 AKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314
Query: 325 S 325
Sbjct: 315 K 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-66
Identities = 49/312 (15%), Positives = 99/312 (31%), Gaps = 58/312 (18%)
Query: 51 REIEERYEL---GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
E+ ER G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 108 IMRHL------------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG- 140
+R L P+ + ++ ++ D + + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 141 -----GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195
L A +T ++ ++ H +G++H L+P + + +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QR 247
Query: 196 APLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVL------KRNYGPEVDVWSAGV 245
+ F V + G P A +L D W+ G+
Sbjct: 248 GGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+Y + C P + G ++ I RS + + + L+ L + RL
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLL 357
Query: 306 AQQVLEHPWLQN 317
Q +E P +
Sbjct: 358 PLQAMETPEYEQ 369
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-65
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 40/294 (13%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++G GEFG + C R +G +A K SKK L +VD ++ REV L
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVL 67
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV 168
+H ++V + +D + + E C GG L D I ++ E + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAI----------------DFGLSVFFKPG 212
++ H ++H D+KP N + D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRI 184
Query: 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G ++A EVL+ N + P+ D+++ + + P G I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHEI 240
Query: 271 RSVLDFRRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
R+ P++ S+ +L++ M+ PDP+RR +A +++H L +A +
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 204 bits (519), Expect = 5e-62
Identities = 54/319 (16%), Positives = 101/319 (31%), Gaps = 38/319 (11%)
Query: 53 IEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+ + LG G F Y T D +N F K + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLME 119
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA-----AAAVT 162
++ + + LV EL G L + I + E+ +
Sbjct: 120 RLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP--------LKAIDFGLSV---FFKP 211
++ +++ H ++H D+KP+NF+ N L ID G S+ F
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G F+ + + E+L + + ++D + +Y +L G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETV 330
L D W + ML+ L + +L KK +
Sbjct: 299 FRRL-PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL----KKVFQQHYTNKI 346
Query: 331 KARLKQFSVMNKLKKRALK 349
+A + V+ KR+ K
Sbjct: 347 RALRNRLIVLLLECKRSRK 365
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 6e-57
Identities = 80/268 (29%), Positives = 122/268 (45%), Gaps = 18/268 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ LG G F L + +A K + K+ + + V RE D+M L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
V L T++DD ++ + + GEL I G + E T IV ++ H G
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRDLKPEN L ++ DFG + + + VG+ Y++PE+L
Sbjct: 151 IIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
D+W+ G I+Y L+ G+PPF A E + Q II+ DF P K A+DLV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLV 263
Query: 293 RKMLDPDPKRRLT------AQQVLEHPW 314
K+L D +RL + HP+
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-54
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 18/282 (6%)
Query: 43 CVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
V GR + E+GRG F Y D E A + +KL T + +
Sbjct: 18 AVGMSNDGR----FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRF 72
Query: 103 RREVDIMRHLPKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+ E ++++ L +H NIV + T + + LV EL G L + +
Sbjct: 73 KEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 131
Query: 159 AAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ + I++ +Q H ++HRDLK +N T +K D GL+ K
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATL-KRASFAK 188
Query: 217 EIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+P +MAPE+ + Y VDV++ G+ + + P ++E Q AQ R
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP-YSE-CQNAAQIYRRVTSGV 246
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ + KV K+++ + + R + + +L H + Q
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-53
Identities = 63/279 (22%), Positives = 103/279 (36%), Gaps = 19/279 (6%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
RE +GRG FG + D++ G A K + + R E+
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACA 105
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L IV L + V++ MEL EGG L I G E A +E ++
Sbjct: 106 GL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLE 164
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPYY 224
H ++H D+K +N L ++ A DFG + K I G+ +
Sbjct: 165 YLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
MAPEV+ +VD+WS+ ++ +L G P+ + I R P P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PS 281
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+ +++ L +P R +A ++ +
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-53
Identities = 78/314 (24%), Positives = 146/314 (46%), Gaps = 26/314 (8%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
AA K ++++ K+ D+ + + + ++++ + LG G
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----------DQFDRIKTLGTG 52
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
FG L +E+G+ +A K + K+K+ IE E I++ + +V L+ +++
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFK 111
Query: 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D++ +++VME GGE+F + G ++E A IV + H +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGV 245
L + ++ DFG + + + + G+P +APE++ Y VD W+ GV
Sbjct: 172 LLIDQQGY---IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL- 304
++Y + G PPF+A+ + + I+ + F P S + KDL+R +L D +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRFG 282
Query: 305 ----TAQQVLEHPW 314
+ H W
Sbjct: 283 NLKNGVNDIKNHKW 296
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-53
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 21/287 (7%)
Query: 47 EPTGREIEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
+ +E YE LG+G +GI Y D N A K I R + +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAA 158
+ E+ + +HL KH+NIV ++ ++ + + ME GG L + ++ E+
Sbjct: 66 LHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSE 217
TK I+E ++ H + ++HRD+K +N L LK DFG S
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTET 182
Query: 218 IVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
G+ YMAPE++ + YG D+WS G + + G PP + E + A A+ + +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFKVGM 240
Query: 275 DFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
P+ +S AK + K +PDP +R A +L +L+ + K
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-52
Identities = 80/268 (29%), Positives = 124/268 (46%), Gaps = 16/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSP 129
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L ++DD +++VME GG+L +++ E+ A T +V + H G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR-- 232
+HRD+KP+N L ++ LK DFG + VG+P Y++PEVLK
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 233 ---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E D WS GV LY +L G PF+A++ G I+ +S+ AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 290 DLVRKMLDPDPKRRLT---AQQVLEHPW 314
+L+ L D + RL +++ H +
Sbjct: 306 NLICAFLT-DREVRLGRNGVEEIKRHLF 332
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-52
Identities = 65/268 (24%), Positives = 125/268 (46%), Gaps = 16/268 (5%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+ R +G+G FG + + +A K ++K+K ++ +V +E+ IM+ L +H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
+V L +++D+ + +V++L GG+L + H+ E +V + +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---- 233
+HRD+KP+N L E + DF ++ + + + G+ YMAPE+
Sbjct: 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 234 YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y VD WS GV Y LL G P+ + + + + +V+ + S+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVS 249
Query: 291 LVRKMLDPDPKRRL-TAQQVLEHPWLQN 317
L++K+L+P+P +R V P++ +
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-51
Identities = 87/309 (28%), Positives = 144/309 (46%), Gaps = 51/309 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE ++G G +G+ + C +R+ G A K K + D ++ RE+ +++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLK 57
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH N+V L + + +HLV E C+ DR + E ++T ++
Sbjct: 58 QL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQA 114
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CHKH +HRD+KPEN L +K DFG + + P + + + V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------- 274
E+L YGP VDVW+ G + LL GVP + +++ V Q +IR L
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQV 229
Query: 275 -----DFR-------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
F +P +S A L++ L DP RLT +Q+L HP+ +
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289
Query: 317 NAKKAPNVS 325
N ++ +++
Sbjct: 290 NIREIEDLA 298
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-51
Identities = 72/335 (21%), Positives = 116/335 (34%), Gaps = 79/335 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSI-------SKKKLRTAVDIEDVRREV 106
+E + +GRG FG+ + ++ + +A K I +++K+ V
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 107 DIMRHLP-----------------------------------------------KHQNIV 119
I+R+ +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK---TIVEVVQMCHKHG 176
+++ M+LC L D + R +R I E V+ H G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-------------VFFKPGEKFSEIVGSPY 223
+MHRDLKP N F +K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 224 YMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE + NY +VD++S G+IL+ LL F + E+ +R+ L F
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-LKFPLLFTQ 297
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
K +V+ ML P P R A ++E+ +N
Sbjct: 298 K-YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-51
Identities = 87/291 (29%), Positives = 143/291 (49%), Gaps = 25/291 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ ++G G GI L ++ +G A K + LR E + EV IMR
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY- 99
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N+V + +Y + ++ME +GG L D IV++ E A V + +++ + H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG K K +VG+PY+MAPEV+ R
Sbjct: 159 AQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
+ Y EVD+WS G+++ ++ G PP+++++ + + R P P KVS
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------RDSPPPKLKNSHKVS 268
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
+D + +ML DP+ R TAQ++L+HP+L L ++ KQ
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG--LPECLVPLIQLYRKQ 317
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ R LG G FG +L R NG +A K + K+ + +E E ++ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTKTIVEVVQMCH 173
I+ + T++D + ++M+ EGGELF + + A AA + ++ H
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFG + + + G+P Y+APEV+
Sbjct: 124 SKDIIYRDLKPENILLD---KNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y +D WS G+++Y +L G PF+ + I+ + L F P P +E+ KDL+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDLL 234
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPW 314
+++ D +RL + V HPW
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 78/266 (29%), Positives = 125/266 (46%), Gaps = 12/266 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ R LG+G FG C R G +ACK + KK+++ E I+ + +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSR 244
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L YE A+ LV+ L GG+L I + + + E A I ++ H+
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K
Sbjct: 305 ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y D W+ G +LY ++ G PF ++ + + R V + + + S A+ L
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 294 KMLDPDPKRRL-----TAQQVLEHPW 314
++L DP RL +A++V EHP
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-50
Identities = 85/287 (29%), Positives = 139/287 (48%), Gaps = 25/287 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A + + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMREN- 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YGP+VD+WS G++ ++ G PP+ E I + P K+S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNPEKLS 243
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKA 332
+D + + L+ D ++R +A+++L+H +L+ AK P SL + A
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 16/270 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG FG + + FA K ++K ++ + R E D++ + +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSK 134
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKH 175
I L ++DD ++LVM+ GG+L + E A +V + H+
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVL--- 230
+HRD+KP+N L ++ DFG + S VG+P Y++PE+L
Sbjct: 195 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSE 286
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ VSE
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 287 NAKDLVRKMLDPDPKR--RLTAQQVLEHPW 314
NAKDL+R+++ R + + +HP+
Sbjct: 312 NAKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 81/325 (24%), Positives = 135/325 (41%), Gaps = 53/325 (16%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
HH + G L E + E+YE +G G +G+ C +++ G A K
Sbjct: 3 HHHHHHSSGVDLGT--ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---- 56
Query: 91 KKLRTAVDIEDVR----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELF 144
K + D + V+ RE+ +++ L +H+N+V L + + +LV E + +
Sbjct: 57 -KFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
+ + I+ + CH H ++HRD+KPEN L + +K DFG
Sbjct: 115 ELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFG 169
Query: 205 LS-VFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ PGE + + V + +Y APE+L YG VDVW+ G ++ + G P F ++
Sbjct: 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 262 EQGVAQ-AIIRSVL---------------DFR-------------RDPWPKVSENAKDLV 292
+ + Q I L F +PK+SE DL
Sbjct: 230 D--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLA 287
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQN 317
+K L DP +R ++L H + Q
Sbjct: 288 KKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 20/269 (7%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HLPKH 115
+ R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVC+ + + +++L GG+L + G ++E I+ ++ H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-- 233
V++RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++
Sbjct: 312 FVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVA 367
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + + ++ S +
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRS 423
Query: 291 LVRKMLDPDPKRRL-----TAQQVLEHPW 314
L+ +L D RRL AQ+V E P+
Sbjct: 424 LLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 20/273 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG F + ++ G +A K ++K + ++ R E D++ + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRR 121
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKH 175
I L ++D+ ++LVME GG+L + G A IV + H+
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR- 232
G +HRD+KP+N L ++ DFG + + VG+P Y++PE+L+
Sbjct: 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 233 -------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-V 284
+YGPE D W+ GV Y + G PF+A++ I+ + V
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 285 SENAKDLVRKMLDPDPKRRLT---AQQVLEHPW 314
E A+D ++++L P+ RL A HP+
Sbjct: 299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 87/359 (24%), Positives = 136/359 (37%), Gaps = 61/359 (16%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEP---TGREIEERY 57
M T + A+ K + +G V+ P R E Y
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVS----RDKDGSKVTTVVATPGQGPDRPQEVSY 56
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ +G G FG+ Y ++G+ A K + + K RE+ IMR L H N
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHCN 108
Query: 118 IVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
IV L+ + +D+ ++LV++ ++ + K + Q+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM--YQL 165
Query: 172 ------CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
H G+ HRD+KP+N L + +TA LK DFG + GE + S YY
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274
APE++ +Y +DVWSAG +L LL G P F ++ II+ VL
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK-VLGTPTREQIR 282
Query: 275 ------------DFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ PW P+ A L ++L+ P RLT + H +
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 76/263 (28%), Positives = 119/263 (45%), Gaps = 15/263 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L +E GD +A K + K + D+E E I+ H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L I + E A I+ + H G+++RDL
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +LCG PF AE E + +AI+ + + + E+A +++ + +P
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNP 263
Query: 301 KRRL------TAQQVLEHPWLQN 317
RL +L HP+ +
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKE 286
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-48
Identities = 84/323 (26%), Positives = 134/323 (41%), Gaps = 55/323 (17%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N K+ TG + E Y + +G G FG+ + E+ + A K + + K
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR 77
Query: 94 RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRI 147
RE+ IMR + KH N+V LK + +D+ ++LV+E ++
Sbjct: 78 FKN-------RELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128
Query: 148 VARGHYTERAAAAVTKTIVEVVQM------CHKHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + K + Q+ H G+ HRD+KP+N L + + LK I
Sbjct: 129 RHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLI 184
Query: 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA 259
DFG + GE + S YY APE++ NY +D+WS G ++ L+ G P F
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 260 ETEQGVAQAIIRSVL---------------------DFRRDPW-----PKVSENAKDLVR 293
E+ II+ VL R P+ P+ +A DL+
Sbjct: 245 ESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
++L+ P RLTA + L HP+
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFD 326
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-48
Identities = 71/258 (27%), Positives = 120/258 (46%), Gaps = 10/258 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L ++ FA K++ K + D+E E ++ +H + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L + +K DFG+ K + G+P Y+APE+L Y VD
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E+ + +I + R + + AKDL+ K+ +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREP 257
Query: 301 KRRLTA-QQVLEHPWLQN 317
++RL + +HP +
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-48
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 14/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + G+++RDL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N + +K DFG+ G G+P Y+APE++ YG VD
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + + ++ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 301 KRRL-----TAQQVLEHPWLQN 317
+RL + + EH + +
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRY 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 81/306 (26%), Positives = 135/306 (44%), Gaps = 23/306 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL- 111
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N + + Y + LVME C G V + E AAVT ++ + H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
H ++HRD+K N L + E +K DFG + P F VG+PY+MAPEV+
Sbjct: 172 SHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAM 225
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP----WPKVS 285
+ Y +VDVWS G+ L PP + I ++ + S
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------ESPALQSGHWS 279
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 345
E ++ V L P+ R T++ +L+H ++ + P + + ++ ++ L+
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQY 337
Query: 346 RALKVI 351
R +K I
Sbjct: 338 RKMKKI 343
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-47
Identities = 76/296 (25%), Positives = 139/296 (46%), Gaps = 15/296 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + + D++++ +E+ IM+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC- 81
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
++V +Y +T + +VME C G + D I R TE A + ++ ++ ++
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLK 231
H +HRD+K N L K DFG++ K + ++G+P++MAPEV++
Sbjct: 142 HFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D+WS G+ + G PP+ I + R P S+N D
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP-ELWSDNFTD 257
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 346
V++ L P++R TA Q+L+HP++++AK L + + + + ++R
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAK--GVSILRDLINEAMDVKLKRQESQQR 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 78/278 (28%), Positives = 125/278 (44%), Gaps = 22/278 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E +E+ ELG G FG Y ++E G A K I ++ ++ED E++I+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATC- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
H IV L Y D + +++E C GG + ++ TE V + ++E +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPEVL- 230
H ++HRDLK N L ++ DFG+S +K +G+PY+MAPEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWP 282
Y + D+WS G+ L + PP V I +S L W
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPSKW- 248
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
S +D ++ LD +P+ R +A Q+LEHP++ +
Sbjct: 249 --SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 18/276 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 77
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 136
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ K + VG+P++MAPEV+K+
Sbjct: 137 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWPKVSENA 288
+ Y + D+WS G+ L G PP V I ++ L+ + S+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---GNY---SKPL 247
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
K+ V L+ +P R TA+++L+H ++ K +
Sbjct: 248 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 71/289 (24%), Positives = 126/289 (43%), Gaps = 28/289 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ YEL +G G + + A K I+ +K +T ++++ +E+ M
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQC- 70
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI--------VARGHYTERAAAAVTKTI 165
H NIV ++ + LVM+L GG + D I G E A + + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIV 219
+E ++ HK+G +HRD+K N L E ++ DFG+S + V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 220 GSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----- 272
G+P +MAPEV+++ Y + D+WS G+ L G P+ V +++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 273 -VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
++ K ++ + ++ L DP++R TA ++L H + Q AK
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 44/304 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIM 109
+RY +LG G +G Y D + A K I + TA+ REV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLL 87
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H+NI+ LK + +HL+ E E +L + + R + ++ V
Sbjct: 88 KEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 170 QMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMA 226
CH +HRDLKP+N L ++ ET LK DFGL+ F P +F+ + + +Y
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R+Y VD+WS I +L P F ++E I
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 272 -------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318
+R + + DL+ ML+ DP +R++A+ LEHP+ +
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
Query: 319 KKAP 322
P
Sbjct: 326 DFDP 329
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-46
Identities = 78/262 (29%), Positives = 129/262 (49%), Gaps = 15/262 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 301 KRRL-----TAQQVLEHPWLQN 317
K+RL A++V+EH + +
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLS 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 4e-46
Identities = 66/268 (24%), Positives = 115/268 (42%), Gaps = 14/268 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G FG L + + +A K + K + D+E E ++ K
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L ++ ++ VME GG+L I G + E A I + G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-Y 234
+++RDLK +N + +K DFG+ G G+P Y+APE++ Y
Sbjct: 463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKG 575
Query: 295 MLDPDPKRRL-----TAQQVLEHPWLQN 317
++ P +RL + + EH + +
Sbjct: 576 LMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LGRG FG + C + G +ACK ++KK+L+ + E I+ + + IV L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLA 251
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
+E T + LVM + GG++ I + E A T IV ++ H+ ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN L + ++ D GL+V K G+P +MAPE+L Y
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + VL+ K S +KD +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 297 DPDPKRRL-----TAQQVLEHPW 314
DP++RL + + HP
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPL 451
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 8e-46
Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 58/308 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
+++ +LG G + Y ++ G A K + KL TA+ RE+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REIS 55
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG-----ELFDRIVARGHYTERAAAAVT 162
+M+ L KH+NIV L D + + LV E + +
Sbjct: 56 LMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+++ + CH++ ++HRDLKP+N L + + LK DFGL+ F P FS V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------- 271
+Y AP+VL R Y +D+WS G IL ++ G P F ++ + I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 272 -----SVL-----------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ L + + N D + +L +P RL+A+Q
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 310 LEHPWLQN 317
L HPW
Sbjct: 292 LHHPWFAE 299
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-46
Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 56/303 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--------RTAVDIEDVRREV 106
++YE ++G G +G + +RE + A K + +L +A+ RE+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REI 52
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKT 164
+++ L KH+NIV L D D + LV E C+ + FD G +
Sbjct: 53 CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQ 109
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPY 223
+++ + CH V+HRDLKP+N L E LK +FGL+ F P +S V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL------ 274
Y P+VL + Y +D+WSAG I + G P F + I R +L
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEE 225
Query: 275 ---------DFRRDP-----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
D++ P PK++ +DL++ +L +P +R++A++ L+HP+
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
Query: 315 LQN 317
+
Sbjct: 286 FSD 288
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 79/263 (30%), Positives = 125/263 (47%), Gaps = 19/263 (7%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNI 118
LG+G +G + T G FA K + K + R A D + E +I+ + KH I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFI 83
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L ++ ++L++E GGELF ++ G + E A I + H+ G++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN + +K DFGL G G+ YMAPE+L R+ +
Sbjct: 144 YRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD WS G ++Y +L G PPF E + I++ L+ +++ A+DL++K+L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEARDLLKKLL 256
Query: 297 DPDPKRRL-----TAQQVLEHPW 314
+ RL A +V HP+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPF 279
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-45
Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 46/297 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y ++G G +G+ Y + ++ + KK+R + E + RE+ I++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH NIV L D + LV E + +L D G A + ++
Sbjct: 56 EL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNG 112
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
+ CH V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y +D+WS G I ++ G P F +E I R +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 273 VL-DFR-----------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
L + + E+ DL+ KML DP +R+TA+Q LEH + +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 24/272 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG + L ++ +A K + K+ + DI+ V+ E + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ + V+E GG+L + + E A + I + H+ G+++RDL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L +K D+G+ +PG+ S G+P Y+APE+L+ YG VD
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 241 WSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 249
Query: 292 VRKMLDPDPKRRL------TAQQVLEHPWLQN 317
++ L+ DPK RL + HP+ +N
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 13/261 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L + DFGL + S G+P Y+APEVL + Y VD
Sbjct: 166 KPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + + ++ +A+ L+ +L D
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDR 278
Query: 301 KRRL----TAQQVLEHPWLQN 317
+RL ++ H +
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSL 299
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-45
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 53/301 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
E Y +LG G + Y + + A K I +L TA+ REV
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVS 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTI 165
+++ L KH NIV L D + ++ LV E + + D +
Sbjct: 53 LLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL 109
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYY 224
+ + CH+ V+HRDLKP+N L + E LK DFGL+ P + + V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166
Query: 225 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------- 271
P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 272 --SVL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+F+ P++ + DL+ K+L + + R++A+ ++HP+
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 317 N 317
+
Sbjct: 287 S 287
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 24/272 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG + L ++ +A + + K+ + DI+ V+ E + H +V L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ + V+E GG+L + + E A + I + H+ G+++RDL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L +K D+G+ +PG+ S G+P Y+APE+L+ YG VD
Sbjct: 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236
Query: 241 WSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 292
Query: 292 VRKMLDPDPKRRL------TAQQVLEHPWLQN 317
++ L+ DPK RL + HP+ +N
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 68/291 (23%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+EL +G G +G Y + G A K + + + E++++E+++++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINMLKKYS 78
Query: 114 KHQNIVCLKDTY------EDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTI 165
H+NI + D + LVME C G + D + E A + + I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+ + H+H V+HRD+K +N L E A +K +DFG+S + + + +G+PY+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 225 MAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
MAPEV+ + Y + D+WS G+ + G PP I R+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 249
Query: 279 DPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324
P P++ S+ + + L + +R +Q+++HP++++ V
Sbjct: 250 -PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 74/301 (24%), Positives = 128/301 (42%), Gaps = 47/301 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y+ ++G G +G+ Y D + + ++ K++R + E + RE+ +++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQG------RIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L D + + LV E E ++ D + + ++
Sbjct: 75 EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRG 131
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CH+H ++HRDLKP+N L + LK DFGL+ F P ++ V + +Y AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y VD+WS G I ++ G P F T+ I
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 273 VL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
L ++ P + DL+ ML DP +R++A+ + HP+ ++
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308
Query: 320 K 320
Sbjct: 309 P 309
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 19/262 (7%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L + + +A K + K L D + E DI+ + H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEV-NHPFIV 89
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
RDLKPEN L E +K DFGLS +K G+ YMAPEV+ R +
Sbjct: 150 RDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D WS GV+++ +L G PF + + I+++ L + +S A+ L+R +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSLLRMLFK 262
Query: 298 PDPKRRL-----TAQQVLEHPW 314
+P RL +++ H +
Sbjct: 263 RNPANRLGAGPDGVEEIKRHSF 284
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 82/317 (25%), Positives = 144/317 (45%), Gaps = 17/317 (5%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE-ERYELGRELGR 65
A + K+ G+ +G ++ V + +E + LG+
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGK 158
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125
G FG L ++ G +A K + K+ + ++ E ++++ +H + LK ++
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF 217
Query: 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKP 184
+ + VME GGELF + ++E A IV + H + V++RDLK
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 185 ENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWS 242
EN + + +K DFGL K G G+P Y+APEVL+ N YG VD W
Sbjct: 278 ENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
GV++Y ++CG PF+ + + + + I+ + F R + AK L+ +L DPK+
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQ 390
Query: 303 RL-----TAQQVLEHPW 314
RL A+++++H +
Sbjct: 391 RLGGGSEDAKEIMQHRF 407
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 43/297 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIM 109
+RYE LG G+F Y D+ A K I KL + +D RE+ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVE 167
+ L H NI+ L D + + + LV + E + T A ++
Sbjct: 67 QEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
++ H+H ++HRDLKP N L LK DFGL+ F P ++ V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R YG VD+W+ G IL LL VP +++ I
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 272 -------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ F P ++ DL++ + +P R+TA Q L+ + N
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-44
Identities = 73/303 (24%), Positives = 127/303 (41%), Gaps = 49/303 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ Y+L R+LGRG++ + + N + K + V + ++RE+ I+ +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86
Query: 112 LPKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L NI+ L D +D + LV E + T+ I++ +
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
CH G+MHRD+KP N + E L+ ID+GL+ F+ PG++++ V S Y+ PE+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPF------------------------WAETEQ 263
L + Y +D+WS G +L ++ PF + +
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 264 -GVAQAIIRSVLDFRRDPW---------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
+ + R W VS A D + K+L D + RLTA++ +EHP
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 314 WLQ 316
+
Sbjct: 322 YFY 324
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 83/272 (30%), Positives = 137/272 (50%), Gaps = 19/272 (6%)
Query: 58 ELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLP 113
EL + LG G +G +L + + G +A K + K + + A E R E ++ H+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +V L ++ +T +HL+++ GGELF + R +TE IV ++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMAPEVLK 231
K G+++RD+K EN L + DFGLS E+ + G+ YMAP++++
Sbjct: 177 KLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 232 RN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSAL 292
Query: 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPW 314
AKDL++++L DPK+RL A ++ EH +
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 77/315 (24%), Positives = 122/315 (38%), Gaps = 49/315 (15%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---- 103
P G RYE E+G G +G Y D +G A K +R
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPI 56
Query: 104 ---REVDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARG 151
REV ++R L +H N+V L D + + V LV E + D+ G
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + H + ++HRDLKPEN L + +K DFGL+ +
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSY 172
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ +V + +Y APEVL + Y VD+WS G I + P F +E I
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 271 R-------------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQ 307
+ P P++ E+ L+ +ML +P +R++A
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 308 QVLEHPWLQNAKKAP 322
+ L+H +L + P
Sbjct: 293 RALQHSYLHKDEGNP 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-42
Identities = 63/387 (16%), Positives = 126/387 (32%), Gaps = 64/387 (16%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE--FGITYLCTDRENGDAFACKSISK 90
HH + L + YEL +G+G L + G+ + I+
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIV 148
+ + ++ E+ + + H NIV + T+ D + +V G D
Sbjct: 63 EACSNE-MVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120
Query: 149 ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV- 207
E A A + + +++ + H G +HR +K + L + + ++
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV---YLSGLRSNLS 177
Query: 208 FFKPGEK-------FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 257
G++ V +++PEVL++N Y + D++S G+ L G PF
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 258 -----------------------------------------WAETEQGVAQAIIRSVLDF 276
++ S D
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK--AR 333
P+ + S + V + L +P R +A +L H + + K+ + +L E ++
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTP 357
Query: 334 LKQFSVMNKLKKRALKVIAQHLSVEEV 360
+ F + + +L EV
Sbjct: 358 ITNFEGSQSQDHSGIFGLVTNLEELEV 384
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-41
Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 55/310 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLR--------TAVDIEDVRRE 105
++YE E+G G +G + D + G A K + +++ + + RE
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTI------RE 61
Query: 106 VDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARGHYTER 156
V ++RHL +H N+V L D + +T + LV E + D++
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTE 120
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALT 177
Query: 217 EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---- 271
+V + +Y APEVL + +Y VD+WS G I + P F ++ I+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 272 ---------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ P + E KDL+ K L +P +R++A L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 313 PWLQNAKKAP 322
P+ Q+ ++
Sbjct: 298 PYFQDLERCK 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 37/301 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E E+G G G + R+ G A K + + + + + ++D++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD 82
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH- 173
IV T+ +T V + MEL + +G ER +T IV+ +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYMAPE 228
KHGV+HRD+KP N L + + +K DFG+S G + G YMAPE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194
Query: 229 VLKRN------YGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPW 281
+ Y DVWS G+ L L G P+ +T+ V +++ +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-------EEP 247
Query: 282 PKV------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
P + S + + V+ L D ++R ++LEH +++ + V + K +
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEVDVASWFKDVMA 306
Query: 336 Q 336
+
Sbjct: 307 K 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 35/272 (12%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDV---RRE 105
G + +YE+ + G G YL DR NG K L + D E E
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAE 129
Query: 106 VDIMRHLPKHQNIVCLKDTYED-----DTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + H +IV + + E D ++VME G L A A
Sbjct: 130 RQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA 186
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
I+ + H G+++ DLKPEN + ++ LK ID G F + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYG 239
Query: 221 SPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+P + APE+++ D+++ G L L +P G+ + DP
Sbjct: 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDP 289
Query: 281 WPKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
K ++ L+R+ +DPDP++R TA+++
Sbjct: 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 77/312 (24%), Positives = 122/312 (39%), Gaps = 59/312 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R+ +R+++ R G+G FG L ++ G + A K + + D RE+ IM+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-------DPRFRNRELQIMQ 71
Query: 111 HLP--KHQNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
L H NIV L+ + D +++VME L +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 162 TKTIVEVVQM------CHK--HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
K + Q+ H V HRD+KP N L N+ LK DFG + P E
Sbjct: 131 IKVFL--FQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNE-ADGTLKLCDFGSAKKLSPSE 186
Query: 214 KFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ S YY APE++ ++Y VD+WS G I ++ G P F + G I+R
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 272 --------------------SVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRR 303
+ + + PW V ++ A DL+ +L P+ R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306
Query: 304 LTAQQVLEHPWL 315
+ + L HP+
Sbjct: 307 MKPYEALCHPYF 318
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 64/301 (21%), Positives = 109/301 (36%), Gaps = 32/301 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + E+GRG +G + +G A K I + + + ++D++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD 79
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEV 168
IV + + MEL FD+ E +T V+
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 169 VQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSP 222
+ ++HRD+KP N L +K DFG+S G+ I G
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 223 YYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRS-VLD 275
YMAPE + + Y DVWS G+ LY L G P+ + +++
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLK 335
+ S + + V L D +R +++L+HP++ ++ V + V L
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-VEVACYVCKILD 308
Query: 336 Q 336
Q
Sbjct: 309 Q 309
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-39
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 1/101 (0%)
Query: 307 QQVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKE 365
H +N +V L T+ LK F N+LKK AL +IA+HL E+ ++
Sbjct: 2 HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRN 61
Query: 366 GFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
F +D+ N G ++ E+ GL K+G+Q D+ ++ +
Sbjct: 62 IFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDI 102
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-39
Identities = 77/338 (22%), Positives = 125/338 (36%), Gaps = 92/338 (27%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
++Y LG+ LG G FGI D E+G FA K + + RE+DIM+ L
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVL 57
Query: 113 PKHQNIVCLKD--------------------------------------TYEDDTAVHLV 134
H NI+ L D + ++++
Sbjct: 58 -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVE--VVQM------CHKHGVMHRDLKPEN 186
ME L + R+ ++ ++ + Q+ H G+ HRD+KP+N
Sbjct: 117 MEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAG 244
L N + LK DFG + P E + S +Y APE++ Y P +D+WS G
Sbjct: 172 LL-VN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 245 VILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------------------DFRRDPWP 282
+ L+ G P F ET + Q I ++ + W
Sbjct: 230 CVFGELILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 283 KV-----SENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
K+ A DL+ ++L +P R+ + + HP+
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-38
Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ + Y +G G +G D+ +G+ A K +S+ ++ + + RE+ +++H
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKH 79
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D + + +LVM + D +I+ ++E +
Sbjct: 80 M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSEEKIQYLVY 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H GV+HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRW 188
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-----------------------W 258
Y APEV+ +Y VD+WS G I+ +L G F
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 259 AETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ A++ I+S+ R + P+ S A DL+ KML+ D +RLTA Q L HP+
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 315 LQ 316
+
Sbjct: 309 FE 310
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-38
Identities = 24/97 (24%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 310 LEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHM 369
+ H ++ + G V K + ++ K +K A+ +IAQ + +V +K F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 370 MDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+D +G I ++L+ GL K G ++P + +L+D +
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLP-YNFDLLLDQI 96
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 69/337 (20%), Positives = 125/337 (37%), Gaps = 58/337 (17%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
K+ G ++ +E ELG G G+ + + + +G A K I + + RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ ++ IV + D + + ME +GG L + G E+ V+ +
Sbjct: 82 LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 166 VEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VG 220
++ + KH +MHRD+KP N L ++ E +K DFG+S G+ + VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVG 192
Query: 221 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ YM+PE L+ Y + D+WS G+ L + G P + + V +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 280 PWPKV----------------------------------------SENAKDLVRKMLDPD 299
P+ S +D V K L +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 300 PKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
P R +Q++ H +++ + V + + +
Sbjct: 313 PAERADLKQLMVHAFIKRSDA-EEVDFAGWLCSTIGL 348
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 48/302 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 84
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ KH+N++ L D + E+ V+LV L D IV T+ +
Sbjct: 85 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+ ++ H ++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRW 194
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 262
Y APE++ +Y VD+WS G I+ LL G F AE
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 263 QGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ + A+ I+S+ + + + A DL+ KML D +R+TA Q L H +
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314
Query: 315 LQ 316
Sbjct: 315 FA 316
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 66/315 (20%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE ++G+G FG + R+ G A K K+ + E RE+ I++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71
Query: 111 HLPKHQNIVCLKD--------TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAA 160
L KH+N+V L + +++LV + CE L + +T
Sbjct: 72 LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP--- 182
Query: 221 SPY--------YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ Y Y PE+L +R+YGP +D+W AG I+ + P TEQ I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 271 R-------------------SVLDFRRD---------PWPKVSENAKDLVRKMLDPDPKR 302
+ L+ + A DL+ K+L DP +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 303 RLTAQQVLEHPWLQN 317
R+ + L H + +
Sbjct: 303 RIDSDDALNHDFFWS 317
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-38
Identities = 81/311 (26%), Positives = 125/311 (40%), Gaps = 62/311 (19%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + RE+ I+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKT 164
+H+NI+ + D T E V++V +L E D +++ H +
Sbjct: 82 F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSN------DHI 130
Query: 165 IVEVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-- 216
+ Q+ H V+HRDLKP N L N T LK DFGL+ P +
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVADPDHDHTGF 187
Query: 217 --EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------------- 257
E V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 258 ----WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLT 305
E + A+ + S+ + PW P A DL+ KML +P +R+
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 306 AQQVLEHPWLQ 316
+Q L HP+L+
Sbjct: 308 VEQALAHPYLE 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 81/316 (25%), Positives = 127/316 (40%), Gaps = 58/316 (18%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G ++ RY + LG G G+ + D + A K I L ++ RE+ I
Sbjct: 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKI 61
Query: 109 MRHLPKHQNIVCLKD--------------TYEDDTAVHLVMELCEGGELFD--RIVARGH 152
+R L H NIV + + + + +V++V E E D ++ +G
Sbjct: 62 IRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGP 116
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
E A ++ ++ H V+HRDLKP N LF N E LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPH 174
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
E + + +Y +P +L NY +D+W+AG I +L G F
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 258 ----------WAETEQGV---AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDP 300
E Q + IR+ + P P +S A D + ++L P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 301 KRRLTAQQVLEHPWLQ 316
RLTA++ L HP++
Sbjct: 295 MDRLTAEEALSHPYMS 310
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 73/311 (23%), Positives = 128/311 (41%), Gaps = 55/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 117
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + T E+ V+LVMEL + + V + + +
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ F E +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 265 V---AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLT 305
+ + + + + +PK+ + A+DL+ KML DP +R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 306 AQQVLEHPWLQ 316
L+HP++
Sbjct: 350 VDDALQHPYIN 360
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E ELGRG +G+ +G A K I + + + + ++DI
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVD 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
V + V + MEL + + + +++ + E + +IV+ ++
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 172 CH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYM 225
H K V+HRD+KP N L + +K DFG+S G ++ G YM
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYM 176
Query: 226 APEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRD 279
APE + + Y + D+WS G+ + L P+ + T + ++ +
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE--PSPQL 234
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVK 331
P K S D + L + K R T ++++HP+ + + VK
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES-KGTDVASFVK 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 15/271 (5%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
G+ I ERY++ +LG G YL D A K+I + E + RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFERE 61
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
V L HQNIV + D E+D +LVME EG L + I + G + A T I
Sbjct: 62 VHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPY 223
++ ++ H ++HRD+KP+N L + K LK DFG++ + + ++G+
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 224 YMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPW 281
Y +PE K D++S G++LY +L G PPF ET +A + I SV + D
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 282 PKVSENAKDLVRKMLDPDPKRR-LTAQQVLE 311
+ ++ +++ + + D R T Q++ +
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKD 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 69/275 (25%), Positives = 121/275 (44%), Gaps = 35/275 (12%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ + E+ +GRG FG+ R K ++ K++ + + + E+ +
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKAFIVELRQLS 56
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H NIV CL LVME EGG L++ + AA
Sbjct: 57 RV-NHPNIVKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 166 VEVVQ-MCHKH-----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ Q + + H ++HRDLKP N L LK DFG + + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNK 164
Query: 220 GSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
GS +MAPEV + + Y + DV+S G+IL+ ++ PF + G A I+ +V + R
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTR 222
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P K + + + L+ + DP +R + +++++
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 69/302 (22%), Positives = 128/302 (42%), Gaps = 48/302 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y + +G G +G D G A K + + ++ + + RE+ +++H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKH 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D T +D T +LVM D +++ E +
Sbjct: 81 M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRW 190
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-----------------------W 258
Y APEV+ Y VD+WS G I+ ++ G F
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 259 AETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
+ A+ ++ + + + + S A +L+ KML D ++R+TA + L HP+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 315 LQ 316
+
Sbjct: 311 FE 312
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 83/327 (25%), Positives = 132/327 (40%), Gaps = 86/327 (26%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDI 108
I ++L LG G +G+ T + G+ A I KK+ RE+ I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVA---I--KKIEPFDKPLFALRTLREIKI 62
Query: 109 MRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTE------ 155
++H KH+NI+ + + ++E+ V+++ EL + D R+++ ++
Sbjct: 63 LKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117
Query: 156 -----RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
RA K + H V+HRDLKP N L N LK DFGL+
Sbjct: 118 IYQTLRA----VKVL-------HGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGLARIID 163
Query: 211 PGEKFSEIVGSP-----------YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVP-- 255
+ +Y APEV+ Y +DVWS G IL L P
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 256 ------------------PFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAK 289
P + + A+ I+S+ + P P+V+
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
DL+++ML DP +R+TA++ LEHP+LQ
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 75/337 (22%), Positives = 130/337 (38%), Gaps = 67/337 (19%)
Query: 46 KEPTGREIEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
+E+ +E G ++GRG +G Y ++ D K + K++ R
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDD---KDYALKQIEGTGISMSACR 67
Query: 105 EVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAA-- 158
E+ ++R L KH N++ L+ D V L+ + E + A +
Sbjct: 68 EIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 159 AAVTKT----IVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS-VFFKPG 212
+ K+ I++ + H + V+HRDLKP N L + E +K D G + +F P
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 267 QA---------IIR---------------------SVLDFRRDPW-------------PK 283
I + DFRR+ + K
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
A L++K+L DP +R+T++Q ++ P+
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 66/318 (20%), Positives = 116/318 (36%), Gaps = 68/318 (21%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----DIEDVR--- 103
++ Y + R + G +G D E G A K + D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 104 REVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTER 156
RE+ ++ H H NI+ L+D ++LV EL D +++
Sbjct: 78 REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIV-- 130
Query: 157 AAAAVTKTIVE--VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
++ ++ + + H+ GV+HRDL P N L + + DF L+
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLARE 183
Query: 209 FKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
+ V +Y APE++ + + VD+WSAG ++ + F
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 258 --------------WAETEQGVAQAIIRSVLDFR-RDPW----PKVSENAKDLVRKMLDP 298
A+ +R+ L W P A DL+ KML+
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 299 DPKRRLTAQQVLEHPWLQ 316
+P+RR++ +Q L HP+ +
Sbjct: 304 NPQRRISTEQALRHPYFE 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 74/366 (20%), Positives = 127/366 (34%), Gaps = 86/366 (23%)
Query: 29 DY--GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACK 86
DY G +H G + RY L R+LG G F +L D N A K
Sbjct: 1 DYRPGGYHPAFKGEPY----------KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK 50
Query: 87 SI-SKKKLRTAVDIEDVRREVDIMRHL----------PKHQNIVCLKD--TYEDDTAVH- 132
+ K A + E + +++ + +I+ L D ++ VH
Sbjct: 51 IVRGDKVYTEAAEDE-----IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105
Query: 133 -LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFL 188
+V E+ G L I H ++K ++ + H+ G++H D+KPEN L
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 189 FANKK---ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAG 244
+K D G + + E ++ + + Y +PEV L +G D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 222
Query: 245 VILYILLCGVPPFWAETEQGVAQ-----AIIRSVLD----------------FRRDPWPK 283
+++ L+ G F + + A I +L F +
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 284 VSENAK-----------------------DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
K D + ML DP++R A ++ HPWL++
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342
Query: 321 APNVSL 326
+ +
Sbjct: 343 MEEIRV 348
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-36
Identities = 62/275 (22%), Positives = 114/275 (41%), Gaps = 33/275 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLP 113
E +++G+G FG+ + ++ A KS+ ++ +REV IM +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 114 KHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H NIV +VME G+L+ R+ + + ++++
Sbjct: 81 NHPNIVKLYGLMHN-------PPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDI 131
Query: 169 VQ-MCHKHG----VMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGS 221
+ + ++HRDL+ N + E AP K DFGLS S ++G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 222 PYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+MAPE + + +Y + D +S +ILY +L G P + E G + I + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEGLR 248
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P+ ++++ DPK+R +++
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 69/311 (22%), Positives = 126/311 (40%), Gaps = 55/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + + E+ V++VMEL + + V + + +
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ G F E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 265 V---AQAIIRSVLDFRRDPW----------------PKVSENAKDLVRKMLDPDPKRRLT 305
+ + + + + + + A+DL+ KML D +R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 306 AQQVLEHPWLQ 316
+ L+HP++
Sbjct: 313 VDEALQHPYIN 323
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 19/267 (7%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
T + +RYELG LG G +L D + A K + + A D RRE
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRRE 62
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVH----LVMELCEGGELFDRIVARGHYTERAAAAV 161
L H IV + DT E +T +VME +G L D + G T + A V
Sbjct: 63 AQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SE 217
+ + H++G++HRD+KP N + + T +K +DFG++ +
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 218 IVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+ Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRR 303
+S + +V K L +P+ R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 74/334 (22%), Positives = 122/334 (36%), Gaps = 73/334 (21%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDIMRH 111
+ RYE+ + +G+G FG D + A K + ++K+ E + I+ H
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEH 149
Query: 112 LPKHQ-----NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKT 164
L K N++ + + + + + EL L++ I ++ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
I++ + HK+ ++H DLKPEN L + + +K IDFG S + ++ + S +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTYIQSRFY 265
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------- 270
APEV L YG +D+WS G IL LL G P E E +I
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 271 --------------RSVLDFRRDPWPKVSENAKDL------------------------- 291
R V +
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 292 ---VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+++ L+ DP R+T Q L HPWL+ P
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 37/265 (13%), Positives = 67/265 (25%), Gaps = 34/265 (12%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P R RY L G + D A + + + +++
Sbjct: 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ + + + D +V E GG L + VA + A +++
Sbjct: 84 RLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAA 140
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H+ GV P + G V + P M
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVS-----------IDGDVV-----------LAYPATMPD 178
Query: 228 EVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---PKV 284
P+ D+ G LY LL P + R +P +
Sbjct: 179 A------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + D R + +
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL 257
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 58/280 (20%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+G +G+G FG Y +G+ A + I ++ ++ +REV R +H+N
Sbjct: 36 EIGELIGKGRFGQVYHGR--WHGEV-AIRLIDIERD-NEDQLKAFKREVMAYRQT-RHEN 90
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQM 171
+V C+ + + ++ LC+G L+ + A+ + + IV+ +
Sbjct: 91 VVLFMGACMSPPH-----LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP------GEKFSEIVGSPYYM 225
H G++H+DLK +N + N K + DFGL +K G ++
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 226 APEVLKRN----------YGPEVDVWSAGVILYILLCGVPPFWAETEQGV-AQAIIRSVL 274
APE++++ + DV++ G I Y L PF + A+AII +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEAIIWQMG 256
Query: 275 DFRRDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ ++ + D++ + + R T ++++
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 70/339 (20%), Positives = 120/339 (35%), Gaps = 80/339 (23%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + + + R++G G FG LC +N +A K + + KK + IE DI
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADI 84
Query: 109 MRHL----PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 162
++ + + NIV + + L+ E G L++ I + +
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------------LKA 200
I++ + K + H DLKPEN L + +K
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
IDFG + F + I+ + Y APEV L + D+WS G +L L G F
Sbjct: 204 IDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
Query: 260 ETEQ-------GVAQAIIRSVLD----------FRRDP----WPKVSENAK--------- 289
+ Q I +++L +D WP+ + +
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321
Query: 290 ------------DLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
D + +L DP R + ++L+H +L+
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 18/263 (6%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ ++G G FG + G A K + ++ A + + REV IM+ L +H N
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPN 95
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKHG 176
IV + +V E G L+ + G + +V + M + H
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 177 ----VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
++HR+LK N L K +K DFGLS + G+P +MAPEVL+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAK 289
+ DV+S GVIL+ L P+ AQ + +R P+ ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 290 DLVRKMLDPDPKRRLTAQQVLEH 312
++ +P +R + +++
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDL 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 62/251 (24%), Positives = 104/251 (41%), Gaps = 8/251 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L R +GRG G Y D A K +S+ V ++RE L +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QE 93
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++V + D E D +++ M L G +L + +G A A+ + I + H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKRN 233
G HRD+KPEN L + +DFG++ + + VG+ YYMAPE +
Sbjct: 154 GATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 234 Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ D+++ +LY L G PP+ + V A I + P + ++
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVI 269
Query: 293 RKMLDPDPKRR 303
+ + +P+ R
Sbjct: 270 ARGMAKNPEDR 280
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 73/331 (22%), Positives = 122/331 (36%), Gaps = 74/331 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
++ERYE+ LG G FG C D G + A K I + K R A R E+++++
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 71
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
+ + V + D + + + EL G F+ + Y +
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
+ ++ H++ + H DLKPEN LF N + ++ DFG +
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264
F E + IV + +Y PEV L+ + DVWS G IL+ G F +
Sbjct: 191 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 265 --------------VAQAIIRSVLDFRRDPWPKVSENAK--------------------- 289
+ + + W + S + +
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 290 ---DLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
DL+R+ML+ DP +R+T + L HP+
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 79/335 (23%), Positives = 122/335 (36%), Gaps = 74/335 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
+ RYE+ LG G FG C D + G A K + + + A E + ++
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLE 66
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
HL V + + +E + +V EL G +D I G + +
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
I + V H + + H DLKPEN LF T +K +DFG +
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264
+ E S +V + +Y APEV L + DVWS G IL G F +
Sbjct: 186 Y--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 265 --------------VAQAIIRSVLDFRRDPWPKVSENAK--------------------- 289
+ + R R W + S +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 290 ---DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA 321
DL++KML+ DP +R+T ++ L+HP+ KK+
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 82/348 (23%), Positives = 133/348 (38%), Gaps = 103/348 (29%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +YEL ++LG+G +GI + DR G+ A K I + + D + RE+ I+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTE 64
Query: 112 LPKHQNIVCLKD--TYEDDTAVHLVMELCE--------GGELFDRIVARGHYTERAAAAV 161
L H+NIV L + ++D V+LV + E L H
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-----HK-------- 111
Query: 162 TKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+ + V Q+ H G++HRD+KP N + N +K DFGLS F +
Sbjct: 112 -QYV--VYQLIKVIKYLHSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRV 165
Query: 216 SEIVGSP----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILL 251
+ + +Y APE+L Y +D+WS G IL +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 252 CGVPPF-------------------WAETEQGV----AQAIIRSVLDFRRDPW------- 281
CG P F E + + A+ +I S+ +
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285
Query: 282 -------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+E A DL+ K+L +P +R++A L+HP++
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 76/271 (28%), Positives = 113/271 (41%), Gaps = 29/271 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQ 116
L +G G FG Y GD A K+ + IE+VR+E + L KH
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKH 175
NI+ L+ + + LVME GG L + + V++ + M + H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 176 G-----VMHRDLKPENFLFANKKETAP-----LKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
++HRDLK N L K E LK DFGL+ + K S G+ +M
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWM 181
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFRRDPWP 282
APEV++ + + DVWS GV+L+ LL G PF +G+ ++ P P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLALPIP 236
Query: 283 K-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
E L+ +PDP R + +L+
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 73/357 (20%), Positives = 129/357 (36%), Gaps = 103/357 (28%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y + +GRG +G YL D+ A K ++ + +D + + RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L K I+ L D +++V+E+ + +L TE KTI
Sbjct: 82 L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTE----EHIKTI- 134
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + H+ G++HRDLKP N L N + +K DFGL+ + + +
Sbjct: 135 -LYNLLLGENFIHESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 221 SP-----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILLC--- 252
+Y APE++ + NY +D+WS G I LL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 253 --------------GVPPFWAETEQGVAQAIIRSVLD----------------------- 275
G F ++ + +S D
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 276 -----------FRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ P +S++ +L+ ML +P +R+T Q L+HP+L++
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 65/324 (20%), Positives = 113/324 (34%), Gaps = 48/324 (14%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
R G LG+G FG T RE G+ K + + +EV +M
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVM 61
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R L +H N++ D ++ + E +GG L I + + V
Sbjct: 62 RCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---------PWSQRV 111
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------------- 206
H ++HRDL N L + + DFGL+
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKNV--VVADFGLARLMVDEKTQPEGL 168
Query: 207 --VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +K +VG+PY+MAPE++ R+Y +VDV+S G++L ++ V
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYL 226
Query: 264 GVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
+V F P + + + D DP++R + ++ WL+ +
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHL 284
Query: 323 NVSLGETVKARLKQFSVMNKLKKR 346
L + ++
Sbjct: 285 AGHLPLGPQLEQLDRGFWETYRRG 308
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 73/338 (21%), Positives = 121/338 (35%), Gaps = 80/338 (23%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + +RYE+ +G+G FG DR + A K I +KK + EV +
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRL 103
Query: 109 MRHLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAV 161
+ + KH IV LK + + LV E+ L+D + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 162 TKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ + + + ++H DLKPEN L N K +A +K +DFG S G++ + +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQYI 219
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSA---------GVILY------------ILLCGVPPF 257
S +Y +PEV L Y +D+WS G L+ + + G+PP
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 258 W----------------------------AETEQGVAQAIIRSVLDFRRDPWPKVSENA- 288
+ + ++L
Sbjct: 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 289 ----------KDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
KDL+ +MLD DPK R+ L+H + +
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 41/270 (15%), Positives = 93/270 (34%), Gaps = 33/270 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L G + + G+ K + + + D E +R H N
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPN 68
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-M 171
++ C L+ G L++ + ++ + AV K +++ + M
Sbjct: 69 VLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGM 124
Query: 172 CHKHG----VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H + L + + + + F+ + + +P ++AP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSFQSPGR----MYAPAWVAP 177
Query: 228 EVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
E L++ D+WS V+L+ L+ PF + + ++ L+ R P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPP 234
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+S + L++ ++ DP +R ++
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+G+ +G G FG Y +GD A K ++ T ++ + EV ++R +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVN 81
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I+ +V + CEG L+ + A E + +++ +
Sbjct: 82 ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE---------MKKLIDIA 126
Query: 173 ----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---V 219
H ++HRDLK N +F ++ T +K DFGL+ +
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 220 GSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSV 273
GS +MAPEV++ Y + DV++ G++LY L+ G P+ + II V
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMV 238
Query: 274 L-DFRRDPWPKVSENA----KDLVRKMLDPDPKRRLTAQQVLEH 312
KV N K L+ + L R + ++L
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 76/379 (20%), Positives = 128/379 (33%), Gaps = 101/379 (26%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + + +I +RYE+ +G G +G D+ A K I +
Sbjct: 32 QHHSSKPTASMPRPH--SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-R 88
Query: 92 KLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDR 146
+D + + RE+ I+ L H ++V + D E +++V+E+ + +
Sbjct: 89 VFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKL 146
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ TE + ++ V+ H G++HRDLKP N L N + +K DFGL+
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL-VN--QDCSVKVCDFGLA 203
Query: 207 -VFFKPGEKFSEIVGSP---------------------------YYMAPEVL--KRNYGP 236
P S++ SP +Y APE++ + NY
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQG-------------VAQAIIRSVLDFRRDP--- 280
+DVWS G I LL + A Q R
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323
Query: 281 ---------------WPKV-SENAKDLVR--------------------------KMLDP 298
+ E+AK +R +ML
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383
Query: 299 DPKRRLTAQQVLEHPWLQN 317
+P +R+T + L HP+ +
Sbjct: 384 NPNKRITINECLAHPFFKE 402
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 57/305 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R + L +G+G +G + + + G+ A K S + D + RE ++
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR------DEKSWFRETELYN 55
Query: 109 MRHLPKHQNIVCL----KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ + T + L+ E G L+D + + + +
Sbjct: 56 TVML-RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLS 113
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I E+ K + HRDLK +N L + D GL+V
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIADLGLAVMHSQSTNQL 170
Query: 217 EI-----VGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGV---------- 254
++ VG+ YMAPEVL + VD+W+ G++L+ + +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
PPF+ + +R +D +R P + L+++ +P RLTA
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
Query: 307 QQVLE 311
++ +
Sbjct: 291 LRIKK 295
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 57/305 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R I L +G+G FG + R G+ A K S + + RE +I
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQ 89
Query: 109 MRHLPKHQNIVCLK--DTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ D ++ T LV + E G LFD + R T + +
Sbjct: 90 TVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALS 147
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
E+V K + HRDLK +N L K+ D GL+V
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 204
Query: 217 EI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV---------- 254
+I VG+ YMAPEVL + + D+++ G++ + +
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
P++ + +R R P ++ ++R+ + RLTA
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 307 QQVLE 311
++ +
Sbjct: 325 LRIKK 329
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 35/72 (48%), Positives = 51/72 (70%)
Query: 335 KQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQI 394
KQFS MNK KK AL+VIA+ LS EE+AG+KE F+M+D G+I +EL+ GL ++G +
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 395 PDTDVQILMDAV 406
++++ LM A
Sbjct: 61 KESEILDLMQAA 72
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 63/325 (19%), Positives = 113/325 (34%), Gaps = 83/325 (25%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI--MRHLPKH 115
++ +++G+G +G ++ R G+ A K + RE +I + +H
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLM-RH 90
Query: 116 QNIVCL----KDTYEDDTAVHLVMELCEGGELFDRI----------------VARG---- 151
+NI+ T ++L+ + E G L+D + G
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
H E+ K + HRDLK +N L K+ D GL+V F
Sbjct: 151 H-------------TEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFIS 194
Query: 212 GEKFSEI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----- 254
+I VG+ YM PEVL + D++S G+IL+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 255 -----PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPK 301
P+ + +R + R +P + L+ + +P
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 302 RRLTAQQVLEHPWLQNAKKAPNVSL 326
RLTA +V + L ++ ++ L
Sbjct: 315 SRLTALRVKKT--LAKMSESQDIKL 337
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 69/373 (18%), Positives = 121/373 (32%), Gaps = 112/373 (30%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
G RY + R+LG G F +L D + A K + K E E+ ++
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLL 87
Query: 110 RHL-------PKHQNIVCLKDTYEDD--TAVH--LVMELCEGGELFDRIVARGH--YTER 156
+ + P + +V L D ++ H +V E+ G L I+ +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146
Query: 157 AAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFA------------------------- 190
+ + +++ + H ++H D+KPEN L +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 191 ---------------------NKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
E +K D G + + + F+E + + Y + EV
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEV 264
Query: 230 -LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-----AIIRSVL--------- 274
+ Y D+WS + + L G F + + + A+I +L
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 275 -------------DFRRD----PWPKVS----------ENAK---DLVRKMLDPDPKRRL 304
D + PW E A D + ML+ P++R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 305 TAQQVLEHPWLQN 317
TA + L HPWL +
Sbjct: 385 TAAECLRHPWLNS 397
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 69/307 (22%), Positives = 114/307 (37%), Gaps = 75/307 (24%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L RG FG + + A K EV + + KH+N
Sbjct: 27 QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI----QDKQSWQNEYEVYSLPGM-KHEN 79
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFD-------------RI---VARG----H 152
I+ + T D + L+ E G L D I +ARG H
Sbjct: 80 ILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ ++ HK + HRD+K +N L N DFGL++ F+ G
Sbjct: 139 -----------EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT---ACIADFGLALKFEAG 184
Query: 213 EKFSEI---VGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG---------- 253
+ + VG+ YMAPEVL +R+ +D+++ G++L+ L
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 254 -VPPFWAET-EQGVAQAIIRSVLDFRRDP-----WPKVSENAK--DLVRKMLDPDPKRRL 304
+ PF E + + + V+ ++ P W K + A + + + D D + RL
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 305 TAQQVLE 311
+A V E
Sbjct: 305 SAGCVGE 311
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-24
Identities = 17/83 (20%), Positives = 38/83 (45%), Gaps = 4/83 (4%)
Query: 326 LGETVKARLKQFSVMNKLKKRALKVIAQHLSV--EEVAGIKEGFHMMDIGNRGKINIDEL 383
+ V +K + + ++ + ++A LSV + I E F+ +D + G ++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 384 RVGLHKLGHQIPDTDVQILMDAV 406
L +G I D+ ++ A+
Sbjct: 62 YTVLASVG--IKKWDINRILQAL 82
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/322 (20%), Positives = 106/322 (32%), Gaps = 61/322 (18%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE--------ERYELGRELGRGEFGITYLCTDRENGDAFA 84
H R + E LG ++GRG FG + R + A
Sbjct: 84 HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143
Query: 85 CKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELF 144
KS ++ +E I++ H NIV L +++VMEL +GG+
Sbjct: 144 VKSC--RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKE 194
+ G + ++QM +HRDL N L K
Sbjct: 201 TFLRTEGARL---------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLKRN-YGPEVDVW 241
LK DFG+S E Y APE L Y E DVW
Sbjct: 252 ---LKISDFGMS---------REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299
Query: 242 SAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
S G++L+ G P+ + Q + + + R + L+ + +P
Sbjct: 300 SFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCWAYEP 356
Query: 301 KRRLTAQQVLEHPWLQNAKKAP 322
+R + + + LQ+ +K
Sbjct: 357 GQRPSFSTIYQ--ELQSIRKRH 376
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-23
Identities = 24/135 (17%), Positives = 55/135 (40%), Gaps = 11/135 (8%)
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQ 336
R ++++ ++ K+ + D K + E + A++ + G+ + +
Sbjct: 39 RDRLEAQIAQKEQEQKAKLAEYDQKVQN------EFDARERAEREREAARGDAAAEKQRL 92
Query: 337 FSVMNKLKKRA-----LKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG 391
S++ L+ A L+ LS E+ +++ F + GK + +L+ L K
Sbjct: 93 ASLLKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYA 152
Query: 392 HQIPDTDVQILMDAV 406
IP+ ++ L V
Sbjct: 153 DTIPEGPLKKLFVMV 167
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 12/91 (13%)
Query: 328 ETVKARLKQFSVMNKLKKRALKVIAQHLS-VEEVAGIKEGFHMMDIGNRGKINIDELRVG 386
+K+F KL + A+ + L+ +EE + + F +D G+++ EL G
Sbjct: 6 TGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEG 65
Query: 387 LHK-----------LGHQIPDTDVQILMDAV 406
K L + +V ++ +V
Sbjct: 66 YRKLMQWKGDTVSDLDSSQIEAEVDHILQSV 96
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-22
Identities = 19/87 (21%), Positives = 31/87 (35%), Gaps = 8/87 (9%)
Query: 320 KAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKIN 379
P LG + M KL+ + L A + G+ F +D ++
Sbjct: 4 LVPRGPLGS---HMDAVDATMEKLRAQCLSRGA-----SGIQGLARFFRQLDRDGSRSLD 55
Query: 380 IDELRVGLHKLGHQIPDTDVQILMDAV 406
DE R GL KLG + + + +
Sbjct: 56 ADEFRQGLAKLGLVLDQAEAEGVCRKW 82
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 62/309 (20%), Positives = 103/309 (33%), Gaps = 68/309 (22%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--H 115
+L +GRG +G Y + A K S + ++ E +I R +P H
Sbjct: 16 KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYR-VPLMEH 66
Query: 116 QNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV---- 166
NI + T + LVME G L ++ ++ + ++
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 167 -----EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---- 217
+K + HRDL N L K DFGLS+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 218 -----IVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGV---------- 254
VG+ YMAPEVL+ + +VD+++ G+I + +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 255 ---PPFWAETEQGVAQAIIRSVLDFRR------DPWPKVSENAKDLVRKML---DPDPKR 302
F E ++ ++ + + W + S + L + D D +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 303 RLTAQQVLE 311
RLTAQ E
Sbjct: 303 RLTAQXAEE 311
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 50/302 (16%)
Query: 33 HHQGNGGHKLCVLKEPTGR----------------EIE-ERYELGRELGRGEFGITYLCT 75
HH + L P + E+E + +LG G++G Y
Sbjct: 181 HHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ A K++ + +++E+ +E +M+ + KH N+V L + +++
Sbjct: 241 WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIT 295
Query: 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPE 185
E G L D + R + V ++ M K +HR+L
Sbjct: 296 EFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 186 NFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEVDVWS 242
N L E +K DFGLS + P + APE L + + DVW+
Sbjct: 348 NCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 243 AGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301
GV+L+ I G+ P+ V + + + D+R + E +L+R +P
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPS 461
Query: 302 RR 303
R
Sbjct: 462 DR 463
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 61/299 (20%), Positives = 102/299 (34%), Gaps = 63/299 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVD 107
I +++ LGR LG+GEFG ++ +F A K + K + + DIE+ RE
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAA 77
Query: 108 IMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
M+ H ++ L +++ + G+L ++A
Sbjct: 78 CMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL-- 134
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ +V+ +HRDL N + A E + DFGLS
Sbjct: 135 --PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS----- 184
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY +A E L Y DVW+ GV ++ I+ G P+
Sbjct: 185 ----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ ++ R P + V M DPK+R + +
Sbjct: 241 AGIENAEI----YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 62/322 (19%), Positives = 109/322 (33%), Gaps = 67/322 (20%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE------ERYELGRELGRGEFGITYLCTDRENGDAF--- 83
HH + + E ++E LG+ LG GEFG ++
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 84 ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELC 138
A K++ K + +IE+ E M+ H N+ VC++ + + +++
Sbjct: 66 AVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFL 188
+ G+L ++ T + +++ +HRDL N +
Sbjct: 124 KYGDLHTYLLYSRLETGPKHI----PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYG 235
+ + DFGLS +I YY +A E L R Y
Sbjct: 180 LR---DDMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
+ DVW+ GV ++ I G+ P+ + +L R P E+ D + +
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----YDYLLHGHRLKQP---EDCLDELYE 280
Query: 295 -MLD---PDPKRRLTAQQVLEH 312
M DP R T +
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 14/100 (14%), Positives = 35/100 (35%), Gaps = 5/100 (5%)
Query: 307 QQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEG 366
Q + + L N + +G + + ++ + + +++ I +
Sbjct: 2 QPPVANFCLWNLQPIQGSWMG-----AACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQW 56
Query: 367 FHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
F +D G + I+EL +G G ++ +M
Sbjct: 57 FMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIF 96
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 67/244 (27%), Positives = 95/244 (38%), Gaps = 49/244 (20%)
Query: 33 HHQGNGGHKLCVLKEPTG--REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
HH + L VL + G +RY + R+LG G FG L D A
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAV 65
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K++ K ++E+DI+R L H++I+ K ++ LVME G L
Sbjct: 66 KAL--KADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAP 197
D Y R + + + ++ Q+C H +HRDL N L N +
Sbjct: 123 RD-------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--- 172
Query: 198 LKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAG 244
+K DFGL+ G + YY APE LK + DVWS G
Sbjct: 173 VKIGDFGLAKAVPEGHE--------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 245 VILY 248
V LY
Sbjct: 225 VTLY 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 61/296 (20%), Positives = 112/296 (37%), Gaps = 58/296 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + A K++ + + + + E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNE 78
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+M+ ++V L ++MEL G+L + + ++
Sbjct: 79 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++QM V HRDL N + A +K DFG++
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFT---VKIGDFGMT-------- 185
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M+PE LK + DVWS GV+L+ I P+
Sbjct: 186 -RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ + V +R V++ P +N D++ + M +PK R + +++
Sbjct: 245 SNEQV----LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 3e-18
Identities = 25/58 (43%), Positives = 40/58 (68%)
Query: 349 KVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
K +A+ LS EE+ G+KE F M+D N G I DEL+ GL ++G ++ +++++ LMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 69/312 (22%), Positives = 110/312 (35%), Gaps = 58/312 (18%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVD 107
I+ L ELG G FG +L ++ K L+ A + D +RE +
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAAAAVT 162
++ L +HQ+IV + + +V E G+L A+ A
Sbjct: 96 LLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L +K DFG+S
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VKIGDFGMS------ 205
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+I + YY M PE + R + E DVWS GV+L+ I G P++
Sbjct: 206 ---RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPW 314
+ I + R P V M +P++R + + V
Sbjct: 263 QLSNTEA----IDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR-- 313
Query: 315 LQNAKKAPNVSL 326
LQ +AP V L
Sbjct: 314 LQALAQAPPVYL 325
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 65/307 (21%), Positives = 113/307 (36%), Gaps = 58/307 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 83
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV ++MEL GG+L + + + + +
Sbjct: 84 ALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS---SLAM 139
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
++++ + ++ +HRD+ N L K DFG++
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 190
Query: 216 SEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
+I + YY M PE + + D WS GV+L+ I G P+ +++
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPWLQN 317
Q V + V R P +N V + M P+ R +LE ++
Sbjct: 251 NQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEY 301
Query: 318 AKKAPNV 324
+ P+V
Sbjct: 302 CTQDPDV 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 60/308 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 124
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV +++EL GG+L + + ++ +
Sbjct: 125 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL---AM 180
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++++ + H + HRD+ N L K DFG++
Sbjct: 181 LDLLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 231
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE + + D WS GV+L+ I G P+ ++
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEHPWLQ 316
+ Q V + V R P +N V + M P+ R +LE ++
Sbjct: 291 SNQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IE 341
Query: 317 NAKKAPNV 324
+ P+V
Sbjct: 342 YCTQDPDV 349
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++ LGR++G G FG YL T+ + + A K + K + E I R L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRIL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
I ++ + LVM+L G +LF+ + + + ++ V
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ H +HRD+KP+NFL + + IDFGL+ ++
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 53/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
E+R+ + R+LG G FG LC GD A KS+ K I D+++E
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKE 73
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I+R+L H+NIV K T + + L+ME G L + + +
Sbjct: 74 IEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---------KI 123
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ + ++ +HRDL N L ++ + +K DFGL+ + +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDK 180
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV L+
Sbjct: 181 E--------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 44/249 (17%), Positives = 77/249 (30%), Gaps = 48/249 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLR--TAVDIEDVRREV 106
+I E LG+G F + RE GD K L E
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+M L H+++V LV E + G L + + I+
Sbjct: 64 SMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---------CINIL 113
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPL-----KAIDFGLSVFFKP 211
+++ ++ ++H ++ +N L +++ K D G+S+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170
Query: 212 GEKFSEIVGSPYY------MAPEVLK--RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
++ + PE ++ +N D WS G L+ I G P A
Sbjct: 171 ------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 263 QGVAQAIIR 271
Q Q
Sbjct: 225 QRKLQFYED 233
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 70/297 (23%), Positives = 106/297 (35%), Gaps = 54/297 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + G+ LG G FG T G A ++ K L+ A + E + E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD----RIVARGHYTERAAAAVTK 163
IM HL +H+NIV L V ++ E C G+L + + A A T
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 164 TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ +++ +HRD+ N L N K DFGL+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLA------- 211
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
+I+ Y MAPE + Y + DVWS G++L+ I G+ P+
Sbjct: 212 --RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
V + V D + P A + M +P R T QQ+
Sbjct: 270 IL---VNSKFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I ++ + +VMEL G L D ++ + + ++ ++
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H +HRD+KP+NFL K+ + IDFGL+ ++ I G+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 224 YM 225
Y
Sbjct: 181 YA 182
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 56/306 (18%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 229 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 289 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 336
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 337 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L K DFGL+ + E + P + APE + +
Sbjct: 389 LRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 502
Query: 298 PDPKRR 303
+P+ R
Sbjct: 503 KEPEER 508
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 65/306 (21%), Positives = 114/306 (37%), Gaps = 56/306 (18%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 146 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 206 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 253
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 254 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L E K DFGL+ + E + P + APE + +
Sbjct: 306 LRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 419
Query: 298 PDPKRR 303
+P+ R
Sbjct: 420 KEPEER 425
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 61/297 (20%), Positives = 107/297 (36%), Gaps = 73/297 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 82 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 127
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++ +HRDL N + E +K DFGL+
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA--------- 175
Query: 216 SEIVGSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
++ YY MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ +L RR P E D + + ML P + R + +++
Sbjct: 236 VNTFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-17
Identities = 55/255 (21%), Positives = 82/255 (32%), Gaps = 60/255 (23%)
Query: 51 REI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
I E+ L +LG G FG+ + A K + L ++D REV
Sbjct: 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
+ M L H+N+ V L + +V EL G L DR+
Sbjct: 73 NAMHSL-DHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG--------- 116
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + +HRDL N L A + +K DFGL
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ 173
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ +Y APE LK R + D W GV L+ + G P+
Sbjct: 174 NDD--------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
Query: 258 WAETEQGVAQAIIRS 272
+ I +
Sbjct: 226 IGLNGSQILHKIDKE 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 45/241 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI+ + +ELG G+FG+ R D A K I + ++ ++ E +M
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE----GSMSEDEFIEEAKVMM 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L H+ +V L + ++ E G L + + H ++++
Sbjct: 75 NL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLE 124
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC +HRDL N L ++ +K DFGLS + G
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 181
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + PEVL + + D+W+ GV+++ I G P+ T A+ I
Sbjct: 182 KF------PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
Query: 271 R 271
+
Sbjct: 236 Q 236
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 51/245 (20%), Positives = 93/245 (37%), Gaps = 51/245 (20%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
E++ E L +ELG G+FG+ L + D A K I + ++ ++ +E M
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE----GSMSEDEFFQEAQTM 57
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L H +V + +++V E G L + + + G +++
Sbjct: 58 MKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL---------EPSQLL 107
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+MC+ H +HRDL N L +K DFG++ + ++
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRY---------VL 155
Query: 220 GSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
Y APEV Y + DVW+ G++++ + G P+ T V
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
Query: 267 QAIIR 271
+ +
Sbjct: 216 LKVSQ 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 43/241 (17%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + +++E+ +E +M+
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 64
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ KH N+V L + +++ E G L D + R + V ++
Sbjct: 65 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--------RECNRQEVSAVVLLY 115
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PGE 213
M K +HRDL N L E +K DFGLS G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + APE L + + DVW+ GV+L+ I G+ P+ V + +
Sbjct: 173 KF------PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
Query: 271 R 271
+
Sbjct: 227 K 227
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 60/263 (22%), Positives = 89/263 (33%), Gaps = 59/263 (22%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
G HH + C ++PT EER+ + +LG+G FG LC GD A
Sbjct: 2 GHHHHHHAQLYAC--QDPT--IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K + + D +RE+ I++ L IV + ++ LVME G L
Sbjct: 58 KQL---QHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKK 193
D + ++ +HRDL N L ++
Sbjct: 114 RDFLQRHRA---------RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164
Query: 194 ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDV 240
+K DFGL+ + YY APE L + + DV
Sbjct: 165 H---VKIADFGLAKLLPLDKD--------YYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 241 WSAGVILY-ILLCGVPPFWAETE 262
WS GV+LY + E
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAE 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 54/253 (21%), Positives = 90/253 (35%), Gaps = 50/253 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDI 108
++ + +G G FG +++G A K + K+ + D D E+++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEV 78
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD------RIVARGHYTERAAAAVT 162
+ L H NI+ L E ++L +E G L D + + + A T
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L K DFGLS
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLS------ 189
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ E Y MA E L Y DVWS GV+L+ I+ G P+
Sbjct: 190 -RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 259 AETEQGVAQAIIR 271
T + + + +
Sbjct: 244 GMTCAELYEKLPQ 256
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 46/244 (18%)
Query: 51 REI-EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
R E + LG G FG + G++ K I + + V
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDH 65
Query: 106 VDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + L H +I +C + + LV + G L D +
Sbjct: 66 MLAIGSL-DHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRG-------- 110
Query: 161 VTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
++ +HG++HR+L N L + + ++ DFG++
Sbjct: 111 -ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADLLP 166
Query: 211 PGEKFSEIVGS--PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
P +K + P +MA E + Y + DVWS GV ++ ++ G P+ V
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
Query: 266 AQAI 269
+
Sbjct: 227 PDLL 230
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 61/307 (19%), Positives = 106/307 (34%), Gaps = 67/307 (21%)
Query: 33 HHQGNGGHKLCVLKEPTGR---------------EIE-ERYELGRELGRGEFGITYLCTD 76
H+ + L +P + + +L + +G+GEFG L
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY----EDDTAVH 132
R N A K ++ + E +M L +H N+V L E+ ++
Sbjct: 215 RGNKVAV-------KCIKNDATAQAFLAEASVMTQL-RHSNLVQL---LGVIVEEKGGLY 263
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
+V E G L D + +RG +++ + +HRDL
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 183 KPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPY-YMAPEVLKRN-YGPE 237
N L + E K DFGL+ + K P + APE L+ + +
Sbjct: 316 AARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKFSTK 366
Query: 238 VDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
DVWS G++L+ I G P+ + V + + ++ D D+++
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYDVMKNCW 423
Query: 297 DPDPKRR 303
D R
Sbjct: 424 HLDAATR 430
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 62/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAA 159
++ +L H NIV L ++ E C G+L + I ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 160 AVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + +++ + +HRDL N L K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA--- 192
Query: 210 KPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 255
+I Y MAPE + Y E DVWS G+ L+ + G
Sbjct: 193 ------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 256 PFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ G+ + + + R P E+A + M DP +R T +Q+
Sbjct: 247 PY-----PGMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 310 LEH 312
++
Sbjct: 299 VQL 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 45/239 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ +E+G G+FG+ +L A K+I + A+ ED E ++M
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE----GAMSEEDFIEEAEVMM 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L H +V L + + LV E E G L D + + ++
Sbjct: 59 KL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---------LFAAETLLG 108
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC + V+HRDL N L + +K DFG++ F G
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGT 165
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
KF P + +PEV Y + DVWS GV+++ + G P+ + V + I
Sbjct: 166 KF------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-16
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 322 PNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINID 381
++ E +K + F+ + + + L + +K+ FH++D G I D
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMV-GLKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 382 ELRVGLHKL---GHQIPDTDVQILMDAV 406
EL L + + + LM A
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I + ++ LV++L G L D + ++ + A K ++ VQ
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 172 CHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
H+ +++RD+KP+NFL N K + +DFG+ F++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 70/305 (22%), Positives = 114/305 (37%), Gaps = 67/305 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFD------RIVARGHYTERA 157
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 83 ILIHIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 158 AAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T+ ++ +HRDL N L + K +K DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLA- 195
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I P Y MAPE + R Y + DVWS GV+L+ I G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 254 VPPFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
P+ GV + R + + R P + + + MLD +P +R T
Sbjct: 248 ASPY-----PGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 308 QVLEH 312
+++EH
Sbjct: 300 ELVEH 304
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 56/279 (20%), Positives = 112/279 (40%), Gaps = 64/279 (22%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPTGREIEERYE-------LGRELGRGEFGITYLCTDR 77
+D+ KL C+ +P ++ +E L ++LG G+FG ++ T
Sbjct: 151 VDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYN 210
Query: 78 ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVH 132
++ A K++ ++ +E E ++M+ L +H + V K+ ++
Sbjct: 211 KHTKV-AVKTMKP----GSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTKE------PIY 258
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
++ E G L D + ++ + + +++ + +HRDL
Sbjct: 259 IITEFMAKGSLLDFL--------KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFF-------KPGEKFSEIVGSPY-YMAPEVLK-RN 233
+ N L + + K DFGL+ + G KF P + APE + +
Sbjct: 311 RAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKF------PIKWTAPEAINFGS 361
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ + DVWS G++L I+ G P+ + V +A+ R
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 55/246 (22%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ + A KS+ + ++ + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQ----GSMSPDAFLAEANLMK 63
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
L +HQ + V ++ ++++ E E G L D + + + + TI
Sbjct: 64 QL-QHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFL--------KTPSGIKLTI 108
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF------ 209
+++ M + +HRDL+ N L + +T K DFGL+
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYT 165
Query: 210 -KPGEKFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G KF P + APE + + + DVWS G++L I+ G P+ T V
Sbjct: 166 AREGAKF------PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 266 AQAIIR 271
Q + R
Sbjct: 220 IQNLER 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 61
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 62 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 111
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 168
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ ++ APE L + DVWS GV+LY
Sbjct: 169 E--------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 92
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 93 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 142
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 199
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV+LY
Sbjct: 200 E--------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 70/317 (22%), Positives = 115/317 (36%), Gaps = 77/317 (24%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DI 99
I+ L RELG G FG +L C ++S K + V
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAE---------CYNLSPTKDKMLVAVKALKDPTLAAR 61
Query: 100 EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA 159
+D +RE +++ +L +H++IV D + +V E + G+L + A G
Sbjct: 62 KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 160 AVTK------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ + +++ + +HRDL N L +K DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDF 177
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
G+S ++ + YY M PE + R + E DVWS GVIL+ I
Sbjct: 178 GMS---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLT 305
G P++ + V I + R P V ML +P++RL
Sbjct: 229 FTYGKQPWFQLSNTEV----IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLN 281
Query: 306 AQQVLEHPWLQNAKKAP 322
+++ + L KA
Sbjct: 282 IKEIYKI--LHALGKAT 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 63/295 (21%), Positives = 107/295 (36%), Gaps = 69/295 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 145
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 146 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 191
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++ K V HRDL N + E +K DFGL+ E
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD---EKFTVKVADFGLARDMYDKEF 247
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
S + MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 248 DS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ +L RR P E D + + ML P + R + +++
Sbjct: 302 TFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 62/248 (25%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
R +G+G FG+ Y + A KS+ ++ +E RE +MR L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGL-N 80
Query: 115 HQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
H N+ + L + H+++ G+L I + T+ +++
Sbjct: 81 HPNVLALIGIMLP----PEGLPHVLLPYMCHGDLLQFIRSPQR---------NPTVKDLI 127
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ +HRDL N + E+ +K DFGL+ +I+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDIL 175
Query: 220 GSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
YY A E L+ + + DVWS GV+L+ +L G PP+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 264 GVAQAIIR 271
+ + +
Sbjct: 236 DLTHFLAQ 243
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 8e-16
Identities = 65/289 (22%), Positives = 94/289 (32%), Gaps = 69/289 (23%)
Query: 28 IDYGTHHQGNGGHKLCVLKEPT--------------------GREIE-ERYELGRELGRG 66
+ + HH + K P REIE R + + +G G
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 67 EFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123
+ G R G A K++ K T D E IM H NI+ L+
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQF-DHPNIIRLEG 117
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---------- 173
+V E E G L + TI+++V M
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLS 168
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--------- 224
G +HRDL N L + K DFGLS + Y
Sbjct: 169 DLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 225 --MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
APE + R + DVWS GV+++ +L G P+W T + V ++
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 62/300 (20%), Positives = 111/300 (37%), Gaps = 58/300 (19%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
+EI ELG FG Y ++++ K L+ E+ R E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK--- 163
+ L +H N+VCL D + ++ C G+L + +V R +++ + +
Sbjct: 64 MLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 164 ---TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ V + H V+H+DL N L +K +K D GL
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLF---- 175
Query: 211 PGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPP 256
E+ + YY MAPE + + + D+WS GV+L+ + G+ P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 257 FWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
+ + Q V + + + + P P ++ V M++ P RR + +
Sbjct: 231 YCGYSNQDV----VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 73/303 (24%), Positives = 107/303 (35%), Gaps = 67/303 (22%)
Query: 43 CVLKEPTGREIE---ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTA 96
P+ R+ E ER ELGR +G G+FG + + A A K+ K +
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSD 432
Query: 97 VDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
E +E MR H +I V ++ V ++MELC GEL + R
Sbjct: 433 SVREKFLQEALTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK 485
Query: 152 HYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + ++ + +HRD+ N L ++ +K
Sbjct: 486 F---------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLG 533
Query: 202 DFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY- 248
DFGLS + S YY MAPE + R + DVW GV ++
Sbjct: 534 DFGLS---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ 308
IL+ GV PF V I R P L+ K DP RR +
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641
Query: 309 VLE 311
+
Sbjct: 642 LKA 644
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 49/241 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ + +L + +G+GEFG L R N A K ++ + E +M
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAV-------KCIKNDATAQAFLAEASVMT 69
Query: 111 HLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L +H N+V L E+ +++V E G L D + R+
Sbjct: 70 QL-RHSNLVQL---LGVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGD 117
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGE 213
+++ + +HRDL N L + E K DFGL+ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTG 174
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K P + APE L+ + + + DVWS G++L+ I G P+ + V +
Sbjct: 175 KL------PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 271 R 271
+
Sbjct: 229 K 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 15/164 (9%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ + +G+++G G FG L + + A K + K R + E + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQL 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGG----ELFDRIVARGHYTERAAAAVTKTIVEV 168
I + +V+EL G +LFD ++ + + ++
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117
Query: 169 VQMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
++ H +++RD+KPENFL K + IDF L+ +
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 64/253 (25%), Positives = 95/253 (37%), Gaps = 62/253 (24%)
Query: 51 REIE-ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEA 67
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
MR H +I V ++ V ++MELC GEL + R +
Sbjct: 68 LTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKY--------- 111
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + ++ + +HRD+ N L ++ +K DFGLS
Sbjct: 112 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLS----- 163
Query: 212 GEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ S YY MAPE + R + DVW GV ++ IL+ GV PF
Sbjct: 164 ----RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219
Query: 259 AETEQGVAQAIIR 271
V I
Sbjct: 220 GVKNNDVIGRIEN 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 58/252 (23%), Positives = 89/252 (35%), Gaps = 62/252 (24%)
Query: 52 EI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
I E L R LG G FG Y + A K+ KK T + E E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAV 65
Query: 108 IMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
IM++L H +I + ++ ++MEL GEL + + +
Sbjct: 66 IMKNL-DHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKN---------S 109
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++ +V +HRD+ N L A+ + +K DFGLS
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLS------ 160
Query: 213 EKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
I YY M+PE + R + DVW V ++ IL G PF+
Sbjct: 161 ---RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
Query: 260 ETEQGVAQAIIR 271
+ V + +
Sbjct: 218 LENKDVIGVLEK 229
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 64/278 (23%), Positives = 98/278 (35%), Gaps = 64/278 (23%)
Query: 34 HQGNGGHKLCVLKEPT---------------GREIE-ERYELGRELGRGEFGITY---LC 74
H GNG KL L+ +E++ + + +G GEFG L
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 75 TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134
+ + A K++ K T D E IM H NI+ L+ V +V
Sbjct: 68 LPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIV 124
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKP 184
E E G L + T++++V M G +HRDL
Sbjct: 125 TEYMENGSLDSFLRKHDA---------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-R 232
N L + K DFGL + E Y +PE + R
Sbjct: 176 RNILINSNLV---CKVSDFGLG-------RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+ DVWS G++L+ ++ G P+W + Q V +A+
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 63/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 88
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + + +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T ++V + +HRDL N L +K DFGL+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 204
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 205 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 257 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 310 LEH 312
+E
Sbjct: 310 VED 312
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-15
Identities = 24/55 (43%), Positives = 38/55 (69%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
A+ LS EE+ G+KE F M+D N G I DEL+ GL ++G ++ +++++ LMDA
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 54/249 (21%), Positives = 86/249 (34%), Gaps = 50/249 (20%)
Query: 51 REIE-ERYELGRELGRGEFGI----TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
EI + +G GEFG + + A K++ K T D E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGE 96
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + ++
Sbjct: 97 AGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EFSV 146
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++V M +HRDL N L + K DFGLS +
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLS-------RV 196
Query: 216 SEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
E Y APE + R + DVWS G++++ ++ G P+W +
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
Query: 263 QGVAQAIIR 271
V +AI
Sbjct: 257 HEVMKAIND 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 51/234 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E+ +R LG+ LG G FG L D++ + A K + K T D+ D+
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLI 122
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + +
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ ++V + +HRDL N L +K DFGL+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLA- 238
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+I YY MAPE L R Y + DVWS GV+L+
Sbjct: 239 --------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 34/193 (17%), Positives = 71/193 (36%), Gaps = 28/193 (14%)
Query: 48 PTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
P G+ ++ ++ LG+++G G FG+ YL + A + + +
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LF 81
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTA----VH--------------LVMELCEGGELFD 145
E+ + + K I + + D + +VME G +L
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK 140
Query: 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
G + + + +++V++ H++ +H D+K N L K + D+GL
Sbjct: 141 ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGL 199
Query: 206 SVFFKPGEKFSEI 218
S + P +
Sbjct: 200 SYRYCPNGNHKQY 212
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 61/255 (23%), Positives = 87/255 (34%), Gaps = 68/255 (26%)
Query: 54 EERYELGRE--------LGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVR 103
+++ L R+ LG G FG R A K + K+ D E++
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMM 58
Query: 104 REVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE IM L + I VC + + LVME+ GG L +V +
Sbjct: 59 REAQIMHQL-DNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEI---- 107
Query: 159 AAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ V ++ H + +HRDL N L N+ K DFGLS
Sbjct: 108 -----PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKA 159
Query: 209 FKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGV 254
+ YY APE + R + DVWS GV ++ L G
Sbjct: 160 LGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 255 PPFWAETEQGVAQAI 269
P+ V I
Sbjct: 212 KPYKKMKGPEVMAFI 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 53/237 (22%), Positives = 81/237 (34%), Gaps = 52/237 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E E E G+ LG G FG T ++ K L+ + + E + E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-------------RIVARGHYT 154
+M L H+NIV L ++L+ E C G+L +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 155 ERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
E T +++ + +HRDL N L +K DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFG 217
Query: 205 LSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
L+ +I+ Y MAPE L Y + DVWS G++L+
Sbjct: 218 LA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 59/247 (23%), Positives = 87/247 (35%), Gaps = 53/247 (21%)
Query: 51 REIEERYELGR-ELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ + ELG G FG ++ D A K + K+ D E++ RE
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVL--KQGTEKADTEEMMREA 387
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
IM L + IV L + + + LVME+ GG L +V + +
Sbjct: 388 QIMHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEI---------PVS 436
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
V ++ H + +HR+L N L N+ K DFGLS +
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADD--- 490
Query: 217 EIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
YY APE + R + DVWS GV ++ L G P+
Sbjct: 491 -----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 263 QGVAQAI 269
V I
Sbjct: 546 PEVMAFI 552
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 69/303 (22%), Positives = 117/303 (38%), Gaps = 63/303 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 134
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAA 158
E+++M+ + KH+NI+ L D +++++E G L + R + +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 159 AAVTK-TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ T ++V + +HRDL N L +K DFGL+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 250
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 251 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 303 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 355
Query: 310 LEH 312
+E
Sbjct: 356 VED 358
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 66/320 (20%), Positives = 101/320 (31%), Gaps = 71/320 (22%)
Query: 55 ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIM 109
E R++G G FG + + F A K + K+ +A D +RE +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALM 104
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHYTE 155
+ NIV L + L+ E G+L
Sbjct: 105 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 156 RAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ + E + + + +HRDL N L +K DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGL 220
Query: 206 SVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILL 251
S I + YY M PE + Y E DVW+ GV+L+ I
Sbjct: 221 S---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
G+ P++ + V I V D P EN + M P R +
Sbjct: 272 YGLQPYYGMAHEEV----IYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 308 QVLEHPWLQNAKKAPNVSLG 327
+ LQ + ++G
Sbjct: 325 SIHRI--LQRMCERAEGTVG 342
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 50/242 (20%), Positives = 82/242 (33%), Gaps = 60/242 (24%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ELG G FG + A K + K + +++ E ++M+ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNP 78
Query: 117 NI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
I +C ++ LVME+ E G L + H ++++
Sbjct: 79 YIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV----------KDKNIIEL 122
Query: 172 CH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
H + +HRDL N L + K DFGLS + E
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADEN------- 172
Query: 222 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 267
YY APE + + + DVWS GV+++ G P+ V
Sbjct: 173 -YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231
Query: 268 AI 269
+
Sbjct: 232 ML 233
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-14
Identities = 17/80 (21%), Positives = 36/80 (45%), Gaps = 4/80 (5%)
Query: 330 VKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHK 389
+ A L++ + + + LS + +K+ F +D G ++ DEL+ L K
Sbjct: 11 IAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQK 69
Query: 390 L---GHQIPDTDVQILMDAV 406
++ +++ + LMDA
Sbjct: 70 FQSDARELTESETKSLMDAA 89
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 60/308 (19%), Positives = 113/308 (36%), Gaps = 68/308 (22%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + LG+ LG GEFG T +++ K L+ + ++ D+ E +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHY 153
+++ + H +++ L D + L++E + G L +R
Sbjct: 79 VLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 154 TERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ T+ +++ + ++HRDL N L A ++ +K DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDF 194
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
GLS ++ Y MA E L Y + DVWS GV+L+ I
Sbjct: 195 GLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 250 LLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRL 304
+ G P+ G+ + + + R P +N + + + ML +P +R
Sbjct: 246 VTLGGNPY-----PGIPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRP 297
Query: 305 TAQQVLEH 312
+ +
Sbjct: 298 VFADISKD 305
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-12
Identities = 15/82 (18%), Positives = 33/82 (40%), Gaps = 4/82 (4%)
Query: 328 ETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGL 387
+ A L+ + + I+ +S + + +KE F ++D G I DEL+ L
Sbjct: 9 SDIAAALRDCQAPDSFSPKKFFQIS-GMSKKSSSQLKEIFRILDNDQSGFIEEDELKYFL 67
Query: 388 HKL---GHQIPDTDVQILMDAV 406
+ + ++ + + A
Sbjct: 68 QRFESGARVLTASETKTFLAAA 89
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-12
Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 5/68 (7%)
Query: 340 MNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDI-GNRGKINIDELRVGLHKLGHQIPDTD 398
M+ + K + L+ E+ K F + + G I+ EL + LG +
Sbjct: 1 MDDIYK----AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 399 VQILMDAV 406
+Q ++D V
Sbjct: 57 LQEMIDEV 64
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-11
Identities = 15/68 (22%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 344 KKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVG-----LHKLGHQIPDTD 398
K A+K+ + + K F +DI GKI +DE+ KL T
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 399 VQILMDAV 406
+
Sbjct: 63 RHQVCVEA 70
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-11
Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 1/68 (1%)
Query: 340 MNKLKK-RALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTD 398
M+K + + L E+ I E F + D+ N G ++ EL+V + LG ++P +
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 399 VQILMDAV 406
+ L+D
Sbjct: 61 ILDLIDEY 68
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 5e-04
Identities = 15/63 (23%), Positives = 31/63 (49%), Gaps = 7/63 (11%)
Query: 348 LKVIAQHL----SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
V+ + + ++E IK F + D + GKI+I LR +LG + D +++ ++
Sbjct: 82 YIVMGEKILKRDPLDE---IKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMI 138
Query: 404 DAV 406
+
Sbjct: 139 EEF 141
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 24/181 (13%), Positives = 60/181 (33%), Gaps = 27/181 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE----DVRREVDIMR 110
+++L R GI Y + +K + ++ ++ + E + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDS----GPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 111 HLPKHQNIVCLKDTYEDDTA----VH-----------LVMELCEGGELFD--RIVARGHY 153
K + K Y LV+ G L + +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL 156
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ER+ V +++ ++ H++ +H ++ EN + ++ + +G + + P
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSG 215
Query: 214 K 214
K
Sbjct: 216 K 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 35/230 (15%), Positives = 80/230 (34%), Gaps = 38/230 (16%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
A Q ++++ K+ G ++ + +++G +G+G
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGE-----------IITDMAAA----AWKVGLPIGQGG 47
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG YL D + ++ + K+ D + E+ + K + I T +
Sbjct: 48 FGCIYLA-DMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105
Query: 128 DTA----VH--------------LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEV 168
++M+ G +L A ++ + ++ I+++
Sbjct: 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDI 164
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
++ H+H +H D+K N L K + +D+GL+ + P
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAY 213
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 325 SLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAG----IKEGFHMMDIGNRGKINI 380
+ K +K A + I Q + E+ A E F D GK+
Sbjct: 8 GSTSDKGLASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNETGKLCY 67
Query: 381 DELRVGLHKLGHQIP-DTDVQILMDAV 406
DE+ G ++ + V+ +
Sbjct: 68 DEVYSGCLEVLKLDEFTSRVRDITKRA 94
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-10
Identities = 12/66 (18%), Positives = 31/66 (46%)
Query: 345 KRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
+A + L +++ +KE F M+D+ G ++ ++++ +LG D ++ ++
Sbjct: 2 DKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK 61
Query: 405 AVSHTL 410
L
Sbjct: 62 EAPGPL 67
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 24/114 (21%), Positives = 38/114 (33%), Gaps = 15/114 (13%)
Query: 332 ARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMD--IGNRGKINIDELRVGLHK 389
L + L L SV E+ + E F + + + G IN +E ++ L K
Sbjct: 19 FDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK 78
Query: 390 LGHQIPDTDVQILMDA--VSHTLHLD-------LAFFREK--VRLKISF-FRWY 431
+ + D H L L+ F + KI F F+ Y
Sbjct: 79 TNKK-ESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLY 131
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-10
Identities = 11/70 (15%), Positives = 24/70 (34%), Gaps = 2/70 (2%)
Query: 337 FSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPD 396
+ + L EE+A ++ F D G++ +E R +L +
Sbjct: 3 HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRP 60
Query: 397 TDVQILMDAV 406
D + + +
Sbjct: 61 ADAEAVFQRL 70
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-09
Identities = 12/56 (21%), Positives = 25/56 (44%)
Query: 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ + L EE+ ++E F D G IN +L + +G+ + ++ L +
Sbjct: 1 MDRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQI 56
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-09
Identities = 18/77 (23%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 333 RLKQFSVMNKLKKRAL---KVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHK 389
+ +Q ++++ K+ L K + ++ G KE + D+ G I+I L+ L K
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 390 LGHQIPDTDVQILMDAV 406
LG +++ L+ V
Sbjct: 61 LGVPKTHLELKKLIGEV 77
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-09
Identities = 16/56 (28%), Positives = 28/56 (50%)
Query: 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+A L+ E++A KE F + D G I EL + LG + ++Q +++ V
Sbjct: 1 MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-09
Identities = 18/56 (32%), Positives = 31/56 (55%)
Query: 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
++Q+L+ E++A KE F + D N G I+ EL + LG + +V LM+ +
Sbjct: 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEI 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 39.0 bits (92), Expect = 7e-04
Identities = 12/44 (27%), Positives = 22/44 (50%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ E F + D G I+ EL+ L +G ++ D +V ++ V
Sbjct: 86 LLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREV 129
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-09
Identities = 17/52 (32%), Positives = 26/52 (50%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
LS E+ IKE F + D G I+ EL+V + LG + ++ LM+
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEY 52
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-09
Identities = 15/74 (20%), Positives = 33/74 (44%), Gaps = 4/74 (5%)
Query: 333 RLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH 392
+ K + +K+ L+ E+ I+E F + D G I+ EL+V + LG
Sbjct: 4 KAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF 59
Query: 393 QIPDTDVQILMDAV 406
+ +++ ++ +
Sbjct: 60 EPKKEEIKKMISEI 73
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-09
Identities = 12/56 (21%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNR-GKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
LS +V ++ F + G+++ D++ + L LG Q + ++ L+D
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEF 59
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 108 IMRHLPKHQNIVCLK-DTYEDDTAVHLVMELCEGGELFD 145
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 40/157 (25%)
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY----------- 224
+HRDL N L + K +K DFGL+ +I P Y
Sbjct: 213 KCIHRDLAARNILLSEKNV---VKICDFGLA---------RDIYKDPDYVRKGDARLPLK 260
Query: 225 -MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA--QAIIRSVLDFRRD 279
MAPE + Y + DVWS GV+L+ I G P+ GV + R + + R
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRM 315
Query: 280 PWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLEH 312
P + + + MLD +P +R T +++EH
Sbjct: 316 RAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-08
Identities = 16/55 (29%), Positives = 28/55 (50%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
A+ L+ E++A KE F + D G I EL + LG + ++Q +++ V
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 55
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 15/82 (18%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 330 VKARLKQFSVMNKLKKRALKVIAQ--HLSVEEVAGIKEGFHMMD--IGNRGKINIDELRV 385
++ K+ + M +++A +VEEV + E F + I + G I+ +E ++
Sbjct: 4 SVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQL 63
Query: 386 GLHKLGHQIPDTDVQILMDAVS 407
L + ++ + + D
Sbjct: 64 ALFRNRNR-RNLFADRIFDVFD 84
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 61/387 (15%), Positives = 109/387 (28%), Gaps = 120/387 (31%)
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDTA 130
L + S KLR I ++ E+ + ++N +V L +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLR----IHSIQAELRRLLKSKPYENCLLV-LLNVQNAKAW 259
Query: 131 VHLVMELCEGGELFD---RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
F+ +I+ +T T R + +F
Sbjct: 260 -----------NAFNLSCKIL------------LT-T---------------RFKQVTDF 280
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAP-EVLKRNYGPEVDVWSA 243
L A L L+ P E + + P EVL N P
Sbjct: 281 LSAATTTHISLDHHSMTLT----PDEVKSLLLKYLDCRPQDLPREVLTTN--P------- 327
Query: 244 GVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM----LDPD 299
+ G+A D W V+ + + + L+P
Sbjct: 328 ------RRLSI--IAESIRDGLA----------TWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 300 PKRRLTAQ------------QVLEHPWLQNAKKAPNVSLGETVKARL--KQ-----FSVM 340
R++ + +L W K V + + K L KQ S+
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 341 N---KLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVG--LHKLGHQIP 395
+ +LK + A H S+ + I + F D + +D +GH +
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPKTF---DSDDLIPPYLD----QYFYSHIGHHLK 482
Query: 396 DTDVQILMDAVSHTLHLDLAFFREKVR 422
+ + + + LD F +K+R
Sbjct: 483 NIE-HPERMTLFRMVFLDFRFLEQKIR 508
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 1e-07
Identities = 63/452 (13%), Positives = 143/452 (31%), Gaps = 110/452 (24%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDREN------GDA------FACKSISKKKLRTA 96
+ EI+ + L + +E + F I ++ + +
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106
Query: 97 VDIEDVRREVDIM---------RHLPKHQNIVCLKDT-YEDDTA----VH---------L 133
+ + D + ++ + Q + L+ E A + +
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV 166
Query: 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKHGVMHRDLKPENFLFANK 192
+++C ++ ++ + + +T++E++Q + ++ + + + +N
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ---IDPNWTSRSDHSSNI 223
Query: 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILY---- 248
K + +I L K PY VL +V +A
Sbjct: 224 KL--RIHSIQAELRRLLK---------SKPYENCLLVLL-------NVQNAKAWNAFNLS 265
Query: 249 --ILL----CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
ILL V T+ A LD + K L+ K LD P+
Sbjct: 266 CKILLTTRFKQV------TDFLSAATTTHISLDHHSMTLTP--DEVKSLLLKYLDCRPQ- 316
Query: 303 RLTAQQVLEHPWLQNAKKAPNVSL-GETVK---ARLKQFSVMNKLKKRALKVIAQHLSVE 358
L + + +P +S+ E+++ A + +N K +I L+V
Sbjct: 317 DLPREVLTTNPRR--------LSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVL 366
Query: 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVS----------- 407
E A ++ F + + +I + L + + +DV ++++ +
Sbjct: 367 EPAEYRKMFDRLSVFPPS-AHIPT-IL-LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 408 -----HTLHLDLAF-FREKVRLKISFFRWYEI 433
+++L+L + L S Y I
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNI 455
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 338 SVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDT 397
+ M + A LS E +A K F M D G I+ EL + LG
Sbjct: 1 ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 398 DVQILMDAV 406
++ +++ V
Sbjct: 57 ELDAIIEEV 65
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-08
Identities = 6/43 (13%), Positives = 21/43 (48%)
Query: 364 KEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ F +D+ G ++ +E++ + K + +Q++ ++
Sbjct: 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 12/78 (15%), Positives = 28/78 (35%), Gaps = 2/78 (2%)
Query: 320 KAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKIN 379
L ++V+ L+ +V ++ + L + +E+ + GF G +N
Sbjct: 26 GLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNEC--PSGVVN 83
Query: 380 IDELRVGLHKLGHQIPDT 397
+ + + Q T
Sbjct: 84 EETFKEIYSQFFPQGDST 101
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 50.5 bits (122), Expect = 7e-08
Identities = 12/49 (24%), Positives = 26/49 (53%)
Query: 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
E+ I+E F + D G I++ EL+V + LG + +++ ++ +
Sbjct: 3 EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 39.0 bits (92), Expect = 6e-04
Identities = 17/63 (26%), Positives = 30/63 (47%), Gaps = 7/63 (11%)
Query: 348 LKVIAQHL----SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
L V+ Q + + EE I + F + D GKI+ L+ +LG + D ++Q ++
Sbjct: 65 LTVMTQKMSEKDTKEE---ILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMI 121
Query: 404 DAV 406
D
Sbjct: 122 DEA 124
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-07
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+A + +++A + F D GKI+ EL L LG + +V+ +M +
Sbjct: 1 MAAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 55
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 1e-07
Identities = 28/202 (13%), Positives = 57/202 (28%), Gaps = 48/202 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDI 108
E+ + ++G G FG + + A K I+ + E++ E+ I
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 109 MRHL--------PKHQNIVCLKDTY------------------------------EDDTA 130
+ L + + + L + D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190
+ +V+E GG +++ + A + + + + HRDL N L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL- 195
Query: 191 NKKETAPLKAIDFGLSVFFKPG 212
K+T+ K
Sbjct: 196 --KKTSLKKLHYTLNGKSSTIP 215
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 1e-07
Identities = 10/49 (20%), Positives = 21/49 (42%)
Query: 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
++V+ KE F + D G I + L+ L + G ++ + +
Sbjct: 3 DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA 51
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-07
Identities = 17/83 (20%), Positives = 36/83 (43%), Gaps = 11/83 (13%)
Query: 335 KQFSVMNKLKKRALKVIAQ-----------HLSVEEVAGIKEGFHMMDIGNRGKINIDEL 383
K F ++ ++R L I + E++ KE + D+ N G+I++ L
Sbjct: 13 KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72
Query: 384 RVGLHKLGHQIPDTDVQILMDAV 406
+ + KLG +++ ++ V
Sbjct: 73 KRMMEKLGVPKTHLEMKKMISEV 95
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-07
Identities = 17/91 (18%), Positives = 33/91 (36%)
Query: 316 QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNR 375
Q+ + G + ++ +NK K ++ K + D+
Sbjct: 3 QSRDLQGGKAFGLLKAQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGN 62
Query: 376 GKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
G I+I L+ L KLG +++ L+ V
Sbjct: 63 GDIDIMSLKRMLEKLGVPKTHLELKRLIREV 93
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 12/61 (19%), Positives = 20/61 (32%)
Query: 345 KRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
+ E+ KE F ++D G I+ D+LR +G + M
Sbjct: 9 AEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMI 68
Query: 405 A 405
Sbjct: 69 K 69
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-07
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 338 SVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDT 397
+ M + A LS E +A K F M D G I+ EL + LG
Sbjct: 1 ASMTDQQAEARA----FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 398 DVQILMDAV 406
++ +++ V
Sbjct: 57 ELDAIIEEV 65
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 28/134 (20%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H++ +HRD+K N L ++ TA K DFGL+ + + S IVG+ YMAPE
Sbjct: 150 HENHHIHRDIKSANILL-DEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP-----WPKV 284
L+ P+ D++S GV+L ++ G +D R+P +
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITG-----------------LPAVDEHREPQLLLDIKEE 249
Query: 285 SENAKDLVRKMLDP 298
E+ + + +D
Sbjct: 250 IEDEEKTIEDYIDK 263
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 44.4 bits (106), Expect = 1e-06
Identities = 9/46 (19%), Positives = 16/46 (34%)
Query: 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ K F D GK+++DE R D+ + +
Sbjct: 1 SSAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-06
Identities = 6/44 (13%), Positives = 21/44 (47%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ F +D+ G ++ +E++ + K + +Q++ ++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-06
Identities = 11/66 (16%), Positives = 20/66 (30%), Gaps = 3/66 (4%)
Query: 344 KKRALKVIAQHL---SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQ 400
A + I L I + F D I+ +E R ++ + D
Sbjct: 4 MATADRDILARLHKAVTSHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFD 63
Query: 401 ILMDAV 406
L + +
Sbjct: 64 RLWNEM 69
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H ++HRD+K N L ++ K DFG+S ++ + + G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILL-DENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 230 LKRNYGPE-VDVWSAGVILYILLCGVPP 256
+ E DV+S GV+L+ +LC
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 46.3 bits (111), Expect = 2e-06
Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 2/70 (2%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLD- 413
++ KE F+M+D G I+ ++L L +G D ++ +M ++
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSEAPGPINFTM 60
Query: 414 -LAFFREKVR 422
L F EK+
Sbjct: 61 FLTMFGEKLN 70
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 16/80 (20%), Positives = 38/80 (47%), Gaps = 6/80 (7%)
Query: 333 RLKQFSVMNKLKKRAL----KVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLH 388
RL + + + R++ + + L + ++ + + F D+ + GK+ +DE+
Sbjct: 4 RLNEQNNESYRYLRSVGNQWQFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPD 63
Query: 389 KLGHQIPDTD--VQILMDAV 406
++ + TD V+ + DAV
Sbjct: 64 RMRQLVNATDEQVEKMRDAV 83
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 16/107 (14%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 318 AKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGK 377
KKA + + +R+ + + +V KE F ++D G
Sbjct: 14 KKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQDKDGF 73
Query: 378 INIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLD--LAFFREKVR 422
I+ +++R LG + ++ ++ ++ L F +++
Sbjct: 74 ISKNDIRATFDSLGRLCTEQELDSMVAEAPGPINFTMFLTIFGDRIA 120
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-06
Identities = 10/55 (18%), Positives = 18/55 (32%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ + + E F +D G I++ EL L G + L+
Sbjct: 18 PSARHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMY 72
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 14/53 (26%), Positives = 26/53 (49%)
Query: 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
H+ + +KE F + D G I+ ELR + LG ++ D +V+ ++
Sbjct: 2 HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEA 54
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 6e-05
Identities = 8/64 (12%), Positives = 21/64 (32%), Gaps = 3/64 (4%)
Query: 344 KKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQIL 402
+++ + + +E F M G + E + L G +Q + + +
Sbjct: 5 NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62
Query: 403 MDAV 406
+
Sbjct: 63 YNTF 66
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 8e-05
Identities = 11/63 (17%), Positives = 26/63 (41%), Gaps = 6/63 (9%)
Query: 338 SVMNKLKKRALKVIAQ--HLSVEEVAGIKEGFHMMDIGNRGKINIDEL----RVGLHKLG 391
L+ L+ I + S ++ + F +D G G ++ ++ + ++ LG
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDFQRIPELAINPLG 63
Query: 392 HQI 394
+I
Sbjct: 64 DRI 66
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 8e-05
Identities = 12/59 (20%), Positives = 21/59 (35%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLD 413
E+V + + + GKI+ID KLG D + + + L +
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDNLTYE 67
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 8e-05
Identities = 11/65 (16%), Positives = 25/65 (38%), Gaps = 5/65 (7%)
Query: 347 ALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDEL-----RVGLHKLGHQIPDTDVQI 401
K+ + + + K F+ +D+ + GKI++DE+ + ++ LG
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 402 LMDAV 406
Sbjct: 62 DAVEA 66
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 12/67 (17%), Positives = 20/67 (29%)
Query: 340 MNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDV 399
KL L+ A++ F ++D G I +DE + G D
Sbjct: 88 WKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDC 147
Query: 400 QILMDAV 406
+
Sbjct: 148 EETFRVC 154
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 6/67 (8%), Positives = 22/67 (32%), Gaps = 2/67 (2%)
Query: 341 NKLKKRALKVIAQHLSVEEVAGIKEGF-HMMDIGNRGKINIDELRVGLHKLGHQIPDTDV 399
+ + + + A ++E + ++ G + + E + ++ V
Sbjct: 3 QQFSWEEAEEN-GAVGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61
Query: 400 QILMDAV 406
+ + A
Sbjct: 62 EAMFRAF 68
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 2e-04
Identities = 13/44 (29%), Positives = 22/44 (50%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
EGF + D GK+ ELR L LG ++ + +V+ ++
Sbjct: 89 YLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGH 132
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 8e-04
Identities = 10/52 (19%), Positives = 21/52 (40%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ +++ KE F + D GKI + + LG + +V ++
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 55
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} Length = 190 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 5/69 (7%)
Query: 340 MNKLKKRALKVIAQ--HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQI-PD 396
+KL + L+ + + +E+ +GF G +N E + + P
Sbjct: 5 QSKLSQDQLQDLVRSTRFDKKELQQWYKGF--FKDCPSGHLNKSEFQKIYKQFFPFGDPS 62
Query: 397 TDVQILMDA 405
+ + +
Sbjct: 63 AFAEYVFNV 71
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 11/51 (21%), Positives = 22/51 (43%)
Query: 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ + ++ F D G I +DELR + LG +P ++ ++
Sbjct: 1 ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREA 51
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 8/45 (17%), Positives = 16/45 (35%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDV 399
+ + AG + + D + G I EL + ++ D
Sbjct: 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDK 49
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 15/62 (24%), Positives = 27/62 (43%)
Query: 345 KRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404
+ L+ E++A KE F + D G I EL + LG + ++Q +++
Sbjct: 296 HKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIN 355
Query: 405 AV 406
V
Sbjct: 356 EV 357
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 18/151 (11%), Positives = 41/151 (27%), Gaps = 20/151 (13%)
Query: 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
E + L P + R R W+ +
Sbjct: 4 TKEAVKASD-----GNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCL-----IKWILS 53
Query: 318 AKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQ--HLSVEEVAGIKEGFHMMDIGNR 375
+ ++ + L+ +V + + L + + +E+ + GF
Sbjct: 54 SAAPQGS---DSSDSELELSTV--RHQPEGLDQLQAQTKFTKKELQSLYRGFKNEC--PT 106
Query: 376 GKINIDELRVGLHKLGHQI-PDTDVQILMDA 405
G ++ D ++ + Q T L +A
Sbjct: 107 GLVDEDTFKLIYSQFFPQGDATTYAHFLFNA 137
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 9e-04
Identities = 10/55 (18%), Positives = 22/55 (40%), Gaps = 2/55 (3%)
Query: 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG--HQIPDTDVQILMDAVSH 408
S V +K F+ +D G I + + ++ ++LMD+++
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTG 55
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 7/50 (14%), Positives = 17/50 (34%)
Query: 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
S+ + E + D G + EL+ + +L +++
Sbjct: 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSP 58
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 436 | |||
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.52 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 99.31 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 99.27 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 99.25 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 99.21 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 99.16 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 99.14 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 99.13 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 99.11 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 99.1 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 99.1 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 99.09 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 99.08 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 99.07 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 99.04 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 99.03 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 99.03 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 99.02 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 99.02 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 99.02 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 99.01 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 99.01 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 99.0 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 99.0 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.99 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.99 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.98 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.98 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 98.97 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.97 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.96 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.96 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.96 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.96 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.95 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.95 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.94 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.94 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.93 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.92 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.92 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.92 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.92 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.91 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.91 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.91 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.9 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.9 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.9 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.9 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.9 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.9 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.88 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.88 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.88 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.87 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.87 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.87 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.86 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.86 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.86 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 98.85 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 98.85 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.84 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.84 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.84 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.83 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.83 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 98.83 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.83 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.83 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.82 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.82 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 98.82 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.81 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 98.81 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.81 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 98.81 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.81 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 98.81 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.79 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.79 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.79 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.79 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 98.78 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.78 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.77 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 98.77 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 98.77 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.77 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 98.77 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.76 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 98.76 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 98.76 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.76 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 98.76 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 98.76 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 98.75 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 98.75 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 98.75 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.74 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 98.74 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 98.71 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 98.71 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 98.71 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 98.7 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 98.7 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 98.69 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 98.69 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 98.69 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 98.68 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 98.67 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 98.67 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 98.67 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.66 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 98.66 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 98.65 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.65 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 98.64 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.63 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.63 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.63 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 98.63 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.61 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 98.6 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.6 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 98.59 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.59 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.58 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.58 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.58 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 98.57 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 98.57 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.56 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.56 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.55 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.55 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 98.54 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.53 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.53 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.52 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 98.52 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.52 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 98.52 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.49 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.49 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 98.49 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 98.48 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.47 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.47 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 98.47 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.47 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 98.46 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 98.46 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.45 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.43 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.43 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.42 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 98.42 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.41 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.41 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.4 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 98.4 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.4 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 98.39 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 98.39 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.39 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 98.37 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 98.36 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 98.36 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 98.35 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 98.32 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.32 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 98.32 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.31 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 98.31 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.3 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.3 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 98.3 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.3 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.3 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 98.29 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.29 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.29 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 98.29 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.28 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 98.28 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.27 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.27 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.27 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 98.27 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.26 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 98.25 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 98.24 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 98.22 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 98.21 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.21 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.2 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 98.19 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 98.19 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 98.18 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 98.17 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.17 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 98.16 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 98.16 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 98.15 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 98.14 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.11 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 98.09 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 98.08 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 98.07 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 98.05 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 98.04 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.04 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 98.01 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.01 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 98.01 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 98.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 98.0 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 |
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-70 Score=545.77 Aligned_cols=385 Identities=36% Similarity=0.619 Sum_probs=342.2
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+..+.++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCC
Confidence 346778999999999999999999999999999999999876655455678899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999998889999999999999999999999999999999999999976666778999999999887
Q ss_pred CCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
..........||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+....+..+...+..+.|..+|++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 76666667789999999999988899999999999999999999999999999999999999888877777889999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCccC---CCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhhhh
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA---PNVSLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKE 365 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~ 365 (436)
+||.+||+.||.+|||+.|+|+||||+..... ...+.......++++|...+++++.++..++..+ +.++...+++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~ 339 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTA 339 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHH
Confidence 99999999999999999999999999865431 2233445667788999999999999999998876 7788999999
Q ss_pred hccccCCCCCCcccHHHH----HHHHHHcCCCCC-------HHHHHHHHHHHhcCCC--cCHhhHHHH----------HH
Q 013816 366 GFHMMDIGNRGKINIDEL----RVGLHKLGHQIP-------DTDVQILMDAVSHTLH--LDLAFFREK----------VR 422 (436)
Q Consensus 366 ~F~~~D~~~~G~i~~~el----~~~l~~lg~~~~-------~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~ 422 (436)
+|..+|.|++|.|+.+|+ ...++.+|...+ +++++++++.+|.|++ |+|+||... ..
T Consensus 340 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~ 419 (484)
T 3nyv_A 340 IFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFVTVAMDRKTLLSRER 419 (484)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHHhccccCcHHH
Confidence 999999999999999999 555555688777 8999999999999988 999999432 46
Q ss_pred HHHhHHhhhhcCC
Q 013816 423 LKISFFRWYEIGG 435 (436)
Q Consensus 423 ~~~~f~~~d~~~~ 435 (436)
+..+|+.||+||+
T Consensus 420 ~~~~F~~~D~d~d 432 (484)
T 3nyv_A 420 LERAFRMFDSDNS 432 (484)
T ss_dssp HHHHHHHHCTTCC
T ss_pred HHHHHHHHCCCCC
Confidence 7789999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-69 Score=546.04 Aligned_cols=385 Identities=33% Similarity=0.571 Sum_probs=339.2
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh----------hhHHHHHHHHHHHHhCCCCCcee
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----------VDIEDVRREVDIMRHLPKHQNIV 119 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~niv 119 (436)
+..+.++|++++.||+|+||+||+|.++.+++.||+|++.+...... ...+.+.+|+.+++++ +||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCC
Confidence 34578899999999999999999999999999999999976543321 2356789999999999 899999
Q ss_pred EEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 120 ~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
++++++.+...+|+|||||+||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999999998888999999999999999999999999999999999999998766666799
Q ss_pred EEeeccccccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 200 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
|+|||++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+....+..+...+...
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999999887666667788999999999998889999999999999999999999999999999999999887777666
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCC---ccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS---LGETVKARLKQFSVMNKLKKRALKVIAQHL- 355 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~- 355 (436)
.|..+|+++++||.+||++||.+|||+.|+|+||||+......... .....+.++++|...+++++.++..+...+
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~ 349 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLT 349 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Confidence 6778999999999999999999999999999999998765433211 123456678888888999999999998887
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc--------CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL--------GHQIPDTDVQILMDAVSHTLH--LDLAFFREK----- 420 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----- 420 (436)
+.++...++++|..+|.|++|.|+.+|+..+++.+ |...++++++++++.+|.||+ |+|+||...
T Consensus 350 ~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~ 429 (504)
T 3q5i_A 350 TLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFISVCMDKQ 429 (504)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHH
T ss_pred cHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhhh
Confidence 88889999999999999999999999999999988 667889999999999999887 999999543
Q ss_pred -----HHHHHhHHhhhhcCC
Q 013816 421 -----VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -----~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 430 ~~~~~~~~~~~F~~~D~d~d 449 (504)
T 3q5i_A 430 ILFSEERLRRAFNLFDTDKS 449 (504)
T ss_dssp HHTCHHHHHHHHHHHCTTCC
T ss_pred cccCHHHHHHHHHHhcCCCC
Confidence 467789999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-70 Score=546.10 Aligned_cols=385 Identities=36% Similarity=0.602 Sum_probs=338.9
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
....+.++|++++.||+|+||+||+|++..++..||+|++.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK 108 (494)
T ss_dssp CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC
Confidence 34457789999999999999999999999999999999997654322 2356789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..+|+|||||+||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++..+....+||+|||++..
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999999998888999999999999999999999999999999999999998766677899999999988
Q ss_pred cCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
..........+||+.|+|||++.+.++.++|||||||++|+|++|..||.+....+....+..+...+..+.|..+|+++
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 77666667788999999999998889999999999999999999999999999999999999988888877888999999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCccC----CCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhh
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKA----PNVSLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGI 363 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l 363 (436)
++||.+||+.||.+|||+.++|+||||+..... ...+.......++++|...+++++.++..++..+ +.++...+
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l 348 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKEL 348 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHH
Confidence 999999999999999999999999999864221 2223334567788999999999999999998887 78889999
Q ss_pred hhhccccCCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------HHH
Q 013816 364 KEGFHMMDIGNRGKINIDELRVGLHKLGH--------QIPDTDVQILMDAVSHTLH--LDLAFFREK----------VRL 423 (436)
Q Consensus 364 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~~ 423 (436)
+++|..+|.|++|.|+.+|+..+++.+|. ..++++++++++.+|.||+ |+|+||... ..+
T Consensus 349 ~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~ 428 (494)
T 3lij_A 349 TDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFVTVAMDRKSLLSKDKL 428 (494)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHSCHHHHTCHHHH
T ss_pred HHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhhhccccHHHH
Confidence 99999999999999999999999999864 4558899999999999887 999999654 357
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.||+||+
T Consensus 429 ~~~F~~~D~d~~ 440 (494)
T 3lij_A 429 ESAFQKFDQDGN 440 (494)
T ss_dssp HHHHHHHCTTCS
T ss_pred HHHHHHHCCCCC
Confidence 789999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-69 Score=540.63 Aligned_cols=382 Identities=36% Similarity=0.631 Sum_probs=337.4
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+++++ +||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEE
Confidence 46789999999999999999999999999999999997654322 2457889999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||||+.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++..+....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999998776777899999999988776
Q ss_pred CCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
.......+||+.|+|||++.+.++.++|||||||++|+|++|..||.+.+..+....+..+...+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999999889999999999999999999999999999999999999988887777888999999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCccCCCC----CccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhhhhh
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV----SLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKEG 366 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~ 366 (436)
|.+||+.||.+|||+.++|+||||+........ ........++++|....++++..+..+...+ +.++...++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~ 336 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI 336 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence 999999999999999999999999876443321 1223456778889999999999999998887 78889999999
Q ss_pred ccccCCCCCCcccHHHHHHHH----HHcCCCCC----------HHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 367 FHMMDIGNRGKINIDELRVGL----HKLGHQIP----------DTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 367 F~~~D~~~~G~i~~~el~~~l----~~lg~~~~----------~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
|..+|.|++|.|+.+||..++ +.+|...+ +++++.+++.+|.||+ |+|+||...
T Consensus 337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~ 416 (486)
T 3mwu_A 337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFIASAIDRTILLSR 416 (486)
T ss_dssp HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHHHHHSCTTTTCCH
T ss_pred HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHHHHHHhhhccchH
Confidence 999999999999999995554 44577666 8899999999999887 999999543
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 417 ~~~~~~F~~~D~d~d 431 (486)
T 3mwu_A 417 ERMERAFKMFDKDGS 431 (486)
T ss_dssp HHHHHHHHHHCSSCS
T ss_pred HHHHHHHHHhCCCCC
Confidence 467889999999885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-66 Score=476.71 Aligned_cols=258 Identities=36% Similarity=0.644 Sum_probs=213.0
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
|..+ ++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+++ +|||||++++++++++
T Consensus 9 G~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 9 GAHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKD 86 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred CCEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECC
Confidence 4444 5799999999999999999999999999999999877665555677899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+||||| +|+|.+++.+++++++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~---~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE---HLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT---TCCEEECCSSCC---
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC---CCCEEEeecCCCeec
Confidence 999999999 6799999999999999999999999999999999999999999999999964 455999999999887
Q ss_pred CCCCcccccccCCcccchhcccc-cC-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.......+.+||+.|||||++.+ .| +.++|||||||++|+|+||+.||.+.+.......+.+....++ ..+|++
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~ 238 (275)
T 3hyh_A 163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPG 238 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHH
T ss_pred CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHH
Confidence 76666677899999999999874 44 6799999999999999999999999998888888887765443 468999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+++||.+||++||++|||+.|+|+||||+.
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 999999999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-66 Score=484.78 Aligned_cols=256 Identities=31% Similarity=0.567 Sum_probs=232.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|++| +|||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999876554444567899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC--
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~-- 212 (436)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~---~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC---CCCEEEEEcCCceecCCCCC
Confidence 999999999999999899999999999999999999999999999999999999964 456999999999977533
Q ss_pred -CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
....+.+||+.|||||++. ..|+.++|||||||++|+|+||..||.+.+..+....+.+....++ ..+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence 2345679999999999987 4699999999999999999999999999999999999988766543 468999999
Q ss_pred HHHHccCCCcCCCCCHHH------HhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e------~l~h~~~~~~ 318 (436)
||.+||++||++|||+.| +++||||++.
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999988 5899999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-65 Score=481.84 Aligned_cols=258 Identities=32% Similarity=0.549 Sum_probs=230.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.| +|||||+++++|++++.+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 356799999999999999999999999999999999765433 345688999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC---CCCEEEecCcCceecCCC
Confidence 99999999999998865 57999999999999999999999999999999999999964 445999999999877543
Q ss_pred -CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+....+.... ......+..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHH
Confidence 3456789999999999987 569999999999999999999999999998888887776643 2334456789999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
||.+||+.||++|||+.|+|+||||++..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-65 Score=469.59 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=219.5
Q ss_pred cce-eeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----CC
Q 013816 55 ERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (436)
Q Consensus 55 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 129 (436)
++| ++.++||+|+||+||+|.++.++..||+|++..... .....+.+.+|+.+|++| +|||||+++++|++ +.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCc
Confidence 444 788899999999999999999999999999986654 344567899999999999 99999999999875 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+|||||||+||+|.+++...+.+++..+..++.||+.||.|||++| |+||||||+|||++. .++.+||+|||+|+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCCE
Confidence 68999999999999999999889999999999999999999999998 999999999999963 23469999999998
Q ss_pred ccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCCCCCcccCH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
... .....+.+||+.|||||++.+.|+.++|||||||++|+|+||+.||.+.... .....+..+.. +.......++
T Consensus 181 ~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 257 (290)
T 3fpq_A 181 LKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIP 257 (290)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCH
T ss_pred eCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCH
Confidence 643 3445667999999999999888999999999999999999999999765544 33444433322 1122345789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
++++||.+||+.||++|||+.|+|+||||++
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-65 Score=483.32 Aligned_cols=256 Identities=27% Similarity=0.536 Sum_probs=223.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++| +|||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 689999999999999999999999999999999987654 344577899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||+||+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK---DGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT---TCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC---CCCEEEcccccceeecCC
Confidence 9999999999999764 35799999999999999999999999999999999999964 445999999999876543
Q ss_pred C-cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 E-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+..+....+.++... ..+..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence 2 2345789999999999874 6999999999999999999999999999999888888887543 234578999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
||.+||++||++|||+.|+|+||||+..
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-63 Score=482.06 Aligned_cols=258 Identities=32% Similarity=0.549 Sum_probs=230.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..+.|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.| +|||||+++++|.+.+.+|
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEE
Confidence 346799999999999999999999999999999999765432 346688999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||||+||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++. .+.|||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~---~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT---TCCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC---CCCEEEecCccceECCCC
Confidence 99999999999998865 46999999999999999999999999999999999999964 445999999999877543
Q ss_pred -CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
....+.+||+.|||||++. ..|+.++|||||||++|||++|..||.+.+..+....+.... ......+..+|+++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHH
Confidence 4456789999999999987 569999999999999999999999999999888888776653 2334456789999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
||.+||+.||++|||+.|+|+||||+...
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-64 Score=469.38 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=220.2
Q ss_pred cceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|++++.||+|+||+||+|++. .+++.||+|++.+...... ....+.+|+.+|+++ +|||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence 57999999999999999999974 4688999999987654322 334688899999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~---~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE---EGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT---TSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC---CCCEEecccccceeccC
Confidence 999999999999999999899999999999999999999999999999999999999964 44599999999986543
Q ss_pred C-CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 G-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. ....+.+||+.|||||++. ..|+.++|||||||++|+|+||..||.+.+..+....+.+....+ +..+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM----PQFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----CCcCCHHHH
Confidence 3 3446779999999999987 569999999999999999999999999999999988888876543 346899999
Q ss_pred HHHHHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+||.+||++||++||| ++|+++||||+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 5799999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-63 Score=467.24 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=221.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+.|++.++||+|+||+||+|+++.+|+.||||++...... .+|+.+|+.| +|||||++++++++++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 5699999999999999999999999999999999765432 4699999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||||+||+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++.++ ..+||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--CCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--CEEEEeeCCCCeEccCCCc
Confidence 99999999999999988999999999999999999999999999999999999997543 2499999999987754321
Q ss_pred ------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 215 ------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 215 ------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
....+||+.|||||++. ..|+.++|||||||++|||+||..||.+.+..+....+......+. ..++.+|++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHH
Confidence 23468999999999987 4699999999999999999999999998877777777777654332 234679999
Q ss_pred HHHHHHHccCCCcCCCCCHHHH-------------hcCcccccCcc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQV-------------LEHPWLQNAKK 320 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~-------------l~h~~~~~~~~ 320 (436)
+++||.+||++||.+|||+.|+ |+|||+.....
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9999999999999999999997 67999987644
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=462.84 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=225.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---- 127 (436)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|+.| +|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence 45678999999999999999999999999999999997543 3344567889999999999 89999999998764
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+.+|||||||+ |+|.+++..++.+++..++.++.||+.||.|||++|||||||||+|||++. .+.+||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~---~~~~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE---NCELKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TCCEEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC---CCCEEEeecce
Confidence 367899999996 589999998889999999999999999999999999999999999999964 45599999999
Q ss_pred ccccCCC-----CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC
Q 013816 206 SVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (436)
Q Consensus 206 a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 278 (436)
|+.+... ....+.+||+.|||||++.+ .++.++||||+|||+|||++|++||.+.+..+....|......+..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9866432 23456799999999999763 4799999999999999999999999999998888887764433221
Q ss_pred CC---------------------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 279 DP---------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 279 ~~---------------------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.. ++.+|+++++||.+||++||++|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 11 235789999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=450.02 Aligned_cols=257 Identities=25% Similarity=0.486 Sum_probs=211.6
Q ss_pred ccccceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+.. ....+.+|+++|+.+.+|||||+++++|++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46789999999999999999999875 467899999986532 3456889999999997899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+++|+|||||+||+|.+++ +.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~--~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC--CCeEEECcCCCCcc
Confidence 9999999999999999988 359999999999999999999999999999999999999753 24599999999976
Q ss_pred cCCCC-----------------------------cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCC
Q 013816 209 FKPGE-----------------------------KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF 257 (436)
Q Consensus 209 ~~~~~-----------------------------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf 257 (436)
..+.. .....+||+.|+|||++.+ .|+.++||||+||++|+|+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53321 1234589999999999864 4899999999999999999999999
Q ss_pred CCCC-HHHHHHHHHHcc--------------------------------------------------ccCCCCCCcccCH
Q 013816 258 WAET-EQGVAQAIIRSV--------------------------------------------------LDFRRDPWPKVSE 286 (436)
Q Consensus 258 ~~~~-~~~~~~~i~~~~--------------------------------------------------~~~~~~~~~~~~~ 286 (436)
.... .......|.... .......|..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6544 333333332100 0011123567899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++++||.+||++||++|||+.|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=439.20 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=199.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-----
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT----- 129 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----- 129 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++| +|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999999999999999997543 344567899999999999 8999999999987544
Q ss_pred -------eEEEEEeccCCCchHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 130 -------AVHLVMELCEGGELFDRIVARGHY---TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 130 -------~~~lv~E~~~g~~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.+|+|||||+||+|.+++..+..+ ++..+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~---~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---CcEE
Confidence 379999999999999999877553 456788999999999999999999999999999999654 4599
Q ss_pred EEeeccccccCCCCc-------------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-H
Q 013816 200 AIDFGLSVFFKPGEK-------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-G 264 (436)
Q Consensus 200 l~DfG~a~~~~~~~~-------------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~ 264 (436)
|+|||+|+....... .+..+||+.|||||++. ..|+.++|||||||++|||++ ||...... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 23458999999999987 469999999999999999996 88543322 1
Q ss_pred HHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
....+.... + ++.++..++.+.+||.+||++||++|||+.|+|+||||++.
T Consensus 236 ~~~~~~~~~--~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLK--F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTC--C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCC--C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 122222211 1 12234567788999999999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=473.89 Aligned_cols=263 Identities=34% Similarity=0.657 Sum_probs=240.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.| +|||||+++++|++++.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 45578999999999999999999999999999999997543 34567889999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|||||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.+.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence 999999999999999864 4679999999999999999999999999999999999999753 24569999999999988
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
........+||+.|||||++. ..|+.++|||||||++|+|++|..||.+.+..+....+......+....++.+|++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 777777889999999999987 4689999999999999999999999999999999999998888777777788999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+||.+||+.||.+|||+.|+|+||||+...
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 999999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=437.46 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=216.7
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|.+.+.||+|+||+||+|++. .++..||||++... .....++|.+|+++|++| +|||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence 367999999999999999999875 45789999999643 344567899999999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
+.+|||||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~--- 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--- 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC---
Confidence 9999999999999999999764 358999999999999999999999999999999999999654
Q ss_pred CCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 013816 196 APLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 270 (436)
..+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 4599999999987644332 23457999999999987 679999999999999999999 899999999988888887
Q ss_pred HccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+... ..+..+|+++.+|+.+||+.||++|||+.++ ++|+++.
T Consensus 245 ~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 245 QGRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred cCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 76432 2235689999999999999999999999999 4566543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-59 Score=468.55 Aligned_cols=255 Identities=27% Similarity=0.474 Sum_probs=218.6
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHH---HHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~---E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+ ++.+++.+ +|||||+++++|++.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence 67999999999999999999999999999999998765432222333333 46667777 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|||||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++. .++|||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~---~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC---CCCEEecccceeeecCC
Confidence 999999999999999999999999999999999999999999999999999999999964 45699999999987654
Q ss_pred CCcccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHccccCCCCCCcccCH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. ...+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+.+ ..++...+..... ..+..+|+
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----~~p~~~S~ 419 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFSP 419 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----CCCTTSCH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----CCCccCCH
Confidence 3 345679999999999985 3 59999999999999999999999997643 2334444444433 33457899
Q ss_pred HHHHHHHHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
++++||.+||+.||.+|++ +.|+++||||+..
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999998 7999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=429.38 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=204.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
+++++.+.||+|+||+||+|++. ..||||+++... ......+.|.+|+.+|+++ +|||||++++++. ++.+|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-~~~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-KDNLAIV 109 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-CCeEEEE
Confidence 57889999999999999999854 359999986543 3445678899999999999 9999999999875 4568999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
||||+||+|.+++... .++++..+..|+.||+.||.|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC---CcEEEeeccCceecccCC
Confidence 9999999999999764 579999999999999999999999999999999999999754 45999999999876432
Q ss_pred --CcccccccCCcccchhcccc----cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC--CCCCccc
Q 013816 213 --EKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--RDPWPKV 284 (436)
Q Consensus 213 --~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 284 (436)
......+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.+.......+.......+ ...++.+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 23356789999999999852 488999999999999999999999988766555554444332222 2234578
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
|+++.+|+.+||+.||++|||+.|++++
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=432.50 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=209.2
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|.+.++||+|+||+||+|+++ .+++.||||++... .....+.|.+|+++|++| +|||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence 357999999999999999999875 36889999999643 344567899999999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 129 TAVHLVMELCEGGELFDRIVAR---------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
+.+|||||||+||+|.+++... +++++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~-- 193 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ-- 193 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC--
Confidence 9999999999999999999753 35899999999999999999999999999999999999965
Q ss_pred CCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
...+||+|||+|+...... ......||+.|||||++. ..|+.++|||||||+||||+| |+.||.+.+..+....
T Consensus 194 -~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 194 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp -TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred -CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4459999999998764432 224568999999999987 569999999999999999999 8999999998888888
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+..+.. ......+|+++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 877542 22335689999999999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=435.19 Aligned_cols=301 Identities=39% Similarity=0.725 Sum_probs=265.8
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 44667899999999999999999999999999999999976543 344567899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
..|+||||+.|++|.+.+..+..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999987766677999999999887
Q ss_pred CCCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||++.+.......+..+...++...|..+++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76656667789999999999874 68999999999999999999999999999988888998888887777788899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHH
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA 352 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 352 (436)
++||.+||+.||++|||+.++|+||||..................+++|....+++..++..+.
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998643322223345566778888887877777665543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=449.21 Aligned_cols=300 Identities=40% Similarity=0.711 Sum_probs=263.0
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
...+.++|++.+.||+|+||+||+|.+..+|+.+|+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 34577899999999999999999999999999999999976543 233567789999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
..|+||||+.||+|.+.+..++.+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999999999999999999999999999999999999999999999987666678999999999876
Q ss_pred CCCC-cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+...++.+.|+.++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 5433 3356789999999999874 6899999999999999999999999999999999999999888888888999999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHH
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVI 351 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 351 (436)
+++||.+||+.||.+|||+.|+|+||||+.................+++|...++++..++..+
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~ 307 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVM 307 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEE
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999865433333334566778888888887777766544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-58 Score=427.85 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=215.0
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
...+++.++||+|+||+||+|.+. .+++.||||++.... .....+.|.+|+.+|++| +|||||++++++.++
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEEC
Confidence 356889999999999999999863 467899999996543 233467899999999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 013816 129 TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~ 192 (436)
+.++||||||++|+|.++|..+ ..+++..+..|+.||+.||.|||+++||||||||+|||++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999653 358999999999999999999999999999999999999654
Q ss_pred CCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 013816 193 KETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (436)
Q Consensus 193 ~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~ 267 (436)
+.+||+|||+|+...... ......||+.|||||++. +.|+.++|||||||+||||+| |..||.+.+..++..
T Consensus 182 ---~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 182 ---LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp ---GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred ---CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 459999999998764332 234568999999999986 679999999999999999998 899999999888888
Q ss_pred HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+..+.. .+..+.+|+++.+|+.+||+.||++|||+.|++++
T Consensus 259 ~i~~~~~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7776543 22335789999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=425.77 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=210.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC-----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||+||+|.+..++ +.||||.+.... .....+.+.+|+.+|.++.+|||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 478999999999999999999986543 679999986543 3345678999999999996569999999998654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 013816 129 -TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~ 191 (436)
+.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999753 34889999999999999999999999999999999999965
Q ss_pred CCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 013816 192 KKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVA 266 (436)
Q Consensus 192 ~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~ 266 (436)
+ +.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||+||||+| |..||.+....+..
T Consensus 221 ~---~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 K---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp G---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred C---CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 4599999999987654332 24568999999999987 579999999999999999998 99999886654444
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+....... .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 298 ~~~i~~g~~~--~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCC--CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 3333332222 2234689999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=424.68 Aligned_cols=267 Identities=39% Similarity=0.714 Sum_probs=240.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..+.++|++++.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.+ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe
Confidence 3567899999999999999999999999999999999987644321 2357899999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~-~~~ikl~DfG~a 206 (436)
.+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999975442 236999999999
Q ss_pred cccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
............+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......+....|..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 9877666667788999999999987 468999999999999999999999999999998888888877776666667899
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+++++||.+||..||.+|||+.|+|+||||+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999999853
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-56 Score=425.16 Aligned_cols=300 Identities=36% Similarity=0.653 Sum_probs=242.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..+.++|++.+.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence 456789999999999999999999999999999999997543221 12457899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 129 TAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+.+|+||||++|++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999998887643 358999999999999999999999999999999999999877667779999999
Q ss_pred cccccCCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 205 LSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 205 ~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+. .......+...........|.
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 9987754432 34568999999999987 46899999999999999999999999875 445666677666555544556
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHH
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA 352 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 352 (436)
.+++++++||.+||+.||++|||+.++|+||||+.................+++|....+++..++..++
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVS 327 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC----------
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999998644322222223445567777666666666555443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=409.06 Aligned_cols=258 Identities=36% Similarity=0.629 Sum_probs=232.7
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999977543 444567899999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA---DMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC---CCCEEEeeccCceecCCC
Confidence 99999999999999998889999999999999999999999999999999999999964 445999999999887766
Q ss_pred CcccccccCCcccchhcccc-cC-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..+....+..+....+ ..+++++.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 243 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCEN 243 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence 66777899999999999874 34 4789999999999999999999999998888888888765433 357999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
||.+||+.||.+|||+.|+|+||||+...
T Consensus 244 li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=412.74 Aligned_cols=295 Identities=42% Similarity=0.733 Sum_probs=235.1
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
....+.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEecC
Confidence 34567789999999999999999999999999999999987542 346688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+.+++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++..+....+||+|||+++.
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999997655567799999999987
Q ss_pred cCCCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHccccCCCCCCcccCH
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+......+....++.++.
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 765545566789999999999874 68999999999999999999999997765544 5666666666666666778999
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHH
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVI 351 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i 351 (436)
++.+||.+||+.||++|||+.++|+||||....... .........+++|....++++.+....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF--VHMDTAQKKLQEFNARRKLKAAVKAVV 343 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCC--SCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCccch--hhhcchHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998754322 233555667778877777776665443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=413.13 Aligned_cols=263 Identities=32% Similarity=0.651 Sum_probs=237.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence 4568999999999999999999999999999999998643 23456789999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 99999999999999997653 69999999999999999999999999999999999999753 24569999999999887
Q ss_pred CCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......+....++.+|+++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 6666667789999999999874 478999999999999999999999999999988899988877766666678999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+||.+||+.||.+|||+.|+|+||||+....
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=411.38 Aligned_cols=267 Identities=37% Similarity=0.707 Sum_probs=237.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 356789999999999999999999999999999999997654322 12467899999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~a 206 (436)
...+++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999997654 2346999999999
Q ss_pred cccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....++.++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876665666778999999999987 568999999999999999999999999998888888887766655544456789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.+.+||.+||+.||++|||+.++|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999853
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=417.26 Aligned_cols=258 Identities=32% Similarity=0.552 Sum_probs=208.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.+ +||||+++++++...+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEE
Confidence 357899999999999999999999999999999999764322 35688999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCcccccccc
Confidence 9999999999999998888899999999999999999999999999999999999996433 345999999999865544
Q ss_pred CcccccccCCcccchhccc-ccCCCC-CchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHccccCCCCCCcccCH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPE-VDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~-~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.......||+.|+|||++. ..++.+ +|||||||++|+|++|..||.+... ......+......+ +....+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--PDDIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--CTTSCCCH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--CCcCCCCH
Confidence 4556678999999999986 345444 8999999999999999999977544 23333444333322 23346899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++++||.+||+.||++|||+.|+++||||...
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=398.02 Aligned_cols=268 Identities=41% Similarity=0.780 Sum_probs=245.1
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF 79 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence 3567899999999999999999999999999999999976653 344567889999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
.++||||++|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999999888889999999999999999999999999999999999999877777779999999998876
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.........||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.......+...+..+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 666666778999999999987 4589999999999999999999999999999988888888888877777788999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+||.+||+.||++|||+.|+|+||||++...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=412.94 Aligned_cols=258 Identities=30% Similarity=0.542 Sum_probs=226.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..+++.+.+||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999876444444567788999999998789999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~ 212 (436)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+.... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~---~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH---EGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC---CCCEEEccccceeecccCC
Confidence 9999999999999998889999999999999999999999999999999999999964 45699999999986432 3
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence 3445678999999999987 4699999999999999999999999999999999999988765543 3589999999
Q ss_pred HHHccCCCcCCCCCH------HHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~------~e~l~h~~~~~~ 318 (436)
|.+||+.||.+||++ .++++||||+..
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999 899999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=398.92 Aligned_cols=265 Identities=44% Similarity=0.823 Sum_probs=241.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|.+..++..+|+|++...... ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeE
Confidence 4678999999999999999999999999999999999765432 357899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++..++....+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999999999998888899999999999999999999999999999999999996655667799999999988776
Q ss_pred CCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......++...+..+++++.+|
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHH
T ss_pred ccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHH
Confidence 66667778999999999998889999999999999999999999999999888888888877666555556789999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
|.+||+.||.+|||+.++|+||||++...
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 99999999999999999999999987544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=406.23 Aligned_cols=256 Identities=30% Similarity=0.564 Sum_probs=228.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999999765433333567789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CCC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~~ 213 (436)
|||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC---CCCEEEeeccchhhcccCCC
Confidence 999999999999988888999999999999999999999999999999999999964 4469999999998643 334
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..+++++++||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 456678999999999986 4689999999999999999999999999888888888877655433 36899999999
Q ss_pred HHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 293 RKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
.+||+.||++|| ++.++++||||+..
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 99999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-54 Score=409.18 Aligned_cols=263 Identities=37% Similarity=0.656 Sum_probs=231.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.++|++.+.||+|+||.||+|.++.+|+.||+|++.+... ...+|++++.++.+||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 4567899999999999999999999999999999999976532 234688888888789999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~~~~ikl~DfG~a~~~ 209 (436)
+|+||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+... +....+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999999988889999999999999999999999999999999999998543 33346999999999876
Q ss_pred CCC-CcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHccccCCCCCCccc
Q 013816 210 KPG-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. ....+....+..+...+....|+.+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 543 33456789999999999874 588999999999999999999999975 4566777888888877777778899
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
|+++++||.+||+.||++|||+.++|+||||.....
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 999999999999999999999999999999976443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=409.94 Aligned_cols=264 Identities=33% Similarity=0.655 Sum_probs=236.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.+ +||||+++++++.+...+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999986542 33456789999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ....+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecC
Confidence 99999999999999987654 69999999999999999999999999999999999999643 23569999999999876
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.........||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....+..++++++
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 655556668999999999987 4588999999999999999999999999988888888888877777777788999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+||.+||+.||.+|||+.++|+||||+....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=394.20 Aligned_cols=262 Identities=37% Similarity=0.670 Sum_probs=225.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|.+..++..+|+|++..... ....+.+.+|+++++++ +||||+++++++.+....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence 467899999999999999999999999999999999976542 33467899999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++||||++|++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++..+....+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3679999999999999999999999999999999999999766666779999999998
Q ss_pred ccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+.......... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 776655556678999999999998889999999999999999999999999988877777666554443322 2357899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+.+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=410.54 Aligned_cols=258 Identities=27% Similarity=0.524 Sum_probs=222.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..++.++.+||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 36899999999999999999999999999999999877655555556788999999987789999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc-CCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~-~~~ 212 (436)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+.. ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~---~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC---CCCEEEeecceeeecccCC
Confidence 9999999999999998889999999999999999999999999999999999999964 456999999999863 334
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHHccccCCCCCCc
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||... ......+.+......++ .
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----T
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----C
Confidence 4556789999999999987 46899999999999999999999999642 22334555555544332 4
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCH------HHHhcCcccccC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~------~e~l~h~~~~~~ 318 (436)
.+++++++||.+||+.||.+||++ .|+++||||+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 689999999999999999999985 899999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=398.53 Aligned_cols=254 Identities=28% Similarity=0.575 Sum_probs=228.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence 6799999999999999999999999999999999765433333567788999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TSCEEECCCSSCEECSS--C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC---CCCEEEeecCcceecCC--c
Confidence 999999999999998888999999999999999999999999999999999999964 45699999999987543 3
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ +.+++++++||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence 34568999999999987 4689999999999999999999999999988888888888765443 458999999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+||+.||++|| ++.++++||||+..
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999 99999999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=392.38 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=225.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+.+.+|+.+++.+ +||||+++++++...+.+|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEE
Confidence 457899999999999999999999999999999998765432 346789999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---CCEEEeeCCCceecCCc
Confidence 999999999999998765 69999999999999999999999999999999999999644 45999999999876543
Q ss_pred C-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+...... .......+++.+.+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHH
Confidence 3 335568999999999986 56899999999999999999999999888877666655544322 22223578999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
||.+||+.||++|||+.|+|+||||+....
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=400.45 Aligned_cols=258 Identities=27% Similarity=0.522 Sum_probs=225.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999887666666677899999999988789999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~ 212 (436)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++... ..
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC---CCCEEEEeccccccccCCC
Confidence 9999999999999988888999999999999999999999999999999999999964 4469999999998643 33
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHHccccCCCCCCc
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA---------ETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.. .........+......++ .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----T
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----C
Confidence 4456678999999999987 4689999999999999999999999965 233344555555544332 4
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCH------HHHhcCcccccC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTA------QQVLEHPWLQNA 318 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~------~e~l~h~~~~~~ 318 (436)
.+++++++||.+||+.||.+||++ .++++||||+..
T Consensus 241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 689999999999999999999995 899999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=400.82 Aligned_cols=266 Identities=35% Similarity=0.654 Sum_probs=211.1
Q ss_pred cccceeec---cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+.++|++. +.||+|+||.||+|.+..+|+.||+|++.+. ....+.+|+.+++.+.+||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34678775 7899999999999999999999999998653 34677899999999966999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
..|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999889999999999999999999999999999999999999987666667999999999866
Q ss_pred CCC-CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHccccCCCCC
Q 013816 210 KPG-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------QGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~~ 280 (436)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||..... .+....+..+...+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 443 2335667899999999987 4689999999999999999999999976433 455666666666555555
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 324 (436)
|..+++++++||.+||+.||.+|||+.++++||||+.....+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~ 283 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence 66789999999999999999999999999999999976554433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=401.09 Aligned_cols=274 Identities=28% Similarity=0.536 Sum_probs=238.5
Q ss_pred ccCCcccccccceeec-cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEE
Q 013816 45 LKEPTGREIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123 (436)
Q Consensus 45 ~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 123 (436)
+....++.+.++|.+. +.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+..||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3445567788999998 889999999999999999999999999976543 23346788999999999977899999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 124 TYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 124 ~~~~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
++...+.+++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.....+.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999999988653 569999999999999999999999999999999999999764446679999
Q ss_pred eeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......+....
T Consensus 177 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp CGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 999998876655556678999999999987 5689999999999999999999999999998888888888877777777
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 788999999999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=403.95 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=228.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999765432233456788899999887689999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-C
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~ 212 (436)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC---CCCEEEeEChhhhhcccCC
Confidence 9999999999999998888999999999999999999999999999999999999964 44699999999986432 2
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++++|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence 3446678999999999986 4689999999999999999999999999998888888877654332 3589999999
Q ss_pred HHHccCCCcCCCCCHH-HHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTAQ-QVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~-e~l~h~~~~~~ 318 (436)
|.+||+.||++||++. ++++||||+..
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999998 99999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=398.62 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=190.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 129 (436)
..+|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+.++ +|||||++++++..++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCce
Confidence 46799999999999999999987 58999999986432 1122334566666788 8999999999997654
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCCCCeEEE
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
.+|||||||+||+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~---~~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT---TSCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC---CCCEEEE
Confidence 689999999999999999764 689999999999999999999987 9999999999999964 4559999
Q ss_pred eeccccccCCCCc-----ccccccCCcccchhcccc-------cCCCCCchhHHHHHHHHHHhCCCCCCCC---------
Q 013816 202 DFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAE--------- 260 (436)
Q Consensus 202 DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~--------- 260 (436)
|||+|+....... ....+||+.|||||++.+ .++.++|||||||+||||+||..||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9999987654332 234589999999999864 3667899999999999999997765321
Q ss_pred ------CHHHHHHHHHHccccCCCCC-C--cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 261 ------TEQGVAQAIIRSVLDFRRDP-W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 261 ------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
........+.........+. + ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12223333333322211111 0 1234578899999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=413.89 Aligned_cols=261 Identities=31% Similarity=0.490 Sum_probs=227.9
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +|||||++++++.+.+.+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 347899999999999999999999999999999999764332222334578899999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+.....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~---~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC---CCCEEEeccceeEeeccC
Confidence 99999999999998875 46999999999999999999999999999999999999964 456999999999876544
Q ss_pred C--cccccccCCcccchhcccc-c----CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 213 E--KFSEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~l~~-~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
. .....+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+..+....+.........+.+..+|
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 3 2346789999999999863 2 7889999999999999999999999999988888888765444444556799
Q ss_pred HHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
+++++||.+||+.+|.+ ||++.|+++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999988 9999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=404.71 Aligned_cols=258 Identities=25% Similarity=0.512 Sum_probs=226.4
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.+ +|||||++++++.+.+.+
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEE
Confidence 3357899999999999999999999999999999999766544444567899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE---HGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC---CCCEEEeccceeeeccC
Confidence 999999999999999998888999999999999999999999999999999999999964 45699999999998776
Q ss_pred CCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHccccCCCCCCccc
Q 013816 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE---TEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+......+ ...+
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----p~~~ 243 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY----PSAW 243 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC----CTTS
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC----CCcC
Confidence 66677889999999999985 24889999999999999999999999743 3334444444443332 2468
Q ss_pred CHHHHHHHHHccCCCcCCCCC-HHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLT-AQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps-~~e~l~h~~~~~ 317 (436)
++++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 999999999999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=402.93 Aligned_cols=257 Identities=26% Similarity=0.456 Sum_probs=229.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+.+||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 46799999999999999999999999999999999875433334567788999999988789999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~ 212 (436)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC---CCcEEEEeCCcccccccCC
Confidence 9999999999999998888999999999999999999999999999999999999964 4469999999998643 23
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..+++++++|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 3455678999999999986 5689999999999999999999999999999888888888765443 4689999999
Q ss_pred HHHccCCCcCCCC-----CHHHHhcCccccc
Q 013816 292 VRKMLDPDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 292 l~~~l~~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
|.+||+.||.+|| ++.++++||||+.
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999 4799999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=398.35 Aligned_cols=267 Identities=39% Similarity=0.719 Sum_probs=235.8
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 4567899999999999999999999999999999999976543221 2467899999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~-~~~ikl~DfG~a 206 (436)
.+.+++||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999988888999999999999999999999999999999999999975442 126999999999
Q ss_pred cccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......++...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8876665556678999999999987 568999999999999999999999999988888888777765554443345789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.+.+||.+||+.||++|||+.++|+||||+..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=396.16 Aligned_cols=265 Identities=35% Similarity=0.605 Sum_probs=221.3
Q ss_pred ccccceeec-cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 52 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++.++.+||||+++++++.+.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 466889995 78999999999999999999999999997653 22457889999999996589999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988889999999999999999999999999999999999999876666669999999987654
Q ss_pred CCC--------cccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH--------------
Q 013816 211 PGE--------KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------- 262 (436)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------------- 262 (436)
... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 123456999999999975 3488999999999999999999999976542
Q ss_pred -HHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 263 -QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 263 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
......+......++...+..+++++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 334555666555444433456899999999999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=400.89 Aligned_cols=254 Identities=29% Similarity=0.559 Sum_probs=228.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 47899999999999999999999999999999999765443334567889999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++....
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSS--
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC---CCCEEEcccccceeccC--
Confidence 9999999999999998888999999999999999999999999999999999999964 44699999999987643
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+..+...++ ..+++++.+||
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 269 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLL 269 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHH
T ss_pred CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 234568999999999986 5689999999999999999999999999998888888888755433 45899999999
Q ss_pred HHccCCCcCCCCC-----HHHHhcCccccc
Q 013816 293 RKMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 293 ~~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
.+||+.||.+||+ +.++++||||+.
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999998 999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=409.36 Aligned_cols=264 Identities=37% Similarity=0.683 Sum_probs=219.5
Q ss_pred ccccceeec-cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 52 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
.+.++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++.++.+||||+++++++..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 345667776 7899999999999999999999999998532 4567899988666699999999999876
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 -DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667899999999999999998753 59999999999999999999999999999999999999875556789999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHccccCCCC
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVLDFRRD 279 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----~~~~~i~~~~~~~~~~ 279 (436)
+++...........+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+..+...++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 998776555556778999999999986 56899999999999999999999999765432 2455666666777777
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCC
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~ 323 (436)
.|..+++++++||.+||+.||++|||+.++|+||||......+.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~ 333 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCC
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCC
Confidence 77889999999999999999999999999999999987654443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=393.32 Aligned_cols=268 Identities=28% Similarity=0.450 Sum_probs=218.1
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC--hhhHHHHHHHHHHHHhCC--CCCceeEEEEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLP--KHQNIVCLKDT 124 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~E~~~l~~l~--~h~niv~~~~~ 124 (436)
.|..+.++|++++.||+|+||+||+|++..+|+.||+|++....... ......+.+|+.+++.+. +||||++++++
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 35567789999999999999999999999999999999987543211 112245667888777762 49999999999
Q ss_pred EEeCC-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 013816 125 YEDDT-----AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (436)
Q Consensus 125 ~~~~~-----~~~lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ 197 (436)
+.... .+++||||+.| +|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++. .+.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~---~~~ 158 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGT 158 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT---TSC
T ss_pred eeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC---CCC
Confidence 98765 58999999975 99999987654 999999999999999999999999999999999999964 345
Q ss_pred eEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC
Q 013816 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 198 ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 159 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 159 VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999998776666666778999999999986 568999999999999999999999999998888877776643332
Q ss_pred CCCCC-----------------------cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 277 RRDPW-----------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 277 ~~~~~-----------------------~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
....| +.+++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 22222 357899999999999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=406.43 Aligned_cols=257 Identities=35% Similarity=0.598 Sum_probs=220.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999765433333346789999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~---~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD---NLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT---TCCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC---CCCEEEEEeccceeccCC
Confidence 999999 6799999988889999999999999999999999999999999999999964 445999999999887766
Q ss_pred CcccccccCCcccchhccccc-C-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
......+||+.|+|||++.+. + ++++|||||||++|+|++|..||.+.........+.. ........+|+++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMPDFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCCTTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCcccCCHHHHH
Confidence 666778899999999998743 3 7899999999999999999999976554332222111 111223458999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
||.+||+.||.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=386.92 Aligned_cols=258 Identities=28% Similarity=0.507 Sum_probs=216.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence 579999999999999999999999999999999976543 333457788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||++| +|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecCCcc
Confidence 999986 55555544 6789999999999999999999999999999999999999654 45999999999876433
Q ss_pred CcccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHccccCCCCC---------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVLDFRRDP--------- 280 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~--------- 280 (436)
.......||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+.........+.+.........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33455688999999999863 3 79999999999999999988877 455555666666654322221111
Q ss_pred ----------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 281 ----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ----------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+.+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 23578999999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=397.14 Aligned_cols=266 Identities=29% Similarity=0.482 Sum_probs=216.4
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
....++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE
Confidence 4456789999999999999999999999999999999975532 222345678999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeeccccc
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~a~~ 208 (436)
+++||||++| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999985 9999999988899999999999999999999999999999999999996433 344599999999987
Q ss_pred cCCC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCc---
Q 013816 209 FKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282 (436)
Q Consensus 209 ~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--- 282 (436)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+...........|+
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 6432 33355678999999999864 48999999999999999999999999988887777776543222222111
Q ss_pred -----------------------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 283 -----------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 283 -----------------------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 1679999999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=412.12 Aligned_cols=263 Identities=29% Similarity=0.489 Sum_probs=226.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence 3457899999999999999999999999999999999764332222334588999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~---~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC---CCCEEEcchhhhhhcc
Confidence 999999999999999987 467999999999999999999999999999999999999964 4469999999997765
Q ss_pred CCCc--ccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-CCC
Q 013816 211 PGEK--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPW 281 (436)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 281 (436)
.... ....+||+.|+|||++. +.++.++|||||||++|||++|..||.+.+..+....+......+.. ..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 4332 23468999999999975 35899999999999999999999999999988888888764322222 223
Q ss_pred cccCHHHHHHHHHccCCCcCC--CCCHHHHhcCcccccC
Q 013816 282 PKVSENAKDLVRKMLDPDPKR--RLTAQQVLEHPWLQNA 318 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~--Rps~~e~l~h~~~~~~ 318 (436)
..+|+++++||.+||..+|++ ||++.|+++||||+..
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 568999999999999999988 9999999999999853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=391.55 Aligned_cols=264 Identities=28% Similarity=0.477 Sum_probs=218.4
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.+..+.++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSE 91 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccC
Confidence 44577899999999999999999999985 599999999865432 222356788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+.+++||||++| +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~ 167 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLAR 167 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCE
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---CCEEEccCcCce
Confidence 999999999985 888877665 459999999999999999999999999999999999999654 459999999998
Q ss_pred ccCCC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC----
Q 013816 208 FFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP---- 280 (436)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---- 280 (436)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+...........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 76533 33455688999999999753 589999999999999999999999988777766666655332222111
Q ss_pred ----------------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 281 ----------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 281 ----------------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 124678999999999999999999999999999998753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=389.36 Aligned_cols=265 Identities=40% Similarity=0.742 Sum_probs=233.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKI-KHENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence 4567899999999999999999999999999999999975432 2345788999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+....+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888889999999999999999999999999999999999999655556779999999997654
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+....+..+++++.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 N-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp C-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 2 2334457999999999987 4588999999999999999999999999988888888888877776666778999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+||.+||+.||++|||+.++|+||||+....
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 9999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=400.33 Aligned_cols=256 Identities=27% Similarity=0.514 Sum_probs=218.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHH-HhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM-RHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l-~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.+|
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEE
Confidence 46899999999999999999999999999999999887655544556677787774 556 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-C
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-P 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~ 211 (436)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++... .
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~---~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC---CCCEEEeeCccccccccC
Confidence 99999999999999998888999999999999999999999999999999999999964 4469999999998643 3
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
.......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+......++ +.+++++++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ 268 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARH 268 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHH
Confidence 34456678999999999987 4689999999999999999999999999998888888887654433 468999999
Q ss_pred HHHHccCCCcCCCCCH----HHHhcCccccc
Q 013816 291 LVRKMLDPDPKRRLTA----QQVLEHPWLQN 317 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~----~e~l~h~~~~~ 317 (436)
||.+||+.||.+||++ .++++||||+.
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999986 69999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=388.43 Aligned_cols=266 Identities=42% Similarity=0.765 Sum_probs=240.2
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..+.++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe
Confidence 35668999999999999999999999999999999999765432 33567899999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++||||++|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888889999999999999999999999999999999999999876666779999999998776
Q ss_pred CCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+..+...+..+.+..+++++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55555566789999999999888999999999999999999999999999888888888887766665556788999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+|.+||+.||++|||+.++|+||||+..
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=401.39 Aligned_cols=261 Identities=35% Similarity=0.646 Sum_probs=227.2
Q ss_pred cccceee--ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 53 IEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 53 ~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
+.+.|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 3455655 678999999999999999999999999997643 34567899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ ....+||+|||+++..
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-TTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-CCCcEEEEeCCCceec
Confidence 99999999999999988764 469999999999999999999999999999999999999643 2356999999999987
Q ss_pred CCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
..........||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....++.+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 7666666678999999999987 568899999999999999999999999999888888888877766666667899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++||.+||+.||.+|||+.|+|+||||+..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=414.19 Aligned_cols=261 Identities=36% Similarity=0.631 Sum_probs=232.0
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+....++|.+++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 344567899999999999999999999999999999999765433333457899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+|+||||++|++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~---~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA---HMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT---TCCEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec---CCCeEEEeccchhhc
Confidence 99999999999999999988888999999999999999999999999999999999999964 445999999999987
Q ss_pred CCCCcccccccCCcccchhccccc--CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.........+||+.|+|||++.+. .+.++|||||||++|+|++|..||.+.........+..+....+ ..++++
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 242 (476)
T 2y94_A 167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPS 242 (476)
T ss_dssp CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHH
T ss_pred cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHH
Confidence 766666677899999999998753 46799999999999999999999998888888787777654322 357899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.+||.+||+.||.+|||+.++++||||+..
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=398.14 Aligned_cols=262 Identities=37% Similarity=0.723 Sum_probs=232.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++++.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34578999999999999999999999999999999987653211 1124568899999999877999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
..+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++. .+.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~---~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD---NMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEEecCcc
Confidence 99999999999999999999988888999999999999999999999999999999999999964 445999999999
Q ss_pred cccCCCCcccccccCCcccchhcccc-------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+..+
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 88876666677889999999998752 47889999999999999999999999988888888887776665555
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
.|..+++.+.+||.+||+.||++|||+.++|+||||+
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 5667899999999999999999999999999999997
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=405.73 Aligned_cols=261 Identities=26% Similarity=0.468 Sum_probs=223.9
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999999764332233345688999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~---~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR---CGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC---CCCEEEeechhheeccC
Confidence 999999999999999875 47999999999999999999999999999999999999964 45699999999987654
Q ss_pred CCc--ccccccCCcccchhccc--------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC-C
Q 013816 212 GEK--FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD-P 280 (436)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~ 280 (436)
... ....+||+.|+|||++. +.++.++|||||||++|||++|..||.+.+..+....+.........+ .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 433 23468999999999985 358999999999999999999999999999888888877643222222 1
Q ss_pred CcccCHHHHHHHHHccCCCcCCC---CCHHHHhcCcccccC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRR---LTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~R---ps~~e~l~h~~~~~~ 318 (436)
...+|+++++||.+||. +|.+| |++.|+++||||+..
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 24689999999999999 99998 599999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=410.97 Aligned_cols=260 Identities=29% Similarity=0.553 Sum_probs=220.2
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++...+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCE
Confidence 34457899999999999999999999999999999999876544444566788999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+|+||||++|++|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---SCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---CCEEEccCCCceec
Confidence 99999999999999999888899999999999999999999998 999999999999999654 45999999999864
Q ss_pred CC-CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KP-GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.. .......+||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 375 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPE 375 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHH
Confidence 32 33446678999999999986 5699999999999999999999999999998888888877655443 458999
Q ss_pred HHHHHHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 288 AKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+.+||.+||+.||.+|| |+.|+++||||+..
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999999 99999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=411.05 Aligned_cols=264 Identities=37% Similarity=0.661 Sum_probs=218.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-----hhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.+|+++ +||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 45678999999999999999999999999999999998754321 11223578999999999 9999999999985
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
...+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred -cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4568999999999999999988888999999999999999999999999999999999999987766778999999999
Q ss_pred cccCCCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCCCCC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 281 (436)
+............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+....+
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 8876655556778999999999974 35788999999999999999999999765433 334455555444444445
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 678999999999999999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=384.80 Aligned_cols=266 Identities=41% Similarity=0.750 Sum_probs=229.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence 45789999999999999999999999999999999976543321 2467899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~-~~~~ikl~DfG~a~~ 208 (436)
..++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999997644 234699999999987
Q ss_pred cCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......+....+..+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76555556678999999999987 56899999999999999999999999998888777777665554443334578999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.+|+.+||+.||++|||+.++|+||||+...
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999998643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=402.04 Aligned_cols=263 Identities=32% Similarity=0.546 Sum_probs=211.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.+.+||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 45678999999999999999999999999999999998654 3445567788999999999955999999999997554
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 -~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++. .+.+||+|||+|+.
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~---~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCEE
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC---CCCEEecCCccccc
Confidence 7899999997 489888876 47999999999999999999999999999999999999964 45699999999986
Q ss_pred cCC----------------------CCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH
Q 013816 209 FKP----------------------GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 264 (436)
Q Consensus 209 ~~~----------------------~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~ 264 (436)
... .......+||++|+|||++. ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 532 11234468999999999975 358999999999999999999999999988877
Q ss_pred HHHHHHHccccCCC-------------------------------------------CCCcccCHHHHHHHHHccCCCcC
Q 013816 265 VAQAIIRSVLDFRR-------------------------------------------DPWPKVSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 265 ~~~~i~~~~~~~~~-------------------------------------------~~~~~~~~~~~~ll~~~l~~~p~ 301 (436)
....+......... .....+++++.+||.+||+.||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 77766542211100 01126789999999999999999
Q ss_pred CCCCHHHHhcCcccccCc
Q 013816 302 RRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 302 ~Rps~~e~l~h~~~~~~~ 319 (436)
+|||+.|+|+||||+...
T Consensus 319 ~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFH 336 (388)
T ss_dssp GSCCHHHHTTSTTTTTTC
T ss_pred cCCCHHHHhCCHHHHHhc
Confidence 999999999999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=382.90 Aligned_cols=265 Identities=38% Similarity=0.679 Sum_probs=235.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC------hhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT------AVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45688999999999999999999999999999999997553211 123467889999999995699999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
...+..++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC---CCcEEEecccc
Confidence 999999999999999999999998888999999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 278 (436)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98877666666778999999999874 24788999999999999999999999998888888888888777766
Q ss_pred CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 279 ~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 66778999999999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=383.83 Aligned_cols=256 Identities=31% Similarity=0.508 Sum_probs=213.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|.+ .+|+.||+|++...... ....+.+.+|+.+++++ +||||+++++++...+.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence 5799999999999999999998 67999999998654322 22346788999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||+++ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR---EGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCCEEEeECccccccCccc
Confidence 999986 998888764 67999999999999999999999999999999999999964 345999999999876432
Q ss_pred CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC-----------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 279 (436)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345678999999999863 48999999999999999999999999888877776665532111111
Q ss_pred --------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 280 --------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 280 --------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 12357899999999999999999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=385.94 Aligned_cols=256 Identities=32% Similarity=0.599 Sum_probs=215.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-----------------------hhhHHHHHHHHHHHH
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------------------AVDIEDVRREVDIMR 110 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-----------------------~~~~~~~~~E~~~l~ 110 (436)
.++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999997654321 112356899999999
Q ss_pred hCCCCCceeEEEEEEEe--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 013816 111 HLPKHQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (436)
Q Consensus 111 ~l~~h~niv~~~~~~~~--~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl 188 (436)
++ +||||+++++++.+ .+.+|+||||+++++|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99 89999999999986 67899999999999998754 3457999999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEEeeccccccCCCC-cccccccCCcccchhccccc----CCCCCchhHHHHHHHHHHhCCCCCCCCCHH
Q 013816 189 FANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (436)
Q Consensus 189 ~~~~~~~~~ikl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~~lltg~~pf~~~~~~ 263 (436)
++. .+.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 170 ~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 VGE---DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp ECT---TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECC---CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 964 3459999999998765433 33556899999999998643 367899999999999999999999988877
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
.....+......++ ..+.+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 77777766554433 2357899999999999999999999999999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=388.27 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=207.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++++ +||||+++++++...+.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEE
Confidence 3579999999999999999999999999999999976532 22346788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 134 VMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
||||++| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLAR 156 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCSSCE
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---CCEEECcCccce
Confidence 9999985 999988654 358999999999999999999999999999999999999644 459999999998
Q ss_pred ccCCC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC-----
Q 013816 208 FFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (436)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~----- 279 (436)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+..........
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 76433 33455689999999999863 58999999999999999999999999988887777765532211111
Q ss_pred -------------------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 280 -------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 280 -------------------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
....+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11247889999999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=398.56 Aligned_cols=267 Identities=34% Similarity=0.671 Sum_probs=228.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccC
Confidence 35678999999999999999999999999999999999765331 234567899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 013816 129 TAVHLVMELCEGGELFDRIVA----------------------------------------RGHYTERAAAAVTKTIVEV 168 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~ 168 (436)
+..++||||++|++|.+++.. ...+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998842 1123677889999999999
Q ss_pred HHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-----cccccccCCcccchhccc---ccCCCCCch
Q 013816 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLK---RNYGPEVDV 240 (436)
Q Consensus 169 l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~---~~~~~~~Di 240 (436)
|.|||++||+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||++. ..++.++||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 9999999999999999999997533 3469999999998653211 234567999999999985 458899999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 241 wSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
|||||++|+|++|..||.+....+....+......+..+.+..+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999999999888888888877776666667899999999999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=388.19 Aligned_cols=258 Identities=31% Similarity=0.541 Sum_probs=215.7
Q ss_pred cccceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..++|++.+.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcC
Confidence 3578999999999999999999985 68999999999765432 223446688999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH---QGHVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT---TSCEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC---CCcEEEEeCCcccc
Confidence 999999999999999999998888999999999999999999999999999999999999964 44599999999976
Q ss_pred cCC-CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 209 FKP-GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 209 ~~~-~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
... ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......++ +.+++
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~ 246 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQ 246 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCH
Confidence 432 23345568999999999986 5689999999999999999999999999988888888877654432 46899
Q ss_pred HHHHHHHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
++++||.+||+.||.+|| ++.++++||||+..
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 89999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=416.63 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=224.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.+ +||||+++++++.+.+.+|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999999775443334456788999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~---~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD---HGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC---CCCeEEEecccceecc
Confidence 99999999999999977543 999999999999999999999999999999999999964 4569999999998876
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHccccCCCCCCcccC
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
........+||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+..... .....+|
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~----~~p~~~s 413 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE----EYSERFS 413 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC----CCCTTSC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc----cCCccCC
Confidence 666666679999999999987 468999999999999999999999998753 2334444444322 2235689
Q ss_pred HHHHHHHHHccCCCcCCCC-----CHHHHhcCccccc
Q 013816 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
+++++||.+||+.||.+|| ++.|+++||||+.
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999999 8999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=391.05 Aligned_cols=260 Identities=30% Similarity=0.523 Sum_probs=218.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.++|++++.||+|+||+||+|.+..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEE
Confidence 457899999999999999999999999999999998654322 2346688999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---CCEEEEEeeccceeccC
Confidence 999999999999999888889999999999999999999999999999999999999643 45999999999865422
Q ss_pred C---cccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 213 E---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
. ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||................ ......+..++++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSA 237 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCHH
Confidence 2 2345689999999999864 3 4778999999999999999999997765542222222221 1223345678999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.+||.+||+.||++|||+.|+++||||+...
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 99999999999999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=381.27 Aligned_cols=261 Identities=35% Similarity=0.630 Sum_probs=225.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence 357899999999999999999999999999999999765443333456789999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~---~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS---AGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT---TSCEEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC---CCCEEEEeccccccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999964 445999999998654332
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......++ ..+++++.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l 237 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHH
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHH
Confidence 334568999999999987 4578899999999999999999999999888887777776544332 4578999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCccCC
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 322 (436)
|.+||+.||.+|||+.|+|+||||+.....+
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 9999999999999999999999998765443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=393.54 Aligned_cols=265 Identities=37% Similarity=0.667 Sum_probs=222.1
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
..+.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++++ +||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence 34678999999999999999999999999999999999765331 112234688999999999 999999999998
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.... +|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 899999999999999998888899999999999999999999999999999999999998766667799999999
Q ss_pred ccccCCCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCCCC
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 280 (436)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+....
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98776544445567999999999873 45889999999999999999999999765433 33444445444333333
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+..+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 4568999999999999999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=392.38 Aligned_cols=268 Identities=24% Similarity=0.407 Sum_probs=224.5
Q ss_pred cccccCCcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----CCCc
Q 013816 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQN 117 (436)
Q Consensus 42 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~h~n 117 (436)
...+....+..+.++|++++.||+|+||+||+|++..+++.||+|++... ......+..|+.+++.+. .|||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 33445567778899999999999999999999999999999999998632 334567788999999994 3999
Q ss_pred eeEEEEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC---
Q 013816 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK--- 192 (436)
Q Consensus 118 iv~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~--- 192 (436)
|+++++++...+..++||||+ |++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 889999998764 49999999999999999999999999999999999999642
Q ss_pred -------------------CCCCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh
Q 013816 193 -------------------KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC 252 (436)
Q Consensus 193 -------------------~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt 252 (436)
.....+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 1256699999999986543 334568999999999976 569999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHccccCCCC---------------------CCc---------------------ccCHHHHH
Q 013816 253 GVPPFWAETEQGVAQAIIRSVLDFRRD---------------------PWP---------------------KVSENAKD 290 (436)
Q Consensus 253 g~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~---------------------~~~~~~~~ 290 (436)
|..||......+....+.......+.. .|+ ..++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 999999888777666655432221100 000 12377889
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
||.+||+.||++|||+.|+|+||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=395.91 Aligned_cols=262 Identities=19% Similarity=0.295 Sum_probs=216.2
Q ss_pred ccceeeccccccC--CceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 54 EERYELGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.++|++++.||+| +||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.+ +|||||++++++.+.+.+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEE
Confidence 4689999999999 999999999999999999999987643 344567889999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~---~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV---DGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEcccccceee
Confidence 9999999999999999875 67999999999999999999999999999999999999964 446999999988654
Q ss_pred CCC--------CcccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc---
Q 013816 210 KPG--------EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--- 275 (436)
Q Consensus 210 ~~~--------~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--- 275 (436)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 221 11233478999999999864 5899999999999999999999999876555444333322111
Q ss_pred ---------------------------------------CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 276 ---------------------------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 276 ---------------------------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
.....+..+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00112345789999999999999999999999999999998
Q ss_pred cCcc
Q 013816 317 NAKK 320 (436)
Q Consensus 317 ~~~~ 320 (436)
....
T Consensus 339 ~~~~ 342 (389)
T 3gni_B 339 QIKR 342 (389)
T ss_dssp GC--
T ss_pred HHhh
Confidence 7544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=383.56 Aligned_cols=262 Identities=31% Similarity=0.589 Sum_probs=216.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence 468999999999999999999999999999999986553 2334456788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK---HSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC---CCCEEEeeCCCchhccCcc
Confidence 9999999999998888888999999999999999999999999999999999999964 446999999999876533
Q ss_pred CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC--------------
Q 013816 213 EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------------- 276 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------------- 276 (436)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2335568999999999986 357999999999999999999999999888776655554321110
Q ss_pred -----CCC--------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 277 -----RRD--------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 277 -----~~~--------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+.. .++.+++++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 000 12467899999999999999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=407.89 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=211.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+|+.+ +||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence 45689999999999999999999999999999999997653 3445667899999999999 999999999999654
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~---~~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeC---CCCEEEEEEEe
Confidence 467999999976 56666643 4899999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------- 277 (436)
|+...........+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+....+.+......
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98876665667789999999999976 5699999999999999999999999999888777766655322110
Q ss_pred ---------------CCCCc----------------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 ---------------RDPWP----------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ---------------~~~~~----------------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
...++ ..++++++||.+||+.||++|||+.|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000 015679999999999999999999999999999853
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=405.43 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=201.1
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
..+.++|++++.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+.+ +||||+++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc
Confidence 35668999999999999999999999999999999998654 34455677899999999999 89999999999843
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~---~~~~kl~DFGl 202 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ---DCSVKVCDFGL 202 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TCCEEECCCTT
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC---CCCEeeccccc
Confidence 36799999998 4699999988888999999999999999999999999999999999999964 45699999999
Q ss_pred ccccCCCC----------------------------cccccccCCcccchhcc-c-ccCCCCCchhHHHHHHHHHHh---
Q 013816 206 SVFFKPGE----------------------------KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLC--- 252 (436)
Q Consensus 206 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwSlG~il~~llt--- 252 (436)
|+...... .....+||++|+|||++ . ..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 98764221 23456889999999975 3 469999999999999999999
Q ss_pred --------CCCCCCCCCH--------------------HHHHHHHHHcccc--------------------CC-------
Q 013816 253 --------GVPPFWAETE--------------------QGVAQAIIRSVLD--------------------FR------- 277 (436)
Q Consensus 253 --------g~~pf~~~~~--------------------~~~~~~i~~~~~~--------------------~~------- 277 (436)
|.+||.+... ......+...... ++
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 6677755431 1122222111000 00
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
...++..++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 11235679999999999999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=386.53 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=212.3
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+..+.++|++.+.||+|+||+||+|.+..+|+.||||++..... ..........|+..+.++.+||||+++++++.+.+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 45566899999999999999999999999999999999865432 33344556667777766668999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG---GCEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEccceeeee
Confidence 999999999 66898888764 469999999999999999999999999999999999999654 4599999999987
Q ss_pred cCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
...........||+.|+|||++.+.++.++|||||||++|+|++|..|+..... ...+..... +......+++++
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~l 281 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYL--PPEFTAGLSSEL 281 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCC--CHHHHTTSCHHH
T ss_pred cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCC--CcccccCCCHHH
Confidence 765555566789999999999988899999999999999999999777755322 223322221 111234689999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.+||.+||+.||++|||+.|+|+||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=377.58 Aligned_cols=260 Identities=33% Similarity=0.645 Sum_probs=227.3
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999999765433233456789999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---CCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---CCEEEecccccccCcc
Confidence 9999999999999999888889999999999999999999999999999999999999643 4599999999876543
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+ .+.++.++++
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF----PPFLSDGSKD 241 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----CTTSCHHHHH
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC----CCcCCHHHHH
Confidence 2 234567999999999987 458999999999999999999999999888877777776654332 2468899999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+|.+||+.||.+|||+.++++||||+....
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=390.66 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=222.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCC
Confidence 46778999999999999999999999999999999999876555555667899999999999 8999999999987654
Q ss_pred ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 130 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT---SCEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC---CCEEEeeccCc
Confidence 349999999999999999988899999999999999999999999999999999999999754 44999999999
Q ss_pred cccCCCC----cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 207 VFFKPGE----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
....... ......||+.|+|||++. ..++.++||||||+++|+|+||..||.+.........+...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8664332 223457999999999987 46889999999999999999999999998887777766665444333334
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+++++.++|.+||+.||.+||++.+++.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 5689999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=397.97 Aligned_cols=264 Identities=27% Similarity=0.513 Sum_probs=212.1
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 128 (436)
..+.++|++++.||+|+||.||+|++..+++.||||++... .......+.+.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCC
Confidence 45678999999999999999999999999999999999754 34455677899999999999 899999999999766
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~~kL~DFGl 175 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGL 175 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTT
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC---CCCEEEccCCC
Confidence 67999999996 599999988888999999999999999999999999999999999999954 45699999999
Q ss_pred ccccCCCC-----------------------cccccccCCcccchhcc-c-ccCCCCCchhHHHHHHHHHHhCC------
Q 013816 206 SVFFKPGE-----------------------KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGV------ 254 (436)
Q Consensus 206 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwSlG~il~~lltg~------ 254 (436)
|+...... .....+||++|+|||++ . ..++.++|||||||++|+|++|.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 98764332 23567899999999985 3 45999999999999999999843
Q ss_pred -----CCCCCCC-----------------HHHHHHHHHHcc-----------------------ccCCCC----CCcccC
Q 013816 255 -----PPFWAET-----------------EQGVAQAIIRSV-----------------------LDFRRD----PWPKVS 285 (436)
Q Consensus 255 -----~pf~~~~-----------------~~~~~~~i~~~~-----------------------~~~~~~----~~~~~~ 285 (436)
++|.+.. .......+.... ...... .++.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 3343322 011122221110 000000 124689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=386.47 Aligned_cols=261 Identities=27% Similarity=0.478 Sum_probs=220.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe------
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------ 127 (436)
.++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence 368999999999999999999999999999999987654332 2345678999999999 89999999999987
Q ss_pred --CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 --DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
.+.+|+||||++| +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CCEEEccch
Confidence 4578999999986 777777654 579999999999999999999999999999999999999644 459999999
Q ss_pred cccccCCC-----CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 205 LSVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 205 ~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|+||..||.+.........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876422 23345678999999998753 489999999999999999999999999988888777776555444
Q ss_pred CCCCccc----------------------------CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 278 RDPWPKV----------------------------SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 278 ~~~~~~~----------------------------~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
...|+.. ++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 4444332 778999999999999999999999999999986543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=376.33 Aligned_cols=261 Identities=37% Similarity=0.640 Sum_probs=219.2
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++...+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCC
Confidence 345568899999999999999999999999999999999765433333457889999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.+++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---SCEEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---CCEEEeeccccccc
Confidence 999999999999999999888889999999999999999999999999999999999999643 45999999999877
Q ss_pred CCCCcccccccCCcccchhccccc-C-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
..........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+.......+ ..++..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 237 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRS 237 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHH
Confidence 655555566899999999998754 3 5789999999999999999999998888777777766543322 357899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+.++|.+||+.||.+|||+.++++||||++.
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=389.21 Aligned_cols=259 Identities=26% Similarity=0.478 Sum_probs=212.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence 5799999999999999999999999999999998654321 1112355799999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||++| +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---CCEEECSSSEEECC----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---CCEEEccCcccccccCCc
Confidence 999975 8988887654 58999999999999999999999999999999999999654 45999999999865432
Q ss_pred CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC---------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 281 (436)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.+.........|
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345678999999999763 5899999999999999999999999999888877777664333322222
Q ss_pred -----------------cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 282 -----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 282 -----------------~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+.+++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 246889999999999999999999999999999987544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=420.16 Aligned_cols=258 Identities=26% Similarity=0.454 Sum_probs=230.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|..++..+.+||+|+++++++++.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999865433333457788999999998789999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC-CC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~-~~ 212 (436)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~---~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS---EGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS---SSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC---CCcEEEeecceeeccccCC
Confidence 9999999999999998889999999999999999999999999999999999999964 4469999999998643 33
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
......+||+.|+|||++. ..|+.++|||||||++|||++|..||.+.+..+....+......++ ..+++++++|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence 4456778999999999987 5699999999999999999999999999999989888888765543 4689999999
Q ss_pred HHHccCCCcCCCCCH-----HHHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTA-----QQVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~-----~e~l~h~~~~~~ 318 (436)
|.+||+.||++||++ .|+++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999997 999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=398.63 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=213.4
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..+.....+|++.+.||+|+||+||+|++..+++ +|+|++..... ...+|+++++.+ +||||+++++++..
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l-~h~niv~l~~~~~~ 103 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIV-KHPNVVDLKAFFYS 103 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEE
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhC-CCCCcceEEEEEEe
Confidence 3455667899999999999999999999877666 88888754322 123699999999 89999999999865
Q ss_pred CC------eEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 013816 128 DT------AVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (436)
Q Consensus 128 ~~------~~~lv~E~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ 197 (436)
.+ .+++||||++++ +.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. ..+.
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~ 180 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PSGV 180 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TTTE
T ss_pred cCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CCCc
Confidence 43 388999999874 444332 3567999999999999999999999999999999999999963 3445
Q ss_pred eEEEeeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 198 ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
+||+|||+|+............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus 181 ~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 181 LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999999988766666667789999999998753 5899999999999999999999999998887776666542111
Q ss_pred -----------------CC---CC-----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 276 -----------------FR---RD-----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 276 -----------------~~---~~-----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
++ .. ..+.+++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 00 00 11247899999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=374.81 Aligned_cols=261 Identities=33% Similarity=0.500 Sum_probs=230.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEE
Confidence 3457899999999999999999999999999999999877655666678899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE---DLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC---CCCEEEEeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999964 44599999999987643
Q ss_pred C-CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 G-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+....... ...+++.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 243 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI----PKHINPVAA 243 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----CTTSCHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC----ccccCHHHH
Confidence 2 3344567999999999986 458899999999999999999999999888777766666554332 246789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+++.+||+.||++|||+.++++||||.....
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 9999999999999999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=385.14 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=222.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++++ +||||+++++++...+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeE
Confidence 3456799999999999999999999999999999999765444444567899999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+. |+|.+.+. ....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEeeccCceecC
Confidence 99999997 57878775 45679999999999999999999999999999999999999754 459999999998654
Q ss_pred CCCcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. .....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.........+...... ......+++
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 280 (348)
T 1u5q_A 206 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSE 280 (348)
T ss_dssp S---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCCTTSCH
T ss_pred C---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCCCCCCH
Confidence 3 24568999999999873 45889999999999999999999999988877766666655432 222346789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+.+||.+||+.||++|||+.++|+||||....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=408.14 Aligned_cols=256 Identities=30% Similarity=0.534 Sum_probs=222.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++++ +||||+++++++...+.+|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEE
Confidence 47899999999999999999999999999999999766543334567889999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 134 VMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~---~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD---DGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC---CCCEEEeecceeeec
Confidence 99999999999998764 36999999999999999999999999999999999999964 456999999999877
Q ss_pred CCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... ....+||+.|+|||++. ..++.++|||||||++|+|+||..||.+.. ..+....+......+ ...
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~----p~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY----PDK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC----CTT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC----Ccc
Confidence 55433 34568999999999987 468999999999999999999999998753 345555666554433 256
Q ss_pred cCHHHHHHHHHccCCCcCCCCC-----HHHHhcCccccc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLT-----AQQVLEHPWLQN 317 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps-----~~e~l~h~~~~~ 317 (436)
+++++++||.+||+.||.+||+ +.++++||||+.
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 8999999999999999999996 589999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=377.99 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=221.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence 35888889999999999999999999999999987543 22457789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CcEEEeeeeeeeecccCcc
Confidence 999999999998764 469999999999999999999999999999999999999643 459999999998765432
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... .......+++++.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCccccCCHHHHHHH
Confidence 335668999999999986 46899999999999999999999999988877776666554322 1222346899999999
Q ss_pred HHccCCCcCCCCCHHHHhcCcccccC
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+||+.||++|||+.++|+||||...
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHccCChhhCcCHHHHhcChhhccC
Confidence 99999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=388.62 Aligned_cols=254 Identities=32% Similarity=0.552 Sum_probs=218.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 456899999999999999999999999999999999987643221 1334577899999999 8999999999999
Q ss_pred eCCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 127 DDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
+.+.+++||||+.+| +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE---DFTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC---CCcEEEeeccc
Confidence 999999999999766 99999998888999999999999999999999999999999999999964 45599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc-cC-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
+.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||...... ..........
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcc
Confidence 988776666667789999999999864 34 78899999999999999999999653221 1112222345
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 899999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=381.43 Aligned_cols=260 Identities=33% Similarity=0.510 Sum_probs=230.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence 3457899999999999999999999999999999999877665666678899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE---DLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC---CCCEEEeeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999964 34599999999987643
Q ss_pred C-CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 G-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+.......+ ..+++++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 269 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAA 269 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHH
Confidence 2 3345567999999999986 4588999999999999999999999998887777777766544332 45789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+||.+||+.||++|||+.++|+||||....
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=385.25 Aligned_cols=267 Identities=39% Similarity=0.724 Sum_probs=196.9
Q ss_pred Ccccccccceeecc-ccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHH-HHhCCCCCceeEEEEEE
Q 013816 48 PTGREIEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-MRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 48 ~~~~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~-l~~l~~h~niv~~~~~~ 125 (436)
+....+.++|++.+ .||+|+||.||+|.+..+|+.||+|++... ....+|+.. ++.+ +||||+++++++
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~-~h~~i~~~~~~~ 91 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQAS-GGPHIVCILDVY 91 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHT-TSTTBCCEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhc-CCCChHHHHHHH
Confidence 33456778999965 699999999999999999999999998542 122334443 4445 999999999999
Q ss_pred Ee----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 126 ED----DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 126 ~~----~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.. ...+++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 456899999999999999998764 699999999999999999999999999999999999998766677899
Q ss_pred EEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHccc
Q 013816 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV----AQAIIRSVL 274 (436)
Q Consensus 200 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~----~~~i~~~~~ 274 (436)
|+|||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+.....
T Consensus 172 l~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 172 LTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp ECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred Eeccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 999999986543 2334567899999999986 5688899999999999999999999976655433 223333444
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCC
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNV 324 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~ 324 (436)
..+...+..+++++.+||.+||+.||.+|||+.++|+||||+.....+..
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 300 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence 45555567899999999999999999999999999999999886555443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=377.48 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=221.9
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.|..+.++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++ +||||+++++++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC
Confidence 3567789999999999999999999999999999999999776655666678899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
+.+|+||||++|++|.+++...+++++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKA 160 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCSSSTT
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEEeCCCccc
Confidence 9999999999999999999988899999999999999999999999999999999999999644 4599999999987
Q ss_pred cCCCC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc-CCCCCCccc
Q 013816 209 FKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKV 284 (436)
Q Consensus 209 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 284 (436)
..... ......||+.|+|||++. ..++.++||||||+++|+|+||..||.+................ ......+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 65332 224467999999999987 45889999999999999999999999988877665555443322 112234568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
++.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 999999999999999999997666666666543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=390.81 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=214.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~~~~~ 132 (436)
..+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+++.. ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 4579999999999999999999764 99999999976543 34456789999999999943 699999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++.....
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCC
Confidence 9999 567899999998888999999999999999999999999999999999999942 45999999999876543
Q ss_pred C---cccccccCCcccchhcccc------------cCCCCCchhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHccccC
Q 013816 213 E---KFSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDF 276 (436)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~ 276 (436)
. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ......+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 2 2345689999999999753 588899999999999999999999977543 33444444433322
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+ ...+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 222 34578999999999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=387.27 Aligned_cols=260 Identities=26% Similarity=0.444 Sum_probs=215.5
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 128 (436)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDET 98 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSS
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCc
Confidence 356789999999999999999999999999999999986542 3444567889999999999 899999999999765
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 129 ----~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..+|+||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg 173 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFG 173 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC---CCCEEEEeee
Confidence 3469999999 7899998876 57999999999999999999999999999999999999964 4569999999
Q ss_pred cccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC------
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------ 276 (436)
+++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9987542 3455689999999998764 68999999999999999999999999888777666665422111
Q ss_pred -----------------CC----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 -----------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 -----------------~~----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.. ..++..++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11 11346789999999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=373.04 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=218.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----CC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 129 (436)
...|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.+ +||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 3569999999999999999999999999999999976544 344577899999999999 89999999999875 46
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+++||||++|++|.+++.....+++..+..++.||+.||.|||++| |+||||||+||+++. ..+.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCcc
Confidence 68999999999999999988888999999999999999999999999 999999999999962 34459999999997
Q ss_pred ccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHccccCCCCCCcccCH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~ 286 (436)
..... ......||+.|+|||++.+.++.++||||||+++|+|++|..||......... ..+...... .......++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCCH
Confidence 65432 33456799999999999888999999999999999999999999875444333 333322211 112235678
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
++.+||.+||+.||.+|||+.++|+||||++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=374.40 Aligned_cols=257 Identities=33% Similarity=0.570 Sum_probs=197.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 5799999999999999999999999999999999765433233457889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~---~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR---NMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT---TCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCCEEEEeecceeeccCCC
Confidence 9999999999999875 56999999999999999999999999999999999999964 445999999999876432
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+... .......++.++.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----DYEMPSFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS----CCCCCTTSCHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc----ccCCccccCHHHHHH
Confidence 2234567999999999986 45889999999999999999999999776554433322221 112234578999999
Q ss_pred HHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 292 VRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
|.+||+.||++|||+.++|+||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=382.07 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=207.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence 34578999999999999999999999999999999997543 233567899999999999 8999999999986543
Q ss_pred -------------------------------------------------------eEEEEEeccCCCchHHHHHhcCC--
Q 013816 130 -------------------------------------------------------AVHLVMELCEGGELFDRIVARGH-- 152 (436)
Q Consensus 130 -------------------------------------------------------~~~lv~E~~~g~~L~~~l~~~~~-- 152 (436)
..++||||++|++|.+++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 38999999999999999987643
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-------------ccccc
Q 013816 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-------------KFSEI 218 (436)
Q Consensus 153 -~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-------------~~~~~ 218 (436)
.++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... .....
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC---CCEEEeecCcccccccchhhcccccccccccccccc
Confidence 4666789999999999999999999999999999999643 469999999998775432 22345
Q ss_pred ccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccC
Q 013816 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (436)
Q Consensus 219 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 297 (436)
.||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+.... ....+...++++.+||.+||+
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHC
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC---CCcccccCChhHHHHHHHHcc
Confidence 7999999999987 4689999999999999999999777521 111122222211 111223567889999999999
Q ss_pred CCcCCCCCHHHHhcCccccc
Q 013816 298 PDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 298 ~~p~~Rps~~e~l~h~~~~~ 317 (436)
.||++|||+.|+|+||||++
T Consensus 312 ~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 312 PSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SSGGGSCCHHHHHHSTTCCC
T ss_pred CCCCcCCCHHHHhhchhhhc
Confidence 99999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=369.88 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=215.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+..+..+.+||||+++++++.+.+.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 4568899999999999999999999999999999999765433 334577889999999987899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--------------
Q 013816 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-------------- 193 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~-------------- 193 (436)
++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 6799999999999999999999999999999999999997544
Q ss_pred --CCCCeEEEeeccccccCCCCcccccccCCcccchhccccc--CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013816 194 --ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (436)
Q Consensus 194 --~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 269 (436)
....+||+|||.+...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 4557999999999876533 234699999999998753 5579999999999999999998775443 23334
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..... ......+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus 241 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCC---CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 44332 12234689999999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=383.11 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=214.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh--hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
..++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc
Confidence 35789999999999999999999999999999999875432211 1124678999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE---NGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC---CCCEEEEecccceec
Confidence 9999999986 888888765 35899999999999999999999999999999999999964 445999999999876
Q ss_pred CCC-CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC-----
Q 013816 210 KPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW----- 281 (436)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 281 (436)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....+....+...........|
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 433 33456789999999999853 4788999999999999999999999998888777777664332222111
Q ss_pred -------------------cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 282 -------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 282 -------------------~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 34578999999999999999999999999999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=374.88 Aligned_cols=255 Identities=27% Similarity=0.522 Sum_probs=213.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 131 (436)
.++|++++.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++++..||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 47899999999999999999999999999999998642 346789999999999559999999999988 6789
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+++....
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECCT
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcCC
Confidence 99999999999988874 489999999999999999999999999999999999997543 2589999999988776
Q ss_pred CCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHH-------------cccc
Q 013816 212 GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIR-------------SVLD 275 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~-------------~~~~ 275 (436)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+.. ....
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 66666778999999999976 358999999999999999999999995443 2222222211 1100
Q ss_pred C--------------------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 F--------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 ~--------------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
. .......+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0 0111223799999999999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=381.29 Aligned_cols=259 Identities=27% Similarity=0.484 Sum_probs=216.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++...+.+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEE
Confidence 468999999999999999999999999999999986653 3344456788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---CcEEEEeCCCceeecCCc
Confidence 99999999998888777889999999999999999999999999999999999999643 46999999999765432
Q ss_pred CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC--------------
Q 013816 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------------- 276 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~-------------- 276 (436)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33355679999999999864 58899999999999999999999999888776655554321110
Q ss_pred C---C----------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 277 R---R----------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 277 ~---~----------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
. . ..++.+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0 0 012357899999999999999999999999999999985
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=380.13 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=216.1
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++...... ...+.+.+|+++++++ +||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC
Confidence 34568999999999999999999999999999999999765432 2357788999999999 8999999999998765
Q ss_pred -eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-CCCCCCeEEEeec
Q 013816 130 -AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDFG 204 (436)
Q Consensus 130 -~~~lv~E~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~-~~~~~~ikl~DfG 204 (436)
..++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+.. ++....+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999976533 899999999999999999999999999999999999832 2344568999999
Q ss_pred cccccCCCCcccccccCCcccchhccc---------ccCCCCCchhHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHH
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIR 271 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlG~il~~lltg~~pf~~~~----~~~~~~~i~~ 271 (436)
+++............||+.|+|||++. ..++.++|||||||++|+|+||..||.... ..+....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 999877666666778999999999874 458899999999999999999999996433 2344444444
Q ss_pred ccccC-------------------C--CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 272 SVLDF-------------------R--RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 272 ~~~~~-------------------~--~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
+.... + ......+++.+.+||.+||+.||++|||+.|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 33210 0 0111234568899999999999999999999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=386.30 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=206.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccc
Confidence 35678999999999999999999999999999999997543 3444567889999999999 8999999999997665
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 130 ----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+|+||||++| +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~---~~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC---CCCEEEEEeec
Confidence 78999999975 7888875 35899999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC-------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~------- 277 (436)
++............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 98766554455678999999999986 4689999999999999999999999998887776666654321110
Q ss_pred ----------CCCC--------------c-------ccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 ----------RDPW--------------P-------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 ----------~~~~--------------~-------~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
...+ + ..++++++||.+||+.||++|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 0 12568999999999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=385.77 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=213.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 127 (436)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence 45789999999999999999999999999999999865432 224799999999 99999999999843
Q ss_pred ---------------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 013816 128 ---------------------------------DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQ 170 (436)
Q Consensus 128 ---------------------------------~~~~~lv~E~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~ 170 (436)
...+++||||++| +|.+.+. ....+++..+..++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999985 7766664 3567999999999999999999
Q ss_pred HHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHH
Q 013816 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILY 248 (436)
Q Consensus 171 ~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~ 248 (436)
|||++||+||||||+|||++. ..+.+||+|||+|+............||+.|+|||++.+ .++.++|||||||++|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNS--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEET--TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcC--CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 999999999999999999963 234599999999998776666677789999999998763 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHccccC-----------------C---CC-----CCcccCHHHHHHHHHccCCCcCCC
Q 013816 249 ILLCGVPPFWAETEQGVAQAIIRSVLDF-----------------R---RD-----PWPKVSENAKDLVRKMLDPDPKRR 303 (436)
Q Consensus 249 ~lltg~~pf~~~~~~~~~~~i~~~~~~~-----------------~---~~-----~~~~~~~~~~~ll~~~l~~~p~~R 303 (436)
+|++|..||.+....+....+....... + .. ....+++++.+||.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999988877777665421110 0 00 112478899999999999999999
Q ss_pred CCHHHHhcCcccccC
Q 013816 304 LTAQQVLEHPWLQNA 318 (436)
Q Consensus 304 ps~~e~l~h~~~~~~ 318 (436)
||+.|+|+||||+..
T Consensus 314 ~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 314 INPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHTSGGGHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=385.83 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=202.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 128 (436)
..+.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCc
Confidence 356689999999999999999999999999999999986542 3445567889999999999 899999999998654
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 129 ----~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..+|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~---~~~~kL~DFG 177 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFG 177 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECC--
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC---CCCEEEeecc
Confidence 5689999999 6799888865 57999999999999999999999999999999999999964 4569999999
Q ss_pred cccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC------
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------ 276 (436)
+++.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.+.....
T Consensus 178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9986542 3455689999999999764 68999999999999999999999999988777666665422111
Q ss_pred -----------------CCCC----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 -----------------RRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 -----------------~~~~----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+... ++..++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 1111 235688999999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=367.61 Aligned_cols=260 Identities=30% Similarity=0.521 Sum_probs=220.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence 457899999999999999999999999999999999765432 3457889999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE---RDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc---CCCEEEeeCCCccccCCC
Confidence 99999999999999987778999999999999999999999999999999999999964 345999999999765432
Q ss_pred C---cccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHccccCCCCCCcccCH
Q 013816 213 E---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||....... ....+..... ....+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--TSTTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--ccCchhhcCH
Confidence 2 2345679999999999864 3 4678999999999999999999997765432 2223332221 2233467899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+.+||.+||+.||++|||+.++++||||+....
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=386.77 Aligned_cols=257 Identities=32% Similarity=0.575 Sum_probs=215.2
Q ss_pred cceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++|++.+.||+|+||.||+|++. .+++.||+|++...... .....+.+.+|+.+++.+.+||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 58999999998754321 112335577899999999679999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999999999999999964 4459999999998654
Q ss_pred CCC--cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHccccCCCCCC
Q 013816 211 PGE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 281 (436)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ......+... .....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~ 286 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----EPPYP 286 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----CCCCC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----CCCCC
Confidence 322 2345689999999999863 378899999999999999999999975432 3333333333 23334
Q ss_pred cccCHHHHHHHHHccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
..++..+.+||.+||+.||.+|| |+.++++||||+..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 57899999999999999999999 99999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=388.45 Aligned_cols=263 Identities=26% Similarity=0.497 Sum_probs=200.6
Q ss_pred ccccccceee-ccccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 50 GREIEERYEL-GRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 50 ~~~~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
...+.+.|++ .++||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.+|+.+ +||||+++++++.
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l-~hpniv~~~~~~~ 88 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFL 88 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhc-CCCCeeeEeeEEe
Confidence 3456788988 458999999999999976 5689999999865432 24678999999999 8999999999995
Q ss_pred e--CCeEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CC
Q 013816 127 D--DTAVHLVMELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KE 194 (436)
Q Consensus 127 ~--~~~~~lv~E~~~g~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~-~~ 194 (436)
. ...+|+||||+.| +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT
T ss_pred cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC
Confidence 4 6789999999975 888877532 248999999999999999999999999999999999999643 34
Q ss_pred CCCeEEEeeccccccCCC----CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-----
Q 013816 195 TAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ----- 263 (436)
Q Consensus 195 ~~~ikl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----- 263 (436)
.+.+||+|||+|+..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 567999999999876432 22345689999999999864 4899999999999999999999999765542
Q ss_pred ----HHHHHHHHccccCCCCCCcc----------------------------------cCHHHHHHHHHccCCCcCCCCC
Q 013816 264 ----GVAQAIIRSVLDFRRDPWPK----------------------------------VSENAKDLVRKMLDPDPKRRLT 305 (436)
Q Consensus 264 ----~~~~~i~~~~~~~~~~~~~~----------------------------------~~~~~~~ll~~~l~~~p~~Rps 305 (436)
+....+...........|.. .++++.+||.+||+.||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 34444444332222222222 2678999999999999999999
Q ss_pred HHHHhcCcccccCc
Q 013816 306 AQQVLEHPWLQNAK 319 (436)
Q Consensus 306 ~~e~l~h~~~~~~~ 319 (436)
+.|+|+||||+...
T Consensus 328 a~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 328 SEQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHHTSGGGTSSS
T ss_pred HHHHhcChhhccCC
Confidence 99999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=377.56 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=210.1
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEEEEEeCCe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTA 130 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~ 130 (436)
..++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+|+.+ .| |||+++++++.....
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeCCE
Confidence 356899999999999999999997 5689999999976543 344567899999999999 55 999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+|||+ .+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++...
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccC
Confidence 9999995 57899999999889999999999999999999999999999999999999952 349999999998765
Q ss_pred CCCc---ccccccCCcccchhccc------------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccc
Q 013816 211 PGEK---FSEIVGSPYYMAPEVLK------------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL 274 (436)
Q Consensus 211 ~~~~---~~~~~gt~~y~aPE~l~------------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~ 274 (436)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4322 23568999999999974 35788999999999999999999999765433 23333333222
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
. .......++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 239 E--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp C--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred c--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 1 12223567899999999999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=381.62 Aligned_cols=260 Identities=28% Similarity=0.477 Sum_probs=218.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
.+.++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcc
Confidence 3457999999999999999999999999999999998643 2344557889999999999 899999999999755
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
...|+||||+.| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++
T Consensus 101 ~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTC
T ss_pred ccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC---CCCEEEEeCcce
Confidence 478999999975 99988866 46999999999999999999999999999999999999964 445999999999
Q ss_pred cccCCCCc----ccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC---
Q 013816 207 VFFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--- 277 (436)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--- 277 (436)
........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 87653321 24568999999999864 3489999999999999999999999988877766666543211110
Q ss_pred --------------------CC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 278 --------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 278 --------------------~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.. .++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 1245789999999999999999999999999999998753
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=388.96 Aligned_cols=264 Identities=26% Similarity=0.428 Sum_probs=217.1
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-----CCCceeEEEEE
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKDT 124 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~ 124 (436)
+..+..+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+. .|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 456778999999999999999999999999999999998643 234467788888888762 57799999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEe
Q 013816 125 YEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 125 ~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
+...+.+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ..+||+|
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~D 245 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVID 245 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEee
Confidence 999999999999996 59999987754 4899999999999999999999999999999999999975432 3489999
Q ss_pred eccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC---
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--- 278 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~--- 278 (436)
||++.... .......||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+.........
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99997653 3344568999999999976 46999999999999999999999999998887776665542110000
Q ss_pred -----------------------------------------------CC-----CcccCHHHHHHHHHccCCCcCCCCCH
Q 013816 279 -----------------------------------------------DP-----WPKVSENAKDLVRKMLDPDPKRRLTA 306 (436)
Q Consensus 279 -----------------------------------------------~~-----~~~~~~~~~~ll~~~l~~~p~~Rps~ 306 (436)
.. ....++++.+||.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 00 01237889999999999999999999
Q ss_pred HHHhcCcccccCccC
Q 013816 307 QQVLEHPWLQNAKKA 321 (436)
Q Consensus 307 ~e~l~h~~~~~~~~~ 321 (436)
.|+|+||||+.....
T Consensus 404 ~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 404 GQALRHPWLRRRLPK 418 (429)
T ss_dssp HHHHTSTTTC-----
T ss_pred HHHhCChhhccCCCC
Confidence 999999999976443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=371.03 Aligned_cols=261 Identities=26% Similarity=0.465 Sum_probs=216.2
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~- 127 (436)
......++|++.+.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++++.+||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 334567899999999999999999999999999999999865432 346788999999999789999999999987
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 128 -----DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 128 -----~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
.+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~---~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE---NAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC---CCCEEE
Confidence 56899999999999999999864 46999999999999999999999999999999999999964 445999
Q ss_pred EeeccccccCCCC-cccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc
Q 013816 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 201 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 273 (436)
+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 9999998664322 234567999999999974 358899999999999999999999998887766665555443
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
. +......+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 251 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 251 A--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp C--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred c--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 2 222235689999999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=381.33 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=219.5
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 104 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDG 104 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETT
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECC
Confidence 4455789999999999999999999999999999999987642 344567899999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.+++||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++..
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC---CCEEEEECCCCcc
Confidence 9999999999999999999888899999999999999999999996 99999999999999654 4599999999875
Q ss_pred cCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI------------------ 269 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i------------------ 269 (436)
... .......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+
T Consensus 182 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 182 LID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 532 1234568999999999987 46899999999999999999999999876654432211
Q ss_pred ------------------------HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 270 ------------------------IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 270 ------------------------~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.... ........++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111 11112234789999999999999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=365.03 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=224.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeE
Confidence 3457899999999999999999999999999999999765432 3467899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC---CCCEEEeecccceecCc
Confidence 999999999999998864 57999999999999999999999999999999999999964 34599999999987654
Q ss_pred CC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... ......++..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHHH
Confidence 32 234567999999999986 4688999999999999999999999988877766666555432 222346899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+||.+||+.||.+|||+.++++||||....
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999999997654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=388.32 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=212.4
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC---
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 128 (436)
....+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++|+.+ +|||||++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHc-CCCCccceeeEEeccCCC
Confidence 345689999999999999999999999999999999865421 234699999999 899999999988542
Q ss_pred ---CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 129 ---TAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
..+++||||+++ +|.+.+. ....+++..+..++.||+.||.|||++||+||||||+|||++.+ ...+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~--~~~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD--TAVLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETT--TTEEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCC--CCeEEec
Confidence 246799999986 6666554 24679999999999999999999999999999999999999743 2348999
Q ss_pred eeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc-----
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----- 274 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----- 274 (436)
|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.+...
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999988766555566789999999999753 589999999999999999999999999887766666554211
Q ss_pred ------------cCC---CCC-----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 275 ------------DFR---RDP-----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 275 ------------~~~---~~~-----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.++ ... .+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 010 001 134689999999999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=366.63 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=199.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEE
Confidence 35789999999999999999999999999999999865422 222233344444456666 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+||||++| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++. .+.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA---LGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT---TCCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeecCCcc
Confidence 99999975 88776653 46799999999999999999999998 9999999999999964 3459999999998
Q ss_pred ccCCCCcccccccCCcccchhcc----c-ccCCCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHccccCCCCCC
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVL----K-RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l----~-~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 281 (436)
............||+.|+|||++ . ..++.++||||||+++|+|+||..||... .............. .....
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPA 236 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCccc
Confidence 77655555556899999999996 2 35788999999999999999999999763 33333444433322 22223
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..+++++.+|+.+||+.||++|||+.|+++||||+...
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 46899999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=372.22 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=219.1
Q ss_pred CcccccccceeeccccccCCceEEEEEEE-cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC------ceeE
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ------NIVC 120 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~------niv~ 120 (436)
..|..+.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.+ +|+ +|++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeEe
Confidence 45667889999999999999999999998 567899999998643 33457788999999988 555 5999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC----
Q 013816 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE---- 194 (436)
Q Consensus 121 ~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~---- 194 (436)
+++++...+.+++||||+ +++|.+++...+ ++++..+..++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999975331
Q ss_pred ------------CCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC
Q 013816 195 ------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (436)
Q Consensus 195 ------------~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 261 (436)
...+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 45699999999986542 334568999999999986 468999999999999999999999998887
Q ss_pred HHHHHHHHHHccccCCC----------------------------------------CCCcccCHHHHHHHHHccCCCcC
Q 013816 262 EQGVAQAIIRSVLDFRR----------------------------------------DPWPKVSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~----------------------------------------~~~~~~~~~~~~ll~~~l~~~p~ 301 (436)
..+....+.......+. ......++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76655544332211110 00112357789999999999999
Q ss_pred CCCCHHHHhcCcccccCc
Q 013816 302 RRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 302 ~Rps~~e~l~h~~~~~~~ 319 (436)
+|||+.|+|+||||+...
T Consensus 319 ~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 319 KRITLREALKHPFFDLLK 336 (339)
T ss_dssp TSCCHHHHTTSGGGGGGG
T ss_pred cccCHHHHhcCHHHHHHh
Confidence 999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=393.05 Aligned_cols=249 Identities=18% Similarity=0.242 Sum_probs=203.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEE-------EE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLK-------DT 124 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~-------~~ 124 (436)
.++|++.+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+++.+. +|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998665555556788999995544443 799999998 77
Q ss_pred EEeCCe-----------------EEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 013816 125 YEDDTA-----------------VHLVMELCEGGELFDRIVARGHYTE-------RAAAAVTKTIVEVVQMCHKHGVMHR 180 (436)
Q Consensus 125 ~~~~~~-----------------~~lv~E~~~g~~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~lH~~~iiH~ 180 (436)
++..+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6799999987655555 7888899999999999999999999
Q ss_pred CCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhccc-c-----------cCCCCCchhHHHHHHH
Q 013816 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----------NYGPEVDVWSAGVILY 248 (436)
Q Consensus 181 dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~-----------~~~~~~DiwSlG~il~ 248 (436)
||||+|||++.+ +.+||+|||+|+... .......| +.|+|||++. . .++.++|||||||++|
T Consensus 231 Dikp~NIll~~~---~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQR---GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTT---CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCC---CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999644 469999999998643 34455678 9999999986 4 5899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 249 ~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+|+||..||.+.........+ ...++.+++++.+||.+||+.||++|||+.++|+||||+.
T Consensus 305 elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHSSCCC------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHCCCCCcccccccchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999665433221111 1223578999999999999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=366.53 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=217.1
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeE
Confidence 45688999999999999999999999999999999986543 33467889999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||++|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---SCEEECCCHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---CCEEEEECCCCcccc
Confidence 999999999999998875 4569999999999999999999999999999999999999644 459999999875432
Q ss_pred CC-CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 211 PG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 211 ~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
.. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+....... ......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 247 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPSK 247 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGG
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCccc
Confidence 11 1223457899999999873 457889999999999999999999999888777766666553321 122346
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.++.++|.+||+.||.+|||+.++++||||+...
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 789999999999999999999999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=365.72 Aligned_cols=259 Identities=27% Similarity=0.468 Sum_probs=215.2
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence 345678999999999999999999999999999999986542 346788999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+++||||++|++|.+++. ....+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---CCEEEeecccchhh
Confidence 999999999999999987 35679999999999999999999999999999999999999654 45999999999776
Q ss_pred CCCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 210 KPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... ........+++.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 254 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDN 254 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-cccCCcccCCHH
Confidence 5432 234567999999999986 4689999999999999999999999988776655554444322 111223457899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=368.19 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=210.4
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
....++|++.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCc
Confidence 34457899999999999999999986 588999999876543 344567899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 131 VHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
+++||||++|++|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++. .+.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~---~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK---KYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT---TCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC---CCcEEECCCCC
Confidence 9999999999999999987653 999999999999999999999999 999999999999964 44699999999
Q ss_pred ccccCCCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 206 SVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 206 a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+....... .....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~ 263 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRN 263 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCcc
Confidence 97654332 234568999999999987 458999999999999999999999999888877766665433322 22356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc--CcccccC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE--HPWLQNA 318 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~--h~~~~~~ 318 (436)
+++++.+||.+||+.||.+|||+.++++ +++++..
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999998 4555543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=379.43 Aligned_cols=263 Identities=27% Similarity=0.440 Sum_probs=217.8
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-----ceeEEE
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-----NIVCLK 122 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-----niv~~~ 122 (436)
..+..+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+..|+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 45567789999999999999999999999999999999998643 234567788999998884465 499999
Q ss_pred EEEEeCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceEeecCCCCCCe
Q 013816 123 DTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 123 ~~~~~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
+++...+.+++||||+.| +|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++.+ ..+.+
T Consensus 123 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCCE
T ss_pred eeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCcE
Confidence 999999999999999965 999999875 45899999999999999999999 5799999999999999642 34569
Q ss_pred EEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 199 KAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 199 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
||+|||+++.... ......||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+.......+
T Consensus 201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999987643 345568999999999987 4689999999999999999999999999888777776655321110
Q ss_pred ------------------CCCC-----------------c-------------------------ccCHHHHHHHHHccC
Q 013816 278 ------------------RDPW-----------------P-------------------------KVSENAKDLVRKMLD 297 (436)
Q Consensus 278 ------------------~~~~-----------------~-------------------------~~~~~~~~ll~~~l~ 297 (436)
...| . ..++++++||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0000 0 001478999999999
Q ss_pred CCcCCCCCHHHHhcCcccccC
Q 013816 298 PDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 298 ~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.||++|||+.|+|+||||+..
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=381.85 Aligned_cols=262 Identities=23% Similarity=0.451 Sum_probs=221.4
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhh--------------HHHHHHHHHHHHhCCCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD--------------IEDVRREVDIMRHLPKH 115 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~--------------~~~~~~E~~~l~~l~~h 115 (436)
+....++|++.+.||+|+||.||+|.+ +|+.||+|++.......... .+.+.+|+.+++++ +|
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 102 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KN 102 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CC
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CC
Confidence 345568999999999999999999998 89999999997654332211 27899999999999 89
Q ss_pred CceeEEEEEEEeCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCc
Q 013816 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDR------IVA--RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPEN 186 (436)
Q Consensus 116 ~niv~~~~~~~~~~~~~lv~E~~~g~~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~N 186 (436)
|||+++++++.+.+.+++||||++|++|.++ +.. ...+++..+..++.|++.||.|||+ +||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 655 5679999999999999999999999 999999999999
Q ss_pred eEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhccccc--CCC-CCchhHHHHHHHHHHhCCCCCCCCCH-
Q 013816 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGP-EVDVWSAGVILYILLCGVPPFWAETE- 262 (436)
Q Consensus 187 Il~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~-~~DiwSlG~il~~lltg~~pf~~~~~- 262 (436)
|+++.+ +.+||+|||++...... ......||+.|+|||++.+. ++. ++||||||+++|+|++|..||.....
T Consensus 183 il~~~~---~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKN---GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTT---SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCC---CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999643 45999999999876443 44566899999999998743 555 89999999999999999999988766
Q ss_pred HHHHHHHHHccccCCCCC---------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 263 QGVAQAIIRSVLDFRRDP---------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
.+....+......++... ...+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 566666655544333210 14689999999999999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=370.99 Aligned_cols=262 Identities=29% Similarity=0.459 Sum_probs=214.1
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE---
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--- 126 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 126 (436)
+..+.++|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSG 81 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTS
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccc
Confidence 456788999999999999999999999999999999998643 344567899999999999 8999999999873
Q ss_pred -----------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 127 -----------DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 127 -----------~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
.....++||||+. ++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+ .
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--D 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT--T
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC--C
Confidence 4478899999997 599988854 579999999999999999999999999999999999999643 3
Q ss_pred CCeEEEeeccccccCCC----CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 013816 196 APLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i 269 (436)
..+||+|||++...... .......+|+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 45899999999876432 1224456799999999875 45889999999999999999999999988877766666
Q ss_pred HHccccC----------------------CCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 270 IRSVLDF----------------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 270 ~~~~~~~----------------------~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
....... ... .++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 5432211 000 1245799999999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=369.16 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=217.8
Q ss_pred ccccceeeccccccCCceEEEEEEEc-CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEE--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE-- 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~-- 126 (436)
...++|++.+.||+|+||.||+|.+. .+|+.||+|++........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45678999999999999999999995 6789999999876543221 1234556777666553 7999999999987
Q ss_pred ---eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 127 ---DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 127 ---~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
....+++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~---~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC---CCCEEEe
Confidence 5678899999998 59999997753 4899999999999999999999999999999999999964 3459999
Q ss_pred eeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC---
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--- 277 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--- 277 (436)
|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+........
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998765444455678999999999976 5689999999999999999999999999888777777664321110
Q ss_pred --------------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 278 --------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 278 --------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
...++.+++.+++||.+||+.||++|||+.++|+||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0112467899999999999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=382.92 Aligned_cols=262 Identities=24% Similarity=0.408 Sum_probs=210.5
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-------CCCceeEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-------KHQNIVCL 121 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-------~h~niv~~ 121 (436)
.+..+.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+. .||||+++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 4566788999999999999999999999999999999998643 334577889999999983 18889999
Q ss_pred EEEEE----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCC-
Q 013816 122 KDTYE----DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK- 193 (436)
Q Consensus 122 ~~~~~----~~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~- 193 (436)
++++. ....+++||||+ +++|.+.+... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 556899999999 55777766654 4699999999999999999999998 999999999999997543
Q ss_pred ---------------------------------------------CCCCeEEEeeccccccCCCCcccccccCCcccchh
Q 013816 194 ---------------------------------------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228 (436)
Q Consensus 194 ---------------------------------------------~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 228 (436)
....+||+|||++..... ......||+.|+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCCh
Confidence 123699999999987643 345568999999999
Q ss_pred ccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHccccCC------------------------
Q 013816 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE------QGVAQAIIRSVLDFR------------------------ 277 (436)
Q Consensus 229 ~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~~~i~~~~~~~~------------------------ 277 (436)
++. ..++.++|||||||++|+|+||..||..... ......+.......+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 986 4589999999999999999999999976442 222222222111000
Q ss_pred --------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 278 --------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 278 --------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.......++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0001234567899999999999999999999999999963
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=377.31 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=220.4
Q ss_pred ccccceeeccccccCCceEEEEEE-----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
...++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+++++ +||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 345789999999999999999999 4457789999998643 2344556789999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.....++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997643 489999999999999999999999999999999999998766667799
Q ss_pred EEeeccccccCCC---CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccc
Q 013816 200 AIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 200 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 274 (436)
|+|||+++..... .......||+.|+|||++. ..++.++|||||||++|+|+| |..||......+....+.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999999754221 2234457899999999976 568999999999999999998 9999999888877777766542
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
. .....+++.+.+|+.+||+.||.+|||+.+++++.|+.
T Consensus 305 ~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 M---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 22346889999999999999999999999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=377.84 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=204.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe--
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA-- 130 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~-- 130 (436)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ......++++.+..+ +||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccc
Confidence 35789999999999999999999999999999999865432 224566788888999 89999999999876443
Q ss_pred -----EEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceEeecCCCCCCeE
Q 013816 131 -----VHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 131 -----~~lv~E~~~g~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
+++||||+++ +|.+.+ .....+++..+..++.|++.||.||| ++||+||||||+|||++.. .+.+|
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEE
Confidence 8899999987 544443 34567899999999999999999999 9999999999999999742 34599
Q ss_pred EEeeccccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 200 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
|+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+.+......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 999999998776666667789999999999753 489999999999999999999999999888777777665321110
Q ss_pred --------------------C--------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 278 --------------------R--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 278 --------------------~--------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
. ......++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 011125688999999999999999999999999999987644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=369.71 Aligned_cols=262 Identities=30% Similarity=0.486 Sum_probs=216.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 128 (436)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccccc
Confidence 45678999999999999999999999999999999998643 3344566788999999999 899999999988654
Q ss_pred ---CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 ---~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~ 158 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLKVCDFGL 158 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTT
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC---CCcEEEEeccc
Confidence 78999999997 589888876 47999999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCC-----------cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc
Q 013816 206 SVFFKPGE-----------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (436)
Q Consensus 206 a~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~ 272 (436)
+....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 98764321 123457899999999864 45889999999999999999999999988776655544332
Q ss_pred cccC------------------------CCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 273 VLDF------------------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 273 ~~~~------------------------~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.... ... .++.+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 1110 000 12467899999999999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=377.07 Aligned_cols=258 Identities=28% Similarity=0.491 Sum_probs=213.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
-.+.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence 346689999999999999999999999999999999997543 3344567889999999999 89999999999987765
Q ss_pred E------EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 131 V------HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 131 ~------~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
. |+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~---~~~~kL~Dfg 189 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFG 189 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECSTT
T ss_pred cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC---CCCEEEEecC
Confidence 4 99999997 58877763 35999999999999999999999999999999999999964 4459999999
Q ss_pred cccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC------
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~------ 276 (436)
+++... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 190 ~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 998654 23445688999999998764 68999999999999999999999999888777666664421110
Q ss_pred -----------------CCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 277 -----------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 277 -----------------~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
... .++.+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 123578999999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=365.37 Aligned_cols=259 Identities=27% Similarity=0.493 Sum_probs=217.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEE--EeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTY--EDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~--~~~~ 129 (436)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.+ +||||+++++++ .+..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 457899999999999999999999999999999999765322 123457899999999999 899999999998 4456
Q ss_pred eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 130 AVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
..++||||+.++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---CcEEeecccccc
Confidence 899999999876 7777765 3569999999999999999999999999999999999999643 459999999998
Q ss_pred ccCCC---CcccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 208 FFKPG---EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 208 ~~~~~---~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----~ 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI----P 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC----C
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC----C
Confidence 76432 22345679999999999864 24778999999999999999999999988887777777664432 2
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..+++.+.+||.+||+.||.+|||+.++++||||+....
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 467899999999999999999999999999999987544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=368.22 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=197.4
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESSSCEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcE
Confidence 35789999999999999999999988999999999865432 22456788999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 133 LVMELCEGGELFDRIVA--------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE---DGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC---CCCEEEEecc
Confidence 99999999999999874 356899999999999999999999999999999999999964 3459999999
Q ss_pred cccccCCCC------cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC
Q 013816 205 LSVFFKPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (436)
Q Consensus 205 ~a~~~~~~~------~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 276 (436)
++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987654322 123457999999999986 358999999999999999999999998877665554444432211
Q ss_pred C------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 277 R------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 277 ~------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
. ...+..+++++.++|.+||+.||.+|||+.++++||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 1 122346789999999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=367.25 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=214.5
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
+...++|++.+.||+|+||.||+|.+..+++ .||||++.... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 3446789999999999999999999986555 59999986542 344567899999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
.+.+|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC---CCCEEECCCCcc
Confidence 99999999999999999999754 57999999999999999999999999999999999999954 456999999999
Q ss_pred cccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
+....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..... ...
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---LPA 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---CCC
Confidence 87654321 22345678899999987 568999999999999999999 9999999988887777766532 223
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
...+++.+.+||.+||+.||.+|||+.++++.
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 35689999999999999999999999999873
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=383.16 Aligned_cols=258 Identities=17% Similarity=0.214 Sum_probs=197.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC-CCCceeEEE-------EEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLK-------DTYE 126 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~-~h~niv~~~-------~~~~ 126 (436)
..|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.|. +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999999999999999998765545556778888977666663 499988865 5555
Q ss_pred eC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceecCC
Q 013816 127 DD-----------------TAVHLVMELCEGGELFDRIVAR-GHYTERAA------AAVTKTIVEVVQMCHKHGVMHRDL 182 (436)
Q Consensus 127 ~~-----------------~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~lH~~~iiH~dl 182 (436)
.. ..+|+||||++ ++|.+++... ..+++... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 33899999998 7999999764 33455555 677799999999999999999999
Q ss_pred CCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCC
Q 013816 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWA 259 (436)
Q Consensus 183 kp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~ 259 (436)
||+|||++. .+.+||+|||+|+.... ......+|+.|+|||++. ..++.++|||||||++|+|+||..||.+
T Consensus 221 kp~NIll~~---~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMP---DGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECT---TSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECC---CCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999964 44599999999987642 222456779999999986 3589999999999999999999999976
Q ss_pred CCHHHHH--HH---HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 260 ETEQGVA--QA---IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 260 ~~~~~~~--~~---i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
....... .. ............++.+++++.+||.+||+.||++|||+.++|+||||++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 6432100 00 00011122223345789999999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=358.11 Aligned_cols=257 Identities=30% Similarity=0.527 Sum_probs=219.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 131 (436)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.. ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence 4689999999999999999999999999999999976543 344567899999999999 89999999998754 6789
Q ss_pred EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceEeecCCCCCCeEEEe
Q 013816 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAID 202 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~NIl~~~~~~~~~ikl~D 202 (436)
++||||++|++|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+||+++. .+.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~---~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG---KQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS---SSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC---CCCEEEec
Confidence 9999999999999998753 34999999999999999999999999 999999999999964 44599999
Q ss_pred eccccccCCCCc-ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 203 FGLSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 203 fG~a~~~~~~~~-~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
||++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..+... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~ 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RI 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc---cC
Confidence 999987654322 23457899999999986 46889999999999999999999999988887777777665432 12
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
...+++++.++|.+||+.||++|||+.++|+|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 24688999999999999999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=358.09 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=208.1
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence 334458999999999999999999999999987543 23457789999999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 137 LCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.. .+.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence 999999999997652 46789999999999999999999999999999999999752 3459999999998765432
Q ss_pred -cccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 -KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 -~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||............ .............+++++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHHH
Confidence 2345679999999999863 3788999999999999999999999764433221111 1111222233456899999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
+||.+||+.||++|||+.++|+||||+....
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 9999999999999999999999999986543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=374.06 Aligned_cols=263 Identities=26% Similarity=0.395 Sum_probs=208.4
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC--------ChhhHHHHHHHHHHHHhCCCCCceeEE
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--------TAVDIEDVRREVDIMRHLPKHQNIVCL 121 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~--------~~~~~~~~~~E~~~l~~l~~h~niv~~ 121 (436)
...+.++|++.+.||+|+||.||+|.+.. |+.||+|++...... .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence 34567899999999999999999999754 999999998654322 222347899999999999 89999999
Q ss_pred EEEEEe-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 122 KDTYED-----DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 122 ~~~~~~-----~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
++++.. ...+|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++. .
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~---~ 170 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---N 170 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---T
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC---C
Confidence 999854 346899999998 5888887654 46999999999999999999999999999999999999964 3
Q ss_pred CCeEEEeeccccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcc
Q 013816 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 273 (436)
+.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 171 NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 459999999998665555556678999999999876 458999999999999999999999999988777766665422
Q ss_pred ccC------------------------CCCC----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 274 LDF------------------------RRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 274 ~~~------------------------~~~~----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
... +... .+..++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 111 0001 13568899999999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=368.92 Aligned_cols=263 Identities=27% Similarity=0.447 Sum_probs=216.4
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcCCC-cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc------eeE
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN------IVC 120 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n------iv~ 120 (436)
..|..+.++|++.+.||+|+||+||+|.+..++ +.||+|++... ....+.+.+|+.+++.+ .|++ ++.
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCVL 86 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCC
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEEE
Confidence 345678899999999999999999999998777 68999998642 33456788999999998 6655 999
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC------
Q 013816 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK------ 192 (436)
Q Consensus 121 ~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~------ 192 (436)
+++++...+.+++||||+ +++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||+...
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 567777776653 69999999999999999999999999999999999999543
Q ss_pred ----------CCCCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC
Q 013816 193 ----------KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (436)
Q Consensus 193 ----------~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~ 261 (436)
.....+||+|||++.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||....
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 245679999999998643 2334568999999999986 568999999999999999999999999887
Q ss_pred HHHHHHHHHHccccCCC----------------------------------------CCCcccCHHHHHHHHHccCCCcC
Q 013816 262 EQGVAQAIIRSVLDFRR----------------------------------------DPWPKVSENAKDLVRKMLDPDPK 301 (436)
Q Consensus 262 ~~~~~~~i~~~~~~~~~----------------------------------------~~~~~~~~~~~~ll~~~l~~~p~ 301 (436)
..+....+.......+. ......+.++.+||.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 76655544432211110 00012245789999999999999
Q ss_pred CCCCHHHHhcCcccccC
Q 013816 302 RRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 302 ~Rps~~e~l~h~~~~~~ 318 (436)
+|||+.|+|+||||+..
T Consensus 324 ~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGL 340 (355)
T ss_dssp TSCCHHHHTTSGGGGGC
T ss_pred hCcCHHHHhcChhhcCC
Confidence 99999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=370.23 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=214.8
Q ss_pred cccceeeccccccCCceEEEEEEEc-------CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+.+||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3578999999999999999999874 345679999986542 3445678999999999997899999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~ 189 (436)
...+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 99999999999999999999998653 47899999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHH
Q 013816 190 ANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (436)
Q Consensus 190 ~~~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 264 (436)
+. .+.+||+|||+++...... ......+|+.|+|||++. ..++.++|||||||++|+|+| |..||.+....+
T Consensus 237 ~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 237 TE---NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CT---TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CC---CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 64 4469999999998665432 223456788999999886 568999999999999999999 999999888777
Q ss_pred HHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....+..+.. ......+++++.++|.+||+.||.+|||+.|++++
T Consensus 314 ~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 314 LFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7666655432 22234689999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.46 Aligned_cols=255 Identities=25% Similarity=0.477 Sum_probs=207.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 127 (436)
+.++|++++.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence 567899999999999999999999999999999998543 33567889999999999 89999999998865
Q ss_pred --------CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 128 --------DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 128 --------~~~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
.+.+|+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. .+.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~---~~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE---SRNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC---CCCE
Confidence 457899999999999999998654 5788999999999999999999999999999999999964 4459
Q ss_pred EEEeeccccccCCC---------------CcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCC-
Q 013816 199 KAIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE- 260 (436)
Q Consensus 199 kl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~- 260 (436)
||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999765421 12244578999999999863 58999999999999999998 55433
Q ss_pred CHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
........+......++.......++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2233444444444444444445678899999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=367.90 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=213.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe-
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 130 (436)
.+.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+ +||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccc
Confidence 45678999999999999999999999999999999987543 3344567889999999999 89999999999987654
Q ss_pred -----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 131 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 131 -----~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~---~~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE---DCELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT---TCCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC---CCcEEEeeccc
Confidence 599999997 58887764 35999999999999999999999999999999999999964 44599999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc---------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~--------- 274 (436)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.+...
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 986542 2345678999999998764 589999999999999999999999998887666655543211
Q ss_pred --------------cCC----CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 275 --------------DFR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 275 --------------~~~----~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
... ...++.+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 000 112346799999999999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=365.06 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=197.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
...++|++.+.||+|+||.||+|.+..++. .||+|++...... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence 445789999999999999999999877765 8999998765433 33567899999999999 999999999999877
Q ss_pred CeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 129 TAV------HLVMELCEGGELFDRIVARG------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 129 ~~~------~lv~E~~~g~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
... ++||||+.|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. .+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~---~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE---DM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC---CC
Confidence 655 99999999999999986542 5899999999999999999999999999999999999964 35
Q ss_pred CeEEEeeccccccCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 013816 197 PLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~ 271 (436)
.+||+|||+++........ ....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 6999999999876443322 2345678899999987 458999999999999999999 9999998888777777665
Q ss_pred ccccCCCCCCcccCHHHHHHHHHccCCCcCCCCC-------HHHHhcCcccccCccC
Q 013816 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-------AQQVLEHPWLQNAKKA 321 (436)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps-------~~e~l~h~~~~~~~~~ 321 (436)
... ....+.+++++.+|+.+||+.||++||| +.++++|||+......
T Consensus 255 ~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 255 GNR---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 442 2233568899999999999999999999 7888899999875443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=370.93 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=211.3
Q ss_pred ccccceeeccccccCCceEEEEEE-----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
...++|++.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.++.++.+||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 345789999999999999999998 45667899999996542 34456789999999999988999999999998
Q ss_pred eCC-eEEEEEeccCCCchHHHHHhcCC-----------------------------------------------------
Q 013816 127 DDT-AVHLVMELCEGGELFDRIVARGH----------------------------------------------------- 152 (436)
Q Consensus 127 ~~~-~~~lv~E~~~g~~L~~~l~~~~~----------------------------------------------------- 152 (436)
..+ .+++||||++||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 48999999999999999976533
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC---ccc
Q 013816 153 -------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFS 216 (436)
Q Consensus 153 -------------~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~---~~~ 216 (436)
+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CcEEEEeccceeeecccccchhcc
Confidence 8999999999999999999999999999999999999654 459999999998664332 234
Q ss_pred ccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHH
Q 013816 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (436)
Q Consensus 217 ~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~ 294 (436)
...||+.|+|||++. ..++.++|||||||++|+|+| |..||.+................. .....+++++.+++.+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLD 331 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--CCCCCCCHHHHHHHHH
Confidence 567899999999986 568999999999999999998 999998776554444444333222 2234688999999999
Q ss_pred ccCCCcCCCCCHHHHhcC
Q 013816 295 MLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 295 ~l~~~p~~Rps~~e~l~h 312 (436)
||+.||.+|||+.++++|
T Consensus 332 ~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCChhhCCCHHHHHHH
Confidence 999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=359.29 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=195.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++..+++.+ +||||+++++++...+.+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEE
Confidence 4689999999999999999999999999999999976532 122233344445567777 99999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+ ++.+..+... ...+++..+..++.|++.||.|||++ ||+||||||+||+++. .+.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~---~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE---RGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT---TSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC---CCCEEEEECCCchhccC
Confidence 99999 5555555443 46799999999999999999999995 9999999999999964 34599999999987655
Q ss_pred CCcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHccccCCCCCCccc
Q 013816 212 GEKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
........||+.|+|||++. ..++.++||||||+++|+|++|..||... ...+....+....... .+....+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMGF 256 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSCC
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCCC
Confidence 55555668999999999973 35788999999999999999999999763 4445555555543322 2223468
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=359.69 Aligned_cols=262 Identities=27% Similarity=0.466 Sum_probs=211.9
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEEEEEe
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYED 127 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~ 127 (436)
......++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++++.. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33455678999999999999999999975 589999999976543 34456789999999999943 6999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+..++||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||++++ +.+||+|||++.
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~ 174 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIAN 174 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccc
Confidence 999999999 557899999998888999999999999999999999999999999999999953 459999999998
Q ss_pred ccCCCCc---ccccccCCcccchhcccc------------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Q 013816 208 FFKPGEK---FSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIR 271 (436)
Q Consensus 208 ~~~~~~~---~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~ 271 (436)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 7644322 234578999999999753 5778999999999999999999999765432 23333333
Q ss_pred ccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..... ......++++.++|.+||+.||.+|||+.++|+||||+...
T Consensus 255 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 255 PNHEI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp TTSCC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ccccc--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 22221 22235688999999999999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=363.48 Aligned_cols=245 Identities=24% Similarity=0.389 Sum_probs=206.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence 46899999999999999999999999999999988542 445667899999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE---NKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT---TSCEEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC---CCCEEEeecccceecccc
Confidence 9999999999999987 467999999999999999999999999999999999999964 445999999999876433
Q ss_pred Ccc---------------cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Q 013816 213 EKF---------------SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----VAQAIIR 271 (436)
Q Consensus 213 ~~~---------------~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~-----~~~~i~~ 271 (436)
... ....||+.|+|||++. ..++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 1567999999999987 468999999999999999999999986532211 0111111
Q ss_pred ccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
. ...+.+++.+.+++.+||+.||++|||+.++++
T Consensus 242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 112467889999999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=351.75 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=213.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEE
Confidence 368999999999999999999986 578899999975432 346789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC---CCEEecccccccccccc
Confidence 99999999999999654 458999999999999999999999999999999999999654 45999999999866433
Q ss_pred C--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+...... ......++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---CCCCcCCHHH
Confidence 2 223446678899999987 568999999999999999999 99999998888777777665322 2234578999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+||+.||++|||+.++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=357.31 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=207.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++ +||||+++++++...+.+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence 357899999999999999999999999999999999766554555567899999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---CCEEEecCccCcccccc
Confidence 999999999999999988889999999999999999999999999999999999999654 45999999999766433
Q ss_pred C--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. ......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...............+.+++++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHH
Confidence 2 234567999999999986 5689999999999999999999999987665533 33333333323333467899999
Q ss_pred HHHHHccCCCcCCCC-CHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRL-TAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rp-s~~e~l~h 312 (436)
++|.+||+.||++|| |+.++++.
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHHH
Confidence 999999999999999 78887763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.83 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=215.7
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCC-CCCceeEEEEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP-KHQNIVCLKDT 124 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~E~~~l~~l~-~h~niv~~~~~ 124 (436)
.+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. .||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 445678899999999999999999999999999999999976643321 12245678999999994 36999999999
Q ss_pred EEeCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEee
Q 013816 125 YEDDTAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 125 ~~~~~~~~lv~E~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
+...+.+++|||++.+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++. ..+.+||+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~Df 194 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLIDF 194 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECCC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEeeC
Confidence 9999999999999986 899999998888999999999999999999999999999999999999973 2345999999
Q ss_pred ccccccCCCCcccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 204 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
|++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.... .+...... ..
T Consensus 195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~----~~ 263 (320)
T 3a99_A 195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF----FR 263 (320)
T ss_dssp TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC----CS
T ss_pred ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccc----cc
Confidence 999876533 3345679999999999863 3 4678999999999999999999996532 22333222 22
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+++++.+||.+||+.||++|||+.++++||||++.
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 4689999999999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.81 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=209.0
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+.+||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 356789999999999999999999999999999999865432 235788999999998899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--CCCeEEEeeccccc
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLSVF 208 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~--~~~ikl~DfG~a~~ 208 (436)
++||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 89999999863 67999999999999999999999999999999999999975433 22399999999987
Q ss_pred cCCCCc--------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHccccC
Q 013816 209 FKPGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDF 276 (436)
Q Consensus 209 ~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~ 276 (436)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 643322 24568999999999987 458999999999999999999999998743 333444443332222
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+........+++.+++..||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21111112239999999999999999999999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=349.28 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=213.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEE
Confidence 578999999999999999999875 577899999865432 346789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR---DLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT---TCCEEECCTTCEEECCTT
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC---CCCEEEccCccceecchh
Confidence 999999999999997754 4999999999999999999999999999999999999964 445999999999876544
Q ss_pred Ccc--cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
... ....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+........ ....++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l 234 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTI 234 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHH
Confidence 322 3345677899999987 468999999999999999999 9999998888877776665543222 24578999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+||+.||.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=359.53 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=217.6
Q ss_pred CCcccccccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEE
Q 013816 47 EPTGREIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (436)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~ 121 (436)
.+..+...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~ 91 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVIKL 91 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCceeeE
Confidence 3444455688999999999999999999983 456899999986542 345567899999999999 89999999
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCc
Q 013816 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------------YTERAAAAVTKTIVEVVQMCHKHGV 177 (436)
Q Consensus 122 ~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~lH~~~i 177 (436)
++++...+.+++||||++|++|.+++..... +++..+..++.||+.||.|||++||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 171 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL 171 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 9999999999999999999999999987543 8899999999999999999999999
Q ss_pred eecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-
Q 013816 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC- 252 (436)
Q Consensus 178 iH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt- 252 (436)
+||||||+||+++.+ +.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|+|
T Consensus 172 vH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 172 VHRDLAARNILVAEG---RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp ECCCCSGGGEEEETT---TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccccchheEEEcCC---CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999754 4599999999987654332 23346788999999986 568999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 253 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
|..||.+.........+..... ......+++++.+++.+||+.||++|||+.+++++
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999988887766666655432 22335789999999999999999999999999885
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=351.55 Aligned_cols=252 Identities=29% Similarity=0.432 Sum_probs=202.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.++|++.+.||+|+||.||+|.+. ++.||+|++....... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence 367999999999999999999974 8999999986543322 23457889999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceEeecCCC-----CCCeEEEeec
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKE-----TAPLKAIDFG 204 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~NIl~~~~~~-----~~~ikl~DfG 204 (436)
+||||++|++|.+++. ...+++..+..++.|++.||.|||++| |+||||||+||+++.... ...+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988875 457999999999999999999999999 899999999999975322 5669999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
++........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+........ ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCcc
Confidence 9986653322 3457999999999986 4589999999999999999999999998887776666655543322 2356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=366.35 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=217.7
Q ss_pred cccccceeeccccccCCceEEEEEEEcCC-------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 123 (436)
+...++|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+++++++.+||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 44568999999999999999999997543 357999998654 234456789999999999988999999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 013816 124 TYEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (436)
Q Consensus 124 ~~~~~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NI 187 (436)
++...+..++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998753 489999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCH
Q 013816 188 LFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE 262 (436)
Q Consensus 188 l~~~~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~ 262 (436)
|++.+ +.+||+|||+++...... ......+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+...
T Consensus 223 ll~~~---~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 223 LVTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp EECTT---CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEcCC---CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99643 459999999998765432 233456788999999986 468999999999999999999 9999998888
Q ss_pred HHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+....+..... ......+++++.+||.+||+.||++|||+.+++++
T Consensus 300 ~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 300 EELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHTTCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777776665432 22235689999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=370.76 Aligned_cols=260 Identities=24% Similarity=0.437 Sum_probs=208.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----------CCCceeEEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNIVCLKD 123 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~niv~~~~ 123 (436)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++++. .||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 46899999999999999999999999999999998643 334567889999999882 1899999999
Q ss_pred EEEeCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCC---
Q 013816 124 TYEDDT----AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK--- 193 (436)
Q Consensus 124 ~~~~~~----~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~--- 193 (436)
++...+ .+++||||+ |++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 987654 789999999 88999999763 4599999999999999999999998 999999999999996432
Q ss_pred CCCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH------HHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE------QGVA 266 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~------~~~~ 266 (436)
....+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|+||..||..... ....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 334699999999987643 334568999999999987 4589999999999999999999999976542 2222
Q ss_pred HHHHHccccCC--------------------------------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHH
Q 013816 267 QAIIRSVLDFR--------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ 308 (436)
Q Consensus 267 ~~i~~~~~~~~--------------------------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e 308 (436)
..+.......+ .......++++.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 22222111000 0011235678899999999999999999999
Q ss_pred HhcCcccccCcc
Q 013816 309 VLEHPWLQNAKK 320 (436)
Q Consensus 309 ~l~h~~~~~~~~ 320 (436)
+|+||||++...
T Consensus 331 ll~hp~f~~~~~ 342 (373)
T 1q8y_A 331 LVNHPWLKDTLG 342 (373)
T ss_dssp HHTCGGGTTCTT
T ss_pred HhhChhhhcccC
Confidence 999999997644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=355.77 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=213.8
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+.+|+|++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 34567899999999999999999999999999999999865432 2457889999999988999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeeccc
Q 013816 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLS 206 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~a 206 (436)
..++||||+ |++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 899999998754 599999999999999999999999999999999999997643 3345999999999
Q ss_pred cccCCCCc--------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHccc
Q 013816 207 VFFKPGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---TEQGVAQAIIRSVL 274 (436)
Q Consensus 207 ~~~~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~ 274 (436)
........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+. ........+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 24567999999999987 46899999999999999999999999774 33333444433222
Q ss_pred cCC-CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 275 DFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 275 ~~~-~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
... ....+.+++++.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111 11124678999999999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=361.59 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=216.7
Q ss_pred ccccceeeccccccCCceEEEEEE-----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
...++|++++.||+|+||.||+|+ +..+++.||+|++... ........+.+|+.+++++ +||||+++++++.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL 103 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEc
Confidence 446789999999999999999999 5567889999998643 2344567889999999999 9999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeE
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.....|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 489999999999999999999999999999999999998766667799
Q ss_pred EEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccc
Q 013816 200 AIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 200 l~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 274 (436)
|+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|+| |..||...........+.....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999997553322 223456789999999986 568999999999999999998 9999988887777666665432
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
......+++.+.++|.+||+.||.+|||+.++++|.|+-
T Consensus 264 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 264 ---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 223356899999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.22 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=209.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhh----HHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD----IEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~----~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
...++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence 44578999999999999999999999999999999987654332221 16789999999999 89999999999866
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCC--CCCeEEEe
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKE--TAPLKAID 202 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~--~~~ikl~D 202 (436)
.. ++||||++|++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+||+++.++. ...+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 6999999999999888655 46999999999999999999999999 999999999999965432 23489999
Q ss_pred eccccccCCCCcccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHccccCC
Q 013816 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFR 277 (436)
Q Consensus 203 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~--~~~i~~~~~~~~ 277 (436)
||+++... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+..... .
T Consensus 173 fg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 248 (287)
T 4f0f_A 173 FGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--R 248 (287)
T ss_dssp CTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--C
T ss_pred CCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--C
Confidence 99997543 3345568999999999983 3478899999999999999999999976654433 333333322 2
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
......+++++.++|.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3334578999999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=364.50 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=211.3
Q ss_pred cccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 4578999999999999999999973 456789999997543 223457899999999999789999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013816 128 DTAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp 184 (436)
.+..++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999997653 278999999999999999999999999999999
Q ss_pred CceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCC
Q 013816 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWA 259 (436)
Q Consensus 185 ~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~ 259 (436)
+|||++.+ +.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|+| |..||.+
T Consensus 201 ~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEcCC---CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999754 4599999999986643322 23456788999999876 568999999999999999998 9999988
Q ss_pred CCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 260 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.........+........ ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 776555555555443322 234679999999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=350.80 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=210.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+.+++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEE
Confidence 468999999999999999999875 678899999975432 346789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC---CCCEEEcccccccccccc
Confidence 9999999999999976 457999999999999999999999999999999999999964 445999999999866433
Q ss_pred Cc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 EK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.. .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+....... .....++.+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l 250 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKV 250 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC---CCCcCCHHH
Confidence 21 23345678899999987 568999999999999999998 999999888887777776653322 224578999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+||+.||.+|||+.++++|
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=352.82 Aligned_cols=255 Identities=27% Similarity=0.500 Sum_probs=202.9
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcE
Confidence 4457899999999999999999999999999999999865555566677899999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~---~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC---CCCEEEEecccee
Confidence 999999999999998864 456899999999999999999999999999999999999964 4459999999998
Q ss_pred ccCCCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHccccCCCCCCcc
Q 013816 208 FFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 208 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~ 283 (436)
...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+... ......+.... ++......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDH 262 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTTT
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCcccc
Confidence 664332 234457899999999976 5688999999999999999999999976432 23333333322 22233356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++++.+||.+||+.||.+|||+.+++++
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=368.52 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=212.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+.+|+.+++++ +||||+++++++...+.+|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999998643 2333456788999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~---~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE---KNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC---CCcEEECcCCCceecCCC
Confidence 999999999999997654 5999999999999999999999999999999999999964 446999999999865433
Q ss_pred Ccc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 213 EKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 213 ~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
... ....+++.|+|||++. +.++.++|||||||++|||+| |..||.+....+....+..+.. .+....++++
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 343 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPCPELCPDA 343 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---CCCCTTCCHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHH
Confidence 211 1223567899999987 568999999999999999998 9999998888776666654432 2223468899
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+||.+||+.||++|||+.++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=361.60 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=215.9
Q ss_pred cccccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
....++|++++.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 344578999999999999999999987 455899999987542 344567899999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~d 181 (436)
...+.+++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999764 5689999999999999999999999999999
Q ss_pred CCCCceEeecCCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCC
Q 013816 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPP 256 (436)
Q Consensus 182 lkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~p 256 (436)
|||+|||++.+ +.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|+| |..|
T Consensus 200 lkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 200 LATRNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSGGGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCcceEEECCC---CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999654 459999999997654322 223456889999999976 568999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 257 FWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 257 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
|.+....+....+..+... .....+++++.+++.+||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9998888777777665432 2234688999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=360.74 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=190.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHH-HHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+..|+. +++.+ +||||+++++++...+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceE
Confidence 478999999999999999999999999999999997542 2334456666776 55555 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 133 LVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
+||||+.| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT---TEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC---CCEEEccCCCc
Confidence 99999986 88777753 56799999999999999999999999 99999999999999654 45999999999
Q ss_pred cccCCCCcccccccCCcccchhccc-----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHcc-ccCCCC
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-LDFRRD 279 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~-~~~~~~ 279 (436)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... +....+..+. ..+...
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 8775554445568999999999972 45889999999999999999999999764322 1111111111 111122
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 2346899999999999999999999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=371.55 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=212.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC
Confidence 35578999999999999999999999999999999999765432 2357788999999999 8999999999998765
Q ss_pred -eEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-CCCCCCeEEEeec
Q 013816 130 -AVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDFG 204 (436)
Q Consensus 130 -~~~lv~E~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~-~~~~~~ikl~DfG 204 (436)
..++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+.. ++....+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999987643 3999999999999999999999999999999999999832 2334568999999
Q ss_pred cccccCCCCcccccccCCcccchhccc---------ccCCCCCchhHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHH
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIR 271 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlG~il~~lltg~~pf~~~----~~~~~~~~i~~ 271 (436)
+++............||+.|+|||++. ..++.++|||||||++|+|++|..||... ...+....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 998876666666778999999999875 35778999999999999999999999642 23344555554
Q ss_pred ccccCC---------------------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 272 SVLDFR---------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 272 ~~~~~~---------------------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+..... ......+++.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 432100 00112345678899999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=349.97 Aligned_cols=251 Identities=26% Similarity=0.333 Sum_probs=201.9
Q ss_pred ccccceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
...++|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+.+|+.+++++ +||||+++++++. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-c
Confidence 3457899999999999999999998654 457999987643 2344567899999999999 8999999999984 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~ 164 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSR 164 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC-----
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC---CEEECcccccc
Confidence 67899999999999999998654 699999999999999999999999999999999999997543 49999999998
Q ss_pred ccCCCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 208 FFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 208 ~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..... ....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~ 241 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPN 241 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---CCCCCC
Confidence 7654332 23345678999999986 568999999999999999996 9999988887777766665432 223357
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.73 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=214.3
Q ss_pred cccceeeccccccCCceEEEEEEE-----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 347899999999999999999985 4567899999987542 334567899999999999889999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 013816 128 DTAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~ 189 (436)
.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999997654 48999999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHH
Q 013816 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (436)
Q Consensus 190 ~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~ 264 (436)
+.+ +.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+.....
T Consensus 179 ~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCC---CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 654 4589999999987654432 23456788999999876 568999999999999999999 999998776555
Q ss_pred HHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 265 ~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
............ .....+++++.+++.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 555444443322 2235689999999999999999999999999885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=359.44 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=210.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEE--EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++++.+||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 368999999999999999999999888865 999886432 2334567899999999997899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 132 HLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~--- 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--- 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC---
Confidence 99999999999999997654 68999999999999999999999999999999999999654
Q ss_pred CCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc
Q 013816 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 273 (436)
+.+||+|||++.............+|+.|+|||++. ..++.++||||||+++|+|+| |..||.+....+....+....
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 459999999997543333334456788999999987 458999999999999999998 999999888777666555432
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......+++++.+||.+||+.||.+|||+.+++++
T Consensus 259 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 ---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222335689999999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=352.96 Aligned_cols=247 Identities=36% Similarity=0.675 Sum_probs=198.9
Q ss_pred ccccceeec-cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 52 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
.+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++.++.+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 345667776 7899999999999999999999999998532 4567899988665599999999999987
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 -DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
...+++||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++..+....+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 778999999999999999998764 69999999999999999999999999999999999999875556779999999
Q ss_pred cccccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccc----cCCCCC
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDP 280 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~----~~~~~~ 280 (436)
++..... ..++.++|||||||++|+|+||..||...........+..... ..+...
T Consensus 166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 9875431 3467789999999999999999999976654332211111111 111111
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCc
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~ 326 (436)
+..+++++.+||.+||+.||.+|||+.|+|+||||++....+..+.
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 2467999999999999999999999999999999998766554443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=371.07 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=201.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++++.+||||+++++++.+.+.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 456778888999999999998754 567999999998643 2356788999999876899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC----------CC
Q 013816 132 HLVMELCEGGELFDRIVARGHY-------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----------KE 194 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~-------~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~----------~~ 194 (436)
|+||||+. |+|.+++...... ++..+..++.||+.||.|||++||+||||||+|||++.. ..
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 5999999765433 223457899999999999999999999999999999754 24
Q ss_pred CCCeEEEeeccccccCCCCc-----ccccccCCcccchhccc--------ccCCCCCchhHHHHHHHHHHh-CCCCCCCC
Q 013816 195 TAPLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAE 260 (436)
Q Consensus 195 ~~~ikl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlG~il~~llt-g~~pf~~~ 260 (436)
...+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 45799999999987754322 23467999999999975 347889999999999999999 99999765
Q ss_pred CHHHHHHHHHHccccCCCCC---CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 261 TEQGVAQAIIRSVLDFRRDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.... ..+........... ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 5433 34455444333221 2245688999999999999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=352.23 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=202.6
Q ss_pred ccccceeeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
...++|++++.||+|+||+||+|+ +..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS 82 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec
Confidence 346789999999999999999998 5678999999998643 344567899999999999 89999999999854
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 --DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
...+++||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~kl~Dfg 159 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFG 159 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC---eEEEccCc
Confidence 456899999999999999998754 499999999999999999999999999999999999997644 49999999
Q ss_pred cccccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH----------------
Q 013816 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------------- 263 (436)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---------------- 263 (436)
++........ .....+|+.|+|||++. ..++.++||||||+++|+|+||..||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9987654322 23345778899999986 56899999999999999999999998543221
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.....+.. . ........+++++.++|.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~-~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 240 HLIELLKN-N--GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHT-T--CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhc-c--CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11111111 1 1222335789999999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=353.16 Aligned_cols=253 Identities=17% Similarity=0.248 Sum_probs=208.7
Q ss_pred cccceeeccccccCCceEEEEEEEcCCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
..++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKL-SHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTS-CCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhC-CCCCEeEEEEEE
Confidence 3578999999999999999999998877 479999986543 33457899999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC-----CCeE
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET-----APLK 199 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~-----~~ik 199 (436)
...+..++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 9999999999999999999999999999999999999765432 2289
Q ss_pred EEeeccccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCC
Q 013816 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (436)
Q Consensus 200 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 277 (436)
|+|||++...... ....||+.|+|||++. ..++.++||||||+++|+|++|..|++..................
T Consensus 162 l~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~- 237 (289)
T 4fvq_A 162 LSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL- 237 (289)
T ss_dssp ECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred eccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC-
Confidence 9999998765322 3456899999999986 458999999999999999999655554444333333333332222
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
....++++.+|+.+||+.||.+|||+.++++| ++..
T Consensus 238 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l 273 (289)
T 4fvq_A 238 ---PAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSL 273 (289)
T ss_dssp ---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTC
T ss_pred ---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHh
Confidence 23467889999999999999999999999997 5443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=356.97 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=203.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC
Confidence 478999999999999999999998887764 777765332 233457899999999999 8999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC---CEEEccCcceeE
Confidence 78999999999999999874 5699999999999999999999999999999999999997644 499999999987
Q ss_pred cCCCCcc---cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
....... ....+|+.|+|||++. ..++.++|||||||++|+|+| |..||.+.........+..... ....+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---CCCCcc
Confidence 6543322 3345688999999976 568999999999999999999 9999988877766655554432 222356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.++.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 89999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=354.81 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=214.9
Q ss_pred ccccceeeccccccCCceEEEEEEEc-------CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 124 (436)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34578999999999999999999975 457889999986542 344567899999999999789999999999
Q ss_pred EEeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 013816 125 YEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (436)
Q Consensus 125 ~~~~~~~~lv~E~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl 188 (436)
+...+.+++||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 999999999999999999999997653 3899999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHH
Q 013816 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (436)
Q Consensus 189 ~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~ 263 (436)
++. .+.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....
T Consensus 190 l~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 190 VTE---NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp ECT---TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EcC---CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 964 44599999999987654332 23346788999999876 568999999999999999999 99999988887
Q ss_pred HHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 264 ~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+....+..... ......+++++.++|.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 267 ELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77776666532 22235689999999999999999999999999885
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=347.76 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=215.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCE
Confidence 3457899999999999999999999999999999998643 23467899999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG---GCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC---CCEEEccCccceec
Confidence 9999999999999999864 348999999999999999999999999999999999999654 45999999999876
Q ss_pred CCCC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.... .......++
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 238 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCP 238 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTCC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---CCCCCCCCC
Confidence 5433 223456788999999987 568999999999999999999 999998887776666555432 222335789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+.+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999999999999999999999977
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=350.15 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=210.9
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEecccc
Confidence 456789999999999999999999999999999999986542 3467899999999 89999999998864
Q ss_pred -------------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 013816 128 -------------DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (436)
Q Consensus 128 -------------~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~ 192 (436)
...+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 45689999999999999999754 579999999999999999999999999999999999999754
Q ss_pred CCCCCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 013816 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271 (436)
Q Consensus 193 ~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~ 271 (436)
+ .+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..|+... ......+..
T Consensus 159 ~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 159 K---QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp T---EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred C---CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 4 49999999998876655556678999999999987 45899999999999999999999987422 122222322
Q ss_pred ccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.. ....+++.+.++|.+||+.||.+|||+.++++|.|.-.
T Consensus 234 ~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 GI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 21 12457899999999999999999999999999977543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=359.76 Aligned_cols=258 Identities=29% Similarity=0.527 Sum_probs=204.1
Q ss_pred cccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---hhHHHHHHHHHHHHhCC---CCCceeEEE
Q 013816 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP---KHQNIVCLK 122 (436)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~E~~~l~~l~---~h~niv~~~ 122 (436)
.+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++.++. +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345678899999999999999999999999999999999976543221 12234567888888874 699999999
Q ss_pred EEEEeCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 123 DTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 123 ~~~~~~~~~~lv~E~-~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
+++...+..++|||+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++. ..+.+||+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~ 182 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLI 182 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEEC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEE
Confidence 999999999999999 789999999998888999999999999999999999999999999999999973 23459999
Q ss_pred eeccccccCCCCcccccccCCcccchhcccc-cC-CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 279 (436)
|||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.... .+......
T Consensus 183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~---- 251 (312)
T 2iwi_A 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH---- 251 (312)
T ss_dssp CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC----
T ss_pred EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC----
Confidence 99999876543 3455679999999999863 33 458999999999999999999996432 23333222
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
....++.++.+||.+||+.||++|||+.++++||||+...
T Consensus 252 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 2246899999999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.99 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=202.0
Q ss_pred ccceeeccccccCCceEEEEEEEc---CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCc
Confidence 468999999999999999999876 567889999986542 344567899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+++||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC---CCCEEECcCcccccc
Confidence 999999999999999997754 6999999999999999999999999999999999999964 456999999999876
Q ss_pred CCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||......+....+..... ......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~ 274 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPPMD 274 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCCTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 54321 12234577899999987 568999999999999999998 9999999888877776655432 222346
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++..+.+++.+||+.||.+|||+.++++
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 8899999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=354.27 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=213.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+.+||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 35789999999999999999999977664 79999986542 334567899999999999779999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR--------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~ 193 (436)
.+.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 99999999999999999998653 3579999999999999999999999999999999999997544
Q ss_pred CCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 013816 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (436)
Q Consensus 194 ~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~ 268 (436)
.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+.........
T Consensus 202 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 202 ---VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp ---EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred ---eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 489999999986543322 23456788999999876 568999999999999999998 9999987766555555
Q ss_pred HHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+........ .....++.+.+++.+||+.||.+|||+.+++++
T Consensus 279 ~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 279 LVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 555443322 234578999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=353.37 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=209.8
Q ss_pred cccceeeccccccCCceEEEEEEE-----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.++.++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 357899999999999999999985 3567899999986542 334556899999999999779999999999876
Q ss_pred CC-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 128 DT-AVHLVMELCEGGELFDRIVARGH----------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 128 ~~-~~~lv~E~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
.+ .+++||||++|++|.+++..... +++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 58999999999999999987543 88999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
.+ +.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+......
T Consensus 183 ~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 EK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp GG---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC---CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 54 4599999999986644322 23456789999999986 568999999999999999998 9999987664443
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
........... .....+++++.+++.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333322221 2224578999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.72 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=206.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcE----EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.++|++++.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.+++++ +||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CC
Confidence 46899999999999999999999888876 67776643321 22235677899999999 8999999999886 56
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~---~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS---PSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS---SSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC---CCeEEECCCCcccc
Confidence 689999999999999999764 57999999999999999999999999999999999999964 44599999999987
Q ss_pred cCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... ......||+.|+|||++. +.++.++||||||+++|+|+| |..||.+....+....+...... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL---AQPQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC---CCCTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCCCc
Confidence 65433 224456788999999987 568999999999999999999 99999888877776666554322 22235
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.++.+++.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78889999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=346.07 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=209.4
Q ss_pred ccceeecc-ccccCCceEEEEEEE--cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGR-ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence 46899998 999999999999954 56678999999876532 233467899999999999 899999999999 5677
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+++||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC---cEEEccCCcceeec
Confidence 899999999999999999888899999999999999999999999999999999999997654 48999999998765
Q ss_pred CCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+..... ......+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 43321 2235678899999986 468889999999999999999 9999998888776666655432 2223568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++++.++|.+||+.||.+|||+.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=347.76 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=203.8
Q ss_pred cccceeeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 53 IEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..++|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTED 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecC
Confidence 35679999999999999999998 56789999999997553 233457899999999999 899999999999876
Q ss_pred --CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 129 --TAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..+++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC---CEEECcccc
Confidence 678999999999999999954 45799999999999999999999999999999999999997654 499999999
Q ss_pred ccccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC--------------CHHHHH
Q 013816 206 SVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE--------------TEQGVA 266 (436)
Q Consensus 206 a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~--------------~~~~~~ 266 (436)
+........ .....||..|+|||++. ..++.++||||||+++|+|+||..|+... ......
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987754432 23456888899999986 56888999999999999999999886322 111111
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
........ .....+.+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 12222211 22234578999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=341.78 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=212.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEE
Confidence 67999999999999999999986 678999999975432 346789999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG---GCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC---CCEEEccccccccccccc
Confidence 9999999999999775 468999999999999999999999999999999999999654 459999999998664321
Q ss_pred --cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 --KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
......+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+...... ......++.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~ 235 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHVY 235 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---CCCccCcHHHH
Confidence 123446778999999987 568899999999999999999 89999988887777777655322 22245789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+||+.||++|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.74 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=199.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+.+|||||++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4799999999999999764 3356899999999865432 23567999999997899999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeeccccccCC
Q 013816 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~a~~~~~ 211 (436)
|||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|+....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999997654 456667789999999999999999999999999999996432 334578999999987654
Q ss_pred CC----cccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 212 GE----KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 212 ~~----~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
.. ......||+.|+|||++. ..++.++|||||||++|+|+| |..||......... .+.............
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLHPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTTSCTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccccCccc
Confidence 32 234567999999999985 346789999999999999999 99998655443322 222211111111223
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 346678999999999999999999999999999753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=352.36 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=215.7
Q ss_pred cccccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 125 (436)
....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeEEEE
Confidence 445688999999999999999999876 457889999986442 334556789999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 126 EDDTAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 126 ~~~~~~~lv~E~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
.+.+..++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. .
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~---~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---D 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT---T
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC---C
Confidence 9999999999999999999998653 35789999999999999999999999999999999999964 3
Q ss_pred CCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 013816 196 APLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~ 270 (436)
+.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 459999999997654322 123446788999999986 568999999999999999999 899999888877777766
Q ss_pred HccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..... .....+++.+.++|.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 EGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 65432 2234689999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=347.11 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=200.1
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
+.++...++|++.+.||+|+||+||+|.+. ..||+|++.... ......+.+.+|+.+++++ +||||++++++. .
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T 90 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-c
Confidence 344666789999999999999999999853 359999986553 3445667899999999999 899999999954 5
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
....++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED---NTVKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEEccceec
Confidence 66789999999999999998644 569999999999999999999999999999999999999754 45999999999
Q ss_pred cccCCC---CcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHccccCCC
Q 013816 207 VFFKPG---EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA-IIRSVLDFRR 278 (436)
Q Consensus 207 ~~~~~~---~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~-i~~~~~~~~~ 278 (436)
...... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........... +.........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 765432 2234567999999999874 3478899999999999999999999987655444433 3343332221
Q ss_pred -CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 279 -DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 279 -~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.....+++++.+||.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 2234688999999999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=348.46 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=205.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEEEEEeCCe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDTA 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~ 130 (436)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++..... .+.+.+|+.+++.+ .|++ +..+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHh-hcCCCCCccccccCCCCc
Confidence 456899999999999999999999999999999999865432 24588999999999 5655 5555555578888
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++..+....+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8899999974 457999999999999999999999999999999999999964444566999999999876
Q ss_pred CCCCc--------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHccccCC
Q 013816 210 KPGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFR 277 (436)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~ 277 (436)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|..||..... ......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54322 24567999999999987 4689999999999999999999999976332 223333333222221
Q ss_pred C-CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 278 R-DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 278 ~-~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
. .....+|+++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1 112457899999999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=343.03 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=211.7
Q ss_pred ccceeecc-ccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGR-ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCC
Confidence 46677777 9999999999999864 46788999998754 2345667899999999999 899999999999 5567
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC---CEEECcccceeee
Confidence 99999999999999998654 4699999999999999999999999999999999999997544 5899999999876
Q ss_pred CCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||......+....+..... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---CCCCCC
Confidence 54322 12345688999999987 568999999999999999998 9999988887777666655432 222357
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
+++++.++|.+||+.||++|||+.+++++.+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 8999999999999999999999999998743
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=356.57 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=206.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
....++|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCe
Confidence 34668999999999999999999996 478999999886542 23467899999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 131 VHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
.++||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE---NFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT---TCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC---CCCEEEeecccc
Confidence 999999999999999886543 4899999999999999999999999999999999999964 456999999999
Q ss_pred cccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHHcccc
Q 013816 207 VFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-------AIIRSVLD 275 (436)
Q Consensus 207 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~-------~i~~~~~~ 275 (436)
....... ......||+.|+|||++. +.++.++||||||+++|+|+||..||......+... ........
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654322 224456899999999975 679999999999999999999999997654321111 01011100
Q ss_pred ------CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 276 ------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 276 ------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
......+..+..+.+++.+||+.||++|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0111123456788999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=354.20 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=197.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~---- 129 (436)
.++|++.+.||+|+||+||+|++. ++.||||++.... .......+|+.+++++ +||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCc
Confidence 468999999999999999999875 8999999986432 2345567799999999 8999999999998744
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCceEeecCCCCCCeE
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH----------GVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.+++||||+++|+|.+++... .+++..+..++.|++.||.|||+. ||+||||||+|||++. .+.+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~---~~~~k 171 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN---NLTAC 171 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT---TCCEE
T ss_pred eEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC---CCeEE
Confidence 479999999999999999764 599999999999999999999999 9999999999999964 45699
Q ss_pred EEeeccccccCCCCc---ccccccCCcccchhcccc------cCCCCCchhHHHHHHHHHHhCCCCCCCCCH--------
Q 013816 200 AIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETE-------- 262 (436)
Q Consensus 200 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~~lltg~~pf~~~~~-------- 262 (436)
|+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999987654332 334679999999999864 356688999999999999999999965321
Q ss_pred --------HHHHHHHHHccccCCCCC-C--cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 263 --------QGVAQAIIRSVLDFRRDP-W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 263 --------~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
......+........... + ...++++.+||.+||+.||++|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112222222111111100 0 1234569999999999999999999999873
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=360.93 Aligned_cols=255 Identities=15% Similarity=0.174 Sum_probs=195.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCC-----CcEEEEEEeeccccCCh--------hhHHHHHHHHHHHHhCCCCCceeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTA--------VDIEDVRREVDIMRHLPKHQNIVC 120 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~i~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~ 120 (436)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++........ .....+..|+..+..+ +||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCe
Confidence 45899999999999999999998765 58899999865421000 0011233445556666 7999999
Q ss_pred EEEEEEeC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 121 LKDTYEDD----TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 121 ~~~~~~~~----~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
+++++... ...|+||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~~ 190 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NP 190 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-CT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-CC
Confidence 99998764 5689999999 99999999876 579999999999999999999999999999999999999732 34
Q ss_pred CCeEEEeeccccccCCCCc--------ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013816 196 APLKAIDFGLSVFFKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 266 (436)
+.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+.......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 5699999999976643221 133469999999999874 5899999999999999999999999754322221
Q ss_pred HHHHHccc-----cCC--CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 267 QAIIRSVL-----DFR--RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 267 ~~i~~~~~-----~~~--~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
........ ... ......+++++.+++..||+.||.+||++.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111000 000 0011457899999999999999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=371.68 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=214.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|+++ +||||+++++++.....+|+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEE
Confidence 467999999999999999999999999999999986543 2457899999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN---HLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC---CcEEEeecccceeccC
Confidence 99999999999999864 458999999999999999999999999999999999999653 4599999999987654
Q ss_pred CCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
... .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+.... .......++++
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 447 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEK 447 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTCCHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence 322 12345678899999987 568999999999999999999 999998888776666555432 22333578999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.+||.+||+.||++|||+.++++.
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.23 Aligned_cols=245 Identities=15% Similarity=0.228 Sum_probs=209.9
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC--CeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--~~~ 131 (436)
.++|++.+.||+|+||.||+|++. ++.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 468999999999999999999984 89999999976532 344567899999999999 899999999999877 788
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++||||++|++|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||+++. .+.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~---~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE---DMTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT---TSCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC---CcceeEEecccee
Confidence 99999999999999998765 4899999999999999999999999 999999999999964 3458999998876
Q ss_pred ccCCCCcccccccCCcccchhcccc-cC---CCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR-NY---GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~---~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
... .....||+.|+|||++.+ .+ +.++||||||+++|+|++|..||...........+....... .....
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (271)
T 3kmu_A 162 SFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPG 235 (271)
T ss_dssp TTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred eec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCC
Confidence 532 234578999999999864 23 337999999999999999999999888877777666554332 23357
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.16 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=206.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-eEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~ 132 (436)
.++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|+++ +||||+++++++.... .+|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceE
Confidence 468999999999999999999875 7899999986542 346799999999999 8999999999987665 799
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC---CCCEEEeeCCCccccc
Confidence 99999999999999987643 799999999999999999999999999999999999964 4469999999998653
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.. .....+|+.|+|||++. ..++.++|||||||++|+|+| |..||......+....+..+. .......+++++
T Consensus 341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~p~~~~~~l 415 (450)
T 1k9a_A 341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAV 415 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---CCCCCTTCCHHH
T ss_pred cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCHHH
Confidence 22 22336788999999986 568999999999999999998 999998887777776666543 222335789999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+||.+||+.||.+|||+.++++
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.79 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=203.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEE----EEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v----avK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
.++|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC
Confidence 478999999999999999999998888765 556554322 233567899999999999 8999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.++|+||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeE
Confidence 78999999999999999874 5699999999999999999999999999999999999997644 499999999987
Q ss_pred cCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
...... .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..... ....+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 643322 23345678899999986 568999999999999999999 9999988887776666555432 222356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.++.++|.+||+.||.+|||+.++++.
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=342.37 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=207.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..++|++.+.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+ +
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-E 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-C
Confidence 457899999999999999999986543 4569999987542 344567899999999999 89999999999865 4
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT---EEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC---cEEeCccCCCcc
Confidence 568999999999999999765 4599999999999999999999999999999999999997644 589999999987
Q ss_pred cCCCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 209 FKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 209 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
...... .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+..... ......+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 239 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR---LPKPDLC 239 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC---CCCCTTC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC---CCCCCCC
Confidence 654322 23456788999999986 568999999999999999998 9999988777766666655432 1223468
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=346.51 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred cccceeeccccccCCceEEEEEEEcC-CCc--EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..++|++.+.||+|+||+||+|.+.. +++ .||+|++...........+.+.+|+.+++++ +||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC
Confidence 35789999999999999999998643 333 6899998766544455678899999999999 8999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC---CEEEcccccccc
Confidence 88999999999999999764 5699999999999999999999999999999999999997544 489999999987
Q ss_pred cCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 209 FKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 209 ~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+........ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCc
Confidence 654332 12346788999999986 458899999999999999999 9999999888877777766543332 235
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++++.+++.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 689999999999999999999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.77 Aligned_cols=256 Identities=17% Similarity=0.217 Sum_probs=199.0
Q ss_pred ccceeeccccccCCceEEEEEEEcC---CCcEEEEEEeeccccCCh--------hhHHHHHHHHHHHHhCCCCCceeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTA--------VDIEDVRREVDIMRHLPKHQNIVCLK 122 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~~~--------~~~~~~~~E~~~l~~l~~h~niv~~~ 122 (436)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++........ .....+.+|+..++.+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 4689999999999999999999987 789999999875431100 1123466788899999 999999999
Q ss_pred EEEEe----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 123 DTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 123 ~~~~~----~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
+++.. ....|+||||+ |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ ...+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~ 192 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQV 192 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTSE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCcE
Confidence 99988 78899999999 999999998877899999999999999999999999999999999999997644 2369
Q ss_pred EEEeeccccccCCCC--------cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Q 013816 199 KAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQA 268 (436)
Q Consensus 199 kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~ 268 (436)
||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+||..||...... .....
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999998664321 1245679999999999874 5899999999999999999999999653221 11111
Q ss_pred HHHcc-ccCCC-----CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 269 IIRSV-LDFRR-----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 269 i~~~~-~~~~~-----~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..... ...+. .....+++++.++|.+||+.||++|||+.++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 11111 11110 0112688999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=349.23 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=206.6
Q ss_pred cccceeeccccccCCceEEEEEEEcCCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..++|.+.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKY 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecC
Confidence 3568999999999999999999987553 459999986542 334556789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+..++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC---CCcEEECCCCcch
Confidence 9999999999999999999765 57999999999999999999999999999999999999964 4469999999998
Q ss_pred ccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 208 FFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..... ....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~~~ 272 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTP 272 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CCCc
Confidence 7643321 12335678899999986 568999999999999999999 9999998888777776665422 2223
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+++.+.+++.+||+.||.+|||+.+++++
T Consensus 273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4688999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.23 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=211.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
...++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+|+++ +||||+++++++. ....
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCcc
Confidence 34578999999999999999999985 57889999987543 2467899999999999 8999999999986 6678
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC---CCcEEEeeCCCceEc
Confidence 9999999999999999754 36899999999999999999999999999999999999964 456999999999876
Q ss_pred CCCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
..... .....+|+.|+|||++. +.++.++|||||||++|||+| |..||.+....+....+..+.. .+....++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~ 411 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCP 411 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---CCCCTTSC
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 43221 12345678899999987 678999999999999999999 9999999888888777766532 22335689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++.+||.+||+.||++|||+.++++
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHH
Confidence 99999999999999999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=344.66 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=199.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc-eeEEEEEEEeCCe
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDTA 130 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n-iv~~~~~~~~~~~ 130 (436)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.+ .|++ +..+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc
Confidence 4568999999999999999999999999999999987654322 3478899999999 5555 5555555678889
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 8899999975 457999999999999999999999999999999999999954445566999999999876
Q ss_pred CCCCc--------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHccccCC
Q 013816 210 KPGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLDFR 277 (436)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~~ 277 (436)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54322 23568999999999987 46889999999999999999999999764322 22222222222111
Q ss_pred -CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 278 -RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 278 -~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
......+++++.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1112457899999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=351.40 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=202.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE----eCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~----~~~ 129 (436)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.+ +||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence 46899999999999999999999999999999998653 344667899999999999 9999999999986 235
Q ss_pred eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 130 AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~---~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD---EGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---CCCEEEEecCc
Confidence 78999999999999998875 467999999999999999999999999999999999999964 34599999998
Q ss_pred ccccCCCC----------cccccccCCcccchhcccc----cCCCCCchhHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Q 013816 206 SVFFKPGE----------KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAI 269 (436)
Q Consensus 206 a~~~~~~~----------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~~lltg~~pf~~~~~--~~~~~~i 269 (436)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~- 259 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA- 259 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH-
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH-
Confidence 87653211 1123457999999999753 368999999999999999999999943111 011111
Q ss_pred HHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..... ..+..+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222 223335789999999999999999999999999997
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=385.27 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=213.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe------
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------ 127 (436)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccC
Confidence 47899999999999999999999999999999998654 2345567899999999999 89999999998755
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 DTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
.+..++||||++|++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 678899999999999999998654 58999999999999999999999999999999999999877666679999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHH---------HH-----
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---------AI----- 269 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~---------~i----- 269 (436)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.......... .+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 999877666666778999999999987 568999999999999999999999997654321100 00
Q ss_pred HHccccC------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 270 IRSVLDF------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 270 ~~~~~~~------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..+...+ +......+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000111 11112346789999999999999999999999999999964
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.66 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=206.9
Q ss_pred ccceeeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE--e
Q 013816 54 EERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--D 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--~ 127 (436)
.++|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+++++++ +||||+++++++. +
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence 3689999999999999999999 4678999999998654 344567799999999999 9999999999886 5
Q ss_pred CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
...+++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC---CEEEcccccc
Confidence 5679999999999999999976 35699999999999999999999999999999999999997644 4999999999
Q ss_pred cccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH--------------HHH
Q 013816 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQ 267 (436)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~--------------~~~ 267 (436)
........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||....... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 23456888899999986 458899999999999999999999985543321 111
Q ss_pred HHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 268 ~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....... .....+.+++++.+||.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 255 ELLEEGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1112111 222335789999999999999999999999999765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=347.11 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=202.2
Q ss_pred cccceeeccccccCCceEEEEEEEcC---CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence 34789999999999999999998765 456899999875432 344567899999999999 8999999999997655
Q ss_pred -----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 130 -----AVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 130 -----~~~lv~E~~~g~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---SCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcE
Confidence 45999999999999999843 3569999999999999999999999999999999999999643 459
Q ss_pred EEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHcc
Q 013816 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 199 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~ 273 (436)
||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||...........+....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999987644321 23346788999999986 468999999999999999999 999998888777776666543
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
. ......+++++.++|.+||+.||.+|||+.+++++
T Consensus 267 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22335688999999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=338.50 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=209.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+++++.+ +||||+++++++. .+..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcE
Confidence 4578999999999999999999975 57789999986543 2357889999999999 8999999999986 45689
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC---CCCEEECCCccccccc
Confidence 9999999999999986543 6999999999999999999999999999999999999964 4559999999998765
Q ss_pred CCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..... ......+++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 237 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNCPE 237 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcccccH
Confidence 4332 23345678999999987 568899999999999999999 9999998888777776665432 222346899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++.+++.+||+.||++|||+.++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=346.70 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=196.4
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEEEEEe-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVCLKDTYED- 127 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~- 127 (436)
+.+.++|++.+.||+|+||+||+|++ +++.||||++... ....+.+|.+++.. + +||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence 45678999999999999999999987 6899999998543 33556677777776 6 89999999998654
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceEeecCCCCC
Q 013816 128 ---DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 128 ---~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
...+++||||+++|+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++. .+
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~---~~ 150 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK---NG 150 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT---TS
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC---CC
Confidence 3568999999999999999954 57999999999999999999999 999999999999999964 44
Q ss_pred CeEEEeeccccccCCCCc-----ccccccCCcccchhcccc-------cCCCCCchhHHHHHHHHHHhC----------C
Q 013816 197 PLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCG----------V 254 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg----------~ 254 (436)
.+||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|+|+|| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 599999999976544322 233489999999999864 344689999999999999999 8
Q ss_pred CCCCCCCH----HHHHHHHHHccccCCCCC----CcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 255 PPFWAETE----QGVAQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 255 ~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.||..... .................+ ....++++.+|+.+||+.||++|||+.++++.
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 88865322 122222222111111111 01245789999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=355.55 Aligned_cols=248 Identities=15% Similarity=0.196 Sum_probs=201.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCC--------CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeE-----
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN--------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC----- 120 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~----- 120 (436)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++... +.+.+|+.+++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence 46899999999999999999999874 889999998643 3578899999999 8999887
Q ss_pred ----------EEEEEEe-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 013816 121 ----------LKDTYED-DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (436)
Q Consensus 121 ----------~~~~~~~-~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NI 187 (436)
+++++.. ...+|+||||+ |++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777766 78899999999 99999999876 6799999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEEeeccccccCCCC--------cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCC
Q 013816 188 LFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW 258 (436)
Q Consensus 188 l~~~~~~~~~ikl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~ 258 (436)
|++.++ ...+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 191 l~~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPED-QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTE-EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCC-CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 997543 1259999999997664322 1234589999999999874 68999999999999999999999997
Q ss_pred CCC--HHHHHHHHH---HccccCC--CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 259 AET--EQGVAQAII---RSVLDFR--RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 259 ~~~--~~~~~~~i~---~~~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
... ......... .....+. ...+..+++++.+||.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 753 222222221 1111111 11234579999999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.02 Aligned_cols=261 Identities=19% Similarity=0.243 Sum_probs=206.4
Q ss_pred CCcccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
........++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 97 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCM 97 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCCCEEEC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhc-cCCCccceEEEEe
Confidence 334456678999999999999999999985 469999999987653222 223688999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceEeecCCCCCCeE
Q 013816 127 DDTAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
..+..++||||++|++|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++. .+.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~---~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE---EFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT---TCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC---CCCEE
Confidence 9999999999999999999997643 489999999999999999999999 9999999999999964 44599
Q ss_pred EEeeccccccCCCC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHc
Q 013816 200 AIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRS 272 (436)
Q Consensus 200 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~----~~~~~~~~i~~~ 272 (436)
|+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|+||..||... ............
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998764332 234556999999999986 56899999999999999999999999421 100011111111
Q ss_pred cccC-----------CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcc
Q 013816 273 VLDF-----------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314 (436)
Q Consensus 273 ~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~ 314 (436)
.... ........++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1110 00111233478999999999999999999999999844
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=346.33 Aligned_cols=251 Identities=26% Similarity=0.349 Sum_probs=203.8
Q ss_pred ccccce-eeccccccCCceEEEEEEE----cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 52 EIEERY-ELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 52 ~~~~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.+.++| ++++.||+|+||+||++.. ..+++.||+|++... ......+.+.+|+.+++++ +||||+++++++.
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCE 103 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhC-CCcchhhEEEEEe
Confidence 455666 9999999999999988753 457899999999754 2344567899999999999 8999999999998
Q ss_pred e--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 127 D--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 127 ~--~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+ ...+++||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++. .+.+||+|||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~---~~~~kl~Dfg 179 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN---DRLVKIGDFG 179 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCGG
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC---CCCEEECCcc
Confidence 7 46889999999999999998765 5999999999999999999999999999999999999964 4559999999
Q ss_pred cccccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHH--------------H
Q 013816 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------V 265 (436)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~--------------~ 265 (436)
++........ .....+|+.|+|||++. ..++.++||||||+++|+|+||..||....... .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 9987754432 23456788999999987 468899999999999999999999986532210 1
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
......... .......+++++.+||.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111122211 22233568999999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=349.10 Aligned_cols=248 Identities=27% Similarity=0.443 Sum_probs=187.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE------
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE------ 126 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~------ 126 (436)
...+|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 346899999999999999999999999999999998543 34456788999999999956999999999984
Q ss_pred --eCCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeE
Q 013816 127 --DDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 127 --~~~~~~lv~E~~~g~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++. .+.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~---~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN---QGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT---TSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC---CCCEE
Confidence 3446899999996 689888865 467999999999999999999999999 999999999999964 34599
Q ss_pred EEeeccccccCCCCcc-------------cccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH
Q 013816 200 AIDFGLSVFFKPGEKF-------------SEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (436)
Q Consensus 200 l~DfG~a~~~~~~~~~-------------~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~ 262 (436)
|+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999876543221 1456899999999973 3578899999999999999999999976544
Q ss_pred HHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCc
Q 013816 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313 (436)
Q Consensus 263 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~ 313 (436)
.. +...... .......+..+.+||.+||+.||.+|||+.++++|-
T Consensus 259 ~~----~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 259 LR----IVNGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HH----hhcCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 32 2222222 222345678899999999999999999999999973
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=360.95 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=205.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+++ +||||+++++++.+ +..+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceE
Confidence 35789999999999999999999864 56799999875432 346799999999999 89999999999866 6789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIE 331 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC---
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC---CCEEECCCccceecC
Confidence 999999999999999743 568999999999999999999999999999999999999643 459999999998765
Q ss_pred CCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....+|+.|+|||++. +.++.++||||||+++|+|+| |..||.+....+....+..+.. .+..+.+++
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~ 408 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPE 408 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCH
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence 3321 22345678899999976 568999999999999999999 9999998888877777765432 222357899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+.+||.+||+.||++|||+.++++.
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=345.61 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=203.4
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeecccc-CChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
.|...+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEE
Confidence 355568999999999999985 689999999875432 2233467899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 135 MELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++.....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE---AFTAKISDFGLARASEK 185 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC---CCcEEEeeccccccccc
Confidence 999999999999874 346899999999999999999999999999999999999964 44699999999987643
Q ss_pred CCc---ccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHccc-------cCC
Q 013816 212 GEK---FSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA----QAIIRSVL-------DFR 277 (436)
Q Consensus 212 ~~~---~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~----~~i~~~~~-------~~~ 277 (436)
... .....||+.|+|||++.+.++.++||||||+++|+|++|..||......... ..+..... ...
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 221 2345799999999999888999999999999999999999999765433222 22211110 001
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.......++.+.+++.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11123456788999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=360.33 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=209.2
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|..|++|+.+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 4678999999999999999999999999999999988654322 34788999999996667888888888899999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+ |++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++..+....+||+|||+++...
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999975 4579999999999999999999999999999999999999644455679999999998765
Q ss_pred CCCc--------ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHccccCCC
Q 013816 211 PGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRR 278 (436)
Q Consensus 211 ~~~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~ 278 (436)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4322 12568999999999987 4689999999999999999999999976443 3333333332221111
Q ss_pred -CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 279 -DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 279 -~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.....+++++.+||..||+.+|++||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111357899999999999999999999998875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=353.85 Aligned_cols=246 Identities=20% Similarity=0.265 Sum_probs=197.4
Q ss_pred ccccceeeccccccCCceEEEEE-----EEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCC---CCceeEEEE
Q 013816 52 EIEERYELGRELGRGEFGITYLC-----TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKD 123 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~-----~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~---h~niv~~~~ 123 (436)
...++|++.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.+++.+ . |+||+++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l-~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERL-KPSMQHMFMKFYS 134 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHS-CGGGGGGBCCEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHh-hhhhhhhhhhhhe
Confidence 33578999999999999999999 46778999999998643 245678888888888 5 899999999
Q ss_pred EEEeCCeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-------
Q 013816 124 TYEDDTAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN------- 191 (436)
Q Consensus 124 ~~~~~~~~~lv~E~~~g~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~------- 191 (436)
++...+..|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 456999999999999999999999999999999999999975
Q ss_pred -CCCCCCeEEEeeccccccC---CCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 013816 192 -KKETAPLKAIDFGLSVFFK---PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266 (436)
Q Consensus 192 -~~~~~~ikl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~ 266 (436)
+...+.+||+|||+|+... ........+||+.|+|||++.+ .++.++|||||||++|+|+||+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 2225679999999996543 3334466789999999999874 589999999999999999999999964432100
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.....+.. ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus 294 ----~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ----KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00001111 1346789999999999999999765555544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=338.21 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=198.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-CCeEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVH 132 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~ 132 (436)
.++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++++ +||||+++++++.. .+.++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceE
Confidence 468999999999999999999874 8999999986432 457789999999999 89999999998754 45789
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||++|++|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC---CCcEEEeecccccccc
Confidence 99999999999999976543 899999999999999999999999999999999999964 4459999999987654
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.. .....+|+.|+|||++. ..++.++||||||+++|+|+| |..||...........+.... .......+++.+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 243 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAV 243 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHHH
Confidence 32 23346788999999986 568999999999999999998 999998887766666554432 223335789999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.++|.+||+.||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=340.39 Aligned_cols=250 Identities=20% Similarity=0.297 Sum_probs=204.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEE-EeCC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY-EDDT 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~-~~~~ 129 (436)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+... ......+.+.+|+.+++++ +||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence 357999999999999999999975443 46899988643 3445567899999999999 899999999985 4567
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC---CCCEEECccccccc
Confidence 889999999999999999764 45899999999999999999999999999999999999964 44699999999986
Q ss_pred cCCCC-----cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 209 FKPGE-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 209 ~~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
..... ......+|+.|+|||++. ..++.++||||||+++|+|++ |.+||...........+....... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QP 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC---CC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC---CC
Confidence 64332 123456788999999986 568999999999999999999 667777666666666665544322 22
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+++.+.+++.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4578999999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.64 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=204.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
-.|.+.+.||+|+||+||+|.+..++. .+|+|++... ......+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCC
Confidence 357888999999999999999765554 7999998643 3445567899999999999 899999999999876655
Q ss_pred -EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 132 -HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 132 -~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. .+.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE---SFTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC---CCcEEeCcCCCcccc
Confidence 999999999999999976 356899999999999999999999999999999999999964 446999999999765
Q ss_pred CCCC-----cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 210 KPGE-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
.... ......+|+.|+|||.+. ..++.++||||||+++|+|++|. +||...........+..... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---LPQPE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---CCCCT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---CCCCc
Confidence 4322 223456788999999987 46899999999999999999955 45555555555555544332 22234
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+.+++.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 678999999999999999999999999873
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=342.63 Aligned_cols=241 Identities=27% Similarity=0.417 Sum_probs=194.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++++ +||||+++++++. +..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEE
Confidence 67999999999999999999874 789999998532 2457899999999999 8999999999876 347899
Q ss_pred EeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 135 MELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHK---HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
|||++|++|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEcccccccc
Confidence 99999999999998664 37899999999999999999999 89999999999999975432 379999999976
Q ss_pred cCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHccccCCCCCCcccC
Q 013816 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+... ........++
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (307)
T 2eva_A 156 IQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG---TRPPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT---CCCCCBTTCC
T ss_pred ccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC---CCCCcccccC
Confidence 542 233457999999999987 46899999999999999999999999754332 222222222 1223345789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.83 Aligned_cols=242 Identities=21% Similarity=0.294 Sum_probs=204.5
Q ss_pred cccccCCceEEEEEEE--cCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
+.||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+|+++ +|||||++++++.. +.+++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence 4799999999999965 4567899999987653 3344567899999999999 89999999999964 5688999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc----
Q 013816 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---- 214 (436)
Q Consensus 139 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---- 214 (436)
+||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC---CEEEEEcCCccccccCcccccc
Confidence 9999999999888899999999999999999999999999999999999997654 589999999987654332
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+..+... .....+++++.+||
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 23345678899999987 469999999999999999998 99999999888877777665422 22346899999999
Q ss_pred HHccCCCcCCCCCHHHHhc
Q 013816 293 RKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~ 311 (436)
.+||+.||++|||+.++++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=367.74 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=204.3
Q ss_pred cceeecc-ccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGR-ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
+++.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+++ +|||||++++++.. +.+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence 4555555 7999999999999876 356779999997542 233567899999999999 99999999999976 568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC---cEEEeeccCccccc
Confidence 9999999999999999754 4599999999999999999999999999999999999997544 59999999998764
Q ss_pred CCCcc----cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... ....+|+.|+|||++. +.++.++|||||||++|||+| |..||.+....+....+..+.. ......+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC 564 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---CCCCTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence 33221 2234568899999987 679999999999999999998 9999998888877777766532 2223468
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++++.+||.+||+.||++|||+.++++
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999854
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=352.11 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=197.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-eCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~ 130 (436)
..|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 46889999999999999999976433 46899988643 3344567899999999999 8999999999864 4568
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC---CCCEEEeeccccccc
Confidence 89999999999999999765 45889999999999999999999999999999999999964 446999999999865
Q ss_pred CCCC-----cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCc
Q 013816 210 KPGE-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (436)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 282 (436)
.... ......+|+.|+|||++. ..++.++|||||||++|+|+| |.+||......+....+..+... ....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~---~~p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---LQPE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC---CCCT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC---CCCC
Confidence 4322 123346778999999986 568999999999999999999 78888776666555555554322 2224
Q ss_pred ccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 283 ~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.+++.+.+++.+||+.||++|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 688999999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=340.04 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=204.0
Q ss_pred ccccceeeccccccCCceEEEEEE----EcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
...++|++++.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Confidence 345789999999999999999998 4568999999998653 334567899999999999 89999999999865
Q ss_pred CC--eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 DT--AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 ~~--~~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
.+ .+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---~~kL~Dfg 190 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDFG 190 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC---cEEEecCc
Confidence 43 789999999999999999876 4599999999999999999999999999999999999997644 49999999
Q ss_pred cccccCCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH------------HH--
Q 013816 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ------------GV-- 265 (436)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~------------~~-- 265 (436)
++........ .....+|..|+|||++. ..++.++||||||+++|+|+||..||...... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 9987654332 12345778899999986 45889999999999999999999998543111 00
Q ss_pred -HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 -AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 -~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
......... .......+++++.++|.+||+.||++|||+.++++
T Consensus 271 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111111111 12223568999999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=362.80 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=210.0
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+++ +||||+++++++.+ ..+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccce
Confidence 35789999999999999999999864 56799999875432 346799999999999 89999999999865 6789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++...
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC---CcEEEcccccceecC
Confidence 999999999999999743 468999999999999999999999999999999999999643 459999999998764
Q ss_pred CCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... .....++..|+|||++. +.++.++|||||||++|+|+| |..||.+....+....+..+.. ......+++
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~~ 491 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPE 491 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence 3221 12345678899999876 568999999999999999999 9999998888877777765432 222356899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.+||.+||+.||++|||+.++++.
T Consensus 492 ~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 492 SLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=341.26 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=194.5
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhC-CCCCceeEEEEEEEeC
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYEDD 128 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l-~~h~niv~~~~~~~~~ 128 (436)
+..+.++|++.+.||+|+||.||+|++. ++.||||++... ......+|.+++..+ .+||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3466789999999999999999999875 899999998543 223445555555543 2899999999999887
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCCC
Q 013816 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 129 ----~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------~iiH~dlkp~NIl~~~~~~~~ 196 (436)
..+++||||++|++|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++. .+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~---~~ 179 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK---NG 179 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT---TS
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC---CC
Confidence 7899999999999999999664 699999999999999999999999 9999999999999964 34
Q ss_pred CeEEEeeccccccCCCCcc-----cccccCCcccchhccccc-CCCC------CchhHHHHHHHHHHhC----------C
Q 013816 197 PLKAIDFGLSVFFKPGEKF-----SEIVGSPYYMAPEVLKRN-YGPE------VDVWSAGVILYILLCG----------V 254 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~-~~~~------~DiwSlG~il~~lltg----------~ 254 (436)
.+||+|||++......... ....||+.|+|||++.+. ++.. +|||||||++|+|+|| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 5999999999766433221 345799999999998743 4443 8999999999999999 7
Q ss_pred CCCCCCCH----HHHHHHHHH-ccccCCCCC---CcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 255 PPFWAETE----QGVAQAIIR-SVLDFRRDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 255 ~pf~~~~~----~~~~~~i~~-~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.||..... ......... .......+. ...+++++.+|+.+||+.||.+|||+.++++|
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77754321 112222221 111111110 12456789999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=356.41 Aligned_cols=251 Identities=16% Similarity=0.224 Sum_probs=199.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-----ChhhHHHHHHHHHHHHhCC--------CCCceeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLP--------KHQNIVC 120 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~--------~h~niv~ 120 (436)
.++|++++.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.+. .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999997 6899999999876432 2234578899999999884 4888888
Q ss_pred EEEEEE------------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 013816 121 LKDTYE------------------------------DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170 (436)
Q Consensus 121 ~~~~~~------------------------------~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~ 170 (436)
+.+++. ..+.+|+||||+++|++.+.+.. ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 887753 26889999999999987777644 56899999999999999999
Q ss_pred HHH-HCCceecCCCCCceEeecCCC-----------------CCCeEEEeeccccccCCCCcccccccCCcccchhcccc
Q 013816 171 MCH-KHGVMHRDLKPENFLFANKKE-----------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232 (436)
Q Consensus 171 ~lH-~~~iiH~dlkp~NIl~~~~~~-----------------~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~ 232 (436)
||| ++||+||||||+|||++.++. ...+||+|||+|+..... ..+||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999987541 226999999999876532 3489999999999987
Q ss_pred cCCCCCchhHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHHccccCCCC---CCcccCHHHHHHHHHccCCCcCCCCCHH
Q 013816 233 NYGPEVDVWSAGVI-LYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRD---PWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (436)
Q Consensus 233 ~~~~~~DiwSlG~i-l~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~---~~~~~~~~~~~ll~~~l~~~p~~Rps~~ 307 (436)
..+.++||||+|++ .+++++|..||..... ......+.......... .++.+|+++++||.+||+.| |+.
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 67889999998777 7788999999843211 11222333221111111 12357889999999999976 999
Q ss_pred HHh-cCcccc
Q 013816 308 QVL-EHPWLQ 316 (436)
Q Consensus 308 e~l-~h~~~~ 316 (436)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=342.42 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=206.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++.+.||+|+||.||+|.+.. .+|+|++...... ....+.+.+|+.+++++ +||||+++++++...+.++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceE
Confidence 35789999999999999999998753 4999998755322 22345677899999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ .+.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccccc
Confidence 9999999999999997654 689999999999999999999999999999999999996 23589999999875432
Q ss_pred ------CCcccccccCCcccchhcccc----------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc
Q 013816 212 ------GEKFSEIVGSPYYMAPEVLKR----------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (436)
Q Consensus 212 ------~~~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 275 (436)
........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 122234568999999998753 3678999999999999999999999988887776666554332
Q ss_pred CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 276 ~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
......++.++.+++.+||+.||.+|||+.++++.
T Consensus 262 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 262 --NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp --CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred --CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 12223578899999999999999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=340.25 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=202.3
Q ss_pred ccccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHh--CCCCCceeEEEEEEEe
Q 013816 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVCLKDTYED 127 (436)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~--l~~h~niv~~~~~~~~ 127 (436)
+..+.++|++.+.||+|+||.||+|.+ +|+.||+|++... ....+.+|++++.. + +||||+++++++..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEEC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeecc
Confidence 355678999999999999999999997 5899999998543 34667889999988 5 89999999999988
Q ss_pred CC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceEeecCCCC
Q 013816 128 DT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 128 ~~----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
.. .+++||||+++++|.+++... .+++..+..++.|++.||.||| +.||+||||||+|||++.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~--- 183 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--- 183 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT---
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC---
Confidence 76 899999999999999999764 6999999999999999999999 8999999999999999644
Q ss_pred CCeEEEeeccccccCCCC-----cccccccCCcccchhccccc-------CCCCCchhHHHHHHHHHHhC----------
Q 013816 196 APLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG---------- 253 (436)
Q Consensus 196 ~~ikl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~~lltg---------- 253 (436)
+.+||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|+||
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 459999999998765443 22455799999999998643 23689999999999999999
Q ss_pred CCCCCCCC-----HHHHHHHHHHccccCCCCC---CcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 254 VPPFWAET-----EQGVAQAIIRSVLDFRRDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 254 ~~pf~~~~-----~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..||.... .......+.........+. ....++.+.+|+.+||+.||++|||+.++++|
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 78986642 2233333322222111110 01344689999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=343.32 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=190.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHH--HHhCCCCCceeEEEEEEEe----
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI--MRHLPKHQNIVCLKDTYED---- 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~--l~~l~~h~niv~~~~~~~~---- 127 (436)
.++|++++.||+|+||.||+|++ +++.||+|++.... ...+..|.++ +..+ +||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence 46899999999999999999976 68999999986432 2344444444 4446 89999999986542
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceEeecCCCCCC
Q 013816 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------GVMHRDLKPENFLFANKKETAP 197 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------~iiH~dlkp~NIl~~~~~~~~~ 197 (436)
...+++||||++||+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++. .+.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~---~~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN---DGT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT---TSC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC---CCc
Confidence 33678999999999999999765 458999999999999999999999 9999999999999964 346
Q ss_pred eEEEeeccccccCCCC---------cccccccCCcccchhcccc--------cCCCCCchhHHHHHHHHHHhCCCCCCCC
Q 013816 198 LKAIDFGLSVFFKPGE---------KFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLCGVPPFWAE 260 (436)
Q Consensus 198 ikl~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~~lltg~~pf~~~ 260 (436)
+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998764321 2234579999999999864 3567899999999999999997776432
Q ss_pred CH-----------------HHHHHHHHHcccc-CC-CCC---CcccCHHHHHHHHHccCCCcCCCCCHHHHhc------C
Q 013816 261 TE-----------------QGVAQAIIRSVLD-FR-RDP---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE------H 312 (436)
Q Consensus 261 ~~-----------------~~~~~~i~~~~~~-~~-~~~---~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~------h 312 (436)
.. ............. .. ... ....++++.+||.+||+.||++|||+.|+++ +
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 1111111111111 00 011 1124568999999999999999999999954 6
Q ss_pred cccccCccC
Q 013816 313 PWLQNAKKA 321 (436)
Q Consensus 313 ~~~~~~~~~ 321 (436)
+|-++....
T Consensus 319 ~~~~~~~~~ 327 (336)
T 3g2f_A 319 IWERNKSVS 327 (336)
T ss_dssp CCCC-----
T ss_pred HHHhcccCC
Confidence 777765443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=361.74 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=208.9
Q ss_pred cccceeeccccccCCceEEEEEEEcCC---CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 129 (436)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+++++ +||||+++++++. ++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cC
Confidence 357899999999999999999998654 467999987543 2344557899999999999 8999999999984 56
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..|+||||++||+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~---~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC---CEEEEecCCCee
Confidence 7899999999999999998654 689999999999999999999999999999999999997644 599999999987
Q ss_pred cCCCCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 209 FKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 209 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..... ....+.+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~ 617 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNC 617 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC---CCCCTTC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCccc
Confidence 654332 23345678999999986 568999999999999999997 9999999888877777766532 2223568
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.+.+||.+||+.||.+|||+.++++.
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=372.77 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=206.1
Q ss_pred CcccccccceeeccccccCCceEEEEEEEcC-CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 48 PTGREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
+.|..+.++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+++++ +||||+++++++.
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE 149 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence 4566778999999999999999999999976 7899999998643 2344566789999999999 8999999999998
Q ss_pred eCCe-----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 127 DDTA-----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 127 ~~~~-----~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
..+. .|+||||++|++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~ 223 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLI 223 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEEC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEE
Confidence 7665 7999999999999887754 79999999999999999999999999999999999999642 58999
Q ss_pred eeccccccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
|||+++..... ....||+.|+|||++.+.++.++|||||||++|+|++|..||.+..... . ......
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~-~~~~~~ 290 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------L-PEDDPV 290 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------C-CTTCHH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------c-cccccc
Confidence 99999876533 4567999999999998777899999999999999999999886432110 0 011111
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
...++.+.+||.+||+.||.+||++.+++.|+|+.
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 23568899999999999999999999999998874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=350.76 Aligned_cols=247 Identities=17% Similarity=0.220 Sum_probs=191.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-Cc----------------
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QN---------------- 117 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~n---------------- 117 (436)
..|.+.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| +|
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 4588999999999999999999999999999998754444444567899999999998 55 21
Q ss_pred -----eeEEEEEEEe-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 013816 118 -----IVCLKDTYED-----DTAVHLVMELCEGGELFDRIVA-------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180 (436)
Q Consensus 118 -----iv~~~~~~~~-----~~~~~lv~E~~~g~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 180 (436)
...+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111122221 23567888877 5699888841 2347788899999999999999999999999
Q ss_pred CCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhcc----------c-ccCCCCCchhHHHHHHHH
Q 013816 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----------K-RNYGPEVDVWSAGVILYI 249 (436)
Q Consensus 181 dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l----------~-~~~~~~~DiwSlG~il~~ 249 (436)
||||+|||++.+ +.+||+|||+++.... .....+| +.|+|||++ . ..++.++|||||||++|+
T Consensus 236 DiKp~NILl~~~---~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQR---GGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTT---CCEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecC---CeEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999654 4499999999886542 3455678 999999998 3 237789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 250 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
|+||+.||...........+ ...+..+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999776543322211 1223468899999999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.43 Aligned_cols=229 Identities=14% Similarity=0.066 Sum_probs=188.8
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.++.++ +||||+++++++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcE
Confidence 6678999999999999999999999999999999999876555555668899999999999 999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.++ .+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g---~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG---DVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS---CEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC---CEEEEecc-------
Confidence 9999999999999998543 46667889999999999999999999999999999997543 47887443
Q ss_pred CCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHccccCCCCCCcccCHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~ 288 (436)
|++| ++.++|||||||++|+|+||+.||.+.+...... ..............+.+++++
T Consensus 175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 4443 6789999999999999999999998765422110 000111110011124689999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
.++|.+||+.||++| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999884
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=303.31 Aligned_cols=233 Identities=17% Similarity=0.135 Sum_probs=158.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCC-------hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
...+.|+.|.+..++....|+.+|+|++.+..... ..+.+++.+|+++|+++..|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 45778888888888888889999999997653221 23456799999999999889999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
||||++|++|.++|...+++++. .|+.||+.||.|+|++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---g~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---QHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---SCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC---CCEEEeecccCeeCCCCC
Confidence 99999999999999998888875 478999999999999999999999999999654 45999999999876543
Q ss_pred CcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
....+.+||+.|||||++.+.+..++|+||+|++++++.++..|+ ...+... +.. ...+..+.
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-----~~~~~~l~ 456 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-----RWNFVLLL 456 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGG-----GCSHHHHH
T ss_pred ccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCC-----CCcHHHHH
Confidence 334567899999999999988889999999999998887664443 1111110 000 01234555
Q ss_pred HHccCCCcCCCCCHHHHhcCcccc
Q 013816 293 RKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
..++..+|..||.......++|..
T Consensus 457 ~~l~~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 457 ALFEKKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp HHHHTGGGSCCGGGSSCCHHHHHH
T ss_pred HHHhCCCCCCCCChhhhccchhHH
Confidence 566666676666666555555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-30 Score=259.64 Aligned_cols=184 Identities=21% Similarity=0.190 Sum_probs=145.4
Q ss_pred eeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh-----hhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
...+.||+|+||.||+|. ..+..+++|.......... ...+.+.+|+++++++ +||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 446789999999999994 4688999998765443322 1245689999999999 9999996555555777789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCc
Confidence 99999999999998865 5689999999999999999999999999999964 6999999999987543
Q ss_pred Cc--------ccccccCCcccchhccc---ccCCCCCchhHHHHHHHHHHhCCCCC
Q 013816 213 EK--------FSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPF 257 (436)
Q Consensus 213 ~~--------~~~~~gt~~y~aPE~l~---~~~~~~~DiwSlG~il~~lltg~~pf 257 (436)
.. .....||+.|+|||++. ..|+..+|+||..+-..+.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 13568999999999986 35888899999999998888877776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=212.99 Aligned_cols=159 Identities=25% Similarity=0.289 Sum_probs=121.7
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh---------------hhHHHHHHHHHHHHhCCCCCceeE
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---------------VDIEDVRREVDIMRHLPKHQNIVC 120 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~---------------~~~~~~~~E~~~l~~l~~h~niv~ 120 (436)
.|.+.+.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++++. |++++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~~ 168 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPK 168 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCC
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcCe
Confidence 455669999999999999999 8899999999864322111 13567899999999994 544444
Q ss_pred EEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEE
Q 013816 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (436)
Q Consensus 121 ~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl 200 (436)
++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ .+.+||
T Consensus 169 ---~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vkl 233 (282)
T 1zar_A 169 ---VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 233 (282)
T ss_dssp ---EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred ---EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEEE
Confidence 4433 45689999999999987 42 123557999999999999999999999999999997 345999
Q ss_pred EeeccccccCCCCcccccccCCcccchhccc-----------ccCCCCCchhHH
Q 013816 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-----------RNYGPEVDVWSA 243 (436)
Q Consensus 201 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-----------~~~~~~~DiwSl 243 (436)
+|||+|+. +..|+|||.+. ..|+..+|+|.+
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 99999864 34578999874 235566676653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=184.84 Aligned_cols=141 Identities=16% Similarity=0.162 Sum_probs=108.2
Q ss_pred ceeeccccccCCceEEEEEEEcCCCcE--EEEEEeeccccCC---------------------hhhHHHHHHHHHHHHhC
Q 013816 56 RYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRT---------------------AVDIEDVRREVDIMRHL 112 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~i~~~~~~~---------------------~~~~~~~~~E~~~l~~l 112 (436)
.|++.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999998778999 9999875432110 01123688999999999
Q ss_pred CCCCce--eEEEEEEEeCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCC
Q 013816 113 PKHQNI--VCLKDTYEDDTAVHLVMELCEG-G----ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKP 184 (436)
Q Consensus 113 ~~h~ni--v~~~~~~~~~~~~~lv~E~~~g-~----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp 184 (436)
.|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.||+||||||
T Consensus 128 -~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 -KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp -HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred -HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 67653 444442 256899999942 3 66655432 235567899999999999999 99999999999
Q ss_pred CceEeecCCCCCCeEEEeecccccc
Q 013816 185 ENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 185 ~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~-----~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID-----KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS-----SEEECCCTTCEET
T ss_pred HHEEEcC-----cEEEEECcccccC
Confidence 9999964 5999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-20 Score=174.03 Aligned_cols=140 Identities=19% Similarity=0.250 Sum_probs=100.1
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-----------ChhhHH--------HHHHHHHHHHhCCCCCc
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----------TAVDIE--------DVRREVDIMRHLPKHQN 117 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----------~~~~~~--------~~~~E~~~l~~l~~h~n 117 (436)
|++++.||+|++|.||+|.+ .+|+.||||+++..... ...... ...+|...|.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 89999999999999999997 47999999987643211 000011 124567777777 4444
Q ss_pred ee--EEEEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 013816 118 IV--CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (436)
Q Consensus 118 iv--~~~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~ 195 (436)
+. ..++. .. .+|||||++|++|.++. ....+..++.|++.+|.+||+.|||||||||.|||++.+++.
T Consensus 175 v~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 22322 22 36999999999886542 122456788999999999999999999999999999875431
Q ss_pred -------CCeEEEeeccccc
Q 013816 196 -------APLKAIDFGLSVF 208 (436)
Q Consensus 196 -------~~ikl~DfG~a~~ 208 (436)
..+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 1378999997654
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=124.53 Aligned_cols=123 Identities=22% Similarity=0.327 Sum_probs=102.9
Q ss_pred cCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 311 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 311 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
.|||+-... .+..++...+..++++|...+++++.++..++..++.++...++++|..+|.|++|.|+.+|+..+++.+
T Consensus 3 ~~~~~~~~~-~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSGR-ENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCCc-cccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 477765433 3445677788999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH---------HHHHHhHHhhhhcCC
Q 013816 391 GHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------VRLKISFFRWYEIGG 435 (436)
Q Consensus 391 g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------~~~~~~f~~~d~~~~ 435 (436)
|..++ .+++.+++.+|.|++ |+|+||... ..+..+|+.+|+||+
T Consensus 82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~~~~~~~~~~~~~~l~~~F~~~D~d~~ 136 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFIAAALDRKQLSKKLIYCAFRVFDVDND 136 (191)
T ss_dssp TCCCC-TTHHHHHHHHCTTCSSSEEHHHHHHHHSCGGGCCHHHHHHHHHHHSTTCS
T ss_pred CCCcH-HHHHHHHHHhCCCCCCeEeHHHHHHHHHhhhhccHHHHHHHHHHhCCCCC
Confidence 99988 899999999999887 999999664 357789999999875
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.52 E-value=9.2e-15 Score=127.56 Aligned_cols=124 Identities=27% Similarity=0.323 Sum_probs=95.9
Q ss_pred cCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 311 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 311 ~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
.|||.+... .+..++...++.++++|...+++++..+..++..++.++...++++|..+|.|++|.|+.+|+..+++.+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 489998654 3456677889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 391 GHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 391 g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
|..++.++++.++..+|.|++ |+|+||.. ...+..+|+.||+||+
T Consensus 87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~ 143 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFLAATIDKQTYLKKEVCLIPFKFFDIDGN 143 (197)
T ss_dssp C----CHHHHHHHHC-------CEEHHHHHHTTCCHHHHCSHHHHHHHHHHHCTTCS
T ss_pred CCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHHHHHCCCCC
Confidence 999999999999999998876 99999943 3367889999999885
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.7e-13 Score=125.05 Aligned_cols=141 Identities=18% Similarity=0.173 Sum_probs=111.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
..|++...++.|+.+.||++.. .++.+++|+....... ....+.+|+.+++.|..+..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4588889999999999999974 3789999998643211 1245889999999996678889999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 174 (436)
||+++|.+|.+.+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876521 222345788899999999998
Q ss_pred -------------------CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 175 -------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 175 -------------------~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++|+|++|.||+++.+ ..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence 458999999999999642 2356999997753
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.1e-11 Score=106.30 Aligned_cols=107 Identities=18% Similarity=0.253 Sum_probs=96.3
Q ss_pred cHHHHHHHHhhHhhhhhHHHHHHHHHhhch--hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHH
Q 013816 327 GETVKARLKQFSVMNKLKKRALKVIAQHLS--VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMD 404 (436)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~l~~i~~~~~--~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~ 404 (436)
...++.+++.|...+.+++.++..++..++ .++...++++|..+|.|++|+|+.+|+..+++.+|. +..++..++.
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~--~~~~~~~~~~ 80 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGI--KKWDINRILQ 80 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCC--CHHHHHHHHH
Confidence 457788999999999999999999999887 788899999999999999999999999999999986 4789999999
Q ss_pred HHhcCCC--cCHhhHHHHH---------HHHHhHHhhhhcCC
Q 013816 405 AVSHTLH--LDLAFFREKV---------RLKISFFRWYEIGG 435 (436)
Q Consensus 405 ~~d~~~~--i~~~ef~~~~---------~~~~~f~~~d~~~~ 435 (436)
.+|.|++ |+|+||...+ .+..+|+.+|+||+
T Consensus 81 ~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~F~~~D~d~~ 122 (180)
T 3mse_B 81 ALDINDRGNITYTEFMAGCYRWKNIESTFLKAAFNKIDKDED 122 (180)
T ss_dssp HHCTTCCSEECHHHHHHHHSCCTTC--CHHHHHHHHHCTTCS
T ss_pred HhCCCCCCcCcHHHHHHHHHhcccCCHHHHHHHHHHHCCCCC
Confidence 9999887 9999996533 57789999999874
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-12 Score=99.22 Aligned_cols=68 Identities=19% Similarity=0.388 Sum_probs=63.0
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.++.++..+++++|+.+|.|++|+|+.+||+.+|+.+|..++++|++++++.+|.||+ |+|+||...|
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~~~m 98 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFVTLL 98 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHHHHT
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHHHHh
Confidence 3467788899999999999999999999999999999999999999999999999987 9999997754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=6.4e-12 Score=114.30 Aligned_cols=136 Identities=14% Similarity=0.143 Sum_probs=98.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEEEEEEeCCeEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~~~~~~~~~~~l 133 (436)
..|.+....+.|..+.||++.. .+|..+++|+.... ....+.+|+.+++.+..+. .+++++.+....+..++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 3466544445666799999864 56788999986543 1245778999999985442 26678988888888999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG------------------------------------- 176 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~------------------------------------- 176 (436)
||||++|.+|. . . ... ...++.++...|..||+..
T Consensus 93 v~e~i~G~~l~--~-~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--S-S--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--T-S--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--c-C--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998883 1 1 122 2356677777777777643
Q ss_pred ---------------------ceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 177 ---------------------VMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 177 ---------------------iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
++|+|++|.||+++.+ ..+.|+|||.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence 9999999999999642 2356999998754
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=5e-12 Score=107.95 Aligned_cols=83 Identities=25% Similarity=0.393 Sum_probs=76.0
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------- 419 (436)
..++.+++..++++|..+|.|++|+|+.+||..+++.+|..+++.++.+++..+|.+++ |+|+||..
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~ 82 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 82 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHHHHHTSSCCSSHH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHHHHHHHhcccCCc
Confidence 35678899999999999999999999999999999999999999999999999999887 99999943
Q ss_pred HHHHHHhHHhhhhcCC
Q 013816 420 KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.||+||+
T Consensus 83 ~~~l~~aF~~fD~d~~ 98 (176)
T 2lhi_A 83 EQELLEAFKVFDKNGD 98 (176)
T ss_dssp HHHHHHHHHHHCSSCS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 4468899999999985
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.25 E-value=4.5e-12 Score=109.54 Aligned_cols=111 Identities=21% Similarity=0.328 Sum_probs=99.2
Q ss_pred CccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc-----------CC
Q 013816 325 SLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-----------GH 392 (436)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-----------g~ 392 (436)
++...+..++++|...+.+++.++..++..+ +.++...+.++|..+|.|++|.|+.+|+..+++.+ |.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~ 82 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDS 82 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccc
Confidence 3456778899999999999999999999988 88889999999999999999999999999999988 77
Q ss_pred CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------HHHHHhHHhhhhcCC
Q 013816 393 QIPDTDVQILMDAVSHTLH--LDLAFFREK----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 393 ~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~~~~~f~~~d~~~~ 435 (436)
.++.+++..+++.+|.|++ |+|+||... ..+..+|..+|+||+
T Consensus 83 ~~~~~~~~~~~~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 137 (191)
T 3khe_A 83 SQIEAEVDHILQSVDFDRNGYIEYSEFVTVCMDKQLLLSRERLLAAFQQFDSDGS 137 (191)
T ss_dssp HHHHHHHHHHHHHTCTTCSSSEEHHHHHHHHSCHHHHCCHHHHHHHHHHHCTTCS
T ss_pred hhhHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhcccchHHHHHHHHHHHCCCCc
Confidence 7788999999999999877 999999654 367789999999874
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.3e-11 Score=101.50 Aligned_cols=100 Identities=39% Similarity=0.590 Sum_probs=87.5
Q ss_pred hhHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cC
Q 013816 336 QFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LD 413 (436)
Q Consensus 336 ~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~ 413 (436)
+|...+.+++..+..+...++.++...+..+|..+|.+++|.|+.+|+..++..+|..++.+++..++..+|.+++ |+
T Consensus 2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~ 81 (166)
T 2aao_A 2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTID 81 (166)
T ss_dssp ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBC
T ss_pred chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEc
Confidence 5667788888889999999999999999999999999999999999999999999999999999999999999877 99
Q ss_pred HhhHHHH----------HHHHHhHHhhhhcCC
Q 013816 414 LAFFREK----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 414 ~~ef~~~----------~~~~~~f~~~d~~~~ 435 (436)
|+||... ..+..+|..+|+||+
T Consensus 82 ~~ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 113 (166)
T 2aao_A 82 YKEFIAATLHLNKIEREDHLFAAFTYFDKDGS 113 (166)
T ss_dssp HHHHHHHHTTCHHHHTTHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHHhhcccHHHHHHHHHHhCCCCC
Confidence 9999543 356789999999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-11 Score=115.62 Aligned_cols=142 Identities=20% Similarity=0.341 Sum_probs=104.7
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEee--ccccCChhhHHHHHHHHHHHHhCCC-CCceeEEEEEEEeC---CeEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDD---TAVHL 133 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~--~~~~~~~~~~~~~~~E~~~l~~l~~-h~niv~~~~~~~~~---~~~~l 133 (436)
++.|+.|.++.||++... +..+++|+.. .... ......+.+|+.+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 567899999999998753 5678888765 2221 1123567889999999843 45588899888766 45899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--------------------------------------- 174 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 174 (436)
||||++|.++.+.. -..+++.....++.++..+|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875421 1246788888999999999999997
Q ss_pred -------------------CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 175 -------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 175 -------------------~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
..++|||++|.|||++.++. ..+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECcccccc
Confidence 35899999999999975432 2358999998864
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.3e-11 Score=116.47 Aligned_cols=83 Identities=23% Similarity=0.384 Sum_probs=75.6
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
..++.+++.+++++|+.+|.|++|+|+.+||..+|+.+|..++++|++++++.+|.|++ |+|+||...
T Consensus 294 E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl~lms~~lk~~d~ 373 (440)
T 3u0k_A 294 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFLIMMARKMKDTDS 373 (440)
T ss_dssp BCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHHHHHHTC------
T ss_pred hhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCh
Confidence 35678999999999999999999999999999999999999999999999999999987 999999532
Q ss_pred -HHHHHhHHhhhhcCC
Q 013816 421 -VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -~~~~~~f~~~d~~~~ 435 (436)
.++..+|+.||+||+
T Consensus 374 eeeLreAFk~fDkDgd 389 (440)
T 3u0k_A 374 EEEIREAFRVFDKDGN 389 (440)
T ss_dssp CHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHHCCCCc
Confidence 357789999999985
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.9e-11 Score=99.34 Aligned_cols=79 Identities=18% Similarity=0.358 Sum_probs=70.9
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------HHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK-----------VRL 423 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~-----------~~~ 423 (436)
+++...++++|..+|.|++|+|+.+||..+++.+|..++.+++..++..+|.|++ |+|+||... ..+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~l 81 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI 81 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHHHHHHHHhccccHHHHH
Confidence 4567789999999999999999999999999999999999999999999999887 999999532 356
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.||+||+
T Consensus 82 ~~~F~~~D~d~~ 93 (143)
T 2obh_A 82 LKAFKLFDDDET 93 (143)
T ss_dssp HHHHHHHCTTCS
T ss_pred HHHHHHhCCCCC
Confidence 789999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.8e-11 Score=111.98 Aligned_cols=185 Identities=18% Similarity=0.234 Sum_probs=123.7
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCc--eeEEEEEEEeCC---eEEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDT---AVHLV 134 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~n--iv~~~~~~~~~~---~~~lv 134 (436)
++.++.|....||++. ..+++|+... ......+.+|+.+|+.+..+.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3558999999999863 4688887532 2345678999999988844433 445555443333 34789
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 174 (436)
||+++|.+|.+.... .++......++.++...|..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988764432 46778888888899988888886
Q ss_pred ------------------CCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCcccccccCCcccchhccc---cc
Q 013816 175 ------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RN 233 (436)
Q Consensus 175 ------------------~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---~~ 233 (436)
..++|+|++|.||+++.+. ...+.|+||+.+....+............-.+|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1369999999999997531 2347899999887643321111111000002333221 11
Q ss_pred CCC------------CCchhHHHHHHHHHHhCCCCC
Q 013816 234 YGP------------EVDVWSAGVILYILLCGVPPF 257 (436)
Q Consensus 234 ~~~------------~~DiwSlG~il~~lltg~~pf 257 (436)
|.. ..+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 221 258999999999999998876
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-10 Score=96.64 Aligned_cols=79 Identities=19% Similarity=0.257 Sum_probs=70.4
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-----HHHHhHHh
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-----RLKISFFR 429 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-----~~~~~f~~ 429 (436)
.++...++.+|..+|.|++|+|+.+||..+++.+|..++++++++++..+|.|++ |+|+||...+ .+..+|+.
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~~~~~~~~~~~~~aF~~ 123 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFLRMMLGKRSAILRMILM 123 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHHHHHCSSGGGGGGGGGG
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHhHHHHHHHHHH
Confidence 4667789999999999999999999999999999999999999999999999887 9999997655 36679999
Q ss_pred hhhcCC
Q 013816 430 WYEIGG 435 (436)
Q Consensus 430 ~d~~~~ 435 (436)
||.||+
T Consensus 124 ~D~d~~ 129 (147)
T 1wy9_A 124 YEEKNK 129 (147)
T ss_dssp CCCC--
T ss_pred HccCCC
Confidence 999875
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=99.14 E-value=1.2e-10 Score=96.60 Aligned_cols=79 Identities=16% Similarity=0.277 Sum_probs=66.3
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH-----HHHhHHh
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR-----LKISFFR 429 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~-----~~~~f~~ 429 (436)
.++...++.+|..+|.|++|+|+.+||..+++.+|..++++++++++..+|.|++ |+|+||...+. +..+|+.
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~~~~~~~~~~i~~aF~~ 125 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFVNMMLGKRSAVLKLVMM 125 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHHHHHHSSSCCHHHHHHC
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHHHhHHHHHHHHHH
Confidence 3556789999999999999999999999999999999999999999999998876 99999977663 6789999
Q ss_pred hhhcCC
Q 013816 430 WYEIGG 435 (436)
Q Consensus 430 ~d~~~~ 435 (436)
||.||+
T Consensus 126 ~D~d~~ 131 (150)
T 2jjz_A 126 FEGKAN 131 (150)
T ss_dssp ------
T ss_pred HcCCCC
Confidence 999875
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=99.13 E-value=3.8e-12 Score=119.49 Aligned_cols=149 Identities=18% Similarity=0.193 Sum_probs=104.2
Q ss_pred cccCHHHHHHHHHcc---CCCcCCCCCHHHHhcC------cccccCccCC----------------CCCc-------cHH
Q 013816 282 PKVSENAKDLVRKML---DPDPKRRLTAQQVLEH------PWLQNAKKAP----------------NVSL-------GET 329 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l---~~~p~~Rps~~e~l~h------~~~~~~~~~~----------------~~~~-------~~~ 329 (436)
..++.++.+|.++++ ..+|++|....+.+.| +|+....... .... ...
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 456788899999998 8999999999999988 8876541100 0000 011
Q ss_pred HHHHHH-hhHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc
Q 013816 330 VKARLK-QFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH 408 (436)
Q Consensus 330 ~~~~~~-~~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~ 408 (436)
++.+++ +|...+.+++ ++..++.++...+..+|..+|.|++|.|+.+|+..+|+.+|..++..++..++..+|.
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D~ 169 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVEN 169 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcC
Confidence 222222 2333333332 3356778888999999999999999999999999999999999999999999999999
Q ss_pred CCC--cCHhhHH----HHHHHHHhHHhhhhcCC
Q 013816 409 TLH--LDLAFFR----EKVRLKISFFRWYEIGG 435 (436)
Q Consensus 409 ~~~--i~~~ef~----~~~~~~~~f~~~d~~~~ 435 (436)
|++ |+|.+|. ....+..+|..||+||+
T Consensus 170 d~~G~I~f~ef~~l~~~~~~l~~~F~~~D~d~d 202 (323)
T 1ij5_A 170 DTKGRMSYITLVAVANDLAALVADFRKIDTNSN 202 (323)
T ss_dssp CCSSTHHHHHHTTSHHHHHTSCCCHHHHCTTCC
T ss_pred CCCCcCcHHHHHhhhhHHHHHHHHHHHHCCCCC
Confidence 877 9999994 34457789999999875
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=99.11 E-value=2.2e-11 Score=102.05 Aligned_cols=81 Identities=17% Similarity=0.249 Sum_probs=69.9
Q ss_pred hchhhhhhhhhhhccccCC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH--------
Q 013816 354 HLSVEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-------- 421 (436)
.++.+++..++++|..+|. |++|+|+..||..+|+.||..+|++|+++|+.. |.+|+ |+|+||...+
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~~-d~~~~g~i~f~eFl~~~~~~~~~~~ 80 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGGT-KKMGEKAYKLEEILPIYEEMSSKDT 80 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTCC-SSTTSCEECHHHHHHHHHHHTTCCT
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHcc-cccCCCcccHHHHHHHHHHhhcccc
Confidence 3567889999999999995 899999999999999999999999999998754 55555 9999996532
Q ss_pred -----HHHHhHHhhhhcCC
Q 013816 422 -----RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -----~~~~~f~~~d~~~~ 435 (436)
.+..||+.||+||+
T Consensus 81 ~~~~~~l~~aF~~fD~d~~ 99 (159)
T 3i5g_C 81 GTAADEFMEAFKTFDREGQ 99 (159)
T ss_dssp TCCHHHHHHHHHHHCTTSS
T ss_pred cchHHHHHHHHHHHhcCCC
Confidence 47789999999985
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=99.10 E-value=4.6e-11 Score=98.79 Aligned_cols=81 Identities=23% Similarity=0.363 Sum_probs=74.1
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------HH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-----------KV 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-----------~~ 421 (436)
++.+++..++++|..+|.|++|+|+.+||..+++.+|..++++++..++..+|.+++ |+|+||.. ..
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~ 83 (148)
T 2lmt_A 4 LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFCGIMAKQMRETDTEE 83 (148)
T ss_dssp CCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHHHHHHHTTTTTTTHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHHHHHHHHhcccCcHH
Confidence 567889999999999999999999999999999999999999999999999999887 99999954 23
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||+||+
T Consensus 84 ~l~~aF~~~D~d~~ 97 (148)
T 2lmt_A 84 EMREAFKIFDRDGD 97 (148)
T ss_dssp HHHHHHHHHHSSCS
T ss_pred HHHHHHHHHCCCCc
Confidence 57889999999985
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=99.10 E-value=1.5e-10 Score=95.65 Aligned_cols=82 Identities=24% Similarity=0.376 Sum_probs=72.6
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------- 420 (436)
.++.++...++.+|..+|.+++|.|+.+|+..+++.+|..++..++..++..+|.|++ |+|+||...
T Consensus 3 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 82 (148)
T 1exr_A 3 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE 82 (148)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhcccCCCcH
Confidence 3566778889999999999999999999999999999999999999999999999877 999999532
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 83 ~~l~~~F~~~D~d~~ 97 (148)
T 1exr_A 83 EELIEAFKVFDRDGN 97 (148)
T ss_dssp HHHHHHHHHHSTTCS
T ss_pred HHHHHHHHHhCCCCC
Confidence 245679999999875
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=99.09 E-value=9.5e-11 Score=97.45 Aligned_cols=80 Identities=25% Similarity=0.419 Sum_probs=71.0
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHH-----------HHH
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFRE-----------KVR 422 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~-----------~~~ 422 (436)
.++.+++..++++|..+|.|++|+|+.+||..+|+.+|..++++++..++.. .++.|+|+||.. ...
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~--~~~~i~f~ef~~~~~~~~~~~~~~~~ 86 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKE--CPGQLNFTAFLTLFGEKVSGTDPEDA 86 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHT--SSSCCCSHHHHHTTTTTTTTCCCHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHh--ccCCccHHHHHHHHHhhhcccccHHH
Confidence 4678899999999999999999999999999999999999999999998864 445699999943 346
Q ss_pred HHHhHHhhhhcCC
Q 013816 423 LKISFFRWYEIGG 435 (436)
Q Consensus 423 ~~~~f~~~d~~~~ 435 (436)
+..||+.||+||+
T Consensus 87 l~~aF~~fD~d~~ 99 (153)
T 3i5g_B 87 LRNAFSMFDEDGQ 99 (153)
T ss_dssp HHHHHHTTCSSCS
T ss_pred HHHHHhccccCCC
Confidence 8899999999985
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-10 Score=88.11 Aligned_cols=64 Identities=19% Similarity=0.192 Sum_probs=57.0
Q ss_pred hhhhhhhhccccC-CCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMD-IGNR-GKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++++|+.+| .|++ |+|+.+||+.+|+. +|..++++++++||+.+|.||+ |+|+||+..+.
T Consensus 8 ~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~~~ 80 (101)
T 3nso_A 8 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLA 80 (101)
T ss_dssp HHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 4568899999997 8887 99999999999997 5788999999999999999988 99999977654
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=8.3e-11 Score=92.58 Aligned_cols=62 Identities=19% Similarity=0.279 Sum_probs=55.9
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.+..++.+|+.+|.+ +|+|+.+||+.+|++ +|...+++++++||+.+|.||+ |+|+||...+
T Consensus 13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~~lm 81 (121)
T 4drw_A 13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLI 81 (121)
T ss_dssp HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 357899999999988 899999999999987 7899999999999999999988 9999995543
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=99.04 E-value=4e-10 Score=92.51 Aligned_cols=85 Identities=26% Similarity=0.393 Sum_probs=74.1
Q ss_pred HHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH--------
Q 013816 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK-------- 420 (436)
Q Consensus 351 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~-------- 420 (436)
|+..++.++...++.+|..+|.+++|.|+.+|+..+++.+|..++..++..++..+|.+++ |+|+||...
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~~~~~~~~~~~ 80 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFLALMSRQLKCN 80 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHHHHHHHHHHTH
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHHhccCC
Confidence 3456778889999999999999999999999999999999999999999999999999887 999999432
Q ss_pred ---HHHHHhHHhhhhcCC
Q 013816 421 ---VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 81 ~~~~~~~~~F~~~D~d~~ 98 (147)
T 4ds7_A 81 DSEQELLEAFKVFDKNGD 98 (147)
T ss_dssp HHHHHHHHHHHHHCTTCS
T ss_pred CcHHHHHHHHHHhCCCCC
Confidence 356789999999874
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=99.03 E-value=3.3e-10 Score=100.28 Aligned_cols=99 Identities=12% Similarity=0.145 Sum_probs=83.7
Q ss_pred hHhhhhhHHHHHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCH
Q 013816 337 FSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDL 414 (436)
Q Consensus 337 ~~~~~~~~~~~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~ 414 (436)
+.....+++.....+...++.++...++++|..+|.|++|.|+.+|+..+++.+|..++.++++.+++.+|.|++ |+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~ 106 (220)
T 3sjs_A 27 YQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHISF 106 (220)
T ss_dssp HHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCBCH
T ss_pred cCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCCH
Confidence 333344555555556677888999999999999999999999999999999999999999999999999998877 999
Q ss_pred hhHHHH----HHHHHhHHhhhhcCC
Q 013816 415 AFFREK----VRLKISFFRWYEIGG 435 (436)
Q Consensus 415 ~ef~~~----~~~~~~f~~~d~~~~ 435 (436)
+||... ..+..+|+.+|+||+
T Consensus 107 ~EF~~~~~~~~~l~~~F~~~D~d~~ 131 (220)
T 3sjs_A 107 YEFMAMYKFMELAYNLFVMNARARS 131 (220)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCCSST
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 999653 457789999999875
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=99.03 E-value=7.7e-10 Score=86.11 Aligned_cols=66 Identities=20% Similarity=0.265 Sum_probs=58.8
Q ss_pred hhhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 357 VEEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.++...++++|+.|| .|++| +|+.+||+.+|+. +|..++++++++||+.+|.|++ |+|+||...+.
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~~~m~ 92 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLS 92 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 345678999999999 89997 9999999999987 7788899999999999999887 99999987664
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=99.02 E-value=6.1e-10 Score=94.95 Aligned_cols=83 Identities=23% Similarity=0.397 Sum_probs=72.2
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
..++.++...++.+|..+|.+++|.|+.+|+..+++.+|..++..+++.++..+|.|++ |+|+||...
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~~~~~~~~~~~~~ 82 (179)
T 2f2o_A 3 DQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDS 82 (179)
T ss_dssp ---CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHHHHHHHHccCccc
Confidence 45677888899999999999999999999999999999999999999999999999877 999999432
Q ss_pred -HHHHHhHHhhhhcCC
Q 013816 421 -VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 83 ~~~~~~~F~~~D~d~~ 98 (179)
T 2f2o_A 83 EEEIREAFRVFDKDGN 98 (179)
T ss_dssp HHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 246789999999875
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=99.02 E-value=3.1e-10 Score=93.80 Aligned_cols=83 Identities=23% Similarity=0.344 Sum_probs=74.3
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
..+++++...+.++|..+|.+++|.|+.+|+..+++.+|..++..++..++..+|.+++ |+|+||...
T Consensus 3 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 82 (153)
T 3ox6_A 3 RSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFVELMGPKLLAETA 82 (153)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHHHHHHHHHTTCCH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHHHHHHHHhhcccc
Confidence 45677888999999999999999999999999999999999999999999999999876 999999532
Q ss_pred -----HHHHHhHHhhhhcCC
Q 013816 421 -----VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -----~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 83 ~~~~~~~~~~~F~~~D~d~~ 102 (153)
T 3ox6_A 83 DMIGVKELRDAFREFDTNGD 102 (153)
T ss_dssp HHHCHHHHHHHHHHHCTTCS
T ss_pred ccccHHHHHHHHHHhCCCCC
Confidence 346789999999874
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=99.02 E-value=4.7e-10 Score=83.28 Aligned_cols=69 Identities=22% Similarity=0.337 Sum_probs=60.6
Q ss_pred HhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 352 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..+++++...++.+|..+|.+++|+|+.+|+..+++.+| .++.++++.++..+|.|++ |+|+||...+
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 72 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFA 72 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 3456677888999999999999999999999999999999 9999999999999999887 9999996654
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=99.01 E-value=6.2e-10 Score=83.41 Aligned_cols=72 Identities=24% Similarity=0.357 Sum_probs=64.7
Q ss_pred HHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 351 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+...++.++...++.+|..+|.+++|+|+.+|+..+++.+|..++.++++.++..+|.|++ |+|+||...+.
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~~~~~ 83 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMV 83 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 3445677788899999999999999999999999999999999999999999999998876 99999976553
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=6e-10 Score=83.87 Aligned_cols=67 Identities=15% Similarity=0.096 Sum_probs=60.0
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
+.++...++++|+.+|.|++|+|+.+|++.+++.+| ++++++++++..+|.|++ |+|+||...+.+.
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~ 72 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFHLV 72 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 456778899999999999999999999999999997 689999999999999887 9999998776543
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=99.00 E-value=5.6e-10 Score=91.22 Aligned_cols=79 Identities=19% Similarity=0.318 Sum_probs=70.8
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-----------HH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-----------RL 423 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-----------~~ 423 (436)
+++...++.+|..+|.+++|.|+.+|+..+++.+|..++.+++..+++.+|.|++ |+|+||...+ .+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~ 81 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFLSMMGRRMKQTTSEDIL 81 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHTTCCCHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHHHHHHHHhcCCChHHHH
Confidence 4567889999999999999999999999999999999999999999999999887 9999995433 46
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.+|+||+
T Consensus 82 ~~~F~~~D~d~~ 93 (142)
T 2bl0_C 82 RQAFRTFDPEGT 93 (142)
T ss_dssp HHHHHHTCCSSC
T ss_pred HHHHHHHCCCCC
Confidence 789999999875
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-09 Score=91.38 Aligned_cols=85 Identities=21% Similarity=0.303 Sum_probs=74.7
Q ss_pred HHhhchhhhhhhhhhhccccCCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH------
Q 013816 351 IAQHLSVEEVAGIKEGFHMMDIGN-RGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV------ 421 (436)
Q Consensus 351 i~~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~------ 421 (436)
+...++.++...++.+|..+|.++ +|.|+.+|+..+++.+|..++.+++..++..+|.|++ |+|+||...+
T Consensus 8 ~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~~~~~~~~~~ 87 (161)
T 1dtl_A 8 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKD 87 (161)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC-
T ss_pred HHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhcc
Confidence 345567788889999999999999 9999999999999999999999999999999999876 9999995422
Q ss_pred --------HHHHhHHhhhhcCC
Q 013816 422 --------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 --------~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 88 ~~~~~~~~~~~~~F~~~D~d~~ 109 (161)
T 1dtl_A 88 DSKGKSEEELSDLFRMFDKNAD 109 (161)
T ss_dssp ----CHHHHHHHHHHHHCTTCS
T ss_pred cccchHHHHHHHHHHHhCCCCC
Confidence 36679999999875
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.98 E-value=4.2e-10 Score=97.05 Aligned_cols=82 Identities=34% Similarity=0.550 Sum_probs=74.2
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
.+++++...++++|..+|.|++|.|+.+|+..+++.+|..++.+++..+++.+|.|++ |+|+||...+
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~ 82 (188)
T 1s6i_A 3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLEREE 82 (188)
T ss_dssp SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCCC
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHhccCHHH
Confidence 4566778899999999999999999999999999999999999999999999999887 9999997654
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 83 ~l~~~F~~~D~d~d 96 (188)
T 1s6i_A 83 NLVSAFSYFDKDGS 96 (188)
T ss_dssp STHHHHHHTTTTCS
T ss_pred HHHHHHHHHCCCCC
Confidence 46789999999875
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.1e-09 Score=91.24 Aligned_cols=82 Identities=21% Similarity=0.329 Sum_probs=73.3
Q ss_pred hchhhhhhhhhhhccccC-CCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH---------
Q 013816 354 HLSVEEVAGIKEGFHMMD-IGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV--------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D-~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~--------- 421 (436)
.+++++...++.+|..+| .+++|+|+.+|+..+++.+|..++.+++..++..+|.+++ |+|+||....
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 85 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFKIIGARFLGEEVN 85 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHCCCCCC
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccccc
Confidence 356677889999999999 9999999999999999999999999999999999999887 9999996544
Q ss_pred ------HHHHhHHhhhhcCC
Q 013816 422 ------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ------~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 86 ~~~~~~~~~~~F~~~D~d~~ 105 (158)
T 2jnf_A 86 PEQMQQELREAFRLYDKEGN 105 (158)
T ss_dssp TTTTSSTHHHHHHHHCSSSS
T ss_pred hhhHHHHHHHHHHHhCCCCC
Confidence 36689999999875
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.97 E-value=6e-10 Score=94.66 Aligned_cols=73 Identities=11% Similarity=0.072 Sum_probs=65.7
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhh
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRW 430 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~ 430 (436)
..++.+|+.+| |++|+|+.+||+.+++.+ |..++++++++|+..+| |++ |+|+||... ..+..+|+.+
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~~~~~~~~~~~~~F~~~ 153 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLVCFLMRLEAMAKTFRNL 153 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHHHHHHHHHHHHHHHHHh
Confidence 46889999999 999999999999999999 99999999999999999 776 999999653 3567899999
Q ss_pred hhcCC
Q 013816 431 YEIGG 435 (436)
Q Consensus 431 d~~~~ 435 (436)
|+||+
T Consensus 154 D~d~~ 158 (174)
T 2i7a_A 154 SKDGK 158 (174)
T ss_dssp CSSSS
T ss_pred CCCCC
Confidence 99885
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.1e-09 Score=92.29 Aligned_cols=82 Identities=20% Similarity=0.387 Sum_probs=73.2
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------H
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-----------K 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-----------~ 420 (436)
.++.++...+.++|..+|.+++|.|+.+|+..+++.+|..++.+++..++..+|.|++ |+|+||.. .
T Consensus 21 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~ 100 (169)
T 3qrx_A 21 GLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFLTMMTAKMGERDSR 100 (169)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHHhcccCcH
Confidence 4567788899999999999999999999999999999999999999999999999877 99999943 3
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 101 ~~~~~~F~~~D~d~~ 115 (169)
T 3qrx_A 101 EEILKAFRLFDDDNS 115 (169)
T ss_dssp HHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHhCCCCC
Confidence 356689999998875
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.1e-09 Score=83.97 Aligned_cols=65 Identities=18% Similarity=0.216 Sum_probs=55.7
Q ss_pred hhhhhhhhhccccC-CCCC-CcccHHHHHHHHHH-cC----CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNR-GKINIDELRVGLHK-LG----HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++++|+.+| .|++ |+|+.+||+.+|+. +| ..++++++++||+.+|.||+ |+|+||...+.
T Consensus 10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~~~m~ 83 (104)
T 3zwh_A 10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLS 83 (104)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHH
Confidence 34678999999997 6775 89999999999996 54 45689999999999999988 99999977654
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.96 E-value=8.2e-10 Score=92.23 Aligned_cols=83 Identities=23% Similarity=0.351 Sum_probs=74.1
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------- 419 (436)
..++.++...++++|..+|.+++|.|+.+|+..+++.+|..++.+++..++..+|.+++ |+|+||..
T Consensus 15 ~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~ 94 (161)
T 3fwb_A 15 SELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFYIVMGEKILKRDP 94 (161)
T ss_dssp TTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHHHHHHHHHHTCCH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHHHHHHHHHhcCCc
Confidence 34577888899999999999999999999999999999999999999999999999877 99999943
Q ss_pred HHHHHHhHHhhhhcCC
Q 013816 420 KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.+|+||+
T Consensus 95 ~~~~~~~F~~~D~d~~ 110 (161)
T 3fwb_A 95 LDEIKRAFQLFDDDHT 110 (161)
T ss_dssp HHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHHcCCCC
Confidence 3356789999999874
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.3e-09 Score=82.32 Aligned_cols=65 Identities=22% Similarity=0.365 Sum_probs=59.0
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.+....++++|..+|.|++|+|+.+||..+++.+|..+++++++++++.+|.|++ |+|+||...+
T Consensus 25 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~ 91 (94)
T 2kz2_A 25 TDSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 91 (94)
T ss_dssp CSCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred CCHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 3455678999999999999999999999999999999999999999999998877 9999997654
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.96 E-value=7.5e-10 Score=83.85 Aligned_cols=67 Identities=24% Similarity=0.137 Sum_probs=59.7
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
+.++...++++|..+|.|++|+|+.+|++.+++.+| +++++++++++.+|.|++ |+|+||...+.+.
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~~~~~~~ 73 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLI 73 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence 456778899999999999999999999999999987 689999999999999877 9999998776543
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.95 E-value=7e-10 Score=80.35 Aligned_cols=67 Identities=25% Similarity=0.454 Sum_probs=61.0
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+.++...++.+|..+|.+++|+|+.+|+..+++.+|..++.++++.++..+|.+++ |+|+||...+.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~~ 70 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFLDIMT 70 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 45677889999999999999999999999999999999999999999999999877 99999976543
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.95 E-value=1.4e-09 Score=81.81 Aligned_cols=65 Identities=22% Similarity=0.380 Sum_probs=59.5
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
+.++...++.+|..+|.+++|+|+.+||..+++.+|..++.+++++++..+|.|++ |+|+||...
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~~~ 70 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFVKM 70 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHHHH
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHH
Confidence 45667789999999999999999999999999999999999999999999998877 999999554
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.94 E-value=2.2e-09 Score=82.71 Aligned_cols=67 Identities=16% Similarity=0.106 Sum_probs=59.9
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
++.++...++++|+.+|. ++|+|+.+|++.+|+++| ++++++.+|++.+|.|++ |+|+||...+.+.
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~id~~EF~~~m~~~ 77 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMFLV 77 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSSCSSBCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 356778889999999999 999999999999999987 689999999999999887 9999998776554
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.2e-09 Score=89.56 Aligned_cols=63 Identities=21% Similarity=0.344 Sum_probs=58.0
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.+++|+|+.+||+.+++.+|..+++++++++++.+|.||+ |+|+||...+
T Consensus 77 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~~~~ 141 (143)
T 2obh_A 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (143)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 34678899999999999999999999999999999999999999999999887 9999997654
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.5e-09 Score=81.61 Aligned_cols=65 Identities=18% Similarity=0.216 Sum_probs=54.4
Q ss_pred hhhhhhhhhccccC-CCCC-CcccHHHHHHHHHH-cC----CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNR-GKINIDELRVGLHK-LG----HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++++|+.+| .|++ |+|+.+||+.+++. +| ...++++++++|+.+|.||+ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~~~ 80 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLS 80 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 34578899999998 6775 89999999999996 65 45689999999999999987 99999977654
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.93 E-value=1.7e-09 Score=90.30 Aligned_cols=86 Identities=22% Similarity=0.306 Sum_probs=76.0
Q ss_pred HHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH--------
Q 013816 350 VIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-------- 419 (436)
Q Consensus 350 ~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-------- 419 (436)
.+...+++++...+.++|..+|.+++|.|+.+|+..+++.+|..++.+++..++..+|.+++ |+|+||..
T Consensus 9 ~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~ 88 (162)
T 1top_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKE 88 (162)
T ss_dssp HHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHH
T ss_pred HhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHHHHHHHHhcc
Confidence 44556788889999999999999999999999999999999999999999999999999877 99999942
Q ss_pred ------HHHHHHhHHhhhhcCC
Q 013816 420 ------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ------~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.+|+||+
T Consensus 89 ~~~~~~~~~~~~~F~~~D~d~~ 110 (162)
T 1top_A 89 DAKGKSEEELANCFRIFDKNAD 110 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCTTCS
T ss_pred ccccccHHHHHHHHHHhCCCCC
Confidence 3346789999998874
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.92 E-value=7.1e-10 Score=94.47 Aligned_cols=63 Identities=22% Similarity=0.403 Sum_probs=57.6
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.|++|+|+.+||+.+|..+|..++++|+++|++.+| ||+ |+|+||...+
T Consensus 81 ~~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~~~m 145 (176)
T 2lhi_A 81 DSEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALL 145 (176)
T ss_dssp HHHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHHHHH
T ss_pred CcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998 776 9999997665
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1e-09 Score=81.46 Aligned_cols=69 Identities=13% Similarity=0.051 Sum_probs=62.0
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHH---HHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTD---VQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e---~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
..++.++...++.+|..+|.+++|+|+.+||..+++.+|..++..+ +.+++..+|.|++ |+| ||...+.
T Consensus 6 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~~~~ 79 (86)
T 1j7q_A 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLTLCS 79 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHHHHH
Confidence 3456677889999999999999999999999999999999999999 9999999999876 999 9976543
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-09 Score=89.24 Aligned_cols=78 Identities=19% Similarity=0.316 Sum_probs=69.1
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH-----------HHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV-----------RLK 424 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~-----------~~~ 424 (436)
+.++...++++|..+|.+++|+|+.+|+..+++.+|..++.+++..++.. .+|.|+|+||...+ .+.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~--~~g~i~~~eF~~~~~~~~~~~~~~~~l~ 79 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE--APGPINFTMFLTMFGEKLNGTDPEDVIR 79 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT--SSSCCCHHHHHHHHHHTTTSSCCHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh--CCCCcCHHHHHHHHHHHhccCCcHHHHH
Confidence 46778899999999999999999999999999999999999999999987 66779999995433 477
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.+|+.||+||+
T Consensus 80 ~~F~~~D~d~~ 90 (143)
T 3j04_B 80 NAFACFDEEAS 90 (143)
T ss_dssp HHHTTSCSSSC
T ss_pred HHHHHHCCCCC
Confidence 89999998874
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.4e-09 Score=82.88 Aligned_cols=65 Identities=20% Similarity=0.183 Sum_probs=57.6
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.+| .+++| +|+.+||+.+++. +|..+++++++++++.+|.|++ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~ 80 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFVVLVA 80 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHHHHHH
Confidence 44678999999997 89998 9999999999997 6788999999999999999887 99999976554
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.91 E-value=7.9e-10 Score=91.82 Aligned_cols=64 Identities=14% Similarity=0.238 Sum_probs=58.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC-CCcCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT-LHLDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-~~i~~~ef~~~~~ 422 (436)
....++.+|+.+|.+++|+|+.+||+.+|+.+|..+|++|+++|++.+|.+ |.|+|+||+..+.
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~dG~I~y~EF~~~m~ 147 (153)
T 3i5g_B 83 PEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLKNKQFNYNKMVDIKG 147 (153)
T ss_dssp CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEETTEECHHHHHHHHH
T ss_pred cHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCCcCEEcHHHHHHHhc
Confidence 346789999999999999999999999999999999999999999999875 3399999988764
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.91 E-value=2.2e-09 Score=90.30 Aligned_cols=81 Identities=17% Similarity=0.313 Sum_probs=71.3
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHHhcCCCcCHhhHHHH-----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-QIPDTDVQILMDAVSHTLHLDLAFFREK----------- 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~~~i~~~ef~~~----------- 420 (436)
..++.++...++.+|..+|.|++|.|+.+|+..+++.+|. .++..++..++... +|.|+|+||...
T Consensus 17 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~--dg~i~~~eF~~~~~~~~~~~~~~ 94 (166)
T 2mys_B 17 SMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA--SGPINFTVFLTMFGEKLKGADPE 94 (166)
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC--CCCcCHHHHHHHHHHHhccCCcH
Confidence 3567788889999999999999999999999999999999 99999999999875 678999999532
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 95 ~~l~~~F~~~D~d~~ 109 (166)
T 2mys_B 95 DVIMGAFKVLDPDGK 109 (166)
T ss_pred HHHHHHHHHhCCCCC
Confidence 357789999999875
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.2e-09 Score=88.61 Aligned_cols=63 Identities=19% Similarity=0.349 Sum_probs=58.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...++.+|+.+|.|++|+|+.+||+.++..+|..++.++++++++.+|.||+ |+|+||...+.
T Consensus 82 ~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~m~ 146 (148)
T 2lmt_A 82 EEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFVWMIS 146 (148)
T ss_dssp HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 4568899999999999999999999999999999999999999999999887 99999987653
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.5e-09 Score=82.16 Aligned_cols=65 Identities=18% Similarity=0.172 Sum_probs=51.9
Q ss_pred hhhhhhhhhccccC-CCC-CCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGN-RGKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~-~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.+| .|+ +|+|+.+||+.+|+. +|..++++++++|++.+|.|++ |+|+||...+.
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~ 79 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVA 79 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence 45678999999999 788 589999999999997 5777899999999999999887 99999977654
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.90 E-value=2.4e-09 Score=75.02 Aligned_cols=60 Identities=18% Similarity=0.291 Sum_probs=55.7
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.++.+|..+|.+++|+|+.+|+..+++.+|..++.++++.++..+|.|++ |+|+||...+
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~ 63 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCI 63 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence 46788999999999999999999999999999999999999999999887 9999997654
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.90 E-value=6.8e-09 Score=89.59 Aligned_cols=75 Identities=23% Similarity=0.353 Sum_probs=67.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----HHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----RLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----~~~~~f~~~d~~~ 434 (436)
..+..+|+.+|.|++|+|+.+|+..+++.+|..+++++++++++.+|.|++ |+|+||...+ .+..+|+.+|+||
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~ 172 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRER 172 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTTC
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHHHHHHHHHHHhCcCC
Confidence 567889999999999999999999999999999999999999999999877 9999996543 5668999999987
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 173 d 173 (191)
T 1y1x_A 173 T 173 (191)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.90 E-value=1.7e-09 Score=90.38 Aligned_cols=63 Identities=21% Similarity=0.311 Sum_probs=57.0
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc--CCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH--TLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~--~~~--i~~~ef~~~~ 421 (436)
....++++|+.+|.+++|+|+.+||+.+|+.+|..++++|+++|++.+|. ||+ |+|+||+..+
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m 149 (159)
T 3i5g_C 83 AADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKV 149 (159)
T ss_dssp CHHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHH
T ss_pred hHHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999885 544 9999998765
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.90 E-value=2.7e-09 Score=88.73 Aligned_cols=82 Identities=17% Similarity=0.347 Sum_probs=69.7
Q ss_pred HhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHH-----------
Q 013816 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREK----------- 420 (436)
Q Consensus 352 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~----------- 420 (436)
...++.++...++.+|..+|.+++|.|+.+|+..+++.+|..++.+++..++. +.+|.|+|+||...
T Consensus 9 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~--~~~g~i~~~eF~~~~~~~~~~~~~~ 86 (156)
T 1wdc_B 9 LTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK--EAPGPLNFTMFLSIFSDKLSGTDSE 86 (156)
T ss_dssp ---CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT--TSSSCCCHHHHHHHHHHHTCSCCCH
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH--hCCCcCcHHHHHHHHHHHhcCCChH
Confidence 34567778889999999999999999999999999999999999999999996 35677999999543
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 87 ~~l~~~F~~~D~d~~ 101 (156)
T 1wdc_B 87 ETIRNAFAMFDEQET 101 (156)
T ss_dssp HHHHHHHHTTCTTCC
T ss_pred HHHHHHHHHHCcCCC
Confidence 346789999999875
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.6e-09 Score=82.55 Aligned_cols=65 Identities=20% Similarity=0.218 Sum_probs=58.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
++...++++|..+|.|++|+|+.+|++.+++.+| ++++++++|++.+|.|++ |+|+||...+.+.
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~~~~~~~ 74 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALRLV 74 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHH
Confidence 4567899999999999999999999999999987 689999999999999877 9999998877654
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=3.5e-09 Score=82.55 Aligned_cols=66 Identities=14% Similarity=0.126 Sum_probs=59.2
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRL 423 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~ 423 (436)
+.++...++++|..+|.|++|+|+.+||+.+++ +..++.+++.++++.+|.|++ |+|+||...+..
T Consensus 9 s~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~~~~~~ 76 (111)
T 2kgr_A 9 PQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFILAMHL 76 (111)
T ss_dssp CHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHHH
Confidence 456778899999999999999999999999998 677899999999999999887 999999776644
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.7e-09 Score=80.13 Aligned_cols=67 Identities=16% Similarity=0.271 Sum_probs=59.8
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..++.++...++.+|..+|.|++|+|+.+|+..+++.+| ++.+++++++..+|.|++ |+|+||...+
T Consensus 19 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dg~I~~~EF~~~~ 87 (91)
T 2pmy_A 19 ADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDADRDGAITFQEFARGF 87 (91)
T ss_dssp CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEECHHHHTHHH
T ss_pred ccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCCCCCCEeHHHHHHHH
Confidence 344667788999999999999999999999999999998 689999999999999887 9999996543
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=3.6e-09 Score=92.13 Aligned_cols=79 Identities=22% Similarity=0.335 Sum_probs=66.3
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLK 424 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~ 424 (436)
..+...++++|..+|.|++|.|+.+|+..+++.+|..++.++++.+++.+|.|++ |+|+||.. ...+.
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~~~~~~~~~~~~~ 112 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFLRALRPPMSQAREAVIA 112 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHTSCCCCHHHHHHHH
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHHHHHHhhcCchHHHHHH
Confidence 4567889999999999999999999999999999999999999999999999877 99999954 33677
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.+|..+|+||+
T Consensus 113 ~~F~~~D~d~~ 123 (204)
T 3e3r_A 113 AAFAKLDRSGD 123 (204)
T ss_dssp HHHHHHCTTCS
T ss_pred HHHHHhCcCCC
Confidence 89999999875
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.87 E-value=5e-09 Score=86.07 Aligned_cols=81 Identities=14% Similarity=0.185 Sum_probs=71.0
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHH---hcCCC-cCHhhHHHH----------
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV---SHTLH-LDLAFFREK---------- 420 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~---d~~~~-i~~~ef~~~---------- 420 (436)
+++++...++.+|..+|.+++|.|+.+|+..+++.+|..++.+++..++..+ |.++. |+|+||...
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~g~i~~~eF~~~~~~~~~~~~~ 81 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQ 81 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccCCcCcHHHHHHHHHHHhccCCc
Confidence 3567788899999999999999999999999999999999999999999999 87755 999999432
Q ss_pred ---HHHHHhHHhhhhcCC
Q 013816 421 ---VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 82 ~~~~~~~~~F~~~D~d~~ 99 (149)
T 2mys_C 82 GTFEDFVEGLRVFDKEGN 99 (149)
T ss_pred chHHHHHHHHHHhCCCCC
Confidence 346689999999875
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.87 E-value=3.7e-09 Score=79.49 Aligned_cols=63 Identities=22% Similarity=0.305 Sum_probs=56.4
Q ss_pred hhhhhhhhccccCCCCCC---cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRG---KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G---~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++++|..+| +++| +|+.+||+.+++. +|..+++++++++++.+|.|++ |+|+||...+.
T Consensus 7 ~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~ 79 (92)
T 3rm1_A 7 AVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFMAFVA 79 (92)
T ss_dssp HHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHHHHHH
Confidence 4567899999999 7666 9999999999999 9999999999999999999887 99999976553
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.87 E-value=1.6e-09 Score=80.57 Aligned_cols=68 Identities=38% Similarity=0.639 Sum_probs=61.0
Q ss_pred HhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 352 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
...++.++...++.+|..+|.+++|+|+.+|+..+++.+|..++.++++++++.+|.+++ |+|+||..
T Consensus 14 ~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~~ 83 (87)
T 1s6j_A 14 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIA 83 (87)
T ss_dssp SSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTT
T ss_pred HHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 344556667789999999999999999999999999999999999999999999999877 99999953
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.7e-09 Score=76.89 Aligned_cols=63 Identities=19% Similarity=0.444 Sum_probs=57.6
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|..+|.+++|+|+.+|+..+++.+|..++.++++.++..+|.+++ |+|+||...+
T Consensus 4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 68 (71)
T 2b1u_A 4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFARML 68 (71)
T ss_dssp THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34678899999999999999999999999999999999999999999998877 9999997654
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1e-09 Score=83.11 Aligned_cols=65 Identities=18% Similarity=0.222 Sum_probs=57.8
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.+| .+++| +|+.+||+.+++. +|..+++++++++++.+|.|++ |+|+||...+.
T Consensus 9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~~~~~ 82 (95)
T 2wcb_A 9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVA 82 (95)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 44678999999999 89998 9999999999987 6778899999999999999887 99999977654
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=5.1e-09 Score=81.95 Aligned_cols=65 Identities=14% Similarity=0.215 Sum_probs=56.6
Q ss_pred hhhhhhhhhccccCC-CCCC-cccHHHHHHHHH-HcCCC-----CCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDI-GNRG-KINIDELRVGLH-KLGHQ-----IPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l~-~lg~~-----~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++.+|..+|. |++| +|+.+||+.+|+ .+|.. +++++++++|+.+|.|++ |+|+||...+.
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~~~~~ 83 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMA 83 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 346788999999995 9999 999999999999 78853 589999999999999887 99999976553
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.6e-09 Score=94.83 Aligned_cols=83 Identities=16% Similarity=0.156 Sum_probs=67.7
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCC--CCCHHHHHHHH-------HHHhcCCC--cCHhhHHHHH
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH--QIPDTDVQILM-------DAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~--~~~~~e~~~~~-------~~~d~~~~--i~~~ef~~~~ 421 (436)
..++.++...++++|..+|.|++|.|+.+|+..+++.+|. .++.+++..++ ..+|.|++ |+|+||...+
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~~~~ 107 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWVEAN 107 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHHHHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 3456677889999999999999999999999999999988 89999999999 99999877 9999996543
Q ss_pred H---------------------HHHhHHhhhhcCC
Q 013816 422 R---------------------LKISFFRWYEIGG 435 (436)
Q Consensus 422 ~---------------------~~~~f~~~d~~~~ 435 (436)
. +..+|+.+|+||+
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 142 (208)
T 2hpk_A 108 RVFAEAERERERRGEPSLIALLSNSYYDVLDDDGD 142 (208)
T ss_dssp HHHHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCS
T ss_pred HHHhhhhhhhhccCChHHHHHHHHHHHHHhCCCCC
Confidence 2 5679999999875
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.84 E-value=5.8e-10 Score=86.74 Aligned_cols=68 Identities=12% Similarity=0.067 Sum_probs=59.9
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
++.++...++++|..+|.|++|+|+.+|++.+++.+| ++++++++|++.+|.|++ |+|+||...+.+.
T Consensus 16 ls~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~I~~~EF~~~m~~~ 85 (110)
T 1iq3_A 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFHLI 85 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 3456778899999999999999999999999999887 678899999999999887 9999998776544
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.84 E-value=3.9e-09 Score=99.70 Aligned_cols=76 Identities=21% Similarity=0.378 Sum_probs=62.1
Q ss_pred HHHHHHhhc-hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 347 ALKVIAQHL-SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 347 ~l~~i~~~~-~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++..+...+ ..+..+.++++|+.+|.|++|+|+.+||+.+|+.+|..++++|+++||+.+|.|++ |+|+||...+.
T Consensus 360 Fl~lms~~lk~~d~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 360 FLIMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp HHHHHHTC------CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHC
T ss_pred HHHHHHHHhcCCChHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHhC
Confidence 334444443 23345678999999999999999999999999999999999999999999999887 99999987663
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.83 E-value=1.5e-09 Score=89.34 Aligned_cols=77 Identities=21% Similarity=0.155 Sum_probs=65.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHH-hcCCC--cCHhhHHHH---------------
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV-SHTLH--LDLAFFREK--------------- 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~-d~~~~--i~~~ef~~~--------------- 420 (436)
+...++++|..+|.+++|.|+.+|+..+++.+|..++.+++..++..+ |.+++ |+|+||...
T Consensus 2 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 81 (148)
T 1m45_A 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAK 81 (148)
T ss_dssp -CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCC
T ss_pred hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHHHHHHHHHhhcccccccc
Confidence 456788999999999999999999999999999999999999999999 98876 999999532
Q ss_pred -HHHHHhHHhhhhcCC
Q 013816 421 -VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 82 ~~~~~~~F~~~D~d~~ 97 (148)
T 1m45_A 82 TEDFVKAFQVFDKEST 97 (148)
T ss_dssp THHHHHHHHTTCSSSS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 346679999999875
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.1e-09 Score=92.13 Aligned_cols=80 Identities=18% Similarity=0.342 Sum_probs=71.5
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH-----------H
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV-----------R 422 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~-----------~ 422 (436)
.++.++...++.+|..+|.|++|+|+.+||..+|+.+|..++..++..++..+ +|.|+|+||...+ .
T Consensus 50 ~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~--~g~i~~~eF~~~~~~~~~~~~~~~~ 127 (196)
T 3dtp_E 50 MFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA--PGPINFTMFLTIFGDRIAGTDEEDV 127 (196)
T ss_dssp SSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS--SSCCBHHHHHHHHHHCCCSSCCHHH
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--cCCCcHHHHHHHHHHHhcCCCcHHH
Confidence 45677888999999999999999999999999999999999999999999887 7889999996543 5
Q ss_pred HHHhHHhhhhcCC
Q 013816 423 LKISFFRWYEIGG 435 (436)
Q Consensus 423 ~~~~f~~~d~~~~ 435 (436)
+..+|..||+||+
T Consensus 128 l~~~F~~~D~d~~ 140 (196)
T 3dtp_E 128 IVNAFNLFDEGDG 140 (196)
T ss_dssp HHHHHHTTCSSSS
T ss_pred HHHHHHHHCCCCC
Confidence 6789999999874
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=98.83 E-value=6.3e-09 Score=87.39 Aligned_cols=75 Identities=16% Similarity=0.206 Sum_probs=66.7
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH----HHHHhHHhhhhcCC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV----RLKISFFRWYEIGG 435 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~----~~~~~f~~~d~~~~ 435 (436)
..++.+|+.+|.+++|+|+.+|+..+++.+|..++++++++++..+|.+|.|+|+||...+ .+..+|+.+|+||+
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~ 148 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQ 148 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBTTBCBHHHHHHHHHHHHHHHHHHHTTCTTCC
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 4678899999999999999999999999999999999999999999666669999996543 56689999999875
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.83 E-value=8.1e-09 Score=78.67 Aligned_cols=65 Identities=15% Similarity=0.194 Sum_probs=54.7
Q ss_pred hhhhhhhhhccccCCCC---CCcccHHHHHHHHHHc-CCCCC----HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGN---RGKINIDELRVGLHKL-GHQIP----DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~---~G~i~~~el~~~l~~l-g~~~~----~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++++|+.+|.++ +|+|+.+||+.+|+.+ +..++ ++++++||+.+|.||+ |+|+||...+.
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~~~m~ 82 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYWTLIG 82 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 34568999999999963 7999999999999974 44444 7899999999999987 99999977664
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.83 E-value=5.9e-09 Score=88.20 Aligned_cols=75 Identities=23% Similarity=0.283 Sum_probs=67.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~~ 434 (436)
..++.+|..+|.+++|+|+.+|+..++..+|..+++++++.++..+|.|++ |+|+||... ..+..+|+.+|+||
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~ 153 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQ 153 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHHHHHCTTS
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 568889999999999999999999999999999999999999999999876 999999653 35678999999987
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 154 d 154 (172)
T 2znd_A 154 D 154 (172)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.8e-09 Score=93.26 Aligned_cols=83 Identities=19% Similarity=0.226 Sum_probs=67.1
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHH-----HHHHHcCCCCCHH-----HHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELR-----VGLHKLGHQIPDT-----DVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
..++.++...++++|..+|.|++|+|+.+|+. .+++.+|..++.. +++.++..+|.|++ |+|+||...
T Consensus 12 ~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~ 91 (195)
T 1qv0_A 12 DFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDG 91 (195)
T ss_dssp CTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHH
T ss_pred ccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHHHHH
Confidence 34477888999999999999999999999999 7888999988877 68999999999877 999999543
Q ss_pred HH-----------------HH----HhHHhhhhcCC
Q 013816 421 VR-----------------LK----ISFFRWYEIGG 435 (436)
Q Consensus 421 ~~-----------------~~----~~f~~~d~~~~ 435 (436)
+. ++ .+|+.||+||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 127 (195)
T 1qv0_A 92 WKQLATSELKKWARNEPTLIREWGDAVFDIFDKDGS 127 (195)
T ss_dssp HHHHHHHHHHHHHTTCCCHHHHHHHHHHHHTC----
T ss_pred HHHHHhhhhhcccccHHHHHHHHHHHHHHHhcCCCC
Confidence 21 22 79999999875
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.82 E-value=3.9e-09 Score=89.48 Aligned_cols=76 Identities=13% Similarity=0.150 Sum_probs=67.6
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc-C-------CCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-G-------HQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLK 424 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g-------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~ 424 (436)
+...++++|..+| +++|.|+.+|+..+++.+ | ..++.++++.++..+|.|++ |+|+||... ..+.
T Consensus 2 ~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~ 80 (173)
T 1alv_A 2 EVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKKWQ 80 (173)
T ss_dssp HHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHHHHHHHHHHHH
Confidence 5678899999999 999999999999999998 6 78899999999999999877 999999653 3577
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.+|+.+|+||+
T Consensus 81 ~~F~~~D~d~~ 91 (173)
T 1alv_A 81 AIYKQFDVDRS 91 (173)
T ss_dssp HHHHHHCTTCC
T ss_pred HHHHHHCCCCC
Confidence 89999999875
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=8.9e-09 Score=79.79 Aligned_cols=65 Identities=25% Similarity=0.363 Sum_probs=60.1
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.++...++.+|..+|.+++|+|+.+|+..+++.+|..++.+++.+++..+|.|++ |+|+||...+
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~~~~ 94 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSGSGETFSYPDFLRMM 94 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 4667789999999999999999999999999999999999999999999999887 9999997654
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.81 E-value=1.8e-09 Score=89.79 Aligned_cols=80 Identities=21% Similarity=0.269 Sum_probs=71.2
Q ss_pred chhhhhhhhhhhccccCC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 355 LSVEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
+++++...++.+|..+|. +++|.|+.+|+..+++.+|..++..++..+ ..+|.+++ |+|+||...
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~~~~~~~~~~~~~ 81 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFLPAYEGLMDCEQG 81 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHHHHHHHHTTSCCC
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHHHHHHHHhhccCC
Confidence 466788899999999999 999999999999999999999999999999 99998877 999999543
Q ss_pred --HHHHHhHHhhhhcCC
Q 013816 421 --VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 --~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 82 ~~~~l~~~F~~~D~d~~ 98 (156)
T 1wdc_C 82 TFADYMEAFKTFDREGQ 98 (156)
T ss_dssp CHHHHHHHHHTTCSSSS
T ss_pred hHHHHHHHHHHhCCCCC
Confidence 356789999999874
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.81 E-value=5.9e-09 Score=87.78 Aligned_cols=75 Identities=19% Similarity=0.249 Sum_probs=66.9
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH----HHHHhHHhhhhcCC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV----RLKISFFRWYEIGG 435 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~----~~~~~f~~~d~~~~ 435 (436)
..+..+|..+|.+++|+|+.+|+..+++.+|..++++++++++..+|.+|.|+|+||...+ .+..+|+.+|+||+
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~ 150 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRYSTSGKITFDDYIACCVKLRALTDSFRRRDSAQQ 150 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHTCBTTBEEHHHHHHHHHHHHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 4688899999999999999999999999999999999999999999666669999996544 57789999999875
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.81 E-value=4.7e-09 Score=85.40 Aligned_cols=75 Identities=13% Similarity=0.173 Sum_probs=66.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHH-------------HHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREK-------------VRLKI 425 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~-------------~~~~~ 425 (436)
+...++++|..+|.|++|.|+.+|+..+++.+|..++.+++.+++. |.+|.|+|+||... ..+..
T Consensus 3 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~--~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~ 80 (140)
T 1ggw_A 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES--TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVK 80 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT--TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh--CCCCcCcHHHHHHHHHHHhcccCcccHHHHHH
Confidence 3567889999999999999999999999999999999999999998 77777999999543 56778
Q ss_pred hHHhhhhcCC
Q 013816 426 SFFRWYEIGG 435 (436)
Q Consensus 426 ~f~~~d~~~~ 435 (436)
+|+.+|+||+
T Consensus 81 ~F~~~D~d~~ 90 (140)
T 1ggw_A 81 GFQVFDKDAT 90 (140)
T ss_dssp HHHTTCSSCS
T ss_pred HHHHhCCCCC
Confidence 9999999875
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=98.81 E-value=6.6e-09 Score=83.57 Aligned_cols=64 Identities=19% Similarity=0.146 Sum_probs=57.8
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
++...++++|+.+| +++|+|+.+|++.+|+++| ++++++++|++.+|.|++ |+|+||...+.+.
T Consensus 48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~d~dG~Ld~~EF~~am~li 113 (139)
T 2jq6_A 48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADVDKDGLLDDEEFALANHLI 113 (139)
T ss_dssp GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCSSCCSEEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 55678999999999 9999999999999999977 789999999999999887 9999998777554
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.81 E-value=7.4e-09 Score=87.68 Aligned_cols=80 Identities=14% Similarity=0.084 Sum_probs=68.8
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHH----HHHHcCCCCCHHHHH-----------HHHHHHhcCCC--cCHhhHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRV----GLHKLGHQIPDTDVQ-----------ILMDAVSHTLH--LDLAFFR 418 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~----~l~~lg~~~~~~e~~-----------~~~~~~d~~~~--i~~~ef~ 418 (436)
++++...++.+|..+|.|++|+|+.+|+.. +++.+|..++.+++. .++..+|.|++ |+|+||.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~ 81 (176)
T 1nya_A 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI 81 (176)
T ss_dssp CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 456778899999999999999999999999 788899999999887 78889999877 9999995
Q ss_pred HH------------------HHHHHhHHhhhhcCC
Q 013816 419 EK------------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 419 ~~------------------~~~~~~f~~~d~~~~ 435 (436)
.. ..+..+|..+|+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 116 (176)
T 1nya_A 82 RVTENLIFEQGEASFNRVLGPVVKGIVGMCDKNAD 116 (176)
T ss_dssp HHHHHHHSSSCHHHHHHHHHHHHHHHHHHTCSSCC
T ss_pred HHHHHHhcCCchhhHHHHHHHHHHHHHHHhcCCCC
Confidence 43 236689999999875
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=98.81 E-value=7.4e-09 Score=85.22 Aligned_cols=63 Identities=21% Similarity=0.347 Sum_probs=57.9
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|+|+.+|++.++..+|..+++++++++++.+|.|++ |+|+||...+
T Consensus 81 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~ 145 (148)
T 1exr_A 81 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMM 145 (148)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 34578889999999999999999999999999999999999999999999877 9999997765
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.80 E-value=4.4e-09 Score=89.03 Aligned_cols=78 Identities=13% Similarity=0.130 Sum_probs=68.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhh
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRW 430 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~ 430 (436)
.+...++++|..+|.+++|.|+.+|+..+++.+| ..++.++++.++..+|.|++ |+|+||... ..+..+|..+
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~F~~~ 83 (172)
T 2znd_A 4 PDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTY 83 (172)
T ss_dssp --CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHHHHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999998 78999999999999999987 999999653 3577899999
Q ss_pred hhcCC
Q 013816 431 YEIGG 435 (436)
Q Consensus 431 d~~~~ 435 (436)
|+||+
T Consensus 84 D~d~~ 88 (172)
T 2znd_A 84 DRDNS 88 (172)
T ss_dssp CTTCS
T ss_pred CCCCC
Confidence 99875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=7.6e-08 Score=89.52 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=94.6
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC--ceeEEEEEEE-eCCeEEEEEec
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYE-DDTAVHLVMEL 137 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~--niv~~~~~~~-~~~~~~lv~E~ 137 (436)
..++.|....||++ |..+++|+-. .......+.+|+.+|+.|..|- .+++++.+.. ..+..++|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788888999987 5678888742 2234567899999999995432 3567777664 45667899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q 013816 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH------------------------------------------ 175 (436)
Q Consensus 138 ~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~------------------------------------------ 175 (436)
++|.++.+.... .++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999888763221 245555555555555555555532
Q ss_pred ------------------CceecCCCCCceEeecCCCCCC-eEEEeecccccc
Q 013816 176 ------------------GVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFF 209 (436)
Q Consensus 176 ------------------~iiH~dlkp~NIl~~~~~~~~~-ikl~DfG~a~~~ 209 (436)
.++|+|++|.||+++.+..... +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999975222333 479999987653
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.79 E-value=4.2e-09 Score=76.38 Aligned_cols=60 Identities=25% Similarity=0.383 Sum_probs=54.9
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..++.+|..+|.+++|+|+.+|+..+++.+| .++.++++.++..+|.|++ |+|+||...+
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~ 64 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFISFC 64 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 3578889999999999999999999999999 9999999999999999876 9999996544
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.79 E-value=2.7e-09 Score=82.20 Aligned_cols=65 Identities=12% Similarity=0.234 Sum_probs=55.5
Q ss_pred hhhhhhhhhccccC-CCCC-CcccHHHHHHHHHH-cCCCCC-HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNR-GKINIDELRVGLHK-LGHQIP-DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.|| .|++ |+|+.+||+.+|+. +|...+ ++++++||+.+|.||+ |+|+||...+.
T Consensus 19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~~~~~ 89 (106)
T 2h2k_A 19 ESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIG 89 (106)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 44678999999999 7986 79999999999986 776554 5789999999999887 99999977654
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.79 E-value=2.7e-09 Score=87.60 Aligned_cols=77 Identities=19% Similarity=0.185 Sum_probs=69.4
Q ss_pred hhhhhhhhhhccccCCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH-----------HHH
Q 013816 357 VEEVAGIKEGFHMMDIGN-RGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV-----------RLK 424 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~-----------~~~ 424 (436)
.++...++.+|..+|.++ +|.|+.+|+..+++.+|..++..++..++..+|.+ |+|+||...+ .+.
T Consensus 10 ~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~--i~~~eF~~~~~~~~~~~~~~~~l~ 87 (146)
T 2qac_A 10 LEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN--LTYEQYLEYLSICVHDKDNVEELI 87 (146)
T ss_dssp HHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE--ECHHHHHHHHHHTCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC--CCHHHHHHHHHHHhcCcchHHHHH
Confidence 456778999999999999 99999999999999999999999999999999988 9999995433 477
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.+|+.||+||+
T Consensus 88 ~~F~~~D~d~~ 98 (146)
T 2qac_A 88 KMFAHFDNNCT 98 (146)
T ss_dssp HHHHTTCTTCS
T ss_pred HHHHHhCCCCC
Confidence 89999999875
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.79 E-value=7.2e-09 Score=87.77 Aligned_cols=74 Identities=15% Similarity=0.178 Sum_probs=66.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~~ 434 (436)
..++.+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+| |++ |+|+||... ..+..+|+.+|+||
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~ 155 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFISCLVRLDAMFRAFKSLDKDG 155 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSC
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 56888999999999999999999999999999999999999999998 665 999999654 45778999999998
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 156 ~ 156 (173)
T 1alv_A 156 T 156 (173)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=98.78 E-value=1.3e-08 Score=89.85 Aligned_cols=73 Identities=15% Similarity=0.102 Sum_probs=63.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----HHHHhHHhh-hhc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----RLKISFFRW-YEI 433 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----~~~~~f~~~-d~~ 433 (436)
..+..+|..+|.|++|+|+.+|+..+++.+|..+++++++.+++.+| ||+ |+|+||...+ .+..+|+.+ |++
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~l~~~~~~F~~~~D~~ 195 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWIAICAFAAQTRSAYQMIFMNP 195 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHHHHHHHHHHHHHHHHHHHTSG
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHHHHHHHHHHHHHHhcccC
Confidence 56888999999999999999999999999999999999999999999 876 9999996544 566899998 766
Q ss_pred C
Q 013816 434 G 434 (436)
Q Consensus 434 ~ 434 (436)
|
T Consensus 196 ~ 196 (220)
T 3sjs_A 196 Y 196 (220)
T ss_dssp G
T ss_pred C
Confidence 5
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.78 E-value=1.2e-09 Score=90.27 Aligned_cols=81 Identities=17% Similarity=0.258 Sum_probs=66.2
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC--CC--cCHhhHHHHH---------
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT--LH--LDLAFFREKV--------- 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--~~--i~~~ef~~~~--------- 421 (436)
+++++...++.+|..+|.+++|+|+.+|+..+++.+|..++.+++..++..+|.+ ++ |+|+||...+
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~~~~~~~~~~~~~ 83 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQ 83 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC----
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHHHHHHHHhccCCC
Confidence 4567788899999999999999999999999999999999999999999999877 65 9999995432
Q ss_pred ----HHHHhHHhhhhcCC
Q 013816 422 ----RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ----~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 84 ~~~~~l~~~F~~~D~d~~ 101 (151)
T 1w7j_B 84 GTYEDYLEGFRVFDKEGN 101 (151)
T ss_dssp ----CCHHHHHTTCTTSS
T ss_pred CcHHHHHHHHHHhCCCCC
Confidence 35569999999875
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.77 E-value=8e-09 Score=89.12 Aligned_cols=76 Identities=17% Similarity=0.288 Sum_probs=68.0
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEI 433 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~ 433 (436)
...++++|..+|.|++|.|+.+|+..++..+|..+++++++.+++.+|.|++ |+|+||... ..+..+|+.+|+|
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~F~~~D~d 105 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFILSMREGFRKRDSS 105 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4678899999999999999999999999888889999999999999999877 999999654 3577899999998
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
|+
T Consensus 106 ~~ 107 (191)
T 1y1x_A 106 GD 107 (191)
T ss_dssp SS
T ss_pred CC
Confidence 74
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=98.77 E-value=4.9e-09 Score=91.01 Aligned_cols=80 Identities=14% Similarity=0.241 Sum_probs=70.1
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-----QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRL 423 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~ 423 (436)
.+..+...+++ |..+|.|++|.|+.+|+..+++.+|. .++.++++.+++.+|.|++ |+|+||... ..+
T Consensus 27 ~~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~~~~~~~~~~ 105 (198)
T 1juo_A 27 FPGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGW 105 (198)
T ss_dssp CTTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHH
T ss_pred CCccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHH
Confidence 34567788889 99999999999999999999999986 6799999999999999877 999999653 457
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.+|+||+
T Consensus 106 ~~~F~~~D~d~~ 117 (198)
T 1juo_A 106 RQHFISFDTDRS 117 (198)
T ss_dssp HHHHHTTCTTCC
T ss_pred HHHHHHhCCCCC
Confidence 789999999875
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=98.77 E-value=1.2e-08 Score=88.48 Aligned_cols=75 Identities=19% Similarity=0.244 Sum_probs=66.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHH----HHHHHhHHhhhhcCC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREK----VRLKISFFRWYEIGG 435 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~----~~~~~~f~~~d~~~~ 435 (436)
..+..+|..+|.|++|+|+.+|+..+++.+|..++++++++++..+|.+|.|+|+||... ..+..+|+.+|+||+
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~d~dg~i~~~eF~~~~~~~~~~~~~F~~~D~d~~ 181 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQ 181 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCC
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 468889999999999999999999999999999999999999999966666999999653 356789999999875
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.77 E-value=8.3e-09 Score=84.36 Aligned_cols=72 Identities=26% Similarity=0.435 Sum_probs=65.1
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHH------------HHHHHhHHhh
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREK------------VRLKISFFRW 430 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~------------~~~~~~f~~~ 430 (436)
++.+|..+|.+++|.|+.+|+..+++.+|..++.+++..++.. |.+|.|+|+||... ..+..+|+.+
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~-~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~ 85 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ-LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRAL 85 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH-HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh-cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHh
Confidence 8899999999999999999999999999999999999999998 77777999999543 3567899999
Q ss_pred hhcCC
Q 013816 431 YEIGG 435 (436)
Q Consensus 431 d~~~~ 435 (436)
|+||+
T Consensus 86 D~d~~ 90 (145)
T 2bl0_B 86 DKEGN 90 (145)
T ss_dssp CSSSS
T ss_pred CCCCC
Confidence 99874
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=98.77 E-value=2.6e-09 Score=74.66 Aligned_cols=59 Identities=14% Similarity=0.228 Sum_probs=54.4
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
++.+|..+|.|++|+|+.+|+..+++.+|..++.++++.++..+|.|++ |+|+||...+
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~ 62 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFY 62 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5678999999999999999999999999988999999999999999887 9999997654
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.76 E-value=7.3e-09 Score=89.04 Aligned_cols=80 Identities=18% Similarity=0.267 Sum_probs=68.9
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHH-----HHHHHcCCCCCHH-----HHHHHHHHHhcCCC--cCHhhHHHHHH-
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELR-----VGLHKLGHQIPDT-----DVQILMDAVSHTLH--LDLAFFREKVR- 422 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~~~~--i~~~ef~~~~~- 422 (436)
+.++...++.+|..+|.|++|+|+.+|+. .+++.+|..++.. +++.+++.+|.|++ |+|+||...+.
T Consensus 11 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~~~~~~ 90 (191)
T 1uhk_A 11 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK 90 (191)
T ss_dssp CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHHHHHHH
Confidence 56778889999999999999999999999 8899999988887 68999999999887 99999954321
Q ss_pred ----------------HH----HhHHhhhhcCC
Q 013816 423 ----------------LK----ISFFRWYEIGG 435 (436)
Q Consensus 423 ----------------~~----~~f~~~d~~~~ 435 (436)
++ .+|+.+|+||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 123 (191)
T 1uhk_A 91 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQN 123 (191)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCS
T ss_pred HhcchhhhhhhhhHHHHHHHHHHHHHHhcCCCC
Confidence 22 79999999875
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.1e-08 Score=82.93 Aligned_cols=65 Identities=22% Similarity=0.215 Sum_probs=58.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++.+|+.+|.+++|+|+.+||+.+++.+| ..++.++++++++.+|.||+ |+|+||...+.
T Consensus 37 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~~~ 104 (135)
T 3h4s_E 37 EFVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLDGDGALNQTEFCVLMV 104 (135)
T ss_dssp HHHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSSCSSSBCHHHHHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 3456788999999999999999999999999999 59999999999999999887 99999966553
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-08 Score=78.53 Aligned_cols=64 Identities=16% Similarity=0.209 Sum_probs=58.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++.+|..+|.+++|+|+.+||..+++.+|..++.+++++++..+|.|++ |+|+||...+.
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~~~~~ 87 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSRFS 87 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHHHC
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHHHHHh
Confidence 45678899999999999999999999999999999999999999999998776 99999977654
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.76 E-value=5e-09 Score=92.56 Aligned_cols=86 Identities=21% Similarity=0.188 Sum_probs=70.8
Q ss_pred HHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHH-----------HhcCCCcCHhhH
Q 013816 350 VIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHK-LGHQIPDTDVQILMDA-----------VSHTLHLDLAFF 417 (436)
Q Consensus 350 ~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~~-----------~d~~~~i~~~ef 417 (436)
.+...++.++...++.+|..+|.|++|+|+.+||..+++. +|..++.+++..++.. +|.+|.|+|+||
T Consensus 37 ~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF 116 (219)
T 3cs1_A 37 AIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEF 116 (219)
T ss_dssp HSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCH
T ss_pred HhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHH
Confidence 3445567788899999999999999999999999999998 7988888777776653 366777999999
Q ss_pred HHH----------HHHHHhHHhhhhcCC
Q 013816 418 REK----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 418 ~~~----------~~~~~~f~~~d~~~~ 435 (436)
... ..+..+|+.||+||+
T Consensus 117 ~~~~~~~~~~~~~~~l~~~F~~~D~d~~ 144 (219)
T 3cs1_A 117 LEFRLMLCYIYDFFELTVMFDEIDASGN 144 (219)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSSSS
T ss_pred HHHHHHHhccchHHHHHHHHHHHCCCCC
Confidence 543 247789999999875
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=98.76 E-value=4.9e-09 Score=78.81 Aligned_cols=64 Identities=16% Similarity=0.305 Sum_probs=56.4
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK---LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++.+|..+| .|++| +|+.+||+.+++. +|. +++.+++++++.+|.|++ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I~f~EF~~~~~ 77 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEIDFKEYSVFLT 77 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 44678999999999 99999 9999999999997 335 889999999999999987 99999977654
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=98.76 E-value=9.8e-09 Score=77.23 Aligned_cols=65 Identities=20% Similarity=0.199 Sum_probs=58.5
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++.+|..+| .+++| +|+.+|+..+++. +|..++++++++++..+|.|++ |+|+||...+.
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 79 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVA 79 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 44667899999999 79999 9999999999998 9999999999999999998876 99999976554
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=98.75 E-value=4e-09 Score=80.60 Aligned_cols=64 Identities=14% Similarity=0.195 Sum_probs=56.0
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHH-----cCC--CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHK-----LGH--QIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~--~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.+|.+ +|+|+.+||+.+|+. +|. .++++++++|++.+|.||+ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~ 79 (100)
T 1psr_A 7 RSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLG 79 (100)
T ss_dssp HHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 4567899999999976 799999999999987 565 6888899999999999887 99999987664
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=98.75 E-value=3.5e-09 Score=77.45 Aligned_cols=63 Identities=22% Similarity=0.467 Sum_probs=57.1
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC-CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+....++ +|..+|.+++|+|+.+|+..+++.+| ..++.+++++++..+|.|++ |+|+||...+
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 71 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLI 71 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHH
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4456788 99999999999999999999999999 99999999999999999876 9999997654
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=98.75 E-value=3.3e-09 Score=77.95 Aligned_cols=64 Identities=16% Similarity=0.236 Sum_probs=57.7
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC--CCCCHHHHHH----HHHHHhcCCC--cCHhhHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG--HQIPDTDVQI----LMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg--~~~~~~e~~~----~~~~~d~~~~--i~~~ef~~~ 420 (436)
+++...+..+|..+|.|++|+|+.+|+..++..+| ..++.+++++ ++..+|.|++ |+|+||...
T Consensus 3 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~~~ 74 (83)
T 1yx7_A 3 CKVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFLNA 74 (83)
T ss_dssp SCSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHHHH
T ss_pred ccHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHHHh
Confidence 44567889999999999999999999999999999 8899999999 9999998877 999999744
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.74 E-value=9.8e-09 Score=88.37 Aligned_cols=82 Identities=13% Similarity=0.110 Sum_probs=71.1
Q ss_pred hchhhhhhhhhhhcccc-CCCCCCcccHHHHHHHHHHc----CCCCCHHHHHHHH-----------HHHhcCCC--cCHh
Q 013816 354 HLSVEEVAGIKEGFHMM-DIGNRGKINIDELRVGLHKL----GHQIPDTDVQILM-----------DAVSHTLH--LDLA 415 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~-D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~~~-----------~~~d~~~~--i~~~ 415 (436)
.++.++...++.+|..+ |.|++|+|+.+|+..++..+ |..++.++++.++ +.+|.|++ |+|+
T Consensus 5 ~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~ 84 (191)
T 2ccm_A 5 QLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKE 84 (191)
T ss_dssp CCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHH
T ss_pred hccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHH
Confidence 34667778899999999 99999999999999999998 9999999999999 89998877 9999
Q ss_pred hHHHH-------------------HHHHHhHHhhhhcCC
Q 013816 416 FFREK-------------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 416 ef~~~-------------------~~~~~~f~~~d~~~~ 435 (436)
||... ..+..+|+.+|+||+
T Consensus 85 Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~d 123 (191)
T 2ccm_A 85 EWLKMWAECVKSVEKGESLPEWLTKYMNFMFDVNDTSGD 123 (191)
T ss_dssp HHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHhccccchhhchHHHHHHHHHHHHHhCCCCC
Confidence 99432 245678999999875
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.74 E-value=1.9e-08 Score=84.56 Aligned_cols=71 Identities=17% Similarity=0.301 Sum_probs=63.2
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhc
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGH-----QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEI 433 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~ 433 (436)
+.|..+|.|++|.|+.+|+..+++.+|. .++.++++.++..+|.|++ |+|+||... ..+..+|..+|+|
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~F~~~D~d 84 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWRQHFISFDSD 84 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4588999999999999999999999987 6899999999999999877 999999653 4677899999998
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
|+
T Consensus 85 ~~ 86 (167)
T 1gjy_A 85 RS 86 (167)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-08 Score=98.28 Aligned_cols=82 Identities=23% Similarity=0.413 Sum_probs=73.0
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
.++.++...++++|..+|.|++|.|+.+||..+|+.+|..++.++++.+++.+|.|++ |+|+||....
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl~ll~~~~~~~~~~ 384 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSE 384 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHHHHHHC------CH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHHHHHHhhccccchh
Confidence 4456677899999999999999999999999999999999999999999999999877 9999996433
Q ss_pred -HHHHhHHhhhhcCC
Q 013816 422 -RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 385 e~l~~aFk~fD~D~d 399 (450)
T 3sg6_A 385 EEIREAFRVFDKDGN 399 (450)
T ss_dssp HHHHHHHHHHCTTCS
T ss_pred hHHHHHHHHhCCCCC
Confidence 46789999999874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.2e-07 Score=86.36 Aligned_cols=133 Identities=17% Similarity=0.198 Sum_probs=94.6
Q ss_pred cccCCce-EEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEeccCCC
Q 013816 63 LGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG 141 (436)
Q Consensus 63 lg~G~~g-~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~~g~ 141 (436)
+..|..| .||+......+..+++|+-... ....+.+|+..|+.|..+-.+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445544 6999887777788999985422 34678899999999866656788999999999999999999998
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 013816 142 ELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------------------------------------------- 175 (436)
Q Consensus 142 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------------------------------------------- 175 (436)
++.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 112233445555555555521
Q ss_pred ------------CceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 176 ------------GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 176 ------------~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.++|+|+.|.|||++.+ ..+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~---~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEG---KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECC---eEEEEEECccccc
Confidence 26899999999999642 2356999997754
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.2e-08 Score=82.00 Aligned_cols=73 Identities=15% Similarity=0.203 Sum_probs=61.7
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-------------HHHHhH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-------------RLKISF 427 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-------------~~~~~f 427 (436)
++++|..+|.+++|.|+.+|+..++..+|..++.+++..+++.+|.+++ |+|+||.... .+..+|
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f 81 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLY 81 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHH
Confidence 5678888999999999999999999999888888999999999988877 9999995544 466889
Q ss_pred HhhhhcCC
Q 013816 428 FRWYEIGG 435 (436)
Q Consensus 428 ~~~d~~~~ 435 (436)
+.+|+||+
T Consensus 82 ~~~D~d~~ 89 (134)
T 1jfj_A 82 KLMDVDGD 89 (134)
T ss_dssp HHHCCSSS
T ss_pred HHHCCCCC
Confidence 99988874
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=98.71 E-value=1.4e-08 Score=85.24 Aligned_cols=71 Identities=17% Similarity=0.269 Sum_probs=63.3
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhc
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGH-----QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEI 433 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~ 433 (436)
..|..+|.|++|.|+.+|+..+++.+|. .++.++++.+++.+|.|++ |+|+||... ..+..+|+.+|+|
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~~~~~~~~~~F~~~D~d 82 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAALNAWKENFMTVDQD 82 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4588999999999999999999999987 6899999999999999887 999999653 4677899999998
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
|+
T Consensus 83 ~~ 84 (165)
T 1k94_A 83 GS 84 (165)
T ss_dssp CC
T ss_pred CC
Confidence 75
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=98.71 E-value=5.6e-09 Score=75.24 Aligned_cols=62 Identities=16% Similarity=0.292 Sum_probs=57.0
Q ss_pred hhhhhhhcccc-CCCCC-CcccHHHHHHHHHHcCCCC--CHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMM-DIGNR-GKINIDELRVGLHKLGHQI--PDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg~~~--~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...++.+|..+ |.+++ |+|+.+|+..+++.+|..+ +.+++++++..+|.|++ |+|+||...+
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~~~~ 71 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMM 71 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 45788899999 99999 9999999999999999999 99999999999999887 9999997654
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=98.70 E-value=6.8e-09 Score=92.18 Aligned_cols=85 Identities=20% Similarity=0.128 Sum_probs=71.3
Q ss_pred HHhhchhhhhhhhhhhccccCCCCCCcccHHHHHH-HHHHcCCCCCHHHHHHHHHHH---------hcCCC--cCHhhHH
Q 013816 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRV-GLHKLGHQIPDTDVQILMDAV---------SHTLH--LDLAFFR 418 (436)
Q Consensus 351 i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~-~l~~lg~~~~~~e~~~~~~~~---------d~~~~--i~~~ef~ 418 (436)
+...++.++...++++|..+|.|++|.|+.+||.. +++.+|..++..++..++..+ |.|++ |+|+||.
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~ 120 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL 120 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence 34456778889999999999999999999999998 556679888888888888877 88776 9999996
Q ss_pred HH----------HHHHHhHHhhhhcCC
Q 013816 419 EK----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 419 ~~----------~~~~~~f~~~d~~~~ 435 (436)
.. ..+..+|+.||+||+
T Consensus 121 ~~~~~~~~~~~~~~l~~~F~~~D~d~d 147 (226)
T 2lvv_A 121 EFRLMLCYIYDIFELTVMFDTMDKDGS 147 (226)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSCSSC
T ss_pred HHHHHHHhccCHHHHHHHHHHHcCCCC
Confidence 52 257789999999885
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-08 Score=78.28 Aligned_cols=64 Identities=20% Similarity=0.341 Sum_probs=58.2
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|..+|.+++|+|+.+|+..+++.+ |..+++++++++++.+|.|++ |+|+||...+
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 107 (109)
T 1bu3_A 39 KSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWAALV 107 (109)
T ss_dssp SCHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred hhHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 345678899999999999999999999999999 888999999999999999887 9999997654
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.69 E-value=1.5e-08 Score=78.65 Aligned_cols=63 Identities=27% Similarity=0.374 Sum_probs=57.7
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.|++|+|+.+|+..+++.+ |..+++++++.+++.+|.|++ |+|+||...+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMV 106 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 44578899999999999999999999999999 999999999999999999877 9999997654
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=98.69 E-value=7.6e-09 Score=78.36 Aligned_cols=64 Identities=19% Similarity=0.280 Sum_probs=55.1
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++...++++|+.+|. .+|+|+.+||+.+++. +|..++++++++|++.+|.||+ |+|+||...+.
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~~~~~ 76 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIA 76 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 456789999999994 5679999999999987 5677899999999999999887 99999976654
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=98.69 E-value=1.6e-08 Score=78.41 Aligned_cols=64 Identities=17% Similarity=0.353 Sum_probs=58.0
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.+++|+|+.+|+..+++.+ |..++++++++++..+|.|++ |+|+||...+
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 38 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMI 106 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred hHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 345678899999999999999999999999999 888999999999999999877 9999997654
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=98.68 E-value=1.4e-08 Score=78.89 Aligned_cols=63 Identities=19% Similarity=0.294 Sum_probs=57.7
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.|++|+|+.+|+..+++.+ |..+++++++.+++.+|.|++ |+|+||...+
T Consensus 40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~EF~~~~ 107 (109)
T 3fs7_A 40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQSLV 107 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45578889999999999999999999999999 899999999999999999887 9999997654
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=98.67 E-value=1.9e-08 Score=78.24 Aligned_cols=64 Identities=20% Similarity=0.376 Sum_probs=58.1
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.+++|+|+.+|+..+++.+ |..+++++++++++.+|.|++ |+|+||...+
T Consensus 39 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 107 (110)
T 1pva_A 39 MSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLV 107 (110)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred chHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 445678899999999999999999999999999 788999999999999999877 9999997654
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=98.67 E-value=6.3e-09 Score=78.41 Aligned_cols=65 Identities=12% Similarity=0.161 Sum_probs=57.1
Q ss_pred hhhhhhhhhccccCC-CCCC-cccHHHHHHHH-HHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDI-GNRG-KINIDELRVGL-HKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l-~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+....++.+|..+|. |++| +|+.+||+.++ +.+|..++..+++++++.+|.|++ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~~~ 76 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVI 76 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 345678999999999 9999 99999999999 788877777889999999999877 99999976553
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=98.67 E-value=2.1e-08 Score=77.75 Aligned_cols=64 Identities=23% Similarity=0.343 Sum_probs=58.1
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.+++|+|+.+|+..+++.+ |..+++++++.+++.+|.|++ |+|+||...+
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLV 106 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence 345678899999999999999999999999999 888999999999999999877 9999997654
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.66 E-value=3.8e-08 Score=82.75 Aligned_cols=64 Identities=22% Similarity=0.379 Sum_probs=58.6
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|+.+|.+++|+|+.+|+..++..+|..++++++++++..+|.|++ |+|+||...+.
T Consensus 99 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 164 (169)
T 3qrx_A 99 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMK 164 (169)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHHHHHC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 35578889999999999999999999999999999999999999999999877 99999977654
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.66 E-value=2.6e-08 Score=84.95 Aligned_cols=80 Identities=14% Similarity=0.169 Sum_probs=68.7
Q ss_pred hhhhhhhhhhhcccc-CCCCCCcccHHHHHHHHHHcC----CCCCHHHHHHH-----------HHHHhcCCC--cCHhhH
Q 013816 356 SVEEVAGIKEGFHMM-DIGNRGKINIDELRVGLHKLG----HQIPDTDVQIL-----------MDAVSHTLH--LDLAFF 417 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~-D~~~~G~i~~~el~~~l~~lg----~~~~~~e~~~~-----------~~~~d~~~~--i~~~ef 417 (436)
+.++...++.+|..+ |.|++|.|+.+|+..++..++ ..++.+++.++ ++.+|.|++ |+|+||
T Consensus 3 s~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef 82 (185)
T 2sas_A 3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEY 82 (185)
T ss_dssp CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHH
Confidence 456678899999999 999999999999999999998 88999998866 899999877 999999
Q ss_pred HHH-------------------HHHHHhHHhhhhcCC
Q 013816 418 REK-------------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 418 ~~~-------------------~~~~~~f~~~d~~~~ 435 (436)
... ..+..+|+.+|+||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~d 119 (185)
T 2sas_A 83 LAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGD 119 (185)
T ss_dssp HHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSS
T ss_pred HHHHHHHhccccchhhhhHHHHHHHHHHHHHHcCCCC
Confidence 432 345679999999874
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.65 E-value=3.5e-08 Score=85.93 Aligned_cols=77 Identities=13% Similarity=0.165 Sum_probs=67.4
Q ss_pred hhhhhhhhccccCCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------HHHH
Q 013816 359 EVAGIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----------RLKI 425 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------~~~~ 425 (436)
+...++++|..+|.+ ++|.|+.+|+..+++.+|...+.++++.++..+|.|++ |+|+||...+ .+..
T Consensus 20 ~~~el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~ 99 (204)
T 1jba_A 20 DAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKW 99 (204)
T ss_dssp HHHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHH
T ss_pred CHHHHHHHHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHH
Confidence 345677889999999 89999999999999999998899999999999999887 9999996544 4678
Q ss_pred hHHhhhhcCC
Q 013816 426 SFFRWYEIGG 435 (436)
Q Consensus 426 ~f~~~d~~~~ 435 (436)
+|+.+|+||+
T Consensus 100 ~F~~~D~d~~ 109 (204)
T 1jba_A 100 TFKIYDKDRN 109 (204)
T ss_dssp HHHHHCSSCS
T ss_pred HHHHhCCCCC
Confidence 9999998874
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.6e-08 Score=85.39 Aligned_cols=79 Identities=15% Similarity=0.110 Sum_probs=66.1
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC----CCCCHHH-HH--------HHHHHHhcCCCcCHhhHHHH---
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG----HQIPDTD-VQ--------ILMDAVSHTLHLDLAFFREK--- 420 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg----~~~~~~e-~~--------~~~~~~d~~~~i~~~ef~~~--- 420 (436)
.++...++.+|..+|.|++|.|+.+|+..+++.+| ..++..+ +. .+++.+|.+|.|+|+||...
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D~~g~i~~~EF~~~~~~ 81 (174)
T 1q80_A 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKE 81 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcCCCCeEcHHHHHHHHHH
Confidence 45677899999999999999999999999999988 8999888 64 57788885556999999532
Q ss_pred ------------HHHHHhHHhhhhcCC
Q 013816 421 ------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ------------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~F~~~D~d~~ 108 (174)
T 1q80_A 82 MVKNPEAKSVVEGPLPLFFRAVDTNED 108 (174)
T ss_dssp HTTSTTCHHHHHTHHHHHHHHHCTTSS
T ss_pred HcCcccHHHHHHHHHHHHHHHhCCCCC
Confidence 346679999999875
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.6e-08 Score=75.48 Aligned_cols=65 Identities=14% Similarity=0.285 Sum_probs=58.0
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLHK---LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+....++.+|..+| .+++| +|+.+|++.+++. +|..++..+++++++.+|.|++ |+|+||...+.
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 78 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLG 78 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 34567899999999 59999 9999999999998 9999999999999999998877 99999976553
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.63 E-value=3.2e-08 Score=82.73 Aligned_cols=76 Identities=14% Similarity=0.080 Sum_probs=63.2
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHH----HHcCCCCCHHHHHHH-----------HHHHhcCCC--cCHhhHHHH--
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGL----HKLGHQIPDTDVQIL-----------MDAVSHTLH--LDLAFFREK-- 420 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l----~~lg~~~~~~e~~~~-----------~~~~d~~~~--i~~~ef~~~-- 420 (436)
...++.+|..+|.|++|+|+.+|+..++ +.+|..++.+++..+ +..+|.|++ |+|+||...
T Consensus 3 ~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~ 82 (166)
T 3akb_A 3 ERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFVTGAV 82 (166)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHHHTHH
T ss_pred HHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 4678899999999999999999999975 556999999888866 588998876 999999421
Q ss_pred ---------------HHHHHhHHhhhhcCC
Q 013816 421 ---------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---------------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 112 (166)
T 3akb_A 83 KRLRDKPDRFAEMARPFLHAALGVADTDGD 112 (166)
T ss_dssp HHHHHSHHHHHHHHHHHHHHHHHHHCSSSS
T ss_pred HHhccCccchHHHHHHHHHHHHHHhCCCCC
Confidence 126789999999875
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.63 E-value=6e-08 Score=80.67 Aligned_cols=64 Identities=22% Similarity=0.400 Sum_probs=58.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+|.|++ |+|+||...+
T Consensus 93 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~~~~ 158 (161)
T 3fwb_A 93 DPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFIAIC 158 (161)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHHHHH
T ss_pred CcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999998876 9999997654
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.63 E-value=4e-08 Score=80.10 Aligned_cols=64 Identities=20% Similarity=0.299 Sum_probs=58.3
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+|.|++ |+|+||...+.
T Consensus 74 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 139 (143)
T 3j04_B 74 PEDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFTRILK 139 (143)
T ss_dssp CHHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHHHHh
Confidence 34578899999999999999999999999999999999999999999998877 99999977653
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.61 E-value=5.3e-08 Score=80.81 Aligned_cols=64 Identities=20% Similarity=0.358 Sum_probs=58.5
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|..+|.+++|+|+.+|+..+++.+|..++++++..++..+|.|++ |+|+||...+
T Consensus 88 ~~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 153 (158)
T 2jnf_A 88 QMQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFMGVM 153 (158)
T ss_dssp TTSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHHHHT
T ss_pred hHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 445678999999999999999999999999999999999999999999999887 9999997653
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.60 E-value=8.2e-08 Score=81.35 Aligned_cols=65 Identities=15% Similarity=0.141 Sum_probs=56.0
Q ss_pred cCCCCCCcccHHHHHHHHHHc------CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhcCC
Q 013816 370 MDIGNRGKINIDELRVGLHKL------GHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEIGG 435 (436)
Q Consensus 370 ~D~~~~G~i~~~el~~~l~~l------g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~~~ 435 (436)
-+.+++|+|+.+||+.+|+.+ |..+++++++.|+..+|.|++ |+|+||... .+++.+|+.|| ||+
T Consensus 13 ~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~~~~~~~~~l~~aF~~fD-d~~ 89 (174)
T 2i7a_A 13 GLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFARLWKRLVHYQHVFQKVQ-TSP 89 (174)
T ss_dssp CSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHHHHHHHHHHHHHHHHHHC-SBT
T ss_pred ccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHHHHHHHHhc-CCC
Confidence 367899999999999999998 678899999999999999987 999999653 45778999999 874
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.60 E-value=6e-08 Score=79.53 Aligned_cols=64 Identities=27% Similarity=0.469 Sum_probs=58.5
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+|.|++ |+|+||...+.
T Consensus 81 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~~~~~ 146 (148)
T 1m45_A 81 KTEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDVL 146 (148)
T ss_dssp CTHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 34678899999999999999999999999999999999999999999999887 99999977653
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=98.59 E-value=2.4e-08 Score=77.34 Aligned_cols=64 Identities=25% Similarity=0.409 Sum_probs=57.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.+...++.+|+.+|.+++|+|+.+|+..+++.+ |..+++++++++++.+|.|++ |+|+||...+
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 106 (108)
T 1rro_A 38 MSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp SCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 345678899999999999999999999999999 688999999999999999877 9999997654
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.58 E-value=3.2e-08 Score=81.82 Aligned_cols=75 Identities=21% Similarity=0.368 Sum_probs=63.2
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------HHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK-----------VRL 423 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~-----------~~~ 423 (436)
+++...++++|..+|.+++|.|+.+|+ ..+..++... ++..++..+|.+++ |+|+||... ..+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el-~~l~~~~~~~---~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~ 77 (155)
T 3ll8_B 2 ADEIKRLGKRFKKLDLDNSGSLSVEEF-MSLPELQQNP---LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKL 77 (155)
T ss_dssp CHHHHHHHHHHHHHCTTCSSSBCHHHH-TTSGGGTTCT---THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHH
T ss_pred HHHHHHHHHHHHHhCcCCCCeEcHHHH-HHhhccccch---HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHH
Confidence 467788999999999999999999999 6777777554 78899999999877 999999543 456
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.+|+||+
T Consensus 78 ~~~F~~~D~d~~ 89 (155)
T 3ll8_B 78 RFAFRIYDMDKD 89 (155)
T ss_dssp HHHHHHHCTTCS
T ss_pred HHHHHHhCCCCC
Confidence 789999999875
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.58 E-value=1e-07 Score=79.85 Aligned_cols=64 Identities=16% Similarity=0.175 Sum_probs=58.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.|++|+|+.+|+..++..+|..+++++++.++..+|.|++ |+|+||...+.
T Consensus 93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~~~~~ 158 (166)
T 2mys_B 93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVIT 158 (166)
T ss_pred cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHHHHHH
Confidence 34578889999999999999999999999999999999999999999999877 99999976643
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=98.57 E-value=1.1e-08 Score=74.12 Aligned_cols=63 Identities=13% Similarity=0.160 Sum_probs=56.5
Q ss_pred hhhhhhhhccccCC-CCCC-cccHHHHHHHHHH-cCCCC-CHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDI-GNRG-KINIDELRVGLHK-LGHQI-PDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~-~~~G-~i~~~el~~~l~~-lg~~~-~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+...++.+|..+|. +++| .|+.+|+..+++. +|..+ +.+++++++..+|.|++ |+|+||...+
T Consensus 5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~ 73 (78)
T 1cb1_A 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLV 73 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHHHHHHHH
Confidence 45678999999999 9999 9999999999986 88877 89999999999999877 9999997654
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=98.57 E-value=8e-08 Score=85.39 Aligned_cols=73 Identities=15% Similarity=0.257 Sum_probs=60.0
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc------------CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL------------GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV---- 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l------------g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---- 421 (436)
...++.+|+.+|.|++|+|+.+|+..+++.+ +...++++++++++.+|.|++ |+|+||...+
T Consensus 137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~ 216 (229)
T 3dd4_A 137 QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFIESCQKDE 216 (229)
T ss_dssp HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHHHHHHTCH
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHHHHHHhCH
Confidence 4578889999999999999999999999987 567788999999999999887 9999997654
Q ss_pred HHHHhHHhhhh
Q 013816 422 RLKISFFRWYE 432 (436)
Q Consensus 422 ~~~~~f~~~d~ 432 (436)
.+..+|..||.
T Consensus 217 ~~~~~~~~~D~ 227 (229)
T 3dd4_A 217 NIMRSMQLFEN 227 (229)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHhccc
Confidence 45567888774
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.56 E-value=6.1e-08 Score=82.59 Aligned_cols=64 Identities=13% Similarity=0.243 Sum_probs=57.5
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHH-HcCCC-C------CHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLH-KLGHQ-I------PDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~-~lg~~-~------~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.|++|+|+.+||..+++ .+|.. + ++++++++++.+|.||+ |+|+||...+
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~ 168 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLEALL 168 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 4456799999999999999999999999999 88877 6 88999999999999987 9999997654
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.56 E-value=7.4e-08 Score=79.25 Aligned_cols=61 Identities=26% Similarity=0.486 Sum_probs=56.6
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHH-cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHK-LGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
...+..+|..+|.+++|+|+.+|+..++.. +|..++++++++++..+|.|++ |+|+||...
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~ 150 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFVRM 150 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHH
Confidence 467889999999999999999999999999 8999999999999999998876 999999764
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.55 E-value=3.8e-08 Score=85.56 Aligned_cols=78 Identities=13% Similarity=0.130 Sum_probs=67.2
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
.++.++...++++|..+|.|++|+|+.+|+..+ +.+|...+ ++.++..+|.|++ |+|+||...+
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~~~~~~~~~~~~~~ 97 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFVRVLAHFRPVEDED 97 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHHHHHGGGSCCCHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHHHHHHHhcccchhc
Confidence 456778889999999999999999999999999 88887665 8899999999877 9999996433
Q ss_pred -----------------HHHHhHHhhhhcCC
Q 013816 422 -----------------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -----------------~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~d 128 (202)
T 2bec_A 98 TETQDPKKPEPLNSRRNKLHYAFQLYDLDRD 128 (202)
T ss_dssp HC-----CCCCTTSHHHHHHHHHHHHCTTCS
T ss_pred ccccccccccccccHHHHHHHHHHHhCCCCC
Confidence 46789999999885
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.55 E-value=1.7e-07 Score=76.68 Aligned_cols=63 Identities=22% Similarity=0.396 Sum_probs=57.5
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....+..+|..+|.+++|+|+.+|+..++..+|..++++++..++.. |.|++ |+|+||...+
T Consensus 82 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~~~~ 146 (149)
T 2mys_C 82 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHI 146 (149)
T ss_pred chHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999 99877 9999997654
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=98.54 E-value=2.7e-07 Score=83.50 Aligned_cols=77 Identities=17% Similarity=0.247 Sum_probs=67.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc----CCCCCHHHHHH----HHHHHhcCCC--cCHhhHHHH--------
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQIPDTDVQI----LMDAVSHTLH--LDLAFFREK-------- 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d~~~~--i~~~ef~~~-------- 420 (436)
....++.+|..+|.+++|+|+.+|+..++..+ |..++.+++.. ++..+|.+++ |+|+||...
T Consensus 101 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~~~~~~~~~~~ 180 (263)
T 2f33_A 101 SCEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMARLLPVQENFL 180 (263)
T ss_dssp CHHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHHHHSCTTTCSH
T ss_pred HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHHHHHHHHHHHH
Confidence 34568899999999999999999999999998 99999999887 9999998876 999999653
Q ss_pred ----------HHHHHhHHhhhhcCC
Q 013816 421 ----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ----------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 181 ~~~~~~~~~~~~~~~~F~~~D~d~~ 205 (263)
T 2f33_A 181 LKFQGIKMCGKEFNKAFELYDQDGN 205 (263)
T ss_dssp HHHHHTCCCHHHHHHHHHHHCCSSS
T ss_pred HHhcCcchHHHHHHHHHHHhCCCCC
Confidence 346689999999874
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-07 Score=78.03 Aligned_cols=65 Identities=29% Similarity=0.392 Sum_probs=58.7
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHH--HhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDA--VSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~--~d~~~~--i~~~ef~~~~~ 422 (436)
.....+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.+++. +|.|++ |+|+||...+.
T Consensus 81 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~ 149 (156)
T 1wdc_C 81 GTFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVM 149 (156)
T ss_dssp CCHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHH
T ss_pred ChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHHHHHh
Confidence 335678899999999999999999999999999999999999999999 999877 99999976553
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.53 E-value=9.6e-08 Score=78.04 Aligned_cols=62 Identities=23% Similarity=0.400 Sum_probs=56.3
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|.|+.+|+..++..+|..+++++++.++..+| |++ |+|+||...+
T Consensus 82 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~l 145 (147)
T 4ds7_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFAALL 145 (147)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHHHHH
Confidence 3457888999999999999999999999999999999999999999999 776 9999997643
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.6e-07 Score=76.74 Aligned_cols=63 Identities=19% Similarity=0.300 Sum_probs=56.0
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|+|+.+|+..++..+|..++++++++++..+|.||.|+|+||...+
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~~~l 144 (146)
T 2qac_A 82 NVEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAFSSEDNIDYKLFCEDI 144 (146)
T ss_dssp CHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSEEEHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCcCcHHHHHHHH
Confidence 356788999999999999999999999999999999999999999988445559999997654
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.3e-08 Score=90.59 Aligned_cols=82 Identities=10% Similarity=0.113 Sum_probs=69.7
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCH------HHHHHHHHHHhcCCC--cCHhhHHHHH----
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPD------TDVQILMDAVSHTLH--LDLAFFREKV---- 421 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~------~e~~~~~~~~d~~~~--i~~~ef~~~~---- 421 (436)
.++..+...++.+|..+|.|++|.|+.+|+..+++.+|..++. .+++.++..+|.|++ |+|+||...+
T Consensus 9 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~Ef~~~~~~~~ 88 (263)
T 2f33_A 9 QSSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYGQRDDGKIGIVELAHVLPTEE 88 (263)
T ss_dssp TTSCCCHHHHHHHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHTTGGGCCBCHHHHHHHTTSCT
T ss_pred hcCcccHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhCCCCCCcCcHHHHHHHHhhhh
Confidence 4556677789999999999999999999999999998766554 789999999998876 9999996543
Q ss_pred ---------------HHHHhHHhhhhcCC
Q 013816 422 ---------------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ---------------~~~~~f~~~d~~~~ 435 (436)
.+..+|..+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~l~~~F~~~D~d~~ 117 (263)
T 2f33_A 89 NFLLLFRCQQLKSCEEFMKTWRKYDTDHS 117 (263)
T ss_dssp THHHHHGGGTSSCHHHHHHHHTTSSTTTC
T ss_pred hHHHHHHHhhccHHHHHHHHHHHHCCCCC
Confidence 45689999999874
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.52 E-value=3.5e-07 Score=75.37 Aligned_cols=121 Identities=20% Similarity=0.249 Sum_probs=79.5
Q ss_pred cCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhhhhhccccCCCC
Q 013816 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKEGFHMMDIGN 374 (436)
Q Consensus 296 l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~ 374 (436)
+..|..-+.+..|+.. +......+ ....+...+..-.....-...++..+.... .......++.+|..+|.++
T Consensus 15 ~D~d~~G~i~~~el~~---l~~~~~~~---~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~ 88 (155)
T 3ll8_B 15 LDLDNSGSLSVEEFMS---LPELQQNP---LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDK 88 (155)
T ss_dssp HCTTCSSSBCHHHHTT---SGGGTTCT---THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTC
T ss_pred hCcCCCCeEcHHHHHH---hhccccch---HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCC
Confidence 4667777888888832 22111111 112222222211111112233333333332 2244567899999999999
Q ss_pred CCcccHHHHHHHHHH-cCCCCCHHHHHHHHHH----HhcCCC--cCHhhHHHHHH
Q 013816 375 RGKINIDELRVGLHK-LGHQIPDTDVQILMDA----VSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 375 ~G~i~~~el~~~l~~-lg~~~~~~e~~~~~~~----~d~~~~--i~~~ef~~~~~ 422 (436)
+|+|+.+|+..++.. +|..++.+++.++++. +|.|++ |+|+||...+.
T Consensus 89 ~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 143 (155)
T 3ll8_B 89 DGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVG 143 (155)
T ss_dssp SSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHHHHG
T ss_pred CCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHh
Confidence 999999999999999 6999999999999998 998877 99999977654
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=98.52 E-value=5.2e-08 Score=88.72 Aligned_cols=80 Identities=21% Similarity=0.237 Sum_probs=68.3
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHH----HcCC--CCCHHHHHHHH----HHHhcCCC--cCHhhHHHH---
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLH----KLGH--QIPDTDVQILM----DAVSHTLH--LDLAFFREK--- 420 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~----~lg~--~~~~~e~~~~~----~~~d~~~~--i~~~ef~~~--- 420 (436)
+..+...++.+|..+|.|++|.|+.+|+..+++ .+|. .++.+++..++ ..+|.||+ |+|+||...
T Consensus 6 ~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~ 85 (272)
T 2be4_A 6 ANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYDATFDGRLQIEELANMILP 85 (272)
T ss_dssp CCCCHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHHHTCCSEEEHHHHHHHHSC
T ss_pred HhcCHHHHHHHHHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhcCCCCCcEeHHHHHHHHhh
Confidence 445567799999999999999999999999999 8998 99999998865 56788877 999999766
Q ss_pred ------------------HHHHHhHHhhhhcCC
Q 013816 421 ------------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ------------------~~~~~~f~~~d~~~~ 435 (436)
..+..+|..+|+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~l~~~F~~~D~d~~ 118 (272)
T 2be4_A 86 QEENFLLIFRREAPLDNSVEFMKIWRKYDADSS 118 (272)
T ss_dssp HHHHHHHHHHHHSCCCCHHHHHHHHHHHCTTCC
T ss_pred hhHHHHHHHhhccCcccHHHHHHHHHHhCCCCC
Confidence 246689999999875
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.52 E-value=1.3e-07 Score=80.23 Aligned_cols=61 Identities=23% Similarity=0.392 Sum_probs=54.3
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
....+..+|..+|.+++|+|+.+|+..++..+|..++++++..++..+|.|++ |+|+||..
T Consensus 82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~ 144 (179)
T 2f2o_A 82 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQ 144 (179)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHHH
Confidence 34568889999999999999999999999999999999999999999999877 99999954
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.9e-07 Score=88.92 Aligned_cols=81 Identities=19% Similarity=0.181 Sum_probs=51.4
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeecccc--CC--hhhHHHHHHHHHHHHhCCCC-C-ceeEEEEEEEeCCeEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RT--AVDIEDVRREVDIMRHLPKH-Q-NIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~--~~~~~~~~~E~~~l~~l~~h-~-niv~~~~~~~~~~~~~l 133 (436)
.+.||.|..+.||++....+++.+++|....... .. ....+.+..|+++++.+..+ | .+++++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4679999999999997655678999998653211 00 11234567898888877332 3 34566643 4455689
Q ss_pred EEeccCCCc
Q 013816 134 VMELCEGGE 142 (436)
Q Consensus 134 v~E~~~g~~ 142 (436)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.49 E-value=8.6e-08 Score=77.96 Aligned_cols=61 Identities=16% Similarity=0.250 Sum_probs=56.0
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
....+..+|..+|.+++|+|+.+|+..++..+|..++++++++++..+| |++ |+|+||...
T Consensus 77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~ 139 (142)
T 2bl0_C 77 SEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFINT 139 (142)
T ss_dssp CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHHTT
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHHHH
Confidence 4557889999999999999999999999999999999999999999999 877 999999653
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.49 E-value=1.6e-07 Score=76.54 Aligned_cols=65 Identities=26% Similarity=0.389 Sum_probs=58.9
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+|.|++ |+|+||...+.
T Consensus 73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 139 (145)
T 2bl0_B 73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFVDMLV 139 (145)
T ss_dssp GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999999877 99999976643
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=8.8e-08 Score=72.86 Aligned_cols=65 Identities=15% Similarity=0.171 Sum_probs=56.2
Q ss_pred hhhhhhhhhccccC-CCCCC-cccHHHHHHHHH-HcC----CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMD-IGNRG-KINIDELRVGLH-KLG----HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D-~~~~G-~i~~~el~~~l~-~lg----~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+....+..+|..+| .+++| +|+.+||+.+++ .+| ..+++++++++++.+|.|++ |+|+||...+.
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~~~~~ 83 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLIG 83 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 34567899999998 99999 999999999998 454 77899999999999999877 99999976553
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=98.48 E-value=2.1e-07 Score=82.38 Aligned_cols=81 Identities=20% Similarity=0.259 Sum_probs=68.0
Q ss_pred hchhhhhhhhhhhccccCCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH---------
Q 013816 354 HLSVEEVAGIKEGFHMMDIG--NRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK--------- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~--~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~--------- 420 (436)
.++.++...+.++|..+|.+ ++|.|+.+|+..++.. +....+.+++.++..+|.|++ |+|+||...
T Consensus 41 ~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~ 119 (226)
T 2zfd_A 41 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEFARALSVFHPNAP 119 (226)
T ss_dssp SCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSC
T ss_pred CCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHccCCC
Confidence 45788889999999999999 9999999999999987 333445667889999999887 999999543
Q ss_pred --HHHHHhHHhhhhcCC
Q 013816 421 --VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 --~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 120 ~~~~l~~~F~~~D~d~~ 136 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQ 136 (226)
T ss_dssp HHHHHHHHHHHHCTTSS
T ss_pred HHHHHHHHHHHhCCCCC
Confidence 247789999999875
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.47 E-value=1.3e-07 Score=81.70 Aligned_cols=62 Identities=16% Similarity=0.198 Sum_probs=57.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.|++|+|+.+||..++ .+|..++.++++.++..+|.|++ |+|+||...+
T Consensus 124 ~~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~l 187 (196)
T 3dtp_E 124 EEDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFAQIL 187 (196)
T ss_dssp CHHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHHHHH
Confidence 34578899999999999999999999999 99999999999999999998887 9999997665
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.47 E-value=9.8e-08 Score=78.52 Aligned_cols=62 Identities=23% Similarity=0.408 Sum_probs=55.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|+|+.+|++.+++.+|..+++++++.++..+| |++ |+|+||...+
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~~~~ 148 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFLKHI 148 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHHHHT
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHHHHH
Confidence 4567888999999999999999999999999999999999999999999 877 9999997653
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=98.47 E-value=2.7e-07 Score=80.34 Aligned_cols=81 Identities=17% Similarity=0.275 Sum_probs=67.9
Q ss_pred hchhhhhhhhhhhccccCCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH---------
Q 013816 354 HLSVEEVAGIKEGFHMMDIG--NRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK--------- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~--~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~--------- 420 (436)
.++.++...+..+|..+|.+ ++|.|+.+|+..++.. .....+.+++.++..+|.|++ |+|+||...
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~ 108 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEFVRSLGVFHPSAP 108 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHHHHHHGGGSTTSC
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHccCCC
Confidence 45778888999999999999 9999999999999987 333445678889999999887 999999543
Q ss_pred --HHHHHhHHhhhhcCC
Q 013816 421 --VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 --~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 109 ~~~~l~~~F~~~D~d~~ 125 (207)
T 2ehb_A 109 VHEKVKFAFKLYDLRQT 125 (207)
T ss_dssp HHHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHHHhCCCCC
Confidence 347789999999875
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.47 E-value=5.5e-07 Score=74.82 Aligned_cols=63 Identities=22% Similarity=0.371 Sum_probs=57.8
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|+|+.+|+..++..+|..++++++..++..+|.|++ |+|+||...+
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~ 158 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 45578899999999999999999999999999999999999999999999877 9999997654
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.47 E-value=2.6e-07 Score=76.45 Aligned_cols=62 Identities=18% Similarity=0.361 Sum_probs=56.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|..+|.+++|+|+.+|+..++..+|..+++++++.+++.+|.| + |+|+||...+.
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~-dg~i~~~eF~~~~~ 149 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVE-GGKFDYVKFTAMIK 149 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEE-TTEECHHHHHHHHH
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCC-CCEEeHHHHHHHHh
Confidence 45788999999999999999999999999999999999999999999887 5 99999976643
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=98.46 E-value=1.7e-08 Score=78.25 Aligned_cols=64 Identities=23% Similarity=0.386 Sum_probs=57.9
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|+.+|.+++|+|+.+|+..+++.+ |..+++++++.+++.+|.|++ |+|+||...+
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 106 (108)
T 2kyc_A 38 KSSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQEMV 106 (108)
T ss_dssp CCSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCSSSSCCCSSHHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence 345678899999999999999999999999999 888999999999999998877 9999997654
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=98.46 E-value=3.3e-07 Score=71.37 Aligned_cols=68 Identities=22% Similarity=0.256 Sum_probs=60.5
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKI 425 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~ 425 (436)
++.++...+.++|+.+|. ++|+|+.+|++..|.+.| ++.+++.++++.+|.|++ |+|+||...|.|..
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~d~dG~Ld~~EF~~aM~Li~ 96 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADMNNDGRMDQVEFSIAMKLIK 96 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHHH
Confidence 456788899999999998 899999999999999875 579999999999999887 99999988777664
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.45 E-value=2.1e-07 Score=75.45 Aligned_cols=61 Identities=23% Similarity=0.427 Sum_probs=56.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|..+|.+++|+|+.+|+..+++.+|..+++++++.++..+|. ++ |+|+||...+
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~-~dg~i~~~eF~~~~ 137 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPV-KDGMVNYHDFVQMI 137 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTC-SSCCSTTTHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccC-CCCcEeHHHHHHHH
Confidence 4678899999999999999999999999999999999999999999997 65 9999997654
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.43 E-value=3.8e-08 Score=85.32 Aligned_cols=63 Identities=21% Similarity=0.277 Sum_probs=55.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc--CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL--GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|+.+|.|++|+|+.+||..++..+ |..+++++++++++.+|.|++ |+|+||...+.
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 4578899999999999999999999999998 778899999999999998877 99999977653
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-07 Score=79.00 Aligned_cols=63 Identities=25% Similarity=0.419 Sum_probs=55.9
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|..+|.+++|+|+.+|+..++..+|..+++++++.++..+|.|++ |+|+||...+
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~ 157 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFM 157 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 45568899999999999999999999999999999999999999999999887 9999997654
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.42 E-value=2.5e-07 Score=80.33 Aligned_cols=64 Identities=17% Similarity=0.327 Sum_probs=57.9
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHH----HhcCCC--cCHhhHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-GHQIPDTDVQILMDA----VSHTLH--LDLAFFREKV 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~~~e~~~~~~~----~d~~~~--i~~~ef~~~~ 421 (436)
.....++.+|..+|.|++|+|+.+|+..++..+ |..++++++++++.. +|.|++ |+|+||...+
T Consensus 111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 181 (202)
T 2bec_A 111 SRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTKSL 181 (202)
T ss_dssp SHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHHTT
T ss_pred cHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHH
Confidence 445678999999999999999999999999999 999999999999998 998877 9999996644
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=98.42 E-value=2.4e-07 Score=95.93 Aligned_cols=80 Identities=16% Similarity=0.170 Sum_probs=71.0
Q ss_pred chhhh-hhhhhhhccccCCCCCCcccHHHHHHHHHHc--------CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH---
Q 013816 355 LSVEE-VAGIKEGFHMMDIGNRGKINIDELRVGLHKL--------GHQIPDTDVQILMDAVSHTLH--LDLAFFREK--- 420 (436)
Q Consensus 355 ~~~~~-~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~--- 420 (436)
++.++ ...++++|..+| +++|.|+.+||..+|+.+ |..++.++++.|+..+|.|++ |+|+||...
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~~l~~~ 603 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTK 603 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHHHHHHH
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 45566 778999999999 999999999999999997 788999999999999999887 999999653
Q ss_pred -HHHHHhHHhhhhcCC
Q 013816 421 -VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 604 ~~~l~~~F~~~D~d~d 619 (714)
T 3bow_A 604 IQKYQKIYREIDVDRS 619 (714)
T ss_dssp HHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHHhCCCCC
Confidence 457789999999875
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3.8e-07 Score=78.44 Aligned_cols=67 Identities=15% Similarity=0.132 Sum_probs=54.0
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHHhHHhhhhc
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKISFFRWYEI 433 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~~f~~~d~~ 433 (436)
.+|+.+|.|++|+|+.+|+..+++.+|..++++++++++..+|.|++ |+|+||...+. ..|...|.+
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~~~~~--~~~~s~d~~ 185 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQHL--GFWYTLDPE 185 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHHH--HHHTTCCGG
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHH--HHccCCCcc
Confidence 89999999999999999999999999999999999999999999877 99999966543 344444443
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.41 E-value=1.8e-07 Score=87.54 Aligned_cols=76 Identities=14% Similarity=0.154 Sum_probs=67.7
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHH-HHHHHhcCCC--cCHhhHHHHH----HHHHhHHhh
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQI-LMDAVSHTLH--LDLAFFREKV----RLKISFFRW 430 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~-~~~~~d~~~~--i~~~ef~~~~----~~~~~f~~~ 430 (436)
.....+..+|..+|.+++|+|+.+|+..++ +|..++..++.. ++..+|.|++ |+|+||...+ .+..+|..|
T Consensus 185 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l--~g~~~~~~ei~~~l~~~~D~d~dG~Is~~EF~~~l~~~~~l~~~F~~~ 262 (323)
T 1ij5_A 185 NDLAALVADFRKIDTNSNGTLSRKEFREHF--VRLGFDKKSVQDALFRYADEDESDDVGFSEYVHLGLCLLVLRILYAFA 262 (323)
T ss_dssp HHHHTSCCCHHHHCTTCCSEECHHHHHHHH--HHTTCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHCCCCCCcCcHHHHHHHH--cCCCCCHHHHHHHHHHHhcCCCCCEEeHHHHHHHHHHHHHHHHHHHHh
Confidence 456678999999999999999999999999 888899999999 9999999877 9999996654 477899999
Q ss_pred hhcCC
Q 013816 431 YEIGG 435 (436)
Q Consensus 431 d~~~~ 435 (436)
|+||+
T Consensus 263 D~d~d 267 (323)
T 1ij5_A 263 DFDKS 267 (323)
T ss_dssp CSSSC
T ss_pred CCCCC
Confidence 99875
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.40 E-value=4.6e-07 Score=77.61 Aligned_cols=67 Identities=15% Similarity=0.153 Sum_probs=58.2
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHHhHHhhhhc
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKISFFRWYEI 433 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~~f~~~d~~ 433 (436)
.+|..+|.|++|+|+.+|+..+++.+|..++.+++++++..+|.|++ |+|+||...+. ..|...|.+
T Consensus 113 ~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~~~~~--~~~~s~d~~ 181 (191)
T 1uhk_A 113 ALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTRQHL--GFWYTMDPA 181 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHHHHH--HHHTTCCGG
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH--HHhcCCCCC
Confidence 89999999999999999999999999999999999999999999877 99999966544 345444443
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=98.40 E-value=5.5e-07 Score=76.66 Aligned_cols=79 Identities=15% Similarity=0.161 Sum_probs=62.2
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHH----------H
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREK----------V 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~ 421 (436)
++.+++..+.+.|..+ |++|.|+.+|+..+++.+|.. .+..+++.+++.+|.||+ |+|+||... .
T Consensus 15 ~s~~~i~~l~~~fd~~--d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~ 92 (183)
T 1s6c_A 15 FTKRELQVLYRGFKNE--XPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE 92 (183)
T ss_dssp CCHHHHHHHHHHHHHH--CTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHHh--CCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHH
Confidence 4555666665555543 688999999999999998765 789999999999998877 999999543 3
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 93 ~~~~~f~~~D~d~~ 106 (183)
T 1s6c_A 93 KLRWTFNLYDINKD 106 (183)
T ss_dssp HHHHHHHHHCTTCS
T ss_pred HHHHHHHHhCCCCC
Confidence 56789999998874
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.40 E-value=8.2e-07 Score=76.13 Aligned_cols=61 Identities=18% Similarity=0.206 Sum_probs=55.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|..+|.|++|+|+.+|+..+++.+| +++++++++++.+|.|++ |+|+||...+.
T Consensus 108 ~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~ 170 (191)
T 2ccm_A 108 TKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDGGKTMVTREIFARLWT 170 (191)
T ss_dssp HHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTTTTSCCBHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 45688999999999999999999999999998 899999999999999877 99999976543
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=98.39 E-value=4.1e-07 Score=77.46 Aligned_cols=73 Identities=18% Similarity=0.298 Sum_probs=58.2
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----CCC----CC----HHHHHHHHHHHhcCCC--cCHhhHHHHH----
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQ----IP----DTDVQILMDAVSHTLH--LDLAFFREKV---- 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~----~~----~~e~~~~~~~~d~~~~--i~~~ef~~~~---- 421 (436)
...+..+|+.+|.|++|+|+.+|+..++..+ |.. ++ .++++++++.+|.|++ |+|+||...+
T Consensus 91 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~~~~~ 170 (183)
T 1s6c_A 91 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESXQEDD 170 (183)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHHHTTSCC
T ss_pred HHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHhcCh
Confidence 4578889999999999999999999999886 643 34 3889999999999887 9999997655
Q ss_pred HHHHhHHhhhh
Q 013816 422 RLKISFFRWYE 432 (436)
Q Consensus 422 ~~~~~f~~~d~ 432 (436)
.+...|..||.
T Consensus 171 ~~~~~l~~~d~ 181 (183)
T 1s6c_A 171 NIMRSLQLFQN 181 (183)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHhhc
Confidence 35566777763
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=98.39 E-value=5.7e-08 Score=98.50 Aligned_cols=75 Identities=17% Similarity=0.145 Sum_probs=14.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-------HHHHhHHhhh
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-------RLKISFFRWY 431 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-------~~~~~f~~~d 431 (436)
..++++|..+|.|++|+|+.+||..+|+.+|..+++++++++++.+|.|++ |+|+||...+ ++..+|+.||
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~~~~~~l~~~~el~~aF~~fD 90 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIETFYKMLTQRAEIDRAFEEAA 90 (624)
T ss_dssp ---------------------------------------------------------CTTHHHHHHTCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhccHHHHHHHHHHhc
Confidence 368899999999999999999999999999999999999999999999877 9999995432 4778999999
Q ss_pred hcCC
Q 013816 432 EIGG 435 (436)
Q Consensus 432 ~~~~ 435 (436)
++.|
T Consensus 91 ~~~G 94 (624)
T 1djx_A 91 GSAE 94 (624)
T ss_dssp TTSS
T ss_pred CCCC
Confidence 8643
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.39 E-value=5.6e-07 Score=77.43 Aligned_cols=64 Identities=23% Similarity=0.308 Sum_probs=55.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHH--cCCCCCH---HHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHK--LGHQIPD---TDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~--lg~~~~~---~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.|++|+|+.+|+..++.. .|..+++ +++++++..+|.|++ |+|+||...+.
T Consensus 120 ~~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 190 (191)
T 3k21_A 120 SKKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSEMMK 190 (191)
T ss_dssp CHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHHHHC
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeECHHHHHHHHc
Confidence 3457888999999999999999999999998 5677776 468999999999887 99999987653
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=98.37 E-value=2.8e-07 Score=95.45 Aligned_cols=74 Identities=18% Similarity=0.235 Sum_probs=66.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----HHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----RLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----~~~~~f~~~d~~~ 434 (436)
..++.+|+.+|.|++|+|+.+||..+|+.+|..+++++++.|+..+| |++ |+|+||...+ .+..+|+.+|+||
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~~~l~~~~~l~~~F~~~D~d~ 683 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPEN 683 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHHHHHHHHHHHHHHHSSSCSSC
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 56888999999999999999999999999999999999999999999 776 9999996543 5668999999987
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 684 d 684 (714)
T 3bow_A 684 T 684 (714)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.36 E-value=1.5e-07 Score=81.40 Aligned_cols=73 Identities=10% Similarity=0.133 Sum_probs=40.8
Q ss_pred hhhhhccccCCC-CCCcccHHHHHHHHHHcCCCCCH-HHHHHHHHHHhcCCC--cCHhhHHHHH----------HHHHhH
Q 013816 362 GIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQIPD-TDVQILMDAVSHTLH--LDLAFFREKV----------RLKISF 427 (436)
Q Consensus 362 ~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~~~~-~e~~~~~~~~d~~~~--i~~~ef~~~~----------~~~~~f 427 (436)
.++.+|..+|.+ ++|.|+.+|+..+++.+|...+. ++++.++..+|.|++ |+|+||...+ .+..+|
T Consensus 15 el~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F 94 (198)
T 2r2i_A 15 ECHQWYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYF 94 (198)
T ss_dssp CHHHHHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHH
Confidence 344555556555 56666666666666665554443 335666666666554 6666663322 344566
Q ss_pred HhhhhcC
Q 013816 428 FRWYEIG 434 (436)
Q Consensus 428 ~~~d~~~ 434 (436)
+.||+||
T Consensus 95 ~~~D~d~ 101 (198)
T 2r2i_A 95 KLYDVDG 101 (198)
T ss_dssp HHHCTTC
T ss_pred HHhcCCC
Confidence 6666555
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=98.36 E-value=3.5e-07 Score=83.19 Aligned_cols=77 Identities=18% Similarity=0.210 Sum_probs=66.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc----CCCCCHHHHHH----HHHHHhcCCC--cCHhhHHHH--------
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQIPDTDVQI----LMDAVSHTLH--LDLAFFREK-------- 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d~~~~--i~~~ef~~~-------- 420 (436)
....++.+|..+|.+++|.|+.+|+..++..+ |..++.+++.. +++.+|.|++ |+|+||...
T Consensus 102 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~~~~~~~~~~~ 181 (272)
T 2be4_A 102 NSVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLARILALQENFL 181 (272)
T ss_dssp CHHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHGGGSCCSSCSS
T ss_pred cHHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHHHHHhhhHHHH
Confidence 34568899999999999999999999999998 89999988765 8999999887 999999543
Q ss_pred --------------HHHHHhHHhhhhcCC
Q 013816 421 --------------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 --------------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 210 (272)
T 2be4_A 182 LQFKMDASSQVERKRDFEKIFAHYDVSRT 210 (272)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHCTTCC
T ss_pred hhhhhhhccccccHHHHHHHHHHhCCCCC
Confidence 347789999999875
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.35 E-value=1.4e-07 Score=82.55 Aligned_cols=74 Identities=15% Similarity=0.187 Sum_probs=48.4
Q ss_pred hhhhhccccCCC-CCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHHhcCCC--cCHhhHHHHH----------HHHHhH
Q 013816 362 GIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQIP-DTDVQILMDAVSHTLH--LDLAFFREKV----------RLKISF 427 (436)
Q Consensus 362 ~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~~~----------~~~~~f 427 (436)
+++.+|..+|.+ ++|.|+.+|+..+++.+|...+ .++++.+++.+|.|++ |+|+||...+ .+..+|
T Consensus 20 ei~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F 99 (211)
T 2ggz_A 20 ETHVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYF 99 (211)
T ss_dssp ----CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHH
Confidence 456667777776 7777777777777777766544 3457777777777766 7777774332 456677
Q ss_pred HhhhhcCC
Q 013816 428 FRWYEIGG 435 (436)
Q Consensus 428 ~~~d~~~~ 435 (436)
+.||+||+
T Consensus 100 ~~~D~d~~ 107 (211)
T 2ggz_A 100 KLYDADGN 107 (211)
T ss_dssp HHHCTTCS
T ss_pred HHhcCCCC
Confidence 77777663
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.34 E-value=6e-07 Score=79.36 Aligned_cols=79 Identities=15% Similarity=0.172 Sum_probs=60.0
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
++.+++..+.+.|... +++|.|+.+|+..+++.+|.. .+..+++.+++.+|.|++ |+|+||...+
T Consensus 48 ~s~~ei~~l~~~Fd~~--d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~ 125 (224)
T 1s1e_A 48 FTKRELQVLYRGFKNE--CPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE 125 (224)
T ss_dssp CCHHHHHHHHHHHHHH--CTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHhh--CCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhcCCCCCcEeHHHHHHHHHHHccCCHHH
Confidence 4555555555554433 478999999999999998754 788899999999998877 9999995432
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||+||+
T Consensus 126 ~l~~~F~~~D~d~d 139 (224)
T 1s1e_A 126 KLRWTFNLYDINKD 139 (224)
T ss_dssp HHHHHHHHHCTTCC
T ss_pred HHHHHHHHHcCCCC
Confidence 56788999998874
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=98.32 E-value=4.9e-07 Score=78.73 Aligned_cols=56 Identities=11% Similarity=0.119 Sum_probs=26.4
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFR 418 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~ 418 (436)
+..+|..+|.+++|.|+.+|+..++..++...+.++++.+++.+|.|++ |+++||.
T Consensus 73 ~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~ 130 (207)
T 2d8n_A 73 AQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEVL 130 (207)
T ss_dssp HHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHHH
Confidence 4444444444444444444444444444444444444444444444443 4444443
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.32 E-value=1.7e-07 Score=81.81 Aligned_cols=78 Identities=13% Similarity=0.174 Sum_probs=64.0
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH------------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE------------ 419 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~------------ 419 (436)
.++.++...++++|..+|.|++|+|+.+|+..++ .+|..++.+ ++++.+|.+++ |+|+||..
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~~-~lg~~~~~~---~l~~~~d~~~~g~i~~~EF~~~~~~~~~~~~~~ 97 (208)
T 2ct9_A 22 GFSHSQITRLYSRFTSLDKGENGTLSREDFQRIP-ELAINPLGD---RIINAFFSEGEDQVNFRGFMRTLAHFRPIEDNE 97 (208)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECTGGGGGCH-HHHTSTTHH---HHHHTTSCTTCSCEEHHHHHHHHHTTSCCC---
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCcHH---HHHHHHcCCCCCcCcHHHHHHHHHhhccccchh
Confidence 4577888899999999999999999999999864 777776654 56777888776 99999942
Q ss_pred --------------HHHHHHhHHhhhhcCC
Q 013816 420 --------------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 --------------~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.||+||+
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~F~~~D~d~d 127 (208)
T 2ct9_A 98 KSKDVNGPEPLNSRSNKLHFAFRLYDLDKD 127 (208)
T ss_dssp --------CCTTSHHHHHHHHHHHHCTTCS
T ss_pred hhcccccccccccHHHHHHHHHHHHCCCCC
Confidence 3456789999999885
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=98.32 E-value=3.2e-07 Score=72.76 Aligned_cols=59 Identities=25% Similarity=0.366 Sum_probs=50.1
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.++...++++|+.+| |+|+.+||+.+++.+|. +++|++++++.+|.||+ |+|+||...+
T Consensus 46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~~~~ 106 (123)
T 2kld_A 46 KNTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQDGDQELTEHEHQQMR 106 (123)
T ss_dssp -----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSSSSCCEECSHHHHHCS
T ss_pred hhHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 345577899999998 99999999999999998 99999999999999887 9999996643
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.31 E-value=4e-07 Score=79.45 Aligned_cols=62 Identities=19% Similarity=0.314 Sum_probs=56.0
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHH----HHHHhcCCC--cCHhhHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-GHQIPDTDVQIL----MDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~~~e~~~~----~~~~d~~~~--i~~~ef~~~ 420 (436)
....++.+|+.+|.|++|+|+.+|+..++..+ |..+++++++++ ++.+|.|++ |+|+||...
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~~ 179 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFVKV 179 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 45678899999999999999999999999996 999999999888 999999877 999999653
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=98.31 E-value=2.6e-07 Score=75.53 Aligned_cols=61 Identities=13% Similarity=0.140 Sum_probs=48.9
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcC--------CCCCHHHHHHHH----HHHhcCCC--cCHhhHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLG--------HQIPDTDVQILM----DAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg--------~~~~~~e~~~~~----~~~d~~~~--i~~~ef~~~ 420 (436)
...++.+|+.+|.|++|+|+.+|+..+++.++ ..++.+++++++ +.+|.|++ |+|+||...
T Consensus 67 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~~ 141 (143)
T 3a4u_B 67 QELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFAKS 141 (143)
T ss_dssp HHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC-
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHHH
Confidence 34677889999999999999999999998883 578999997777 88899887 999999654
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=5.9e-07 Score=76.55 Aligned_cols=78 Identities=12% Similarity=0.101 Sum_probs=63.6
Q ss_pred hchhhhhhhhhhhccccCC-----CC-C--CcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC--CC-cCHhhHHHH--
Q 013816 354 HLSVEEVAGIKEGFHMMDI-----GN-R--GKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT--LH-LDLAFFREK-- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~-----~~-~--G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--~~-i~~~ef~~~-- 420 (436)
.++.+++..+.+.|..+|. |+ + |.|+.+|+.. ++.+|..++.++ ++..+|.| |. |+|+||...
T Consensus 13 ~ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~~~~---l~~~~D~d~~G~~I~~~EF~~~~~ 88 (183)
T 1dgu_A 13 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKER---ICRVFSTSPAKDSLSFEDFLDLLS 88 (183)
T ss_dssp SCCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTTHHH---HHHHHSCSSSSCCCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcHHHH---HHHHhCCCCCCCEecHHHHHHHHH
Confidence 3466778889999999999 68 8 9999999999 999999888765 45555654 66 999999543
Q ss_pred ---------HHHHHhHHhhhhcCC
Q 013816 421 ---------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 89 ~~~~~~~~~~~l~~~F~~~D~d~~ 112 (183)
T 1dgu_A 89 VFSDTATPDIKSHYAFRIFDFDDD 112 (183)
T ss_dssp HHSTTCCHHHHHHHHHHHHCTTCS
T ss_pred HhcCCCCHHHHHHHHHHHhCCCCC
Confidence 367789999999875
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1e-06 Score=73.37 Aligned_cols=60 Identities=10% Similarity=0.157 Sum_probs=54.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|..+|.+++|+|+.+|+..++..+| ++.++++.++..+|.|++ |+|+||...+
T Consensus 97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 158 (166)
T 3akb_A 97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIVPAF 158 (166)
T ss_dssp HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSBCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 34588899999999999999999999999998 899999999999999887 9999997654
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.30 E-value=1.4e-06 Score=75.27 Aligned_cols=77 Identities=13% Similarity=0.096 Sum_probs=66.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH---------------
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV--------------- 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~--------------- 421 (436)
....+..+|..+|.+++|.|+.+|+..++..++...+.+++..+++.+|.||+ |+++||...+
T Consensus 50 ~~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~ 129 (198)
T 2r2i_A 50 ANKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTA 129 (198)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCH
T ss_pred hHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhH
Confidence 34568889999999999999999999999999888889999999999999887 9999995433
Q ss_pred --HHHHhHHhhhhcCC
Q 013816 422 --RLKISFFRWYEIGG 435 (436)
Q Consensus 422 --~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|.||+
T Consensus 130 ~~~~~~~f~~~D~d~d 145 (198)
T 2r2i_A 130 EEFTNMVFDKIDINGD 145 (198)
T ss_dssp HHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 25678999998874
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.30 E-value=3.8e-07 Score=80.08 Aligned_cols=63 Identities=13% Similarity=0.300 Sum_probs=55.2
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHH----HHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-----QIPDTDVQI----LMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...++.+|+.+|.|++|+|+.+||..++..+|. .++++++++ +++.+|.|++ |+|+||...+.
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~EF~~~~~ 201 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 201 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHH
Confidence 457889999999999999999999999999865 788888775 8999999877 99999976654
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.2e-06 Score=73.68 Aligned_cols=61 Identities=21% Similarity=0.196 Sum_probs=55.2
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|..+|.|++|+|+.+|+..++..+| +++++++.++..+|.|++ |+|+||...+.
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~~ 155 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFVIAGS 155 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCceEeHHHHHHHHH
Confidence 46788999999999999999999999999996 789999999999999877 99999976654
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.29 E-value=6.3e-07 Score=68.64 Aligned_cols=60 Identities=20% Similarity=0.216 Sum_probs=51.2
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHH-----cCCCCCH-----------HHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHK-----LGHQIPD-----------TDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~-----lg~~~~~-----------~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.++.+|..+|.|++|+|+.+|+..++.. +|...+. ..+..++..+|.|++ |+|+||...+
T Consensus 21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 98 (103)
T 1snl_A 21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLAST 98 (103)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHH
T ss_pred CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcCCHHHHHHHH
Confidence 5788899999999999999999999996 4766553 348899999999988 9999997654
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.29 E-value=1.1e-06 Score=74.74 Aligned_cols=83 Identities=13% Similarity=0.185 Sum_probs=64.7
Q ss_pred HHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc---CC--CcCHhhHHH---
Q 013816 348 LKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH---TL--HLDLAFFRE--- 419 (436)
Q Consensus 348 l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~---~~--~i~~~ef~~--- 419 (436)
+..++......+...+++.|..+| ++|+|+.+||..++ |...++++++++++.+|. ++ .|+|+||..
T Consensus 15 l~~~~~~~~~~~~~~~~~~F~~~D--~dG~I~~~el~~~l---g~~~~~~~~~~i~~~~d~~~~~~~~~i~~~ef~~~~~ 89 (179)
T 3a8r_A 15 LQFVTAKVGNDGWAAVEKRFNQLQ--VDGVLLRSRFGKCI---GMDGSDEFAVQMFDSLARKRGIVKQVLTKDELKDFYE 89 (179)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHC--BTTBEEGGGHHHHH---TCCSCHHHHHHHHHHHHHHHTCCSSEECHHHHHHHHH
T ss_pred HHHHHhccchhhHHHHHHHHhccC--CCCCCcHHHHHHHH---CCCCcHHHHHHHHHHHHHhccCCCCCcCHHHHHHHHH
Confidence 444555544456778889999999 79999999999854 888889999999988873 33 399999943
Q ss_pred -------HHHHHHhHHhhhhcCC
Q 013816 420 -------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -------~~~~~~~f~~~d~~~~ 435 (436)
..++..+|+.||+||+
T Consensus 90 ~~~~~~~~~~l~~~F~~~D~d~d 112 (179)
T 3a8r_A 90 QLTDQGFDNRLRTFFDMVDKNAD 112 (179)
T ss_dssp HHHCCCHHHHHHHHHHHHCTTCS
T ss_pred HHcCCCHHHHHHHHHHHHCCCCC
Confidence 2357789999999985
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.29 E-value=4.7e-07 Score=87.45 Aligned_cols=63 Identities=22% Similarity=0.381 Sum_probs=57.7
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.|++|+|+.+||+.+++.+|..++++++++++..+|.|++ |+|+||...+
T Consensus 383 ~~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv~~L 447 (450)
T 3sg6_A 383 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMM 447 (450)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHHHHH
T ss_pred hhhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999998776 9999997654
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=98.29 E-value=5.9e-07 Score=76.96 Aligned_cols=73 Identities=11% Similarity=0.078 Sum_probs=45.3
Q ss_pred hhhhhccccCCC-CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHH----------HHHHHhH
Q 013816 362 GIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREK----------VRLKISF 427 (436)
Q Consensus 362 ~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~~~~~f 427 (436)
.+..+|..+|.+ ++|.|+.+|+..+++.++.. .+.++++.+++.+|.|++ |+|+||... ..+..+|
T Consensus 26 el~~~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f 105 (190)
T 2l2e_A 26 ELQQWYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAF 105 (190)
T ss_dssp HHHHHHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHH
Confidence 355556666666 57777777777777766433 445566667777766655 777777432 2455667
Q ss_pred HhhhhcC
Q 013816 428 FRWYEIG 434 (436)
Q Consensus 428 ~~~d~~~ 434 (436)
+.+|+||
T Consensus 106 ~~~D~d~ 112 (190)
T 2l2e_A 106 QLYDLDN 112 (190)
T ss_dssp HHHCTTS
T ss_pred hHccCCC
Confidence 7776655
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.28 E-value=4.6e-07 Score=75.72 Aligned_cols=62 Identities=23% Similarity=0.351 Sum_probs=48.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.+++|.|+.+|+..+++.+| ++++++++++..+|.|++ |+|+||...+.
T Consensus 97 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~~~dg~i~~~eF~~~~~ 160 (166)
T 2aao_A 97 REDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQDNDGRIDYNEFVAMMQ 160 (166)
T ss_dssp TTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCTTCSSSBCHHHHHHHHC
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 345788999999999999999999999999887 578899999999999877 99999976653
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=98.28 E-value=1.4e-06 Score=74.57 Aligned_cols=75 Identities=15% Similarity=0.105 Sum_probs=65.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-----------------
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----------------- 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------------- 421 (436)
..+..+|..+|.+++|.|+.+|+..++..++...+.+++..+++.+|.|++ |+++||...+
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 1fpw_A 63 DFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDE 142 (190)
T ss_dssp HHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCC
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 357888999999999999999999999999988899999999999999887 9999995433
Q ss_pred -----HHHHhHHhhhhcCC
Q 013816 422 -----RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -----~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|.||+
T Consensus 143 ~~~~~~~~~~f~~~D~d~d 161 (190)
T 1fpw_A 143 ATPEMRVKKIFKLMDKNED 161 (190)
T ss_dssp CCHHHHHHHHHHHHTTTCS
T ss_pred chHHHHHHHHHHHhCCCCC
Confidence 35578999998874
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.27 E-value=1.8e-07 Score=80.35 Aligned_cols=60 Identities=17% Similarity=0.382 Sum_probs=54.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|..+|.+++|+|+.+|+..++..+| +++++++++++.+|.|++ |+|+||...+
T Consensus 81 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~Is~~EF~~~~ 142 (188)
T 1s6i_A 81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMM 142 (188)
T ss_dssp CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 45788999999999999999999999999888 688899999999999887 9999996654
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=74.75 Aligned_cols=63 Identities=13% Similarity=0.300 Sum_probs=55.7
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-----CCCHHHHHH----HHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-----QIPDTDVQI----LMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...++.+|+.+|.|++|+|+.+|+..++..+|. .+++++++. ++..+|.|++ |+|+||...+.
T Consensus 97 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 170 (183)
T 1dgu_A 97 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 170 (183)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 457889999999999999999999999999976 688888886 9999999887 99999977653
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.27 E-value=4.1e-07 Score=80.09 Aligned_cols=64 Identities=13% Similarity=0.120 Sum_probs=57.7
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-QIPDTDVQILMDAVSHTLH--LDLAFFREKVRL 423 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~ 423 (436)
...+..+|..+|.|++|+|+.+||..++..+|. .++.+++++++..+|.|++ |+|+||...+.-
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~~~~~~ 195 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFAAWASA 195 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHH
Confidence 457889999999999999999999999999987 7899999999999999887 999999776543
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=5.2e-07 Score=96.11 Aligned_cols=80 Identities=16% Similarity=0.270 Sum_probs=70.3
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------H
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK-----------V 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~-----------~ 421 (436)
++.++...++.+|..+|.|++|+|+.+||..+++.+|..+++++++.++..+|.||+ |+|+||... .
T Consensus 719 l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~~~~~~~~~~~ 798 (863)
T 1sjj_A 719 ISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFIDFMSRETADTDTAD 798 (863)
T ss_dssp SSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHHHTHHHHSTTCSSSH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHH
Confidence 445677889999999999999999999999999999999999999999999999887 999999543 2
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.| +||+
T Consensus 799 ~l~~aF~~~-~d~~ 811 (863)
T 1sjj_A 799 QVMASFKIL-AGDK 811 (863)
T ss_dssp HHHHHHHGG-GTSS
T ss_pred HHHHHHHHH-hCCC
Confidence 567899998 6664
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.26 E-value=8.5e-07 Score=77.26 Aligned_cols=58 Identities=14% Similarity=0.318 Sum_probs=53.6
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+..+|..+|.|++|+|+.+|+..+++.+| ++++++++++..+|.|++ |+|+||...+.
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 189 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTDKSGKLERTELVHLFR 189 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTTCCSSBCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 78899999999999999999999999999 899999999999999877 99999976553
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.8e-06 Score=73.95 Aligned_cols=75 Identities=13% Similarity=0.073 Sum_probs=65.4
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-----------------
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----------------- 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------------- 421 (436)
..+..+|..+|.+++|.|+.+|+..++..++...+.+++..+++.+|.|++ |+++||...+
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~ 142 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDE 142 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCccccc
Confidence 467788999999999999999999999999988999999999999999877 9999995433
Q ss_pred -----HHHHhHHhhhhcCC
Q 013816 422 -----RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -----~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|.||+
T Consensus 143 ~~~~~~~~~~f~~~D~d~d 161 (190)
T 2l2e_A 143 DTPEKRVNKIFNMMDKNKD 161 (190)
T ss_dssp CCTHHHHHHHHHHHTCCSS
T ss_pred ccHHHHHHHHHHHhCCCCC
Confidence 34568999998874
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.2e-07 Score=76.98 Aligned_cols=72 Identities=21% Similarity=0.298 Sum_probs=58.7
Q ss_pred HHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHH-------HcCCCCCHHHHHHHHHHHhc-CCC--cCHhhHHH
Q 013816 350 VIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLH-------KLGHQIPDTDVQILMDAVSH-TLH--LDLAFFRE 419 (436)
Q Consensus 350 ~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~-------~lg~~~~~~e~~~~~~~~d~-~~~--i~~~ef~~ 419 (436)
.+...........+..+|..+|.|++|+|+.+|+..++. ..|...++++++++++.+|. |++ |+|+||..
T Consensus 98 ~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~~ 177 (204)
T 3e3r_A 98 ALRPPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQD 177 (204)
T ss_dssp HTSCCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHHH
T ss_pred HHHhhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHHH
Confidence 333333344556789999999999999999999999998 45777888999999999998 777 99999965
Q ss_pred HH
Q 013816 420 KV 421 (436)
Q Consensus 420 ~~ 421 (436)
.+
T Consensus 178 ~~ 179 (204)
T 3e3r_A 178 YY 179 (204)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=6.5e-07 Score=85.04 Aligned_cols=86 Identities=9% Similarity=0.075 Sum_probs=56.1
Q ss_pred ecccc-ccCCceEEEEEEEc--C----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEEEEEeC-
Q 013816 59 LGREL-GRGEFGITYLCTDR--E----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDD- 128 (436)
Q Consensus 59 ~~~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~- 128 (436)
..+.| +.|....+|++... . ++..+++|+..............+.+|+.+++.|..+ -.+++++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88989999988643 1 2667889876443200000113467888888888544 3567888877655
Q ss_pred --CeEEEEEeccCCCchH
Q 013816 129 --TAVHLVMELCEGGELF 144 (436)
Q Consensus 129 --~~~~lv~E~~~g~~L~ 144 (436)
+..|+|||+++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=98.24 E-value=7.7e-07 Score=76.18 Aligned_cols=75 Identities=7% Similarity=0.127 Sum_probs=56.7
Q ss_pred hhhhhhccccCCC-CCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------HHHHHh
Q 013816 361 AGIKEGFHMMDIG-NRGKINIDELRVGLHKL-GHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------VRLKIS 426 (436)
Q Consensus 361 ~~l~~~F~~~D~~-~~G~i~~~el~~~l~~l-g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~~~~~ 426 (436)
..+..+|..+|.+ ++|.|+.+|+..+++.+ +...+..+++.++..+|.|++ |+|+||... ..+..+
T Consensus 25 ~~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~ 104 (190)
T 1g8i_A 25 KEVQQWYKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWA 104 (190)
T ss_dssp HHHHHHHHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHH
Confidence 3455667777776 78999999999998887 333567788889998888877 999999433 246678
Q ss_pred HHhhhhcCC
Q 013816 427 FFRWYEIGG 435 (436)
Q Consensus 427 f~~~d~~~~ 435 (436)
|+.+|+||+
T Consensus 105 f~~~D~d~~ 113 (190)
T 1g8i_A 105 FKLYDLDND 113 (190)
T ss_dssp HHHHCTTCS
T ss_pred HHhhcCCCC
Confidence 888888874
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-06 Score=74.83 Aligned_cols=75 Identities=15% Similarity=0.106 Sum_probs=64.7
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-----------------
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----------------- 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------------- 421 (436)
..+..+|..+|.+++|.|+.+|+..++..++...+.+++..+++.+|.|++ |+++||...+
T Consensus 63 ~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~ 142 (193)
T 1bjf_A 63 KFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDE 142 (193)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGG
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCccc
Confidence 356788999999999999999999999999888889999999999999887 9999996543
Q ss_pred -----HHHHhHHhhhhcCC
Q 013816 422 -----RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -----~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 143 ~~~~~~~~~~f~~~D~d~d 161 (193)
T 1bjf_A 143 STPEKRTEKIFRQMDTNRD 161 (193)
T ss_dssp SSHHHHHHHHHHHSCTTCS
T ss_pred ccHHHHHHHHHHHhCCCCC
Confidence 25578999998874
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.21 E-value=6.8e-07 Score=76.73 Aligned_cols=74 Identities=14% Similarity=0.102 Sum_probs=61.9
Q ss_pred hhhhhccccCCC-CCCcccHHHHHHHHHHcCCCC-CHHHHHHHHHHHhcCCC--cCHhhHHHH----------HHHHHhH
Q 013816 362 GIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQI-PDTDVQILMDAVSHTLH--LDLAFFREK----------VRLKISF 427 (436)
Q Consensus 362 ~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~~-~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~~~~~~f 427 (436)
++..+|..+|.+ ++|.|+.+|+..+++.++... +.++++.++..+|.|++ |+|+||... ..+..+|
T Consensus 26 ~i~~~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f 105 (193)
T 1bjf_A 26 EIQEWYKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAF 105 (193)
T ss_dssp HHHHHHHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHH
Confidence 456678888888 899999999999999997654 46778999999999987 999999543 3567899
Q ss_pred HhhhhcCC
Q 013816 428 FRWYEIGG 435 (436)
Q Consensus 428 ~~~d~~~~ 435 (436)
+.+|+||+
T Consensus 106 ~~~D~d~~ 113 (193)
T 1bjf_A 106 SMYDLDGN 113 (193)
T ss_dssp HHHCTTCS
T ss_pred hhcCCCCC
Confidence 99999874
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.3e-06 Score=74.85 Aligned_cols=61 Identities=18% Similarity=0.255 Sum_probs=55.3
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|+.+|.|++|+|+.+|+..++. |..++++++++++..+|.|++ |+|+||...+.
T Consensus 122 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~~~~ 184 (191)
T 3khe_A 122 RERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDKNNDGEVDFEEFVEMMQ 184 (191)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 35688899999999999999999999998 888999999999999999877 99999977654
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.20 E-value=1.7e-06 Score=72.93 Aligned_cols=60 Identities=25% Similarity=0.269 Sum_probs=55.0
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...++.+|..+|.+++|+|+.+|+..++..+| +++++++.+++.+|.|++ |+|+||...+
T Consensus 101 ~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~~~~ 162 (176)
T 1nya_A 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 34678899999999999999999999999998 899999999999999887 9999997665
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=98.19 E-value=3.7e-06 Score=74.47 Aligned_cols=79 Identities=14% Similarity=0.159 Sum_probs=64.0
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc-CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------H
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-GHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------V 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------~ 421 (436)
++.+++..+.+.|.. .+++|.|+.+|+..++..+ +...+..+++.+++.+|.|++ |+|+||... .
T Consensus 61 ~s~~ei~~l~~~F~~--~d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~ 138 (229)
T 3dd4_A 61 FTKKELQILYRGFKN--ECPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFDTDHNGAVSFEDFIKGLSILLRGTVQE 138 (229)
T ss_dssp HHHHHHHHHHHHHHT--TCCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTCSSCCSSCCHHHHHHHHHHHHHSCHHH
T ss_pred CCHHHHHHHHHHHHh--hCCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcCCCCCCeEeHHHHHHHHHHHcCCChHH
Confidence 456677778788865 5678999999999999985 556677888999999999887 999999542 3
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||+||+
T Consensus 139 ~l~~~F~~~D~d~d 152 (229)
T 3dd4_A 139 KLNWAFNLYDINKD 152 (229)
T ss_dssp HHHHHHHHHCTTCS
T ss_pred HHHHHHHHhCCCCC
Confidence 57789999999875
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.19 E-value=3.8e-06 Score=74.17 Aligned_cols=73 Identities=19% Similarity=0.340 Sum_probs=57.9
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----CCC----C----CHHHHHHHHHHHhcCCC--cCHhhHHHHHH---
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQ----I----PDTDVQILMDAVSHTLH--LDLAFFREKVR--- 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~----~----~~~e~~~~~~~~d~~~~--i~~~ef~~~~~--- 422 (436)
...++.+|+.+|.|++|+|+.+|+..++..+ |.. + +.++++++++.+|.|++ |+|+||...+.
T Consensus 124 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~~~~~~~~ 203 (224)
T 1s1e_A 124 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLESCQEDD 203 (224)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHTCH
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHhCH
Confidence 4567889999999999999999999999886 643 2 34889999999999887 99999976543
Q ss_pred -HHHhHHhhhh
Q 013816 423 -LKISFFRWYE 432 (436)
Q Consensus 423 -~~~~f~~~d~ 432 (436)
+...|..++.
T Consensus 204 ~l~~~l~~~~~ 214 (224)
T 1s1e_A 204 NIMRSLQLFQN 214 (224)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHhcCCCC
Confidence 3445555543
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.18 E-value=3.5e-06 Score=76.01 Aligned_cols=73 Identities=18% Similarity=0.289 Sum_probs=60.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----C--------CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----G--------HQIPDTDVQILMDAVSHTLH--LDLAFFREKV---- 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---- 421 (436)
...+..+|+.+|.|++|+|+.+|+..++..+ | ...++++++++++.+|.|++ |+|+||...+
T Consensus 164 ~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~~~~~ 243 (256)
T 2jul_A 164 HEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFLETCQKDE 243 (256)
T ss_dssp HHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHHHHHHHCS
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhCH
Confidence 4567888999999999999999999999886 5 34578899999999999887 9999997654
Q ss_pred HHHHhHHhhhh
Q 013816 422 RLKISFFRWYE 432 (436)
Q Consensus 422 ~~~~~f~~~d~ 432 (436)
.+..+|..||.
T Consensus 244 ~l~~~l~~~d~ 254 (256)
T 2jul_A 244 NIMNSMQLFEN 254 (256)
T ss_dssp SHHHHHHHHHH
T ss_pred HHHHHHHhhcc
Confidence 34456776664
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.17 E-value=5.2e-06 Score=72.47 Aligned_cols=63 Identities=16% Similarity=0.254 Sum_probs=54.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcC-----CCCCHHH-HHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLG-----HQIPDTD-VQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg-----~~~~~~e-~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|+.+|.|++|+|+.+|+..++..++ ..++.++ ++.+++.+|.|++ |+|+||...+.
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~ 162 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFINGMA 162 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 45688899999999999999999999999986 6667654 8999999999887 99999976553
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.17 E-value=1.8e-07 Score=79.96 Aligned_cols=63 Identities=11% Similarity=0.121 Sum_probs=49.6
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc------CCCCCHHHHHHHH---------HHHhcCCC--cCHhh
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL------GHQIPDTDVQILM---------DAVSHTLH--LDLAF 416 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l------g~~~~~~e~~~~~---------~~~d~~~~--i~~~e 416 (436)
.++.++...++.+|..+|.|++|+|+.+|+..+++.+ |..++.+++..++ +.+|.|++ |+|+|
T Consensus 7 ~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~~E 86 (186)
T 2hps_A 7 SERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVNAT 86 (186)
T ss_dssp HHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHHHH
T ss_pred cccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccHHH
Confidence 3456677788888999999999999999998888766 7777778887775 67777665 77777
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=98.16 E-value=3e-06 Score=73.66 Aligned_cols=74 Identities=15% Similarity=0.175 Sum_probs=58.8
Q ss_pred hhhhhccccCCC-CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------HHHHhH
Q 013816 362 GIKEGFHMMDIG-NRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREKV----------RLKISF 427 (436)
Q Consensus 362 ~l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------~~~~~f 427 (436)
.+..+|..+|.+ ++|.|+.+|+..+++.++.. .+.+++..+++.+|.|++ |+|+||...+ .+..+|
T Consensus 34 ~i~~~f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f 113 (207)
T 2d8n_A 34 ELCSWYQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAF 113 (207)
T ss_dssp HHHHHHHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHH
T ss_pred HHHHHHHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHH
Confidence 455567777777 68999999999999988764 778889999999998877 9999996544 456788
Q ss_pred HhhhhcCC
Q 013816 428 FRWYEIGG 435 (436)
Q Consensus 428 ~~~d~~~~ 435 (436)
+.+|+||+
T Consensus 114 ~~~D~d~~ 121 (207)
T 2d8n_A 114 SLYDVDGN 121 (207)
T ss_dssp HHHCTTCS
T ss_pred HHhcCCCC
Confidence 99988774
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.5e-06 Score=75.46 Aligned_cols=71 Identities=17% Similarity=0.119 Sum_probs=57.5
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHHhHHhhhhc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKISFFRWYEI 433 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~~f~~~d~~ 433 (436)
..+..+|..+|.|++|+|+.+||..+++.+ |...+ ++++++..+|.|++ |+|+||...+.....=..-|.|
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~d~dG~Is~~EF~~~~~~~~~~~~~d~~ 208 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDTNGSGVVTFDEFSCWAVTKKLQVCGDPD 208 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCCSCSSCEEHHHHHHHHHHHHHHHHCCCC
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCCCCCCcEeHHHHHHHHHhcCCCCCCCcc
Confidence 578899999999999999999999999988 65544 59999999999887 9999998776654333333433
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=98.15 E-value=2.6e-06 Score=72.54 Aligned_cols=61 Identities=16% Similarity=0.267 Sum_probs=53.8
Q ss_pred hhhhhhc--cccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGF--HMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F--~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..+..+| ..+|.+++|+|+.+|+..++..+|..+++++++++++.+|.|++ |+|+||...+
T Consensus 100 ~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~ 164 (186)
T 2hps_A 100 AVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFLVTV 164 (186)
T ss_dssp TTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHH
Confidence 4455555 66799999999999999999999999999999999999999887 9999997654
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=98.14 E-value=2.8e-06 Score=90.64 Aligned_cols=74 Identities=16% Similarity=0.220 Sum_probs=66.7
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----HHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----RLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----~~~~~f~~~d~~~ 434 (436)
..++.+|+.+|.|++|+|+.+||+.+++.+|..+++++++.++..+| |++ |+|+||...+ .+..+|+.+|+||
T Consensus 607 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~~~~~~~~~l~~~F~~~D~d~ 685 (900)
T 1qxp_A 607 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFVRCLVRLEILFKIFKQLDPEN 685 (900)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHHHHHHHHHHHHHHHHHSCSSC
T ss_pred HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHHHHHHHHHHHHHHHHhhCCCC
Confidence 57889999999999999999999999999999999999999999998 766 9999996543 4678999999987
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 686 ~ 686 (900)
T 1qxp_A 686 T 686 (900)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.1e-06 Score=71.91 Aligned_cols=59 Identities=15% Similarity=0.295 Sum_probs=53.4
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC----------CCcCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT----------LHLDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----------~~i~~~ef~~~~ 421 (436)
..+..+|..+|.|++|+|+.+|+..+++ +..++++++++++..+|.| |.|+|+||...+
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~~~d~~~~~~~~G~i~~~eF~~~l 176 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHSIKKGIPREHIINKISFQEFKDYM 176 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHTC---------CCCBCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhhccCcccccccCCeeeHHHHHHHH
Confidence 5788999999999999999999999998 6789999999999999986 559999997654
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.09 E-value=6.2e-06 Score=71.45 Aligned_cols=76 Identities=12% Similarity=0.094 Sum_probs=64.6
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------------
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------------- 420 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------------- 420 (436)
...+..+|..+|.|++|.|+.+|+..++..++...+.+++..+++.+|.|++ |+++||...
T Consensus 58 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~ 137 (204)
T 1jba_A 58 TQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEA 137 (204)
T ss_dssp HHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTS
T ss_pred HHHHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccc
Confidence 3456778999999999999999999999999888889999999999999887 999999432
Q ss_pred ----------HHHHHhHHhhhhcCC
Q 013816 421 ----------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ----------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 138 ~~~g~~~~~~~~~~~~f~~~D~d~d 162 (204)
T 1jba_A 138 EQQGKLLTPEEVVDRIFLLVDENGD 162 (204)
T ss_dssp STTTCCCCHHHHHHHHHHHHCCSCC
T ss_pred cccCchhhHHHHHHHHHHHhCCCCC
Confidence 235568899988874
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.8e-06 Score=73.33 Aligned_cols=61 Identities=18% Similarity=0.279 Sum_probs=54.4
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|..+|.|++|+|+.+|+..+++.+| ++++++.++++.+|.|++ |+|+||...+.
T Consensus 104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~ef~~~~~ 166 (185)
T 2sas_A 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELYY 166 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcCCCCCcCcHHHHHHHHH
Confidence 35688999999999999999999999999888 678899999999999887 99999976543
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=98.07 E-value=4.4e-06 Score=71.35 Aligned_cols=63 Identities=21% Similarity=0.375 Sum_probs=53.4
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----C--------CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----G--------HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|..+|.|++|+|+.+|+..++..+ | ...+.+++.++++.+|.|++ |+|+||...+.
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~~~~~ 174 (190)
T 1g8i_A 98 DEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSK 174 (190)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHHHHHH
Confidence 4567888999999999999999999999883 3 35678899999999999887 99999976553
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=98.05 E-value=9.9e-06 Score=71.52 Aligned_cols=64 Identities=20% Similarity=0.281 Sum_probs=55.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHH----HcCCCCCHHHHHHHHH----HHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLH----KLGHQIPDTDVQILMD----AVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~----~lg~~~~~~e~~~~~~----~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.|++|+|+.+|+..++. .+|..+++++++++++ .+|.|++ |+|+||...+.
T Consensus 120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~~~~ 193 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLVL 193 (226)
T ss_dssp HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 345788999999999999999999999996 5799999999877765 8999887 99999976554
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=98.04 E-value=8e-06 Score=69.73 Aligned_cols=72 Identities=18% Similarity=0.330 Sum_probs=58.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHH----cC--------CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH----
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHK----LG--------HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR---- 422 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~----lg--------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~---- 422 (436)
..+..+|..+|.|++|+|+.+|+..++.. +| ...+.++++++++.+|.|++ |+|+||...+.
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~~~~~ 178 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDPS 178 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSSTT
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHhChH
Confidence 46778899999999999999999999988 34 33678899999999999887 99999976553
Q ss_pred HHHhHHhhhh
Q 013816 423 LKISFFRWYE 432 (436)
Q Consensus 423 ~~~~f~~~d~ 432 (436)
+...|..+|.
T Consensus 179 ~~~~~~~~d~ 188 (190)
T 1fpw_A 179 IIGALNLYDG 188 (190)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHhhccc
Confidence 4456666663
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.9e-05 Score=72.01 Aligned_cols=74 Identities=12% Similarity=0.139 Sum_probs=41.5
Q ss_pred cccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----CCCceeEEE-E--EEEeCCeEEE
Q 013816 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQNIVCLK-D--TYEDDTAVHL 133 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~-~--~~~~~~~~~l 133 (436)
..|+.|..+.||++... +..+++|+.... . ..+..|+.+++.|. ..|.++... + +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666778999998753 345899987542 1 33444555555442 124433210 0 1235678899
Q ss_pred EEeccCCCch
Q 013816 134 VMELCEGGEL 143 (436)
Q Consensus 134 v~E~~~g~~L 143 (436)
+|||++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=7.1e-06 Score=81.29 Aligned_cols=63 Identities=19% Similarity=0.290 Sum_probs=55.7
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....+..+|+.+|.|++|+|+.+|+..++.. ..+++++++++++.+|.|++ |+|+||...+.
T Consensus 415 ~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~~~~~ 479 (484)
T 3nyv_A 415 LSRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDKNNDGEVDFDEFQQMLL 479 (484)
T ss_dssp HHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCTTCCSEEEHHHHHHHHH
T ss_pred CcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHH
Confidence 33457889999999999999999999999987 56799999999999999888 99999977653
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.1e-06 Score=76.99 Aligned_cols=78 Identities=12% Similarity=0.101 Sum_probs=60.3
Q ss_pred hchhhhhhhhhhhccccCC-----CC-C--CcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC--CC-cCHhhHHHH--
Q 013816 354 HLSVEEVAGIKEGFHMMDI-----GN-R--GKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT--LH-LDLAFFREK-- 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~-----~~-~--G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--~~-i~~~ef~~~-- 420 (436)
.++.+++..+.+.|..+|. |+ + |.|+.+||.. ++.+|..++.++ +++.+|.| |. |+|+||...
T Consensus 44 ~~s~~ei~~l~~~F~~~D~~~~~~d~~~~dG~I~~~E~~~-l~~lg~~~~~~~---lf~~~D~d~dG~~I~f~EF~~~~~ 119 (214)
T 2l4h_A 44 FLTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKER---ICRVFSTSPAKDSLSFEDFLDLLS 119 (214)
T ss_dssp SCCHHHHHHHHHHHHHHSCGGGCCHHHHTTSEECHHHHTT-CHHHHTSTTHHH---HHHHHCCSSSCCSEEHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhCcccccccccccCCcCCHHHHHH-hhccCCChHHHH---HHHHhCcCCCCCEecHHHHHHHHH
Confidence 4577788888889999988 55 6 9999999998 888888877654 56666664 56 999999532
Q ss_pred ---------HHHHHhHHhhhhcCC
Q 013816 421 ---------VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---------~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.||+||+
T Consensus 120 ~~~~~~~~~~~l~~~F~~~D~d~d 143 (214)
T 2l4h_A 120 VFSDTATPDIKSHYAFRIFDFDDD 143 (214)
T ss_dssp HTSSCSCHHHHHHHHHHHHCTTCS
T ss_pred HHcCCCCHHHHHHHHHHHhCCCCC
Confidence 367789999998874
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=98.01 E-value=1e-06 Score=94.01 Aligned_cols=75 Identities=15% Similarity=0.145 Sum_probs=56.6
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH--------QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKI 425 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~ 425 (436)
...++++|..+| +++|.|+.+||..+|+.++. .++.++++.|++.+|.|++ |+|+||... ..+..
T Consensus 533 ~~~l~~~F~~~D-~~dG~Is~~El~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~l~~ 611 (900)
T 1qxp_A 533 DDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRIRNYLT 611 (900)
T ss_dssp --------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHc-CCCCcCCHHHHHHHHHHhhcccccccCCCCCHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHHHHHH
Confidence 678999999999 99999999999999999875 7899999999999999877 999999654 46788
Q ss_pred hHHhhhhcCC
Q 013816 426 SFFRWYEIGG 435 (436)
Q Consensus 426 ~f~~~d~~~~ 435 (436)
+|+.||+||+
T Consensus 612 ~F~~~D~d~~ 621 (900)
T 1qxp_A 612 IFRKFDLDKS 621 (900)
T ss_dssp HHGGGCTTCC
T ss_pred HHHhhCCCCC
Confidence 9999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.01 E-value=2.6e-05 Score=75.77 Aligned_cols=77 Identities=8% Similarity=0.010 Sum_probs=45.8
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeecccc--CC----hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RT----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~--~~----~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
++.||.|..+.||++.. ++..++||....... .. ......+..|+..+..-.....+++++.+. ....++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 46689999999999963 567899994322110 00 012233444443332211234567777665 566789
Q ss_pred EEecc-CC
Q 013816 134 VMELC-EG 140 (436)
Q Consensus 134 v~E~~-~g 140 (436)
|||++ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 87
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.01 E-value=5.1e-06 Score=74.96 Aligned_cols=75 Identities=12% Similarity=0.084 Sum_probs=63.9
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH------------------
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK------------------ 420 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~------------------ 420 (436)
..+..+|..+|.|++|.|+.+|+..++..++...+.++++.+++.+|.|++ |+++||...
T Consensus 129 ~~~~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~ 208 (256)
T 2jul_A 129 TYAHFLFNAFDADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILRE 208 (256)
T ss_dssp HHHHHHHHHSSCSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCC
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccch
Confidence 457778999999999999999999999998877889999999999999887 999999543
Q ss_pred ----HHHHHhHHhhhhcCC
Q 013816 421 ----VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ----~~~~~~f~~~d~~~~ 435 (436)
..+..+|..+|.||+
T Consensus 209 ~~~~~~~~~~f~~~D~d~d 227 (256)
T 2jul_A 209 DAPLEHVERFFQKMDRNQD 227 (256)
T ss_dssp CCHHHHHHHHHHHSCCSTT
T ss_pred hhHHHHHHHHHHHHCCCCC
Confidence 235578899988874
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=98.00 E-value=1.5e-05 Score=69.21 Aligned_cols=64 Identities=14% Similarity=0.257 Sum_probs=54.8
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHH----HcCCCCCHHHHHHHH----HHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLH----KLGHQIPDTDVQILM----DAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~----~lg~~~~~~e~~~~~----~~~d~~~~--i~~~ef~~~~~ 422 (436)
....+..+|..+|.|++|+|+.+|+..++. .+|..++++++++++ +.+|.|++ |+|+||...+.
T Consensus 109 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~~~~ 182 (207)
T 2ehb_A 109 VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWKDFVS 182 (207)
T ss_dssp HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 345688999999999999999999999996 569999999987766 48999887 99999977654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=8.5e-07 Score=88.05 Aligned_cols=63 Identities=21% Similarity=0.344 Sum_probs=38.3
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...+..+|+.+|.|++|+|+.+||..++..+|..+++++++++++.+|.|++ |+|+||...+.
T Consensus 416 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~~~~~ 480 (486)
T 3mwu_A 416 RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFVEMLQ 480 (486)
T ss_dssp HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999999887 99999976553
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.98 E-value=5.9e-06 Score=65.84 Aligned_cols=56 Identities=23% Similarity=0.289 Sum_probs=41.4
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
..+..+|..+|.+++|+|+.+|+..++..+|..+ +.+++..+|.|++ |+|+||...
T Consensus 75 ~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D~~~dg~i~~~ef~~~ 132 (134)
T 1jfj_A 75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKADANGDGYITLEEFLEF 132 (134)
T ss_dssp HHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHHCSSSSEEEHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhCCCCCCcEeHHHHHHH
Confidence 3477778888888888888888888887776543 7777877777766 888888543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=5.4e-05 Score=70.12 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=60.4
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC--CceeEEEEEEEeCCeEEEEEec
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHLVMEL 137 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~lv~E~ 137 (436)
.+.|+.|....+|++.. .+..+++|+.... ....+..|+..|+.|..+ ..+++++.+....+..++|||+
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 46689999999999874 4678889986432 246788999998888433 5688899888888899999999
Q ss_pred cCCCch
Q 013816 138 CEGGEL 143 (436)
Q Consensus 138 ~~g~~L 143 (436)
++|.++
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 436 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-93 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-90 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-90 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-88 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-86 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-85 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-83 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-82 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-81 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-80 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-79 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-79 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-75 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-75 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-74 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-73 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-71 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-69 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-66 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-65 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-63 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-63 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-62 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-59 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-44 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 4e-09 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 8e-09 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 1e-06 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 2e-06 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 6e-06 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 8e-06 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 1e-05 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 3e-05 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 5e-05 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 2e-04 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 2e-04 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 6e-04 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 8e-04 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 0.002 | |
| d1qx2a_ | 76 | a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [Tax | 0.002 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 0.002 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 0.003 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 0.003 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 0.003 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 0.003 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 0.004 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 0.004 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 280 bits (718), Expect = 7e-93
Identities = 114/307 (37%), Positives = 176/307 (57%), Gaps = 8/307 (2%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+I + Y+ LG G F L D+ A K I+KK L + E+ ++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHK 63
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+ KH NIV L D YE ++L+M+L GGELFDRIV +G YTER A+ + +++ V+
Sbjct: 64 I-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
H G++HRDLKPEN L+ + E + + DFGLS PG S G+P Y+APEVL
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
+ Y VD WS GVI YILLCG PPF+ E + + + I+++ +F W +S++AKD
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKV 350
+R +++ DP++R T +Q L+HPW+ A + ++ ++V ++K+ +K K+ A
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ-AFNA 300
Query: 351 IA--QHL 355
A +H+
Sbjct: 301 TAVVRHM 307
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 275 bits (704), Expect = 1e-90
Identities = 89/305 (29%), Positives = 161/305 (52%), Gaps = 12/305 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ ++ + +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 348
D V ++L + K R+TA + L+HPWL+ + + + T LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLIKKDL 290
Query: 349 KVIAQ 353
++
Sbjct: 291 NMVVS 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 276 bits (706), Expect = 2e-90
Identities = 96/336 (28%), Positives = 159/336 (47%), Gaps = 28/336 (8%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + C ++ G F K I+ +D V+ E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEI 77
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTI 165
IM L H ++ L D +ED + L++E GGELFDRI A + +E +
Sbjct: 78 SIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ H+H ++H D+KPEN + K+ + +K IDFGL+ P E + +
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APE++ R G D+W+ GV+ Y+LL G+ PF E + Q + R +F D + V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN---------------------AKKAPN 323
S AKD ++ +L +P++RLT LEHPWL+ +K +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
Query: 324 VSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEE 359
+ R+ FS + K + + ++ + +E
Sbjct: 316 WPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 269 bits (689), Expect = 5e-88
Identities = 91/272 (33%), Positives = 140/272 (51%), Gaps = 7/272 (2%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + T+R G+ FA K + D E VR+E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEI 74
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTI 165
M L +H +V L D +EDD + ++ E GGELF+++ +E A + +
Sbjct: 75 QTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H++ +H DLKPEN +F K+ LK IDFGL+ P + G+ +
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFA 192
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APEV + + G D+WS GV+ YILL G+ PF E + + + + + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
SE+ KD +RK+L DP R+T Q LEHPWL
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 261 bits (668), Expect = 8e-86
Identities = 100/275 (36%), Positives = 142/275 (51%), Gaps = 16/275 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD------IEDVRREVDI 108
E YE LGRG + C + +A K I + E +EVDI
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + ++EV
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 229 VL-------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
S+ KDLV + L P++R TA++ L HP+ Q
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (664), Expect = 5e-85
Identities = 100/270 (37%), Positives = 152/270 (56%), Gaps = 6/270 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 68 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ P +K IDFGL+ G +F I G+P ++APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
AKD +R++L DPK+R+T Q L+HPW++
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (660), Expect = 9e-85
Identities = 92/263 (34%), Positives = 143/263 (54%), Gaps = 10/263 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
V+HRD+KPEN L + E LK DFG SV P + + + G+ Y+ PE+++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R F V+E A+DL+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQ 316
++L +P +R ++VLEHPW+
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 256 bits (656), Expect = 2e-83
Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 15/302 (4%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H N + + Y + LVME C G V + E AAVT ++ +
Sbjct: 72 L-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H ++HRD+K N L + +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ Y +VDVWS G+ L PP + I ++ + SE
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEY 242
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 347
++ V L P+ R T++ +L+H ++ + P + + ++ ++ L+ R
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYRK 300
Query: 348 LK 349
+K
Sbjct: 301 MK 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 4e-82
Identities = 80/276 (28%), Positives = 138/276 (50%), Gaps = 11/276 (3%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +++Y ++G+G G Y D G A + ++ ++ E + E+ +MR
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL 230
H + V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R YGP+VD+WS G++ ++ G PP+ E I + K+S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFR 247
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
D + + LD D ++R +A+++L+H +L+ AK +++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 4e-81
Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 12/271 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G+ HRD+KPEN L + LK DFGL+ F+ + +++ G+ Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 232 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R + VDVWS G++L +L G P+ ++ + + +PW K+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPL 237
Query: 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
L+ K+L +P R+T + + W K
Sbjct: 238 ALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 1e-80
Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 25/288 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ G+ LG G F L + +A K + K+ + + V RE D+M L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 66
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H V L T++DD ++ + + GEL I G + E T IV ++ H
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G++HRDLKPEN L E ++ DFG + P K + VG+ Y++PE+L
Sbjct: 127 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ D+W+ G I+Y L+ G+PPF A E + Q II+ DF K A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARD 239
Query: 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQN-------AKKAPNVS 325
LV K+L D +RL ++ + HP+ ++ + P ++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 1e-79
Identities = 82/277 (29%), Positives = 129/277 (46%), Gaps = 16/277 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ +E+ ELG G FG Y ++E A K I K ++ED E+DI+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASC- 66
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
H NIV L D + + + +++E C GG + ++ TE V K ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL- 230
H + ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
R Y + DVWS G+ L + PP V I +S P + S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAP 322
N KD ++K L+ + R T Q+L+HP++ P
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 6e-79
Identities = 97/320 (30%), Positives = 156/320 (48%), Gaps = 20/320 (6%)
Query: 53 IEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
I + Y+ + LG G G ++ + FA K + RREV++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWR 60
Query: 112 LPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
+ +IV + D YE+ + +VME +GGELF RI RG +TER A+ + K+I
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E +Q H + HRD+KPEN L+ +K+ A LK DFG + + +PYY+
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDP 280
APEVL Y D+WS GVI+YILLCG PPF++ ++ + + +F
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 340
W +VSE K L+R +L +P +R+T + + HPW+ + K P L + + +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 300
Query: 341 NKLKKRALKVIAQHLSVEEV 360
+ ++ + + E++
Sbjct: 301 DVKEEMTSALATMRVDYEQI 320
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 3e-75
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 13/274 (4%)
Query: 50 GREIEERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + R+ + E+GRG F Y D E A + +KL T + + + E ++
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEM 61
Query: 109 MRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
++ L +H NIV D++E + LV EL G L + + + +
Sbjct: 62 LKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 165 IVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
I++ +Q H ++HRDLK +N + +K D GL+ K ++G+P
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL-KRASFAKAVIGTP 177
Query: 223 YYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
+MAPE+ + Y VDV++ G+ + + P+ + S +
Sbjct: 178 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDK 236
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
K+++ + + R + + +L H + Q
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 7e-75
Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 49/309 (15%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I + + RE+ ++
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC- 61
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV + D + + ME +GG L + G E+ V+ +++ +
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
KH +MHRD+KP N L ++ E +K DFG+S S VG+ YM+PE L+
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG 177
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----------------- 274
+Y + D+WS G+ L + G P + + V
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 275 -----------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+ P S +D V K L +P R +Q++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 312 HPWLQNAKK 320
H +++ +
Sbjct: 298 HAFIKRSDA 306
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-74
Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 21/274 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 61
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 169 VQMCHK-----HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSP 222
++ CH+ H V+HRDLKP N K+ +K DFGL+ F+ VG+P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YYM+PE + R Y + D+WS G +LY L +PPF A +++ +A I R
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIP 235
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315
+ S+ +++ +ML+ R + +++LE+P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 7e-74
Identities = 73/266 (27%), Positives = 126/266 (47%), Gaps = 10/266 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + L + LG+G FG +L ++ FA K++ K + D+E E ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + + T++ + VME GG+L I + + A I+ +Q H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-R 232
G+++RDLK +N L + +K DFG+ G+ K + G+P Y+APE+L +
Sbjct: 122 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y VD WS GV+LY +L G PF + E+ + +I + + + AKDL+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLL 234
Query: 293 RKMLDPDPKRRLTA-QQVLEHPWLQN 317
K+ +P++RL + +HP +
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 230 bits (587), Expect = 1e-73
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 7/274 (2%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T + +RYELG LG G +L D A K + R RRE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 109 MRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L H IV + DT E +T ++VME +G L D + G T + A V
Sbjct: 61 AAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG-LSVFFKPGEKFSEIVGSPY 223
+ + H++G++HRD+KP N + + + ++ + + ++G+
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+S + +V K L +P+ R + ++
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 9e-72
Identities = 83/272 (30%), Positives = 132/272 (48%), Gaps = 20/272 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVDIM 109
+E +Y++G LG G FG Y + A K + K ++ ++ + V EV ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 110 RHL-PKHQNIVCLKDTYEDDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVE 167
+ + ++ L D +E + L++E E +LFD I RG E A + ++E
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V+ CH GV+HRD+K EN L + LK IDFG K +++ G+ Y P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R +G VWS G++LY ++CG PF + E IIR + FR +VS
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
+ L+R L P R T +++ HPW+Q+
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 227 bits (579), Expect = 2e-71
Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 14/272 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HL 112
+ + R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
IVC+ + + +++L GG+L + G ++E I+ ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H V++RDLKP N L E ++ D GL+ F K VG+ YMAPEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 179
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + I R L + S +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS 238
Query: 291 LVRKMLDPDPKRRLT-----AQQVLEHPWLQN 317
L+ +L D RRL AQ+V E P+ ++
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 221 bits (564), Expect = 1e-69
Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++ R LG G FG +L R NG +A K + K+ + +E E ++ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ + T++D + ++M+ EGGELF + + A + ++ H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + +K DFG + + + + G+P Y+APEV+ +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y +D WS G+++Y +L G PF+ + I+ + L F P +E+ KDL+
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233
Query: 294 KMLDPDPKRRL-----TAQQVLEHPWLQN 317
+++ D +RL + V HPW +
Sbjct: 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-67
Identities = 77/270 (28%), Positives = 130/270 (48%), Gaps = 15/270 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++ + LG+G FG L ++ G +A K + K+ + ++ E ++++ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + LK ++ + VME GGELF + +TE A IV ++ H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRN 233
V++RD+K EN + +K DFGL G G+P Y+APEVL+ N
Sbjct: 124 RDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
YG VD W GV++Y ++CG PF+ + + + + I+ + F +S AK L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236
Query: 293 RKMLDPDPKRRL-----TAQQVLEHPWLQN 317
+L DPK+RL A++V+EH + +
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-66
Identities = 84/353 (23%), Positives = 138/353 (39%), Gaps = 51/353 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + +T + RE+ I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLR 62
Query: 112 LPKHQNIVCLKDTYEDDTAVHL----VMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ + D T + ++ G +L+ + H + I+
Sbjct: 63 F-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE----KFSEIVGSPY 223
++ H V+HRDLKP N L + LK DFGL+ P +E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y APE++ + Y +D+WS G IL +L P F + I+ + ++
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 282 ---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPW 314
P A DL+ KML +P +R+ +Q L HP+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 315 LQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGF 367
L+ + + E A K ++ L K LK L EE A + G+
Sbjct: 298 LEQYYDPSDEPIAE---APFKFDMELDDLPKEKLK----ELIFEETARFQPGY 343
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 213 bits (542), Expect = 3e-66
Identities = 75/304 (24%), Positives = 128/304 (42%), Gaps = 49/304 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ Y+L R+LGRG++ + + N + K + K + ++RE+ I+ +L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 88
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
NI+ L D +D + LV E + T+ I++ + C
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
H G+MHRD+KP N + + E L+ ID+GL+ F+ PG++++ V S Y+ PE+L
Sbjct: 146 HSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------------- 274
+ Y +D+WS G +L ++ PF+ + I VL
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 275 ------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ VS A D + K+L D + RLTA++ +EHP+
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 317 NAKK 320
K
Sbjct: 324 TVVK 327
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-66
Identities = 74/313 (23%), Positives = 126/313 (40%), Gaps = 49/313 (15%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P E+ +YE ++G+G FG + R+ G A K + + + I RE+
Sbjct: 4 PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIK 61
Query: 108 IMRHLPKHQNIVCLKDTYEDDTA--------VHLVMELCEGGELFDRIVARGHYTERAAA 159
I++ L KH+N+V L + + ++LV + CE +T
Sbjct: 62 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----- 214
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNR 177
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
++ V + +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 273 VLDFRRDPWPKV----------------------------SENAKDLVRKMLDPDPKRRL 304
+ WP V A DL+ K+L DP +R+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 305 TAQQVLEHPWLQN 317
+ L H + +
Sbjct: 298 DSDDALNHDFFWS 310
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-66
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 20/272 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI + +G+ +G G FG Y + A K ++ T ++ + EV ++R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVV 169
+H NI+ Y + +V + CEG L+ + + + + + + +
Sbjct: 60 KT-RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMA 226
H ++HRDLK N +K DFGL+ +F ++ GS +MA
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 227 PEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDP 280
PEV++ Y + DV++ G++LY L+ G P+ + ++ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ K L+ + L R Q+L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 8e-66
Identities = 80/316 (25%), Positives = 124/316 (39%), Gaps = 47/316 (14%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ R E Y + +G G FG+ Y ++G+ A K + + K RE+
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNREL 64
Query: 107 DIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGG---ELFDRIVARGHYTERA 157
IMR L H NIV L+ + +D+ ++LV++ A+
Sbjct: 65 QIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
+ + H G+ HRD+KP+N L +TA LK DFG + GE
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275
+ S YY APE++ +Y +DVWSAG +L LL G P F ++ II+ +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 276 FRRDPW-------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
R+ P+ A L ++L+ P RLT +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 311 EHPWLQNAKKAPNVSL 326
H + + PNV L
Sbjct: 302 AHSFFDELRD-PNVKL 316
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-65
Identities = 74/289 (25%), Positives = 115/289 (39%), Gaps = 33/289 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMRHLPKH 115
E LG G+F Y D+ A K I A D RE+ +++ L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NI+ L D + + + LV + E T A ++ ++ H+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--R 232
++HRDLKP N L LK DFGL+ F P ++ V + +Y APE+L R
Sbjct: 120 WILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---------- 282
YG VD+W+ G IL LL VP +++ I ++ + WP
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
++ DL++ + +P R+TA Q L+ + N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 5e-64
Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 17/277 (6%)
Query: 55 ERYELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMR 110
E +EL + LG G +G +L + + G +A K + K + + A E R E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ + +V L ++ +T +HL+++ GGELF + R +TE IV ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
HK G+++RD+K EN L + + DFGLS F E+ + G+ YMAP+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 229 VLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++ + VD WS GV++Y LL G PF + E+ I R +L ++S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317
AKDL++++L DPK+RL A ++ EH + Q
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 7e-64
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL- 112
+++YE E+G G +G + D +NG F + + REV ++RHL
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 113 -PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTI 165
+H N+V L D + +T + LV E + + V + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H H V+HRDLKP+N L + + K DFGL+ + + +V + +Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
APEVL ++ Y VD+WS G I + P F ++ I+ + + WP+
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 284 ----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320
+ E KDL+ K L +P +R++A L HP+ Q+ ++
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (518), Expect = 3e-63
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++YE ++G G +G + +RE + A K + V RE+ +++ L K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-K 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+NIV L D D + LV E C+ G + +++ + CH
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L E K +FGL+ F P +S V + +Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 232 RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
+ Y +D+WSAG I L P F + I R + + W
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317
PK++ +DL++ +L +P +R++A++ L+HP+ +
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (523), Expect = 3e-63
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 16/269 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++++ + LG G FG L +E+G+ +A K + K+K+ IE E I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L+ +++D++ +++VME GGE+F + G ++E A IV + H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + ++ DFG + K + + G+P +APE++ +
Sbjct: 160 LDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y VD W+ GV++Y + G PPF+A+ + + I+ + F S + KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270
Query: 294 KMLDPDPKRRL-----TAQQVLEHPWLQN 317
+L D +R + H W
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (514), Expect = 9e-63
Identities = 84/290 (28%), Positives = 127/290 (43%), Gaps = 34/290 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y ++G G +G+ Y + G+ FA K I +K + RE+ I++ L K
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGI-PSTTIREISILKEL-K 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NIV L D + LV E + V G A + ++ + CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--------- 282
+ Y +D+WS G I ++ G P F +E I R + WP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 283 ----------------KVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ E+ DL+ KML DP +R+TA+Q LEH + +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-62
Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 44/304 (14%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ Y + +G G +G D G A K + + ++ + + RE+ +
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRL 70
Query: 109 MRHLPKHQNIVCLKDTYEDD------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ +H+N++ L D + D T +LVM G +++ E +
Sbjct: 71 LKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV 127
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTR 182
Query: 223 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+Y APEV+ Y VD+WS G I+ ++ G F + I++ +
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 281 W---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHP 313
S A +L+ KML D ++R+TA + L HP
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 314 WLQN 317
+ ++
Sbjct: 303 YFES 306
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 8e-62
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 35/302 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ ++G G +G+ Y ++ G+ A K I + T RE+ +++ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-N 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV L D + ++LV E + F A + +++ + CH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKR 232
H V+HRDLKP+N L + +K DFGL+ F P ++ V + +Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
Y VD+WS G I ++ F ++E I R++ W
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA-KKAPNV 324
P + E+ + L+ +ML DP +R++A+ L HP+ Q+ K P++
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296
Query: 325 SL 326
L
Sbjct: 297 RL 298
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-60
Identities = 61/289 (21%), Positives = 104/289 (35%), Gaps = 36/289 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMRH 111
E E G+ LG G FG T ++ K L+ D E + E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------- 152
L H+NIV L ++L+ E C G+L + + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 153 ----YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
T + + ++ +HRDL N L + K +K DFGL+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARD 213
Query: 209 FKPGEKFS---EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ +MAPE L Y + DVWS G++L+ I GV P+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+I++ F+ D +E +++ D ++R + +
Sbjct: 274 ANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-60
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 26/294 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +G G FG +++G K+ + D D E++++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARGHYTERAA 158
H NI+ L E ++L +E G L D + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
+ + + +HRDL N L K DFGLS + K +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLSRGQEVYVKKTMG 186
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDF 276
+MA E L + Y DVWS GV+L+ ++ G P+ T + + + + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GY 243
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH--PWLQNAKKAPNVSLGE 328
R + + DL+R+ P R + Q+L L+ K N +L E
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-59
Identities = 58/269 (21%), Positives = 105/269 (39%), Gaps = 22/269 (8%)
Query: 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + + +L + +G+GEFG L R G+ A K I + E +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASV 53
Query: 109 MRHLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
M L +H N+V L E+ +++V E G L D + +RG + +
Sbjct: 54 MTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ + +HRDL N L + K DFGL+ + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE L+ + + + DVWS G++L+ + G P+ + V + + ++ D
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDG 224
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
++++ D R + Q+ E
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 4e-59
Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K + + ++ + + RE+ +++H
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 112 LPKHQNIVCLKDTYEDDTAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ KH+N++ L D + ++ + + G + IV T+ + I+
Sbjct: 74 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------- 277
E++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 278 -------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316
+ + + A DL+ KML D +R+TA Q L H +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (490), Expect = 5e-59
Identities = 51/281 (18%), Positives = 91/281 (32%), Gaps = 21/281 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I ++ + +VMEL ++ + + ++ ++
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYY 224
H +HRD+KP+NFL K+ + IDFGL+ ++ + + G+ Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--- 280
+ D+ S G +L G P+ Q R P
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLEHPWLQN 317
+ + Q+ + + +
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 61/276 (22%), Positives = 101/276 (36%), Gaps = 19/276 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ L +LG G FG+ + A K + L ++D REV+ M
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVV 169
L H+N++ L + +V EL G L DR+ GH+ + + E +
Sbjct: 67 SL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYM 225
+HRDL N L A + +K DFGL + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE LK R + D W GV L+ + G P+ + I + R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319
++ +++ + P+ R T + + +L A+
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (480), Expect = 2e-57
Identities = 67/284 (23%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISK-KKLRTAVDIEDVRREVDI 108
+EI+ ++ + +G GEFG + G +I K T D E I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE 167
M H N++ L+ T V ++ E E G L + G +T + + I
Sbjct: 81 MGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE------IVGS 221
++ +HRDL N L + K DFGLS F +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE ++ R + DVWS G++++ ++ G P+W T Q V AI + D+R
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLP 253
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
P L+ D R Q++ L + PN
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 8e-57
Identities = 54/280 (19%), Positives = 109/280 (38%), Gaps = 18/280 (6%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + + ++E+ +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 68
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEV 168
+ KH N+V L + +++ E G L D + + + I
Sbjct: 69 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
++ K +HRDL N L +K DFGLS + + A
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE L N + + DVW+ GV+L+ + + + ++ D+R +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCP 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325
E +L+R +P R + ++ + + + ++S
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQ--AFETMFQESSIS 280
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-56
Identities = 59/275 (21%), Positives = 105/275 (38%), Gaps = 22/275 (8%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI E L +LG+G FG ++ T A K++ + E +E +M+
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMK 67
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +H+ +V L ++ +++V E G L D + + + I
Sbjct: 68 KL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
+ + +HRDL+ N L K DFGL+ + E + A
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + DVWS G++L L G P+ + V + R +R P+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 239
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLE--HPWLQN 317
E+ DL+ + +P+ R T + + + +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-56
Identities = 55/271 (20%), Positives = 98/271 (36%), Gaps = 20/271 (7%)
Query: 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G FG + A K + K + +++ E ++M+ L + I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V + E ++ LVME+ E G L + H ++ + + ++ + +
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVLKRN- 233
HRDL N L + K DFGLS + E + + + APE +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 234 YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS GV+++ G P+ V + + R DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLM 243
Query: 293 RKMLDPDPKRRLTAQQV---LEHPWLQNAKK 320
D + R V L + + +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-56
Identities = 55/263 (20%), Positives = 100/263 (38%), Gaps = 17/263 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +ELG G+FG+ R A K I + + ++ E +M +L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-S 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMCH 173
H+ +V L + ++ E G L + + R + + + K + E ++
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+HRDL N L ++ +K DFGLS + E + PEVL
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + + D+W+ GV+++ I G P+ T A+ I + R SE
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVY 231
Query: 290 DLVRKMLDPDPKRRLTAQQVLEH 312
++ R T + +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-56
Identities = 59/263 (22%), Positives = 103/263 (39%), Gaps = 17/263 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+E+G G+FG+ +L N D A K+I + + ED E ++M L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-S 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCH 173
H +V L + + LV E E G L D + + + + + E +
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+ V+HRDL N L + +K DFG++ F + + + +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 232 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + DVWS GV+++ + G P+ + V + I FR S +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVY 232
Query: 290 DLVRKMLDPDPKRRLTAQQVLEH 312
++ P+ R ++L
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 8e-56
Identities = 64/279 (22%), Positives = 99/279 (35%), Gaps = 23/279 (8%)
Query: 55 ERYELG-RELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + ELG G FG R A K + + + D E++ RE IM
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQ 65
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQ 170
L + IV L + + + LVME+ GG L +V R A + + ++
Sbjct: 66 L-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE----IVGSPYYMA 226
+ +HRDL N L N+ K DFGLS + + + A
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 227 PEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + R + DVWS GV ++ L G P+ V I + R + P+
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPEC 237
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQV---LEHPWLQNAKK 320
L+ + R V + + A K
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-55
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 53/311 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K + + + + RE+ +M+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKC 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+NI+ L + + E+ V+LVMEL + + + + +
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 128
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + + K +DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 226 APE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
APE +L Y VD+WS G I+ ++ F +I
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 272 -------------------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA 306
S+ + + A+DL+ KML DP +R++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 307 QQVLEHPWLQN 317
L+HP++
Sbjct: 306 DDALQHPYINV 316
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-55
Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 19/270 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVD 107
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEAL 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIV 166
MR H +IV L ++ V ++MELC GEL + R + +
Sbjct: 61 TMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYY 224
+ +HRD+ N L ++ +K DFGLS + + K S+ +
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
MAPE + R + DVW GV ++ IL+ GV PF V I R P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPP 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
L+ K DP RR ++
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-55
Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 20/267 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ A KS+ + + + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMK 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +HQ +V L + ++++ E E G L D + T + I E
Sbjct: 64 QL-QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYMA 226
+ + +HRDL+ N L ++ K DFGL+ + E + + A
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + + DVWS G++L ++ G P+ T V Q + R +R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNC 235
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311
E L+R P+ R T +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 180 bits (456), Expect = 5e-54
Identities = 49/274 (17%), Positives = 94/274 (34%), Gaps = 20/274 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I + ++ LV++L + ++ + A K ++ VQ
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 173 HKHGVMHRDLKPENFLFANK--KETAPLKAIDFGLSVFFKPGE--------KFSEIVGSP 222
H+ +++RD+KP+NFL K + +DFG+ F++ + + G+
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP- 280
YM+ R D+ + G + L G P+ Q R + P
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 281 ---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
E + + +
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 9e-53
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 32/287 (11%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--------------- 152
++ +L H NIV L ++ E C G+L + + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 153 ---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + + + + +HRDL N L + + T K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDI 195
Query: 210 KPGEKF---SEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLC-GVPPFWAETEQG 264
K + +MAPE + E DVWS G+ L+ L G P+
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+I+ FR D+++ D DP +R T +Q+++
Sbjct: 256 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-52
Identities = 51/267 (19%), Positives = 97/267 (36%), Gaps = 16/267 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E ++ + LG G FG Y G+ ++ K+LR A +++ E +M
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMA 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ + ++ L T + + G L + + + I + +
Sbjct: 67 SV-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAP 227
++HRDL N L + +K DFGL+ EK +MA
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R Y + DVWS GV ++ L+ G P+ ++ + + R P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICT 239
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312
+ ++ K D R ++++
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-52
Identities = 56/283 (19%), Positives = 100/283 (35%), Gaps = 30/283 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+R LG+ LG G FG L A K + D+ D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARG 151
+M+ + KH+NI+ L D +++++E G L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + ++ +HRDL N L
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+K + +MAPE L R Y + DVWS GV+L+ I G P+ + + + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
R D + ++R P +R T +Q++E
Sbjct: 251 KE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 5e-49
Identities = 53/299 (17%), Positives = 95/299 (31%), Gaps = 42/299 (14%)
Query: 48 PTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IED 101
P +E E R++G G FG + ++ K L+ D
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------- 153
+RE +M + NIV L + L+ E G+L + + + +
Sbjct: 63 FQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 154 ----------------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197
+ + + + + + +HRDL N L
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--- 178
Query: 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC- 252
+K DFGLS + + +M PE + N Y E DVW+ GV+L+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
G+ P++ + V + +L+R P R + +
Sbjct: 239 GLQPYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 9e-49
Identities = 62/284 (21%), Positives = 104/284 (36%), Gaps = 23/284 (8%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREV 106
EI + +G GEFG Y + + A K++ K T D E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 60
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + G ++ + + I
Sbjct: 61 GIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSEIVGS 221
++ +HRDL N L + K DFGLS + + S
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE + R + DVWS G++++ ++ G P+W + V +AI FR
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLP 233
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPN 323
L+ + + RR ++ L +AP+
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-47
Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 23/272 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 83
Query: 111 HLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
H N++ L + + +V+ + G+L + I H T + + +
Sbjct: 84 DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-----IVGSPY 223
++ +HRDL N + K +K DFGL+ E S
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+MA E L+ + + DVWS GV+L+ L+ G PP+ + +++ RR
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQ 255
Query: 282 PK-VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
P+ + +++ K P + R + +++
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 55/282 (19%), Positives = 109/282 (38%), Gaps = 30/282 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + E A K++++ + + E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----------YTE 155
+M+ ++V L ++MEL G+L + + +
Sbjct: 74 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 156 RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213
+ I + + + + +HRDL N + A +K DFG++ +
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYY 189
Query: 214 -KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K + + +M+PE LK + DVWS GV+L+ I P+ + + V + ++
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
D + +L+R +PK R + +++
Sbjct: 250 E---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 51/300 (17%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
I L +G+G FG + R G+ A K S ++ R+ E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQTVML 54
Query: 113 PKHQNIVCLKDTYEDD----TAVHLVMELCEGGELFDRIVARGHYTERA-------AAAV 161
+H+NI+ D T + LV + E G LFD + E A+ +
Sbjct: 55 -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFS 216
+E+V K + HRDLK +N L D GL+V +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPN 170
Query: 217 EIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQG----- 264
VG+ YMAPEVL + D+++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 265 ------VAQAIIRSVLDFRRDP-------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311
+ + + V + + P + ++R+ + RLTA ++ +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 57/287 (19%), Positives = 108/287 (37%), Gaps = 31/287 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVD 107
E +R +LG+ LGRG FG C++++ K L+ + R E+
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 108 IMRHLPKHQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHY------------- 153
I+ H+ H N+V L + + +++E C+ G L + ++ +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 154 ---TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L + K +K DFGL+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIY 185
Query: 211 PGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV-PPFWAETEQGV 265
+ + +MAPE + Y + DVWS GV+L+ + P+
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312
++ R + + + +P +R T +++EH
Sbjct: 246 FCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 4e-44
Identities = 64/333 (19%), Positives = 113/333 (33%), Gaps = 66/333 (19%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
RY L R+LG G F +L D N A K + K+ T E E+ +++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 113 -------PKHQNIVCLKDTYED--DTAVHLVMELCEGG---ELFDRIVARGHYTERAAAA 160
+I+ L D + VH+VM G +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 161 VTKTIVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAI-DFGLSVFFKPGEKFSEI 218
++K ++ + M + G++H D+KPEN L L I L E ++
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ + Y +PEVL +G D+WS +++ L+ G F + +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 270 ------------------------------------IRSVLDFRRDPWPKVSENAKDLVR 293
+ VL + ++ D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 294 KMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSL 326
ML DP++R A ++ HPWL++ + +
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 2e-19
Identities = 43/204 (21%), Positives = 69/204 (33%), Gaps = 25/204 (12%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACK-----SISKKKLRTAVDIEDVR-REVDIMR 110
+G+ +G G+ + C E K S KK++ D D+ + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 111 HLPKHQNIVCLKDTYE----DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+ + + L+ ++MEL + E V I+
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
E V + G++H DL N L + + + IDF SV E + EI+
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNI 168
Query: 227 PEVLKRNYGPEVDVWSAGVILYIL 250
R Y E D+ S I IL
Sbjct: 169 ITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 55.4 bits (132), Expect = 4e-09
Identities = 20/114 (17%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 293 RKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIA 352
D + A++ E + A + + + + + LK + L+
Sbjct: 57 LAEYDQKVQNEFDARERAERE--REAARGDAAAEKQRLASLLKDLED-DASGYNRLRPSK 113
Query: 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
LS E+ +++ F + GK + +L+ L K IP+ ++ L V
Sbjct: 114 PMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMV 167
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 50.3 bits (120), Expect = 8e-09
Identities = 25/58 (43%), Positives = 40/58 (68%)
Query: 349 KVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
K +A+ LS EE+ G+KE F M+D N G I DEL+ GL ++G ++ +++++ LMDA
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.8 bits (103), Expect = 1e-06
Identities = 17/55 (30%), Positives = 29/55 (52%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
+ +L+ E++A KE F + D N G I+ EL + LG + +V LM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 45.8 bits (107), Expect = 2e-06
Identities = 24/60 (40%), Positives = 38/60 (63%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH 411
A+ LS EE+ G+KE F M+D N G I DEL+ GL ++G ++ +++++ LMDA
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 60
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 42.3 bits (99), Expect = 6e-06
Identities = 14/59 (23%), Positives = 25/59 (42%), Gaps = 1/59 (1%)
Query: 349 KVIAQHLSVEEVAGIKEGFHMMDI-GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
K + L+ E+ K F + + G I+ EL + LG ++Q ++D V
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEV 61
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 41.5 bits (97), Expect = 8e-06
Identities = 15/52 (28%), Positives = 26/52 (50%)
Query: 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
L+ E++A KE F + D G I EL + LG + ++Q +++ V
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 53
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 44.4 bits (104), Expect = 1e-05
Identities = 20/136 (14%), Positives = 44/136 (32%), Gaps = 4/136 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACK----SISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G G + D+E+ A K + I+ R E + +H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ + Y D VME ++ + + G + + + + + + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 177 VMHRDLKPENFLFANK 192
+ + K F N
Sbjct: 152 LEPKVKKQLVKQFTNP 167
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 41.8 bits (97), Expect = 3e-05
Identities = 17/57 (29%), Positives = 29/57 (50%)
Query: 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH 408
+ +L+ E++A KE F + D N G I+ EL + LG + +V LM+ +
Sbjct: 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDV 57
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 41.1 bits (95), Expect = 5e-05
Identities = 12/53 (22%), Positives = 21/53 (39%), Gaps = 1/53 (1%)
Query: 349 KVIAQHLSVEEVAGIKEGFHMMDI-GNRGKINIDELRVGLHKLGHQIPDTDVQ 400
K + L+ E+ K F + + G I+ EL + LG ++Q
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQ 54
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 37.5 bits (87), Expect = 2e-04
Identities = 12/45 (26%), Positives = 20/45 (44%), Gaps = 1/45 (2%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLG-HQIPDTDVQILMDAV 406
I F + D G I+ DE + + K+G + D +V+ M
Sbjct: 4 ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 48
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 37.7 bits (87), Expect = 2e-04
Identities = 15/54 (27%), Positives = 23/54 (42%)
Query: 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
LS E +A K F M D G I+ EL + LG ++ +++ V
Sbjct: 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 38.4 bits (88), Expect = 6e-04
Identities = 12/55 (21%), Positives = 22/55 (40%), Gaps = 3/55 (5%)
Query: 354 HLSVEEVAGIKEGFHMMD--IGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
SV E+ + E F + + + G IN +E ++ L K + + D
Sbjct: 10 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKK-ESLFADRVFDLF 63
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 36.0 bits (83), Expect = 8e-04
Identities = 12/44 (27%), Positives = 22/44 (50%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
I + F + D N G I I +LR +LG + + ++Q ++
Sbjct: 11 ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 54
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.7 bits (82), Expect = 0.002
Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 3/60 (5%)
Query: 350 VIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAV 406
LS + +K+ F +D G ++ DEL+ L K ++ +++ + LMDA
Sbjct: 30 FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} Length = 76 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Score = 34.9 bits (80), Expect = 0.002
Identities = 12/48 (25%), Positives = 22/48 (45%), Gaps = 5/48 (10%)
Query: 356 SVEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHKLGHQIPDTDVQI 401
S EE IK F + G+ +I+ +EL++ + LG + +
Sbjct: 3 SPEE---IKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTL 47
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.6 bits (83), Expect = 0.002
Identities = 7/46 (15%), Positives = 20/46 (43%)
Query: 351 IAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPD 396
+ H +E+ + + F +D+ N G ++++E + +
Sbjct: 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQ 51
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 35.3 bits (81), Expect = 0.003
Identities = 17/82 (20%), Positives = 30/82 (36%), Gaps = 4/82 (4%)
Query: 328 ETVKARLKQFSVMNKLKKRALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGL 387
E +K + F+ + + L + +K+ FH++D G I DEL L
Sbjct: 9 EDIKKAIGAFTAADSFDHKKF-FQMVGLKKKSADDVKKVFHILDKDKSGFIEEDELGSIL 67
Query: 388 HKLGHQ---IPDTDVQILMDAV 406
+ + + LM A
Sbjct: 68 KGFSSDARDLSAKETKTLMAAG 89
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 36.4 bits (83), Expect = 0.003
Identities = 11/53 (20%), Positives = 22/53 (41%), Gaps = 1/53 (1%)
Query: 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTL 410
EEV + F + G+ +++ EL L+K+ + PD ++
Sbjct: 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSM 52
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 35.6 bits (81), Expect = 0.003
Identities = 15/53 (28%), Positives = 26/53 (49%)
Query: 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAV 406
L+ E++A KE F + D G I EL + LG + ++Q +++ V
Sbjct: 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 54
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 35.8 bits (81), Expect = 0.003
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 2/51 (3%)
Query: 355 LSVEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHKLGHQIPDTDVQILM 403
LS +E+ +K+ F + D G G ++ +L LG + DV +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG 51
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.3 bits (80), Expect = 0.004
Identities = 10/46 (21%), Positives = 17/46 (36%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH 408
KE F + D GKI + + LG + +V ++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKS 47
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 35.4 bits (80), Expect = 0.004
Identities = 13/49 (26%), Positives = 22/49 (44%)
Query: 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH 411
K+ F + D +G I D L L +G+ + VQ +++A S
Sbjct: 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRD 52
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 436 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.39 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.35 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.34 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.31 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.31 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.29 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.26 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.23 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.23 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.2 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.18 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.18 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 99.12 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 99.08 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 99.07 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 99.0 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.95 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.95 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.92 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.91 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.88 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.87 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.87 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.87 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.87 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.86 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.86 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.86 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.85 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.83 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 98.82 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.82 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.81 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 98.79 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.79 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.78 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 98.77 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.77 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 98.73 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.73 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.72 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.72 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.71 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.69 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 98.69 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.69 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.68 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.66 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.65 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.65 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.65 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.64 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.64 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.63 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.63 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.62 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.61 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.61 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.6 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 98.59 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.58 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.58 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.56 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 98.55 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.55 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.54 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 98.52 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.51 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.49 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.48 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 98.45 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 98.43 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 98.41 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 98.41 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.37 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.36 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.34 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 98.33 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.32 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.31 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.31 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.29 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 98.28 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 98.23 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.19 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.19 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 98.18 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.18 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 98.15 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 98.11 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 98.08 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.07 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 98.07 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 97.98 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 97.96 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 97.94 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.93 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 97.92 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 97.9 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 97.83 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.77 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 97.73 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 97.73 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 97.71 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 97.7 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 97.63 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 97.62 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 97.6 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 97.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.5 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 97.42 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.38 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 97.36 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 97.33 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 96.94 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 96.84 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 96.71 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 96.7 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 96.45 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 96.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.73 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 95.4 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 94.98 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 94.45 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 94.34 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 94.3 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 94.23 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 94.0 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 93.97 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 93.58 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 93.18 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 93.07 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 92.96 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.86 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 91.91 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 91.75 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 91.16 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 90.55 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 90.28 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 89.99 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 89.86 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 89.42 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 89.29 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 88.8 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 88.06 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 87.77 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 87.61 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 86.68 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 85.27 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 85.03 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 84.33 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 83.72 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 83.29 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 82.93 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-66 Score=481.14 Aligned_cols=283 Identities=38% Similarity=0.741 Sum_probs=231.7
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
+.+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+++ +|||||++++++.+++.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 457889999999999999999999999999999999998765432 345688999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
+|+|||||+||+|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999998899999999999999999999999999999999999999876667789999999999877
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
........+||+.|+|||++. +.|+.++|||||||++|+|+||..||.+....+....+.+....+..+.++.+|++++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 666667789999999999987 4689999999999999999999999999999889999998888777777788999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhh
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQF 337 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (436)
+||.+||++||++|||+.|+|+||||+..... .......+...+++.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~-~~~~~~~~~~~~~~~ 288 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKN 288 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC-CCCCHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc-ccccchhHHHHHHHH
Confidence 99999999999999999999999999864322 233444444444444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-64 Score=459.31 Aligned_cols=254 Identities=35% Similarity=0.630 Sum_probs=229.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++++++ +|||||++++++.+++.+|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999866544444567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...... .
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCSCSCCCCC-C
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---CCEeecccceeeecCCC-c
Confidence 9999999999999988899999999999999999999999999999999999999654 45999999999876533 3
Q ss_pred ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.+..+....+.+....++ +.+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence 456789999999999874 589999999999999999999999999998888888877654432 458999999999
Q ss_pred HccCCCcCCCCCHHHHhcCccccc
Q 013816 294 KMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 294 ~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+||++||++|||+.|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-63 Score=462.91 Aligned_cols=266 Identities=37% Similarity=0.708 Sum_probs=240.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCC---hhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+++ +|||||++++++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence 46789999999999999999999999999999999998765432 23467899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCeEEEeecccc
Q 013816 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~-~~~ikl~DfG~a~ 207 (436)
+.+|+|||||+||+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+|.
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999999998889999999999999999999999999999999999999976542 3469999999999
Q ss_pred ccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
............||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+......++...++.+|+
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 887766677789999999999987 4589999999999999999999999999999988888888776665555567899
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++++||.+||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999853
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-64 Score=458.43 Aligned_cols=258 Identities=30% Similarity=0.525 Sum_probs=219.3
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|+++ +|||||++++++.+++.+|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEE
Confidence 46799999999999999999999999999999999765432 2346789999999999 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||||+||+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---CCEEEccchhheeeccCC
Confidence 99999999999999888889999999999999999999999999999999999999654 459999999998764332
Q ss_pred ---cccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 214 ---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 214 ---~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.....+||+.|||||++.+ . ++.++|||||||++|+|+||+.||................. ....+++.+|+++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHHH
Confidence 2356789999999999864 4 46789999999999999999999977654433333333222 2334457899999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++||.+||+.||++|||+.|+|+||||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=455.18 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=226.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+++ +|||||++++++.+++.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEE
Confidence 346899999999999999999999999999999999765432 357799999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---CcEeeccchhheeeccc
Confidence 99999999999987765 479999999999999999999999999999999999999644 45999999999877543
Q ss_pred -CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
......+||+.|+|||++. +.++.++|||||||++|+|+||..||.+.+.......+...... ....++.+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence 3445678999999999987 45899999999999999999999999988887776666654322 22334678999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
||.+||++||++|||+.|+|+||||+...
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-62 Score=465.57 Aligned_cols=263 Identities=33% Similarity=0.658 Sum_probs=239.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... ..+...+.+|+.+|++| +|||||+++++|.+++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4578999999999999999999999999999999997643 33456789999999999 9999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+|||||+||+|.+.+...+ ++++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence 9999999999998876654 69999999999999999999999999999999999999643 345699999999998877
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
........||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+.+....++...++.+|+++++
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 76667789999999999987 45899999999999999999999999999999999999998888777778899999999
Q ss_pred HHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 291 LVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
||.+||++||.+|||+.|+|+||||+....
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999986543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-62 Score=465.73 Aligned_cols=263 Identities=34% Similarity=0.657 Sum_probs=238.5
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+-++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++| +|||||++++++.+++.+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEE
Confidence 34578999999999999999999999999999999996542 34567899999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheecc
Confidence 999999999999999854 4579999999999999999999999999999999999999653 23569999999999887
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.........||+.|||||++. ..++.++|||||||++|+|+||..||.+.+..+....+......+....++.+|++++
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 766667789999999999987 4589999999999999999999999999999999999988887777766778999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+||.+||+.||++|||++|+|+||||+...
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-62 Score=447.97 Aligned_cols=255 Identities=23% Similarity=0.406 Sum_probs=218.5
Q ss_pred cce-eeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe----CC
Q 013816 55 ERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (436)
Q Consensus 55 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----~~ 129 (436)
++| ++.++||+|+||+||+|++..+++.||+|++..... .....+.+.+|+++|+++ +|||||++++++++ ..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence 444 778899999999999999999999999999977654 344567899999999999 89999999999875 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 130 ~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
.+|+|||||+||+|.+++.+...+++..+..++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||+|+
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCcce
Confidence 68999999999999999998889999999999999999999999998 999999999999963 23459999999998
Q ss_pred ccCCCCcccccccCCcccchhcccccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHccccCCCCCCcccCH
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
.... ......+||+.|+|||++.+.++.++|||||||++|+|+||+.||.+.... .....+..+.. +.......++
T Consensus 164 ~~~~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~ 240 (270)
T d1t4ha_ 164 LKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIP 240 (270)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCH
T ss_pred eccC-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCH
Confidence 6543 334567899999999999988999999999999999999999999765543 34444443322 1122345789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
++++||.+||++||++|||+.|+|+||||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-62 Score=455.02 Aligned_cols=256 Identities=32% Similarity=0.570 Sum_probs=226.7
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+++ +|||||++++++.+++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999876544444567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~---~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC---CceEEecccccceecccCCc
Confidence 999999999999999899999999999999999999999999999999999999964 4459999999998775332
Q ss_pred --cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHH
Q 013816 214 --KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (436)
Q Consensus 214 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 290 (436)
.....+||+.|+|||++. ..++.++|||||||++|+|+||..||.+.+..+....+.+....++ ..+|+++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence 334568999999999987 4689999999999999999999999999998888888887655433 468999999
Q ss_pred HHHHccCCCcCCCCCHHH------HhcCcccccC
Q 013816 291 LVRKMLDPDPKRRLTAQQ------VLEHPWLQNA 318 (436)
Q Consensus 291 ll~~~l~~~p~~Rps~~e------~l~h~~~~~~ 318 (436)
||.+||+.||++|||+.| +++||||+..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999988 5889999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1e-61 Score=446.55 Aligned_cols=262 Identities=38% Similarity=0.684 Sum_probs=237.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCCh------hhHHHHHHHHHHHHhCCCCCceeEEEEEEEe
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~------~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 127 (436)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+++++..|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 5789999999999999999999999999999999987654321 1234688999999999569999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
++.+|||||||+||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC---CCCeEEccchhee
Confidence 9999999999999999999999899999999999999999999999999999999999999954 4559999999999
Q ss_pred ccCCCCcccccccCCcccchhcccc-------cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 280 (436)
............||+.|+|||++.+ .++.++||||+||++|+|+||+.||.+.+.......+.++...++...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8876666677889999999998752 367899999999999999999999999999988888998877777777
Q ss_pred CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 281 ~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++.+|+++++||.+||++||++|||+.|+|+||||+..
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 78899999999999999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-62 Score=456.47 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=228.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|+++ +|||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEE
Confidence 346799999999999999999999999999999999877655555667899999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
+|||||.||+|..++..++++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---CCEEEeecccccccCC-
Confidence 999999999998888888889999999999999999999999999999999999999754 4599999999987543
Q ss_pred CcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
.....||+.|||||++. +.|+.++|||||||++|+|++|..||.+.+..+....+....... .....+|+++
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~ 243 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYF 243 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CSCTTSCHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCCCHHH
Confidence 34568999999999974 348899999999999999999999999988888777777664432 2234689999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
++||.+||+.||++|||+.|+|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-62 Score=452.66 Aligned_cols=256 Identities=31% Similarity=0.499 Sum_probs=224.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.+.|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+++|+++ +|||||++++++.+++.+|+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEE
Confidence 467999999999999999999999999999999997643 33457789999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||||+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---CCEEEEechhhhccCCC
Confidence 9999999999998765 4569999999999999999999999999999999999999654 45899999999765322
Q ss_pred -CcccccccCCcccchhccc------ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 213 -EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 213 -~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.......||+.|+|||++. ..|+.++|||||||++|+|+||+.||.+.+..+....+.+..... ...+..+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCC
Confidence 2334678999999999873 347899999999999999999999999988888888887765322 22235789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
+++++||.+||+.||++|||+.|+|+||||+.
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-62 Score=459.00 Aligned_cols=262 Identities=32% Similarity=0.649 Sum_probs=238.1
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||+||+|.++.+|+.||+|++.... .+...+.+|+++|+.+ +|||||++++++++++.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 46789999999999999999999999999999999997542 2345688999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+|||||+||+|.+++..++ .+++..++.++.||+.||.|||++||+||||||+|||++.+ ....+||+|||+++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999998765 69999999999999999999999999999999999999754 34569999999999887
Q ss_pred CCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
.........||+.|+|||.+. ..++.++|||||||++|+|++|..||.+.+..+....+.+....++...++.+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 666667778999999999976 5689999999999999999999999999999999999998887776666678999999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
+||.+||+.||++|||+.|+|+||||+...
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999997643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-61 Score=454.56 Aligned_cols=256 Identities=30% Similarity=0.565 Sum_probs=232.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+++ +|||||++++++++.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence 5799999999999999999999999999999999876544444567899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC-CC
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~-~~ 213 (436)
||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---CCEEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999654 5699999999987643 34
Q ss_pred cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.+.+..+....+......++ ..+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence 456789999999999987 5699999999999999999999999999999988888888765443 46899999999
Q ss_pred HHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 293 RKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 293 ~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
.+||++||.+||+ +.|+++||||+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999994 9999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-61 Score=442.95 Aligned_cols=253 Identities=31% Similarity=0.541 Sum_probs=212.1
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~~ 132 (436)
++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++|+++ +|||||++++++.+ ++.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 579999999999999999999999999999999987654 344567899999999999 99999999999864 56789
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceEeecCCCCCCeEEEee
Q 013816 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAIDF 203 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~-----iiH~dlkp~NIl~~~~~~~~~ikl~Df 203 (436)
+|||||+||+|.+++.. +..+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEEeec
Confidence 99999999999998854 457999999999999999999999976 9999999999999654 45999999
Q ss_pred ccccccCCCC-cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 204 GLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 204 G~a~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
|+|+...... ......||+.|+|||++. ..|+.++|||||||++|+|+||..||.+.+..+....+..+.... .+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 9998875443 335678999999999987 468999999999999999999999999999888888887765432 23
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWL 315 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~ 315 (436)
..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4689999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-60 Score=447.75 Aligned_cols=254 Identities=28% Similarity=0.571 Sum_probs=230.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+++ +|||||++++++.+++.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 5699999999999999999999999999999999866544444567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~---~g~vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYVPD--V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TSCEEECCCSSCEECSS--C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC---CCCEEEecCccceEecc--c
Confidence 999999999999999999999999999999999999999999999999999999964 44599999999987653 3
Q ss_pred ccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+.+..+....+.+....++ +.+|++++++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 456789999999999875 589999999999999999999999999999988888888755432 468999999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+||++||.+|+ |++++|+||||++.
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=455.66 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=216.8
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
..++|++++.||+|+||+||+|+++.+|+.||+|++.... .....+.+.+|+.+|+++ +|||||+++++|.+.+.+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4578999999999999999999999999999999997653 233457899999999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
+||||++||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++. .+.+||+|||+|+...+
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~---~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS---RGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT---TCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC---CCCEEEeeCCCccccCC
Confidence 999999999999999988899999999999999999999997 49999999999999964 44599999999986643
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------------
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-------------------- 270 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~-------------------- 270 (436)
....+.+||+.|+|||++. ..|+.++||||+||++|||++|+.||.+.+.........
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2234578999999999987 469999999999999999999999997765432211000
Q ss_pred ------------------Hcccc--CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 271 ------------------RSVLD--FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 271 ------------------~~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
..... .+..+...+|.++++||.+||+.||++|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00000 00111124689999999999999999999999999999998643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-61 Score=455.08 Aligned_cols=266 Identities=35% Similarity=0.662 Sum_probs=224.3
Q ss_pred ccccceeecc-ccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe---
Q 013816 52 EIEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (436)
Q Consensus 52 ~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--- 127 (436)
.+-++|+++. .||+|+||+||+|++..+|+.||||++... ..+.+|+.++.++.+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3557899875 599999999999999999999999998642 4577899997766589999999999976
Q ss_pred -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 -DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
+..+|+|||||+||+|.+++..+ ..+++.+++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46789999999999999999875 369999999999999999999999999999999999999877777889999999
Q ss_pred cccccCCCCcccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHc----cccCCCC
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----VLDFRRD 279 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~----~~~~~~~ 279 (436)
+|+............||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+.+.......+... ...++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9998877777777899999999999874 6999999999999999999999999876655544444333 2333333
Q ss_pred CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCC
Q 013816 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVS 325 (436)
Q Consensus 280 ~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~ 325 (436)
.+..+|+++++||.+||+.||++|||+.|+|+||||++....+..+
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~ 285 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence 4457899999999999999999999999999999998765554443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-60 Score=449.12 Aligned_cols=254 Identities=29% Similarity=0.558 Sum_probs=229.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+ +|||||++++++.+...+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 6899999999999999999999999999999999766544444567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~ 214 (436)
|||+.||+|.+.+...+.+++..++.++.||+.||.|||++|||||||||+|||++. .+.+||+|||+|+.... .
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~---~g~ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSS--C
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC---CCCEEeeeceeeeeccc--c
Confidence 999999999999998889999999999999999999999999999999999999964 44699999999988753 3
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~ 293 (436)
.....||+.|||||++. ..++.++|||||||++|+|+||..||.+.+.......+......+ +..+|+++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHHH
Confidence 34578999999999987 458999999999999999999999999999888888888775443 3468999999999
Q ss_pred HccCCCcCCCC-----CHHHHhcCcccccC
Q 013816 294 KMLDPDPKRRL-----TAQQVLEHPWLQNA 318 (436)
Q Consensus 294 ~~l~~~p~~Rp-----s~~e~l~h~~~~~~ 318 (436)
+||++||.+|+ |+.++++||||+..
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999995 99999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-59 Score=448.18 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=219.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHH---HHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~---E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+ |+.+++.+ +|||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 57999999999999999999999999999999997654433223333444 46677777 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~---~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS---SSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC---CCcEEEeeeceeeecCC
Confidence 999999999999999999889999999999999999999999999999999999999964 44599999999987654
Q ss_pred CCcccccccCCcccchhccc-c-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. ......||+.|+|||++. + .|+.++|||||||++|+|+||+.||.+....... .+.+.........+..+|++++
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence 3 345568999999999985 3 4899999999999999999999999876543322 3344444444455567999999
Q ss_pred HHHHHccCCCcCCCCC-----HHHHhcCcccccC
Q 013816 290 DLVRKMLDPDPKRRLT-----AQQVLEHPWLQNA 318 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps-----~~e~l~h~~~~~~ 318 (436)
+||.+||++||++||| +.|+++||||++.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-59 Score=440.33 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=226.5
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHH-hCCCCCceeEEEEEEEeCCeEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR-HLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~-~l~~h~niv~~~~~~~~~~~~~l 133 (436)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|..++. .+ +|||||++++++.+++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 57999999999999999999999999999999998654433345567777887776 56 99999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~---~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK---DGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT---TSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC---CCceeccccchhhhccccc
Confidence 9999999999999999889999999999999999999999999999999999999964 445899999999866543
Q ss_pred CcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHH
Q 013816 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 291 (436)
.......||+.|+|||++. +.++.++|||||||++|+|+||+.||.+.+..+....+......+ ...+|+++++|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CccCCHHHHHH
Confidence 3345578999999999987 569999999999999999999999999999988888887765433 24689999999
Q ss_pred HHHccCCCcCCCCCHH-HHhcCcccccC
Q 013816 292 VRKMLDPDPKRRLTAQ-QVLEHPWLQNA 318 (436)
Q Consensus 292 l~~~l~~~p~~Rps~~-e~l~h~~~~~~ 318 (436)
|.+||++||++|||+. ++++||||+..
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999995 89999999863
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-59 Score=435.46 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=215.1
Q ss_pred eccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh--hHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEe
Q 013816 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV--DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E 136 (436)
.++.||+|+||+||+|+++.+|+.||||++......... ..+.+.+|+.+|+++ +|||||++++++..++.+|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 457899999999999999999999999999765432211 134688999999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-cc
Q 013816 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KF 215 (436)
Q Consensus 137 ~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~-~~ 215 (436)
|+.|+++..+...+..+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~---~~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE---NGVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC---CCccccccCccccccCCCcccc
Confidence 9999888777666778999999999999999999999999999999999999964 4459999999998765433 34
Q ss_pred cccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC-------------
Q 013816 216 SEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------------- 280 (436)
Q Consensus 216 ~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------- 280 (436)
...+||+.|+|||++. ..|+.++|||||||++|+|+||..||.+.+..+....+.+.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 5568999999999875 3579999999999999999999999999998888877765432221111
Q ss_pred -----------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 281 -----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 281 -----------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++.+++++++||.+||+.||++|||+.|+|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 135688999999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-58 Score=426.86 Aligned_cols=262 Identities=27% Similarity=0.418 Sum_probs=222.6
Q ss_pred cccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC-
Q 013816 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (436)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 129 (436)
..+.++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+++++.+ +|||||++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 35778999999999999999999999999999999999877666666677899999999999 9999999999997654
Q ss_pred ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 130 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
.+|+||||++|++|.+++...+++++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||.+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~ 158 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIA 158 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhh
Confidence 4899999999999999999888999999999999999999999999999999999999997544 4899999998
Q ss_pred cccCCCC----cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 207 VFFKPGE----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
....... .....+||+.|+|||++.+ .+++++|||||||++|+|+||..||.+.+..+....+.+.....+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 7654322 3345689999999999874 5899999999999999999999999999988888888877666555566
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccc
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQ 316 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~ 316 (436)
+.+|+++.+||.+||++||.+||+..+.|.|+|.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 78999999999999999999999555555566654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=425.65 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=216.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChh---hHHHHHHHHHHHHhCC-CCCceeEEEEEEEeC
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLP-KHQNIVCLKDTYEDD 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~---~~~~~~~E~~~l~~l~-~h~niv~~~~~~~~~ 128 (436)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+....... ....+.+|+.+|+++. .|||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467899999999999999999999999999999999876543321 2234678999999983 399999999999999
Q ss_pred CeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 TAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 ~~~~lv~E~~~g-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
+.+|+||||+.+ +++.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+|+
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~--~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC--CCeEEECccccce
Confidence 999999999986 6788888888899999999999999999999999999999999999999743 3459999999998
Q ss_pred ccCCCCcccccccCCcccchhcccc-c-CCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.... ...+...||+.|+|||++.+ . ++.++|||||||++|+|+||..||.+. ..+.+....+ .+.+|
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~----~~~~s 228 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF----RQRVS 228 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCC----SSCCC
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCC----CCCCC
Confidence 7543 34456789999999999863 3 467899999999999999999999653 2344444333 24689
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
+++++||.+||+.||++|||+.|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=425.09 Aligned_cols=261 Identities=27% Similarity=0.446 Sum_probs=216.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+++|+++ +|||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence 5799999999999999999999999999999999655422 22356889999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC-
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~- 212 (436)
|||+.|+.+...... ...+++..+..++.||+.||+|||++|||||||||+|||++. ...+||+|||+|+.....
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~---~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT---EGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc---cCcceeccCCcceeccCCc
Confidence 999976544333333 356999999999999999999999999999999999999964 345899999999877543
Q ss_pred CcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCC----------
Q 013816 213 EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP---------- 280 (436)
Q Consensus 213 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------- 280 (436)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.+.........
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3445668999999999865 3468899999999999999999999998888777776655332222111
Q ss_pred ---------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 281 ---------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 281 ---------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
.+.+|+++++||.+||++||++|||+.|+|+||||++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 1356789999999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-57 Score=422.93 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=216.2
Q ss_pred ccceeeccccccCCceEEEEEEEcCC-CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC--CCCceeEEEEEEEe---
Q 013816 54 EERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED--- 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~--~h~niv~~~~~~~~--- 127 (436)
.++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+|+.|. +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 57899999999999999999999766 66799999976543322 2234567777776652 79999999999853
Q ss_pred --CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 --DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~---~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC---CCCeeecchh
Confidence 3578999999998777544433 356899999999999999999999999999999999999964 3458999999
Q ss_pred cccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-----
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----- 278 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~----- 278 (436)
+++............||+.|+|||++. ..|+.++||||+||++|+|+||+.||.+.+..+....+.+.......
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998776666667789999999999876 56999999999999999999999999999888877777653211110
Q ss_pred ------------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 279 ------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 279 ------------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
..+..+++.+++||.+||++||++|||+.|+|+||||++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 112457899999999999999999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-56 Score=416.21 Aligned_cols=257 Identities=31% Similarity=0.492 Sum_probs=216.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+++ +|||||++++++.+++..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence 58999999999999999999985 7899999999765432 23357899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
|||+.++.+..+....+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||.|.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---CCEEecccccceecccCcc
Confidence 9999887777777777889999999999999999999999999999999999999654 458999999998765432
Q ss_pred cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCC------------
Q 013816 214 KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD------------ 279 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 279 (436)
......||+.|+|||.+. ..++.++|||||||++|+|++|+.||.+.+..+....+..........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 334567899999999975 347899999999999999999999999888877777665432221111
Q ss_pred -------------CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 280 -------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 280 -------------~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
..+.+++++++||.+||++||++|||+.|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12356889999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-56 Score=413.34 Aligned_cols=248 Identities=20% Similarity=0.320 Sum_probs=210.7
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... ...+++.+|+++|+++ +|||||++++++.+.+.+|+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEE
Confidence 368999999999999999999999999999999986543 2457899999999999 89999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC---CcEEEccccceeecCC
Confidence 99999999999999764 468999999999999999999999999999999999999654 4599999999987654
Q ss_pred CCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHH
Q 013816 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (436)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 288 (436)
... .....||+.|+|||++. +.|+.++|||||||++|||++|..||...........+..... ....+..+|+++
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~l 245 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKV 245 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--CCCCCTTCCHHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC--CCCCCccchHHH
Confidence 332 23456899999999976 6799999999999999999997766554444333333333332 233345789999
Q ss_pred HHHHHHccCCCcCCCCCHHHHhc
Q 013816 289 KDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 289 ~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
++||.+||+.||++|||+.|+++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=410.57 Aligned_cols=250 Identities=22% Similarity=0.406 Sum_probs=205.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||+||+|++ +..||||++..... .....+.+.+|+.+|+++ +|||||++++++. .+.+++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEE
Confidence 36799999999999999999974 34699999976543 344678899999999999 9999999999864 556899
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCC
Q 013816 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~ 212 (436)
|||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~---~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---SSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC---CCEEEccccceeecccc
Confidence 99999999999999754 569999999999999999999999999999999999999754 45899999999876432
Q ss_pred ---CcccccccCCcccchhccc----ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-ccccCC-CCCCcc
Q 013816 213 ---EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVLDFR-RDPWPK 283 (436)
Q Consensus 213 ---~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~-~~~~~~ 283 (436)
.......||+.|||||++. +.|+.++|||||||++|||+||+.||.+.+.......+.. +..... ......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2335678999999999985 2478899999999999999999999988766554444443 322211 123456
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+|+++.+||.+||+.||++|||+.|++++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-55 Score=411.29 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=204.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc---EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+++|+++ +|||||++++++...+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 4679999999999999999999987764 58888875432 344567899999999999 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC---CCcEEECCcccceEc
Confidence 99999999999999988764 56999999999999999999999999999999999999964 456999999999876
Q ss_pred CCCCcc------cccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCC
Q 013816 210 KPGEKF------SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (436)
Q Consensus 210 ~~~~~~------~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 281 (436)
...... ....||+.|+|||++. +.++.++|||||||++|||+| |..||.+....+....+.++. ..+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---~~~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---RLPPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCC
Confidence 543221 2245789999999986 569999999999999999998 899999998888777776543 22334
Q ss_pred cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 282 ~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+++++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5789999999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=408.54 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=205.7
Q ss_pred cccccCCceEEEEEEEc--CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEEEecc
Q 013816 61 RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (436)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv~E~~ 138 (436)
++||+|+||+||+|.+. .+++.||||++..... +....+.+.+|+.+|+++ +|||||++++++.. +.+++|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcC
Confidence 46999999999999865 3457899999975543 334567899999999999 99999999999865 4678999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCCc----
Q 013816 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---- 214 (436)
Q Consensus 139 ~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---- 214 (436)
+||+|.+++.....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC---cccccchhhhhhcccccccccc
Confidence 9999999999988999999999999999999999999999999999999997654 489999999987654322
Q ss_pred ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHHHHH
Q 013816 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (436)
Q Consensus 215 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll 292 (436)
.....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+....+.++.. .+....+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHHHHHH
Confidence 13457899999999986 568999999999999999998 8999999888877777766432 223356899999999
Q ss_pred HHccCCCcCCCCCHHHHh---cCccc
Q 013816 293 RKMLDPDPKRRLTAQQVL---EHPWL 315 (436)
Q Consensus 293 ~~~l~~~p~~Rps~~e~l---~h~~~ 315 (436)
.+||+.||++|||+++++ +|+|+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999984 55554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-56 Score=419.07 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=212.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCc-----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999876554 69999886543 2234567899999999987899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013816 129 TAVHLVMELCEGGELFDRIVAR-----------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPE 185 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 185 (436)
+.+|+|||||+||+|.+++..+ ..+++..+..++.||+.||.|||+++|+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999999754 24789999999999999999999999999999999
Q ss_pred ceEeecCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCC
Q 013816 186 NFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAE 260 (436)
Q Consensus 186 NIl~~~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~ 260 (436)
|||++.+ +.+||+|||+|+....... .....||+.|||||++. +.++.++|||||||++|||+| |..||.+.
T Consensus 194 Nill~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccC---CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999654 4599999999987654332 23567899999999886 679999999999999999998 89999887
Q ss_pred CHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 261 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+.......+......+ +.+..+|+++++||.+||+.||++|||++|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKM--DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7766666666655433 3335789999999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=414.31 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=215.0
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe------
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------ 127 (436)
-++|++++.||+|+||+||+|++..+|+.||||++...... .....++.+|+.+|+++ +||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccc
Confidence 37899999999999999999999999999999998766443 23456788999999999 89999999998754
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 128 --~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+.+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~---~~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR---DGVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TSCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC---CCcEEeeecce
Confidence 4568999999988777655555677999999999999999999999999999999999999965 44599999999
Q ss_pred ccccCCCC-----cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC
Q 013816 206 SVFFKPGE-----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (436)
Q Consensus 206 a~~~~~~~-----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 278 (436)
++...... .....+||+.|+|||++. ..+++++|||||||++|+|++|+.||.+.+.......+.+....+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97665322 223467999999999975 35899999999999999999999999998888777777665443333
Q ss_pred CCCcc----------------------------cCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 279 DPWPK----------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 279 ~~~~~----------------------------~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
..+.. .++++++||.+||++||++|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 22211 36788999999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=406.76 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=212.8
Q ss_pred cceeeccc-cccCCceEEEEEEEcCC--CcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRE-LGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~-lg~G~~g~Vy~~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|.+.+. ||+|+||+||+|.++.+ +..||||++... ......+.+.+|+++|+++ +|||||++++++.. +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence 56888884 99999999999987643 457999998654 2445678899999999999 89999999999865 568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC---ceeeccchhhhccc
Confidence 9999999999999987654 5799999999999999999999999999999999999997644 48999999998775
Q ss_pred CCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+....+.++.. ....+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence 4332 23457899999999987 679999999999999999998 9999998888777777766432 2233578
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHH---hcCcccc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQV---LEHPWLQ 316 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~---l~h~~~~ 316 (436)
|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999888 5667664
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-55 Score=415.72 Aligned_cols=255 Identities=27% Similarity=0.524 Sum_probs=213.4
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe--CCeE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~--~~~~ 131 (436)
.++|++++.||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|+.+..||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 36899999999999999999999999999999998643 246788999999999669999999999984 4579
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
++|||||.+++|.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+|+....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccC
Confidence 9999999999997653 4699999999999999999999999999999999999997543 3489999999998877
Q ss_pred CCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHc-------------ccc
Q 013816 212 GEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRS-------------VLD 275 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~-~~~~~i~~~-------------~~~ 275 (436)
........||+.|+|||.+.+ .++.++||||+||++|+|++|..||...... .....+... ...
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 777777899999999999753 4799999999999999999999999765432 222222110 000
Q ss_pred --------------------CCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 --------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 --------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.....+..+++++++||.+||++||++|||++|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01112235789999999999999999999999999999998743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=403.70 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=202.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|.+. +++.||||++.... ...+++.+|+++++++ +|||||++++++..++.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence 46999999999999999999975 57889999987543 2346799999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---GCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---CCeEecccchheeccCCC
Confidence 9999999999988755 568999999999999999999999999999999999999754 459999999998765433
Q ss_pred c--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .....||+.|+|||++. +.++.++|||||||++|||+| |.+||...+..+....+..+... .....+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---CCCTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHH
Confidence 2 23467899999999987 569999999999999999999 56777777777777777665332 22346789999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+|+.+||+.||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=416.96 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=213.6
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe------
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~------ 127 (436)
.-+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+++ +||||++++++|..
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCS
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCC
Confidence 3479999999999999999999999999999999976532 234799999999 99999999999854
Q ss_pred CCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeec
Q 013816 128 DTAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (436)
Q Consensus 128 ~~~~~lv~E~~~g~~L~~~---l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG 204 (436)
..++|+|||||+++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~DFG 168 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCDFG 168 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECCCT
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEeccc
Confidence 3457999999987643332 23455799999999999999999999999999999999999997543 358999999
Q ss_pred cccccCCCCcccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc-------
Q 013816 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------- 275 (436)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~------- 275 (436)
+++............||+.|+|||.+. ..++.++||||+||++|||++|+.||...+..+....+.+....
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 999887777677789999999999865 35899999999999999999999999988887776666542110
Q ss_pred ----------CC--------CCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 ----------FR--------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 ----------~~--------~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
++ ....+..++++.+||.+||++||++|||+.|+|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 011245789999999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=405.16 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=211.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++++.||+|+||+||+|.++ +++.||||++.... ...+.+.+|+.+|+++ +|||||++++++. ++.+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~-~~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhC-CCCCEeEEEeeec-cCCeEE
Confidence 468999999999999999999975 67889999986543 2357899999999999 9999999999875 456789
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++|+|.+++... .++++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~---~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec---ccceeeccccceEEccC
Confidence 99999999999877543 35999999999999999999999999999999999999964 45599999999998765
Q ss_pred CCc--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
... .....||+.|+|||++. +.++.++|||||||++|||+|| .+||......+....+..+.. ......++++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---~~~p~~~~~~ 238 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNCPEE 238 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCcccChHH
Confidence 432 24567899999999987 5699999999999999999995 555666666666666665432 2223568999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc--Cccccc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE--HPWLQN 317 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~--h~~~~~ 317 (436)
+.+|+.+||+.||++|||+.++++ |+||..
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999998 777753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=397.63 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=215.4
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|+++ +++.||||++.+... ..+.+.+|+.+++++ +|||||++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence 46899999999999999999984 788999999976533 346899999999999 899999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||+|+......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~---~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT---TCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC---CCcEEECcchhheeccCCC
Confidence 999999999988655 456899999999999999999999999999999999999964 4569999999998765443
Q ss_pred c--ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 214 ~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
. .....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+..++...+.++.. ...+...++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---LYRPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCCCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccccHHHH
Confidence 2 23467899999999987 568999999999999999998 8999999998888887776532 223356889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+||.+||+.||++|||+.++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=416.92 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=212.4
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+++|+.+ +|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 36789999999999999999999999999999999997643 3445567899999999999 8999999999997654
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecc
Q 013816 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (436)
Q Consensus 130 ----~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~ 205 (436)
.+|+||||+ |.+|...+. +..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~---~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc---ccccccccccc
Confidence 579999999 557766654 467999999999999999999999999999999999999964 45589999999
Q ss_pred ccccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHcccc--------
Q 013816 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (436)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~-------- 275 (436)
|+... ...+...||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 168 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 98764 34456789999999998753 4789999999999999999999999888776655544332111
Q ss_pred ---------------CCCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCc
Q 013816 276 ---------------FRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAK 319 (436)
Q Consensus 276 ---------------~~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~ 319 (436)
.... ..+.+++++++||.+||+.||++|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1111 1245789999999999999999999999999999998743
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=403.13 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=220.0
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~lv 134 (436)
++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.+ +||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence 589999999999999999999999999999999976543 334567899999999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC-
Q 013816 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~- 213 (436)
+|++.|++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+ ..+||+|||.|+......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---CceeeeecchhhcccCCCc
Confidence 9999999999888888899999999999999999999999999999999999999654 458999999998775433
Q ss_pred cccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHccccCCC------------
Q 013816 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFW-AETEQGVAQAIIRSVLDFRR------------ 278 (436)
Q Consensus 214 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~------------ 278 (436)
......+++.|+|||++.. .++.++|||||||++|+|++|..||. +.+..+....+.........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344567889999998763 37899999999999999999999864 44555555554432221111
Q ss_pred -------------CCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccC
Q 013816 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNA 318 (436)
Q Consensus 279 -------------~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~ 318 (436)
...+.+++.+++||.+||++||.+||||+|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1123568899999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=414.16 Aligned_cols=261 Identities=29% Similarity=0.474 Sum_probs=212.1
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|++| +||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeecccc
Confidence 45678999999999999999999999999999999997543 344567889999999999 9999999999987653
Q ss_pred ---eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 130 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 130 ---~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
.+|++ +|+.||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~---~~~~kl~DfG~a 156 (345)
T d1pmea_ 82 QMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TCDLKICDFGLA 156 (345)
T ss_dssp TCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTC
T ss_pred ccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC---CCCEEEcccCce
Confidence 34555 556689999998764 7999999999999999999999999999999999999964 446999999999
Q ss_pred cccCCCC----cccccccCCcccchhccc--ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC----
Q 013816 207 VFFKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---- 276 (436)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~---- 276 (436)
....... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||.+.................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 8664332 234567999999999975 357889999999999999999999998877655544443211110
Q ss_pred -------------------CCC----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 277 -------------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 277 -------------------~~~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
... .++.+|+++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 001 13467899999999999999999999999999999986543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=414.14 Aligned_cols=260 Identities=32% Similarity=0.569 Sum_probs=221.2
Q ss_pred cceeeccccccCCceEEEEEEE---cCCCcEEEEEEeeccccC-ChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTD---RENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~i~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++|++++.||+|+||+||+|++ +.+|+.||||++.+.... .....+.+.+|+++++++.+||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999997 346899999998765432 222345688999999999444899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++++|||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---CCEEEeeccchhhhc
Confidence 99999999999999999998899999999999999999999999999999999999999654 459999999998764
Q ss_pred CC--CcccccccCCcccchhcccc---cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 211 PG--EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 211 ~~--~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.. .......||+.|+|||.+.+ .++.++|||||||+||+|+||..||.+.........+.+............+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 33 23355789999999999753 47889999999999999999999998876665555565554444444456799
Q ss_pred HHHHHHHHHccCCCcCCCC-----CHHHHhcCccccc
Q 013816 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLEHPWLQN 317 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rp-----s~~e~l~h~~~~~ 317 (436)
+++++||.+||++||++|| |++|+|+||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=395.28 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=202.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
.++|++++.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.+|+++ +|||||++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence 468999999999999999999987553 56888887543 3444567899999999999 9999999999985 567
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||+++.++ .+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC---cEEEccchhheec
Confidence 89999999999999987654 5699999999999999999999999999999999999997654 4999999999876
Q ss_pred CCCC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccC
Q 013816 210 KPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (436)
Q Consensus 210 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 285 (436)
.... ......||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..+....+.++.. .+.++.+|
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 5432 234567899999999987 579999999999999999998 8999999888888887776542 23446789
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-54 Score=394.69 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=206.8
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~l 133 (436)
.++|++.+.||+|+||+||+|+++.+ +.||||++..... ..+.+.+|+.+++++ +|||||++++++. .+.+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEE
Confidence 36899999999999999999998654 6799999965432 347899999999999 9999999999985 456789
Q ss_pred EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++|+|...+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~---~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC---CcEEEcccchhhhccC
Confidence 9999999999988854 3569999999999999999999999999999999999999654 4599999999987654
Q ss_pred CC--cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHccccCCCCCCcccCHH
Q 013816 212 GE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (436)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 287 (436)
.. ......||+.|+|||++. +.++.++|||||||++|||+||..| +......+....+.++. ..+..+.++++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CCCCCcccCHH
Confidence 33 224467899999999986 6799999999999999999996554 55566666666665543 22344678999
Q ss_pred HHHHHHHccCCCcCCCCCHHHHhc--CcccccCc
Q 013816 288 AKDLVRKMLDPDPKRRLTAQQVLE--HPWLQNAK 319 (436)
Q Consensus 288 ~~~ll~~~l~~~p~~Rps~~e~l~--h~~~~~~~ 319 (436)
+++||.+||+.||++|||+.++++ ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999988 88997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=410.57 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=215.3
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~---- 128 (436)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.. ......+.+.+|+++|+++ +|||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccc
Confidence 4578999999999999999999999999999999997653 3445567889999999999 899999999998633
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccc
Q 013816 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~ 207 (436)
...+++|+|+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~---~~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc---ccccccccchhc
Confidence 334566777889999998854 579999999999999999999999999999999999999654 458999999997
Q ss_pred ccCCCCcccccccCCcccchhcccc--cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccCCC-------
Q 013816 208 FFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------- 278 (436)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~------- 278 (436)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.+.......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 653 34456789999999998653 4689999999999999999999999998887777766554322110
Q ss_pred ----------------C----CCcccCHHHHHHHHHccCCCcCCCCCHHHHhcCcccccCcc
Q 013816 279 ----------------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKK 320 (436)
Q Consensus 279 ----------------~----~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 320 (436)
. .+..+++++++||.+||+.||++|||+.|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0 12357899999999999999999999999999999987544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=408.21 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=203.2
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-----
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----- 127 (436)
+.++|+++++||+|+||+||+|+++.+|+.||||++.+... +......+.+|+.+|+++ +|||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccc
Confidence 45789999999999999999999999999999999976543 445567899999999999 89999999999953
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccc
Q 013816 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (436)
Q Consensus 128 -~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a 206 (436)
...+|+|||||.|+ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---~~~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC-
T ss_pred cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---cceeeechhhh
Confidence 47899999999765 44444 3468999999999999999999999999999999999999653 45899999999
Q ss_pred cccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHccccC---------
Q 013816 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------- 276 (436)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--------- 276 (436)
+............||+.|+|||++. ..+++++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 8877666667788999999999986 468999999999999999999999999888776665554322110
Q ss_pred -------------CCCC----------------CcccCHHHHHHHHHccCCCcCCCCCHHHHhcCccccc
Q 013816 277 -------------RRDP----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQN 317 (436)
Q Consensus 277 -------------~~~~----------------~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~ 317 (436)
.... ....++++++||.+||++||++||||+|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0124678899999999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=391.93 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=201.3
Q ss_pred cceeeccccccCCceEEEEEEEcCCC----cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
+.|++.+.||+|+||+||+|.++.++ ..||||++.... .......+.+|+++|+++ +|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence 46999999999999999999987655 479999986542 344556799999999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++||||+.++++.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC---CCeEEEcccchhhcc
Confidence 99999999999999888765 56999999999999999999999999999999999999964 456999999999876
Q ss_pred CCCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHccccCCCCCCcc
Q 013816 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (436)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 283 (436)
..... .....||+.|+|||++. +.++.++|||||||++|||+|| .+|+...+..+....+..+. ..+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---~~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC---CCCCchh
Confidence 54322 23456899999999987 5699999999999999999995 45555566666666555442 2233356
Q ss_pred cCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 284 VSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 284 ~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
+++++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=401.06 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=209.9
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcE--EEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
++|++.+.||+|+||+||+|+++.+|.. ||||.+.... .....+.+.+|+++|.++.+|||||++++++.+.+.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 6799999999999999999999888875 6677765332 33345679999999999867999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 013816 133 LVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~ 196 (436)
+||||++||+|.+++..+ ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ .
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~---~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---Y 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---G
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC---C
Confidence 999999999999998653 468999999999999999999999999999999999999654 4
Q ss_pred CeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHccc
Q 013816 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVL 274 (436)
Q Consensus 197 ~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~ 274 (436)
.+||+|||+|+............||+.|+|||.+. +.++.++|||||||++|||++|. +||.+.+..+....+.++.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~- 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence 58999999998765444445567999999999986 56999999999999999999965 6788888777777665542
Q ss_pred cCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 275 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
....+..+++++++||.+||+.||++|||+.|+++|
T Consensus 244 --~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 233445789999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=391.96 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=203.2
Q ss_pred cceeeccccccCCceEEEEEEEcC-CC--cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRE-NG--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
++|++.+.||+|+||.||+|++.. ++ ..||||++.+.........+.+.+|+.+|+++ +|||||++++++.+ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 579999999999999999998643 33 46899998776655555677899999999999 99999999999965 467
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+++|++.+.+..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc---ceeeccchhhhhcc
Confidence 8999999999999877654 5699999999999999999999999999999999999998654 49999999999875
Q ss_pred CCCc----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 211 PGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
.... .....||+.|+|||++. ..++.++|||||||++|||+| |..||.+.+..+....+.+....+ +.++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCcccc
Confidence 4432 23456788999999987 568999999999999999998 899999999998888887765433 334678
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
|+++++||.+||+.||++|||+.++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999964
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=397.06 Aligned_cols=248 Identities=20% Similarity=0.273 Sum_probs=205.2
Q ss_pred cceeeccccccCCceEEEEEEEcCCCc----EEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCe
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 130 (436)
++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+++++ +|||||++++++.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-C
Confidence 469999999999999999999988876 57888775432 233467899999999999 899999999999865 5
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeecccccc
Q 013816 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (436)
Q Consensus 131 ~~lv~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~ 209 (436)
.++++||+.+++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC---CeEeeccccceec
Confidence 67888999999999888764 5799999999999999999999999999999999999997644 4899999999877
Q ss_pred CCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCccc
Q 013816 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (436)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 284 (436)
..... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..+....+..+.. .+..+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---CCCCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccc
Confidence 54332 23456899999999876 569999999999999999998 8999988887777766665432 2233578
Q ss_pred CHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 285 SENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 285 ~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++++.+|+.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=393.77 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=200.1
Q ss_pred ccceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||.||+|.+.. +++.||||++.... .....+.+.+|+.++.++.+||||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3689999999999999999999754 34689999986542 3345677888999999887899999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 013816 129 -TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (436)
Q Consensus 129 -~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~ 191 (436)
..+++|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 5689999999999999999653 24889999999999999999999999999999999999965
Q ss_pred CCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 013816 192 KKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVA 266 (436)
Q Consensus 192 ~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~ 266 (436)
+ +.+||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||+|| ..||.+....+..
T Consensus 170 ~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 K---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp G---GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred C---CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 459999999998664332 234568999999999987 5689999999999999999986 5678766554444
Q ss_pred HHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 267 ~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
..+....... .....+++++++||.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444433222 2335689999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-52 Score=390.86 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=212.7
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||+||+|+++ .+++.||||++.... .....+.+.+|+++|+++ +||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence 468999999999999999999975 356789999986542 344567899999999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013816 129 TAVHLVMELCEGGELFDRIVARG------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp 184 (436)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999986432 378899999999999999999999999999999
Q ss_pred CceEeecCCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCC-CCCCC
Q 013816 185 ENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWA 259 (436)
Q Consensus 185 ~NIl~~~~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~-~pf~~ 259 (436)
+|||++.+ +.+||+|||+|+...+.. ......||+.|+|||.+. ..++.++|||||||++|||++|. +||.+
T Consensus 169 ~NILld~~---~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEECCC---CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999654 459999999998664432 224567899999999987 56999999999999999999985 68988
Q ss_pred CCHHHHHHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 260 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.+..+....+.++.. ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 246 ~~~~e~~~~v~~~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888888776543 2223578999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=384.65 Aligned_cols=242 Identities=23% Similarity=0.351 Sum_probs=199.8
Q ss_pred cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE-eCCeEEE
Q 013816 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHL 133 (436)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~-~~~~~~l 133 (436)
++|++++.||+|+||.||+|.+ +|..||||+++.+. ..+.+.+|+++++++ +|||||++++++. .++.+|+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEE
Confidence 5799999999999999999997 47899999996532 347799999999999 9999999999885 4567899
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCC
Q 013816 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (436)
Q Consensus 134 v~E~~~g~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~ 211 (436)
||||+++|+|.+++..+. .+++..+..++.||+.||.|||+++|+||||||+|||++. .+.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~---~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC---CCCEeecccccceecCC
Confidence 999999999999996543 4899999999999999999999999999999999999964 44589999999987543
Q ss_pred CCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHccccCCCCCCcccCHHHH
Q 013816 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (436)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 289 (436)
......+|+.|+|||++. +.+++++|||||||++|||+| |++||...+..+....+.++. ..+..+.+++++.
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~ 230 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVY 230 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHHH
T ss_pred --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCccCCHHHH
Confidence 234457899999999986 679999999999999999998 789998888877777775542 2233356889999
Q ss_pred HHHHHccCCCcCCCCCHHHHhcC
Q 013816 290 DLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 290 ~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
+||.+||+.||.+|||+.+++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHH
Confidence 99999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=387.93 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=209.5
Q ss_pred ccceeeccccccCCceEEEEEEEcCCC-------cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEE
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 126 (436)
.++|++++.||+|+||.||+|++..++ ..||||++.+.. .......+.+|...+.++.+|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999976554 479999987543 34456788999999999878999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 127 ~~~~~~lv~E~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
+++.+++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 999999999999999999999754 2489999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEEeeccccccCCCC---cccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
.+ +.+||+|||+++...... ......||+.|+|||.+. +.|+.++|||||||++|||+| |.+||.+.+....
T Consensus 170 ~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 ED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TT---CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CC---CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 54 458999999998765432 234467899999999986 679999999999999999998 7999988888877
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+..+. .......+++++++||.+||+.||++|||+.|+++
T Consensus 247 ~~~i~~~~---~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 247 FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTC---CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCC---CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 76665542 22333578999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=386.53 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=213.0
Q ss_pred ccceeeccccccCCceEEEEEEEc-----CCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 478999999999999999999863 456799999997543 3445678999999999997799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 013816 129 TAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~ 190 (436)
..+++|||||+||+|.+++.... .+++..+..++.||+.||+|||+++++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987543 588999999999999999999999999999999999997
Q ss_pred cCCCCCCeEEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHh-CCCCCCCCCHHHH
Q 013816 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (436)
Q Consensus 191 ~~~~~~~ikl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~llt-g~~pf~~~~~~~~ 265 (436)
.+ +.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||......+.
T Consensus 180 ~~---~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 HG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp TT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cc---CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 54 4589999999987654332 24468899999999987 568999999999999999998 6666766666566
Q ss_pred HHHHHHccccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 266 ~~~i~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
...+....... .....+|+++.+||.+||+.||++|||+.++++
T Consensus 257 ~~~~i~~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCC--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66665544332 233468999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=385.35 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=206.6
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+.++|++++.||+|+||+||+|++..+|+.||||++...... +.+.+|+++++.+..|++|+.+..++.+.+.+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 3567899999999999999999999999999999998764322 35788999999995455667777778899999
Q ss_pred EEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccC
Q 013816 132 HLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~ 210 (436)
++||||+.+ +|.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++..+....+||+|||+|+...
T Consensus 79 ~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999999954 6655554 45679999999999999999999999999999999999999776667789999999998775
Q ss_pred CCC--------cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---ccccCC-
Q 013816 211 PGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVLDFR- 277 (436)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~~~~~~~i~~---~~~~~~- 277 (436)
... ......||+.|+|||++.+ .++.++|||||||++|||+||..||...........+.. .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 432 2245689999999999874 589999999999999999999999987655443332221 111111
Q ss_pred CCCCcccCHHHHHHHHHccCCCcCCCCCHHH---HhcCccccc
Q 013816 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ---VLEHPWLQN 317 (436)
Q Consensus 278 ~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e---~l~h~~~~~ 317 (436)
....+.+|+++.+|+.+||+.+|++||++.+ +|+|+|.+.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 1123468999999999999999999999874 467776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=382.76 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=213.8
Q ss_pred ccceeeccccccCCceEEEEEEEcC-----CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
.++|++++.||+|+||+||+|.+.. +++.||||++.... .......+.+|+.+++++ +|||||++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecC
Confidence 3789999999999999999998752 35789999987542 344556799999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCe
Q 013816 129 TAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~i 198 (436)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ...+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~---~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT---TCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC---CceE
Confidence 9999999999999999988642 24688999999999999999999999999999999999964 4569
Q ss_pred EEEeeccccccCCCCc---ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHcc
Q 013816 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSV 273 (436)
Q Consensus 199 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg-~~pf~~~~~~~~~~~i~~~~ 273 (436)
||+|||+|+....... .....||+.|+|||.+. +.++.++||||||+++|||+|| ..||.+.+..+....+.++.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999986643322 23457899999999987 5688899999999999999998 58888888888888777654
Q ss_pred ccCCCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 274 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
. ....+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 253 ~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 253 L---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 22235689999999999999999999999999983
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=375.69 Aligned_cols=245 Identities=20% Similarity=0.278 Sum_probs=199.5
Q ss_pred eccccccCCceEEEEEEEcCCC---cEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEe-CCeEEEE
Q 013816 59 LGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHLV 134 (436)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~lv 134 (436)
..++||+|+||+||+|++..++ ..||||++... ......+++.+|+++|+++ +|||||++++++.. ++.+++|
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence 3578999999999999986543 36899998643 3455678899999999999 89999999999765 5689999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEEeeccccccCCCC
Q 013816 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (436)
Q Consensus 135 ~E~~~g~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~~~~~~ 213 (436)
||||++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++. ...+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~---~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC---CCCEEEecccchhhccccc
Confidence 9999999999988755 35778899999999999999999999999999999999964 4569999999998765432
Q ss_pred c-----ccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHccccCCCCCCcccCH
Q 013816 214 K-----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPWPKVSE 286 (436)
Q Consensus 214 ~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 286 (436)
. .....||+.|+|||.+. +.++.++||||||+++|||+||..||.... ..+....+..+.. ....+.+++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~---~~~p~~~~~ 261 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQPEYCPD 261 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC---CCCCTTCCH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCcccCcH
Confidence 2 23357899999999976 679999999999999999999877776543 3334444444432 222346789
Q ss_pred HHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 287 NAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 287 ~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
++.+||.+||+.||++|||+.|+++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-49 Score=369.47 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=207.5
Q ss_pred cccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeEE
Q 013816 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (436)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 132 (436)
+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.|.+|+|++.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 56789999999999999999999999999999999865432 2456789999999966799999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCeEEEeecccccc
Q 013816 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFF 209 (436)
Q Consensus 133 lv~E~~~g~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~--~~~~ikl~DfG~a~~~ 209 (436)
+||||+ |++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++... ....+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 679999887654 699999999999999999999999999999999999997532 3456999999999876
Q ss_pred CCCC--------cccccccCCcccchhcccc-cCCCCCchhHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHccccC-
Q 013816 210 KPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDF- 276 (436)
Q Consensus 210 ~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~- 276 (436)
.... ......||+.|||||++.+ .+++++|||||||++|+|+||..||.+... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2345689999999999874 599999999999999999999999975433 22233332221111
Q ss_pred CCCCCcccCHHHHHHHHHccCCCcCCCCCHHHHhc
Q 013816 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLE 311 (436)
Q Consensus 277 ~~~~~~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~ 311 (436)
.....+.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11122468899999999999999999999877644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=366.56 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=189.1
Q ss_pred ccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHH--HHHHHHHhCCCCCceeEEEEEEEeCC--
Q 013816 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (436)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~--~E~~~l~~l~~h~niv~~~~~~~~~~-- 129 (436)
.++|.+.+.||+|+||.||+|++ +|+.||||++.... ...+. .|+..+..+ +|||||++++++...+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVML-RHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCc
Confidence 46799999999999999999986 58999999986432 23333 455555677 8999999999987654
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCceEeecCCCCCCeE
Q 013816 130 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--------HGVMHRDLKPENFLFANKKETAPLK 199 (436)
Q Consensus 130 --~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~~iiH~dlkp~NIl~~~~~~~~~ik 199 (436)
.+|+||||+++|+|.+++.+. .+++..+..++.|++.||.|+|+ +||+||||||+|||++. .+.+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~---~~~~K 148 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCC 148 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT---TSCEE
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC---CCCeE
Confidence 689999999999999999765 68999999999999999999996 59999999999999964 45699
Q ss_pred EEeeccccccCCCC-----cccccccCCcccchhccccc-------CCCCCchhHHHHHHHHHHhCCCCCCCC-------
Q 013816 200 AIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAE------- 260 (436)
Q Consensus 200 l~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~~lltg~~pf~~~------- 260 (436)
|+|||+++...... ......||+.|+|||++.+. ++.++|||||||+||||+||..||...
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 99999998775432 22356899999999998642 566899999999999999998876321
Q ss_pred --------CHHHHHHHHHHccccCCCCC-C--cccCHHHHHHHHHccCCCcCCCCCHHHHhcC
Q 013816 261 --------TEQGVAQAIIRSVLDFRRDP-W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLEH 312 (436)
Q Consensus 261 --------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~ll~~~l~~~p~~Rps~~e~l~h 312 (436)
........+.........+. + ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12222222222222111110 0 1123468999999999999999999999774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-47 Score=364.58 Aligned_cols=265 Identities=25% Similarity=0.439 Sum_probs=200.0
Q ss_pred ccccc-cceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCC----------CCCce
Q 013816 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNI 118 (436)
Q Consensus 50 ~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~----------~h~ni 118 (436)
|+.+. +||+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.+. .||||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 44444 57999999999999999999999999999999997542 23467788999988872 35889
Q ss_pred eEEEEEEEe--CCeEEEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecC
Q 013816 119 VCLKDTYED--DTAVHLVMELCEGGELFDRI---VARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANK 192 (436)
Q Consensus 119 v~~~~~~~~--~~~~~lv~E~~~g~~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~NIl~~~~ 192 (436)
+++++++.. ....+++|+++.++...... .....+++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999988754 46677777776654433222 233568999999999999999999998 899999999999999754
Q ss_pred CCC---CCeEEEeeccccccCCCCcccccccCCcccchhccc-ccCCCCCchhHHHHHHHHHHhCCCCCCCCCHH-----
Q 013816 193 KET---APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----- 263 (436)
Q Consensus 193 ~~~---~~ikl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~~lltg~~pf~~~~~~----- 263 (436)
+.. ..++++|||.|.... ......+||+.|+|||++. ..++.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 432 248999999997654 3335668999999999876 56899999999999999999999999654321
Q ss_pred -HHHHHHHHccc------------------------cC--------------CCCCCcccCHHHHHHHHHccCCCcCCCC
Q 013816 264 -GVAQAIIRSVL------------------------DF--------------RRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (436)
Q Consensus 264 -~~~~~i~~~~~------------------------~~--------------~~~~~~~~~~~~~~ll~~~l~~~p~~Rp 304 (436)
........... .. ....+...++++++||.+||++||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111111000 00 0011123467899999999999999999
Q ss_pred CHHHHhcCcccccCcc
Q 013816 305 TAQQVLEHPWLQNAKK 320 (436)
Q Consensus 305 s~~e~l~h~~~~~~~~ 320 (436)
|++|+|+||||++...
T Consensus 321 ta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDTLG 336 (362)
T ss_dssp CHHHHHTCGGGTTCTT
T ss_pred CHHHHhcCcccCCCCC
Confidence 9999999999996543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.2e-27 Score=205.01 Aligned_cols=167 Identities=21% Similarity=0.237 Sum_probs=123.7
Q ss_pred eeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccC-----C----------hhhHHHHHHHHHHHHhCCCCCceeEE
Q 013816 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----T----------AVDIEDVRREVDIMRHLPKHQNIVCL 121 (436)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~-----~----------~~~~~~~~~E~~~l~~l~~h~niv~~ 121 (436)
+.+.+.||+|+||+||+|++. +|+.||||+++..... . ........+|+..+.++ .|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 467899999999999999984 7999999987532110 0 11123456788999999 89999988
Q ss_pred EEEEEeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCeEEE
Q 013816 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (436)
Q Consensus 122 ~~~~~~~~~~~lv~E~~~g~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~NIl~~~~~~~~~ikl~ 201 (436)
+++. . .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++.+ .++|+
T Consensus 80 ~~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~----~~~li 144 (191)
T d1zara2 80 YAWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWII 144 (191)
T ss_dssp EEEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT----EEEEC
T ss_pred EEec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC----CEEEE
Confidence 8653 2 269999999876532 4556677899999999999999999999999999999743 28999
Q ss_pred eeccccccCCCCcccccccCCcccc------hhcccccCCCCCchhHHHHHH
Q 013816 202 DFGLSVFFKPGEKFSEIVGSPYYMA------PEVLKRNYGPEVDVWSAGVIL 247 (436)
Q Consensus 202 DfG~a~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~DiwSlG~il 247 (436)
|||.|........ ..|.. .+.+.+.|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999976542211 11222 123346789999999986443
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.39 E-value=3.3e-13 Score=97.21 Aligned_cols=73 Identities=22% Similarity=0.341 Sum_probs=66.6
Q ss_pred HHHhhchhhhhhhhhhhccccCCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 350 VIAQHLSVEEVAGIKEGFHMMDIGN-RGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 350 ~i~~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....+++++...++++|+.+|.++ +|+|+..||+.+|+++|..++++|++++++++|.||+ |+|+||...+.
T Consensus 4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl~im~ 79 (82)
T d1wrka1 4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMV 79 (82)
T ss_dssp HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 3445778899999999999999995 7999999999999999999999999999999999887 99999987764
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.35 E-value=8.2e-13 Score=95.06 Aligned_cols=69 Identities=25% Similarity=0.380 Sum_probs=64.5
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.++.+++..++++|..+|.+++|+|+..||+.+|+.+|..+++.|+++|+..+|.|++ |+|+||...+.
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~~~m~ 77 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMV 77 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 4578888999999999999999999999999999999999999999999999999887 99999987664
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.34 E-value=4.6e-13 Score=95.58 Aligned_cols=69 Identities=26% Similarity=0.432 Sum_probs=64.5
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..++++++..++++|..+|.+++|+|+.+||+.+|+.+|..++++++.+++..+|.+++ |+|+||...+
T Consensus 2 ~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~~~m 72 (77)
T d1f54a_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALM 72 (77)
T ss_dssp CCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 35678889999999999999999999999999999999999999999999999999987 9999998765
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.31 E-value=1.8e-12 Score=93.23 Aligned_cols=64 Identities=22% Similarity=0.362 Sum_probs=59.7
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
++++..++++|+.+|.|++|+|+..||+.+|+.+| .++++|+++++..+|.||+ |+|+||...+
T Consensus 2 ~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~~ 67 (81)
T d2opoa1 2 PQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFTDFA 67 (81)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 56788999999999999999999999999999999 5899999999999999988 9999997655
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.31 E-value=1.1e-12 Score=92.45 Aligned_cols=68 Identities=25% Similarity=0.433 Sum_probs=63.9
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++++++..++++|+.+|.+++|+|+..|++.+++.+|..++++++..+++.+|.|++ |+|+||...+.
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHh
Confidence 467888999999999999999999999999999999999999999999999999987 99999987664
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.29 E-value=9.6e-13 Score=95.99 Aligned_cols=71 Identities=38% Similarity=0.629 Sum_probs=65.7
Q ss_pred HHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 349 KVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 349 ~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
..|+..++.+++..++++|+.+|.+++|+|+.+||+.+|+.+|..++++|++++++.+|.|++ |+|+||..
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl~ 83 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIA 83 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHTT
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHHH
Confidence 345667788888899999999999999999999999999999999999999999999999988 99999964
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.26 E-value=4.1e-12 Score=89.78 Aligned_cols=63 Identities=22% Similarity=0.358 Sum_probs=58.7
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+.++.+|+.+|.+++|+|+..||+.+|+.+|..++++++++|+..+|.|++ |+|+||...+.
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~~~m~ 72 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFLKMME 72 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 3478899999999999999999999999999999999999999999999987 99999987653
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.23 E-value=5.3e-12 Score=89.92 Aligned_cols=67 Identities=21% Similarity=0.366 Sum_probs=61.5
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
+..+.++++|..+|.+++|+|+.+||+.+|+.+|..++..++.++++.+|.|++ |+|+||...+...
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~ 74 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKT 74 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHT
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHHcc
Confidence 445679999999999999999999999999999999999999999999999988 9999998877544
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.23 E-value=3.5e-12 Score=87.47 Aligned_cols=60 Identities=23% Similarity=0.401 Sum_probs=56.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
+.++++|+.+|.+++|+|+.+|++.+++.+|..++++|++++++.+|.|++ |+|+||...
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~~~ 64 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQM 64 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHHHH
Confidence 468899999999999999999999999999999999999999999999887 999999764
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=6.3e-12 Score=84.95 Aligned_cols=57 Identities=26% Similarity=0.488 Sum_probs=54.8
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFR 418 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~ 418 (436)
+++++|..+|.+++|+|+..||+.+|+.+|..+++++++.|++.+|.|++ |+|+||+
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhc
Confidence 57889999999999999999999999999999999999999999999987 9999996
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.20 E-value=1.3e-11 Score=85.24 Aligned_cols=61 Identities=18% Similarity=0.288 Sum_probs=56.9
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.++++|+.+|.|++|+|+..|++.+++.+|..+++++++++++.+|.|++ |+|+||...+.
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m~ 64 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFTSCIE 64 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHHHHHH
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 46789999999999999999999999999999999999999999999988 99999977654
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.18 E-value=9.7e-12 Score=89.29 Aligned_cols=63 Identities=25% Similarity=0.432 Sum_probs=58.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...++++|..+|.+++|+|+.+||+.+++.+|..++++|+++++..+|.|++ |+|+||...++
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~~~m~ 78 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMK 78 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHHHHHS
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHHHHHH
Confidence 3468899999999999999999999999999999999999999999999887 99999987654
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.18 E-value=3.8e-12 Score=88.03 Aligned_cols=62 Identities=23% Similarity=0.478 Sum_probs=57.1
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+.++++|+.+|.+++|+|+.+||+.+|+.+|.. +|++|++.|++.+|.||+ |+|+||...+.
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 458899999999999999999999999999885 799999999999999988 99999987654
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=5.9e-11 Score=97.65 Aligned_cols=75 Identities=16% Similarity=0.201 Sum_probs=67.5
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHH----HHHHHHhHHhhhhcCC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFRE----KVRLKISFFRWYEIGG 435 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~----~~~~~~~f~~~d~~~~ 435 (436)
..++.+|+.+|.|++|+|+.+||+.+++.+|..+++++++.++..+|.||.|+|+||+. ...+..+|+.+|+||.
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~~g~i~~~eFi~~~~~l~~~~~~F~~~D~d~~ 148 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKNGRIFFDDYVACCVKLRALTDFFRKRDHLQQ 148 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBTTBCBHHHHHHHHHHHHHHHHHHHTTCTTCC
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 46788999999999999999999999999999999999999999999999999999954 3345678999999874
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=99.08 E-value=9.9e-11 Score=94.07 Aligned_cols=79 Identities=18% Similarity=0.376 Sum_probs=69.6
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHH-----------HHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFRE-----------KVRL 423 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~-----------~~~~ 423 (436)
++++++.+++++|..+|.+++|.|+.+|+..+|+.+|..++++|+.+++. +.+|.|+|+||.. ...+
T Consensus 1 L~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~--~~~~~i~~~eF~~~~~~~~~~~~~~~~l 78 (142)
T d1wdcb_ 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK--EAPGPLNFTMFLSIFSDKLSGTDSEETI 78 (142)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT--TSSSCCCHHHHHHHHHHHTCSCCCHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH--hccCccccccccccccccccccchhhhH
Confidence 35788999999999999999999999999999999999999999999986 4456699999954 3457
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..||+.||+||+
T Consensus 79 ~~aF~~~D~d~~ 90 (142)
T d1wdcb_ 79 RNAFAMFDEQET 90 (142)
T ss_dssp HHHHHTTCTTCC
T ss_pred HHhhhhhcccCC
Confidence 789999999985
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=99.07 E-value=8.1e-11 Score=89.37 Aligned_cols=63 Identities=27% Similarity=0.371 Sum_probs=57.3
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
...++.+|+.+|.|++|+|+.+||+.+++.+ |..++++|+++|++++|.|++ |+|+||...+.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (109)
T d5pala_ 40 DAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFAKMVA 107 (109)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHHHHHHHHH
Confidence 4578999999999999999999999999886 788999999999999999887 99999987653
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=99.00 E-value=1.6e-10 Score=87.68 Aligned_cols=62 Identities=21% Similarity=0.397 Sum_probs=56.4
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...++.+|+.+|.|++|+|+.+||+.+++.+ |..++++|+++|++.+|.||+ |+|+||...+
T Consensus 40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~EF~~~m 106 (109)
T d1pvaa_ 40 ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFETLV 106 (109)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHHHHHHHH
Confidence 3567889999999999999999999999987 678999999999999999988 9999997765
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.95 E-value=4.7e-10 Score=84.79 Aligned_cols=65 Identities=17% Similarity=0.362 Sum_probs=57.6
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++.+|+.+|.+++|+|+.+|++.+++.+ +..++++++++|++.+|.|++ |+|+||+..+.
T Consensus 37 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~~~m~ 106 (107)
T d2pvba_ 37 KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFAAMIK 106 (107)
T ss_dssp SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHHHHHHHc
Confidence 344578999999999999999999999999998 456899999999999999877 99999987653
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.95 E-value=6.2e-10 Score=89.70 Aligned_cols=82 Identities=24% Similarity=0.389 Sum_probs=72.8
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------H
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-----------K 420 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-----------~ 420 (436)
.++.++...++++|+.+|.+++|+|+.+|+..++...|..++..++..++..+|.+++ |+|+||.. .
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~ 81 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLSLMARKMKEQDSE 81 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHHHHHHHHhhccChH
Confidence 3567788899999999999999999999999999999999999999999999998776 99999943 2
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..+..+|+.+|+||+
T Consensus 82 ~~~~~~F~~~D~d~~ 96 (146)
T d1exra_ 82 EELIEAFKVFDRDGN 96 (146)
T ss_dssp HHHHHHHHHHSTTCS
T ss_pred HHHHHHHHHhCCCCC
Confidence 356789999999875
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=1e-09 Score=78.95 Aligned_cols=62 Identities=16% Similarity=0.216 Sum_probs=57.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
....+.++|..+|.+++|+|+.+|++.+|..+|..++++|++.++..+|.|++ |+|.||...
T Consensus 18 ~~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl~~ 81 (83)
T d1wlza1 18 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFLSR 81 (83)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHHHH
Confidence 34678899999999999999999999999999999999999999999999876 999999754
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.91 E-value=5.5e-10 Score=89.93 Aligned_cols=76 Identities=14% Similarity=0.184 Sum_probs=65.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC--C--CcCHhhHHH-------------HHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT--L--HLDLAFFRE-------------KVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--~--~i~~~ef~~-------------~~~ 422 (436)
.++++++|..+|.+++|+|+.+||..+|+.+|..++.+|+.+++...+.+ + .|+|+||.. ...
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~ 82 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFED 82 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHHH
Confidence 45788999999999999999999999999999999999999999987665 2 399999943 224
Q ss_pred HHHhHHhhhhcCC
Q 013816 423 LKISFFRWYEIGG 435 (436)
Q Consensus 423 ~~~~f~~~d~~~~ 435 (436)
+..+|+.||+||+
T Consensus 83 l~~aF~~~D~d~~ 95 (145)
T d2mysc_ 83 FVEGLRVFDKEGN 95 (145)
T ss_pred HHHHHHHhhcCCC
Confidence 7789999999885
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.88 E-value=3.9e-10 Score=85.42 Aligned_cols=65 Identities=25% Similarity=0.394 Sum_probs=57.8
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHc---CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL---GHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
......++++|+.+|.|++|+|+.+|++.+++.+ |..+++++++++++.+|.|++ |+|+||...+
T Consensus 37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~~~m 106 (108)
T d1rroa_ 37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQEMV 106 (108)
T ss_dssp GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHHHHH
T ss_pred cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 3445678899999999999999999999999987 567899999999999999887 9999998765
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.87 E-value=9.7e-10 Score=83.44 Aligned_cols=64 Identities=23% Similarity=0.333 Sum_probs=56.9
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcC---CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG---HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg---~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++.+|+.+|.|++|+|+.+|++.+++.++ ..+++++++.|++.+|.|++ |+|+||...+.
T Consensus 39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~EF~~~m~ 107 (109)
T d1rwya_ 39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHHHHHHHHH
Confidence 345778899999999999999999999999874 56899999999999999988 99999987653
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.87 E-value=1.5e-09 Score=86.96 Aligned_cols=64 Identities=17% Similarity=0.328 Sum_probs=58.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC-cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH-LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~-i~~~ef~~~~~ 422 (436)
....+..+|+.+|.+++|+|+.+||+.+++.+|..+|++|+++|++.+|.|+. |+|+||...+.
T Consensus 74 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~~G~I~y~eF~~~l~ 138 (142)
T d1wdcb_ 74 SEETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVEGGKFDYVKFTAMIK 138 (142)
T ss_dssp CHHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEETTEECHHHHHHHHH
T ss_pred hhhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCCCCEEcHHHHHHHHh
Confidence 34678899999999999999999999999999999999999999999998754 99999987653
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.87 E-value=5.6e-10 Score=78.83 Aligned_cols=62 Identities=16% Similarity=0.324 Sum_probs=52.9
Q ss_pred hhhhhhccccCCC--CCCcccHHHHHHHHHHcCCCCC--HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 361 AGIKEGFHMMDIG--NRGKINIDELRVGLHKLGHQIP--DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 361 ~~l~~~F~~~D~~--~~G~i~~~el~~~l~~lg~~~~--~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+.++.+|+.||.+ ++|+|+.+||+.+|+.+|..++ +.|++++++.+|.||+ |+|+||...+.
T Consensus 5 eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~~~m~ 72 (76)
T d1qx2a_ 5 EEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFLVMMK 72 (76)
T ss_dssp HHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHHHHHH
T ss_pred HHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHHHHHH
Confidence 4678889988653 5799999999999999988776 4579999999999988 99999987654
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.87 E-value=4.5e-09 Score=87.90 Aligned_cols=76 Identities=22% Similarity=0.368 Sum_probs=67.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHHhhhhc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFFRWYEI 433 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~~~d~~ 433 (436)
...+..+|..+|.+++|+|+.+||+.++..+|..+++++++.+++.+|.|++ |+|+||.. ...+..+|+.+|.+
T Consensus 83 ~~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~~~~~~l~~~~~~F~~~D~~ 162 (182)
T d1y1xa_ 83 ILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYVELSIFVCRVRNVFAFYDRE 162 (182)
T ss_dssp HHHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred ccccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3457788999999999999999999999999999999999999999999877 99999965 34577899999987
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
++
T Consensus 163 ~~ 164 (182)
T d1y1xa_ 163 RT 164 (182)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.86 E-value=4.6e-10 Score=91.20 Aligned_cols=79 Identities=20% Similarity=0.239 Sum_probs=67.0
Q ss_pred hhhhhhhhhhhccccCC--CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH-----------
Q 013816 356 SVEEVAGIKEGFHMMDI--GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----------- 420 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----------- 420 (436)
+.+++..++++|..+|. +++|.|+.+||+.+|+.+|..+|++|+..++. .+.+++ |+|+||...
T Consensus 2 s~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~~-~~~~~~~~i~~~eFl~~~~~~~~~~~~~ 80 (152)
T d1wdcc_ 2 SQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG-THKMGEKSLPFEEFLPAYEGLMDCEQGT 80 (152)
T ss_dssp CHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTTC-CSSTTSCEECHHHHHHHHHHHTTSCCCC
T ss_pred CHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhhh-hhccccccccccccccccccccccchhH
Confidence 56788899999999994 88999999999999999999999999988754 466655 999999542
Q ss_pred -HHHHHhHHhhhhcCC
Q 013816 421 -VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 -~~~~~~f~~~d~~~~ 435 (436)
..+..||+.||+||+
T Consensus 81 ~~~l~~aF~~~D~~~~ 96 (152)
T d1wdcc_ 81 FADYMEAFKTFDREGQ 96 (152)
T ss_dssp HHHHHHHHHTTCSSSS
T ss_pred HHhhhhhhhccccccC
Confidence 247789999999875
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.86 E-value=9e-10 Score=88.05 Aligned_cols=75 Identities=13% Similarity=0.189 Sum_probs=63.7
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH-------------HHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV-------------RLKI 425 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~-------------~~~~ 425 (436)
+...++++|..+|.+++|+|+.+||..+|+.+|..++.+++.++.. +.+|.|+|+||...+ .+..
T Consensus 3 ~~~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~~~--~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~ 80 (140)
T d1ggwa_ 3 DDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES--TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVK 80 (140)
T ss_dssp CCTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT--TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhhhc--cccccccchhhhhhhhhhhhcchhhHHHHHHH
Confidence 3467899999999999999999999999999999999999887643 344559999995533 4788
Q ss_pred hHHhhhhcCC
Q 013816 426 SFFRWYEIGG 435 (436)
Q Consensus 426 ~f~~~d~~~~ 435 (436)
||+.||+||+
T Consensus 81 aF~~~D~d~~ 90 (140)
T d1ggwa_ 81 GFQVFDKDAT 90 (140)
T ss_dssp HHHTTCSSCS
T ss_pred HHHHHhccCC
Confidence 9999999875
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.86 E-value=1.8e-09 Score=88.62 Aligned_cols=83 Identities=23% Similarity=0.330 Sum_probs=73.2
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------- 419 (436)
..++.+++.+++++|..+|.+++|+|+.+||+.+++.++..+++.++.+++..+|.+++ ++|.||..
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~~~~~~~~~~~~~~ 91 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFLVMMVRQMKEDAK 91 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehhhhhhhhhhhhhcc
Confidence 34578888899999999999999999999999999999999999999999999999877 99999922
Q ss_pred ---HHHHHHhHHhhhhcCC
Q 013816 420 ---KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ---~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.+|+||+
T Consensus 92 ~~~~~~~~~aF~~~D~d~~ 110 (162)
T d1topa_ 92 GKSEEELANCFRIFDKNAD 110 (162)
T ss_dssp HHHHHHHHHHHHHHCTTCS
T ss_pred cCcHHHHHHHHHHHCCCCC
Confidence 2346679999999875
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.85 E-value=1.4e-09 Score=87.65 Aligned_cols=83 Identities=25% Similarity=0.393 Sum_probs=74.3
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------- 419 (436)
..++.+++..++++|+.+|.|++|+|+.+|+..++...|..+++.++..++...+.++. ++|++|..
T Consensus 2 ~~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (146)
T d1lkja_ 2 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFLALMSRQLKSNDS 81 (146)
T ss_dssp CCCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHHHHHHHHHTCCCCH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHHHHHHHHhhccccH
Confidence 35678889999999999999999999999999999999999999999999999998876 99999932
Q ss_pred HHHHHHhHHhhhhcCC
Q 013816 420 KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ~~~~~~~f~~~d~~~~ 435 (436)
...+..||+.||+||.
T Consensus 82 ~~~~~~aF~~~D~d~~ 97 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGD 97 (146)
T ss_dssp HHHHHHHHHHHCSSSS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 3467789999999885
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.83 E-value=2.7e-09 Score=85.18 Aligned_cols=79 Identities=19% Similarity=0.378 Sum_probs=70.4
Q ss_pred hhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-----------HHHH
Q 013816 357 VEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-----------KVRL 423 (436)
Q Consensus 357 ~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-----------~~~~ 423 (436)
.++.++++++|..+|.+++|+|+.+|+..+++..|..++++++..++..+|.+++ |+|+||.. ...+
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~~~~l 81 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFLTVMTQKMSEKDTKEEI 81 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHHHHHHHHHhhhccHHHH
Confidence 4567889999999999999999999999999999999999999999999998877 99999932 3347
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|..+|++++
T Consensus 82 ~~~f~~~d~~~~ 93 (141)
T d2obha1 82 LKAFKLFDDDET 93 (141)
T ss_dssp HHHHHHHCTTCS
T ss_pred HHHHHHhcccCC
Confidence 789999998774
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=3.7e-09 Score=87.55 Aligned_cols=74 Identities=19% Similarity=0.258 Sum_probs=66.7
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCCcCHhhHHHHH----HHHHhHHhhhhcCC
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLHLDLAFFREKV----RLKISFFRWYEIGG 435 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~i~~~ef~~~~----~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|.+++|+|+.+|+..+|..+|..+++++++.+++++|.+|.|+|+||...+ .+..+|+.+|+||+
T Consensus 78 ~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~~g~i~~~eF~~~~~~~~~~~~~f~~~D~d~~ 155 (172)
T d1juoa_ 78 GWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYIACCVKLRALTDSFRRRDTAQQ 155 (172)
T ss_dssp HHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSSSSEEHHHHHHHHHHHHHHHHHHHHTCTTCC
T ss_pred hhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 456679999999999999999999999999999999999999999999999999996543 46789999999974
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.82 E-value=3.7e-09 Score=86.01 Aligned_cols=83 Identities=22% Similarity=0.309 Sum_probs=73.3
Q ss_pred hhchhhhhhhhhhhccccCCCC-CCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGN-RGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE---------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~-~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~---------- 419 (436)
..++.++...++++|..+|.++ +|.|+.+|+..+|+++|..+++.++.+++..++.++. +++++|..
T Consensus 6 ~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (156)
T d1dtla_ 6 EQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRSMKDDS 85 (156)
T ss_dssp GGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHHHC---
T ss_pred HHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhhhhhhhhcccccc
Confidence 4567788899999999999995 8999999999999999999999999999999999876 99999932
Q ss_pred ----HHHHHHhHHhhhhcCC
Q 013816 420 ----KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 ----~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.||+||+
T Consensus 86 ~~~~~~~l~~~F~~~D~d~~ 105 (156)
T d1dtla_ 86 KGKSEEELSDLFRMFDKNAD 105 (156)
T ss_dssp --CHHHHHHHHHHHHCTTCS
T ss_pred cccHHHHHHHHHHHhCcCCC
Confidence 3357789999999985
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.81 E-value=2.3e-09 Score=89.74 Aligned_cols=78 Identities=17% Similarity=0.296 Sum_probs=69.3
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHHhhh
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFFRWY 431 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~~~d 431 (436)
++.+.++++|+.+|.|++|+|+.+|+..+|+.+|..+++++++.++..+|.|++ |+|+||.. ...+..+|..+|
T Consensus 15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef~~~~~~~~~~~~~F~~~D 94 (182)
T d1y1xa_ 15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFKDLHHFILSMREGFRKRD 94 (182)
T ss_dssp CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhccccccccccccccccccccccccccccchhccc
Confidence 445689999999999999999999999999999999999999999999999887 99999955 335668999999
Q ss_pred hcCC
Q 013816 432 EIGG 435 (436)
Q Consensus 432 ~~~~ 435 (436)
++++
T Consensus 95 ~~~~ 98 (182)
T d1y1xa_ 95 SSGD 98 (182)
T ss_dssp TTSS
T ss_pred cccc
Confidence 8764
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=98.79 E-value=5.6e-09 Score=87.51 Aligned_cols=75 Identities=16% Similarity=0.193 Sum_probs=62.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEI 433 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~ 433 (436)
...++.+|+.+|.|++|.|+..||+.+|+.+|..++++.++.|+.. +.+++ |+|+||+.. ..+..+|..+|++
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~-~~~~dg~i~f~eFi~~~~~l~~~~~~F~~~D~~ 170 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVAR-FADDELIIDFDNFVRCLVRLEILFKIFKQLDPE 170 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHH-TSCSSSBCCHHHHHHHHHHHHHHHHHHHHSCSS
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHH-hcCCCCcCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3567889999999999999999999999999999998877777765 45555 999999553 3566789999998
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
|+
T Consensus 171 ~~ 172 (188)
T d1qxpa2 171 NT 172 (188)
T ss_dssp CC
T ss_pred CC
Confidence 74
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.79 E-value=2.6e-09 Score=89.39 Aligned_cols=83 Identities=34% Similarity=0.550 Sum_probs=73.6
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH---------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV--------- 421 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~--------- 421 (436)
..++.+++..++++|+.+|.+++|+|+.+|+..+++.+|..++..+++.++..+|.+++ |+|++|....
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~ 81 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFIAATVHLNKLERE 81 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHHHHHTTSSSSCCC
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHHHHHHHhhcccccH
Confidence 35677888899999999999999999999999999999999999999999999999887 9999995422
Q ss_pred -HHHHhHHhhhhcCC
Q 013816 422 -RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -~~~~~f~~~d~~~~ 435 (436)
.+..+|..+|.+++
T Consensus 82 e~l~~aF~~~D~d~~ 96 (182)
T d1s6ia_ 82 ENLVSAFSYFDKDGS 96 (182)
T ss_dssp CSTHHHHHHTTTTCS
T ss_pred HHHHHHHHHHhhcCC
Confidence 46778999988864
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=3.4e-09 Score=78.12 Aligned_cols=68 Identities=24% Similarity=0.144 Sum_probs=60.5
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLK 424 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~ 424 (436)
+++++...+.++|+.+|.|++|+|+.+|++.++.+.| ++.+++.++++.+|.|++ |+|+||...+.|.
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~am~Li 73 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLI 73 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHH
Confidence 4567788899999999999999999999999999876 589999999999999887 9999998776654
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=98.77 E-value=3.5e-09 Score=83.68 Aligned_cols=72 Identities=17% Similarity=0.259 Sum_probs=64.2
Q ss_pred hhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH-------------HHHHHHhHH
Q 013816 364 KEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE-------------KVRLKISFF 428 (436)
Q Consensus 364 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~-------------~~~~~~~f~ 428 (436)
..+|+.+|.|++|.|+.+|+..+++.+|...++++++.++..+|.+++ |+|+||.. ...+..+|+
T Consensus 3 e~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~ 82 (134)
T d1jfja_ 3 EALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYK 82 (134)
T ss_dssp HHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhccccccccccccccccccccccccccccccccccc
Confidence 467999999999999999999999999999999999999999999987 99999933 335678999
Q ss_pred hhhhcCC
Q 013816 429 RWYEIGG 435 (436)
Q Consensus 429 ~~d~~~~ 435 (436)
.+|++++
T Consensus 83 ~~D~~~~ 89 (134)
T d1jfja_ 83 LMDVDGD 89 (134)
T ss_dssp HHCCSSS
T ss_pred ccccccC
Confidence 9998764
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.77 E-value=6.6e-09 Score=76.08 Aligned_cols=69 Identities=14% Similarity=0.122 Sum_probs=61.3
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKI 425 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~ 425 (436)
+++++...++++|..+|.+++|+|+.+|++..+.+.| ++.+++.++++.+|.|++ |+|+||...+.+..
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~~a~~li~ 73 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFCAAFHLVV 73 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHHHHHHHHH
Confidence 4677888999999999999999999999999999986 688999999999999988 99999976665543
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=98.73 E-value=5.3e-09 Score=87.78 Aligned_cols=75 Identities=19% Similarity=0.190 Sum_probs=63.3
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHHhhhhc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFFRWYEI 433 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~~~d~~ 433 (436)
...+..+|..+|.|++|+|+.+||+.+|+.+|..++.+.++ ++...|.|++ |+|+||+. ...+..+|+.+|+|
T Consensus 90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~-~~~~~d~d~dg~I~f~eFi~~~~~l~~~~~~F~~~D~~ 168 (186)
T d1df0a1 90 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQ-VIVARFADDELIIDFDNFVRCLVRLEILFKIFKQLDPE 168 (186)
T ss_dssp HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHH-HHHHHHCCSTTEECHHHHHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHH-HHHHHHcCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35678899999999999999999999999999999977655 5556788877 99999954 34567899999999
Q ss_pred CC
Q 013816 434 GG 435 (436)
Q Consensus 434 ~~ 435 (436)
|+
T Consensus 169 ~~ 170 (186)
T d1df0a1 169 NT 170 (186)
T ss_dssp CC
T ss_pred CC
Confidence 85
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.73 E-value=7.3e-09 Score=83.13 Aligned_cols=78 Identities=18% Similarity=0.284 Sum_probs=62.3
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHH-HHHHHHHHHhcCCCcCHhhHHH-----------HHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDT-DVQILMDAVSHTLHLDLAFFRE-----------KVRL 423 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~-e~~~~~~~~d~~~~i~~~ef~~-----------~~~~ 423 (436)
+.+++.+++++|..+|.+++|+|+.+|+..+|+.+|...+.. ++..++. +.+|.|+|+||.. ...+
T Consensus 2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~--~~~g~i~~~eF~~~~~~~~~~~~~~~~l 79 (145)
T d2mysb_ 2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIK--EASGPINFTVFLTMFGEKLKGADPEDVI 79 (145)
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHH--hccCceeechhhhhhhhcccccchHHHH
Confidence 567788999999999999999999999999999999765544 3444433 3455699999943 3367
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.||++|+
T Consensus 80 ~~aF~~fD~~~~ 91 (145)
T d2mysb_ 80 MGAFKVLDPDGK 91 (145)
T ss_pred HHHHHhhhhccc
Confidence 889999999986
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.72 E-value=3.4e-09 Score=85.25 Aligned_cols=75 Identities=21% Similarity=0.189 Sum_probs=61.9
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc-CCC--cCHhhHHHHH----------------
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH-TLH--LDLAFFREKV---------------- 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-~~~--i~~~ef~~~~---------------- 421 (436)
..++++|..+|.+++|+|+.+||..+|+++|..++.+|+++++...+. +++ |+|+||...+
T Consensus 2 ~~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~ 81 (146)
T d1m45a_ 2 RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTE 81 (146)
T ss_dssp CCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTH
T ss_pred hHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHH
Confidence 357899999999999999999999999999999999999999975443 332 9999995433
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|++++
T Consensus 82 ~l~~~F~~~D~~~~ 95 (146)
T d1m45a_ 82 DFVKAFQVFDKEST 95 (146)
T ss_dssp HHHHHHHTTCSSSS
T ss_pred HHHHHHHhhccccc
Confidence 36778999999875
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.72 E-value=9.9e-09 Score=82.39 Aligned_cols=63 Identities=21% Similarity=0.347 Sum_probs=58.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.+++|+|+.+|++..+..+|..+++++++++++.+|.|++ |+|+||...+
T Consensus 80 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 80 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFVRMM 144 (146)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 35578899999999999999999999999999999999999999999999876 9999997754
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.71 E-value=1.5e-08 Score=74.17 Aligned_cols=73 Identities=19% Similarity=0.169 Sum_probs=58.6
Q ss_pred hhhhhhhcccc-CCCCC-CcccHHHHHHHHHHcC-----CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-HHHHhH-H
Q 013816 360 VAGIKEGFHMM-DIGNR-GKINIDELRVGLHKLG-----HQIPDTDVQILMDAVSHTLH--LDLAFFREKV-RLKISF-F 428 (436)
Q Consensus 360 ~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg-----~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-~~~~~f-~ 428 (436)
+..+.++|..+ |.+++ |+|+.+||+.+|+.++ ...+++++++||+.+|.|++ |+|+||...+ .+..++ +
T Consensus 8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l~~~~~~ 87 (93)
T d1zfsa1 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFVVLVAALTVACNN 87 (93)
T ss_dssp HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHHHHHH
Confidence 46788899887 88875 9999999999999874 45679999999999999998 9999998766 344444 3
Q ss_pred hhhh
Q 013816 429 RWYE 432 (436)
Q Consensus 429 ~~d~ 432 (436)
.|+.
T Consensus 88 ~~~~ 91 (93)
T d1zfsa1 88 FFWE 91 (93)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 3343
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.69 E-value=8.6e-09 Score=82.17 Aligned_cols=62 Identities=23% Similarity=0.399 Sum_probs=56.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcC-CCcCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHT-LHLDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-~~i~~~ef~~~~ 421 (436)
...+.++|+.+|.+++|+|+.+||+.+|..+|..++++|++++++.+|.+ |.|+|+||...+
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~dG~I~y~eF~~~m 137 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVKDGMVNYHDFVQMI 137 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCSSCCSTTTHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCCCCEEeHHHHHHHH
Confidence 45688999999999999999999999999999999999999999999876 449999998765
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.69 E-value=8.4e-08 Score=79.20 Aligned_cols=74 Identities=14% Similarity=0.157 Sum_probs=62.5
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d~~~ 434 (436)
..++.+|+.+|.+++|+|+..|++.+|+..|..+++++++.++. .|.|++ |+|+||+.. ..+..+|+.||+||
T Consensus 77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~-~d~d~~G~i~~~EF~~~~~~~~~~~~~f~~~D~d~ 155 (173)
T d1alva_ 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIR-RYSDEGGNMDFDNFISCLVRLDAMFRAFKSLDKDG 155 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHH-HHTCSSSCBCHHHHHHHHHHHHHHHHHHHHHSSSC
T ss_pred hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhc-cccCCCCeEeHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 35677899999999999999999999999999999998887775 455666 999999653 35668999999998
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 156 ~ 156 (173)
T d1alva_ 156 T 156 (173)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.69 E-value=1.3e-08 Score=81.66 Aligned_cols=61 Identities=23% Similarity=0.400 Sum_probs=56.7
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.+.++.+|+.+|.+++|+|+.+||+.++..+|..++++++++|++++| |++ |+|+||...+
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~~~m 144 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFAALL 144 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHHHHh
Confidence 457889999999999999999999999999999999999999999999 776 9999998765
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.68 E-value=1.5e-08 Score=81.87 Aligned_cols=63 Identities=29% Similarity=0.362 Sum_probs=56.5
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCC--C--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTL--H--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~--~--i~~~ef~~~~ 421 (436)
....+.++|+.+|.+++|+|+.+||+.+|..+|..+|++|+++|++.+|.++ + |+|+||...+
T Consensus 80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~ 146 (152)
T d1wdcc_ 80 TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKV 146 (152)
T ss_dssp CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHH
T ss_pred HHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHH
Confidence 3457889999999999999999999999999999999999999999998643 3 9999997765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=3.9e-08 Score=87.04 Aligned_cols=90 Identities=18% Similarity=0.140 Sum_probs=65.7
Q ss_pred ccccceeeccccccCCceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeCCeE
Q 013816 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (436)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 131 (436)
.+-+.|++.+..+.++.+.||++. ..++.+++|+........ ...+.+|...+..|..+--+++++.+..+++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 334567777766556667899875 456778888876543322 234678888888886665678888888899999
Q ss_pred EEEEeccCCCchHHH
Q 013816 132 HLVMELCEGGELFDR 146 (436)
Q Consensus 132 ~lv~E~~~g~~L~~~ 146 (436)
++||++++|.++.+.
T Consensus 86 ~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 86 NLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEECCSSEEHHHH
T ss_pred EEEEEeccccccccc
Confidence 999999999877543
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.66 E-value=2.5e-08 Score=83.14 Aligned_cols=75 Identities=23% Similarity=0.278 Sum_probs=65.8
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHHhhhhcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFFRWYEIG 434 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~~~d~~~ 434 (436)
..++.+|+.+|.+++|.|+.+|++.++...|..+++++++++++.+|.+++ |+|+||.. ...+..+|..+|++|
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~~~~~~l~~l~~~F~~~D~~~ 165 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFIQGCIVLQRLTDIFRRYDTDQ 165 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHHHHHCTTC
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 356788999999999999999999999999999999999999999988766 99999954 335778999998776
Q ss_pred C
Q 013816 435 G 435 (436)
Q Consensus 435 ~ 435 (436)
+
T Consensus 166 d 166 (181)
T d1hqva_ 166 D 166 (181)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.65 E-value=1.4e-08 Score=81.34 Aligned_cols=62 Identities=16% Similarity=0.184 Sum_probs=57.6
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|+.+|.+++|+|+.++++.+|+.+|..++++|++++++.+|.|++ |+|.||...+
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~~~l 139 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNICYVI 139 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHh
Confidence 4568889999999999999999999999999999999999999999999877 9999997765
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.65 E-value=1.9e-09 Score=76.22 Aligned_cols=64 Identities=14% Similarity=0.178 Sum_probs=53.8
Q ss_pred hhhhhhhhccccCC--CCCCcccHHHHHHHHHHc--CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDI--GNRGKINIDELRVGLHKL--GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~--~~~G~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
....++.+|+.+|. ++.|+|+.+||+.+++.+ +...+.+++++||+.+|.|++ |+|+||...+.
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~~l~~ 74 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQVLVK 74 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHHHHHH
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHHHHHH
Confidence 45678899999875 346899999999999997 555677889999999999988 99999976653
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.65 E-value=7.7e-09 Score=84.09 Aligned_cols=63 Identities=25% Similarity=0.419 Sum_probs=56.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....+..+|+.+|.+++|+|+.+|++.++..+|..++++|++++++.+|.|++ |+|+||...+
T Consensus 89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~~~l 153 (156)
T d1dtla_ 89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFM 153 (156)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence 34568899999999999999999999999999999999999999999999887 9999998765
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.64 E-value=1.5e-08 Score=84.45 Aligned_cols=77 Identities=13% Similarity=0.141 Sum_probs=66.3
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHhHHhhh
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKISFFRWY 431 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~f~~~d 431 (436)
+.+.+..+|+.+|.+++|+|+.+|+..+|+.++. ..+.++++.+++.+|.|++ |+|+||... ..+..+|+.+|
T Consensus 17 ~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl~~~~~~~~~~~~f~~~D 96 (181)
T d1hqva_ 17 DQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFTGVWKYITDWQNVFRTYD 96 (181)
T ss_dssp CHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred cHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHHhhhhhcccccccccccc
Confidence 4467889999999999999999999999999875 4789999999999999876 999999653 34668999999
Q ss_pred hcCC
Q 013816 432 EIGG 435 (436)
Q Consensus 432 ~~~~ 435 (436)
+++.
T Consensus 97 ~~~~ 100 (181)
T d1hqva_ 97 RDNS 100 (181)
T ss_dssp TTCC
T ss_pred cccc
Confidence 8874
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=1.8e-09 Score=86.08 Aligned_cols=74 Identities=19% Similarity=0.258 Sum_probs=63.0
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc----CCCcCHhhHHHHH-------------HHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH----TLHLDLAFFREKV-------------RLK 424 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~----~~~i~~~ef~~~~-------------~~~ 424 (436)
+++++|..+|.+++|.|+.+||..+|+.+|..++++|+.+++...+. +|.|+|++|...+ .+.
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~ 80 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYL 80 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCH
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHH
Confidence 36889999999999999999999999999999999999999986653 3349999994322 367
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.||+.+|+||+
T Consensus 81 ~aF~~~D~d~~ 91 (139)
T d1w7jb1 81 EGFRVFDKEGN 91 (139)
T ss_dssp HHHHTTCTTSS
T ss_pred HhhhhccCCCC
Confidence 89999999875
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.63 E-value=1.3e-08 Score=75.12 Aligned_cols=64 Identities=8% Similarity=0.113 Sum_probs=53.4
Q ss_pred hhhhhhhhcccc-CCCCC-CcccHHHHHHHHHHcCC--CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMM-DIGNR-GKINIDELRVGLHKLGH--QIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~lg~--~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+ |.+++ |+|+.+||+.+++.++. ..+.++++++|+.+|.|++ |+|+||...+.
T Consensus 12 ~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~~l~~ 81 (98)
T d1yuta1 12 SIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIG 81 (98)
T ss_dssp HHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHHH
Confidence 356788999887 77775 99999999999998643 3567789999999999988 99999977654
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.63 E-value=1.2e-08 Score=81.99 Aligned_cols=62 Identities=27% Similarity=0.489 Sum_probs=57.3
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
.+.+..+|..+|.+++|+|+.+||..+|..+|..++++|+++++..+|.|++ |+|+||...+
T Consensus 80 ~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~~~i 143 (146)
T d1m45a_ 80 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFIEDV 143 (146)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHHHHH
T ss_pred HHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 4568899999999999999999999999999999999999999999999877 9999997654
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.62 E-value=2.2e-08 Score=80.21 Aligned_cols=62 Identities=23% Similarity=0.407 Sum_probs=55.1
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++++|+.+|.+++|+|+.+||+.+|..+|..++++|+++|++. |.|++ |+|+||+..+
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dG~I~y~eF~~~l 142 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFVKHI 142 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-cCCCCCeEEHHHHHHHH
Confidence 44568899999999999999999999999999999999999999975 66665 9999997654
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.61 E-value=1.3e-08 Score=74.11 Aligned_cols=63 Identities=17% Similarity=0.236 Sum_probs=53.8
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc-----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-----GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+|.+ +|+|+.+||..+++.+ +...++.+++++++.+|.||+ |+|+||...+.
T Consensus 7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~ 76 (92)
T d1a4pa_ 7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFFSLIA 76 (92)
T ss_dssp HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHHHHHH
Confidence 356789999999987 7999999999999873 445578889999999999988 99999976553
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.61 E-value=3.4e-08 Score=71.81 Aligned_cols=64 Identities=19% Similarity=0.201 Sum_probs=54.3
Q ss_pred hhhhhhhhcccc-CCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMM-DIGNRG-KINIDELRVGLHKL-----GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+ |.+|+| +|+.+||+.+|++. +...++.++++||+.+|.||+ |||+||...+.
T Consensus 7 ~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~ 79 (93)
T d1ksoa_ 7 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYVRSLA 79 (93)
T ss_dssp HHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHHHHHH
Confidence 356788889887 999999 59999999999875 344678999999999999998 99999976553
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.60 E-value=7.2e-08 Score=78.63 Aligned_cols=63 Identities=22% Similarity=0.371 Sum_probs=57.5
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|+.+|.+++|+|+.+|++.++...|...+.++++.+++.+|.|++ |+|+||+..+
T Consensus 94 ~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~l 158 (162)
T d1topa_ 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFLKMM 158 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999877 9999998764
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=2.1e-08 Score=82.93 Aligned_cols=79 Identities=15% Similarity=0.248 Sum_probs=66.7
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCC-----CCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHH
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ-----IPDTDVQILMDAVSHTLH--LDLAFFREK----VRLK 424 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~-----~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~ 424 (436)
+.++...++..|..++ +++|.|+..||..+|+++|.. ++.++++.|+..+|.||+ |+|+||... ....
T Consensus 2 p~~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~~~~~~~~~~~ 80 (172)
T d1juoa_ 2 PGQTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFKELWAVLNGWR 80 (172)
T ss_dssp TTCCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHHHHHHhhhhhh
Confidence 4456677899999886 789999999999999998755 468899999999999987 999999643 3566
Q ss_pred HhHHhhhhcCC
Q 013816 425 ISFFRWYEIGG 435 (436)
Q Consensus 425 ~~f~~~d~~~~ 435 (436)
.+|+.+|+||.
T Consensus 81 ~~f~~~D~d~s 91 (172)
T d1juoa_ 81 QHFISFDTDRS 91 (172)
T ss_dssp HHHHTTCTTCC
T ss_pred HHHHHhCcCCC
Confidence 89999999885
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.58 E-value=1.8e-08 Score=72.70 Aligned_cols=64 Identities=14% Similarity=0.278 Sum_probs=56.0
Q ss_pred hhhhhhhhcccc-CCCCCC-cccHHHHHHHHHH---cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMM-DIGNRG-KINIDELRVGLHK---LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+ |++++| +|+..|++.+++. +|...+++++++||+.+|.||+ |+|+||...+.
T Consensus 7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~~l~~ 77 (89)
T d1k8ua_ 7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYVTFLG 77 (89)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHHHHHH
Confidence 356788899887 999998 6999999999998 5777889999999999999998 99999977654
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.58 E-value=5.2e-08 Score=71.01 Aligned_cols=64 Identities=20% Similarity=0.253 Sum_probs=54.0
Q ss_pred hhhhhhhhcccc-CCCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMM-DIGNR-GKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+ |.+++ |+|+.+||+.+|+. ++...+++++++|++.+|.|++ |+|+||...+.
T Consensus 7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~ 79 (93)
T d3c1va1 7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLS 79 (93)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHHHHHH
Confidence 356788999987 66665 47999999999987 4677899999999999999988 99999977554
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.56 E-value=1.1e-07 Score=75.49 Aligned_cols=63 Identities=21% Similarity=0.344 Sum_probs=58.2
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
....++.+|..+|.+++|.|+..+|..++..+|..++++++.++++.+|.|++ |+|+||...+
T Consensus 77 ~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~~~m 141 (141)
T d2obha1 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFLRIM 141 (141)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred cHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHHHhC
Confidence 35678899999999999999999999999999999999999999999999877 9999997754
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4.4e-08 Score=80.04 Aligned_cols=71 Identities=18% Similarity=0.272 Sum_probs=57.9
Q ss_pred hhhccccCCCCCCcccHHHHHHHHHHcCCCC-----CHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHHhhhh
Q 013816 364 KEGFHMMDIGNRGKINIDELRVGLHKLGHQI-----PDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFFRWYE 432 (436)
Q Consensus 364 ~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~-----~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~~~d~ 432 (436)
...|+.+ .+.+|.|+.+||+.+|+.+|.+. +.+.++.|+..+|.|++ |+|+||.. ...++.+|+.||+
T Consensus 3 ~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~~l~~~~~~~~~~F~~fD~ 81 (165)
T d1k94a_ 3 YTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFKELWAALNAWKENFMTVDQ 81 (165)
T ss_dssp HHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHHHHhhccchhHHHHHHhCC
Confidence 3445555 57799999999999999988654 57889999999998887 99999954 4467789999999
Q ss_pred cCC
Q 013816 433 IGG 435 (436)
Q Consensus 433 ~~~ 435 (436)
||.
T Consensus 82 d~s 84 (165)
T d1k94a_ 82 DGS 84 (165)
T ss_dssp TCC
T ss_pred CCC
Confidence 875
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=4.4e-08 Score=71.82 Aligned_cols=68 Identities=16% Similarity=0.106 Sum_probs=59.5
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKI 425 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~ 425 (436)
++.++...+.++|..+| +++|+|+.+|++..|.+.| ++.+++++|+..+|.|++ |+|+||...+.|..
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~~a~~Li~ 73 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVY 73 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHH
Confidence 46778888999999999 8899999999999999876 578999999999999988 99999976665543
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=2.8e-08 Score=78.90 Aligned_cols=62 Identities=23% Similarity=0.398 Sum_probs=53.5
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
.....++++|+.+|.+++|+|+.+||+.++..+|..++++|++.|+.. |.|++ |+|+||+..
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~~~ 137 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFLKH 137 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHHHH
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHHHH
Confidence 345578999999999999999999999999999999999999999975 77766 999999764
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.52 E-value=3.7e-08 Score=81.39 Aligned_cols=77 Identities=13% Similarity=0.114 Sum_probs=64.9
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCC--------CCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ--------IPDTDVQILMDAVSHTLH--LDLAFFRE----KVRL 423 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~ 423 (436)
+++.+++++|..+|. .+|.|+..||..+|+++|.. ++.+++..++..+|.|++ |+|+||.. ...+
T Consensus 1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~~~~~~~ 79 (173)
T d1alva_ 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLWNNIKKW 79 (173)
T ss_dssp CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhhhhhhhhhHH
Confidence 367789999999994 48999999999999987543 567899999999999987 99999954 3356
Q ss_pred HHhHHhhhhcCC
Q 013816 424 KISFFRWYEIGG 435 (436)
Q Consensus 424 ~~~f~~~d~~~~ 435 (436)
..+|+.||+||.
T Consensus 80 ~~~f~~~D~d~~ 91 (173)
T d1alva_ 80 QAIYKQFDVDRS 91 (173)
T ss_dssp HHHHHHHCTTCC
T ss_pred HHHHHHhccCCC
Confidence 679999999874
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.51 E-value=1.8e-08 Score=72.38 Aligned_cols=63 Identities=14% Similarity=0.146 Sum_probs=54.5
Q ss_pred hhhhhhhcccc-CCCCCCc-ccHHHHHHHHHH-cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 360 VAGIKEGFHMM-DIGNRGK-INIDELRVGLHK-LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 360 ~~~l~~~F~~~-D~~~~G~-i~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+..+..+|+.+ |.+++|. ++.+||+.+++. +|..+++++++++|+++|.||+ |+|+||...+.
T Consensus 9 i~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~~l~~ 76 (87)
T d1xk4a1 9 LNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFLILVI 76 (87)
T ss_dssp HHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 45788889887 8999986 589999999986 7888888899999999999988 99999977654
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.49 E-value=1.1e-07 Score=79.45 Aligned_cols=60 Identities=17% Similarity=0.148 Sum_probs=55.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
...+..+|..+|.+++|+|+.+|++.+++.+|..+++++++.+++.+|.|++ |+|+||+.
T Consensus 104 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~ 165 (187)
T d1uhka1 104 RIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMTR 165 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHHH
T ss_pred HHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHHH
Confidence 3457889999999999999999999999999999999999999999999887 99999964
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.48 E-value=1.1e-07 Score=79.60 Aligned_cols=61 Identities=16% Similarity=0.144 Sum_probs=52.1
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..+..+|..+|.+++|+|+.+|+..++..+|..+++++++.|++.+|.|++ |+|+||...+
T Consensus 107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~~~~ 169 (189)
T d1qv0a_ 107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMTRQH 169 (189)
T ss_dssp HHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHHHHH
T ss_pred HHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence 356678999999999999999999999999999999999999999999887 9999996654
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=98.45 E-value=5.8e-08 Score=81.24 Aligned_cols=74 Identities=16% Similarity=0.153 Sum_probs=63.3
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCC--------CCCHHHHHHHHHHHhcCCC--cCHhhHHHH----HHHHHh
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGH--------QIPDTDVQILMDAVSHTLH--LDLAFFREK----VRLKIS 426 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~~~~--i~~~ef~~~----~~~~~~ 426 (436)
+.++++|..+| +++|.|+..||..+|+.+|. .++.+++..++..+|.|++ |+|+||... ..+..+
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~ 96 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFYILWTKIQKYQKI 96 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhHHHHHHH
Confidence 45889999998 89999999999999988753 3578899999999999988 999999543 457789
Q ss_pred HHhhhhcCC
Q 013816 427 FFRWYEIGG 435 (436)
Q Consensus 427 f~~~d~~~~ 435 (436)
|+.||+||.
T Consensus 97 F~~~D~d~s 105 (186)
T d1df0a1 97 YREIDVDRS 105 (186)
T ss_dssp HHHHCTTCC
T ss_pred HHhhCCCCC
Confidence 999999874
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=4.8e-08 Score=80.01 Aligned_cols=80 Identities=19% Similarity=0.307 Sum_probs=65.2
Q ss_pred HhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------
Q 013816 352 AQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE---------- 419 (436)
Q Consensus 352 ~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~---------- 419 (436)
...++.+++..++++|..+|.+++|+|+.+||..++..... ..+++++..+|.+++ |+|+||..
T Consensus 7 ~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~----~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~ 82 (165)
T d1auib_ 7 CSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN----PLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGD 82 (165)
T ss_dssp CCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTC----TTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCC
T ss_pred cCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCC----HHHHHHHHHHccccchhhhhhhhhhhccccccchh
Confidence 45678899999999999999999999999999876654433 246678999999877 99999943
Q ss_pred -HHHHHHhHHhhhhcCC
Q 013816 420 -KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.+|+||+
T Consensus 83 ~~~~~~~~f~~~d~d~~ 99 (165)
T d1auib_ 83 KEQKLRFAFRIYDMDKD 99 (165)
T ss_dssp HHHHHHHHHHHHCTTCS
T ss_pred hHHHHHHHHHHhccccc
Confidence 3357789999999885
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=98.41 E-value=2e-08 Score=84.03 Aligned_cols=79 Identities=18% Similarity=0.205 Sum_probs=52.5
Q ss_pred hhhhh-hhhhhhccccCCCCCCcccHHHHHHHHHHcCCC--------CCHHHHHHHHHHHhcCCC--cCHhhHHH----H
Q 013816 356 SVEEV-AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ--------IPDTDVQILMDAVSHTLH--LDLAFFRE----K 420 (436)
Q Consensus 356 ~~~~~-~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~~~~--i~~~ef~~----~ 420 (436)
+.++. +.++++|..+| +++|.|+..||..+|.++|.. ++.++++.|+..+|.|++ |+|+||.. .
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF~~l~~~~ 92 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEFNILWNRI 92 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHHHHHHhhh
Confidence 34444 35889999999 558999999999988776543 467889999999999987 99999953 4
Q ss_pred HHHHHhHHhhhhcCC
Q 013816 421 VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ~~~~~~f~~~d~~~~ 435 (436)
..++.+|+.||+||.
T Consensus 93 ~~~~~~F~~~D~d~s 107 (188)
T d1qxpa2 93 RNYLTIFRKFDLDKS 107 (188)
T ss_dssp HHHHHHHGGGCTTCC
T ss_pred HHHHHHHHHhCCCCC
Confidence 457789999999985
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.41 E-value=2e-07 Score=78.07 Aligned_cols=76 Identities=13% Similarity=0.150 Sum_probs=61.4
Q ss_pred hhhhhhhccccCC-CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----------HHHHh
Q 013816 360 VAGIKEGFHMMDI-GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV----------RLKIS 426 (436)
Q Consensus 360 ~~~l~~~F~~~D~-~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~----------~~~~~ 426 (436)
..++++.|..|.. +++|+|+.+|+..++..++...+..+++.+++.+|.|++ |+|.||.... .+..+
T Consensus 20 ~~ei~~~~~~F~~~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~ 99 (189)
T d1jbaa_ 20 AAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWT 99 (189)
T ss_dssp HHHHHHHHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHH
T ss_pred HHHHHHHHHHhcccCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHH
Confidence 3345555555543 358999999999999999999999999999999999988 9999995432 45679
Q ss_pred HHhhhhcCC
Q 013816 427 FFRWYEIGG 435 (436)
Q Consensus 427 f~~~d~~~~ 435 (436)
|+.||.||+
T Consensus 100 F~~~D~d~~ 108 (189)
T d1jbaa_ 100 FKIYDKDRN 108 (189)
T ss_dssp HHHHCSSCS
T ss_pred HhhhccCCC
Confidence 999999885
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.37 E-value=4.2e-07 Score=64.82 Aligned_cols=64 Identities=17% Similarity=0.160 Sum_probs=51.8
Q ss_pred hhhhhhhhcccc-CCCCCC-cccHHHHHHHHHHc-----CCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMM-DIGNRG-KINIDELRVGLHKL-----GHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~-D~~~~G-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.+..+..+|+.+ +.++++ +|+.+||+.++++. +...+++.++++|+.+|.||+ |||+||...+.
T Consensus 6 ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~~li~ 78 (87)
T d1e8aa_ 6 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVA 78 (87)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHHHHHH
Confidence 356788889887 556554 79999999999983 345578999999999999998 99999976554
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=5e-08 Score=73.61 Aligned_cols=70 Identities=11% Similarity=0.085 Sum_probs=60.4
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHHh
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKIS 426 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~~ 426 (436)
++.++...+.++|..+|.+++|+|+.+|++..|.+.| ++.+++.++++.+|.|++ |+++||...+.|...
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~~am~Li~~ 87 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFCAAFHLIVA 87 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHHHHHHHHHH
Confidence 4567778899999999999999999999999998765 577889999999999887 999999877766543
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.34 E-value=5.9e-08 Score=54.61 Aligned_cols=31 Identities=35% Similarity=0.575 Sum_probs=29.0
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLG 391 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 391 (436)
++++++|+.||+|++|+|+.+||+.+|+.||
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 4789999999999999999999999999886
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=98.33 E-value=9.8e-08 Score=86.96 Aligned_cols=81 Identities=19% Similarity=0.245 Sum_probs=69.8
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----HHHHHHhHH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE----KVRLKISFF 428 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----~~~~~~~f~ 428 (436)
++.++...++++|..+|.+++|.|+.+|++.+|+.+|..++++++..++..+|.|++ |+|.||.. ...+..+|.
T Consensus 116 l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~~~~~~~~~~~~~F~ 195 (321)
T d1ij5a_ 116 LSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLVAVANDLAALVADFR 195 (321)
T ss_dssp CCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHTTSHHHHHTSCCCHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhhhhhhhhhhhhHHHH
Confidence 355667789999999999999999999999999999999999999999999999887 99999943 334456788
Q ss_pred hhhhcCC
Q 013816 429 RWYEIGG 435 (436)
Q Consensus 429 ~~d~~~~ 435 (436)
.+|.++.
T Consensus 196 ~~d~d~~ 202 (321)
T d1ij5a_ 196 KIDTNSN 202 (321)
T ss_dssp HHCTTCC
T ss_pred HHhhccc
Confidence 8888764
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.32 E-value=8e-08 Score=71.15 Aligned_cols=64 Identities=13% Similarity=0.142 Sum_probs=52.2
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCC-------CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-------QIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-------~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
..+..+..+|+.++ +++|+|+.+||+.+|+..+. ..++.++++||+.+|.|++ |+|+||...+.
T Consensus 7 ~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~~li~ 79 (100)
T d1psra_ 7 RSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFLSLLG 79 (100)
T ss_dssp HHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHHHHHH
Confidence 34567788888887 67899999999999998653 2355678999999999988 99999977653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.31 E-value=5.3e-07 Score=84.49 Aligned_cols=82 Identities=18% Similarity=0.186 Sum_probs=52.5
Q ss_pred ccccccCCceEEEEEEEcCCCcEEEEEEeecccc----CChhhHHHHHHHHHHHHhCCCC--CceeEEEEEEEeCCeEEE
Q 013816 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (436)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~i~~~~~----~~~~~~~~~~~E~~~l~~l~~h--~niv~~~~~~~~~~~~~l 133 (436)
.+.||.|....||++.+..+++.+++|.-..... ..+...++...|+.+|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999999877788999996532111 0112334566788888876443 346666654 4555679
Q ss_pred EEeccCCCch
Q 013816 134 VMELCEGGEL 143 (436)
Q Consensus 134 v~E~~~g~~L 143 (436)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.31 E-value=1.8e-07 Score=69.25 Aligned_cols=61 Identities=20% Similarity=0.183 Sum_probs=49.1
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCC----------------CHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQI----------------PDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~----------------~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.++.+|..+|.|++|+|+.+||..++++++..+ ....++.+++.+|.|++ |+|+||.....
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~~~~~ 95 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQ 95 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHh
Confidence 367889999999999999999999998753211 13357889999999998 99999976543
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.29 E-value=4e-07 Score=67.10 Aligned_cols=62 Identities=21% Similarity=0.237 Sum_probs=55.2
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHHHH
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVRLKI 425 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~~~ 425 (436)
.+.+.|+.+|.+++|+|+.+|+...+++.| ++.+++.++++.+|.|++ |+++||...+.|..
T Consensus 12 ~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~~am~Li~ 75 (99)
T d1qjta_ 12 VYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFFVALRLVA 75 (99)
T ss_dssp HHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHHHHHHHHH
Confidence 456789999999999999999999999876 689999999999999887 99999987776653
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.28 E-value=5.8e-07 Score=74.69 Aligned_cols=82 Identities=20% Similarity=0.246 Sum_probs=68.4
Q ss_pred hhchhhhhhhhhhhccccCCC--CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH---------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIG--NRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE--------- 419 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~--~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~--------- 419 (436)
..++.+++..+.+.|..+|.+ ++|+|+.+|+..++..++...+. .++.+++.+|.|++ |+|+||+.
T Consensus 9 t~Fs~~ei~~L~~~F~~~d~~~~~~G~i~~~ef~~~l~~~~~~~~~-~~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~ 87 (183)
T d2zfda1 9 TVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESL-FADRVFDLFDTKHNGILGFEEFARALSVFHPNA 87 (183)
T ss_dssp SSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCH-HHHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTS
T ss_pred CCCCHHHHHHHHHHHHHHCcCCCCCCcCcHHHHHHHHHhcCCCCCH-HHHHHHHHHccCCCCcCcHHHHHHHHHhhhccC
Confidence 356888999999999998865 68999999999999888776554 57899999999887 99999953
Q ss_pred --HHHHHHhHHhhhhcCC
Q 013816 420 --KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 --~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.||.||+
T Consensus 88 ~~~~~~~~~F~~~D~d~~ 105 (183)
T d2zfda1 88 PIDDKIHFSFQLYDLKQQ 105 (183)
T ss_dssp CHHHHHHHHHHHHCTTSS
T ss_pred cHHHHHHHhhcccccCCC
Confidence 3357779999999985
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=2.8e-07 Score=76.97 Aligned_cols=73 Identities=16% Similarity=0.257 Sum_probs=55.7
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcC------------CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH--
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG------------HQIPDTDVQILMDAVSHTLH--LDLAFFREKVR-- 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~-- 422 (436)
....++.+|+.+|.|++|+|+.+|+..++..+. ....++.++.+++++|.||+ |+|+||.....
T Consensus 94 ~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~ 173 (187)
T d1g8ia_ 94 LDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQEGSKAD 173 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHC
T ss_pred hhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHC
Confidence 345688899999999999999999999887541 12335678899999999988 99999966443
Q ss_pred --HHHhHHhhh
Q 013816 423 --LKISFFRWY 431 (436)
Q Consensus 423 --~~~~f~~~d 431 (436)
+...|..||
T Consensus 174 p~~~~~l~~~~ 184 (187)
T d1g8ia_ 174 PSIVQALSLYD 184 (187)
T ss_dssp HHHHHHHCCBT
T ss_pred HHHHHHHHHhh
Confidence 444555554
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.19 E-value=5.9e-07 Score=74.48 Aligned_cols=76 Identities=14% Similarity=0.191 Sum_probs=59.4
Q ss_pred HHHHHHhhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC------------CCCCHHHHHHHHHHHhcCCC--c
Q 013816 347 ALKVIAQHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG------------HQIPDTDVQILMDAVSHTLH--L 412 (436)
Q Consensus 347 ~l~~i~~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~~~~--i 412 (436)
++..++..........++.+|+.+|.|++|+|+.+|+...+..+. ...+++.++++++++|.||+ |
T Consensus 81 Fl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~I 160 (181)
T d1bjfa_ 81 FIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKL 160 (181)
T ss_dssp HHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEE
T ss_pred HHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcE
Confidence 344444444444456788899999999999999999999998752 24567789999999999998 9
Q ss_pred CHhhHHHHHH
Q 013816 413 DLAFFREKVR 422 (436)
Q Consensus 413 ~~~ef~~~~~ 422 (436)
+|+||...+.
T Consensus 161 s~~EF~~~~~ 170 (181)
T d1bjfa_ 161 SLEEFIRGAK 170 (181)
T ss_dssp CHHHHHHHHH
T ss_pred eHHHHHHHHH
Confidence 9999976553
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.19 E-value=1.1e-06 Score=72.24 Aligned_cols=60 Identities=25% Similarity=0.269 Sum_probs=53.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|..+|.+++|+|+.+|++.+++.+| ++++++++++..+|.|++ |+|+||...+
T Consensus 101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~~~~ 162 (176)
T d1nyaa_ 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELLTAV 162 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHHHHH
Confidence 34577889999999999999999999999887 589999999999999988 9999997653
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.18 E-value=4.4e-07 Score=76.67 Aligned_cols=79 Identities=16% Similarity=0.194 Sum_probs=62.8
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHHhcCCC--cCHhhHHHHH----------
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIP-DTDVQILMDAVSHTLH--LDLAFFREKV---------- 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~~~---------- 421 (436)
++..++..+.+.|. +.+++|.|+.+|+..++..++.... ...++.++..+|.|++ |+|.||...+
T Consensus 22 f~~~ei~~l~~~F~--~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~ 99 (201)
T d1omra_ 22 FTEEELSSWYQSFL--KECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQ 99 (201)
T ss_dssp SCHHHHHHHHHHHH--HHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGG
T ss_pred CCHHHHHHHHHHHH--HHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHH
Confidence 56777777877774 4567899999999999999876554 4556889999999987 9999995422
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||+||+
T Consensus 100 ~l~~~F~~~D~d~~ 113 (201)
T d1omra_ 100 KLEWAFSLYDVDGN 113 (201)
T ss_dssp SHHHHHHHHCTTCS
T ss_pred HHHHHHHHHccCCC
Confidence 46789999999885
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.18 E-value=1.8e-07 Score=77.86 Aligned_cols=62 Identities=18% Similarity=0.397 Sum_probs=55.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
..+.+..+|..+|.+++|+|+..+|..++..+| +++++++.|++.+|.|++ |+|+||...+.
T Consensus 80 ~~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d~DG~Is~~EF~~~m~ 143 (182)
T d1s6ia_ 80 REENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFAAMMR 143 (182)
T ss_dssp CCCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHHHTTS
T ss_pred cHHHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcCCCCeEeHHHHHHHHH
Confidence 345788999999999999999999999999887 688999999999999988 99999977653
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.15 E-value=2.3e-06 Score=71.30 Aligned_cols=132 Identities=17% Similarity=0.168 Sum_probs=78.4
Q ss_pred HHHHHHHHHccCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhH---hhhhhHHHHHHHHHhhchhhhhhh
Q 013816 286 ENAKDLVRKMLDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFS---VMNKLKKRALKVIAQHLSVEEVAG 362 (436)
Q Consensus 286 ~~~~~ll~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~i~~~~~~~~~~~ 362 (436)
.+++++-+.-.+.+|+-+.+..|.-+. ++.... ......+...++.+. ....-...++..+...........
T Consensus 21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~~~---~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~ 95 (189)
T d1jbaa_ 21 AQLQEWYKKFLEECPSGTLFMHEFKRF--FKVPDN---EEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHK 95 (189)
T ss_dssp HHHHHHHHHHHSSSTTCCEEHHHHHHH--HHCCSS---STTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHH
T ss_pred HHHHHHHHHhcccCCCCeeeHHHHHHH--HHHcCC---CccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHH
Confidence 456666666667778888888776442 322111 111112222222321 111122223333333322233456
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHc----------------CCCCC-HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKL----------------GHQIP-DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~l----------------g~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
++.+|+.+|.|++|.|+.+|+..++..+ +...+ ++.++++++.+|.|++ |+|+||...+.
T Consensus 96 ~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~~~~~ 174 (189)
T d1jbaa_ 96 LKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGAR 174 (189)
T ss_dssp HHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHHHHHT
T ss_pred HHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHHHHHH
Confidence 7788999999999999999998877643 11122 4556889999999987 99999977654
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.11 E-value=6.9e-07 Score=74.16 Aligned_cols=59 Identities=19% Similarity=0.307 Sum_probs=52.5
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..+..+|..+|.|++|+|+.+|++.+++.+| ++.++++.++..+|.|++ |+|+||....
T Consensus 105 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d~dG~i~~~EF~~~~ 165 (185)
T d2sasa_ 105 NRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYKELY 165 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHHHHH
T ss_pred HHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 3577889999999999999999999999876 578899999999999987 9999996643
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=2.1e-06 Score=70.93 Aligned_cols=65 Identities=12% Similarity=0.292 Sum_probs=51.2
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHc-----CCCCCHHHH----HHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKL-----GHQIPDTDV----QILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l-----g~~~~~~e~----~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
.....++.+|+.+|.|++|+|+.+|+..+++.+ +..++++++ +.+++++|.|++ |+|+||...+.
T Consensus 92 ~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~~~~ 167 (180)
T d1xo5a_ 92 TPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQHVIS 167 (180)
T ss_dssp CHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHHHHH
T ss_pred CHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHH
Confidence 334578889999999999999999999999986 455666554 457778898877 99999976554
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.07 E-value=1.3e-06 Score=72.25 Aligned_cols=79 Identities=14% Similarity=0.135 Sum_probs=63.9
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHHhcCCC--cCHhhHHH----------HH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIP-DTDVQILMDAVSHTLH--LDLAFFRE----------KV 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~----------~~ 421 (436)
++.+++..+.+.|. +.+++|+|+..|+...+..++...+ ...++.++..+|.+++ |+|+||+. ..
T Consensus 18 fs~~ei~~l~~~F~--~~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~ 95 (181)
T d1bjfa_ 18 FTEHEIQEWYKGFL--RDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQ 95 (181)
T ss_dssp CCHHHHHHHHHHHH--HHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHH
T ss_pred CCHHHHHHHHHHHH--hhCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHH
Confidence 57777888888874 4567899999999999999876555 4567889999999987 99999943 33
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
.+..+|+.||.||+
T Consensus 96 ~~~~~f~~~D~d~d 109 (181)
T d1bjfa_ 96 KLKWAFSMYDLDGN 109 (181)
T ss_dssp HHHHHHHHHCTTCS
T ss_pred HHHHHHHHhccCCC
Confidence 56679999999875
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=98.07 E-value=2.8e-06 Score=69.68 Aligned_cols=60 Identities=22% Similarity=0.174 Sum_probs=53.5
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...+..+|..+|.+++|+|+.+|+..+++.+|. +.+++..+++.+|.|++ |+|+||+...
T Consensus 93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~d~dG~Is~~Ef~~~~ 154 (174)
T d2scpa_ 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDTNNDGLLSLEEFVIAG 154 (174)
T ss_dssp HTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred HHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCCCCCCcEeHHHHHHHH
Confidence 445788999999999999999999999998874 67889999999999988 9999997764
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.06 E-value=2.4e-06 Score=71.24 Aligned_cols=73 Identities=16% Similarity=0.252 Sum_probs=57.6
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHcCC------------CCCHHHHHHHHHHHhcCCC--cCHhhHHHHH----
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKLGH------------QIPDTDVQILMDAVSHTLH--LDLAFFREKV---- 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~------------~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~---- 421 (436)
...+..+|+.+|.|++|.|+.+|+...++.+.. ...++.++++++.+|.|++ |+|+||....
T Consensus 98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~~~~~~~p 177 (190)
T d1fpwa_ 98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFREGSKVDP 177 (190)
T ss_dssp THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHHHHHHSST
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHCH
Confidence 456788999999999999999999999986532 1124678999999999988 9999996554
Q ss_pred HHHHhHHhhhh
Q 013816 422 RLKISFFRWYE 432 (436)
Q Consensus 422 ~~~~~f~~~d~ 432 (436)
.+..+|..||.
T Consensus 178 ~i~~~l~~~d~ 188 (190)
T d1fpwa_ 178 SIIGALNLYDG 188 (190)
T ss_dssp THHHHHHHHHC
T ss_pred HHHHHhhhhcc
Confidence 45567777763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.4e-05 Score=69.56 Aligned_cols=74 Identities=11% Similarity=0.119 Sum_probs=51.4
Q ss_pred cccCCc-eEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCC-CceeEEEEEEEeCCeEEEEEeccCC
Q 013816 63 LGRGEF-GITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTAVHLVMELCEG 140 (436)
Q Consensus 63 lg~G~~-g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h-~niv~~~~~~~~~~~~~lv~E~~~g 140 (436)
+..|.. +.||++.. ..+..+++|...... ...+..|+..++.|..+ -.+++++.+..+.+..++||++++|
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 444443 67898874 457778889764332 23466777777766332 2367788888888899999999998
Q ss_pred Cch
Q 013816 141 GEL 143 (436)
Q Consensus 141 ~~L 143 (436)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 765
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.98 E-value=3e-06 Score=69.87 Aligned_cols=79 Identities=15% Similarity=0.150 Sum_probs=59.5
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCC-HHHHHHHHHHHhcCCC--cCHhhHHH----------HH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIP-DTDVQILMDAVSHTLH--LDLAFFRE----------KV 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~~~~--i~~~ef~~----------~~ 421 (436)
++..++..+.+.|.. .+++|.|+.+|+..++..++.... ...++.|+..+|.|++ |+|+||.. ..
T Consensus 10 ft~~ei~~l~~~F~~--~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~ 87 (178)
T d1s6ca_ 10 FTKRELQVLYRGFKN--ECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHE 87 (178)
T ss_dssp CCHHHHHHHHHHHHH--HCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHH--HCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHH
Confidence 456667777666643 456789999999999998876554 4445889999999887 99999943 33
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
++..+|+.||.||+
T Consensus 88 ~~~~~f~~~D~~~~ 101 (178)
T d1s6ca_ 88 KLRWTFNLYDINKD 101 (178)
T ss_dssp HHHHHHHHHCTTCS
T ss_pred HHHHHHHhhccCCC
Confidence 56678999988875
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=4.9e-06 Score=69.14 Aligned_cols=79 Identities=11% Similarity=0.138 Sum_probs=58.2
Q ss_pred chhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHH-HHHHHHHHhcCCC--cCHhhHHH----------HH
Q 013816 355 LSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTD-VQILMDAVSHTLH--LDLAFFRE----------KV 421 (436)
Q Consensus 355 ~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e-~~~~~~~~d~~~~--i~~~ef~~----------~~ 421 (436)
++..++..+.+.|... +++|.++..++...+..++......+ ++.+++.+|.+++ |+|+||+. ..
T Consensus 19 fs~~Ei~~l~~~F~~~--~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e 96 (187)
T d1g8ia_ 19 FTEKEVQQWYKGFIKD--CPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDE 96 (187)
T ss_dssp SCHHHHHHHHHHHHHH--CTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHH
T ss_pred CCHHHHHHHHHHHHHH--CCCCCcCHHHHHHHHHHhcCCCCHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhh
Confidence 4667777777777543 46788999999998888876655444 4668888888877 99999932 33
Q ss_pred HHHHhHHhhhhcCC
Q 013816 422 RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ~~~~~f~~~d~~~~ 435 (436)
++..+|+.||.||+
T Consensus 97 ~l~~~F~~~D~d~d 110 (187)
T d1g8ia_ 97 KLRWAFKLYDLDND 110 (187)
T ss_dssp HHHHHHHHHCTTCS
T ss_pred hHHHHHHHHhcCCC
Confidence 56678999988875
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.94 E-value=2.3e-05 Score=63.44 Aligned_cols=121 Identities=18% Similarity=0.170 Sum_probs=75.3
Q ss_pred cCCCcCCCCCHHHHhcCcccccCccCCCCCccHHHHHHHHhhHhhhhhHHHHHHHHHhhc-hhhhhhhhhhhccccCCCC
Q 013816 296 LDPDPKRRLTAQQVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALKVIAQHL-SVEEVAGIKEGFHMMDIGN 374 (436)
Q Consensus 296 l~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~-~~~~~~~l~~~F~~~D~~~ 374 (436)
+..|..-.++..|+...+.... .+..+.+...+..-....--...++..+.... .......+..+|..+|.++
T Consensus 25 ~D~d~~G~I~~~E~~~~~~~~~------~~~~~~l~~~~d~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~~d~d~ 98 (165)
T d1auib_ 25 LDLDNSGSLSVEEFMSLPELQQ------NPLVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDK 98 (165)
T ss_dssp HCTTCCSEECHHHHTTSHHHHT------CTTHHHHHHHHCTTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHHHCTTC
T ss_pred HCCCCCCCCcHHHHHHhhhccC------CHHHHHHHHHHccccchhhhhhhhhhhccccccchhhHHHHHHHHHHhcccc
Confidence 4566677788888755322111 11112222222111111111223333444333 3344567899999999999
Q ss_pred CCcccHHHHHHHHHHc-CCCCC----HHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 375 RGKINIDELRVGLHKL-GHQIP----DTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 375 ~G~i~~~el~~~l~~l-g~~~~----~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+|+|+.+|+...++.. |..++ +..++.++.++|.|++ |+|+||...+.
T Consensus 99 ~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~i~~ 153 (165)
T d1auib_ 99 DGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCAVVG 153 (165)
T ss_dssp SSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHHHHG
T ss_pred cccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHHHHh
Confidence 9999999999999875 66665 4557788889999887 99999987664
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.93 E-value=3.9e-06 Score=65.39 Aligned_cols=57 Identities=23% Similarity=0.283 Sum_probs=49.7
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
..++.+|+.+|.+++|+|+.+|+...+..++. +++.++++.+|.|++ |+|+||...+
T Consensus 75 ~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D~d~dG~is~~EF~~~~ 133 (134)
T d1jfja_ 75 IGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKADANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHHCSSSSEEEHHHHHHHH
T ss_pred ccccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHCCCCCCCCCHHHHHHHh
Confidence 45677899999999999999999999987654 688899999999987 9999997754
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.92 E-value=1.3e-05 Score=66.71 Aligned_cols=73 Identities=15% Similarity=0.133 Sum_probs=63.3
Q ss_pred hhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-------------------
Q 013816 363 IKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV------------------- 421 (436)
Q Consensus 363 l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~------------------- 421 (436)
+.++|+.+|.+++|.|+..|+..++..++....++.++.+++.+|.||+ |+++||...+
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~ 144 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEAT 144 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCC
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhh
Confidence 4678999999999999999999999999887889999999999999988 9999995433
Q ss_pred ---HHHHhHHhhhhcCC
Q 013816 422 ---RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ---~~~~~f~~~d~~~~ 435 (436)
....+|+.+|.||+
T Consensus 145 ~~~~v~~if~~~D~d~d 161 (190)
T d1fpwa_ 145 PEMRVKKIFKLMDKNED 161 (190)
T ss_dssp HHHHHHHHHHHHTTTCS
T ss_pred HHHHHHHHHHHhCCCCC
Confidence 24568999998874
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=97.90 E-value=3.7e-06 Score=76.11 Aligned_cols=63 Identities=14% Similarity=0.133 Sum_probs=56.2
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCC-CCCHHHHHHHHHHHhcCCC--cCHhhHHHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGH-QIPDTDVQILMDAVSHTLH--LDLAFFREKVRL 423 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~~ 423 (436)
..+..+|..+|.|++|+|+.+|++.++..+|. .++.+++..++..+|.|++ |+|+||+..+-|
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~~~ml~ 318 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFVMLVLL 318 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHHHHHHH
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHHHHHHH
Confidence 34567899999999999999999999999987 4888999999999999988 999999887754
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=97.83 E-value=4.4e-05 Score=54.25 Aligned_cols=62 Identities=19% Similarity=0.210 Sum_probs=49.1
Q ss_pred hhhhhhhcccc-CCCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMM-DIGNR-GKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..+..+|+.+ ..+++ ++++.+||+..+++ ++....+..++++|+.+|.|++ |||+||...+
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~~li 78 (90)
T d3cr5x1 8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFMAFV 78 (90)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 45677888877 44554 68999999999997 3444457789999999999988 9999996654
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.77 E-value=8.9e-06 Score=43.45 Aligned_cols=31 Identities=29% Similarity=0.476 Sum_probs=27.2
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcC
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLG 391 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg 391 (436)
+++.+.|+.||+|+||+|+.+||..+++.-|
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 4677889999999999999999999988643
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=97.73 E-value=1.5e-05 Score=65.08 Aligned_cols=78 Identities=14% Similarity=0.158 Sum_probs=53.4
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcC--CCCCHHHHHH-------HHHH--HhcCC--CcCHhhHHHHH---
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLG--HQIPDTDVQI-------LMDA--VSHTL--HLDLAFFREKV--- 421 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg--~~~~~~e~~~-------~~~~--~d~~~--~i~~~ef~~~~--- 421 (436)
...+.++.+|+.+|.|++|+|+.+|+..++..++ .......... .... .+.++ .|+++||....
T Consensus 3 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~ 82 (174)
T d2scpa_ 3 LWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFINSMKEM 82 (174)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHHhccccchhHHHHHhHHhhhhhccccccccCCCCcCcHHHHHHHHHhh
Confidence 3567889999999999999999999999987653 2222222222 1221 13444 39999994322
Q ss_pred ------------HHHHhHHhhhhcCC
Q 013816 422 ------------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 ------------~~~~~f~~~d~~~~ 435 (436)
.+..+|+.+|+||+
T Consensus 83 ~~~~~~~~~~~~~~~~~F~~~D~d~d 108 (174)
T d2scpa_ 83 VKNPEAKSVVEGPLPLFFRAVDTNED 108 (174)
T ss_dssp TSCGGGTHHHHTHHHHHHHHHCTTCS
T ss_pred hcchhhHHHHHHHHHHHHHHHCCCcc
Confidence 46679999999985
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=97.73 E-value=1.4e-05 Score=66.30 Aligned_cols=80 Identities=19% Similarity=0.170 Sum_probs=56.2
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHH-----HHHcCCCCCHHHHHHHHHHHh-----cCC--CcCHhhHHHHH--
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVG-----LHKLGHQIPDTDVQILMDAVS-----HTL--HLDLAFFREKV-- 421 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~-----l~~lg~~~~~~e~~~~~~~~d-----~~~--~i~~~ef~~~~-- 421 (436)
.++.+..++.+|..+|.|++|.|+.+|+... ++.+|...+..+..+++...+ .+. .|+++||...+
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~~~~~~~ 88 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQFLDGWKQ 88 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHHHHHHHH
Confidence 3456778999999999999999999999764 456788888888766665543 222 29999993222
Q ss_pred -------------------HHHHhHHhhhhcCC
Q 013816 422 -------------------RLKISFFRWYEIGG 435 (436)
Q Consensus 422 -------------------~~~~~f~~~d~~~~ 435 (436)
.+..+|..+|+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 121 (189)
T d1qv0a_ 89 LATSELKKWARNEPTLIREWGDAVFDIFDKDGS 121 (189)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHTC----
T ss_pred HHHHhhhccccccHHHHHHHHHHHHHHHccCCC
Confidence 34458999998875
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.71 E-value=9.6e-06 Score=66.92 Aligned_cols=80 Identities=15% Similarity=0.163 Sum_probs=57.9
Q ss_pred hhhhhhhhhhhccc-cCCCCCCcccHHHHHHHHHHcC----CCCCHHH-----------HHHHHHHHhcCCC--cCHhhH
Q 013816 356 SVEEVAGIKEGFHM-MDIGNRGKINIDELRVGLHKLG----HQIPDTD-----------VQILMDAVSHTLH--LDLAFF 417 (436)
Q Consensus 356 ~~~~~~~l~~~F~~-~D~~~~G~i~~~el~~~l~~lg----~~~~~~e-----------~~~~~~~~d~~~~--i~~~ef 417 (436)
+..+...++.+|+. +|.|++|.|+.+|+..++..++ ....... ...+....|.+++ |++++|
T Consensus 3 t~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~~ 82 (185)
T d2sasa_ 3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEY 82 (185)
T ss_dssp CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeHh
Confidence 44567789999986 6999999999999999988763 1222221 2344556677766 999999
Q ss_pred HHHH-------------------HHHHhHHhhhhcCC
Q 013816 418 REKV-------------------RLKISFFRWYEIGG 435 (436)
Q Consensus 418 ~~~~-------------------~~~~~f~~~d~~~~ 435 (436)
...+ .+..+|+.+|+||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 119 (185)
T d2sasa_ 83 LAMWEKTIATCKSVADLPAWCQNRIPFLFKGMDVSGD 119 (185)
T ss_dssp HHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHCTTSS
T ss_pred hHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHccCCC
Confidence 5433 25679999999874
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.70 E-value=3.4e-05 Score=63.21 Aligned_cols=60 Identities=22% Similarity=0.392 Sum_probs=46.8
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----C--------CCCCHHHHHHHHHHHhcCCC--cCHhhHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----G--------HQIPDTDVQILMDAVSHTLH--LDLAFFRE 419 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~~~~--i~~~ef~~ 419 (436)
...++.+|+.+|.+++|.|+.+|+...+..+ + ....+..++.+++.+|.|++ |+|+||..
T Consensus 86 ~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~~ 159 (178)
T d1s6ca_ 86 HEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFLE 159 (178)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 4567888999999999999999998876543 1 12234557889999999888 99999964
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=97.63 E-value=1.8e-05 Score=65.46 Aligned_cols=80 Identities=16% Similarity=0.135 Sum_probs=57.8
Q ss_pred hhhhhhhhhhhccccCCCCCCcccHHHHHHHHH-----HcCCCCCHHHHHHHHHHHhc-----CCC--cCHhhHHH----
Q 013816 356 SVEEVAGIKEGFHMMDIGNRGKINIDELRVGLH-----KLGHQIPDTDVQILMDAVSH-----TLH--LDLAFFRE---- 419 (436)
Q Consensus 356 ~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~-----~lg~~~~~~e~~~~~~~~d~-----~~~--i~~~ef~~---- 419 (436)
++.....++.+|+.+|.|++|.|+.+|+...+. .+|..++..++...+...+. ... +++.+|..
T Consensus 7 ~p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 86 (187)
T d1uhka1 7 NPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYIEGWKK 86 (187)
T ss_dssp CHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHhhhhcccccccccccHHHHHHHHHH
Confidence 345567889999999999999999999977654 36777777776665554332 122 88998821
Q ss_pred -----------------HHHHHHhHHhhhhcCC
Q 013816 420 -----------------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -----------------~~~~~~~f~~~d~~~~ 435 (436)
...+..+|+.+|+||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~~ 119 (187)
T d1uhka1 87 LATDELEKYAKNEPTLIRIWGDALFDIVDKDQN 119 (187)
T ss_dssp HHHHHHHHHHTTCCCHHHHHHHHHHHHHCTTCS
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHHccCCC
Confidence 1136679999999875
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.62 E-value=4e-05 Score=64.12 Aligned_cols=74 Identities=11% Similarity=0.078 Sum_probs=61.2
Q ss_pred hhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH-----------------
Q 013816 362 GIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR----------------- 422 (436)
Q Consensus 362 ~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~----------------- 422 (436)
.+..+|+.+|.+++|.|+..|+..++..+.....++.++.+++.+|.||+ |+.+||...+.
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~ 143 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPED 143 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGG
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhh
Confidence 34678999999999999999999999888777778889999999999987 99999943321
Q ss_pred -------HHHhHHhhhhcCC
Q 013816 423 -------LKISFFRWYEIGG 435 (436)
Q Consensus 423 -------~~~~f~~~d~~~~ 435 (436)
...+|+.+|+||+
T Consensus 144 ~~~~~~~~~~if~~~D~d~d 163 (201)
T d1omra_ 144 ENTPEKRAEKIWGFFGKKDD 163 (201)
T ss_dssp GSSHHHHHHHHHHHTTCCTT
T ss_pred hccHHHHHHHHHHHhCCCCC
Confidence 2357899988875
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.60 E-value=7.3e-05 Score=61.43 Aligned_cols=62 Identities=19% Similarity=0.275 Sum_probs=49.9
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHH----cCCCCCHHHH----HHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHK----LGHQIPDTDV----QILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~----lg~~~~~~e~----~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
...++.+|+.+|.|++|.|+.+|+...+.. .|..+++.++ .++++.+|.|++ |+|+||...+
T Consensus 90 ~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~~~ 161 (183)
T d2zfda1 90 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRSLV 161 (183)
T ss_dssp HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHHHH
T ss_pred HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence 346778899999999999999999887754 3677777665 456778999887 9999996654
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=97.50 E-value=5.8e-05 Score=56.19 Aligned_cols=61 Identities=11% Similarity=0.101 Sum_probs=46.9
Q ss_pred CCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH-------------HHHhHHhhhhcCC
Q 013816 373 GNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR-------------LKISFFRWYEIGG 435 (436)
Q Consensus 373 ~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~-------------~~~~f~~~d~~~~ 435 (436)
+++|.|+..|+...+.. ...+.++++++++.+|.||+ |+.+|+...+. +...|+.+|.||+
T Consensus 19 d~dG~idf~EF~~~~~~--~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~d 94 (109)
T d1pvaa_ 19 KAEGSFNHKKFFALVGL--KAMSANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGD 94 (109)
T ss_dssp CSTTCCCHHHHHHHHTC--TTSCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCS
T ss_pred CCCCCCcHHHHHHHHHH--ccCCHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCc
Confidence 46688999999766542 23468889999999999988 99999965542 3457788898885
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.50 E-value=0.00011 Score=68.22 Aligned_cols=78 Identities=13% Similarity=0.125 Sum_probs=52.8
Q ss_pred ceeeccccccCCceEEEEEEEcC-------CCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCCceeEEEEEEEeC
Q 013816 56 RYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (436)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 128 (436)
..++ +.|+.|-.-.+|++.... ..+.|.+++.... . ..-...+|..+++.+..+.-.+++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E---TESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--c---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 3443 568888889999998653 2356777765421 1 223456799999988666555688877642
Q ss_pred CeEEEEEeccCCCch
Q 013816 129 TAVHLVMELCEGGEL 143 (436)
Q Consensus 129 ~~~~lv~E~~~g~~L 143 (436)
.+|+||++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 589999988654
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=97.42 E-value=5.7e-05 Score=54.14 Aligned_cols=62 Identities=15% Similarity=0.150 Sum_probs=49.0
Q ss_pred hhhhhhhcccc-CCCCC-CcccHHHHHHHHHH-----cCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMM-DIGNR-GKINIDELRVGLHK-----LGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~-D~~~~-G~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..+..+|..+ ..+|+ ++++.+||+.++++ ++..-.++.++++|+.+|.|++ |+|+||...+
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~~li 78 (95)
T d1qlsa_ 8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFLNLI 78 (95)
T ss_dssp HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHHH
Confidence 45677788776 34454 68999999999986 4455567889999999999988 9999996644
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.38 E-value=8.9e-05 Score=53.01 Aligned_cols=62 Identities=19% Similarity=0.181 Sum_probs=45.4
Q ss_pred hhhhhhhccccC-CCCC-CcccHHHHHHHHHH-cC----CCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 360 VAGIKEGFHMMD-IGNR-GKINIDELRVGLHK-LG----HQIPDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 360 ~~~l~~~F~~~D-~~~~-G~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
+..+..+|+.+. .+++ ++++.+||+..+++ ++ ....+..++++++.+|.|++ |+|+||...+
T Consensus 8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~li 78 (94)
T d1j55a_ 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFV 78 (94)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHHHHH
Confidence 446777888763 3443 58999999999987 33 33345679999999999988 9999996654
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=97.36 E-value=0.00011 Score=54.59 Aligned_cols=75 Identities=7% Similarity=0.084 Sum_probs=53.2
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHHH---------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKVR--------- 422 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~--------- 422 (436)
.++.+++.. ++..+| .+|.|+..|+...+.. ..-++++++++++.+|.|++ |+.+|+...+.
T Consensus 5 ~l~~~di~~---~~~~~~--~~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~ 77 (109)
T d5pala_ 5 VLKADDINK---AISAFK--DPGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDL 77 (109)
T ss_dssp TSCHHHHHH---HHHHTC--STTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCC
T ss_pred HccHHHHHH---HHHhcC--CCCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcC
Confidence 344444444 444444 4589999999866532 22368899999999999988 99999965542
Q ss_pred ----HHHhHHhhhhcCC
Q 013816 423 ----LKISFFRWYEIGG 435 (436)
Q Consensus 423 ----~~~~f~~~d~~~~ 435 (436)
+...|+.+|.||+
T Consensus 78 ~~~e~~~~~~~~D~d~d 94 (109)
T d5pala_ 78 NDTETKALLAAGDSDHD 94 (109)
T ss_dssp CHHHHHHHHHHHCTTCS
T ss_pred CHHHHHHHHHHhCCCCC
Confidence 4567888898875
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=97.33 E-value=0.0002 Score=57.90 Aligned_cols=76 Identities=14% Similarity=0.110 Sum_probs=55.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc----CCCCCHHHHH-----------HHHHHHhcCCC--cCHhhHH----
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL----GHQIPDTDVQ-----------ILMDAVSHTLH--LDLAFFR---- 418 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l----g~~~~~~e~~-----------~~~~~~d~~~~--i~~~ef~---- 418 (436)
.+.++++|..+|.|++|.|+.+|++.++.++ +...+..++. .++...+.+++ |++.++.
T Consensus 6 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 85 (176)
T d1nyaa_ 6 SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIRVTE 85 (176)
T ss_dssp HHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccHHHHHHHHh
Confidence 3467888999999999999999999998775 4455544433 33445556655 9999982
Q ss_pred --------------HHHHHHHhHHhhhhcCC
Q 013816 419 --------------EKVRLKISFFRWYEIGG 435 (436)
Q Consensus 419 --------------~~~~~~~~f~~~d~~~~ 435 (436)
....+..+|..+|.|++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~F~~~D~d~d 116 (176)
T d1nyaa_ 86 NLIFEQGEASFNRVLGPVVKGIVGMCDKNAD 116 (176)
T ss_dssp HHHSSSCHHHHHHHHHHHHHHHHHHTCSSCC
T ss_pred hhhhhhhhhhhHHHHHHHHHHHHHHHccCCC
Confidence 12246679999998874
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.19 E-value=4.3e-06 Score=68.28 Aligned_cols=66 Identities=8% Similarity=0.105 Sum_probs=38.1
Q ss_pred cCCCCCCcccHHHHHHHHHHcCCCC--CHHHHHHHHHHHhcCCC--cCHhhHHHHH-------HHHHhHHhhhhcCC
Q 013816 370 MDIGNRGKINIDELRVGLHKLGHQI--PDTDVQILMDAVSHTLH--LDLAFFREKV-------RLKISFFRWYEIGG 435 (436)
Q Consensus 370 ~D~~~~G~i~~~el~~~l~~lg~~~--~~~e~~~~~~~~d~~~~--i~~~ef~~~~-------~~~~~f~~~d~~~~ 435 (436)
+|.|++|.|+.+||..+++..+..+ +.+++..++...|.+++ |+|+||.... ++..+|..||.||+
T Consensus 16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D~~~~~~i~F~eF~~~~~~l~~r~ei~~~F~~~d~d~~ 92 (170)
T d2zkmx1 16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAK 92 (170)
T ss_dssp HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHHSCCHHHHTTCC-------
T ss_pred cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhccccccCCCccCHHHHHHHHhccCCHHHHHHHHHHHcCCCC
Confidence 6888888888888888876543222 23344555556666665 8888884322 45567888887764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.00096 Score=59.90 Aligned_cols=70 Identities=13% Similarity=0.150 Sum_probs=45.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEeeccccCChhhHHHHHHHHHHHHhCCCCC-ceeEEE-----EEEEeCCeEEEEEeccCCC
Q 013816 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLK-----DTYEDDTAVHLVMELCEGG 141 (436)
Q Consensus 68 ~g~Vy~~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E~~~l~~l~~h~-niv~~~-----~~~~~~~~~~lv~E~~~g~ 141 (436)
--.||++.. .+|..|++|+.+.... ..+++..|+..+..|.++. .++... ..+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999985 5789999999754321 3466778888888773221 111111 1235577889999999874
Q ss_pred c
Q 013816 142 E 142 (436)
Q Consensus 142 ~ 142 (436)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=96.94 E-value=0.00051 Score=50.62 Aligned_cols=67 Identities=7% Similarity=-0.024 Sum_probs=48.4
Q ss_pred hhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHHH-------------HHHHhHHh
Q 013816 365 EGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREKV-------------RLKISFFR 429 (436)
Q Consensus 365 ~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~~-------------~~~~~f~~ 429 (436)
.++...+. +|.|+..|+...+..-+ -+.++++.+++.+|.||+ |+.+||...+ .+...|+.
T Consensus 12 ~~~~~~~~--~gsi~~~eF~~~~~l~~--~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~ 87 (107)
T d2pvba_ 12 AALAACSA--ADSFKHKEFFAKVGLAS--KSLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLAD 87 (107)
T ss_dssp HHHHHTCS--TTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHH
T ss_pred HHHHhccC--CCCcCHHHHHHHHhccc--CCHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHH
Confidence 34444444 46799999887665322 367889999999999988 9999996543 24567888
Q ss_pred hhhcCC
Q 013816 430 WYEIGG 435 (436)
Q Consensus 430 ~d~~~~ 435 (436)
+|+||+
T Consensus 88 ~D~d~d 93 (107)
T d2pvba_ 88 GDKDGD 93 (107)
T ss_dssp HCTTCS
T ss_pred hCCCCC
Confidence 888875
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=96.84 E-value=0.0011 Score=45.92 Aligned_cols=61 Identities=16% Similarity=0.231 Sum_probs=45.9
Q ss_pred hhhhhhhccccC-CCC-CCcccHHHHHHHHHH-cCCCC-----CHHHHHHHHHHHhcCCC--cCHhhHHHH
Q 013816 360 VAGIKEGFHMMD-IGN-RGKINIDELRVGLHK-LGHQI-----PDTDVQILMDAVSHTLH--LDLAFFREK 420 (436)
Q Consensus 360 ~~~l~~~F~~~D-~~~-~G~i~~~el~~~l~~-lg~~~-----~~~e~~~~~~~~d~~~~--i~~~ef~~~ 420 (436)
+..+..+|+.+. .++ .++++..||+..+++ ++.-+ .+.-++++++.+|.|++ |+|.||...
T Consensus 9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~~l 79 (83)
T d1xk4c1 9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIML 79 (83)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHHHH
Confidence 345677787774 233 468999999999997 54333 34458999999999988 999999654
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=96.71 E-value=0.0018 Score=47.80 Aligned_cols=76 Identities=11% Similarity=0.035 Sum_probs=54.3
Q ss_pred hhchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHHH----------
Q 013816 353 QHLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFREK---------- 420 (436)
Q Consensus 353 ~~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~~---------- 420 (436)
..++.+++..+...| +.+|.|+..++...+...+ .++++++++++.+|.||+ |+.+||...
T Consensus 4 ~~~~~~~i~~~~~~~-----~~~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~ 76 (109)
T d1rwya_ 4 DLLSAEDIKKAIGAF-----TAADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARD 76 (109)
T ss_dssp HHSCHHHHHHHHHTT-----CSTTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCC
T ss_pred hhcCHHHHHHHHHhc-----ccCCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhcccccc
Confidence 344555555554443 3357899999987765433 368899999999999998 999999432
Q ss_pred ---HHHHHhHHhhhhcCC
Q 013816 421 ---VRLKISFFRWYEIGG 435 (436)
Q Consensus 421 ---~~~~~~f~~~d~~~~ 435 (436)
.+....|+.+|.||+
T Consensus 77 ~~~~e~~~~~~~~D~d~d 94 (109)
T d1rwya_ 77 LSAKETKTLMAAGDKDGD 94 (109)
T ss_dssp CCHHHHHHHHHHHCTTCS
T ss_pred CCHHHHHHHHHHhCCCCC
Confidence 235667888888875
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.70 E-value=0.002 Score=52.29 Aligned_cols=73 Identities=7% Similarity=0.015 Sum_probs=56.5
Q ss_pred hhhhccccCCC-CCCcccHHHHHHHHHHcCCC-CCHHHHHHHHHHHhcCCC--cCHhhHHHHHH----------------
Q 013816 363 IKEGFHMMDIG-NRGKINIDELRVGLHKLGHQ-IPDTDVQILMDAVSHTLH--LDLAFFREKVR---------------- 422 (436)
Q Consensus 363 l~~~F~~~D~~-~~G~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~~~--i~~~ef~~~~~---------------- 422 (436)
..++|+.+|.+ ++|.|+.+|+..++..+... ..++.++.+++.+|.||+ |+.+|+...+.
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~ 138 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEM 138 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHH
Confidence 35678888987 68999999999999887544 446678889999999988 99999954321
Q ss_pred ---HHHhHHhhhhcCC
Q 013816 423 ---LKISFFRWYEIGG 435 (436)
Q Consensus 423 ---~~~~f~~~d~~~~ 435 (436)
...+|+.+|.|++
T Consensus 139 ~~~v~~~~~~~D~d~d 154 (180)
T d1xo5a_ 139 KQLIDNILEESDIDRD 154 (180)
T ss_dssp HHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHhCCCCC
Confidence 2247888888774
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.45 E-value=0.0015 Score=52.57 Aligned_cols=61 Identities=15% Similarity=0.029 Sum_probs=38.3
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHcCCC----------CCHHHHHHHHHHHhcCCC------cCHhhHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQ----------IPDTDVQILMDAVSHTLH------LDLAFFREKV 421 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~----------~~~~e~~~~~~~~d~~~~------i~~~ef~~~~ 421 (436)
..+..+|..+|.|++|+||.+||...|+.-... ++.+.++++|.....+.+ |++++|...+
T Consensus 78 ~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~~fL 154 (170)
T d2zkmx1 78 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFL 154 (170)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHHHHH
Confidence 357789999999999999999999999876433 567788999998876532 9999996643
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.34 E-value=0.0011 Score=48.87 Aligned_cols=75 Identities=12% Similarity=0.058 Sum_probs=53.6
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHHH------------
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFRE------------ 419 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~~------------ 419 (436)
.++.+++..+... ...+|.++.+++...+.. ...+.++++++++.+|.||+ |+++||..
T Consensus 5 ~ls~~dI~~~l~~-----~~~~~s~~~~~F~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l 77 (108)
T d1rroa_ 5 ILSAEDIAAALQE-----CQDPDTFEPQKFFQTSGL--SKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDAREL 77 (108)
T ss_dssp TSCHHHHHHHHHH-----TCSTTCCCHHHHHHHHSG--GGSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCC
T ss_pred hCCHHHHHHHHHh-----cccCCCccHHHHHHHHcc--CcCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCC
Confidence 3455555554333 245678999998554432 22478899999999999998 99999943
Q ss_pred -HHHHHHhHHhhhhcCC
Q 013816 420 -KVRLKISFFRWYEIGG 435 (436)
Q Consensus 420 -~~~~~~~f~~~d~~~~ 435 (436)
..++...|+.+|+||+
T Consensus 78 ~~~~~~~~~~~~D~d~d 94 (108)
T d1rroa_ 78 TESETKSLMDAADNDGD 94 (108)
T ss_dssp CHHHHHHHHHHHCCSSS
T ss_pred CHHHHHHHHHHhCCCCC
Confidence 3467789999999985
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.73 E-value=0.0045 Score=54.93 Aligned_cols=31 Identities=32% Similarity=0.472 Sum_probs=24.6
Q ss_pred CCceecCCCCCceEeecCCCCCCeEEEeeccccc
Q 013816 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (436)
Q Consensus 175 ~~iiH~dlkp~NIl~~~~~~~~~ikl~DfG~a~~ 208 (436)
.|+||+|+.++||+++.+. ..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE---LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred cccccCCcchhhhhccccc---ceeEeccccccc
Confidence 4799999999999997432 247999997753
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=95.40 E-value=0.019 Score=36.12 Aligned_cols=66 Identities=15% Similarity=0.156 Sum_probs=55.1
Q ss_pred hchhhhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc-CCC---cCHhhHHH
Q 013816 354 HLSVEEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH-TLH---LDLAFFRE 419 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-~~~---i~~~ef~~ 419 (436)
.+.+++.++..++|..||.|....--..+-..+|++||...+..|.+.++++... .|+ |.=+|+..
T Consensus 7 algpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargpkgdkknigpeewlt 76 (86)
T d1j7qa_ 7 ALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPEEWLT 76 (86)
T ss_dssp CCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTTHHHH
T ss_pred ccCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCCCCccccCCHHHHHH
Confidence 3456778888999999999999888888999999999999999999999997654 343 88788743
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.98 E-value=0.0063 Score=39.88 Aligned_cols=41 Identities=7% Similarity=0.024 Sum_probs=33.7
Q ss_pred CHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 395 PDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 395 ~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
|++++++.++.+|.|++ |+++||.. ..++...|+.+|.|++
T Consensus 1 Seeel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~ 53 (65)
T d1fw4a_ 1 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGD 53 (65)
T ss_dssp CCHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCS
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCC
Confidence 46889999999999988 99999943 3367778899888874
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=94.45 E-value=0.0046 Score=43.34 Aligned_cols=57 Identities=9% Similarity=0.163 Sum_probs=42.4
Q ss_pred CCCcccHHHHHHHHHHcCCCCCHHH---HHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 374 NRGKINIDELRVGLHKLGHQIPDTD---VQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 374 ~~G~i~~~el~~~l~~lg~~~~~~e---~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
++|.|+.++- .+...+++++ +++.++.+|.||+ |+++||.. ..++...|+.+|.||+
T Consensus 2 ~~g~id~~~~-----~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~ 73 (87)
T d1s6ja_ 2 SSGHIDDDDK-----HMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKS 73 (87)
T ss_dssp CSSSSSSHHH-----HSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCS
T ss_pred CCCccCchHH-----HHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCC
Confidence 5688887773 3445555544 5788999999988 99999944 3367788999998875
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.34 E-value=0.024 Score=41.96 Aligned_cols=69 Identities=12% Similarity=0.034 Sum_probs=52.9
Q ss_pred hchhhhhhhhhhhccccC---CCCCCcccHHHHHHHHHHcCC--CCCHHHHHHHHHHHhcCCC----------cCHhhHH
Q 013816 354 HLSVEEVAGIKEGFHMMD---IGNRGKINIDELRVGLHKLGH--QIPDTDVQILMDAVSHTLH----------LDLAFFR 418 (436)
Q Consensus 354 ~~~~~~~~~l~~~F~~~D---~~~~G~i~~~el~~~l~~lg~--~~~~~e~~~~~~~~d~~~~----------i~~~ef~ 418 (436)
+++..++..+.+.|+... .+.+|.|+.++++..+..+.. ..+..-++.+++.+|.+++ |+|.||+
T Consensus 21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv 100 (118)
T d1tuza_ 21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS 100 (118)
T ss_dssp HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence 456778888888886542 256799999999999998633 2456777889999999853 9999997
Q ss_pred HHHH
Q 013816 419 EKVR 422 (436)
Q Consensus 419 ~~~~ 422 (436)
-.+.
T Consensus 101 ~~LS 104 (118)
T d1tuza_ 101 CYFS 104 (118)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6544
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=94.30 E-value=0.014 Score=39.16 Aligned_cols=42 Identities=5% Similarity=0.014 Sum_probs=31.9
Q ss_pred CCHHHH---HHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 394 IPDTDV---QILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 394 ~~~~e~---~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
+|++|+ ++.++.+|.||+ |+++||.. ...+..+|+.+|.||+
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~ 58 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGN 58 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCS
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCC
Confidence 566555 556889999988 99999943 3467788999998874
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=94.23 E-value=0.012 Score=39.89 Aligned_cols=45 Identities=7% Similarity=0.024 Sum_probs=36.2
Q ss_pred CCCCCHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 391 GHQIPDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 391 g~~~~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
|+.=+++++++.++.+|.|++ |+.+||.. ..++...|+.+|.||+
T Consensus 3 ge~d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~ 59 (77)
T d1oqpa_ 3 GERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDD 59 (77)
T ss_dssp TTSSHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSS
T ss_pred CCccHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCC
Confidence 555567889999999999988 99999943 3366778999988875
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=94.00 E-value=0.02 Score=39.19 Aligned_cols=42 Identities=7% Similarity=0.033 Sum_probs=34.2
Q ss_pred CCHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 394 IPDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 394 ~~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
-+++++.++++.+|.||+ |+.+||.. ..++...|..+|.||+
T Consensus 12 ~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~d 65 (81)
T d1fi5a_ 12 KTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNND 65 (81)
T ss_dssp CCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSS
T ss_pred CCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCC
Confidence 367889999999999998 99999943 3367778889888774
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.97 E-value=0.027 Score=29.76 Aligned_cols=28 Identities=11% Similarity=0.241 Sum_probs=24.0
Q ss_pred CHHHHHHHHHHHhcCCC--cCHhhHHHHHH
Q 013816 395 PDTDVQILMDAVSHTLH--LDLAFFREKVR 422 (436)
Q Consensus 395 ~~~e~~~~~~~~d~~~~--i~~~ef~~~~~ 422 (436)
+++|+.++++.+|+|++ |+-+||..+..
T Consensus 2 sEeELae~FRifDkNaDGyiD~eEl~~ilr 31 (34)
T d1ctda_ 2 SEEELANAFRIFDKNADGYIDIEELGEILR 31 (34)
T ss_dssp HHHHHHHHHHTTCCSSSSCBCHHHHHHHHH
T ss_pred CHHHHHHHHHHHccCCcccccHHHHHHHHH
Confidence 57899999999999998 99999976654
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=93.58 E-value=0.04 Score=30.20 Aligned_cols=27 Identities=7% Similarity=0.167 Sum_probs=21.2
Q ss_pred CHHHHHHHHHHHhcCCC--cCHhhHHHHH
Q 013816 395 PDTDVQILMDAVSHTLH--LDLAFFREKV 421 (436)
Q Consensus 395 ~~~e~~~~~~~~d~~~~--i~~~ef~~~~ 421 (436)
|++|+++-++.+|.||+ |+.+|+...+
T Consensus 1 seeel~eAF~~FDkDg~G~Is~~EL~~vm 29 (33)
T d2hf5a1 1 SEEEIREAFRVFDKDGNGYISAAELRHVM 29 (33)
T ss_dssp CHHHHHHHHHHHSSSCCSCBCHHHHHHHT
T ss_pred CHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence 56788888888888888 8888875543
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.18 E-value=0.04 Score=35.23 Aligned_cols=39 Identities=5% Similarity=-0.072 Sum_probs=31.1
Q ss_pred HHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 397 TDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 397 ~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
+|+.+.++.+|.+++ |+.+||.. ..++...|+.+|.||+
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~d 51 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSN 51 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTT
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCC
Confidence 578889999999887 99999944 3366778888888874
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=93.07 E-value=0.029 Score=38.37 Aligned_cols=39 Identities=5% Similarity=0.014 Sum_probs=31.5
Q ss_pred HHHHHHHHHHhcCCC--cCHhhHHH---------HHHHHHhHHhhhhcCC
Q 013816 397 TDVQILMDAVSHTLH--LDLAFFRE---------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 397 ~e~~~~~~~~d~~~~--i~~~ef~~---------~~~~~~~f~~~d~~~~ 435 (436)
++++++++.+|.||+ |+..||.. ..++..+|+.+|.||+
T Consensus 6 ~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~ 55 (81)
T d2opoa1 6 ADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGD 55 (81)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCC
Confidence 467889999999988 99999943 3356778999999885
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=92.96 E-value=0.034 Score=36.34 Aligned_cols=30 Identities=27% Similarity=0.499 Sum_probs=25.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
..+...|..+|.|++|.|+.+|+..++.++
T Consensus 37 ~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 37 EDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 356677899999999999999999988764
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.86 E-value=0.034 Score=37.35 Aligned_cols=42 Identities=5% Similarity=0.012 Sum_probs=34.3
Q ss_pred CCHHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 394 IPDTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 394 ~~~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
.+++++.++++.+|.+|+ |+.+||.. ..++...|+.+|.||+
T Consensus 6 ~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~d 59 (75)
T d1jc2a_ 6 KSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNND 59 (75)
T ss_dssp CCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSC
T ss_pred CcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCC
Confidence 478899999999999988 99999943 3367778888888764
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=91.91 E-value=0.051 Score=36.58 Aligned_cols=43 Identities=2% Similarity=-0.013 Sum_probs=32.1
Q ss_pred CCCHHH---HHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 393 QIPDTD---VQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 393 ~~~~~e---~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
++|++| ++++++.+|.|++ |+.+|+.. ..++...|+.+|.||+
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~ 60 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGN 60 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCC
Confidence 466665 4556888999988 99999943 3367778888888774
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.75 E-value=0.063 Score=36.54 Aligned_cols=42 Identities=12% Similarity=0.027 Sum_probs=31.7
Q ss_pred CCHHH---HHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 394 IPDTD---VQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 394 ~~~~e---~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
+|+++ +++.+..+|.||+ |+.+||.. ..++...|+.+|.||+
T Consensus 8 Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~ 64 (81)
T d1avsa_ 8 LSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGS 64 (81)
T ss_dssp BCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCC
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCC
Confidence 35554 4566888999988 99999943 3367788999998875
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=91.16 E-value=0.035 Score=36.47 Aligned_cols=39 Identities=10% Similarity=0.101 Sum_probs=31.5
Q ss_pred HHHHHHHHHHhcCCC--cCHhhHHH-----------HHHHHHhHHhhhhcCC
Q 013816 397 TDVQILMDAVSHTLH--LDLAFFRE-----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 397 ~e~~~~~~~~d~~~~--i~~~ef~~-----------~~~~~~~f~~~d~~~~ 435 (436)
+|+.+.++.+|.+++ |+.+||.. ..++...|+.+|.||+
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~d 53 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGN 53 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGG
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCC
Confidence 678899999999887 99999932 3467778899988874
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.55 E-value=0.014 Score=44.84 Aligned_cols=52 Identities=13% Similarity=0.039 Sum_probs=41.8
Q ss_pred hhccccCCC-CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhcCCC--cCHhhHH
Q 013816 365 EGFHMMDIG-NRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSHTLH--LDLAFFR 418 (436)
Q Consensus 365 ~~F~~~D~~-~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~~~--i~~~ef~ 418 (436)
=-|..+|.| +||+++..||..+.+.| ...+.-++.+++..|.|++ |++.||.
T Consensus 81 W~F~~LD~n~~D~~L~~~EL~~l~~~L--~~~e~C~~~F~~~CD~n~D~~Is~~EW~ 135 (151)
T d1sraa_ 81 WQFGQLDQHPIDGYLSHTELAPLRAPL--IPMEHCTTRFFETCDLDNDKYIALDEWA 135 (151)
T ss_dssp HHHHHHCCTTCSSEECTTTTGGGGSTT--STTGGGHHHHHHHHCTTCSSSEEHHHHH
T ss_pred eehhhcCCCCCCCccCHHHHHHHHHhh--cCCchHHHHHHHHhcCCCCCcCCHHHHH
Confidence 349999999 59999999998765433 2345668899999999887 9999994
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.28 E-value=0.11 Score=36.57 Aligned_cols=39 Identities=8% Similarity=-0.066 Sum_probs=31.1
Q ss_pred HHHHHHHHHHhcCCC--cCHhhHHH--------HHHHHHhHHhhhhcCC
Q 013816 397 TDVQILMDAVSHTLH--LDLAFFRE--------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 397 ~e~~~~~~~~d~~~~--i~~~ef~~--------~~~~~~~f~~~d~~~~ 435 (436)
+.++++++.+|.||+ |+.+|+.. ...+..+|..+|.||+
T Consensus 10 ~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~d 58 (95)
T d1c07a_ 10 AKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDC 58 (95)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCS
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCC
Confidence 346789999999988 99999944 3367789999998875
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=89.99 E-value=0.094 Score=36.74 Aligned_cols=32 Identities=16% Similarity=0.215 Sum_probs=27.5
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
....+.++|..+|.|+||.|+.+|+...+.++
T Consensus 50 ~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l 81 (93)
T d3c1va1 50 DEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 81 (93)
T ss_dssp SHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence 34567888999999999999999999888775
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.86 E-value=0.052 Score=40.05 Aligned_cols=59 Identities=10% Similarity=0.007 Sum_probs=43.4
Q ss_pred CCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHH--------hcCCCcCHhhHHHH------------HHHHHhHHhhhhc
Q 013816 374 NRGKINIDELRVGLHKLGHQIPDTDVQILMDAV--------SHTLHLDLAFFREK------------VRLKISFFRWYEI 433 (436)
Q Consensus 374 ~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~--------d~~~~i~~~ef~~~------------~~~~~~f~~~d~~ 433 (436)
..+.++.+++.++.+.-. ++..||+++++.+ +.+|.|++++|... .....+|+.||++
T Consensus 4 ~~s~l~p~~l~~L~~~T~--fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~ 81 (118)
T d1tuza_ 4 ERGLISPSDFAQLQKYME--YSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETG 81 (118)
T ss_dssp CCSCSCHHHHHHHHHHHH--HCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCC
T ss_pred ccCCCCHHHHHHHHHHcC--CCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccc
Confidence 457799999987776532 4677888888887 45566999999543 2344699999998
Q ss_pred C
Q 013816 434 G 434 (436)
Q Consensus 434 ~ 434 (436)
+
T Consensus 82 ~ 82 (118)
T d1tuza_ 82 H 82 (118)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.42 E-value=0.12 Score=34.49 Aligned_cols=30 Identities=20% Similarity=0.398 Sum_probs=26.3
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
..+.+.|..+|.|++|.|+.+|+...+.++
T Consensus 45 ~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 45 STLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp CSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 357778999999999999999999988875
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=89.29 E-value=0.12 Score=36.09 Aligned_cols=31 Identities=13% Similarity=0.156 Sum_probs=26.4
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
...+.++|..+|.|+||+|+.+|+...+..+
T Consensus 48 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 48 PLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp TTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 3457788999999999999999998888765
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.80 E-value=0.34 Score=31.60 Aligned_cols=55 Identities=20% Similarity=0.330 Sum_probs=42.3
Q ss_pred hhhhhhhhhccccCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHHhc-------CCCcCHhhHHHH
Q 013816 358 EEVAGIKEGFHMMDIGNRGKINIDELRVGLHKLGHQIPDTDVQILMDAVSH-------TLHLDLAFFREK 420 (436)
Q Consensus 358 ~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-------~~~i~~~ef~~~ 420 (436)
+..+++.++|+.+ .++..+||.+||+.. ++.++++-++..+.. .|-.+|..|...
T Consensus 5 ~TaEqv~~aFr~l-A~~KpyVT~~dL~~~-------L~peqaeyc~~~M~~y~~~~~~~~ayDY~sF~~~ 66 (73)
T d1h8ba_ 5 DTAEQVIASFRIL-ASDKPYILAEELRRE-------LPPDQAQYCIKRMPAYSGPGSVPGALDYAAFSSA 66 (73)
T ss_dssp STHHHHHHHHHHH-TTSCSSBCHHHHHHH-------SCHHHHHHHHHHSCSCCCSSCCTTCBCHHHHHHH
T ss_pred ccHHHHHHHHHHH-hCCCCeeCHHHHHhh-------cCHHHHHHHHHHCcccCCCCCCCCcccHHHHHHH
Confidence 4456788889988 566889999999854 377889999998864 223999999664
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.06 E-value=0.12 Score=36.64 Aligned_cols=29 Identities=7% Similarity=0.126 Sum_probs=25.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHK 389 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 389 (436)
..+..+|..+|.|++|.|+.+|+..++++
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 35778899999999999999999988765
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.77 E-value=0.16 Score=34.50 Aligned_cols=40 Identities=5% Similarity=-0.041 Sum_probs=32.2
Q ss_pred HHHHHHHHHHHhcCCC--cCHhhHHH----------HHHHHHhHHhhhhcCC
Q 013816 396 DTDVQILMDAVSHTLH--LDLAFFRE----------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 396 ~~e~~~~~~~~d~~~~--i~~~ef~~----------~~~~~~~f~~~d~~~~ 435 (436)
...+.++++.+|.+++ |+.+||.. ..++..+|..+|.|++
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~ 70 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAK 70 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTT
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCC
Confidence 5678899999999987 99999943 3467778899988764
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=87.61 E-value=0.25 Score=34.92 Aligned_cols=31 Identities=19% Similarity=0.210 Sum_probs=27.1
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
...+.++|..+|.|+||.|+.+|+..++..+
T Consensus 51 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 81 (100)
T d1psra_ 51 TNYLADVFEKKDKNEDKKIDFSEFLSLLGDI 81 (100)
T ss_dssp CCGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 3567888999999999999999999888765
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=86.68 E-value=0.15 Score=35.62 Aligned_cols=31 Identities=16% Similarity=0.306 Sum_probs=26.9
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
...+.+.|+.+|.|++|.|+.+|+..++..+
T Consensus 51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l 81 (93)
T d1zfsa1 51 ADAVDKIMKELDENGDGEVDFQEFVVLVAAL 81 (93)
T ss_dssp HHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 4567788999999999999999999888765
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=85.27 E-value=0.17 Score=35.28 Aligned_cols=32 Identities=13% Similarity=0.138 Sum_probs=27.4
Q ss_pred hhhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 359 EVAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 359 ~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
....+.+.+..+|.|+||.|+-+|+...+..+
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l 81 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACL 81 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 34567888999999999999999999888765
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=85.03 E-value=0.31 Score=33.39 Aligned_cols=31 Identities=19% Similarity=0.180 Sum_probs=26.7
Q ss_pred hhhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 360 VAGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 360 ~~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
...+.+.+..+|.|+||.|+-+|+...+..+
T Consensus 50 ~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 50 KAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 4567888999999999999999998887764
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=84.33 E-value=0.47 Score=31.97 Aligned_cols=29 Identities=21% Similarity=0.362 Sum_probs=24.6
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHH
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHK 389 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~ 389 (436)
..+.+.+..+|.|++|.|+.+|+...+.+
T Consensus 52 ~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 52 EELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 45666788899999999999999888764
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=83.72 E-value=0.53 Score=32.14 Aligned_cols=30 Identities=27% Similarity=0.450 Sum_probs=25.9
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
..+.+.+..+|.|+||.|+.+|+...+..+
T Consensus 49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 49 KGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp TCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 356777889999999999999999888765
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.29 E-value=0.25 Score=34.31 Aligned_cols=42 Identities=12% Similarity=-0.028 Sum_probs=31.7
Q ss_pred CCHHH---HHHHHHHHhcCCC--cCHhhHHH--------HHHHHHhHHhhhhcCC
Q 013816 394 IPDTD---VQILMDAVSHTLH--LDLAFFRE--------KVRLKISFFRWYEIGG 435 (436)
Q Consensus 394 ~~~~e---~~~~~~~~d~~~~--i~~~ef~~--------~~~~~~~f~~~d~~~~ 435 (436)
+|++| ++++++.+|.|++ |+.+|+.. ...+..+|+.+|.||+
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~l~~~~l~~i~~~~D~d~d 57 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKD 57 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCS
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHccCCHHHHHHHHHHhCCCCC
Confidence 45554 4568888898887 99999943 3467789999998875
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=82.93 E-value=0.24 Score=33.18 Aligned_cols=30 Identities=20% Similarity=0.468 Sum_probs=26.3
Q ss_pred hhhhhhccccCCCCCCcccHHHHHHHHHHc
Q 013816 361 AGIKEGFHMMDIGNRGKINIDELRVGLHKL 390 (436)
Q Consensus 361 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~l 390 (436)
..+...+..+|.|++|.|+.+|+...+.++
T Consensus 47 ~~v~~~~~~~D~d~dG~Idf~EF~~l~~~l 76 (78)
T d1cb1a_ 47 RTLDDLFQELDKNGDGEVSFEEFQVLVKKI 76 (78)
T ss_dssp CCSSHHHHHTCCCSSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHH
Confidence 357788999999999999999999888775
|